,entity,author_name,overall_polarity
0,two CLL,Hematopoiesis News,Negative
1,two AV MCL,Michael Wang MD,Negative
3,CLL,Toby Eyre,Postive
5,AstraZeneca Calquence CLL,David Ledger,Postive
6,England Wales More,Wales Cancer Forum,Negative
7,AstraZeneca Calquence,European Pharmaceutical Review,Negative
8,Superstar NICE CLL,Graham Collins,Postive
9,CLL Ibrutinib yesterday UK Pirtobrutinib CllSociety,CLL Ireland,Negative
10,Optimal Management CLL Acalabrutinib nineteen March two thousand and one Subramanian Mumbai two Group Dr Harshit Khurana Advani,Mice Ideas,Negative
11,CLL,Farooq Wandroo,Postive
12,today Thursday March The National Institute Health Care Excellence NICE CLL England,Leukaemia Care,Postive
13,rituximab FCR rituximab BR,Helen Oram,Postive
14,today Thursday eighteen March two thousand,HealthWatch,Negative
16,AstraZeneca Calquence CLL,Pharma Trader,Postive
17,AstraZeneca Calquence CLL,Everything Pharma,Postive
18,AstraZeneca Calquence CLL,IJPSonline,Postive
19,AstraZeneca Calquence CLL,Iceberg Vision,Postive
22,PharmiwebNews,Pharma News,Postive
23,UK CLL Ireland JanRynne DonnellyStephen HSELive hseNCCP paulreiddublin PaulMcauliffe RoisinShortall,CLL Ireland,Negative
24,NICEComms AstraZeneca Calquence DaiichiSankyo Nilemdo Nustendi,pharmaphorum,Negative
25,NICEComms CLL UK FCR BR CLL Enjoyed CLLSupport Chair Trustees Auckland Sky News Great CLL,Toby Eyre,Postive
26,one Study,Lymphoma Papers,Negative
28,michaelwangmd MDAndersonNews,Lymphoma Hub,Negative
29,CLL,Trip Database,Negative
30,TwitterSupport one,Osgood,Postive
33,ICYMI TiP,Kartos Therapeutics,Negative
34,Argentina one Janssen Vaccines two three AstraZeneca AB four Amgen Lanadelumab de cenicriviroc,Apoli Naria,Negative
35,Maria four FDA two thousand and thirteen Ibrutinib FDA two thousand and seventeen FDA two thousand and twenty Brexucarbatagene Autoleucel FDA,Michael Wang MD,Postive
41,BTK Ublituximab Ibrutinib TGTherapeutics,Jeff Sharman,Postive
43,primario de eficacia en,IM Medico,Negative
44,US AstraZeneca Calquence AZN,FirstWord Pharma,Postive
45,ICYMI Overall three,Home Journal,Negative
46,CLL Research Acalabrutinib An Analysis Cardiovascular Events,Tom Henry MBA RPh CPh,Negative
49,Mantle Cell Lymphoma Survival Likely Affected Reason Acalabrutinib Discontinuation,AJMC,Negative
50,CALQUENCE Beneficial CLL Study CLL,Patient Worthy,Negative
53,gvhdsm chronicGVHD StephanieLeeMD Number,Hemalatha Rangarajan MD,Negative
54,Mantle Cell Lymphoma Treatment Market two thousand and two thousand,mednetnews,Negative
55,CLL,Bita Fakhri,Negative
56,twenty thousand National Centre Pharmacoeconomics,NCPE,Negative
57,Lesen Sie Beitrag Arzt Schmerz Leukamie Immuntherapie Neutropenie Mutation Acalabrutinib Zulassung Studie,JOURNAL ONKOLOGIE,Negative
58,Dr Danilov CLL MedTwitter Healthcare,Oncology Learning Network,Negative
59,Dr Graff MercyOneDSM CLL recent year Calquence AstraZeneca Watch,Oncology Learning Network,Negative
62,AstraZeneca Calquence Meets Primary Efficacy,TrialSite News,Negative
64,Japan Lyfebulb,Lyfebulb,Negative
66,AstraZeneca Imbruvica,The Medical Ed Cons,Negative
67,three AstraZeneca,Home Journal,Negative
68,AstraZeneca Imbruvica,CarnivoresHealth,Negative
69,AstraZeneca Imbruvica,Portfolio Penny,Negative
70,AstraZeneca Imbruvica,FancyFinancy,Negative
71,AstraZeneca Imbruvica,Robo Schmobo,Negative
72,AstraZeneca Imbruvica,Financial Carnivores,Negative
73,PFS three CLL,Lymphoma Hub,Negative
74,AMMHemato un nouveau chez Leucemie Lymphoide Chronique Retrouvez,NetCancer,Negative
75,two,DMGAZ,Negative
77,CLL,Blood Advances,Negative
82,Five Tuesday January two thousand Roundup MM Medical Marketing Media BoosterShot Calquence Merck MMMnews CNBC,AnalySource Premier Drug Pricing Services,Negative
83,AstraZeneca Calquence Johnson Johnson BTK Imbruvica three,Helix BioPharma,Negative
84,AstraZeneca Calquence Johnson Johnson BTK Imbruvica three,AlphaBronze,Negative
85,CALQUENCE met Primary Efficacy Endpoint Trial Against Ibrutinib Chronic,TrialSite News,Negative
86,Calquence Imbruvica AstraZeneca,Plexus Ventures,Negative
89,Japan,BiopharmaAsia,Negative
94,testa testa contro nella linfocitica,Roberto Bonin,Negative
95,CLL,Taro Shiga,Negative
96,AstraZeneca Calquence Imbruvica,Susan,Postive
97,Monday Quick Takes Comirnaty Australia Hong Kong Albireo Iterum Calquence meet Phase three CLL,BioCentury,Negative
98,Three year first Calquence second BTK AstraZeneca AbbVie first Imbruvica,Endpoints News,Negative
99,AstraZeneca Imbruvica BioPharma Dive Oncology,Pharma Top News,Negative
101,AstraZeneca Calquence Imbruvica,FiercePharma,Postive
102,Jain American Journal Hematology,Benlazar Amine,Negative
103,Japan,WebWire,Negative
104,testa testa contro nella linfocitica,Tecnomedicina,Negative
105,three CLL,HemOnc Today,Postive
106,CALQUENCE Met Primary BrainSights,BrainSights iOS App,Negative
107,AstraZeneca Calquence Imbruvica,Dr Timos Papagatsias,Postive
108,AstraZeneca Calquence Imbruvica,NewExpressNews,Postive
109,AstraZeneca Imbruvica AZN ABBV JNJ,BioPharma Dive,Negative
110,AstraZeneca Calquence Johnson Johnson Imbruvica AZN JNJ,Market Intelligence Healthcare,Negative
111,AstraZeneca Imbruvica,Ben Fidler,Negative
112,AstraZeneca Calquence Imbruvica,PharmaBian Ji Chang ,Postive
114,Calquence Imbruvica,cafepharma,Negative
115,AstraZeneca Calquence Approved Japan CLL,Calgary Herald,Negative
116,Three year first Calquence second BTK AstraZeneca AbbVie first Imbruvica Jasonmmast,Endpoints News,Negative
117,Imbruvica,David Ledger,Negative
118,CLL,Biotech Tech Stock Focus,Postive
119,AstraZeneca Calquence Imbruvica Eli Lilly,Dr Timos Papagatsias,Postive
120,AZN CALQUENCE Met Primary Efficacy Endpoint Trial Against,Corporate News,Negative
121,AstraZeneca Calquence Imbruvica Eli Lilly,PharmaBian Ji Chang ,Postive
123,Calquence Japan,InvestorsObserver,Negative
124,Calquence Approved Japan CLL,Devdiscourse,Negative
126,AstraZeneca Calquence,CHItraders,Postive
129,AstraZeneca CALQUENCE Met Primary,Quant Data,Negative
130,Imbruvica,PharmaTimes,Negative
131,AZN CALQUENCE Met Primary Efficacy Endpoint Trial Against,OTC Dynamics Inc,Negative
132,CALQUENCE Met Primary,Latest News Business Wire,Negative
133,CALQUENCE Met Primary,IMPharma News,Negative
134,CALQUENCE Met Primary,Crwe World,Negative
135,Today three Learn,AstraZenecaUS,Negative
136,AZN CALQUENCE Met Primary Efficacy Endpoint Trial Against,Stock Titan,Negative
137,AstraZeneca Calquence,Gordon Gekko,Postive
138,AstraZeneca Calquence AZN,Investor News,Postive
139,AstraZeneca Calquence,Stocks tweet,Postive
140,AstraZeneca Calquence,Breaking News,Postive
141,AstraZeneca Calquence three AstraZeneca Calquence,Soumyajyoti Biswas,Postive
142,AstraZeneca Calquence AbbVie BTK Imbruvica Japan,pharmaphorum,Negative
143,AstraZeneca Calquence Japan CLL AZN,Shifting Wealth,Negative
144,CLL,dough,Negative
145,AstraZeneca Calquence AZN,Shifting Wealth,Negative
146,Goldman Astrazeneca auf Ziel five hundred Einstufung Studiendaten Calquence zur,FinanzLinksRatings,Negative
147,Goldman Astrazeneca auf Ziel five hundred Einstufung Studiendaten Calquence FINANZTREFF,FinanzLinksRatings,Negative
149,Japan,News,Negative
150,Calquence Approved Japan CLL,Josekun,Negative
151,AstraZeneca Japan Calquence,Josekun,Postive
154,AZN Calquence Japan,Kevin Jacobs,Negative
156,Japan CLL,Golden Casino News,Negative
157,Calquence Met Primary Endpoint Against Ibrutinib ATRIAL FIBRILLATION,Kevin Jacobs,Postive
159,AstraZeneca Japan Calquence,EIN Presswire Pharmaceutical Newswire,Postive
160,LiveSquawk AZN AstraZeneca Plc Calquence Met Primary Endpoint Against Ibrutinib Calquence Met Primary,Value Vector,Negative
161,Calquence Approved Japan CLL,Devdiscourse,Negative
162,Calquence Met Primary Endpoint Against Ibrutinib,Devdiscourse,Negative
163,CALQUENCE MET PRIMARY EFFICACY,Mathan,Negative
164,Japan,Cision News,Negative
165,Japan CLL,Cision News,Negative
166,Japan,Company News HQ,Negative
169,AstraZeneca Plc Calquence Met Primary Endpoint Against Ibrutinib Calquence Met Primary,LiveSquawk,Negative
170,The European Medicines Agency Review Acalabrutinib Treatment Adult Patients Chronic,TYR Kinase paper,Negative
173,AstraZeneca New,Health Radio Online,Negative
174,Check Comparing,Medivizor,Postive
175,Ruxolitinib Etoposide Ibrutinib Selinexor Lenalidomide,Aaron Goodman Papa Heme,Negative
176,CADTH Calquence Chronic Read,CADTH,Negative
177,first Richters CLL,Toby Eyre,Postive
178,Bruton,Lymphoma Papers,Negative
180,Learn Comparing Leukemia,Medivizor,Negative
181,two thousand,Top News Corner,Negative
182,Mit Acalabrutinib kam Dezember ein BTK Markt Der Neuling two thousand fourteen Ibrutinib Leukamie eingesetzt,Pharmazeutische Zeitung,Negative
184,Global Acalabrutinib Market Analysis Report two thousand and,Amar Bhandari,Negative
185,two thousand,Industry News Engine,Negative
186,PFS CLL Seymour,Targeted Oncology,Negative
187,Europa Ha prima linea quanto nella malattia,Medicina Informazione,Negative
188,CLL,acalabrutinib,Negative
189,CLL SLL,acalabrutinib,Negative
190,five hundred CLL ninety CI,acalabrutinib,Negative
193,five hundred CLL ninety CI,acalabrutinib,Negative
196,CLL SLL,acalabrutinib,Negative
199,CLL,acalabrutinib,Negative
200,CLL one BM three FCR two Tx roids fail three PRCA Tx IST,Joseph Cioccio DO,Negative
201,Rituximab Acalabrutinib Durvalumab,CureHuntr,Negative
202,Ian Flinn SarahCannonDocs HemOnc,VJHemOnc,Negative
203,Rituximab Acalabrutinib Durvalumab CNS Condition Summary Primary Central Nervous System,TrialBulletin,Negative
204,discus rationale evaluate CLL,OncLive SOSS,Negative
205,PFS CLL Seymour CLL,Targeted Oncology,Negative
208,CLL four,Oncology Nursing News,Negative
209,della leucemia linfatica cronica con risultati significativi MRD Le Francesca Romana Mauro,EmatoInfo,Negative
210,CLL four,Oncology Nursing News,Negative
211,Check Comparing,Medivizor,Negative
213,two AstraZeneca Calquence,pharmanewsintel,Postive
218,CLL SLL Learn,Ashleigh Walls,Negative
219,CLL CLL CALQUENCE CLL,bargainbriana,Postive
220,CLL SLL Learn,April Golightly,Negative
221,AZN LR OP Multiple Oncology Tagrisso Lynparza Calquence Enhertu Imfinzi,dough,Negative
222,WHO Solidarity Trials,jorge,Negative
223,Investigacion Los four su perfil de seguridad cardiovascular linfocitica,iSanidad,Negative
224,four su perfil de seguridad cardiovascular linfocitica,iSanidad,Negative
226,CLL,Trip Database,Negative
227,Kinumpirma ng Department Health gagamitin sa World Health Organization,"Radyo La Verdad one thousand, three hundred and fifty",Negative
228,median month seventeen seven,CURE Magazine,Negative
229,gagamitin sa YouTube,"Radyo La Verdad one thousand, three hundred and fifty",Negative
230,today AstraZeneca AstraZeneca Calquence,Ronald Chavin,Negative
231,gagamitin sa DOH,UNTV News Rescue,Negative
232,five Avigan bilang gamot Pilipinas gamot kontra,DZBB Super Radyo,Negative
233,kasama sa,Radyo Agila DZEC one thousand and sixtytwo Khz,Negative
234,Solidarity Trial Maria Rosario Vergeire,CNN Philippines,Negative
235,Acalabrutinib bilang bahagi solidarity sa paghanap ng gamot para sa hindi na World Health Organization WHO,DZBB Super Radyo,Negative
237,CLL SLL Learn,This Messy Season Family Blog,Negative
238,Qia Ti Ni  Huo De Liao Wan Jie Huo Bu Fen,Yin Du Meng Jia La Kang Yan Yao ,Negative
239,CLL SLL Learn,Cook Eat Go,Negative
240,Los datos de Calquence de four su perfil de seguridad cardiovascular,IM Medico,Negative
241,CLL CLL CALQUENCE,William Sweeney,Postive
242,CLL CLL,Caryn Bailey,Negative
243,CALQUENCE day night CALQUENCE CLL SLL Learn,Christi,Postive
245,CLL CLL,Kami Allen,Negative
246,CALQUENCE,acalabrutinib,Negative
248,Don AstraZeneca CALQUENCE year,acalabrutinib,Negative
251,CALQUENCE,acalabrutinib,Negative
253,This year ASH two thousand and twenty CLL,acalabrutinib,Negative
264,Don Dr Michael Wang AstraZeneca,acalabrutinib,Negative
267,CLL CLL CALQUENCE CLL,Coralie Seright Lovebugs Postcards,Postive
268,CLL CLL,Elizabeth hurt,Negative
269,monoterapia Paolo Ghia,EmatoInfo,Negative
270,ND,Benlazar Amine,Negative
274,AVO Acalabrutinib Venettoclax CLL,Benlazar Amine,Negative
277,Calquence AstraZeneca CLL first,pharmaphorum,Negative
278,Monday January two thousand,NICE,Postive
280,AstraZeneca Calquence BeiGene Imbruvica Calquence CLL,Bionest Partners,Postive
281,CLL CLL CALQUENCE CLL,Lisa,Postive
282,CLL SLL Learn,Tamara Bowman,Negative
284,two thousand and,Benlazar Amine,Negative
285,AstraZeneca Calquence PharmaTimes AstraZeneca CLL,Plexus Ventures,Postive
286,AstraZeneca Calquence,Pharmafocus,Postive
287,NICEComms AstraZeneca Calquence,Cpl Life Sciences,Negative
288,BTK,Targeted Oncology,Negative
289,England CLL,Pharma News,Postive
290,four,Pharma News,Negative
291,AstraZeneca Calquence,Jon Angelo,Postive
292,four,NwokeAgulu,Negative
293,Day three CLL,Prescient Healthcare Group,Negative
296,contra linfocitica Union Europea,Smart Clinical Pharmacology,Negative
301,New CALQUENCE ASH,acalabrutinib,Negative
305,This year ASH two thousand and twenty CLL,acalabrutinib,Negative
306,ASH Imbruvica,vshariharakrishnan,Negative
309,UK rituximab MCL Hopefully two thousand two,Toby Eyre,Postive
311,CALQUENCE Data Across,Investor News,Negative
312,Three Years BrainSights,BrainSights iOS App,Negative
313,BTK,Targeted Oncology,Negative
314,ASH two thousand and twenty Imbruvica FiercePharma,Pharma Top News,Negative
315,MCL,David Ledger,Negative
316,Today MShadman MD two thousand nine hundred two,SeattleCancerCareAlliance,Negative
317,CALQUENCE Data Across,IMPharma News,Negative
318,CALQUENCE Data Across,Biotech Tech Stock Focus,Negative
319,CALQUENCE Shows Efficacy Tolerability Three Years Patients With,Crwe World,Negative
320,four,Company News HQ,Negative
321,CLL SLL Learn,Anne Sweden,Negative
322,AZ Calquence MCL,News,Negative
323,Three Years,Pharmacutical Daily,Negative
324,seven hundred Calquence CLL AstraZeneca BCOSCardioOnc,The British Journal Cardiology,Negative
325,Less Than one Analysis,Devdiscourse,Negative
326,Three Years,OTC Dynamics Inc,Negative
327,Three Years,Stock Titan,Negative
328,Three Years,Investor News,Negative
329,CLL SLL Learn,Keeping Life Sane,Negative
330,CALQUENCE Data Across,OTC Dynamics Inc,Negative
331,AstraZeneca four CV CLL,Shifting Wealth,Negative
332,four,Cision News,Negative
333,CV CLL Today CV four CLL,AstraZenecaUS,Negative
334,CALQUENCE Data Across,Stock Titan,Negative
335,Imbruvica,Biotech Tech Stock Focus,Negative
336,MCL,Carsten Wenzel,Negative
337,two Calquence,BiopharmaAsia,Negative
338,Day two CLL,Prescient Healthcare Group,Negative
341,AstraZeneca Calquence,Gordon Gekko,Negative
342,AstraZeneca Calquence,Investor News,Negative
346,AstraZeneca Study MCL Pharmashot AstraZeneca,PharmaShots Incisive news three shot,Negative
349,CALQUENCE Join,acalabrutinib,Postive
360,ASH Imbruvica,cafepharma,Negative
361,three year,Shifting Wealth,Negative
362,ASH Imbruvica,analyst land news,Negative
363,TNF,Enosi Life Sciences,Negative
364,ASH Imbruvica,ExBulletin,Negative
365,ASH Imbruvica healthcare,Dr Timos Papagatsias,Negative
366,Three Years two thousand and,Wall Justin Bieber,Negative
367,ASH Imbruvica,PharmaCrowd,Negative
368,Johnson Johnson ASH Imbruvica Fintech Zoom FintechZoom Fintech Blockchain Crypto,FintechZoom,Negative
369,ASH Imbruvica,Continental Clinical,Negative
370,ASH Imbruvica,NewExpressNews,Negative
372,ASH Imbruvica,PharmaBian Ji Chang ,Negative
373,three year,Company News HQ,Negative
374,CALQUENCE Shows Efficacy Three Years BrainSights,BrainSights iOS App,Negative
375,Clive Zent BTK,Anthony Mato,Postive
376,CALQUENCE Shows Efficacy Three Years,Pharmacutical Daily,Negative
377,CALQUENCE Shows Efficacy Three Years,Stock Market News,Negative
378,CALQUENCE Astrazeneca MCL,Hottest Stocks Now,Negative
379,Three Years,OTC Dynamics Inc,Negative
380,Three Years,Corporate News,Negative
381,CALQUENCE Shows Efficacy Three Years,IMPharma News,Negative
382,CALQUENCE Shows Efficacy Three Years,Investor News,Negative
383,CALQUENCE Shows Efficacy Three Years,Crwe World,Negative
384,CALQUENCE Shows Efficacy Three Years,Latest News Business Wire,Negative
385,Today MCL Learn,AstraZenecaUS,Negative
386,three year,Cision News,Negative
387,Three Years,Stock Titan,Negative
389,Don Dr Michael Wang AstraZeneca,acalabrutinib,Negative
390,ORR Ibrutinib Acalabrutinib,Ingrid Glimelius,Negative
391,year one MCL Ibrutinib Acalabrutinib Zuma two,Maria Badillo MSN RN OCN CCRP,Negative
392,BTKis Nicola CLL CLL,Toby Eyre,Postive
393,New CALQUENCE,acalabrutinib,Negative
394,Btk,Bouter,Negative
400,contra linfocitica Union Europea,BIOCIENCIA,Negative
401,La Agencia Europea de Medicamentos EMA el tratamiento de leucemia linfocitica cronica una de la La un,Medscape ES,Negative
402,CALQUENCE BIBrands CALQUENCE CLL SLL EMAapproval CLL,Brand Institute Inc,Postive
403,contra linfocitica Union Europea,Dr Pablo Marcelo Lombardo,Negative
404,CLL SLL Learn,Rebecca Miller,Negative
405,CLL CLL CALQUENCE CLL,LaVonne Cladoosby Long,Postive
406,CLL CLL CALQUENCE CLL,Kelly Tomlinson,Postive
407,This year ASH two thousand and twenty CLL,acalabrutinib,Negative
409,seven Paolo Ghia CALQUENCE CLL,acalabrutinib,Negative
415,CLL CLL,Mommy Playbook,Negative
416,ABIM MedEd,knowmedge,Negative
417,CLL SLL Learn,IceCreamStickyFinger,Negative
418,CLL CLL,Brittany,Negative
419,CLL CLL CALQUENCE,Carrie,Postive
420,DOH AstraZeneca,Christian Yosores,Postive
421,DOH Solidarity Therapeutics Trial AstraZeneca,Inquirer,Negative
422,DOH Solidarity Therapeutics Trial AstraZeneca,jovic yee,Negative
423,CLL CLL CALQUENCE CLL,Maria,Postive
424,CLL CLL,Heidi Bee,Postive
425,CLL SLL Learn,Catherine Lewis,Negative
427,New Medivizor Comparing,Medivizor,Negative
429,CLL CLL CALQUENCE,Kathy Hodson,Postive
430,CALQUENCE day night CALQUENCE CLL SLL Learn,Home Jobs MOM,Postive
431,CLL SLL Learn,Angie Agerter,Negative
432,CLL CLL CALQUENCE,Ana,Postive
433,Don AstraZeneca CALQUENCE year,acalabrutinib,Negative
437,CLL CLL CALQUENCE CLL,Lindsey,Postive
438,one kommt da Markt Es Behandlungsoption Leukamie CLL,Gelbe Liste,Negative
439,CLL SLL Learn,icefairy,Negative
440,CLL CLL CALQUENCE CLL,Imperfect Women,Postive
441,CALQUENCE day night CALQUENCE CLL SLL Learn,Candy Washington,Postive
442,CLL CLL CALQUENCE,Lauren Beth,Postive
443,Medivizor,Lynne Mac Lean,Negative
444,Medivizor,Paul Wright,Negative
446,AstraZeneca,TF two,Negative
447,CLL SLL Learn,Leave The Cannoli,Negative
448,Headline News Steals CALQUENCE day night CALQUENCE,Mafiusa,Negative
449,CALQUENCE day night CALQUENCE CLL SLL Learn,Emily Reviews,Postive
450,CLL SLL Learn,Kelly Alex,Negative
451,CLL CLL CALQUENCE,Deliciously Savvy,Postive
452,CLL CLL CALQUENCE,Deliciously Savvy,Postive
453,Xin Xing Hu Xi Qi Zheng Zhuang  woYou Yuan Huan Zhe Xiang,teizu,Negative
454,CALQUENCE dans,Haute Autorite de sante,Negative
455,CLL SLL Learn,Cleverly Changing,Negative
456,CLL CLL CALQUENCE,ELMENS,Postive
457,CLL SLL Learn,Alexandria,Negative
458,CLL CLL CALQUENCE,Jaclyn,Postive
459,CLL SLL Learn,Stephanie BeautyBrite,Negative
460,CLL CLL CALQUENCE,Stephanie BeautyBrite,Postive
461,CLL SLL Learn,Jennifer Soltys,Negative
462,CLL CLL CALQUENCE,Vanessa Diaz,Postive
463,CLL CLL CALQUENCE,Colleen Padilla,Postive
464,CLL CLL CALQUENCE,Jenn,Postive
465,CLL CLL CALQUENCE,Jays SweetNSour Life,Postive
466,AstraZeneca,FancyFinancy,Negative
467,AstraZeneca Calquence Fails Pair Phase two,FancyFinancy,Negative
468,UE linfocitica,Zazoom Social News,Negative
469,CLL SLL Learn,Kimberly Kong,Negative
470,Ying Ben She Chao Yi   Hu Xi Bu Quan Wei Fa Zheng noSheng Cun Yao Ping Jia Xiang Mu Cheng,watcher,Negative
471,five DrDanPersky MCL CLL BTK,Toby Eyre,Negative
472,CLL EU,Amber Koehler,Postive
473,CLL CLL,Mariah Moon,Negative
475,CLL CLL,Erica Valentin,Negative
476,Bruton,Lymphoma Papers,Negative
479,Pembrolizumab Plus Acalabrutinib Metastatic Urothelial Carcinoma,PracticeUpdate,Negative
481,CLL CLL,Amy Smith,Negative
483,CLL CLL,MomGlenz,Negative
484,CLL CLL,Da Vinci Also follow OutdoorsyBW,Negative
485,Die Europaische Kommission Wirkstoff Acalabrutinib Zulassung Behandlung von chronisch Leukamie CLL,Gelbe Liste,Negative
489,Chuang Yao  Chuang Yao AI AI Jie Xue Xi  koronauirusu Coronavirus,korona AI,Negative
493,CALQUENCE day night CALQUENCE CLL Learn,What dearie,Postive
494,AstraZeneca,BiotechBioPharma,Negative
495,CADTH Acalabrutinib Calquence,CADTH,Negative
496,AstraZeneca Calquence Fails Pair Phase two,BiotechBioPharma,Negative
497,CLL SLL Learn,melissa weintraub,Negative
498,CLL SLL Learn,HEATHER Pink Ninja Blogger,Negative
499,CLL SLL Learn,Garf,Negative
500,CLL SLL day,Your Helpful Wendy,Negative
501,AstraZeneca,Financial Carnivores,Negative
502,AstraZeneca Calquence Fails Pair Phase two,Financial Carnivores,Negative
503,CLL CLL,My Life,Negative
504,AstraZeneca,Quant Data,Postive
505,AstraZeneca,Swedish Biotech,Negative
506,two Calquence,itsumoNao nderuRen ,Negative
507,AstraZeneca Calquence Fails Pair Phase two,Swedish Biotech,Negative
508,AstraZeneca first CALQUENCE Connections November ET Join Learn,CURE Magazine,Postive
509,CLL CLL,Wrapped Up,Negative
510,CLL CLL,pamelamaynard,Negative
511,CLL CLL,SensiblySara,Negative
512,CLL CLL,The Frugal Navy Wife,Negative
513,CLL CLL,Christine The Growing Creatives,Negative
517,CLL CLL,The Zamp Camp,Negative
518,CLL CLL,Lori Felix,Negative
519,CLL Treatment Research Final ASCEND CLL AscendStudy Acalabrutinib,Michele,Negative
520,CLL CLL,niecyisms CLC Studios,Negative
521,CLL SLL Learn,Liz Cleland,Negative
522,CLL CLL,TheYumYumFoodie,Negative
523,CLL SLL Learn,Susie Reviews,Negative
524,CLL CLL,Amanda Taylor,Negative
525,CALQUENCE day night CALQUENCE CLL Learn,This Mama Cooks On Diet,Postive
526,CLL CLL,Shelly Belly,Negative
527,CALQUENCE day night CALQUENCE CLL Learn,MissingLynxx,Postive
529,CLL CLL,Krystal,Negative
530,two Results Calquence,BiopharmaAsia,Negative
531,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
532,Oncology News Update Oncology News Australia,Oncology News Australia,Postive
535,Ying Ben She Chao Yi,watcher,Negative
537,CLL CLL,Kaila Yu,Negative
540,CLL CLL,Olivia Douglass,Negative
541,CLL SLL Learn,Susie Reviews,Negative
542,CLL SLL Learn,Trendy Cyndie Reviewz Newz,Negative
543,CLL CLL,Momma Lew Food Fun Reesa Lewandowski,Negative
544,day night CALQUENCE CLL Learn,Jessica,Postive
545,CLL SLL Learn,Tara Pittman,Negative
547,AstraZeneca Calquence Fails Pair Phase two Trials BioSpace,Vikesh Gudka,Negative
549,AstraZeneca,CarnivoresHealth,Negative
550,AstraZeneca Calquence Fails Pair Phase two,CarnivoresHealth,Negative
552,AstraZeneca Calquence,ECAM Norway,Negative
553,NOVITA NEL LEUCEMIA LINFATICA CRONICA Approvato Calquence Acalabrutinib Newsletter Xagena Medicina Ematologia Medicina OncoEmatologia Xagena,Carlo Franzini,Negative
554,AstraZeneca November Jeff Sharman Jim Jim Becky Learn,CURE Magazine,Postive
556,MedLancr,Official Page,Negative
557,two Trials Calquence Fails Reduce Mortality Respiratory Failure Patients Hospitalized,PILOTforPULMONARY,Negative
558,un Bruton AstraZenecaES,EL GLOBAL,Negative
559,AstraZeneca two Press Registrations EricTopol MartinLandray,Kari Tikkinen,Negative
560,AstraZeneca BioPharma Dive,Pharma Top News,Negative
561,Costco AstraZeneca Blockchain Crypto,FintechZoom,Negative
562,con la vacuna de la Aprobado el tratamiento contra Leucemia linfocitica ma comun en pacientes,Ester Hernandez,Negative
563,linfocitica AstraZeneca OncoReporte,ecancer en espanol,Negative
564,CLL,Journal NCCN,Negative
565,AstraZenaca,European Pharmaceutical Review,Postive
566,AstraZeneca Calquence,Carlo Centemeri,Negative
568,La UE Calquence AstraZeneca linfocitica,Salvador,Negative
571,AstraZeneca,cafepharma,Negative
572,AstraZeneca Calquence Fails Pair Phase two,Pharmaceutical,Negative
573,One AstraZeneca Calquence RecheckHealth,Serena Tinari,Negative
574,AstraZeneca ElonMusk,Pharma Prime Time,Negative
575,AstraZeneca Calquence el tratamiento de adultos con linfocitica,Miguel Angel Grullon,Negative
576,olan ilaci koronavirus tedavisinde etkisiz kaldi gore koronavirus sorunlari baskilamasi kan kanseri,Sosyal Medya,Negative
577,La BTK de la COVID aumentaria la proporcion de pacientes vivos,investigando,Negative
578,discus rationale evaluate CLL,OncLive SOSS,Negative
579,AstraZeneca Calquence Fails Pair Phase two,BioCalifornia,Negative
580,AZN Calquence AGNPF Covid NP,Helen Ong,Negative
582,AstraZeneca AZN Calquence Fails Coronavirus Study Yahoo,Takehiko Yoshino,Negative
584,EU Calquence Astrazenica onder ziekenhuis Hoe dan,Brainstormer,Negative
586,BTK,Pharmaceutical Market Europe,Negative
589,AstraZeneca Calquence,FiercePharma,Negative
590,AstraZeneca AZN Calquence Fails Coronavirus Study Yahoo,Nikita,Negative
591,two Trials BioSpace,Biotech Tech Stock Focus,Negative
593,AstraZeneca Calquence FiercePharma,Mandy Alcuria,Negative
594,today AstraZeneca,Ronald Chavin,Negative
595,AstraZeneca Calquence,Continental Clinical,Negative
596,today White House,Endpoints News,Negative
597,two Calquence,WebWire,Negative
598,Otro NO funciona en evitar con el posicionamiento de AstraZeneca,Infectotuits,Negative
599,potentsial'nogo,ZdravMedInfo,Negative
600,olan unlu ilac AstraZeneca tarafindan kan kanseri Calquence ilacinin korona,Koronavirus Haber,Negative
601,AstraZeneca Calquence,maybeawriter,Negative
602,olan ilaci koronavirus tedavisinde etkisiz kaldi gore koronavirus sorunlari baskilamasi kan kanseri,Siber Gazete,Negative
603,AstraZeneca Calquence Fails Pair Phase two Trials BioSpace,Kevin Paul Oge,Negative
604,AstraZeneca Calquence,Dr Timos Papagatsias,Negative
605,AstraZeneca Calquence,NewExpressNews,Negative
607,Moderna three AstraZeneca Calquence COVID FiercePharma,Synergy Healthcare LLC,Negative
609,La UE Calquence AstraZeneca para la linfocitica,Redaccion Medica,Negative
610,AstraZeneca Kristin Jensen,Ben Fidler,Negative
613,AstraZeneca Calquence,PharmaBian Ji Chang ,Negative
614,Disappointing BTK,Nathan Vardi,Negative
616,FDA Medicago first,Endpoints News,Negative
618,Kanser ortaya,ABC Gazetesi,Negative
619,FDA AstraZeneca,Dr Timos Papagatsias,Negative
620,AstraZeneca Calquence,Leonid Schneider,Negative
622,one Calquence,Imran Iftikhar,Negative
623,CRS,Anand Patel,Negative
624,roughly twenty AZN Calquence two,Allison Gatlin,Negative
626,two Calquence Small Molecules,mednetnews,Negative
627,AstraZeneca Calquence,Jon Angelo,Negative
629,potentsial'nogo,Novosti GMP,Negative
630,AstraZeneca Calquence,CDE News,Negative
631,two Calquence,Company News HQ,Negative
632,AstraZenca Calquence,PharmaShots Incisive news three shot,Negative
633,Coronavirus Medicamento AstraZeneca,Terra,Negative
635,AstraZeneca Calquence,The Medical Ed Cons,Negative
636,two BTK BSC,Soumyajyoti Biswas,Postive
637,SFBN Feed AstraZeneca Calquence AstraZeneca BayArea,San Francisco Biotechnology Network,Negative
638,BTK Update CALAVI Phase two Calquence,Daniel Drucker,Negative
639,AstraZeneca Calquence,PharmaBian Ji Chang ,Negative
640,AstraZeneca Calquence,Endpoints News,Negative
641,AstraZeneca Calquence,CHItraders,Negative
642,two Calquence,PressReleasePoint,Negative
643,AstraZeneca Calquence,Gordon Gekko,Negative
644,AstraZeneca Calquence,Breaking News,Negative
645,AstraZeneca Calquence AZN,Market Intelligence Healthcare,Negative
646,canakinumab la semaine qui echoue sur le,Nicolas Viudez,Negative
648,AstraZeneca Announced Calavi Phase Ii Trials Calquence Patients Hospitalised With Respiratory Symptoms Did Not Meet Primary Endpoint Related Tickers,Quant Data,Negative
649,AstraZeneca Calquence,FirstWord Pharma,Negative
650,AstraZeneca Calquence,Al Arabiya English,Negative
651,AstraZeneca Calquence,Bloomberg Australia,Negative
652,El farmaco contra la leucemia los ensayos,Economia Digital,Negative
653,AstraZeneca Calquence,Bloomberg,Negative
655,BioToday Qi Ye,Healthcare,Negative
656,AstraZeneca AstraZeneca Plc Thursday Calquence FinancialPersonal,guestpostingservices,Negative
658,Qi Ye,PharmaBian Ji Chang ,Negative
659,two Calquence,Cision News,Negative
660,EU,Ritrattodellasalute,Negative
661,The European Commission AstraZeneca Calquence CLL,LARVOL,Negative
662,TUMORI,one Malati Invisibili,Negative
664,EU,Chris Manfuso,Negative
665,LA CE BTK para la linfocitica cronica asi como el linfoma linfocitico Combinado monoterapia reduciria el riesgo de progresion de enfermedad,investigando,Negative
666,Europe CLL,Benlazar Amine,Negative
667,EU,David Ledger,Negative
669,One BTK CLL,Samir Sheth,Postive
670,AstraZeneca EU Leukaemia Nasdaq AstraZeneca,Plexus Ventures,Postive
672,Salud de Notimex,Jose Viurquis,Negative
674,Venetoclax obinutuzumab England NICE FCR CLL,Blood Cancer Uncensored,Postive
675,Zdravilo Calquence EU odobreno za zdravljenje kronicne limfocitne levkemije,Sporocila za javnost,Negative
676,EU,gRttwit,Negative
677,Europa nuova un farmaco target di sia prima sia dopo ricaduta,Repubblica Salute,Negative
678,EU,BiopharmaAsia,Negative
680,EU,Pharma Trader,Negative
681,EU,Iceberg Vision,Negative
682,EU,Everything Pharma,Negative
684,EU,PharmaCrowd,Negative
685,Terapia Europa,Salutedomani,Negative
687,Terapia Europa,Antonio Caperna,Negative
688,Terapia Europa,Derma News OK,Negative
689,Europa prima linea nella malattia,Medinews,Negative
690,Europe CLL Acalabrutinib two,Lymphoma Hub,Postive
692,AstraZeneca Calquence EU Chronic Leukaemia Pharmashot,PharmaShots Incisive news three shot,Negative
695,EU,WebWire,Negative
696,WHO Solidarity Remdesivir Samiran Panda,Himani Chandna,Negative
697,AstraZeneca Calquence European Union EU Cancer,HealthcarePRwire,Negative
698,EU,IndustryPRwire,Negative
699,EU FREE,LARVOL,Postive
701,AstraZeneca Calquence OK Europe CLL,Stocks tweet,Negative
702,AstraZeneca BTK Calquence Europe CLL,FirstWord Pharma,Negative
703,EU,Company News HQ,Negative
704,European Calquence CLL,The Pharma Letter,Negative
706,AstraZeneca Announced Calquence Approved Eu,Quant Data,Negative
707,AstraZeneca Announced Calquence Approved EU,Inara Bright,Negative
708,AstraZeneca Calquence European Union CCL US,Mehrdad Yousefi,Postive
709,EU Chronic,WheelieDealer,Negative
710,AstraZeneca Calquence EU CLL,GraniteShares Europe,Negative
711,Calquence Approved EU CLL,EIN Presswire EU Politics Newswire,Negative
712,EU,Golden Casino News,Negative
713,Pembrolizumab Pembrolizumab Acalabrutinib,Urology,Negative
714,Pembrolizumab Plus Acalabrutinib Metastatic Urothelial Carcinoma,Oncology,Negative
715,Safety Study Richard Furman PrecisionMedicine,WCM Englander Institute Precision Medicine,Postive
716,One Versus Zanubrutinib,Aloysius Pendergast,Negative
717,Mantle Cell,acalabrutinib,Negative
718,Mantle Cell,acalabrutinib,Negative
740,two sixty PD eleven AEs one two,Toby Eyre,Postive
741,HAE Med Berotralstat AZ Acalabrutinib Clear PAFSC Review OrphanPacific HAE berotralstat de,MEDWAVE,Negative
742,discus rationale evaluate CLL,OncLive SOSS,Negative
743,CLL BTK Learn Richard Furman WeillCornell,Michele,Negative
744,Pembrolizumab Pembrolizumab Acalabrutinib,Oncology,Negative
745,Pembrolizumab Plus Acalabrutinib Metastatic Urothelial,Urology,Negative
746,CI Andy Davies CNS Data Phase ACCEPT TRIAL ASH two thousand and twenty,Kate Cwynarski,Postive
747,BTK CLL three ASCEND,David Henry,Negative
748,Richard Furman Bruton BTK CLL PatientPower,WCM Lymphoma,Postive
749,Science Global one,torisan obsoleted,Negative
750,rituximab,Lymphoma Papers,Postive
751,ICMR Interferon Acalabrutinib WHO Solidarity ChandnaHimani,ThePrint Science,Negative
753,ICMR Interferon Acalabrutinib WHO Solidarity ChandnaHimani,Shekhar Gupta,Negative
754,ICMR Interferon Acalabrutinib WHO Solidarity ChandnaHimani,ThePrintIndia,Negative
755,Kombination Obinutuzumab zeigt Vergleich zu anderen Leukamie CLL Fludarabin,univadis,Negative
757,discus three CLL,OncLive SOSS,Negative
758,Try Calquence two hundred four month,Marty Fecarotta,Negative
759,World Health Organization,Medelis OncologyCRO,Negative
760,WHO Covid Solidarity CDSCO ICMR AstraZeneca,Medical Dialogues,Negative
761,HAE Med Berotralstat AZ OrphanPacific,MEDWAVE,Postive
762,CLL,Lymphoma Hub,Negative
763,solidarity World Health Organization WHO two thousand and,SunStar Cebu,Negative
765,MT HemOncToday seven two thousand and twenty AstraZeneca Burd LLSusa CLLsm,Mike Thompson MD PhD FASCO,Negative
767,AstraZeneca Pharma India Calquence India Oct,ENTIRE MARKET INFORMATION,Negative
769,SOLIDARITY BTK four Bemcentinib Capsule UK,Antibiotic Ghanem,Negative
770,AstraZeneca Calquence India,ExpPharma,Negative
771,BTK one Btk,Thiago Carvalho,Negative
772,Two SOLIDARITY one Gilead two week US EU two,Julien Potet,Negative
773,AstraZeneca Pharma India Calquence India Oct,zavingsin,Negative
775,AstraZeneca Pharma India Calquence India Oct,IIFLMarkets,Negative
776,AstraZeneca Pharma India Calquence India Oct,TheUemployed,Negative
777,Maria Rosario Vergeire Friday World Health Organization WHO DoktorNews,Doktor Net PH,Negative
778,solidarity World Health Organization WHO two thousand and nineteen,Sun Star Pampanga,Negative
779,World Health Organization,News,Negative
780,World Health Organization,News Channel,Negative
781,AstraZeneca India India Us India,Dayco India,Negative
782,AstraZeneca Calquence AstraZeneca,Medical Dialogues,Negative
783,Mantle Cell Lymphoma Calquence PERSISTENT SYSTEMS pr CAPIOT,Vikas kumar sharma,Postive
784,AstraZeneca Pharma Calquence India October india,FinReach,Negative
785,AstraZeneca Pharma Company Calquence India October,MADURAI TRADING ACADEMY,Negative
786,Pharma Calquence India October India March twelve,Enritchansrajpandey,Negative
787,AstraZeneca Pharma Company Calquence India October,Karthik Raja,Negative
788,AstraZeneca India October CancerDrug Calquence,The Hans India,Negative
789,AstraZeneca Pharma Drug AstraZeneca Pharma India one hundred October,Markets Today,Negative
790,StocksToWatch today AstraZeneca Calquence India,Ancient Stock Analysis,Negative
792,AstraZeneca Pharma Calquence India October KPMG October eight UPL Mauritius UPL Corporation,Markets Today,Negative
793,CLL,Medscape Pharmacists,Negative
794,AstraZeneca Pharma Calquence India October,Markets Today,Negative
795,October two thousand and twenty Alert Calquence Medicine,NEERAJ BAJPAI,Postive
796,AstraZeneca Pharma one hundred,BloombergQuint,Negative
797,ASTRAZENECA PHARMA CO,Redbox India,Postive
800,ASTRAZEN Launch Of Acalabrutinib Capsules,BSE Corporate News,Negative
801,letsBeatCorona IndiaFightsCorona,myupchar,Negative
802,ICMR Covid,ITSM Industrial,Negative
803,Solidarity,Teena Thacker,Negative
805,ICMR Covid,PINSIDER NEWS,Negative
807,Ri Jing,Ri Jing medeikaru,Negative
808,ICMR Covid,Guwahati News,Negative
809,India Council Medical Research ICMR World Heath Organization Solidarity,Economic Times,Negative
810,CLL SLL,gannabiTong Xin ,Negative
811,ICMR ICMR AstraZeneca Acalabrutinib,Mango News,Negative
812,ICMR Covid App,MAJ DR SINGH SG Medallist SIACHEN GLACIER,Negative
815,ICMR Covid,JINU JAMES,Negative
816,ICMR Covid,ET Industry News,Negative
817,Covid ICMR Dexamethasone ClinicalTrial,ETHealthWorld,Negative
818,CLL,Freddy Pizart,Negative
819,ICMR Covid,Aaj Ka Samachar,Negative
820,ICMR Covid,Ketan,Negative
823,ICMR WHO Solidarity,Ganesha,Negative
824,ICMR WHO Solidarity ThePrint ChandnaHimani,ThePrint Science,Negative
825,CLL,Medscape,Negative
826,WHO Solidarity Remdesivir Solidarity,Himani Chandna,Negative
827,ICMR WHO Solidarity ThePrint ChandnaHimani,ThePrintIndia,Negative
831,CLL,MDEdge,Negative
834,CLL,Medscape Oncology,Negative
835,CLL,MDedge Hematology Oncology,Negative
837,CLL three BTK,eDNA,Negative
838,two,ClinicalTrialsData,Postive
839,two,ClinicalTrialsData,Postive
840,one Study Evaluate Relative Bioavailability Proton Pump Inhibitor Rabeprazole Effect Food Effect Particle Size Effect,ClinicalTrialsData,Negative
842,Xie Bing  Man Xing Xie Bing CLL,gannabiTong Xin ,Negative
843,Ri Jing,Ri Jing medeikaru,Negative
845,El Instituto Nacional del Cancer para ayudar el Salud Informacion el estudio en Notimex,Taan Pacheco,Negative
846,AstraZeneca Amy Burd PhD John Byrd MD,HemOnc Today,Negative
847,Healio,Cancer Review,Negative
848,Healio,Cancer Update,Negative
852,CALQUENCE Drug Profile two thousand and,DrugPatentWatch,Negative
855,acalabrutinib drug BTK Briton Tyrosine Kinase,Vasanthi Ilangovan,Negative
856,FLOTUS EricTrump DonaldJTrumpJr IvankaTrump WeLoveTrump Acalabrutinib Calquence,Sherry,Negative
857,Hydroxychloroquine Remdesivir Calquence Jakafi Ilaris Mavrilimumab Decepticon,Sid Murlidhar,Postive
859,Check Acalabrutinib,Medivizor,Negative
860,three CLL,Oncology Tube,Negative
861,AstraZeneca Caluquence Keep Inspiring AstraZeneca,dtw Research Inc,Negative
862,September OhioState CLL ClinicalTrial,Cancer Discovery,Negative
865,Pembrolizumab JournalCancer AlvaAjjai MRHarrisonMD MattMilowsky,Tian Zhang MD MHS,Negative
866,ErleneSeymour,OncLive SOSS,Negative
869,Paolo Ghia MD CLL three,Oncology Tube,Negative
871,KingsCollegeNHS UHSFT RichtersSyndrome,TAP Clinical Trial Network,Negative
874,Michael Wang MD,Oncology Tube,Negative
876,nine RichtersSyndrome Anna Nicole,TAP Clinical Trial Network,Negative
877,beagle dog plasma application pharmacokinetic study JPBA,BioMassSpec,Negative
878,Learn CALQUENCE CLL,acalabrutinib,Negative
880,MCL,KOLKATA RAVI SPECIALITIES PHARMA,Negative
881,MCL,worldwide medicine,Negative
883,two Lymphomas,CureHuntr,Negative
884,two,TrialBulletin,Negative
887,BTK CLL APTO GC eight hundred and six,Helen Ong,Negative
890,CLL,Stem Cells News,Postive
891,CLL two thousand and,chadi nabhan MD MBA FACP,Postive
894,Woyach Role Acalabrutinib CLL,Oncology News Update,Negative
895,Calquence Prescribing Information,Gabriel Chinchilla,Negative
898,CONGRESS MorieGertz MayoClinic,Lymphoma Hub,Negative
899,AstraZeneca Paolo Ghia MD PhD,HemOnc Today,Negative
900,CLL Study,Seema Ali Bhat,Negative
901,CLL WCC sixty one hundred and two Teamhaem,TeamHaem,Negative
902,ASCEND Ghia CLL,Lymphoma Hub,Postive
903,China Italy,Ronald Chavin,Postive
904,Deauville Maintenance rituximab v Acalabrutinib,Luis Villela,Negative
906,SCI Steve Coutre obinutuzumab,Steven Artandi MD PhD,Negative
907,three Idelalisib Plus Rituximab Bendamustine Plus Rituximab PFS CLL,Mahmoud Aljurf,Postive
909,Obinutuzumab TX CLL PI,MD Anderson Leukemia,Negative
910,Idelalisib Plus Rituximab Bendamustine Plus Rituximab,The ASCO Post,Negative
912,Drs Seema Jennifer Woyach CLL,The ASCO Post,Negative
913,one thousand six hundred Australians today PBS Calquence,Sydney,Negative
915,Federal Health September one Keytruda PBS Calquence Acalabrutinib CLL SLL Great AstraZeneca,Lymphoma Australia,Postive
916,World Lymphoma Awareness AstraZeneca Calquence Australian CLL SLL,Rozalina Sarkezians,Negative
917,PBS Australian,haemdoc,Negative
918,BTKinhibitors,Specialty Pharmacy Continuum,Negative
920,Calquence PBS,Leukaemia Foundation,Postive
921,BTK DanaFarber LeedsHospitals BTKinhibitors,Narinder Grewal MD,Negative
922,BTK DanaFarber LeedsHospitals BTKinhibitors,Anesthesiology News,Negative
923,Bruton BTK,MW Gunter,Negative
924,Check Acalabrutinib,Medivizor,Negative
925,September one Calquence PBS first Video,Greg Hunt,Negative
926,three Rituximab Bendamustine Plus Rituximab,filippo masini,Negative
930,ICYMI two three ASCEND,Home Journal,Negative
931,one Calquence Brukinsa one,Jasdeep Sandhu,Postive
932,AstraZeneca BTKinhibitors,Specialty Pharmacy Continuum,Negative
933,randomized pembrolizumab v pembrolizumab UrothelialCancer OncoAlert KatsuakiMaehara VivekSubbiah,Ivan Gonzalez,Negative
934,two,Ignacio Duran,Negative
935,US FDA BTK CLL SLL BTK,ACS Journal Cancer,Postive
936,UrothelialCancer TiansterZhang al JournalCancer WileyNews DukeCancer,Medicine Matters oncology,Negative
938,ICYMI two three ASCEND,Home Journal,Negative
941,pembrolizumab two,OncologyNurseAdvisor,Negative
942,Suivi Pres de one four,Fondation ARC,Negative
945,MCL Clinical Journal Oncology Nursing,Hematology Advisor,Negative
946,MCL Clinical Journal Oncology,CancerTherapyAdvisor,Negative
947,CLL,CONQUER patient voice,Negative
949,AE,OncologyNurseAdvisor,Negative
950,AE MCL,OncologyNurseAdvisor,Negative
951,Urothelkarzinom Pembrolizumab,univadis,Negative
954,el medicamento FDA la tormenta de citoquinas,TekCrispy,Negative
955,three Rituximab Bendamustine Plus Rituximab,Trip Database,Negative
956,Calquence,CURE Magazine,Negative
957,AstraZeneca two thousand and ten half billion dollar,garvs,Negative
958,ten Peru al Covid Los Plasma three Ivermectina Mavrilimumab Tocilzumab Solidaridad four,Alejandro de Bary,Negative
962,four Bruton Tyrosine Kinase Only three Ibrutinib Zanubrutinib Oceabrutinib,PharmacyPhunQuiz,Negative
963,Learn Acalabrutinib Leukemia,Medivizor,Negative
964,two,ImmunotherapyPapers,Negative
965,OncologyNursing MCL AstraZeneca,Maria Badillo MSN RN OCN CCRP,Postive
966,Calquence,CURE Magazine,Negative
968,Man Xing Xie Bing  niDui Ying,onkoro,Negative
969,BTK two,Guru Sonpavde MD,Postive
971,one AstraZeneca BTK US,Nash Peters,Postive
972,JournalCancer two TiansterZhang IO,Ali Khaki,Negative
973,OpenAccess two,ACS Journal Cancer,Negative
974,IDATwitter,InfectiousDiseaseAdv,Negative
975,The European Medicines Agency CLL,LymphomaAction,Postive
976,avancee de la leucemie ActusHemato Laly Nsiala,Hematologie,Negative
979,two CLL PI MDAndersonNews Leukemia,MD Anderson Leukemia,Negative
985,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
988,AstraZeneca BTKinhibitors,Specialty Pharmacy Continuum,Negative
989,AstraZeneca BTKinhibitors,InfectiousDiseaseSE,Negative
990,AstraZeneca BTKinhibitors,ClinicalOncologyNews,Negative
991,AstraZeneca BTKinhibitors,Pharmacy Practice News,Negative
992,BTK BTK Learn,COTA Inc,Negative
993,eighty percent fifty percent FDA EUA one,Pete Afrasiabi,Postive
994,AstraZeneca BTKinhibitors,Pharmacy Practice News,Negative
995,EMA Recommends Marketing Authorisation Acalabrutinib Bruton,ESMO Eur Oncology,Negative
996,zur Zulassung al empfohlen Ein Leukamie dem BTK Position einnimmt Acalabrutinib BTK,Arzte Zeitung,Negative
998,Green Light Avapritinib GIST Acalabrutinib CLL,AGD Biomedicals,Negative
999,AstraZeneca,Ronald Chavin,Negative
1001,CLL,Lymphoma Hub,Postive
1002,CytokineStorm,Meedo,Negative
1003,Green Light Avapritinib GIST Acalabrutinib CLL,AGD Biomedicals,Negative
1004,Calquence Recommended EU,BiopharmaAsia,Postive
1005,Study Evaluate,TrialBulletin,Negative
1006,Study Evaluate Effects Inhibitor Acalabrutinib,CureHuntr,Negative
1008,eighty percent fifty percent FDA EUA,Pete Afrasiabi,Postive
1010,Hoffnung Zulassung von zwei Krebsmedikamenten Europaischen Union Die Europaische Arzneimittelagentur Zulassung von Calquence Acalabrutinib Imfinzi Durvalumab,APOTHEKE ADHOC,Negative
1011,Man Xing Xie Bing CLL,gannabiTong Xin ,Negative
1012,BTKZu Hai Yao Xiang Zhou deCheng Ri Jing,Ri Jing medeikaru,Negative
1013,Study Evaluate Relative Bioavailability Proton Pump Inhibitor Rabeprazole Effect Food Effect Particle Size Effect,TrialBulletin,Negative
1014,Study Evaluate Relative Bioavailability Proton Pump Inhibitor Rabeprazole Effect Food Effect Particle Size Effect,CureHuntr,Negative
1015,AstraZeneca BTKinhibitors,InfectiousDiseaseSE,Negative
1017,Zhi Liao,Tweets,Negative
1019,EMA CLL,Andy Vermaut,Negative
1021,BTKZu Hai Yao Xiang Zhou deCheng,Yi Liao niyusuSu Bao ,Negative
1022,BTKZu Hai Yao Xiang Zhou deCheng,Yi Xue Xue Hui niyusu,Negative
1023,BTKZu Hai Yao Xiang Zhou deCheng,PharmaBian Ji Chang ,Negative
1024,Two AstraZeneca Imfinzi Calquence,Jon Angelo,Negative
1025,Two AstraZeneca Imfinzi Calquence,Pharmafocus,Negative
1026,EU,Company News HQ,Postive
1027,Astra Zenecas Calquence EU,Finwire News,Negative
1028,AstraZeneca Calquence Receives Positive CHMP Opinion,Contentoflifer,Negative
1029,EU cll,GraniteShares Europe,Negative
1030,AstraZeneca Calquence EU,DirectorsTalk,Postive
1031,AstraZeneca Calquence EU,Francis Alexander,Postive
1032,EU,Cision News,Postive
1033,AstraZeneca PLC Calquence CLL,Daniel Macdonald,Postive
1035,BTK nineteen,Latika,Negative
1036,DEL CHMP DELL EMA PER ACALABRUTINIB,one Malati Invisibili,Negative
1038,AIFA,Emergency Live,Negative
1039,European AstraZeneca Calquence,Investor News,Negative
1040,European AstraZeneca Calquence CLL,Investor News,Negative
1041,European AstraZeneca Calquence CLL,Benigno Pinera,Negative
1042,European AstraZeneca Calquence CLL,Breaking News,Negative
1043,TargetedOnc EndCancer,MD Anderson Cancer Center,Negative
1044,Acalabrutinib Managing Adverse Events,Maria Badillo MSN RN OCN CCRP,Negative
1047,NEOPLASIE,one Malati Invisibili,Negative
1048,Richard Furman BTK OncLive,WCM Lymphoma,Negative
1051,AACRCovid,Jill Feldman,Postive
1052,Covid,SAyub Mazher,Negative
1053,Louis Staudt Lymphoma BTK AACRcovid,Liz Highleyman,Negative
1054,Louis Staudt theNCI Acalabrutinib Calquence AACRcovid,Liz Highleyman,Negative
1056,Louis Staudt theNCI Calquence AACRcovid,Liz Highleyman,Negative
1057,CALQUENCE ljyl l`lj,dubai GlobalNews,Negative
1061,Lymphoma,Lymphoma Papers,Negative
1063,Virtual Congress Trial,Health Radio Online,Negative
1064,CLL BTK BID BTK QD BloodJournal,Talha Badar,Negative
1065,El Medicamento Acalabrutinib la la proteina Tirosina quinasa de Bruton asocio reduccion de la de la respuesta Muerte de los criticos,Pacientesconidp,Negative
1071,India sixty one hundred and forty Acalabrutinib Covid,Om Prakash Sharma,Negative
1072,India sixty one hundred and forty Acalabrutinib Covid ChandnaHimani,ThePrint Science,Negative
1074,one hundred and forty sixty ChandnaHimani,ThePrintHindi,Negative
1075,India sixty one hundred and forty Acalabrutinib Covid,Mohd wamique,Negative
1077,month India two Calquence,Ronald Chavin,Negative
1078,Calquence AstraZeneca,Prof Archie,Negative
1079,AstraZeneca two BTK one hundred and forty,Divyesh Mundra,Negative
1080,India AstraZeneca one hundred and forty sixty India,Himani Chandna,Negative
1081,Astrazenica India sixty one hundred and forty Acalabrutinib Covid,GK,Negative
1082,India sixty one hundred and forty Acalabrutinib Covid,seshutatikola,Negative
1083,India sixty one hundred and forty Acalabrutinib Covid ChandnaHimani,ThePrintIndia,Negative
1085,l`lmy@ l'dwy@ `n TrH CALQUENCE klkwyns ' klbrwtynyb l`lj lGdd,lsys~ Hbyb lmlyyn,Negative
1086,WhiteCoats BeDrEffective,WhiteCoats,Negative
1087,CALQUENCE l`lj b'ql mn ls`r l`lmy AmwalalghadAR,'mwl lGd,Negative
1088,CALQUENCE l`lj,SHtk twentyfour,Negative
1092,ASTRAZENECA PREPARAT ACALABRUTINIB OT LIMFOMY KANDIDAT NA OT,Afex Capital,Negative
1093,SEC daily,Stocktrend,Negative
1100,Lymphoma,Raman Pathak Quant Trader,Negative
1101,Lymphoma,Medical Dialogues,Negative
1103,AstraZeneca Calquence first quarter two thousand and Calquence AstraZeneca CLL SLL,dtw Research Inc,Negative
1104,Inhibition Bruton Jun five two thousand and twenty nineteen,Mike Thompson MD PhD FASCO,Negative
1105,nine Calquence CLL Enhertu China US Farxiga,dough,Negative
1107,Sunny Kim OHSUNews CLL Cancer,Vinay Prasad MD MPH,Negative
1108,AstraZeneca Announces April fifteen two thousand and twenty Matthew Fowler CancerNetwrk AZ Press Release,Mike Thompson MD PhD FASCO,Negative
1109,Inhibition Bruton Jun five two thousand and twenty nineteen,Mike Thompson MD PhD FASCO,Negative
1111,Cancer Research Time Two Pandemics Highlights Bruton BTK,Javed Khan,Negative
1112,John,The ASCO Post,Negative
1113,CLL Lucky,Ellen Kendall,Postive
1114,CLL BTK,Blood Journal,Negative
1115,obinutuzumab versus chlorambucil obinutuzumab chronic three,FarmaciaHUAP,Negative
1116,CALQUENCE Drug Profile two thousand and,DrugPatentWatch,Negative
1117,Prof Paolo Ghia ASCEND v idelalisib rituximab bendamustine rituximab chronic Watch Oncology CLL,ecancer,Negative
1118,Richard Furman OncLive nine,WCM Lymphoma,Negative
1120,FDA,Jon,Postive
1121,BTK CLL CLL BTK Blood American Society Hematology,Benlazar Amine,Postive
1122,BTK Amazing Clinical CLL BTK Blood American Society Hematology,Eduardo Flavio Oliveira Ribeiro,Postive
1123,CLL John Byrd,CURE Magazine,Negative
1124,three RichtersSyndrome OUHospitals ChurchillHospital,TAP Clinical Trial Network,Negative
1125,OncoAlert Clinical CLL BTK American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
1126,CLL SLL,acalabrutinib,Negative
1131,five hundred CLL ninety CI,acalabrutinib,Negative
1141,CLL,acalabrutinib,Negative
1146,Obinutuzumab CLL,The ASCO Post,Negative
1148,New Drug,AustralianPrescriber,Negative
1149,PULSEBEATNEWS,MedTech PULSE,Negative
1150,three hundred and sixty,National Comprehensive Cancer Network NCCN,Negative
1152,three day,ahealthierphilly,Negative
1154,IndustriaFarmaceutica Acalabrutinib de AstraZenecaES linfocitica presentaron el Congreso Anual de la Asociacion Europea de Hematologia,Redaccion Medica,Negative
1156,New Acalabrutinib,Medivizor,Negative
1157,Dra Adriana Scheliga CLL,hemomeeting,Negative
1158,linfocitica,Ciencia,Negative
1160,linfocitica,Lab Tests Online ES,Negative
1161,Counts,Singh,Negative
1163,three two thousand and twenty three two thousand and twenty ten HUMIRA CLL,dough,Postive
1164,BTK BTK BTK,Michael Wang MD,Negative
1165,Probably Baricitinib Btk,Lu Chen nobias,Negative
1167,NEW Acalabrutinib,Medivizor,Negative
1168,Alessandra Tedeschi,EmatoInfo,Negative
1169,Alan Skarbnik ASCEND Cll,hemomeeting,Negative
1170,three day,ahealthierphilly,Negative
1172,linfocitica cronica refractaria,Kevin Marcelo,Negative
1173,AscentagePharma AcertaPharma Acerta BTK,DDNews Online,Negative
1181,usado contra bloquearia la proteina BTK provoca la propagacion de la Especialistas los casos el Peru,Revista Caretas,Negative
1183,TheLancet CLL,LymphomaAction,Postive
1184,WeillCornell Lymsm,VJHemOnc,Postive
1186,three day,ahealthierphilly,Negative
1188,Thomas Witzig fifteen two thousand and nineteen two hundred and sixtyseven thousand four hundred,FarmaciaHUAP,Negative
1189,John ten four year BTK,CLL Advocates Network,Negative
1190,Ghia ASCEND CLL,Lymphoma Hub,Negative
1191,Reapertura de centros La OIT de un usado contra bloquearia la proteina BTK provoca la propagacion de,Revista Caretas,Negative
1192,CarenetYi Liao,Jiu Bao  Yi Fu ,Negative
1193,usado contra bloquearia la proteina BTK provoca la propagacion de la Especialistas los casos el Peru,Revista Caretas,Negative
1194,Reapertura de centros La OIT de un usado contra bloquearia la proteina BTK provoca la propagacion de,Revista Caretas,Negative
1195,Lancet forty,Michael Wang MD,Postive
1196,della leucemia linfatica cronica rendendolo un La parole di Alessandra Tedeschi,EmatoInfo,Negative
1197,ceux essai exploratoire de de BTK chez le,Marseille Immunopole,Negative
1198,CONGRESS John Byrd CLL,Lymphoma Hub,Negative
1199,Bruton IgE,ToxiVen,Negative
1200,CaretasEnCasa La el ritonavir la ivermectina graf de estos en los ultimos dia usado el tratamiento de leucemia,Revista Caretas,Negative
1203,McKesson,HLC,Negative
1204,ATENCION El usado contra bloquearia la proteina BTK provoca la propagacion de la Especialistas los casos el Peru,Revista Caretas,Negative
1205,BTKinhibitor Supplemental RoschewskiMD al SciImmunology,Marseille Immunopole,Postive
1206,Medical News Bulletin,Apostz,Negative
1208,CL,Clinical Cancer Research,Negative
1209,Richard Furman MD PrecisionMedicine,WCM Englander Institute Precision Medicine,Negative
1210,AstraZeneca Calquence week Calquence,pharmanewsintel,Negative
1211,Los medico han publicado Science Immunology Consideran BTK Salud Acalabrutinib,Saber Vivir,Negative
1212,Acerta Pharma,DemiurgeTech,Negative
1213,Da Paolo Ghia un sui dati dell ASCEND presentato ad nella linfatica cronica,EmatoInfo,Negative
1214,Manana CARETAS El con la reactivacion economica La OIT de un drastico del trabajo la proteina provoca la propagacion de la Esto ma en,Revista Caretas,Negative
1217,two three ASCEND,Home Journal,Negative
1218,US Oncology Research Read Forbes,McKesson Corporation,Negative
1219,ASCEND Paolo Ghia,EmatoInfo,Negative
1220,Meaning Scientists ScienceMagazine,teen get cancer,Negative
1221,two biosimilar rituximab lenalidomide acalabrutinib,Pharma News,Postive
1222,two biosimilar rituximab lenalidomide acalabrutinib,Pharma News,Postive
1225,First FDA,Mak,Postive
1226,ASCEND Rituximab Bendamustine Plus Rituximab Acalibrutinib CLL,abej,Negative
1228,BTK OncoAlert,Andreas Charalambous,Negative
1229,Medicos del hospital Walter Reed Maryland Estados Unidos el medicamento,Saber Vivir,Negative
1230,BTK,The Cancer Letter,Negative
1231,last week Response twenty zero,iflyplaces,Postive
1233,zonder obinutuzumab chloorambucil en obinutuzmab al CLL,MedNet,Negative
1234,three day,ahealthierphilly,Negative
1235,European Union Novo Nordisk Rybelsus,Knowledge,Negative
1236,AstraZeneca AstraZeneca Leukemia Oncology ClinicalTrials CalquenceTrials Biopharmaceutical Biotechnology Pharmaceutical DrugDevelopment DrugDiscovery,Drug Discovery World,Negative
1237,BTK el momento el tratamiento la tormenta de citoquinas muy graf,Emanuel Vila,Negative
1238,BTK four hundred and,Emanuel Vila,Negative
1239,ONT,Living Safely,Negative
1241,HealthDay June twelve two thousand and Physician Briefing,Rafael Carrasco,Negative
1242,BTK nineteen,Beyond Conventional Cancer Therapies,Negative
1243,La persona de algunos de los paises QuedateEnCasa QuedateEnRadio,Rock Pop,Negative
1244,two,BiopharmaAsia,Negative
1246,Nuovi two che un regime combinato Truxima ben tollerato ed efficace nella terapia del,Roberto Bonin,Negative
1247,AstraZeneca Blood Cancer Drug Calquence,Julie Lakeview,Negative
1248,Nuovi two che un regime combinato Truxima ben tollerato ed efficace nella terapia del,Tecnomedicina,Negative
1249,AstraZeneca Blood Cancer Drug Calquence,ZC,Negative
1250,AstraZeneca Blood Cancer Drug Calquence,Swedish Biotech,Negative
1251,two,Investor News,Postive
1252,AstraZeneca Blood Cancer Drug Calquence,Financial Carnivores,Negative
1254,two biosimilar rituximab lenalidomide acalabrutinib,Pharmacutical Daily,Postive
1255,two biosimilar rituximab lenalidomide,Crwe World,Negative
1258,Nieuwe,Business Wire Dutch,Negative
1259,Neue Vertraglichkeit Wirksamkeit de Therapieschemas Lenalidomid und Acalabrutinib,Business,Negative
1261,two biosimilar rituximab lenalidomide acalabrutinib,Latest News Business Wire,Postive
1263,La tormenta de citoquinas de la podria ser calmada con Acalabrutinib Sciece de un estudio observacional nineteen Pero un terapeutico coronavirus,Antonio Guerrero,Negative
1264,roguinshitekontentsuhe Xin Gui Hui Deng Lu Yi Shi,Yi Liao niyusuSu Bao ,Negative
1266,Kanser,Haberdar,Negative
1267,Kanser,BirGun Gazetesi,Negative
1268,BTK nineteen Over day MAJORITY,Hikmet Geckil,Negative
1269,Staudt TalkingHeads,Randall Brenneman,Negative
1270,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1271,LEUCEMIA LINFATICA CRONICA DIMOSTRATA EFFICACIA LA TOLLERABILITA LUNGO one risultati studi al Congresso EHA,Medicina Informazione,Negative
1272,Kanser,Haberdar,Negative
1273,dimostrata affidabilita tollerabilita di ACALABRUTINIB,Angelo Piemontese,Negative
1274,eight four eight two eight,Meedo,Negative
1275,Kanser,BirGun Gazetesi,Negative
1276,JCO ASCEND Phase three,Yong Yi ,Negative
1277,ASCEND Paolo Ghia lymsm,LYMPHOMA MYELOMA CONNECT,Negative
1278,Bruton BTK,Andreas Sofroniou,Negative
1279,Celebrating Inclusion Diversity LGBTQA Pride Month,Stephen Richards,Postive
1280,Coronavirus eight Policenama,Policenama,Negative
1281,obinutuzumab v chlorambucil CLL three,Yong Yi ,Negative
1282,AstraZeneca Blood Cancer Drug Calquence BioSpace,Hamid Mazloomi,Negative
1283,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1284,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1285,ScienceMagazine,VirginSlayerIncelius,Negative
1287,dicho Acalabrutinib LaSexta Noche,Karan,Negative
1288,CLL two fourteen date six four SPM two three PD ten CR seven DoR EFS EAMS CLL,Toby Eyre,Negative
1289,BTK,Pat Salber MD MBA,Negative
1290,BTK Inhibition Bruton,Stephanie,Negative
1291,Coronavirus Can Set Off Cytokine These Drugs Remdesivir Acalabrutinib Calquence CytoSorb Europe,Ruth Ann Crystal MD,Negative
1293,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1294,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1296,Proponen al farmaco para frenar la respuesta hiperinflamatoria mediada citoquinas graf de,Cuaderno de Ciencia,Negative
1298,Don,Marcela SaebLima,Postive
1299,AZN Calquence two AstraZeneca,GraniteShares Europe,Negative
1300,two three ASCEND Calquence AstraZeneca AstraZeneca,Smart Industry News,Negative
1301,three day,ahealthierphilly,Negative
1302,ScienceMagazine,VirginSlayerIncelius,Negative
1310,Se encuentra BTK el coronavirus,Dario Hiven,Negative
1311,Parece ya se necesitan la contra ESTUDIO EN el Acalabrutinib al virus incluso UCI,Yerson Gutierrez Ch,Negative
1312,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1313,Coronavirus Can Set Off Cytokine These Drugs,Muzaffar Qazilbash,Negative
1314,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1316,Richard Furman CLL Waldenstroms OncologyTimes,WCM Lymphoma,Negative
1318,Science Immunology Acalabrutinib,SAFH,Negative
1319,Coronavirus PruebanFarmaco Coronavirus usado contra Se trata del Acalabrutinib,Diario HOY,Negative
1320,Start weekend eight minute This week States,MPR,Negative
1321,Cohort today TC Bec Dr Fox,TAP Clinical Trial Network,Negative
1322,Coronavirus Calquence AstraZeneca,Stray,Negative
1323,Encontraron farmaco que vence la ma graf de la,Alo Ciudadano,Negative
1324,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1325,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1326,HealthDay,HealthDay News,Negative
1327,AstraZeneca Calquence two four year,NASDAQ,Negative
1328,ASCEND Calquence eighteen month Calquence,EuropaWire,Postive
1329,four year Calquence,EuropaWire,Negative
1330,two three ASCEND,EuropaWire,Negative
1331,dimostrata efficacia la tollerabilita lungo Leucemia linfatica cronica,Cerca Soluzioni Cruciverba,Negative
1332,BTK Inhibitor Acalabrutinib one three day,Matt Willemsen,Negative
1333,Un nineteen requirieron un el medicamento,Sociedad Quimica de Panama,Negative
1334,tva nya Calquence lifesciencesweden pharma,Life Science Sweden,Negative
1335,un un prolungato pretrattati,Medinews,Negative
1336,della leucemia linfatica cronica la forma piu dell,Ritrattodellasalute,Negative
1337,two,Company News HQ,Negative
1338,rendesivir hidroxicloro pantallas la nueva,Luis Ruiz,Negative
1341,Medscape BTK nineteen,Freddy Pizart,Negative
1343,two,Cision News,Negative
1344,Coca Cola,Daniel Lopez,Negative
1345,Bruton BTK BTK TRADUC,Voz Entrerriana,Negative
1346,Coca Cola,himanshu singh,Negative
1348,Parece ya se necesitan la vacunas el Acalabrutinib al virus incluso UCI,MEMEO,Negative
1349,Una critico probaron con exito el Acalabrutinib un farmaco ya,Aldo Solis,Negative
1350,el uso del medicamento Acalabrutinib un usado el tratamiento de los pacientes criticos,Radio Chaparrastique FM,Negative
1351,el tratamiento de casos severos de ScienceMagazine publica de mejoria nineteen Ahora un,Carlos Arturo Alvarez Moreno,Negative
1352,Leyendo la inflamacion provocada el covid haran estudios con pacientes de ma Panama un BTK Supongo OMS,Felix,Negative
1353,AstraZeneca Calquence MailOnline,fausto hiraldo zabal,Negative
1354,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1355,Monticelli Rocky Mountain Cancer Centers Francis Calquence,Mercy Durango,Negative
1356,un farmaco de AstraZeneca de Covid Hallada Covid BarricadaNews LaVanguardia,Barricada Azul,Negative
1357,Hidroxicloroquina escena pero el numero de muertos incrementa dia dia,Daniel Murriel,Negative
1359,Encontraron farmaco que vence la ma graf de la,Enrique Lopez COVIDseRESPIRA,Negative
1361,Evan Kirstel Twitter one Coke Coca Cola Twitter,Vasyl Pawlowsky,Postive
1362,BTK nineteen,Medscape Pharmacists,Negative
1363,medicamento para Inhibition Bruton,Miguel Angel Grullon,Negative
1364,Prueban el Acalabrutinib,Apunte Digital,Negative
1365,Buena noticia para pacientes de coronavirus graf prueban,Apunte Digital,Negative
1366,Buena noticia para pacientes de coronavirus graf prueban un,Apunte Digital,Negative
1367,Buena noticia para pacientes de coronavirus graf prueban un,Apunte Digital,Negative
1369,SI SE SALVA ALGUNA CREYENDO EN LA COMUNIDAD CIENTIFICA,LEON,Negative
1371,RegaCarlos,Victoria Recche,Negative
1372,nineteen BTK,John Damianos,Negative
1373,one three cogunda iltihaplanmada,ahmet duran,Negative
1375,BTK nineteen,Medscape,Negative
1376,BTK,Pat Salber MD MBA,Negative
1380,Prueban el Acalabrutinib,Apunte Digital,Negative
1381,Prueban el Acalabrutinib,Apunte Digital,Negative
1382,Buena noticia para pacientes de coronavirus graf prueban un farmaco ya El Acalabrutinib,Apunte Digital,Negative
1383,Prueban el Acalabrutinib,Apunte Digital,Negative
1384,Prueban el Acalabrutinib,Apunte Digital,Negative
1385,Buena noticia para pacientes de coronavirus graf prueban un farmaco ya El Acalabrutinib,Apunte Digital,Negative
1386,Buena noticia para pacientes de coronavirus graf prueban un farmaco ya El Acalabrutinib,Apunte Digital,Negative
1387,Buena noticia para pacientes de coronavirus graf prueban un farmaco ya El Acalabrutinib,Apunte Digital,Negative
1388,El estudio fue desarrollado el bloqueo de la proteina BTK reduciria la mejoraria el,Pagina Central Jujuy,Negative
1389,un de la celulas para ayudar los pacientes con con ma agudas de la enfermedad Calquence AstraZeneca,construir,Negative
1390,nuevo medicamento salvaria persona contagiadas de,El Grillo de Yucatan,Negative
1391,el producto e Benjamin Nunez Vega Le un farmaco de AstraZeneca BTK el tratamiento de algunos canceres,Benjamin Nunez Vega,Negative
1393,Coca Cola,Daniel Lopez,Negative
1394,BTK de Bruton el tratamiento de algunos canceres eleven eight de ellos la tormenta de citoquinas ocasionada,Manuel Muro,Negative
1395,Una critico probaron con exito un farmaco ya contra exito la enfermedad,Radio Mambi seven hundred and ten,Negative
1396,EEUU Investigadores el uso del medicamento Acalabrutinib un usado el tratamiento de los pacientes criticos,Oscar Peraza,Negative
1397,EEUU Investigadores el uso del medicamento Acalabrutinib un usado el tratamiento de los pacientes criticos,OPR,Negative
1398,EEUU Investigadores el uso del medicamento Acalabrutinib un usado el tratamiento de los pacientes criticos,ITR Noticias Oficial,Negative
1399,el uso del medicamento Acalabrutinib un usado el tratamiento de los pacientes criticos,Noticias,Negative
1400,El uso del Acalabrutinib contra exito la enfermedad El,Loreto Noticias,Negative
1401,Una critico probaron con exito un farmaco ya Infobae,Patricio Sanchez,Negative
1403,Farmaco Acalabrutinib,pawel,Negative
1404,Calquence,Gupta Gastro,Postive
1405,lo comentado Gracias un,Moet,Negative
1406,one Article BTK Inhibitor,Cate Shanahan MD,Negative
1408,Xin Xing kokoroshiea akaraburuchinibu Gong Kai Shuang Ji Xing Zhang Hai Qing Bao Xin Xing,Tweets,Negative
1409,JosepCorbella,Pedro Vallin,Negative
1410,Coca Cola SmartNews,Linda Dudek,Negative
1412,El farmaco acalabrutinib un controla la mejora la la mayoria de los pacientes de menudo en un one three,Jose Manuel Bautista,Negative
1413,PhillyVoice,MARIA da GLORIA,Negative
1414,un AstraZeneca regula toda la tormenta de citoquinas provoca el coronavirus,Salvajes,Negative
1415,Xin Xing,natsume Gan Xian  herusukea,Negative
1417,un de la enzima quinasa de Bruton nineteen mejora su capacidad de toxicos anado un un,Gorka Orive,Negative
1418,Hallada primeros resultados con para luchar contra la tormenta de citoquinas,joan carles contel,Negative
1421,Coca Cola BGR,AaMaldives,Negative
1424,Coca Cola kwl khr `,Saud Nasser Aldosery,Negative
1425,contra nota de vanesalop Clarin con la opinion de,CEPROFAR Centro de Profesionales Farmaceuticos,Negative
1426,Credit Doctors CocaCola,Convenience Store News,Postive
1428,CocaCola Pepsi BGR Doctors Coca Cola,AAA,Postive
1429,one Coke Coca Cola,Evan Kirstel,Postive
1430,AstraZeneca Blood Cancer Drug Calquence,HealthIT Biotech,Negative
1431,AstraZeneca Blood Cancer Drug Calquence,Truth Studio,Negative
1432,BTK Inhibitor Acalabrutinib,Teresa MASIA PERALES,Negative
1433,AstraZeneca Blood Cancer Drug Calquence,MySmallCap,Negative
1434,Coca Cola BGR,Barbara Lazarus,Negative
1435,Coca Cola,Duarte,Negative
1436,BTK CRP AstraZeneca WilsonWyndham,Bernard Fox,Postive
1437,Calquence Coca Cola AWESOME Trump,JT Badenov,Postive
1439,Coca Cola BGR,Sharon Gilbert,Postive
1440,Coca Cola,GeekinfoNow,Negative
1443,Coca Cola,Chris Smith,Negative
1446,Coca Cola,Noah Swint,Negative
1447,ASCEND CLL,ASCO Publications,Negative
1450,BTK Inhibitor Acalabrutinib,StaySafe,Negative
1452,Se,Diario de Chiapas,Negative
1453,BTK Inhibitor Acalabrutinib,Syrian white,Negative
1454,AstraZeneca Calquence,atoxquiteran,Postive
1455,Bruton BTK Science Immunology five June two thousand and,Erwin Loh,Negative
1456,BTK Inhibitor Acalabrutinib,"Carlos Camargo DRE one million, nine hundred and eightyeight thousand, four hundred and thirtyone",Negative
1457,BTK Inhibitor Acalabrutinib,Josh Marshall,Negative
1459,Se,Mundo Sano,Negative
1460,BTK Inhibitor Acalabrutinib,BIOCIENCIA,Negative
1461,National Cancer Institute,ahealthierphilly,Negative
1462,BTK Inhibitor Acalabrutinib,Para,Negative
1464,BTK Inhibitor Acalabrutinib,Andy Vermaut,Negative
1466,Calquence,Colorado Headlines,Negative
1467,Calquence,Oncology Nursing News,Postive
1468,Calquence The US Oncology Network The Network Results,Vanessa Abrahamson,Negative
1470,Bruton BTK,PSBR,Negative
1471,BTK,Pat Salber MD MBA,Negative
1472,nineteen Hospitalized MedNews,eCare Vault Inc,Postive
1473,benefique Un,Pierre Bezier,Negative
1474,BTK,Home Journal,Negative
1475,AstraZeneca Blood Cancer Drug Calquence,Epidemiology Publishers Feed,Negative
1477,AstraZeneca Bruton BTK AstraZeneca,London,Negative
1478,AstraZeneca Calquence AstraZeneca PharmaTimes,The PMI Pharmaceutical Managers Institute,Postive
1479,Bruton BTK,Health Evangelists,Negative
1484,AstraZeneca,Around The Globe News,Negative
1485,Acalabrutinib Elle Bruton BTK qui,Phil Montreal,Negative
1486,AstraZeneca,SitaravammaputrSamba,Negative
1488,two thousand and twenty Tagrisso Imfinzi,dough,Postive
1489,BTK,Waggoner Lab,Negative
1490,BTK,Monica,Negative
1491,AstraZeneca Calquence,Redivex News,Postive
1492,BTK nineteen eleven eight eighteen,Thiago Carvalho,Negative
1493,benefique,News Canada FR,Negative
1494,benefique,Le Journal de Montreal,Negative
1495,NIH Bruton BTK,Cancer Research Institute,Negative
1496,el covid nineteen Las Ketchup,Martin Capote,Negative
1498,un Segun los hallazgos del estudio Science Immunology Referencia FUENTE Science Immunology,victor torres,Negative
1499,Calquence CLL John Byrd,CURE Magazine,Negative
1500,BTK Acalabrutinib Wikipedia,Bonny,Negative
1501,Un contra severos de coronavirus fue probado con buenos nineteen faltan ma completos muy caro,SalvadorSchwartzmann,Negative
1505,BTKinhibitor BTK Fenebrutinib SLE RA,Peter Nash,Negative
1506,AstraZeneca Blood Cancer Drug Calquence,Pharmaceutical,Negative
1512,AstraZeneca Blood Cancer Drug Calquence,BioCalifornia,Negative
1513,AstraZeneca,MediHelp Solutions,Negative
1515,AZ Calquence,David Ledger,Negative
1516,Inhibition Bruton Acalabrutinib nineteen,denni evindekal stayhome restaacasa,Negative
1517,VidaySalud Investigaciones el tratamiento graf conoce ma,Noticias Enfasis,Negative
1519,AZ Calquence,PharmaTimes,Negative
1521,Covid Studio su Science Immunology,PharmaStar,Negative
1522,National Cancer Institute,ahealthierphilly,Negative
1523,Calquence,Global Business Alliance,Negative
1524,ONT,Living Safely,Negative
1525,AZ Calquence,eCare Vault Inc,Negative
1526,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Synergy Healthcare LLC,Negative
1527,week,Cheryl Lubbert,Postive
1528,theNCI CancerResearch,NCI Media Relations,Negative
1529,AstraZeneca Data,Hashim,Negative
1530,nineteen,Krishan Maggon,Postive
1531,AstraZeneca Calquence,Meghan Mott,Negative
1532,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,EBD Group,Negative
1535,AstraZeneca,RVGSM,Negative
1536,RCT Bruton HPLovecraft,Dr Darren Flower,Negative
1537,nineteen,David Ledger,Postive
1538,one,Amesh Adalja,Negative
1539,CORONAVIRUS ASTRA DRUG POTENTIAL Calquence Calquence supp Oxygen Science Immunology,john markarian,Negative
1540,BTK,LiberalFish,Negative
1541,Outbreak News,Cheryl Amber Dotson,Negative
1542,Bruton BTK three day,Nnankya,Negative
1543,AZ Calquence,Barry Curry,Negative
1545,AstraZeneca Cancer,Journal Clinical Cellular Immunology,Negative
1548,AstraZeneca,PharmaShots Incisive news three shot,Negative
1549,AstraZeneca BTK Calquence,Jon Angelo,Negative
1550,AZ Calquence,Everything Pharma,Negative
1551,AZ Calquence,Pharma Trader,Negative
1552,AstraZeneca Calquence AZN,Investor News,Postive
1555,Complex Event Analysis NEWS twenty million two hundred thousand six hundred and eight five hundred and one PST Top News Focus republican,SiteFocus,Negative
1556,Bruton BTK three day,European Pharmaceutical Review,Negative
1557,ForbesTech AstraZeneca Calquence,mariuskarma,Negative
1558,AstraZeneca BTK Calquence,Pharmafocus,Negative
1559,Cytokine,Sharon Gilbert,Negative
1560,ResearchHighlight Acalabrutinib,Roots Analysis,Negative
1561,Complex Event Analysis NEWS twenty million two hundred thousand six hundred and eight,SiteFocus,Negative
1562,Der BTK Acalabrutinib zur Behandlung Lymphome wurde Studie Science Immunology Zytokinsturm,KFL,Negative
1563,AstraZeneca Calquence,Forbes Tech,Negative
1564,Wirkung Bethesda Der zur Behandlung Lymphome wurde Studie Studie Biologika,Deutsches Arzteblatt,Negative
1565,AZ Calquence,PharmaCrowd,Negative
1567,Liao Yao  akaraburuchinibu E Xing rinpaZhong  ,Wind Rose,Negative
1568,nineteen,Matt Willemsen,Postive
1569,AstraZeneca Calquence,ClinicalTrialsArena,Negative
1570,aussdh BloodCancer Acalabrutinib Corona,sakalmedia,Negative
1571,Liao Yao  Bloomberg,Stray,Negative
1572,AstraZeneca Calquence Clinical Trials Arena,arthur james lobo,Negative
1573,Bruton BTK,Journal Cancer Research,Negative
1574,three Rituximab Bendamustine Plus Rituximab,INDoximity,Negative
1575,el medicamento un,El Diario NTR Guadalajara,Negative
1576,bytm drsth Hdyth f`ly@ mmtz@ one hundred nty'jh t`fy eight knw `ly lwksjyn t`fy two eight f`ly@ `ljy@,Hakeem Shalaby,Negative
1577,Guo Sheng Mian Yi Fan Ying noJian BTK Hai Yao,silexZhi noWen Xian sabisu,Negative
1579,AZN Data Calquence BTK nineteen Discharge fifty mech SciImmunology,SY Investing,Negative
1580,Bruton BTK,Health Evangelists,Negative
1581,BTK,Health Evangelists,Negative
1584,UK five one two three four five Zilucoplan AUThackeray DrMuffi CytokineStorm,DestroyTheAadhaar TwiLightOFTheGODS,Negative
1589,Study The,Arsalan Ashraf,Negative
1590,Respiratory Distress,Nazish Jawad,Negative
1591,zdravilo ki zdravljenje limfomov je pokazalo Zdravilo inibira ki vlogo pri tako da je zmanjsalo potrebo po dodatnem kisiku,Roman Jerala,Negative
1593,un de la,Salud junto,Negative
1594,Calquence AstraZenca Health Tips News,The Daily Protein,Negative
1596,CLL Lactobacillus,Dr Boominathan PhD,Negative
1597,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Armin Hamidian,Negative
1598,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Armin Hamidian,Negative
1599,AstraZeneca Calquence FE,masudkarim,Negative
1600,Bruton BTK,MW Gunter,Negative
1601,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Vishnu Live,Negative
1603,Roschewski BTK,Dave On Call,Negative
1605,fifty,Bargad,Negative
1606,Cacncermedicinen Acalabrutinib Liten,jorgenponder om coronavirusepidemin,Negative
1608,CLL,iflyplaces,Postive
1609,Nat Cancer Institute nineteen Bruton BTK,delthia rick,Negative
1610,Inhibition Bruton BTK CytokineStorm,Robert West PhD,Negative
1611,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,VIRALFLEX,Negative
1612,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,cafepharma,Negative
1613,CoronavirusHace Reuters Foto de archivo Bolsa de Nueva York five Reuters Calquence de AstraZeneca LON,mercado digital twentyfour,Negative
1614,el cancer de AstraZeneca los pacientes,Codigo Libre,Negative
1615,AstraZeneca,Antibiotic Ghanem,Negative
1617,inhibiteur selectif de la BTK donne de resultats sou,Lavergne,Negative
1618,Nuevo FDA el proceso inflamatorio mejor Tormenta severos,Alex Covarrubias,Negative
1619,ClinicalStudy BrutonTyrosineKinase BTK,BioNews Central,Negative
1623,nineteen,Forbes Science,Negative
1624,one BTK Dampen Cytokinestorm Infection SciImmunology Acalabrutinib Ibrutinib CLL,Prof John,Negative
1626,CLL,Bob Turner,Negative
1627,BTK,Mr Graham,Negative
1628,BTK,Jill,Negative
1629,HealthyLife CoronavirusOutbreak CoronaLockdown,debuglies,Negative
1630,BTK June five SciImmunology theNCI AstraZeneca TheUSONetwork,Ifor Williams,Negative
1632,Tecnologia Estudio el medicamento FDA la tormenta de citoquinas Noticias TendenciasTech,TendenciasTech,Negative
1633,day,Amir Faisal,Negative
1634,Bruton BTK,Deccan Herald,Negative
1635,AstraZeneca Calquence Journal,Business Journal,Negative
1636,Calquence,Business Today,Negative
1637,nineteen gravi difficolta respiratorie,Medimagazine,Negative
1638,BTK BTK,Singh,Negative
1639,BTK eight eleven,Singh,Negative
1640,one hundred al dia ten fourteen dia,MAURICIO BERNAL,Negative
1644,BTKnoZu Hai Ji  Acalabrutinib AZ,otsuru,Negative
1645,nineteen,PressReleasePoint,Postive
1647,Calquence de AstraZeneca los pacientes peor de la enfermeda,The Mexico Post,Negative
1648,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Dr Timos Papagatsias,Postive
1649,BTK,Tariq Janjua MD,Negative
1650,La de la farmaceutica el respaldo de Institutos Nacionales de Salud de Estados Unidos,Proceso,Negative
1653,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,American Capital Rec,Negative
1654,BTK Cytokine,Pavithran,Negative
1655,BTK,LCW,Negative
1656,nineteen,World Pharma News,Postive
1659,att lagga kritiska kardiovaskular sa,Kenneth Bodin,Negative
1660,Calquence de AstraZeneca mostro indicios de peor de la enfermedad,ContraReplica,Negative
1661,nineteen,Company News HQ,Postive
1662,five Jun,Roland Baker,Negative
1663,BTK,Antibiotic Ghanem,Negative
1664,tTwr four jd mnhm remdesivir Hly llHlt Zhrt nty'j Acalabrutinib Selective Bruton jd rbn ykrm,'HmdSlHAhmd Saleh,Negative
1665,Calquence de AstraZeneca los pacientes peor de la enfermedad los tratamientos,Radio Tepeaca,Negative
1667,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Health News,Negative
1668,el medicamento FDA la tormenta de citoquinas,TekCrispy,Negative
1670,EDNInforma El Calquence de AstraZeneca los pacientes peor de la enfermedad AstraZeneca,EDN TV HN,Negative
1671,Xin Xing BTK,Yan Jiu Zhe  Yi Bo  He Tian Zhong Shi ,Negative
1672,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,BenExact,Negative
1673,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,ChicagoSchoolofYoga,Negative
1674,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,AID Recruitment Solutions,Negative
1675,Erkrankungen Inhibition Bruton,Thomas Kloss,Negative
1676,SciImmunology,National Cancer Institute,Negative
1678,nineteen,LLZ Consulting,Postive
1679,AstraZeneca Calquence,FirstWord Pharma,Negative
1680,Actemra,Ronald Chavin,Negative
1681,BTK,lucy gorelli,Negative
1682,Calquence nineteen BTKinhibitor,GraniteShares Europe,Postive
1683,FDA Approved Drug,NanoTrac Technologies,Postive
1684,Astra Zeneca kliniska av de nineteen Calquence,Dagens industri,Negative
1685,Zenecas kliniska Calquence ho nineteen ett,Omni Ekonomi,Negative
1687,AstraZeneca Calquence BTK Quarantine QuaratineLife,Adam Grant,Postive
1689,Covid,Medical Dialogues,Negative
1690,ScienceMagazine,VirginSlayerIncelius,Negative
1691,AstraZeneca Calquence,The Jerusalem Post,Negative
1693,AstraZeneca Calquence Science Immunology Calquence,WallStBetsDotCom,Negative
1694,nineteen,Cision News,Postive
1695,nineteen SciImmunology,Meagan Phelan,Negative
1697,NIH,Patricia Kime,Negative
1698,AstraZeneca Calquence un medicamento Reuters,Gualestrit,Negative
1699,ASTRAZENECA CANCER DRUG CALQUENCE SHOWS INITIAL,Al,Negative
1701,June five Reuters Calquence,Paul Marc,Negative
1702,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,kubsv,Negative
1705,ASTRAZENECA CANCER DRUG CALQUENCE,Jeremy,Negative
1706,AstraZeneca Calquence Reuters,WallStBetsDotCom,Postive
1707,AstraZeneca Calquence Showed Improvement In Small Group Of Hospitalized Patients,Nathan Vardi,Negative
1708,ASTRAZENECA CANCER DRUG CALQUENCE,Sharp street trading insight,Negative
1710,ASTRAZENECA CANCER DRUG CALQUENCE SHOWS INITIAL,Breaking Market News,Negative
1711,ASTRAZENECA CANCER DRUG CALQUENCE,Breaking Market News,Negative
1712,ASTRAZENECA CANCER DRUG CALQUENCE,Redbox Global,Negative
1713,ASTRAZENECA CANCER DRUG CALQUENCE,First Squawk,Negative
1714,AstraZeneca Cancer Drug Calquence,LiveSquawk,Negative
1716,Friday Lymphoma Lunch Richters UK lymSM CLLsm,Chan Cheah,Negative
1717,calquence mantlecelllymphona,AustralianPrescriber,Negative
1718,Visita El Post En la celulas del sistema inmune que ya ha sido tratado con al menos otro,Doctiplus,Negative
1719,Study Finds Single,Oncology Times,Negative
1720,Leukemia MCL,Michael Wang MD,Negative
1721,three ASCEND PFS rituximab bendamustine CLL,NatureRevClinOncol,Postive
1722,Acerta Pharma one BTK,joewhitworth,Negative
1723,three Rituximab Bendamustine CLL,Francesco Bertoni,Negative
1724,AcertaPharma Acalabrutinib Bruton BTK CLL,DelveInsight,Negative
1725,UK five Nebulised Heparin Bemcentinib Acalabrutinib Zilucoplan ArvindKejriwal AUThackeray,Manam,Negative
1726,UK five five first Nebulised Heparin Bemcentinib Acalabrutinib Zilucoplan,Antibiotic Ghanem,Negative
1727,five UK one four Calquence Bemcentinib Zilucoplan,Julien Potet,Negative
1728,Five thirty Heparin Bemcentinib Calquence Zilucoplan,Catherine Leong,Negative
1729,New Study Finds Single,Oncology Times,Negative
1731,Richard Furman ASCO eight thousand,Weill Cornell Medicine,Negative
1732,Virtual,Cancer Medicine,Negative
1733,PhII Sun May,Cancer Medicine,Negative
1734,three Rituximab Bendamustine Plus Rituximab,ClinOwl Oncology,Negative
1735,CLL Update Ibrutinib CLL four CLL,Mariam Alasfour,Negative
1736,CONGRESS ASCEND Paolo Ghia SanRaffaeleMI CLL,Lymphoma Hub,Negative
1737,three Rituximab Bendamustine Plus Rituximab CLL,Benlazar Amine,Negative
1738,ASCEND first CLL Clear CLL ASCEND Phase three CLL,Toby Eyre,Postive
1739,CLL SLL,acalabrutinib,Negative
1744,five hundred CLL ninety CI,acalabrutinib,Negative
1754,CLL,acalabrutinib,Negative
1759,three Rituximab Bendamustine Plus Rituximab,filippo masini,Negative
1762,three Rituximab Bendamustine Plus Rituximab,ALI ALAHMARI,Negative
1768,Bruce CLL two thousand and twelve,Leukaemia Foundation,Postive
1769,Published Expert Review Clinical Pharmacology Jurczak BTK,Michael Wang MD,Negative
1770,CLL SLL,acalabrutinib,Negative
1771,Coronavirus le Calquence un traitement efficace,Sebastien Jemeferaivacciner,Negative
1772,Mantle Cell,acalabrutinib,Negative
1787,Mantle Cell,acalabrutinib,Negative
1792,Coronavirus le Calquence un traitement efficace,Laurent Pradal,Negative
1793,CLL,Lymphoma Hub,Postive
1796,two CLL SLL,Lymphoma Hub,Postive
1799,AstraZeneca Announces April fifteen two thousand and twenty Matthew Fowler CancerNetwrk AZ Press Release,Mike Thompson MD PhD FASCO,Negative
1800,dans,Industrie Pharma Magazine,Negative
1801,CLL,Andy Evens,Negative
1802,theNCI Historically Btk one,Lu Chen nobias,Negative
1803,Marisol Urbieta Oncologie France AstraZeneca explique que va etre dans la lutte contre de Nicolas VIUDEZ AstraZeneca,Sylvie Latieule,Negative
1804,dans industrie pharma actus,Fabien Prevots,Negative
1805,two,CURE Magazine,Postive
1806,PO BUY United two Lynparza,dough,Postive
1810,CLL,Targeted Oncology,Negative
1811,Leslie CLL,Targeted Oncology,Negative
1812,one,Targeted Oncology,Negative
1814,Obinutuzumab,Anastasios Raptis MD,Negative
1816,Glosario de Veronica Saladrigas Menda three thousand two hundred ABG zero Consulta,Fernando Navarro,Negative
1817,Suan rimupaza Calquence,Zhi Yao san,Negative
1818,Skills Challenge Clinical Pearls four,Medscape Education,Negative
1819,Skills Challenge Clinical Pearls three,Medscape Education,Negative
1820,CLL,FarmaOnco,Negative
1822,CI,Andy Evens,Postive
1823,Vergleichsstudie Acalabrutinib da Leukamie CLL two Jahren Anteil,univadis,Negative
1825,Guardians Galaxy,Phil Kinzler,Negative
1827,Tocilizumab Acalabrutinib,Tom Gara,Negative
1828,twelve EPS BUY United Calquence Enhertu Roxa,dough,Postive
1829,AstraZeneca Begin Calquence Study Coronavirus Treatment,Buried On,Negative
1830,un,Clinica Hallwang,Negative
1831,obinutuzumab,Hallwang Clinic,Negative
1833,Bao rinpaZhong,Sey Shan Deng Sheng ,Negative
1835,Politico Remdesivir Acalabrutinib Baricitinib Favipiravir tablet Tocilizumab,Chris Yeh,Negative
1837,AstraZeneca Announces,Victor YosefMelt Campos,Negative
1838,AstraZeneca Calquence Power Belongs,Sante,Negative
1841,one Zoom first next week MS AstraZeneca,Katie Wilkinson,Negative
1842,AstraZeneca Calquence BusinessNews Cambridge Coronavirus Health LifeScience,Excelya,Negative
1843,Obinutuzumab CLL,The ASCO Post,Negative
1844,TNShi Yan,MEDWAVE,Negative
1845,James Learn CLL,The James,Negative
1846,New Drug,AustralianPrescriber,Negative
1847,Obinutuzumab,Anastasios Raptis MD,Negative
1848,AstraZeneca,WWFHTX,Negative
1849,three obinutuzumab CLL,Michael Wang MD,Negative
1850,AstraZeneca Calquence NIH FiercePharma,CarThera,Negative
1851,BTK Xin Xing Xiang Yan Kai Shi Yi Yao,Shohta Kadomura Hospital Pharmacist,Negative
1853,AstraZeneca Calquence NIH,clinicalsourcing,Negative
1856,two,CURE Magazine,Postive
1857,AstraZeneca Read,NLSDays,Negative
1858,PR TIMES,pengintaimuzu,Negative
1863,obinutuzumab versus chlorambucil obinutuzmab,MHC,Negative
1864,Acalabrutinib Calquence,Oncology Nursing News,Negative
1865,AstraZeneca Learn,Luminasllc,Negative
1866,NIH Francis Collins Background,Ned Pagliarulo,Negative
1867,Calquence one fifteen,AIS Health,Negative
1868,COVIDnCancer AstraZeneca Calquence Clinical OneOncology AmericanCancer Society Read,The Cancer Letter,Negative
1869,Collins Astrazeneca,Zach Brennan,Negative
1870,obinutuzumab versus chlorambucil obinutuzmab three,Tom Heston,Negative
1871,Nurse Times Nurse Times Coronavirus la tempesta Si Sanita NurseTimes,Nurse Times,Negative
1872,obinutuzumab versus chlorambucil obinutuzmab three,renalRCTs,Negative
1873,Lancet Acalabrutinib CLL FDA PNN JournalWatch,Michael Posey,Negative
1874,AstraZeneca,Paul Brackley,Negative
1875,Selektif Bruton Acalabrutinib Calquence Announces CALAVI Trial Examine Acalabrutinib Patients,deniztural,Negative
1876,AstraZeneca Calquence Shows Early,Olivier Elemento,Negative
1878,Calquence BTK APTO,Persimmon Tree Investments,Negative
1880,BTK BTK,RahumJ,Postive
1881,obinutuzumab versus chlorambucil obinutuzmab three,ClinOwl,Negative
1883,BTK BTK,Targeted Oncology,Negative
1884,Shi Yan Kai Shi Ding Ri,REAL TONARINO,Negative
1885,two RichtersSyndrome,TAP Clinical Trial Network,Negative
1886,OncoAlert obinutuzumab versus chlorambucil obinutuzmab CLL three CLLsm,Raul Cordoba MD PhD,Negative
1887,TheLancet three obinutuzumab,RIOH,Postive
1888,BTK,Nathan Twala,Negative
1890,BTK,Oncology Nursing News,Negative
1891,AstraZeneca Announces,Unal Metin Tokat,Negative
1892,AstraZeneca AstraZeneca,Home Journal,Postive
1893,The Lancet Very,Anthony Mato,Negative
1895,CLL Congrats TheLancet,Deborah Stephens,Postive
1896,three pharma week Article one Article two Article three Roundup ThisWeek PharmaForecast,Fraser Dove International,Negative
1897,AstraZeneca Initiates CALAVI Clinical Trial With Calquence Against,Pharma Journalist,Negative
1898,AstraZeneca Karyopharm AhlstromJenny,MyelomaDad,Postive
1899,Overheden kunnen maar doemdenken mbt Binnekort Remdesivir Dit kunnen stuk gamechangers,StockWatcher,Negative
1900,AstraZeneca,Pharma Business Int,Negative
1902,AstraZeneca Begins Clinical Trial Calquence Treatment,hehehenohebimetarou,Negative
1903,TheLancet obin v Great CLL CLL Congrats,Toby Eyre,Postive
1904,obinutuzumab versus chlorambucil obinutuzmab three,Krishan Maggon,Negative
1907,TheLancet obinutuzmab CLLsm,Chan Cheah,Postive
1908,obinutuzumab versus chlorambucil obinutuzmab three,Juan Marquet,Negative
1910,obinutuzumab versus chlorambucil obinutuzmab three Lancet,Young Hematologists,Negative
1912,AstraZeneca Calquence BTK,Wayne Radinsky,Negative
1914,ICYMI AstraZeneca Calquence,We Work Health Virginia,Negative
1915,three fda,Jeff Sharman,Postive
1919,AstraZeneca Calquence NIH,Anna Lubas,Negative
1920,Calquence biopharma pharmaceutical pharma,BioPoint Inc,Postive
1921,APTO BTK BTK,Jonathan Faison,Postive
1922,BTK,Targeted Oncology,Postive
1923,AstraZeneca,BioCanRx Canada Immunotherapy Network,Negative
1924,BTK,Earle Burgess,Negative
1925,Medicamento Calquence da AstraZeneca contra,Maria Rejane Rocha,Negative
1926,AstraZeneca Calquence,Cpl Life Sciences,Negative
1928,UK Acalabrutinib Ireland CllIreland JanRynne,Michael Rynne,Postive
1931,AstraZeneca Calquence NIH,vshariharakrishnan,Negative
1932,AstraZeneca Announces,Jorie graham,Negative
1934,AstraZeneca Calquence MailOnline,Biggomamma,Negative
1936,AstraZeneca Calquence,BiopharmaMASH,Negative
1937,BTK,Dragana Obradovic,Negative
1938,CLL obinutuzumab venetoclax,Medscape Oncology,Negative
1940,Assessing Acalabrutinib Burton one four hundred,Clinical Trials Research,Negative
1941,two Blood American Society Hematology,Dr Comeau MD,Negative
1942,AstraZeneca Btk Calquence,Philly,Postive
1943,AstraZeneca AstraZeneca Calquence April,PharmacyWeek Kevin,Negative
1944,Pharma,Edwin van Bloois PhD,Negative
1945,AstraZeneca,David Ledger,Negative
1946,AstraZeneca Plc Calquence,McGill Oncology,Negative
1948,Trump daily Netherlands AstraZeneca four hundred,EuroSavant,Negative
1949,Forbesbr Medicamento Calquence da AstraZeneca contra,Forbes Brasil,Negative
1952,AstraZeneca BioPharma Dive,Sharky Sarah,Negative
1953,AstraZeneca BioPharma Dive,Diving News,Negative
1954,one,BioPharma Dive,Postive
1955,Chronic BTK Ibrutinib Acalabrutinib CLL,Patient Power,Negative
1956,TargetedOnc,Dalia ElGamal,Negative
1957,AstraZeneca Calquence NIH,Aspen Biosciences,Negative
1960,AstraZeneca Calquence NIH,Emilio Mordini,Negative
1961,AstraZeneca Begin Calquence Study Coronavirus Treatment,ASOII,Negative
1962,AstraZeneca Calquence,one Am Biotech,Negative
1963,Calquence,David Ledger,Negative
1964,AstraZeneca,CDE News,Negative
1965,AstraZeneca Initiates CALAVI Study Evaluating Calquence AstraZeneca,Adi Singh,Negative
1966,AstraZeneca two BTK,Shawn Friend,Negative
1967,AstraZeneca two BTK,Prestige Scientific,Negative
1968,AstraZeneca BTK se basa evidencia cientifica solida respalda el papel de la BTK de citocinas inflamatorias,Miguel Angel Grullon,Negative
1972,prota dedomena apo te khrese Calquence te AstraZeneca,Nikolaos Mastrogiorgis,Negative
1973,AstraZeneca Test Impact Cancer Drug Calquence Coronavirus Patients AstraZeneca,Plexus Ventures,Negative
1974,Coronavirus AstraZeneca Calquence,MDDigitasTV,Negative
1975,Pharma Bie Cun Yao Zhi Yan Kai Shi,Duo Yang Xing niFu muYe Qiu woWang muZhe ,Negative
1976,AstraZeneca Calquence MailOnline,Robert,Negative
1977,AstraZeneca Calquence AZ,Clinithink,Negative
1979,National Cancer Institute,Rocky,Negative
1980,British,Olatunde Ayodeji,Postive
1981,Arsaken Korona,HealthTalk,Negative
1982,AstraZenecaSE ett,Ulla Nyman,Negative
1983,dedomena apo khrese tou Calquence,Insider Cyprus,Negative
1984,AstraZeneca Initiates CALAVI Study Evaluating Calquence AstraZeneca,PharmaShots Incisive news three shot,Negative
1986,AstraZenecaNL,martijn antonisse,Negative
1987,AstraZeneca Calquence,Sergey Minaev,Negative
1988,Coronavirus AstraZeneca,AAA,Negative
1990,prota dedomena apo te khrese Calquence te AstraZeneca,DIOGENIS CHARALAMPIDIS,Negative
1991,British,Cathlene Sareli,Postive
1993,AstraZeneca Calquence Article AMP Reuters,Jennifer Ng,Negative
1995,AstraZeneca Calquence NIH,EIPG,Negative
1997,SmartNews,Jared,Negative
2000,AstraZeneca,World Pharma News,Negative
2001,AstraZeneca,WebWire,Negative
2002,AstraZeneca medicamento indicado para tto da ONCONEWS,Onconews,Negative
2004,contra el coronaviru GoogleAlerts,httpp,Negative
2005,PWMJohnson Bruton TKI,Prof David Sebag,Negative
2007,Please,Kim Kovarik,Postive
2008,AZN Tuesday Calquence,MAISA,Negative
2009,British,World News In Tweets,Postive
2010,British,The Independent,Postive
2012,BTK,Anand Patel,Negative
2013,AstraZeneca Test Impact Cancer Drug Calquence Coronavirus Patients,Boya Wang,Negative
2014,AstraZeneca Calquence MailOnline,Dorothy,Negative
2015,AstraZeneca Calquence AstraZeneca MailOnline,DJGOLDEN,Postive
2016,PharmaScrip AstraZeneca Taskforce Starts With Calquence Trial PharmaScrip,ZorgNL,Negative
2018,AstraZeneca Calquence,Daily Mail,Negative
2020,China two Tuesday British AstraZeneca one,Pablo AQ,Negative
2021,CytokineStorm,LAKSHMIN NANDAGOPAL,Negative
2024,AstraZeneca Test Impact Cancer Drug Calquence Coronavirus Patients,Prasad Wakchaure PhD,Negative
2026,AstraZeneca Launches Drug Calquence,Giuseppe LiMandri,Negative
2027,AstraZeneca Calquence Reuters,PhRMA,Negative
2032,BTK Ibrutinib Acalabrutinib Ohio Anderson TOMORROW CLL,Andrew Schorr,Postive
2033,AstraZeneca Taskforce Starts,Scrip,Negative
2035,AstraZeneca Calquence NIH,Scott Weston,Negative
2036,AstraZeneca Learn Forbes,Qbox,Postive
2038,two CLL,Blood Journal,Negative
2041,AstraZeneca Calquence NIH,PharmaBian Ji Chang ,Negative
2042,Astra Zenecas Calquence har USA CoronaVirusSverige,The Dude,Negative
2045,AstraZeneca Clinicaltrial,Cancer Clinical Trials All,Negative
2048,British,The Independent,Postive
2049,EXCLUSIVE AstraZeneca Calquence,Vinay Prasad MD MPH,Postive
2050,AstraZeneca,CP Graduate Academy,Negative
2051,AstraZeneca Calquence CytokineStorm,SY Investing,Negative
2053,AstraZeneca Calquence AZN,Market Intelligence Healthcare,Negative
2054,Calquence Calquence CALAVI,EuropaWire,Postive
2055,Calquence BTK Calquence CALAVI,EuropaWire,Negative
2056,AstraZeneca Calquence,EuropaWire,Negative
2057,AstraZeneca Calquence CALAVI AstraZeneca,EuropaWire,Negative
2059,Calquence BTK,Ned Pagliarulo,Negative
2060,calquence lmstkhdm lHlt lmt'khr@ shrk@ bHthy,Agha,Postive
2061,AstraZeneca Calquence,Lillian Albert,Negative
2062,AstraZeneca Calquence FDA CocaCola,Ant Pope,Negative
2063,contra el coronavirus,El Cierre Digital,Negative
2065,AstraZeneca,RTTNews Top Stories,Negative
2066,almost half CLL,CONQUER patient voice,Negative
2067,AstraZeneca Calquence Calquence,ClinicalTrialsData,Negative
2068,AstraZeneca Calquence Calquence,NASDAQ,Negative
2069,AstraZeneca,PressReleasePoint,Negative
2070,Zenica farmaceutska kompanija klinicko TESTIRANJE CALQUENCE za Ovaj koristi protiv tipova cancera,Budimirka Vuletic,Negative
2071,Calquence,PharmaTimes,Negative
2072,AstraZeneca Calquence,Omer Haghi,Negative
2073,AstraZeneca Calquence MailOnline,Ashish Ranjan Swain,Negative
2074,AstraZeneca BTK,CharlesPollackMD,Negative
2075,AstraZeneca Calquence,RizonSon,Negative
2076,AJBCSurveys,SJ Lefevre,Postive
2077,NCI,Juan Ivancevich MD,Negative
2079,AstraZeneca Calquence MailOnline,Julia Chidley,Negative
2080,AstraZeneca Calquence Reuters,Open Outcrier,Negative
2081,AstraZeneca Calquence,ExpPharma,Negative
2082,ELABOREAZA DE RELANSARE EC DE one thousand five hundred,zarnescu valentin,Negative
2083,inicia el ensayo clinico Calquence contra,Investors Squad,Negative
2084,AstraZeneca,Company News HQ,Negative
2085,AstraZeneca Calquence BarringtonJames DrugTrial,Barrington James,Negative
2088,AstraZeneca Calquence MartheFourcade,John Lauerman,Negative
2090,AstraZeneca,BiopharmaAsia,Negative
2091,Calquence,Julianna Tatelbaum,Negative
2092,AstraZeneca Calquence,Daily Mail,Negative
2093,AstraZeneca Calquence AZN,The Fly,Negative
2094,AstraZeneca,Jon Angelo,Negative
2095,AstraZeneca Calquence drug treatment,New Model Adviser,Negative
2096,AstraZeneca Calquence,Wealth Manager,Negative
2097,AstraZeneca Calquence,Reuters,Negative
2098,AstraZeneca Calquence Reuters,Hargreaves Lansdown,Negative
2100,AstraZeneca,Pharmafocus,Negative
2101,CV UPDATE AstraZeneca,Downtown News,Negative
2102,CV UPDATE AstraZeneca,Cool FM News,Negative
2103,CV UPDATE AstraZeneca,DowntownCountry News,Negative
2104,AstraZeneca Calquence,TheArticleTrunk,Negative
2105,Calquence,TheStreet,Negative
2106,Cambridge AstraZeneca one Calquence Cambridgeshire HeartNews,Heart News East,Negative
2107,AstraZeneca six,Working Capital Consulting,Negative
2108,AstraZeneca Calquence Reuters HLInvest,daniel,Negative
2110,FTSE one hundred,Commercial Awareness,Negative
2111,AstraZeneca,Nordic Life Science,Negative
2112,AZ,Career Biotech,Negative
2113,AZ Calquence AstraZeneca,The PMI Pharmaceutical Managers Institute,Negative
2115,Calquence one bee,PhD,Postive
2116,AstraZeneca Calquence,Kate,Negative
2117,AstraZeneca BTK AZN,FirstWord Pharma,Negative
2118,AstraZeneca Calquence,CHItraders,Negative
2119,startar klinisk som verkar den inflammatoriska skapar stora problem,Maths Nilsson,Negative
2120,Astra AstraZeneca,Oliver Haill WFH,Negative
2121,AstraZeneca Calquence Healthcare,Altizem,Negative
2122,AstraZeneca FTSE one hundred Calquence drug treatment Read FundFanatic,Citywire,Negative
2123,AstraZeneca Calquence MailOnline,STRANGER THAN FICTION NEWS,Negative
2124,Calquence,Saleh Stevens,Negative
2126,AstraZeneca Calquence,Jimmys Post,Negative
2127,Calquence,TheArticleTrunk,Negative
2128,Calquence ICU ITU US Europe,Recruitment,Negative
2130,AstraZeneca Calquence,odenOracle,Negative
2131,AstraZeneca Calquence CoronavirusUpdates,EMG GOLD,Negative
2132,AstraZeneca Calquence,chorley chicken,Negative
2133,AstraZeneca Calquence VigorBot Medicine,Medicine Briefly,Negative
2135,Calquence,Buddug Light,Negative
2136,SOMEONE one AstraZeneca Calquence MailOnline,Sheikh Anvakh lqT yryd lT`m mr@ 'khr~,Negative
2137,AstraZeneca Calquence,Reuters UK,Negative
2138,AstraZeneca Calquence,Kristin Gustavsen,Negative
2139,AstraZeneca Calquence,Sante,Negative
2140,testar cancerlakemedel mot LakemedelsVarlden,Lakemedelsvarlden,Negative
2141,AstraZeneca Calquence,LBC News,Negative
2142,AstraZeneca Calquence,John Tawn,Negative
2144,Astra Zenecas senaste hoppet att behandla Det Forbes,Roslund,Negative
2146,AstraZeneca Calquence,OCS Channel,Negative
2147,Calquence AZN GSK,Investor News,Negative
2148,AstraZeneca Test Impact Cancer Drug Calquence Coronavirus Patients Reuters,Israel Stagman,Negative
2149,EXCLUSIVE AstraZeneca Calquence,Ranjeet,Postive
2150,Reuters,Vanya Aleksandrova,Negative
2151,AstraZeneca Calquence coming day United States Europe,OnTheFritz,Negative
2152,UK Zeneca un sur de malades de Il fifteen thousand Euros sixty,Aldo Sterone,Negative
2153,AstraZeneca Calquence,Devdiscourse,Negative
2154,AstraZeneca Calquence,Bistosh World,Negative
2156,AstraZeneca Calquence,Suede en Algerie,Negative
2157,AstraZeneca Article AMP Reuters,Adam Fraise,Negative
2158,AstraZeneca Calquence,Daily Mail,Negative
2159,AstraZeneca Calquence,Laleh,Negative
2160,Small Manufacture Trials way Anecdotal,Team McKimmie VHIT,Postive
2161,AstraZeneca VigorBot Medicine,Medicine Briefly,Negative
2164,AstraZeneca,biotoday,Negative
2165,AstraZeneca Calquence Really,Lorena Delgado Varas,Postive
2166,AstraZeneca Calquence,Kungens Kurva,Negative
2167,AstraZeneca Calquence,chorley chicken,Negative
2168,MEDICIN,Samtiden,Negative
2169,AstraZeneca Calquence,David Madden,Negative
2170,Corona Calquence,Kaj Jakobsson,Negative
2171,AstraZeneca Calquence,ST Foreign Desk,Negative
2172,AstraZeneca Calquence,The Straits Times,Negative
2173,AstraZeneca Calquence,Devdiscourse,Negative
2175,AstraZeneca,Pani Blondynka,Negative
2176,Astra,Jonas Medin,Negative
2177,lyckas,Stefan Fahlander,Negative
2178,AstraZeneca Calquence,Matti Wallin,Negative
2179,Calquence BTK,John Wilander,Negative
2180,AstraZeneca Calquence,Stefan Laurell,Negative
2181,AZN BTK Calquence BGNE NOVN,Bio Station,Negative
2184,AstraZeneca,Cision News,Negative
2185,Imbruvica,Forbes Science,Negative
2188,BTK,Pengyu Yang,Postive
2190,seventytwo hour FDA,PeterDFokes,Negative
2191,BTK EXCLUSIVE AstraZeneca Calquence,Kenneth Farber,Postive
2195,Ibrutinib CLL,Shouting people underpants,Postive
2198,AstraZeneca DavidSteensma EricTopol,Vineeth Sukrithan,Postive
2199,Calquence Imbruvica,Maria Badillo MSN RN OCN CCRP,Postive
2201,BTK,John Leonard MD,Negative
2202,BTK Coronavirus,Howard Green MD,Negative
2204,one Calquence Imbruvica tAPTO eight hundred and six,Joe,Negative
2206,Forbes BTK EXCLUSIVE AstraZeneca Calquence,Grant Beasley,Postive
2214,British AstraZeneca Calquence,Global Capital Asset Management,Negative
2215,Erlotinib Sunitinib Lapatinib Dasatinib CML,PharmaFactz,Negative
2216,Leukemia,Antoine Gara,Negative
2218,British AstraZeneca Calquence,Omondi Nyangla,Negative
2219,British AstraZeneca Calquence,Forbes,Negative
2220,BTK,Matthew Herper,Negative
2221,eight seventeen thirty Key Calquence CLL Enhertu,dough,Postive
2224,AstraZeneca Calquence,Nathan Vardi,Negative
2228,OncoAlert CLL two American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
2229,two Blood American Society Hematology CLL,Benlazar Amine,Negative
2230,Antitumor Potency Chimeric Antigen Therapy Lisocabtagene,Garbine Lizeaga,Negative
2231,two Blood American Society Hematology,Aloysius Pendergast,Negative
2232,European Union Novo Nordisk Rybelsus two thousand and twenty,Knowledge,Postive
2233,European Union Novo Nordisk Rybelsus two thousand and twenty,Knowledge,Negative
2235,AGN two thousand and twenty two three SKYRIZI two thousand and twenty BI HUMIRA IMBRUVICA CLL,dough,Postive
2236,Second BTK CLL,ALI ALAHMARI,Negative
2239,three,Crwe World,Negative
2241,almost half CLL Calquence Gazyva Venclexta,CONQUER patient voice,Negative
2242,three,Targeted Oncology,Negative
2243,ICYMI Lori Leslie MD John Theurer,Home Journal,Negative
2244,Erlotinib Sunitinib Lapatinib Dasatinib CML,PharmaFactz,Negative
2245,Irish first JanRynne CllIreland,Michael Rynne,Negative
2246,Overall Sharman,Targeted Oncology,Negative
2247,UTSWNews,OncLive SOSS,Negative
2249,CLL UK AstraZeneca CLL,Toby Eyre,Postive
2251,CLL DanaFarber ImmunoOnc,VJHemOnc,Negative
2252,two CLL BTK ORR QD,NatureRevClinOncol,Negative
2253,CLL BTK Blood American Society Hematology,ALI ALAHMARI,Negative
2254,two,Cancer Care,Negative
2255,CLL BTK Haematology,ClinOwl Haematology,Negative
2256,two thousand and,IWMF,Negative
2260,Krista Isaac,Anthony Mato,Postive
2261,three TN Study CLL Chaitra Ujjani three,Oncology Tube,Negative
2262,Obinutuzumab Superior Obinutuzumab Plus,The ASCO Post,Postive
2263,March OhioState CLL ClinicalTrial,Cancer Discovery,Negative
2264,Obinutuzumab Superior Obinutuzumab Plus,The ASCO Post,Postive
2265,Import Market Calquence India,Motilal Oswal Financial Services Ltd,Negative
2266,AstraZeneca India DCGI,Medical Dialogues,Negative
2267,DanaFarber,OncLive SOSS,Negative
2268,Trend Overman two Bruton pembrolizumab,paper link,Negative
2269,AstraZeneca Pharma DCGI Calquence,IIFLMarkets,Negative
2270,Trend Overman two Bruton pembrolizumab,paper link,Negative
2271,Trend Overman two Bruton pembrolizumab,paper link,Negative
2272,Trend Overman two Bruton pembrolizumab,paper link,Negative
2273,Trend Overman two Bruton pembrolizumab,paper link,Negative
2274,Trend Overman two Bruton pembrolizumab,paper link,Negative
2275,Overman two Bruton pembrolizumab,paper link,Negative
2276,AstraZeneca Pharma India Ltd DCGI Equity Bulls,Dr Timos Papagatsias,Postive
2278,michaelwangmd one acala,Luis Villela,Negative
2279,TC Bec STELLAR yesterday two RichtersSyndrome,TAP Clinical Trial Network,Negative
2280,Trend Overman two Bruton pembrolizumab,paper link,Negative
2281,Trend Overman two Bruton pembrolizumab,paper link,Negative
2282,Trend Overman two Bruton pembrolizumab,paper link,Negative
2283,Trend Overman two Bruton pembrolizumab,paper link,Negative
2284,Trend Overman two Bruton pembrolizumab,paper link,Negative
2286,Overman two Bruton pembrolizumab,paper link,Negative
2290,New AusPAR Calquence CLL SLL,TGA Australia,Negative
2293,CLL UTSWNews,OncLive SOSS,Negative
2296,Project Orbis FDA CLL SLL,PressReleasePoint,Negative
2299,Beatson yesterday two RichtersSyndrome NHSGGC CLTAP,TAP Clinical Trial Network,Negative
2300,New JITC two Bruton pembrolizumab,Journal ImmunoTherapy Cancer,Negative
2301,two Bruton pembrolizumab,Lymphoma Papers,Negative
2302,New AusPAR Calquence Acalabrutinib,TGA Australia,Negative
2304,CancerMedMDA BTK Pembro PancreaticCancer,Anirban Maitra,Negative
2306,Calquence Acalabrutinib Yi Chong Ji Mei Yi Zhi Ji Gua Yong Wei Shou Shou Zhi Shao Yi Chong Yi Qian Zhi Liao Cheng Huan Zhe Tao Xi Bao Lin Ba Liu  MCL,GenericDrugs,Negative
2308,Today two Bruton pembrolizumab,Scitrus,Negative
2309,Jeff Sharman TN FDA CLL,Oncology Learning Network,Negative
2310,obinutuzumab obinutuzumab plus chlorambucil CLL,ASH Clinical News,Postive
2311,RWD RWE,Raul Cordoba MD PhD,Negative
2312,Ryan mclsm lymsm,Targeted Oncology,Negative
2313,MCL,Trip Database,Negative
2314,two RichtersSyndrome ClinicalTrials,TAP Clinical Trial Network,Negative
2316,MCL MCLsm,Targeted Oncology,Negative
2317,Two BTK CLL two,Targeted Oncology,Negative
2318,BTK,Targeted Oncology,Negative
2319,macroglobulinemie van Waldenstrom,MedNet,Negative
2320,CLL Cancer Care,Shohta Kadomura Hospital Pharmacist,Negative
2321,Richard Furman CLL OncLive,WCM Lymphoma,Negative
2323,Acalabrutinib Monotherapy Active,Saeid Shamsian MD,Negative
2324,MCL,Trip Database,Negative
2325,Bruton Desempena un Ejemplos Calquence Indicacion Efectos trombocitopenia leucopenia,JDiegoTR,Negative
2326,BTK Calquence Indication Leucopenia Anemia Fatigue Headache,Ph Abdulluh,Negative
2327,BTK Calquence Indication Leucopenia Anemia Fatigue Headache,PharmaFactz,Negative
2328,Waldenstrom mmsm,Benlazar Amine,Negative
2330,Waldenstrom two,Lymphoma Papers,Negative
2331,BTK,Cure Cancer Now,Negative
2333,discus Calquence,OncLive SOSS,Negative
2334,ICYMI obinutuzumab,Home Journal,Negative
2335,Click CLL,The James,Negative
2337,two yr ago ASA five CardioOnc CardioOncology EimanJahangir,Juan,Postive
2338,three Bcell,Renal Cell Carcinoma,Negative
2342,CLL BTK Jennifer Woyach OhioState HemeOnc,VJHemOnc,Negative
2344,CLL WVCancer HemeOnc,VJHemOnc,Negative
2346,CLL,Hematology Advisor,Postive
2347,WVCancer CLL,ClinicalOncologyNews,Negative
2349,CLL,Adam Kittai,Negative
2350,CLL,ASH Clinical News,Postive
2351,eighty two year,Raj Chakraborty,Negative
2352,last month Waldenstrom Read WmukInfo,LymphomaAction,Negative
2353,Tussle Southampton Oxford Ston one Oxford,Early Phase Clinical Trials Unit Oxford,Postive
2355,FDA Calquence CLL PhramaTimes,Braeden Lichti,Negative
2357,three Jeff Sharman three,Oncology Tube,Negative
2358,Today American Society Hematology two thousand and nineteen George Follows ASH CLL,Leukaemia Care,Negative
2359,year alone Calquence one,Treximo,Postive
2360,obinutuzumab,Medivizor,Negative
2361,obinutuzumab leu medivizor,Medivizor,Negative
2362,obinutuzumab,Medivizor,Negative
2363,obinutuzumab Leukemia,Medivizor,Negative
2364,obinutuzumab,Medivizor,Negative
2365,obinutuzumab,Medivizor,Negative
2366,Waldenstrom two The Lancet Haematology,Lia Palomba,Negative
2367,CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously three CALQUENCE,Oncology Tube,Negative
2368,Leukemia Okay one,Quiet Flows Dan,Negative
2370,CLL SLL,ASH Clinical News,Postive
2371,Waldenstrom monoterapia ACALABRUTINIB un recaida Lancet Haematol two thousand and nineteen,Mauricio Ambriz,Negative
2372,FDA Calquence,MolecularMatch,Negative
2373,CLL eight,NatureRevClinOncol,Negative
2374,Learn CLL,The James,Negative
2375,Great UK,Toby Eyre,Postive
2376,Roger Owen first ORR Only one AF,Graham Collins,Postive
2377,The UK CLL Forum CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
2378,one hundred and six Waldenstrom ORR fourteen LysaLymphoma,Lysa Lymphoma,Negative
2379,Ji Zhi Liao Hai Yao Ji Tou Yu gaYi Shi Xuan Ze Zhi Liao yorimoYou Yi niPFSwoYan Chang,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
2380,Leslie,Targeted Oncology,Negative
2381,gen Btk,Sujeet Kumar,Negative
2382,three Calquence obinutuzumab Gazyva obinutuzumab chlorambucil Leukeran WVCancer,Brian Mattys,Negative
2383,two CLL,NatureRevClinOncol,Negative
2385,OhioState CLL ClinicalTrial,Cancer Discovery,Negative
2386,AstraZeneca Canada hui Sante Canada,journal le soir,Negative
2387,OhioState CLL ClinicalTrial,Cancer Discovery,Negative
2389,Bruton one ImmunoOnc,NatureRevClinOncol,Negative
2392,Therapy Lisocabtagene,Chimeric Antigen Receptor,Negative
2393,CLL Jennifer Woyach MD,OncLive SOSS,Negative
2394,Calquence monoterapia alla chemioimmunoterapia standard,Carlo Franzini,Negative
2395,Antitumor Potency Chimeric Antigen Therapy Lisocabtagene,Memory,Negative
2396,Antitumor Potency Chimeric Antigen Therapy Lisocabtagene,Lymphoma Papers,Negative
2397,ICYMI Acalabrutinib obinutuzumab plus chlorambucil,Home Journal,Negative
2398,Antitumor Potency Chimeric Antigen Therapy Lisocabtagene,TumorImmunoPapers,Negative
2400,CLL Ibrutinib Acalabrutinib Nice,Prof John,Postive
2403,five Mato Ibrutinib CLL,OncLive SOSS,Negative
2404,Pelotonia Institute FDA two thousand and nineteen two thousand and twenty,Becca Peterson,Postive
2407,BTK inhibitor inc Sharman cllsm,Targeted Oncology,Postive
2408,two thousand and nineteen FDA ONAYLARI atezolizumab crizanlizumab enfortumabvedotin fda kansertedavisi memorialatasehirhematoloji onkoloji profdrhisari trastuzumabde,Ismail Sari,Negative
2409,CLL two thousand and Annual,Targeted Oncology,Postive
2410,obinutuzumab versus obinutuzumab plus chlorambucil,Targeted Oncology,Negative
2412,CLL,Benlazar Amine,Negative
2415,two,Lymphoma Papers,Negative
2416,two Read OLN,Oncology Learning Network,Postive
2420,two CLL BloodJournal two AF seven five CR four,Toby Eyre,Negative
2421,one one Calquence Twitter one,Matthew Rehrl MD MS,Negative
2422,one FDA MCL,Michael Wang MD,Negative
2423,Lymphoma Calquence kayak,Matthew Rehrl MD MS,Negative
2426,one one Time,Amanda Marie,Negative
2427,zanubrutinib Eventually BTK statin,Tim Fenske,Negative
2431,ASH two thousand and nineteen one AstraZenica one,Michael Wang MD,Negative
2433,two Roger Owen Waldenstrom,The Lancet Haematology,Postive
2434,Waldenstrom mmsm,Benlazar Amine,Negative
2435,three obinutuzumab v acalabrutinib CLL,Lymphoma Hub,Negative
2436,Waldenstrom two,Nicolas Zarjevski,Negative
2437,CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously,Oncology Tube,Negative
2443,Richard Furman CLL,WCM Lymphoma,Negative
2444,CLL Jeff Sharman,Health,Negative
2445,James Gerson MD MCL,OncLive SOSS,Negative
2447,three,Targeted Oncology,Negative
2451,CLL,acalabrutinib,Negative
2453,CLL,acalabrutinib,Negative
2460,Health WVCancer obinutuzumab chronic CLL CancerNews,Sarah Williams,Negative
2461,Mantle Cell,acalabrutinib,Negative
2467,one risultati di tollerabilita questa,Ritrattodellasalute,Negative
2469,Jeff Sharman MD obinutuzumab,Health,Negative
2480,Mantle Cell,acalabrutinib,Negative
2485,Jeff Sharman Obinutuzumab Chlorambucil,The ASCO Post,Negative
2486,CLL,Crwe World,Negative
2488,CLL,HCP Feed,Negative
2490,TUMORI LA PROGRESSIONE SIA COMBINAZIONE,one Malati Invisibili,Negative
2491,Zanubrutinib ASH,Paul Rennert,Postive
2492,one,Simon Rule,Negative
2493,Calquence Nuevas aprobadas para linfocitica CLL SLL,Daniel Garcia Estrada Retire,Negative
2495,APPROVALS,MEDWAVE,Negative
2496,two,COPD News,Postive
2497,migliora salutedomani,Salutedomani,Negative
2498,ASH CLL,Labofine,Negative
2499,AbbVie Imbruvica Calquence,Labofine,Negative
2505,Leucemia linfatica,Zazoom Social News,Negative
2506,Calquence Vascepa Oxbryta,Charnwood Molecular,Negative
2508,AstraZeneca Calquence Wins FDA Approval Chronic,BioPharmaDevice,Postive
2509,obinutuzumab,Home Journal,Negative
2510,Furman,Targeted Oncology,Negative
2511,AstraZeneca Calquence US,Raimo Skottman,Negative
2512,mejora la supervivencia linfocitica AstraZeneca,Luis Pereira Lopez,Negative
2513,AstraZeneca Calquence,Acobur,Negative
2514,mejora la supervivencia linfocitica,Renovatio Biomedica,Negative
2515,obinutuzumab plus chlorambucil,Home Journal,Negative
2517,AstraZeneca Calquence Steps Up CLL,Pharma Regulatory,Negative
2518,mejora la supervivencia linfocitica cronica los resultados Fase three AstraZeneca,IM Medico,Negative
2519,PharmaScrip AstraZeneca Calquence Steps Up CLL,ZorgNL,Negative
2521,Merck ArQule AbbVie Imbruvica AstraZeneca Calquence,BioPharma Dive,Negative
2522,AstraZeneca Calquence Steps Up CLL,Scrip,Negative
2523,AstraZeneca Calquence linfocitica,Redaccion Medica,Negative
2524,linfocitica,Acta Sanitaria,Negative
2525,Merck Lilly Merck ArQule AbbVie Imbruvica AstraZeneca Calquence EliLilly,BioPortfolio Eli Lilly news research,Negative
2527,AstraZeneca el tiempo los pacientes linfocitica,Francisco Acedo,Negative
2528,AstraZeneca Calquence CLL PharmaTimes AstraZeneca,Plexus Ventures,Negative
2529,AZ Calquence CLL,David Ledger,Negative
2530,ASH CLL FiercePharma,Lampgen Clinical Research,Negative
2531,Furman WeillCornell CLL,Targeted Oncology,Negative
2533,AZ Calquence CLL News PharmaTimes ClinicalResearch CLL,Recruitment,Negative
2534,un,Carlo Franzini,Negative
2536,Data Acalabrutinib Monotherapy CLL,Saeed Valadbaygi,Negative
2537,Jeff Sharman CLL,medwireNews,Negative
2539,Furman,Targeted Oncology,Negative
2542,AstraZeneca,Alex Keown,Postive
2544,three CALQUENCE obinutuzumab month,Philly Bio,Negative
2545,AstraZeneca Calquence Wins FDA Approval Chronic,HealthyCarnivores,Postive
2547,AstraZeneca Calquence CLL,Pharmaceutical Market Europe,Negative
2548,AstraZeneca Calquence,Pharmafocus,Postive
2550,AstraZeneca Calquence Wins FDA Approval Chronic,About Medtech,Postive
2551,AZ Calquence,eCare Vault Inc,Negative
2552,CLL AstraZeneca,Pharma Business Int,Negative
2553,AstraZeneca Calquence CLL,lukabiotech,Negative
2554,AZ Calquence CLL,Saleh Stevens,Negative
2555,FDA Project Orbis,Jon Gardner,Negative
2556,Nicholas Richardson ProjectOrbis,Kelly Norsworthy MD,Negative
2557,HemOncToday,US Oncology Network,Postive
2558,AZ Calquence Imbruvica,ACHUTHAN,Negative
2559,AZ Calquence Imbruvica,ACHUTHAN,Negative
2560,AZ Calquence CLL,Everything Pharma,Negative
2561,AZ Calquence CLL,Pharma Trader,Negative
2562,AZ Calquence CLL,Barry Curry,Negative
2563,AstraZeneca TN Study Previously Untreated AstraZeneca,PharmaShots Incisive news three shot,Negative
2564,obinutuzumab ibrutinib rituximab ibrutinib Learn Breaking Data CLL Rapid Impact Report,Breaking Data,Negative
2567,CLL,CellworksLife,Negative
2568,AstraZeneca Calquence,Jon Angelo,Postive
2569,AstraZeneca Calquence,Pharmafocus,Postive
2570,AZ Calquence Imbruvica,cafepharma,Negative
2571,AZ Calquence CLL healthcare pharma,PharmaTimes,Negative
2573,Calquence,Career Biotech,Negative
2574,CLL,Pharma Regulatory,Negative
2577,ASCENDShi Yan  Calquence CLL,Tweets,Negative
2580,Calquence Acalarutinib Mantle Cell Lymphoma CLL two thousand and seventeen Food Drug Administration Government FDA,Majalah Farmasetika,Negative
2581,Calquence Acalarutinib Mantle Cell Lymphoma CLL two thousand and seventeen Food Drug Administration,Info Farmasi Terkini,Negative
2582,Xin Zhao Ji Shi,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
2586,Richard Furman CLL,WCM Lymphoma,Negative
2587,Woyach OhioState CLL BTK,Amber Koehler,Negative
2588,CONGRESS Jennifer Woyach CLL,Lymphoma Hub,Negative
2589,CLL BTK BTK twelve mon cllsm,Mark Geyer,Negative
2590,CLL twelve month,Chan Cheah,Negative
2592,CLL TargetedOnc,Matthew Davids MD MMSc,Negative
2593,AstraZeneca Imbruvica,pharmaphorum,Postive
2595,ASH nineteen obinutuzumab mejora la,contacto sciencelink,Negative
2596,eight MRD Lampson,Targeted Oncology,Negative
2597,obinutuzumab chlorambucil CLL WVCancer,ASH Clinical News,Negative
2598,AstraZeneca BTK Calquence CLL,FirstWord Pharma,Negative
2600,Project Orbis FDAOncology,The ASCO Post,Negative
2601,Healio,Oncology Board,Postive
2602,ASH CLL,PharmaCrowd,Negative
2603,ASH weekend week ago CLL,Phil Talamo,Postive
2606,ASH CLL,EIPG,Negative
2607,Acalabrutinib Combination With For Relapsed Refractory,CureHuntr,Negative
2609,ASH CLL,Continental Clinical,Negative
2610,ASH CLL pharma,Dr Timos Papagatsias,Postive
2611,ASH CLL,NewExpressNews,Negative
2612,ASH CLL,analyst land news,Negative
2614,ASH Clinical News,Aloysius Pendergast,Postive
2615,CLL,Dave Hughes,Postive
2616,CLL fifteen month JanRynne,Michael Rynne,Postive
2618,PFS CLL obinutuzumab plus chlorambucil three,Targeted Oncology,Postive
2619,Lampson two CLL,Targeted Oncology,Negative
2622,CalquenceHCP AstraZeneca one hundred eight Ben Lampson DanaFarber,HemOnc Today,Negative
2623,Wayne,Brian Skorney,Negative
2625,Brands one Venclexta two Imbruvica daily KnowNow,Qollor,Postive
2626,Bruce Cheson CLL LombardiCancer,Ayushi Chauhan,Negative
2627,BTK AE CLL,Toby Eyre,Negative
2628,Leukemia Venclexta,Watzan,Negative
2629,Amgen Calquence Imbruvica Novartis Kite NVS GILD,Jon Gardner,Negative
2630,first CLL Obinutuzumab NHS,Raakhee Shah,Negative
2631,TheUSONetwork,HemOnc Today,Negative
2632,FYI Ibrutinib twenty IMHO,Paul DeSantis PharmD,Negative
2633,CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously three CALQUENCE,Cancer News,Negative
2634,AstraZeneca CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously three CompanyNews,Trading News,Negative
2635,AstraZeneca Calquence Known,flylemurs,Postive
2636,two month Starting Ven TLS CLL,Amber Koehler,Negative
2637,CLL BM,Luis Villela,Negative
2638,CONGRESS Lampson DanaFarber two CLL BM CR lymsm,Lymphoma Hub,Negative
2639,MRD TLS uMRD,Mark Geyer,Negative
2640,CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously,Latest News Business Wire,Negative
2641,BloodCancer Check CLL,AstraZenecaUS,Negative
2642,obinutuzumab beat chlorambucil obinutuzumab PFS obinutuzumab,Mark Geyer,Negative
2643,CALQUENCE Significantly Prolonged Time Patients Lived Without Disease Progression Death Previously Lymphocy AZN,Investor News,Negative
2644,TN CLL Jeff Sharman,Sigrid Skanland,Negative
2645,three six hundred and fortytwo seven two,Cancer Medicine,Negative
2646,CR CLL,Amber Koehler,Postive
2648,CLL One BTK,Marcio,Negative
2649,Jeff Sharman CLL three Obinutuzumab PFS Obinutuzumab Chrorambucil CLL,The Lancet Haematology,Postive
2652,TN CLL,Alan Skarbnik,Postive
2653,Obinutuzumab OFS GChl,Alan Skarbnik,Postive
2656,two,Lung Cancer News,Negative
2657,CLL Calquence Canadian ProjectOrbis Drugandmeddevice,Health Canada PHAC,Negative
2658,homologation acceleree de Calquence qui la leucemie LLC Canadiens ProjetOrbis Medicamentsetinstrumentsmedicaux,Sante Canada et ASPC,Negative
2669,three obinutuzumab Gazyva five hundred CLL,Brian Mattys,Negative
2671,FDA Therapy Approved,BioRealty Inc,Postive
2672,CLL ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
2674,Jeezus one million,BiotechObserver,Negative
2675,The Food Drug Administration John Byrd,CURE Magazine,Postive
2676,AstraZeneca Calquence Wins FDA Approval Chronic,CarnivoresHealth,Postive
2677,FDA Calquence AstraZeneca CLL SLL,Drug Topics,Negative
2678,AstraZeneca linfocitica,Acobur,Negative
2679,AstraZeneca presentara los datos del ensayo three linfocitica,IM Medico,Negative
2680,AstraZeneca Calquence Wins FDA Approval Chronic,Olderpreneurs,Postive
2681,OncoAlert Preliminary Safety Efficacy Results Phase two CLL,Raul Cordoba MD PhD,Negative
2682,OncoAlert three CLL,Raul Cordoba MD PhD,Negative
2683,FDA CLL SLL,Health,Postive
2684,AstraZeneca los primeros datos de en leucemia linfocitica,Pharma Jonpi,Negative
2685,presenta datos de Calquence linfocitica,Redaccion Medica,Negative
2686,FDA CLL SLL FDAapproval,Health,Negative
2687,IndustriaFarmaceutica AstraZeneca linfocitica,Redaccion Medica,Negative
2688,AstraZeneca linfocitica ActaSanitaria SaludDigital,LifeStyle Profesional El Neuropediatra,Negative
2689,Calquence linfocitica,Acta Sanitaria,Negative
2691,Them US Food Drug Administration Thursday November Calquence NDA two hundred and ten thousand two hundred Deferasirox two hundred and ten thousand nine hundred Givlaari two hundred and twelve thousand one hundred and ninetyfour,Living Safely,Negative
2692,FDA Approves SLL Evidence ASCEND lymsm,ESMO Eur Oncology,Negative
2693,CLL SLL,Lymphoma Hub,Negative
2694,CognitrexCancerDigest FDA AstraZeneca Calquence,Cognitrex Consultants,Postive
2696,FDA second,Viglya,Negative
2698,CLL SLL US Australia Canada,Medscape Pharmacists,Negative
2700,FDA,Volmar PhD,Negative
2702,Calquence Receives FDA Approval Treatment Patients Chronic SLL,Shohta Kadomura Hospital Pharmacist,Negative
2704,Study Investigate Use Acalabrutinib,CureHuntr,Negative
2705,FDA Approves SLL Evidence ASCEND,ESMO Eur Oncology,Negative
2706,FDA,ClinicalOncologyNews,Negative
2707,FDA Approves Calquence Treatment Option Adults CLL,BioNews,Negative
2708,AstraZeneca Calquence Wins FDA Approval Chronic,VCapital,Postive
2711,AstraZeneca Calquence Wins FDA Approval Chronic,Swedish Biotech,Postive
2713,AstraZeneca Calquence Wins FDA Approval Chronic,Chelli Miller,Postive
2714,LeucemiaLinfatica Fda approva PharmaStar ECM,Medical Evidence,Negative
2715,LeucemiaLinfatica Fda approva PharmaStar ECM,Professione Farmacia,Negative
2719,CLL,Arab Medical Pro,Negative
2724,FDA AstraZeneca Calquence Pharmafile,SDG UNWomen,Negative
2725,FDA AstraZeneca Calquence Pharmafile,hcrffngo SDG,Negative
2728,TGA CLL SLL TGA,TGA Australia,Negative
2729,MCL WeillCornell,WCM Lymphoma,Negative
2730,FDA Approves,New Drug Approvals,Negative
2732,CLL,ADIL Med Monitor,Negative
2733,Calquence obinutuzumab plus,MPR,Negative
2734,AstraZeneca Calquence CLL,Thomas Senechal,Negative
2735,FDA khronicheskim,ZdravMedInfo,Negative
2736,Calquence Uses Side Effects Interactions,Linex,Negative
2738,FDA,David Ledger,Negative
2739,CLL SLL US Australia Canada,Medscape,Negative
2740,FDA AstraZeneca Calquence,Pharmafocus,Negative
2741,FDA AstraZeneca Calquence,Jon Angelo,Negative
2742,AstraZeneca Calquence Wins FDA Approval,Pharma Regulatory,Postive
2743,AstraZeneca Calquence Catches Up With,Pharma Regulatory,Negative
2744,AstraZeneca Calquence Wins FDA Approval Chronic,cafepharma,Postive
2745,Two Drugs Givlaari Xcopri Project Orbis Collaboration Calquence,Derrick,Negative
2747,two Learn James,The James,Negative
2748,AstraZeneca Calquence Wins FDA Approval Chronic,Corixis,Postive
2749,AstraZeneca Calquence Wins FDA Approval Chronic,Pharmaceutical,Postive
2752,AstraZeneca Calquence Wins FDA Approval Chronic,Biotechnology,Postive
2753,AstraZeneca Calquence Wins FDA Approval Chronic,BioCalifornia,Postive
2756,AstraZeneca FDA BTK,Investor News,Negative
2757,TGA CLL SLL,AUS Gov News,Negative
2758,Project Orbis The FDA,Home Journal,Negative
2759,Medivizor,Chocolatiere Phys,Postive
2763,Project Orbis CLL US Canada Australia CllSociety CLL FDA,Tom Henry,Postive
2764,AstraZeneca Calquence Imbruvica CLL,Yanbo Zhang,Negative
2765,FDA Approves Acalabrutinib Treat,CellworksLife,Postive
2766,Calquence CLL SLL Calquence CLL SLL ty'ydyh,Phana,Negative
2767,FDA khronicheskim,Novosti GMP,Negative
2768,PharmaScrip,ZorgNL,Negative
2769,CLL SLL US Australia Canada,Medscape Oncology,Negative
2770,AstraZeneca Calquence Catches Up With PharmaScrip,Scrip,Negative
2771,FDA Approves Acalabrutinib Treat,Stayin Alive Body Mind Spirit,Postive
2773,The US Food Drug Administration FDA AstraZeneca Calquence CLL SLL,Regulatory Jobs,Negative
2774,AstraZeneca,IT Recruiter,Postive
2776,AstraZeneca FDA,Investor News,Postive
2778,FDA PS HematologyConferences CancerConferences Hematology,Vijaya,Negative
2779,Drs John Jen Woyach Hematology second BTK CLL,Yiping Yang MD PhD,Postive
2780,AstraZeneca Calquence CLL,EIPG,Negative
2781,CLL Ibrutinib fifteen CR four Imbruvica,SHM,Negative
2782,CLL SLL,FA Technologies,Postive
2783,AstraZeneca Calquence Imbruvica CLL Without Imbruvica AZN,Bionest Partners,Postive
2784,Friday AstraZeneca Calquence Project ORBIS FDA Canada Australia,BioCentury,Negative
2785,SLL MedNews,Zaspera,Postive
2786,Xin Zhao Ji Shi   FDA Approves Acalabrutinib CLL Indication,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
2787,CLL,Arab Medical Pro,Negative
2789,AstraZeneca Calquence CLL,Endpoints News,Negative
2790,AstraZeneca FDA Calquence,Pharmaceutical Market Europe,Postive
2791,Efficacy Safety BTK Adult Patients Previously Treated Mantle Cell Lymphoma three two thousand and RSVP Jason McDonald eight hundred and one,onsVegas,Negative
2792,CLL SLL,Mazen,Postive
2793,CALQUENCE,acalabrutinib,Negative
2794,CALQUENCE,acalabrutinib,Negative
2795,CALQUENCE,acalabrutinib,Negative
2805,FDA CLL SLL,CancerCare,Negative
2806,AstraZeneca Calquence Wins FDA Approval BioSpace,The Oncologist,Postive
2807,CLL SLL,Medical Xpress,Postive
2808,Project Orbis FDA CLL SLL,ALI ALAHMARI,Negative
2809,FDA Approves,CHSeaton,Negative
2811,FDA CLL,MDEdge,Negative
2812,FDA CLL,MDedge Hematology Oncology,Negative
2813,Key FDA,BioPharma Dive,Postive
2814,FDA,Carsten Wenzel,Negative
2816,FDA thebarislowforFDAapproval,Bernie Marini,Postive
2817,AstraZeneca Imbruvica FDA,Lung Cancer News,Postive
2818,AstraZeneca Imbruvica FDA,Cancer News,Postive
2819,AstraZeneca FDA Nod Calquence Line Extension CLL,Access WallStreet,Negative
2820,FDA Calquence CLL,PharmaTimes,Negative
2821,Brukinsa,Trustwell Law Group LLP,Postive
2822,FDA second Orbis Calquence,Paladin,Negative
2823,The US Food Drug Administration FDA AstraZeneca Calquence CLL SLL,Ltd,Negative
2824,FDA,Saleh Stevens,Negative
2825,AstraZeneca Calquence CLL healthcare pharma,Dr Timos Papagatsias,Postive
2827,AstraZeneca Calquence CLL,world CROs,Negative
2828,AstraZeneca Calquence Imbruvica CLL,PharmaCrowd,Negative
2829,FDA,Targeted Oncology,Negative
2830,FDA Imbruvica,Claude Waddington,Negative
2831,AstraZeneca Calquence FDA,Tina Witte,Negative
2832,FDA Imbruvica,ACHUTHAN,Negative
2833,CLL today Ibrutinib,Pallawi Torka,Postive
2835,AstraZeneca Calquence AbbVie Imbruvica,pharmaphorum,Negative
2836,Six month first three AstraZeneca FDA BTK Calquence The one,Casper Paardekooper,Negative
2837,AstraZeneca Calquence CLL,Endpoints News,Negative
2838,FDA Calquence CLL,Career Biotech,Negative
2839,FDA Calquence CLL pharma,Pharma Regulatory,Negative
2840,USA AstraZeneca,The Pharma Letter,Postive
2841,FDA AstraZeneca,Drug Store News,Negative
2842,US,Pharma Business Int,Negative
2843,FDA TGAgovau ProjectOrbis Singapore HealthSciencesAuthority Switzerland FDAOncology FDAMedia AstraZeneca ZacharyBrennan,FlatBio,Postive
2844,AstraZeneca FDA Calquence pharma,Pharma Regulatory,Postive
2846,Pharma Industry News November two thousand and nineteen Roche Atezolizumab India Laurus Labs Vidakhapatnam USFDA AstraZeneca Calquence USFDA Roche Laurus Zydus Calquence,PharmaState,Negative
2847,AstraZeneca Calquence CLL six month,dough,Postive
2848,AstraZeneca Calquence FDA,FirstWord Pharma,Negative
2849,FDA Approves Acalabrutinib CLL,Jorge Oliveira,Negative
2850,CLL NEUTRAL NEUTRAL Calquence CLL,ResearchPool,Postive
2851,Yesterday FDA second Project Orbis CLL SLL lymsm hemeonc,NatureRevClinOncol,Postive
2852,FDA Approves CLL,Barbara Jacoby,Negative
2853,FDA CLL SLL,Krizsan Szilvia MD,Postive
2854,AstraZeneca Calquence Project Orbis,PharmaShots Incisive news three shot,Negative
2855,FDA AstraZeneca Calquence,Career Biotech,Negative
2856,FDA second AstraZeneca FDA,Krishan Maggon,Negative
2859,FDA second BTK today CLL,Deborah Stephens,Negative
2860,FDA,Saeed Valadbaygi,Negative
2861,FDA,RTTNews Top Stories,Negative
2862,FDA,Bitcoin Headline News,Negative
2863,November two thousand and nineteen FDA Calquence CLL SLL Calquence Prescribing Information,Bichoy Gabra,Negative
2864,FDA Canadian CLL BTK,Snowdome Foundation,Postive
2865,FDA Approves,FDA Daily,Negative
2866,Project Orbis FDA CLL SLL Orbis FDA CLL SLL,Junaid Jay Abdulghani MD PhD,Negative
2867,AstraZeneca Calquence Imbruvica CLL,EIPG,Negative
2869,FDA Approves,NewExpressNews,Negative
2870,US Food amp Drug Administration Thursday November Calquence NDA two hundred and ten thousand two hundred Deferasirox two hundred and ten thousand nine hundred Givlaari two hundred and twelve thousand one hundred and ninetyfour FDA,Living Safely,Negative
2871,GLYC AZN Calquence FDA Approval ONTX Pipeline BIIB ENTA ENTX IMRN,BioPharmCatalyst,Negative
2872,FDA Approves,FDA Daily,Negative
2873,AstraZeneca Calquence Imbruvica CLL,cafepharma,Negative
2874,FDA Approves,HCP Feed,Negative
2875,FDA Approves Acalabrutinib CLL,Tom Henry MBA RPh CPh,Negative
2876,FDA Approves Acalabrutinib Part Project Orbis Orbis four,Jeff Szer,Negative
2877,CLL,AstraZenecaUS,Postive
2878,US Australia Canada,Hmd,Negative
2879,AstraZeneca Calquence FDA CLL SLL,octagonchem,Negative
2880,FDA,CLL Society Inc,Negative
2881,Project Orbis FDA CLL,Cancer News,Negative
2882,FDA UPDATE November two thousand and Food Drug Administration FDA CALQUENCE AstraZeneca,Lymphoma Research Foundation,Negative
2883,Project Orbis,The ASCO Post,Negative
2884,FDA Approves Acalabrutinib CLL Indication,SpecialtyPTimes,Negative
2885,SLL FDA CLL,Michael Hallek,Postive
2886,FDA el tratamiento de la LLC ScienceLink,contacto sciencelink,Negative
2887,two thousand and nineteen FDA CALQUENCE AstraZeneca,FDA Oncology,Negative
2888,Project Orbis FDA CLL SLL,Pharm Digest,Negative
2889,CLL,Sigrid Skanland,Negative
2890,CALQUENCE Approved,Crwe World,Negative
2891,Project Orbis FDA CLL SLL,The Oncologist,Negative
2892,CALQUENCE Approved three tolerabilityCALQUENCE,Diagnostics News,Postive
2893,AstraZeneca Calquence Imbruvica CLL,analyst land news,Negative
2896,ASCEND Calquence Tx PFS,Tontarn Chutima,Postive
2898,AstraZeneca US FDA Calquence,Financial Journal,Negative
2899,FDA AstraZeneca Calquence,Investor News,Negative
2900,FDA AstraZeneca Calquence,Breaking News,Negative
2901,FYI This week,OncoPharm,Postive
2902,FDA Approves CLL,Jason Broderick,Negative
2904,FDA CLL SLL,Lisa Astor,Postive
2905,CLL US,Cision News,Negative
2906,FDA CLL,Jeff Sharman,Postive
2907,Any Grade AEs,Paul DeSantis PharmD,Negative
2908,AstraZeneca Calquence Imbruvica CLL,Dr Timos Papagatsias,Postive
2909,AstraZeneca Calquence Imbruvica CLL,Carly Helfand,Negative
2910,US,Cision News,Negative
2911,FDA Approves Acalabrutinib CLL,Kerri Wachter,Negative
2912,FDA BTK CLL SLL FDA Project Orbis CLL,Phil Talamo,Postive
2913,AstraZeneca Calquence Imbruvica CLL,NewExpressNews,Negative
2914,FDA CLL SLL,The Medical Letter,Postive
2915,FDAOncology CLL,Amber Koehler,Postive
2916,Approves,Joe,Postive
2917,AstraZeneca Calquence Imbruvica CLL,Pharma Regulatory,Negative
2918,FDA Calquence,Oncology Nursing News,Negative
2919,CLL twelve Imbruvica,Paul DeSantis PharmD,Postive
2920,FDAOncology ProjectOrbis CLL SLL OncLive,ATOPP Summit,Negative
2921,FDA Approves CLL,HCP Feed,Negative
2922,FDA,Matthew Davids MD MMSc,Postive
2923,FDA second CLLsm,Naveen Pemmaraju MD,Negative
2924,FDA hemonctoday,Chocolatiere Phys,Postive
2926,One CLL FDA Approves CLL,Anastasios Raptis MD,Postive
2928,CLL three ASH,Alan Skarbnik,Postive
2929,second ProjectOrbis CLL SLL,FDA Oncology,Negative
2930,FDA Approves CLL,Silas Inman,Negative
2931,FDA Approves Acalabrutinib CLL,Oncology Strategies,Negative
2935,FDA Project Orbis CLL SLL,Jacob Bell,Postive
2939,two,Lung Cancer News,Negative
2941,Update ASH TN CLL MedEd,LYMPHOMA MYELOMA CONNECT,Negative
2942,Regimens,Renal Cell Carcinoma,Negative
2943,CLL,Health,Negative
2946,Pascal Soriot La Chine AstraZeneca BeiGeneUSA USA Pharma China Calquence Celgene Brukinsa,Nathalia Le Hen,Negative
2947,Zanubrutinib FDA,Michael Wang MD,Postive
2948,BeiGene FDA Chinese Brukinsa AbbVie Imbruvica AstraZeneca Calquence,Cancer News,Negative
2949,Brukinsa AbbVie Imbruvica AstraZeneca Calquence,BioPharma Dive,Negative
2952,three FDA BTK BTK,Michael Wang MD,Postive
2953,CLL three CancerNews,Sarah Williams,Negative
2954,three obinutuzumab v obinutuzumab chlorambucil CLL Data MedEd,LYMPHOMA MYELOMA CONNECT,Negative
2955,First CLL nine twelve ORR IBR Nice,Toby Eyre,Postive
2956,Lymphoma,Lymphoma Papers,Negative
2958,BTK,Toby Eyre,Negative
2959,Woyach BTK MUT CLL BTK ten one two BTK MUT MUT Time,Toby Eyre,Negative
2960,Acalabrutinib Clinical Experience MDACC four michaelwangmd mcl MDAndersonNews,Maria Badillo MSN RN OCN CCRP,Negative
2961,one twenty three,Talal Hilal,Negative
2963,three obinutuzumab ninety CLL,LYMPHOMA MYELOMA CONNECT,Negative
2966,three CLL,AstraZenecaUS,Negative
2968,three Chronic ASH two thousand and Annual,Pharmacutical Daily,Negative
2969,three Chronic ASH two thousand and,Saeed Valadbaygi,Negative
2970,three Chronic,Crwe World,Negative
2971,three ASH two thousand and nineteen Annual Meeting,Renal Cell Carcinoma,Postive
2972,ASH two thousand and nineteen one Obinutuzumab CLL,CLL Society Inc,Postive
2974,ASH obinutuzumab CLL Acala Proud NovantHealth,Alan Skarbnik,Negative
2976,three ASH two thousand and Annual,Cision News,Negative
2978,Calquence CLL ASH Nov Roxadustat CV ASN Nov SABCS,dough,Negative
2979,Cohen obinutizumab,Ajay Nooka MD MPH,Negative
2981,Health Canada MCL,Health Canada PHAC,Negative
2982,Sante Canada LCM un,Sante Canada et ASPC,Negative
2983,AbbVie Imbruvica Calquence,EIPG,Negative
2984,AbbVie Imbruvica Calquence,cafepharma,Negative
2985,AbbVie Imbruvica Calquence,FiercePharma,Negative
2986,AbbVie Imbruvica Calquence,Dr Timos Papagatsias,Postive
2987,AbbVie Imbruvica Calquence WinWay,Worldcatholicnews,Negative
2988,AbbVie Imbruvica Calquence pharma,Pharma Regulatory,Negative
2989,CLL max Imbruvica Calquence,Paul DeSantis PharmD,Postive
2990,Richters,Graham Collins,Negative
2991,three ASCEND,Targeted Oncology,Negative
2992,fifty Rogers,Targeted Oncology,Negative
2993,Calquence,BioPharma Dive,Postive
2994,BTK,Targeted Oncology,Negative
2995,Julie Durocher AstraZeneca,Michael Wang MD,Negative
2996,McGill University Acalabrutinib Canada two week ago Eric Kader AstraZeneca Montreal,Michael Wang MD,Postive
2997,AstraZeneca Paul Vardanis,Michael Wang MD,Postive
2998,SWOG,Jonathan Friedberg,Postive
2999,SVB Leerink Porges MRK Schering Plough Keytruda BMY Medarex Sovaldi SNY Genzyme,Ned Pagliarulo,Postive
3000,BTK,Targeted Oncology,Negative
3005,OncoAlert,Raul Cordoba MD PhD,Negative
3006,Michael Wang Lymphoma Myeloma BTK zanubrutinib mantle cell MCL,Cancer Medicine,Negative
3007,AstraZeneca Canada Calquence,PharmaShots Incisive news three shot,Negative
3008,Health Canada,Zeal Access,Negative
3009,Health Canada MCL,Alicia Bell IFBB Pro,Negative
3010,AstraZeneca Calquence OK Canada,Breaking News,Negative
3012,CLL Herbert Eradat MD,OncLive SOSS,Negative
3013,CLL Herbert Eradat MD,OncLive SOSS,Negative
3014,PubMed NCBI,Tim Fenske,Negative
3015,Eradat Discusses Data With Acalabrutinib CLL,OncLive SOSS,Negative
3016,Comparison Three Chemotherapy Regimens Treatment Patients With Newly two three,Lung Cancer News,Negative
3017,Paolo Ghia BTK,ESH Haematology,Negative
3018,two Learn,Cancer Trials Support Unit,Negative
3019,Bruton Tyrosine Kinase Irreversible BTK BTK,Michael Wang MD,Negative
3021,Wang Rule et al Long CR PET mDOR AE eight acala v MCL,Toby Eyre,Negative
3024,Ibrutinib Therapie CLL,Medical Tribune,Negative
3025,three ASCEND today Rituximab CLL,Sharon Worcester,Postive
3026,MCL,Lymphoma Hub,Negative
3027,La FDA la designacion de terapia innovadora de acalabrutinib para la linfocitica,Rafael Ortiz Gimenez,Negative
3028,NHL,Renal Cell Carcinoma,Negative
3029,Siddiqi second CLL FDA Acalabrutinib,Targeted Oncology,Postive
3032,Siddiqi second CLL FDA,Targeted Oncology,Postive
3033,Sf@ lkhtrq ldw Calquence FDA,Molecular Biology MEMBS mjtm` lbywlwjy ljzyy'y@,Negative
3034,Siddiqi three ASCEND,Targeted Oncology,Negative
3035,JP Pascal Soriot PS Astra Tagrisso Imfinzi,dough,Postive
3036,CONGRESS obinutuzumab CLL Jennifer Woyach High RR,Lymphoma Hub,Negative
3037,CONGRESS TN RR TN RR Lymsm Lymphoma,Lymphoma Hub,Postive
3038,seven two Pipeline Roxa Busy Lynparza Roxa Calquence Epanova,dough,Postive
3039,Calquence API EU Brexit,Living Safely,Negative
3041,RMELiveWM,RedMedEd,Negative
3042,FDA,Verdi Oncology,Negative
3043,ASCO rituximab polatuzumab vedotin obinutuzumab lenalidomide today,Breaking Data,Negative
3044,Calquence API EU Brexit,Living Safely,Negative
3045,Study Acalabrutinib Versus Chlorambucil Plus Rituximab Adult Subjects With Previously Untreated,TrialBulletin,Negative
3046,Study Acalabrutinib Versus Chlorambucil Plus Rituximab Adult Subjects With Previously Untreated,CureHuntr,Negative
3048,EU,EIPG,Negative
3049,EU,RAC Medical Consulting,Negative
3050,EU,Pharma Regulatory,Negative
3051,EU,rapsorg,Negative
3052,first MCL FDA,Michael Wang MD,Postive
3053,Kerry Rogers MD,The ASCO Post,Negative
3054,six hundred CLL second malignancy cllsm,Targeted Oncology,Negative
3056,CLL,Oncology Tube,Negative
3057,FDA CLL,Lampe Company,Negative
3068,FDA,SpecialtyPTimes,Negative
3069,CLL CLLsm Calquence,CLL Society Inc,Postive
3071,CLL,Cancer Stem Cell News,Negative
3072,AstraZeneca Lynparza FDA,Thomas Senechal,Postive
3073,LymphocyticLeukemia Trial Site News AstraZeneca,TrialSite News,Postive
3074,AstraZeneca Calquence Gets FDA,Stanley Suen,Negative
3075,two thousand and nineteen Tagrisso Calquence Lynparza Imfinzi two Fasenra Symbicort four,dough,Postive
3077,AZ Calquence,Haybury,Negative
3079,FDA CLL,Shohta Kadomura Hospital Pharmacist,Negative
3080,The US Food Drug Administration FDA CLL,Lymphoma Hub,Negative
3082,FDA Calquence,EMG GOLD,Negative
3083,AstraZeneca Calquence CLL FDA CLL CLL,Saief Kazmi,Postive
3084,FDA,SpecialtyPTimes,Negative
3086,FDA Cllsm,Targeted Oncology,Negative
3088,AstraZeneca Calquence,Plexus Ventures,Negative
3089,Calquence US,Pharma Business Int,Negative
3091,two AstraZeneca Lynparza FDA,John Carroll,Postive
3092,two thousand and fourteen AstraZeneca,BioSpace,Negative
3093,AstraZeneca Lynparza FDA Calquence AZN,Endpoints News,Postive
3094,AZ Calquence,PharmaTimes,Negative
3095,Granted,The Pharmaceutical Marketing Group,Negative
3096,FDA,ZdravMedInfo,Negative
3097,FDA FDA,COPD News,Negative
3098,CLL ASCEND BTK PallawiTorkaMD,Suchitra Sundaram,Postive
3099,FDA,Targeted Oncology,Negative
3100,AZ Calquence,Digital Pharma,Negative
3102,AstraZeneca Calquence,Ltd,Negative
3103,AstraZeneca,The Pharma Letter,Negative
3104,Two,BioCalifornia,Postive
3105,AZ Calquence,David Ledger,Negative
3106,FDA,Jason Broderick,Negative
3107,FDA,Crwe World,Negative
3108,AstraZeneca Lynparza FDA Calquence Endpoints News,Lampgen Clinical Research,Postive
3109,AstraZeneca Lynparza FDA,Miles Collier,Postive
3112,AZ Calquence,Pharma Regulatory,Negative
3113,AstraZeneca Pascal Soriot today,Andrea Wilkinson,Postive
3114,FDA BloodCancer CLL,AstraZenecaUS,Negative
3115,CLL,HemOnc Today,Negative
3116,Granted,Crwe World,Negative
3117,Granted,Latest News Business Wire,Negative
3118,Granted two US Food Drug Administration,Renal Cell Carcinoma,Postive
3119,AstraZeneca Lynparza FDA healthcare pharma CI,Dr Timos Papagatsias,Postive
3121,AstraZeneca Lynparza FDA,Endpoints News,Postive
3122,AstraZeneca Lynparza FDA,John Carroll,Postive
3123,FDA,Novosti GMP,Negative
3126,AstraZeneca Calquence AstraZeneca,PharmaShots Incisive news three shot,Negative
3127,AstraZeneca US two,Mehrdad Yousefi,Postive
3129,US FDA,WheelieDealer,Negative
3132,AstraZeneca plc Calquence,Francis Alexander,Negative
3138,CLLsm,CLL Society Inc,Negative
3141,PO one two three four five Calquence CLL EPS,dough,Negative
3142,BTK ChronicLymphocyticLeukemia CLL,Michele,Postive
3143,ASCEND CLL Barbara Eichhorst Leusm,VJHemOnc,Negative
3144,Kerry Rogers MD,The ASCO Post,Negative
3145,CLL BTK Sameem Abedin MD,OncLive SOSS,Negative
3146,Abedin MD MedicalCollege CLL,OncLive SOSS,Negative
3147,Kipps BTK,Michael Wang MD,Postive
3148,Abedin Discusses Differences,OncLive SOSS,Negative
3150,BTK,Lymphoma Papers,Negative
3151,BJH Single BTK Spriano,Francesco Bertoni,Negative
3152,BTK Spriano British Journal LymSM,Benlazar Amine,Negative
3153,EPS one Roxat two three four five Calquence CLL,dough,Negative
3154,Tam al Zanubrutinib CLL BTK one AF Only two ORR CLL TN PD,Toby Eyre,Negative
3155,Le zanubrutinib inhibiteur de Bruton TK one dans la leucemie dans Dans BloodJournal,Jeremie Zerbit,Negative
3156,PFS rituximab chronic Paolo Ghia,ASH Clinical News,Negative
3158,EHA CLL Bruton BTK MDedgetweets,David Henry,Postive
3159,Karmali MCL BTK,Targeted Oncology,Negative
3160,CLL AstraZeneca three ASCEND EHACongress last month LymphomaNews,LymphomaAction,Negative
3162,New Acalabrutinib,Medivizor,Negative
3164,HealthEconJA Phase Clinical Early Economic Evaluation Acalabrutinib,HealthEconBot,Negative
3165,PPSD four one hundred,Pharmacy News Research,Negative
3167,DAEPOCHR Bcell nonHodgkin,Renal Cell Carcinoma,Negative
3168,Calquence Acalabrutinib Global Drug Overview Outlook two thousand,SPI News,Negative
3169,Learn CLL,The James,Postive
3170,Report two thousand and nineteen eight thousand two hundred and eleven eight thousand two hundred and eleven eight thousand two hundred and twenty eight thousand two hundred eight thousand two hundred and seventeen,Renal Cell Carcinoma,Negative
3171,Report two thousand and,Latest News Business Wire,Negative
3173,CLL,Medscape Pharmacists,Negative
3174,Three BTK PancreaticCancer Ibrutinib Ibrutinib Durvalumab Acalabrutinib Keytruda,Anirban Maitra,Negative
3175,two thousand and nineteen AcalabrutinibhaZai Fa Xing matahaNan Zhi Xing nioiteZhu shiiYou Yi,Clinical Newswire,Negative
3177,DAEPOCHR Bcell nonHodgkin,Renal Cell Carcinoma,Negative
3178,ASCEND con rituximab AstraZenecaES Acalabrutinib,iSanidad,Negative
3179,AstraZeneca anuncia los resultados del ensayo llamado three ASCEND,iSanidad,Negative
3180,para la linfocitica cronica recurrente AstraZenecaES,iSanidad,Negative
3181,CLL,Medscape Oncology,Negative
3182,prolunga il twelve,Medicina Informazione,Negative
3183,para la linfocitica AstraZeneca LeucemiaLinfociticaRecurrente,iSanidad,Negative
3184,CLL,Medscape Oncology,Negative
3188,ASCEND con rituximab AstraZeneca LeucemiaLinfociticaRecurrente,iSanidad,Negative
3189,NewfusionApps Science News,Delreo Johnson,Negative
3192,Helen James AstraZeneca Calquence StrathScience,StrathPharm Bio,Negative
3193,CLL Hematology HematologyConferences,Pulsus Conferences,Negative
3194,Calquence AstraZeneca,Acobur,Negative
3196,para la linfocitica AstraZeneca LeucemiaLinfociticaRecurrente,iSanidad,Negative
3197,AstraZeneca la supervivencia linfocitica cronica recurrente refractaria,Pharma Jonpi,Negative
3198,Kerry Rogers OhioState HemeOnc,VJHemOnc,Negative
3199,AstraZeneca Calquence CLL Data Sets It Up For Regulatory Submissions two thousand and,Jorge Oliveira,Negative
3200,Prof Paolo Ghia two thousand and nineteen ASCEND Watch,ecancer,Postive
3202,Imfinzi Catalyst Roxat two three four five Calquence CLL,dough,Postive
3203,AZN ABBV JNJ Biotech Analysis two thousand and,Terry Chrisomalis,Negative
3204,AstraZeneca Calquence CLL Data Sets It Up For Regulatory Submissions two thousand and,Stocks,Negative
3205,AstraZeneca Calquence CLL Data Sets It Up For Regulatory Submissions two thousand and,Seeking Alpha,Negative
3209,Woyach Highlights Data CLL,Crwe World,Negative
3210,Woyach Highlights Data CLL OncLive Calquence obinutuzumab Gazyva ArtificialIntelligence Privacy Toronto,Saeed Valadbaygi,Negative
3211,two thousand and eighteen Dr two thousand and CLL,Joe,Postive
3213,AstraZeneca CLL,HemOnc Today,Negative
3214,asutorazenekaZhu Shi Hui,Zhong Jing Liang Tai Lang ,Negative
3215,CLL Hematology HematologyConferences,Vijaya,Negative
3219,PIP,Pharma Regulatory,Negative
3221,Mantle Cell Lymphoma Program Excellence Anderson one FDA MCL michaelwangmd,Michael Wang MD,Postive
3225,LEUCEMIA LINFATICA CRONICA ACALABRUTINIB MIGLIORA IL,Salutedomani,Negative
3227,Published The ASCO Post,Dr Timos Papagatsias,Postive
3230,ASCEND,The ASCO Post,Negative
3233,nuova arma terapeutica un che un,Ritrattodellasalute,Negative
3234,VIDEO Acalabrutinib Ibrutinib CLL Kerry Roger OhioState CLLsm,VJHemOnc,Negative
3235,migliora il,PharmaStar,Negative
3236,CLL CLL ASkarbnik,Mazyar Shadman MD MPH,Postive
3237,LEUCEMIA LINFATICA CRONICA ACALABRUTINIB MIGLIORA IL,Antonio Caperna,Negative
3238,LEUCEMIA LINFATICA CRONICA ACALABRUTINIB MIGLIORA IL,Salutedomani,Negative
3240,LEUCEMIA LINFATICA CRONICA ACALABRUTINIB MIGLIORA IL,Derma News OK,Negative
3241,CONGRESS three ASCEND rituximab plus,Lymphoma Hub,Postive
3242,Ghia al ASCEND,Toby Eyre,Postive
3243,migliora il Leucemia linfatica,Cerca Soluzioni Cruciverba,Negative
3244,migliora il Leucemia linfatica,Zazoom Social News,Negative
3246,BTKIs,Natacha Bolanos,Negative
3248,CONGRESS Kerry Rogers OhioState two CLL,Lymphoma Hub,Postive
3251,EHA two thousand and nineteen Oncology News Australia,Oncology News Australia,Postive
3252,New Post Seven,Lymphoma News Today,Negative
3253,AstraZeneca Calquence Imbruvica CLL SoC CLL,Bionest Partners,Negative
3254,AZ Calquence CLL,PharmaTimes,Negative
3255,AstraZeneca UK,The Pharma Letter,Negative
3257,AstraZeneca Calquence Imbruvica CLL,cafepharma,Negative
3258,AstraZeneca Calquence Imbruvica CLL,cafepharma,Negative
3260,AstraZeneca Calquence Imbruvica CLL,EIPG,Negative
3261,AZ Calquence threatens Imbruvica,EIPG,Negative
3262,AstraZeneca Calquence Imbruvica CLL CI,Dr Timos Papagatsias,Postive
3267,linfocitica cronica refractaria ScienceLink,contacto sciencelink,Negative
3269,AstraZeneca Calquence Imbruvica CLL,FiercePharma,Negative
3270,AstraZeneca Calquence Imbruvica CLL,Labofine,Negative
3271,AstraZeneca Calquence Imbruvica CLL pharma,Pharma Regulatory,Negative
3273,AstraZeneca ASCEND,PharmaShots Incisive news three shot,Negative
3274,AZ Calquence CLL,David Ledger,Negative
3275,AZ Calquence CLL,Barry Curry,Negative
3276,AZ Calquence CLL,Everything Pharma,Negative
3277,AstraZenica Calquence Johnson Imbruvica,Cancer Stat Essential News Research Analysis,Negative
3281,AZ Calquence threatens Imbruvica pharma,Pharma Regulatory,Negative
3282,AZ Calquence CLL,Pharma Trader,Negative
3283,AstraZeneca Calquence UK Imbruvica,pharmaphorum,Negative
3284,AZ Calquence CLL pharma regulatory,Pharma Regulatory,Negative
3286,AstraZeneca Calquence AZN,FirstWord Pharma,Negative
3287,CLL ASCEND Paolo Ghia,EmatoInfo,Negative
3288,Calquence AndrewScottTV,Proactive,Postive
3289,Ri Jing,Ri Jing medeikaru,Negative
3291,AstraZeneca Calquence,Mike van Dulken,Negative
3292,Babcock Serco AstraZeneca,Mehrdad Yousefi,Negative
3293,AstraZeneca PLC Calquence,Francis Alexander,Negative
3294,Astra Zeneca Calquence,FinInsyn,Negative
3295,Astra Zeneca Calquence,Sverige,Negative
3301,Woyach,Targeted Oncology,Negative
3304,Learn Phase three CLL today,AstraZenecaUS,Negative
3305,CONGRESS Paolo Ghia Universita San Raffaele ASCEND three CLL Lymphoma,Lymphoma Hub,Negative
3307,IdR CLL ORR,Andres Chang MD PhD,Negative
3309,Keytruda,Clarivate Cortellis,Negative
3313,CONGRESS Maddocks pembrolizumab,Lymphoma Hub,Negative
3315,AstraZeneca Phase three Trial Site News,TrialSite News,Negative
3319,Mark Tomorrow PM three CLL,AstraZenecaUS,Negative
3321,CLL DrRaulCordoba,chadi nabhan MD MBA FACP,Negative
3322,Paolo Ghia Acalabrutinib CLL,oncoletter,Negative
3323,nuova CLL ASCEND CiceriFabio micdicataldo MariaTeresaEs albertomussetti AGiustacchini,EmatoInfo,Negative
3324,Zanubrutinib Acalabrutinib CLL Ibrutinib Susan UofCalifornia CLLsm,VJHemOnc,Negative
3325,Ghia ASCEND CLL CiceriFabio,EmatoInfo,Negative
3327,two thousand and nineteen ASCO Annual Meeting CLL,Targeted Oncology,Negative
3328,MayoClinic,Blood Journal,Negative
3331,Qian Zhi Liao Li,Zhong Jing Liang Tai Lang ,Negative
3332,Qian Zhi Liao Li,PR TIMESbizinesu,Negative
3333,Qian Zhi Liao Li,PR TIMESniyusu,Negative
3336,ICYMI AstraZeneca Calquence Imbruvica second three CLL JNJ ABBV,Carly Helfand,Postive
3337,Woyach CLLsm Leusm,Targeted Oncology,Negative
3338,three AstraZeneca dans la leucemie chronique de,oncohebdo,Negative
3340,AstraZeneca,Cluster Salud AE,Negative
3341,CLL,Flow Paradigm,Negative
3342,two obinutuzumab CLL PS HematologyConferences,Vijaya,Negative
3343,AstraZeneca Calquence,Cpl Life Sciences,Negative
3344,BJH EnteOspedaliero CascioneLuciano,Francesco Bertoni,Negative
3345,AZ Calquence,David Ledger,Negative
3346,AstraZeneca Calquence,Cpl Life Sciences,Negative
3348,AstraZeneca Calquence Imbruvica second three CLL FiercePharma,Advera Health,Postive
3349,CLL,Flow Paradigm,Negative
3350,BTK WM WMIWMF IWMF,Patient Worthy,Postive
3352,AstraZeneca Calquence Meets Endpoint CLL Study,ASOII,Negative
3353,Calquence Phase three CLL,Pharma Business Int,Postive
3354,LEUCEMIA LINFATICA CRONICA three,one Malati Invisibili,Negative
3355,AstraZeneca Calquence,ACHUTHAN,Negative
3356,AstraZeneca Calquence Imbruvica second three CLL Calquence Gazyva CLL,Bionest Partners,Postive
3357,Kerry Rogers MD,The ASCO Post,Negative
3358,AstraZeneca Calquence PharmaTimes AstraZeneca CLL,Plexus Ventures,Negative
3359,AstraZeneca Calquence CLL,world CROs,Negative
3360,AstraZeneca Calquence CLL Calquence AstraZeneca,Pharma Tech Focus,Negative
3361,AstraZeneca,The Pharma Letter,Negative
3362,three,PharmaStar,Negative
3363,three,PharmaStar,Negative
3364,AstraZeneca Calquence BTK,Endpoints News,Negative
3365,CLL obinutuzumab CLLsm,Targeted Oncology,Negative
3366,ScienceLink,contacto sciencelink,Negative
3367,hemonctoday,Chocolatiere Phys,Negative
3368,AstraZeneca Calquence Imbruvica second three CLL FiercePharma two thousand and nineteen six six,FPCsWorld,Postive
3369,three,BioSpace,Negative
3373,AstraZeneca Calquence Imbruvica second three CLL,FiercePharma,Postive
3374,Calquence Hits Endpoint three,Scrip,Negative
3375,AstraZeneca Calquence BTK AbbVie,EIPG,Negative
3376,AstraZeneca Calquence,EIPG,Negative
3377,AstraZeneca Calquence,Pharmafocus,Negative
3378,CLL CLLsm,CLL Society Inc,Postive
3379,AZ Calquence,PharmaTimes,Negative
3380,AstraZeneca BioSpace,Alex Keown,Negative
3381,Leusm,SSBMT lkhlyljdh`y@,Negative
3383,AstraZeneca Ends Another Calquence Trial Early,OBR,Negative
3384,AstraZeneca Calquence,cafepharma,Negative
3385,AstraZeneca,BioCalifornia,Negative
3387,AstraZeneca,PharmaShots Incisive news three shot,Negative
3388,AstraZeneca Calquence BTK AbbVie gt gt gt CI healthcare,Dr Timos Papagatsias,Postive
3389,Leukemia CLL,HemOnc Today,Negative
3390,AstraZeneca Calquence BTK AbbVie,DennisPartners,Negative
3391,AstraZeneca Calquence BTK AbbVie,Amber Tong,Negative
3392,AstraZeneca Calquence BTK AbbVie,Endpoints News,Negative
3394,Woyach,Targeted Oncology,Negative
3395,AZ Calquence,Oncology Forum UK,Negative
3396,AstraZeneca Calquence CLL one,Investor News,Postive
3397,CLL one,Breaking News,Postive
3398,AZ Calquence,Pharma Regulatory,Negative
3399,Astra Zeneca Calquence,FinInsyn,Negative
3400,Astra Zeneca Calquence,Sverige,Negative
3401,AstraZeneca Calquence,Pharmafocus,Negative
3402,AstraZeneca Calquence,pharmaphorum,Negative
3403,AstraZeneca Calquence,Jon Angelo,Negative
3404,AstraZeneca BTK Calquence second AZN,FirstWord Pharma,Negative
3405,AstraZeneca Read More Here,Jesmond Saliba,Negative
3407,three,WheelieDealer,Postive
3410,AstraZeneca Calquence Phase three,Mike van Dulken,Negative
3412,AstraZeneca Calquence Phase three AZN,Francis Alexander,Negative
3415,Leusm,Targeted Oncology,Negative
3417,Visita El Post En la celulas del sistema inmune que ya ha sido tratado con al menos otro,Doctiplus,Negative
3419,obinutuzumab CLL,Clarivate Cortellis,Negative
3420,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL obinutuzumab Woyach one,Mike Thompson MD PhD FASCO,Negative
3421,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL,Mike Thompson MD PhD FASCO,Negative
3422,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL Woyach Responses,Mike Thompson MD PhD FASCO,Negative
3424,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL,Mike Thompson MD PhD FASCO,Negative
3425,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL,Mike Thompson MD PhD FASCO,Negative
3426,lymsm CLLsm Tues Chairs Bartlett Davids seven thousand five hundred CLL,Mike Thompson MD PhD FASCO,Negative
3427,CLL,CLL Society Inc,Negative
3428,Trial Site News,TrialSite News,Negative
3429,second,HemOnc Today,Negative
3430,PlymUni LYMsm Lymphoma TrialUpdate HemOnc,VJHemOnc,Negative
3431,Astrazeneca drug CALQUENCE,BioCalifornia,Negative
3432,Astrazeneca drug CALQUENCE,DrugPatentWatch,Negative
3433,AstraZeneca Oncology Hematology first FDA,Michael Wang MD,Negative
3435,Investigate Influence Severe Hepatic Impairment Pharmacokinetics Acalabrutinib,CureHuntr,Negative
3437,RS,Europe PMC article,Negative
3438,al TN CLL ANC eleven nine four two AF TN RR pt Blooducation CLL,Toby Eyre,Negative
3443,CLL ClinicalTrials,Blood Advances,Negative
3445,ASCO Calquence Imbruvica CLL FiercePharma,Advera Health,Negative
3446,Yi Liao Man Xing,QLifeProYi Liao Qing Bao ,Negative
3449,ASCO Calquence Imbruvica CLL,EIPG,Negative
3450,ASCO Calquence Imbruvica CLL,Total Pharma News,Negative
3452,ASCO Calquence Imbruvica CLL,PharmaCrowd,Negative
3453,ASCO Calquence Imbruvica CLL,FiercePharma,Negative
3454,ASCO Imbruvica CLL AZN pharma,Carly Helfand,Negative
3455,ASCO Calquence Imbruvica CLL CI pharma,Dr Timos Papagatsias,Postive
3456,ASCO Calquence Imbruvica CLL pharma,Pharma Regulatory,Negative
3457,ASCO Calquence Imbruvica CLL,Labofine,Negative
3459,Current Issue Disseminated Cryptococcal Infection Patient Receiving Acalabrutinib,Infectdis,Negative
3460,AstraZeneca,AJMC,Negative
3462,AstraZeneca Calquence Imbruvica three CLL,vshariharakrishnan,Postive
3466,Xin Zhao Ji Shi,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
3469,Acala ORR Oxford Important,Toby Eyre,Negative
3470,AstraZeneca PharmaTimes rituximab Calquence nonHodgkins,Plexus Ventures,Negative
3471,OncoAlert CLL Blood Advances,Raul Cordoba MD PhD,Negative
3472,AstraZeneca llmrHl@ ASCEND CLL three,Molecular Biology MEMBS mjtm` lbywlwjy ljzyy'y@,Postive
3473,Venetoclax Acalabrutinib Treating Patients With Relapsed Refractory Mantle Cell two,Cancer News,Negative
3474,AstraZeneca dans la leucemie three ASCEND,oncohebdo,Negative
3477,AE,Bernie Marini,Negative
3478,three ASCEND CLL CLL first Jose Baselga CLL one,Taylor Lab UM,Negative
3479,Brian Koffman CLL,CLL Society Inc,Negative
3480,CLLsm,Targeted Oncology,Postive
3481,CLL,CLL Society Inc,Negative
3484,AcertaPharma FortySeven,DDNews Online,Negative
3485,three CLL,CancerTherapyAdvisor,Negative
3486,Weekly AZ Imbruvica Rival Reports Positive Trial FDA RareDisease,pharmavoice,Postive
3487,Read TargetedTherapy ClinicalTrials,ecancer,Negative
3488,CLL,CLL Society Inc,Negative
3490,AZ Calquence,PharmaTimes,Negative
3491,AstraZeneca three ASCEND Calquence Calquence,Decipher Analytics,Postive
3493,Calquence AstraZeneca,The PMI Pharmaceutical Managers Institute,Negative
3494,AstraZeneca Calquence Imbruvica three CLL Calquence Imbruvica CLL,Bionest Partners,Postive
3495,AstraZeneca Calquence three,Pharmafocus,Postive
3496,Watch AbbVie AstraZeneca one AstraZeneca Calquence,Plexus Ventures,Negative
3497,CLL PFS Leusm,Targeted Oncology,Postive
3498,AZ Calquence,Everything Pharma,Negative
3499,AZ Calquence,Pharma Trader,Negative
3500,AZ Calquence,PharmaCrowd,Negative
3501,AZ Calquence,Pharma Regulatory,Negative
3502,AZ Calquence,Barry Curry,Negative
3503,Calquence three,Pharmamarketeer,Postive
3504,Calquence three,Pharmamarketeer,Postive
3505,Calquence three,Jon Angelo,Postive
3506,AstraZeneca Calquence three,Pharmafocus,Postive
3507,AstraZeneca Calquence Phase UK,The Pharma Letter,Negative
3508,AstraZeneca Calquence three,Career Biotech,Negative
3510,AstraZeneca ASCEND AstraZeneca,PharmaShots Incisive news three shot,Negative
3512,AstraZeneca Calquence Imbruvica three CLL healthcare CI,Dr Timos Papagatsias,Postive
3513,Ji Zhi Liao Hai Yao Ji Tou Yu gaYi Shi Xuan Ze Zhi Liao yorimoYou Yi niPFSwoYan Chang   Ri Jing,Ri Jing medeikaru,Negative
3514,Calquence AZN Acerta ABBV Imbruvica,BioPharma Dive,Negative
3518,AstraZeneca Calquence Imbruvica three CLL FiercePharma,Advera Health,Postive
3519,AstraZeneca Calquence AstraZeneca Acerta Imbruvica,Cancer News,Negative
3520,AstraZeneca,Stephanie Malveira,Negative
3521,AstraZeneca Calquence Imbruvica three CLL,PharmaCrowd,Postive
3522,AstraZeneca Announce Calquence Phase three,BiopharmaAsia,Negative
3523,three ASCEND,CURE Magazine,Negative
3524,AstraZeneca Calquence Imbruvica three CLL,Labofine,Postive
3525,AstraZeneca Calquence Imbruvica three CLL pharma,Pharma Regulatory,Postive
3526,AstraZeneca Calquence Imbruvica three CLL,FiercePharma,Postive
3527,linfocitica Estudio three ASCEND,contacto sciencelink,Negative
3529,Xin Zhao Ji Shi   Ji Zhi Liao Hai Yao Ji Tou Yu gaYi Shi Xuan Ze Zhi Liao yorimoYou Yi niPFSwoYan Chang,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
3530,UBS Astrazeneca auf Ziel four hundred Pence ZURICH Analyser Die Schweizer Grossbank UBS Einstufung Daten Calquence Kursziel von ONVISTA,FinanzLinksRatings,Negative
3532,Goldman five thousand Pence Einstufung Daten Calquence FINANZTREFF,FinanzLinksRatings,Negative
3533,Goldman five thousand Pence Einstufung Daten Calquence,FinanzLinksRatings,Negative
3534,AstraZeneca three Calquence,pharmaphorum,Negative
3535,three ASCEND,PressReleasePoint,Negative
3536,Calquence Imbruvica JNJ ABBV,Jacob Plieth,Negative
3537,Xin Zhao Ji Shi   Ji Zhi Liao Hai Yao Ji Tou Yu gaYi Shi Xuan Ze Zhi Liao yorimoYou Yi niPFSwoYan Chang,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
3538,AstraZeneca Calquence three,EMG GOLD,Postive
3539,AstraZeneca Calquence AZN,FirstWord Pharma,Negative
3540,Ji Zhi Liao Hai Yao Ji Tou Yu gaYi Shi Xuan Ze Zhi Liao yorimoYou Yi niPFSwoYan Chang,Ke Xue niyusu,Negative
3541,AstraZeneca Calquence Phase three ASCEND First three CLL two thousand and,Mike van Dulken,Negative
3542,AstraZeneca Company three ASCEND Calquence AZN Pharma,Robert Barron MCSI,Postive
3543,AstraZeneca Plc Calquence Phase three ASCEND AZN,Francis Alexander,Negative
3544,CLL Astra Calquence CLL,DrugGenius,Postive
3545,Astra Calquence CLL,Brad Loncar,Postive
3546,three ASCEND,Cision News,Negative
3547,Calquence PhIII ASCEND,Cision News,Negative
3550,AstraZeneca Calquence three ASCEND,The Fly,Negative
3551,Three six Mafia PandoraMusic Calquence,Arthur Barbato,Negative
3552,CLL Danielle Brander one,OncLive SOSS,Negative
3553,Study Acalabrutinib,CureHuntr,Negative
3554,Chinese,Renal Cell Carcinoma,Negative
3555,Chinese two,TrialBulletin,Negative
3557,CLL,Oncology Tube,Negative
3561,FDA MCL Bijal Shah MD MoffittNews,OncLive SOSS,Negative
3562,Bijal Shah BTK,Bichoy Gabra,Negative
3563,Bijal Shah Cancer Center Compares BTK Inhibitors Ibrutinib Acalabrutinib,Bichoy Gabra,Negative
3564,four,Chan Cheah,Negative
3565,two thousand and nineteen Acalabrutinib Calquence,Maria Badillo MSN RN OCN CCRP,Negative
3566,Matthew Davids DanaFarber CLL,OncLive SOSS,Negative
3567,today ONS Congress two thousand and nineteen MDAndersonNews Calquence,Maria Badillo MSN RN OCN CCRP,Negative
3568,Lymphoma,Lymphoma Papers,Negative
3569,Oncology Nursing Society Congress two thousand and nineteen Anaheim PI,Maria Badillo MSN RN OCN CCRP,Negative
3570,CHOPR CHOPR,Cancer News,Negative
3571,PHOENIX Convincing EFS two Richters CLL,Toby Eyre,Postive
3572,Japan Tagrisso Imfinzi Lynparza Calquence,dough,Postive
3573,ASH EndCancer MedEd CLL,Oncology Tube,Negative
3574,SenSanders,Arthur Barbato,Negative
3575,Headaches MDAnderson ASHClinicalNews ASH Acalabrutinib LLSusa EndCancer,Oncology Tube,Negative
3576,Novita OncoEmatologia Aggiornamenti Medicina Database Ematologia OncoEmatologia,Carlo Franzini,Negative
3577,ASH EndCancer MedEd CLL,Oncology Tube,Negative
3578,MDAnderson ASHClinicalNews LLSusa EndCancer MedEd,Oncology Tube,Negative
3579,three Ibrutinib Leukemia,Targeted Oncology,Negative
3580,CLL Barrientos Ibrutinib BloodCancer,Targeted Oncology,Negative
3581,CLL CLL,Cancer News,Negative
3582,Novita OncoEmatologia Aggiornamenti Xagena WEB,Carlo Franzini,Negative
3583,Barrientos CLL CLLsm Leukemia BloodCancer,Targeted Oncology,Negative
3586,age eighteen Mantle Cell,Renal Cell Carcinoma,Negative
3587,CLL,CLL Society Inc,Negative
3588,CLL BloodCancer Leukemia,CLL Society Inc,Postive
3592,CLL,CLL Society Inc,Negative
3594,Pembro,Paulo Bergerot,Negative
3595,three SHINE ECHO SYMPATICO Kite Car,Michael Wang MD,Negative
3597,Shine three Echo five hundred two hundred and fifty,Michael Wang MD,Negative
3598,CLL John OhioState CLLsm Leusm,VJHemOnc,Negative
3599,al Bioavailability Metabolism Excretion Acalabrutinib,DMD ASPET,Negative
3600,Share Journal OfTreatment Deadline February two thousand and,Journal Blood Disorder Treatment,Postive
3601,idelalisib copanlisib,RedMedEd,Negative
3602,Astrazeneca drug CALQUENCE,Mazen,Negative
3603,Astrazeneca drug CALQUENCE Annual Drug Patent Expirations CALQUENCE Calquence one NDA four,Pharmacy News Research,Negative
3604,Astrazeneca drug CALQUENCE,BioCalifornia,Negative
3605,Astrazeneca drug CALQUENCE,DrugPatentWatch,Negative
3607,Anvisa aprovou registro de acalabrutinibe LCM tenham pelo menos Confira aprovacao,Oncologia Brasil,Negative
3608,three CLL Shagun Arora MD UCSFCancer,OncLive SOSS,Negative
3617,TargetedOnc,filippo masini,Negative
3620,OncLive,Rogel Cancer Center,Negative
3622,CLL,Oncology Tube,Negative
3628,Robert Dean MD ClevelandClinic MCL,OncLive SOSS,Negative
3629,New Post Calquence Shows Durable Responses Untreated Patients Phase Trial,Lymphoma News Today,Negative
3631,CLL,Oncology Tube,Postive
3637,Calquence,dyke loose,Negative
3640,BTK rituximab alone MCL,Targeted Oncology,Postive
3641,Aprovado novo ja tenham LCM Confira Anvisa,Anvisa,Negative
3642,un BTK,Carlo Franzini,Negative
3644,Anvisa novo Medicamento ja tenham revistamedicinasa,Revista Medicina,Negative
3645,MCL,Targeted Oncology,Negative
3646,Aprovado novo ja tenham LCM Confira Anvisa,Anvisa,Negative
3647,eurekamag,EurekaMag,Negative
3648,Phillips Cancer BloodCancer,Targeted Oncology,Negative
3651,CLL,Oncology Tube,Negative
3653,CLL,Oncology Tube,Negative
3655,Phillips Lymphoma,Targeted Oncology,Postive
3657,MCL,Targeted Oncology,Negative
3661,MCL five six Phillips Oncology,Targeted Oncology,Negative
3663,Lymphoma,Targeted Oncology,Negative
3664,two,BioNews,Negative
3665,New Post Calquence Shows Durable Responses Relapsed Refractory two,Lymphoma News Today,Negative
3666,MCL five Phillips UMich,Targeted Oncology,Negative
3667,Phillips Lymphomas lymsm,Targeted Oncology,Postive
3668,Phillips ASH Lymphoma MCL,Targeted Oncology,Negative
3669,Sun CLL one hundred BID CLLsm,Targeted Oncology,Postive
3670,last year ASH BTK Phillips MCL year Lymphoma,Targeted Oncology,Negative
3671,MantleCell,Targeted Oncology,Negative
3675,Ibrutinib FDA November two thousand and four year later second October,Michael Wang MD,Postive
3678,ninety MCL,Targeted Oncology,Negative
3681,Bruton Tyrosine Kinase Ibrutinib Acalabrutinib,Michael Wang MD,Negative
3682,Jackie Barrientos CLL ASH two thousand and eighteen six hundred Acalabrutinib Abstract two hundred Umbralisib Pembrolizumab Abstract two hundred CAR Cells Ibrutinib Abstract,Anthony Mato,Postive
3685,AstraZeneca Calquence CLL AZN,Carly Helfand,Postive
3686,One NVS JNJ Tremfya Cosentyx CLL Keytruda NSCLC PFE Oral,Andy Biotech,Negative
3687,Updates Acalabrutinib Data,Oncology Times,Negative
3688,ASH CR,Michael Wang MD,Negative
3691,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
3693,AstraZeneca Calquence CLL healthcare pharma pharmaceutical CI,Dr Timos Papagatsias,Postive
3694,AZ Calquence CLL,FiercePharma,Postive
3695,AstraZeneca,Mehrdad Yousefi,Negative
3697,Wang MCL,Targeted Oncology,Postive
3699,AstraZeneca Calquence ASH two thousand and eighteen,The Pharma Letter,Postive
3702,Calquence ASH two thousand and eighteen,Cision News,Negative
3703,Safety Efficacy Acalabrutinib Plus,Rogel Cancer Center,Negative
3704,today,Rogel Cancer Center,Negative
3705,Calquence ASH two thousand and eighteen,PressReleasePoint,Negative
3707,John OhioState CLL,Lymphoma Hub,Postive
3708,Bruce Cheson KEY John Front,Anthony Mato,Negative
3710,BTK Shown,Jeff Sharman,Negative
3711,MCL CLL,AstraZenecaUS,Negative
3712,AE fortytwo month,Anthony Mato,Negative
3713,New Data CALQUENCE Presented ASH two thousand and eighteen,Crwe World,Negative
3715,Ujjani one Ibrutinib Read Lymphoma,Targeted Oncology,Negative
3716,AstraZeneca ASH two thousand and eighteen New Calquence MCL,EuropaWire,Negative
3717,AstraZeneca ASH two thousand and eighteen CLL,EuropaWire,Negative
3718,AstraZeneca two thousand and eighteen American Society Hematology Annual Meeting,EuropaWire,Negative
3720,BTK CLL Brian Hill PhD ClevelandClinic,OncLive SOSS,Negative
3722,LymphomaAction BTK Ibrutinib Acalabrutinib Ibrutinib CLL MCL,Helen Jane Mee,Postive
3723,Sprague Dawley,Lymphoma Papers,Negative
3726,MassSpec DMD,BioMassSpec,Negative
3727,An Application Pharmacokinetic Study Dawley JPBA,BioMassSpec,Negative
3729,La monoterapia della macroglobulinemia Waldenstrom,Carlo Franzini,Negative
3731,AFib Acalabrutinib,PersonalizeAF,Negative
3733,CLL Aspergillosis Hep BTK CLL,Toby Eyre,Negative
3734,CLL Acalabrutinib,Anna Deveau,Negative
3736,receipt month,Jeff Sharman,Negative
3739,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3740,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3741,San Diego Dave Johnson Acerta multibillion,Jeff Cranmer,Negative
3743,Bruton Kinase,Ed,Negative
3744,BTK Ibrutinib Acalabrutinib Lymphoma,VJHemOnc,Negative
3745,La un el primer me de tratamiento,WGM,Negative
3746,La recaida el uso de omeprazol,WGM,Negative
3749,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3750,Bijal Shah MD MoffittNews,OncLive SOSS,Negative
3751,Bijal Shah MD MoffittNews,OncLive SOSS,Negative
3753,Shah Compares Toxicity Profiles Ibrutinib Acalabrutinib,OncLive SOSS,Negative
3754,Bijal Shah Cancer Center Compares BTK Inhibitors Ibrutinib Acalabrutinib,Bichoy Gabra,Negative
3756,Macroglobulinemia Lymsm NonHodgkin,VJHemOnc,Postive
3757,FDA Lymphoma,Strand Urgent Care,Postive
3758,IBRUTINIB ACALABRUTINIB TYROSINE,Gopal,Negative
3759,Utilizing Acalabrutinib Alone Combination Follicular Lymphoma,Oncology Times,Negative
3760,Christopher Flowers MD MS BTK,CCO Oncology,Postive
3761,Bijal Shah MoffittNews,OncLive SOSS,Negative
3762,Shah Chair,donnashort,Negative
3764,Novita OncoEmatologia Xagena Acalabrutinib,Carlo Franzini,Negative
3768,Waldenstrm,Oncology Tube,Postive
3769,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3770,WEEKEND Pip Nicolson Prof Steve Watson Inhibition Of Btk,UoB Cardiovascular,Negative
3771,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3773,CLL,Oncology Tube,Postive
3774,PipNicolson Btk GPVI,Cells Molecules Research UoB,Negative
3775,AstraZeneca,ProStockMarkets,Negative
3777,AstraZeneca,Oncology Tube,Negative
3778,Calquence AstraZeneca Calquence,ResearchPool,Negative
3779,BTK Ibrutinib,CellworksLife,Postive
3780,FDA linfomas de celulas del manto,ASEPO Asociacion ES,Negative
3781,Wang BTK Lymphoma,Targeted Oncology,Negative
3782,CLL,Oncology Tube,Postive
3783,WM Simon Rule,Lymphoma Hub,Negative
3784,Waldenstrom Owen MD lymsm,The ASCO Post,Postive
3788,ClinicalTrials UK Phase Combination Acalabrutinib With Patient Diffuse,Avery Hudson,Postive
3789,LOL ARQL SNSS APTO TGTX LOXO,Bill Nye XBI Guy,Postive
3790,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3791,ASH two thousand and Atlanta John CLL YouTube,CLL Society Inc,Negative
3792,AcertaPharma SFBTBiotech,SF Biz Times Events,Negative
3793,WM Waldenstromsmacroglobulinemia,MDedge Hematology Oncology,Postive
3796,Ibrutinib Acalabrutinib,Michael Wang MD,Negative
3797,BTK,Targeted Oncology,Negative
3798,Waldenstrom Macroglobulinemia,Lampe Company,Negative
3799,Waldenstroms CTSM,VJHemOnc,Postive
3800,AstraZeneca first one Live EHA,Clarivate Cortellis,Negative
3801,Venetoclax Presentation Zanubrutinib one thousand one hundred tonight,Judith Trotman,Negative
3802,EHA,Clarivate Cortellis,Negative
3803,First WM,Lymphoma Hub,Negative
3805,KALKVENS CALQUENCE pokaza,Vavilin Dima,Negative
3806,Macroglobulinemia Waldenstrom Fase two Bruton resposta duradoura Novas,Philip Bachour,Negative
3807,compare anticancer drug one hundred and two NTRC one hundred SUMOylation BTK,NTRC,Negative
3808,KALKVENS CALQUENCE pokaza,oioreeze,Negative
3809,blinatumomab inotuzumab info,Cancer DDIs,Negative
3811,Calquence Set Drug Calquence EU Pharma Calquence Vs Imbruvica CLL three,ResearchPool,Negative
3812,Jia Ruan,WCM Lymphoma,Negative
3814,Waldenstrom Macroglobulinemia,Oncology Tube,Negative
3815,Peter Martin,WCM Lymphoma,Negative
3816,MCL Diabetic,Pharmacy Medications Health Blog,Negative
3817,Waldenstrom,CancerTherapyAdvisor,Negative
3818,nyphospital proud Waldenstrom,WCMNYPJCTO,Postive
3820,Waldenstrom WM BTK,Alkis Papachristos PharmD PhD,Negative
3821,Richard Furman Waldenstrom lymsm,WCM Lymphoma,Negative
3822,Communicated Mantle Cell Lymphoma,John Leonard MD,Negative
3823,seven thousand five hundred Waldenstroms,Jason Westin MD FACP,Postive
3825,Ibrutinib,Raul Cordoba MD PhD,Negative
3826,lymsm seven thousand five hundred Acalabrutinib Waldenstroms Macroglobulinemia,Hedrick,Negative
3828,KALKVENS CALQUENCE pokaza,Alekhander,Negative
3829,KALKVENS CALQUENCE pokaza,Shim Beauty,Negative
3830,weekly Tonight ASH two thousand and seventeen tonight MCL,ESOncology,Postive
3831,KALKVENS CALQUENCE pokaza,Sasha Schultz,Negative
3832,KALKVENS CALQUENCE pokaza,Ahma,Negative
3833,one BLOCK,Charles Weiler,Negative
3834,KALKVENS CALQUENCE pokaza,Valentina,Negative
3835,Tagrisso Calquence TWTR,Gregory,Negative
3836,CR lymSM,Chan Cheah,Postive
3837,KALKVENS CALQUENCE pokaza,sgee geh,Negative
3838,TWTR Imbruvica ABBV JNJ,Gregory,Negative
3840,MayoClinic SitemanCenter,Oncology Times,Negative
3841,KALKVENS CALQUENCE pokaza,Yolo,Negative
3842,KALKVENS CALQUENCE pokaza,Svetlana,Negative
3843,KALKVENS CALQUENCE pokaza,Alex Step,Negative
3844,KALKVENS CALQUENCE pokaza,Girl internet,Negative
3845,KALKVENS CALQUENCE pokaza,anton,Negative
3846,KALKVENS CALQUENCE pokaza,Eugen Plamadeala,Negative
3847,ref,Francesco Bertoni,Negative
3849,KALKVENS CALQUENCE pokaza,NucleoX,Negative
3850,Twitter MD Anderson,Chloe Mac,Negative
3851,KALKVENS CALQUENCE pokaza,qweqweqwe qweqweqwe,Negative
3852,Dyer et al acalabrutinib rel ref five one one GCB ABC two twelve month,Graham Collins,Postive
3853,Ryan Jacobs MD Carolinas,OncLive SOSS,Negative
3854,one MCL Ryan Jacobs MD Carolinas,OncLive SOSS,Negative
3855,NHL,elizabeth,Negative
3858,KALKVENS CALQUENCE pokaza,Egor gaga,Negative
3859,KALKVENS CALQUENCE pokaza,Aleksei,Negative
3860,KALKVENS CALQUENCE pokaza,Sviatoslav Kuvshinov,Negative
3863,KALKVENS CALQUENCE pokaza,Rini Kharuka,Negative
3865,KALKVENS CALQUENCE pokaza,President,Negative
3867,two obinutuzumab,Cancer News,Negative
3869,Condition Summary Negative Chronic,TrialBulletin,Negative
3870,KALKVENS CALQUENCE pokaza,antitela,Negative
3871,KALKVENS CALQUENCE pokaza,Kiriushka Reikh,Negative
3872,KALKVENS CALQUENCE pokaza,MLM ZARABOTOK,Negative
3873,BloodCancer,Oncology Times,Negative
3874,CancerResearch Today John Theurer,Targeted Oncology,Negative
3877,KALKVENS CALQUENCE pokaza,Kirill Antonov,Negative
3878,KALKVENS CALQUENCE pokaza,John Smith,Negative
3879,KALKVENS CALQUENCE pokaza,Rushaniia Ramazanova,Negative
3880,MCL Lymphomas,Targeted Oncology,Postive
3881,KALKVENS CALQUENCE pokaza,olair,Negative
3882,KALKVENS CALQUENCE pokaza,Miha Fil,Negative
3884,MayoClinic SitemanCenter BloodCancer,Oncology Times,Negative
3885,KALKVENS CALQUENCE pokaza,Asmaa,Negative
3886,KALKVENS CALQUENCE pokaza,Ignat Ilyushonok,Negative
3887,Wang MD,The ASCO Post,Negative
3888,two,BioNews,Postive
3889,New Post Phase two,Lymphoma News Today,Postive
3890,KALKVENS CALQUENCE pokaza,Polacsek Viktor,Negative
3891,KALKVENS CALQUENCE pokaza,dfgfgf resgrsy,Negative
3892,KALKVENS CALQUENCE pokaza,adsadasds,Negative
3893,KALKVENS CALQUENCE pokaza,aaaaaaaaaaaaaa,Negative
3894,KALKVENS CALQUENCE pokaza,Vanish,Negative
3895,KALKVENS CALQUENCE pokaza,Natal'ia Antonova,Negative
3896,KALKVENS CALQUENCE pokaza,Avifors,Negative
3897,KALKVENS CALQUENCE pokaza,fggfgfgfg,Negative
3898,KALKVENS CALQUENCE pokaza,Floyd,Negative
3900,KALKVENS CALQUENCE pokaza,Arif,Negative
3901,KALKVENS CALQUENCE pokaza,Gorovaia Liudmila,Negative
3902,KALKVENS CALQUENCE pokaza,antoha,Negative
3903,KALKVENS CALQUENCE pokaza,Dima Bezbabchenko,Negative
3904,KALKVENS CALQUENCE pokaza,Aehb Lehb,Negative
3905,KALKVENS CALQUENCE pokaza,Miller,Negative
3906,KALKVENS CALQUENCE pokaza,Eva Barats,Negative
3907,KALKVENS CALQUENCE pokaza,Final,Negative
3908,KALKVENS CALQUENCE pokaza,Anton Zborovskii,Negative
3909,KALKVENS CALQUENCE pokaza,Girl internet,Negative
3910,KALKVENS CALQUENCE pokaza,Rain Dimp,Negative
3911,AndreGoyMD,Targeted Oncology,Negative
3913,KALKVENS CALQUENCE pokaza,Moira Tsiglerr,Negative
3914,KALKVENS CALQUENCE pokaza,Sergei Fedasov,Negative
3915,KALKVENS CALQUENCE pokaza,Seba,Negative
3916,KALKVENS CALQUENCE pokaza,Ivan Alekseevich,Negative
3917,KALKVENS CALQUENCE pokaza,Sergio Ramoz,Negative
3918,KALKVENS CALQUENCE pokaza,Seva Trubchaninov,Negative
3919,Hematology Oncology,Targeted Oncology,Negative
3920,KALKVENS CALQUENCE pokaza,Nina Greshnikova,Negative
3921,KALKVENS CALQUENCE pokaza,alexei,Negative
3922,KALKVENS CALQUENCE pokaza,Gogol Marat,Negative
3923,KALKVENS CALQUENCE pokaza,Mao Ge,Negative
3924,KALKVENS CALQUENCE pokaza,annmarie,Negative
3925,KALKVENS CALQUENCE pokaza,mir rukodel'nykh materialov,Negative
3926,KALKVENS CALQUENCE pokaza,Igor,Negative
3927,KALKVENS CALQUENCE pokaza,Rinat Sabyrov,Negative
3928,KALKVENS CALQUENCE pokaza,Akhmad Tii,Negative
3929,KALKVENS CALQUENCE pokaza,Aleksei Sevast'ianov,Negative
3930,KALKVENS CALQUENCE pokaza,vladislav,Negative
3931,KALKVENS CALQUENCE pokaza,asdfghjkl,Negative
3932,KALKVENS CALQUENCE pokaza,Egr pork,Negative
3933,KALKVENS CALQUENCE pokaza,Dlia Gruppy,Negative
3934,KALKVENS CALQUENCE pokaza,Aleksadr Nevskii,Negative
3935,KALKVENS CALQUENCE pokaza,Liudmila Kazakova,Negative
3936,KALKVENS CALQUENCE pokaza,SAShA MIKUS,Negative
3937,KALKVENS CALQUENCE pokaza,paaldy vroaypva,Negative
3938,KALKVENS CALQUENCE pokaza,ggg,Negative
3939,KALKVENS CALQUENCE pokaza,Shizuka,Negative
3940,KALKVENS CALQUENCE pokaza,victor,Negative
3941,KALKVENS CALQUENCE pokaza,Maksim Maksimilian,Negative
3942,KALKVENS CALQUENCE pokaza,Petrovich,Negative
3944,KALKVENS CALQUENCE pokaza,Il'ia Petukh,Negative
3945,KALKVENS CALQUENCE pokaza,Casio Velardo,Negative
3946,KALKVENS CALQUENCE pokaza,qwer,Negative
3947,KALKVENS CALQUENCE pokaza,Karsakbai,Negative
3948,KALKVENS CALQUENCE pokaza,Kseniia,Negative
3950,KALKVENS CALQUENCE pokaza,Dmitrii,Negative
3951,KALKVENS CALQUENCE pokaza,Fedia Popovich',Negative
3953,KALKVENS CALQUENCE pokaza,Stervochka,Negative
3954,KALKVENS CALQUENCE pokaza,Kiril Imifodii,Negative
3955,KALKVENS CALQUENCE pokaza,den kurmankulove,Negative
3956,KALKVENS CALQUENCE pokaza,Nastia Kuznetsova,Negative
3957,KALKVENS CALQUENCE pokaza,Ekaterina Valer'evna,Negative
3958,KALKVENS CALQUENCE pokaza,aaaaaaaaaaa,Negative
3959,KALKVENS CALQUENCE pokaza,Aleksandr Slugin,Negative
3961,KALKVENS CALQUENCE pokaza,Vadim,Negative
3962,KALKVENS CALQUENCE pokaza,Anastasiia,Negative
3963,KALKVENS CALQUENCE pokaza,Iurii Markov,Negative
3964,KALKVENS CALQUENCE pokaza,Fotter,Negative
3965,KALKVENS CALQUENCE pokaza,Alex Swarni,Negative
3967,KALKVENS CALQUENCE pokaza,Dima,Negative
3968,KALKVENS CALQUENCE pokaza,GidRealty,Negative
3969,KALKVENS CALQUENCE pokaza,NICK FISHER,Negative
3970,KALKVENS CALQUENCE pokaza,didim,Negative
3973,KALKVENS CALQUENCE pokaza,Heisenberg,Negative
3974,KALKVENS CALQUENCE pokaza,dAN'KA,Negative
3975,KALKVENS CALQUENCE pokaza,Elena Pogorelova,Negative
3976,KALKVENS CALQUENCE pokaza,Artiom Ivanenko,Negative
3977,FDA,Targeted Oncology,Postive
3978,KALKVENS CALQUENCE pokaza,serggg kozlov,Negative
3979,KALKVENS CALQUENCE pokaza,Aleksandr Ch,Negative
3980,KALKVENS CALQUENCE pokaza,Realty,Negative
3981,KALKVENS CALQUENCE pokaza,lev,Negative
3982,KALKVENS CALQUENCE pokaza,eka,Negative
3983,KALKVENS CALQUENCE pokaza,qsxc,Negative
3984,KALKVENS CALQUENCE pokaza,grheuhe,Negative
3985,one first weekly VA Heme,Oana Paun,Postive
3986,KALKVENS CALQUENCE pokaza,vasia pupkin,Negative
3987,KALKVENS CALQUENCE pokaza,Egor Nichei,Negative
3988,KALKVENS CALQUENCE pokaza,Asd Faasdd,Negative
3989,KALKVENS CALQUENCE pokaza,Maksim Fomin,Negative
3990,KALKVENS CALQUENCE pokaza,dima burii,Negative
3991,KALKVENS CALQUENCE pokaza,Anyasokolka,Negative
3992,KALKVENS CALQUENCE pokaza,Panda Kungfu,Negative
3993,KALKVENS CALQUENCE pokaza,Sergei Demchenko,Negative
3994,KALKVENS CALQUENCE pokaza,Andrei Travka,Negative
3995,KALKVENS CALQUENCE pokaza,semen semenov,Negative
3996,KALKVENS CALQUENCE pokaza,Vasia Gorgos,Negative
3998,FDA Calquence Read,Targeted Oncology,Negative
3999,KALKVENS CALQUENCE pokaza,Andrey Bodnik,Negative
4000,KALKVENS CALQUENCE pokaza,Megajin,Negative
4001,KALKVENS CALQUENCE pokaza,fwefwewe,Negative
4002,KALKVENS CALQUENCE pokaza,Iulia Borshcheva,Negative
4003,KALKVENS CALQUENCE pokaza,dibil real'no,Negative
4004,KALKVENS CALQUENCE pokaza,Denis Luk'ianenko,Negative
4005,KALKVENS CALQUENCE pokaza,Man World,Negative
4006,KALKVENS CALQUENCE pokaza,Kseniia Arkhipova,Negative
4007,KALKVENS CALQUENCE pokaza,Vika Kovalova,Negative
4008,KALKVENS CALQUENCE pokaza,Ekaterina Potapova,Negative
4009,KALKVENS CALQUENCE pokaza,Vika Novikova,Negative
4010,KALKVENS CALQUENCE pokaza,Dmitrii Tkach,Negative
4011,KALKVENS CALQUENCE pokaza,Iul'ka Filipova,Negative
4012,KALKVENS CALQUENCE pokaza,Ekaterina Golubeva,Negative
4014,KALKVENS CALQUENCE pokaza,Iaroslav Skripchenko,Negative
4015,KALKVENS CALQUENCE pokaza,Gono Pablo,Negative
4016,KALKVENS CALQUENCE pokaza,Zakhar Irmanov,Negative
4017,KALKVENS CALQUENCE pokaza,Iuliia Loskutova,Negative
4018,KALKVENS CALQUENCE pokaza,Roman,Negative
4019,KALKVENS CALQUENCE pokaza,Chakhlik Nevmiruchii,Negative
4020,KALKVENS CALQUENCE pokaza,Muravt'ev Dmitrii,Negative
4021,KALKVENS CALQUENCE pokaza,Vlad Sornokov,Negative
4022,KALKVENS CALQUENCE pokaza,Petia botov,Negative
4024,KALKVENS CALQUENCE pokaza,Sonomakid,Negative
4025,KALKVENS CALQUENCE pokaza,Dmitrii Bereza,Negative
4026,KALKVENS CALQUENCE pokaza,Alex,Negative
4027,KALKVENS CALQUENCE pokaza,Vlada Levina,Negative
4028,KALKVENS CALQUENCE pokaza,Vadim Abdul,Negative
4029,KALKVENS CALQUENCE pokaza,Kristina,Negative
4030,KALKVENS CALQUENCE pokaza,Lucy Redfox,Negative
4031,KALKVENS CALQUENCE pokaza,Iosif,Negative
4032,KALKVENS CALQUENCE pokaza,kivihajeh,Negative
4033,KALKVENS CALQUENCE pokaza,william brock jones,Negative
4034,KALKVENS CALQUENCE pokaza,loh lol,Negative
4035,KALKVENS CALQUENCE pokaza,paaldy vroaypva,Negative
4036,KALKVENS CALQUENCE pokaza,three hundred and eighty,Negative
4037,KALKVENS CALQUENCE pokaza,Anton,Negative
4038,KALKVENS CALQUENCE pokaza,Rza Hesenov,Negative
4039,KALKVENS CALQUENCE pokaza,Taniushka Pashchenko,Negative
4041,KALKVENS CALQUENCE pokaza,Dod bed,Negative
4043,KALKVENS CALQUENCE pokaza,Aleksei,Negative
4044,KALKVENS CALQUENCE pokaza,Frank,Negative
4046,KALKVENS CALQUENCE pokaza,ilusha,Negative
4047,KALKVENS CALQUENCE pokaza,chingis han,Negative
4048,KALKVENS CALQUENCE pokaza,fdsfds,Negative
4049,LOXO BTK JNJ Wonder AZN,Bobby,Postive
4050,KALKVENS CALQUENCE pokaza,Rozak,Negative
4051,KALKVENS CALQUENCE pokaza,Riko Miko,Negative
4052,KALKVENS CALQUENCE pokaza,ahhahah lol,Negative
4053,KALKVENS CALQUENCE pokaza,JACK,Negative
4055,KALKVENS CALQUENCE pokaza,Misha lapko,Negative
4056,KALKVENS CALQUENCE pokaza,Dima Ianin,Negative
4057,KALKVENS CALQUENCE pokaza,Egor,Negative
4058,KALKVENS CALQUENCE pokaza,Rodzher,Negative
4059,KALKVENS CALQUENCE pokaza,Aleksandr Pen'kov,Negative
4060,KALKVENS CALQUENCE pokaza,Muradinio Rustuy,Negative
4061,KALKVENS CALQUENCE pokaza,Alisa Stepanova,Negative
4062,KALKVENS CALQUENCE pokaza,Nika Gavryshyk,Negative
4063,KALKVENS CALQUENCE pokaza,Vlad,Negative
4064,KALKVENS CALQUENCE pokaza,kedr,Negative
4065,KALKVENS CALQUENCE pokaza,Ivan Shuma,Negative
4066,KALKVENS CALQUENCE pokaza,Marry,Negative
4067,KALKVENS CALQUENCE pokaza,Maks Khudeev,Negative
4068,KALKVENS CALQUENCE pokaza,Ghghhg,Negative
4069,KALKVENS CALQUENCE pokaza,maxxam,Negative
4070,KALKVENS CALQUENCE pokaza,jdskxjsj,Negative
4071,KALKVENS CALQUENCE pokaza,Aleksei Chervinskii,Negative
4073,KALKVENS CALQUENCE pokaza,Oleg Markov,Negative
4074,KALKVENS CALQUENCE pokaza,Vova Sidorov,Negative
4075,KALKVENS CALQUENCE pokaza,John Valent,Negative
4077,KALKVENS CALQUENCE pokaza,Vitalii Krans,Negative
4078,KALKVENS CALQUENCE pokaza,Ivan Verta,Negative
4080,KALKVENS CALQUENCE pokaza,Ruslan Ibragimov,Negative
4082,KALKVENS CALQUENCE pokaza,Edik Sadovoi,Negative
4083,KALKVENS CALQUENCE pokaza,Regina Titanova,Negative
4084,KALKVENS CALQUENCE pokaza,Ekaterina Gordeeva,Negative
4085,KALKVENS CALQUENCE pokaza,Stetsiuk Dmitrii,Negative
4086,KALKVENS CALQUENCE pokaza,Gkydkjf,Negative
4087,KALKVENS CALQUENCE pokaza,MuzKg,Negative
4088,KALKVENS CALQUENCE pokaza,jyghj,Negative
4089,KALKVENS CALQUENCE pokaza,sasa,Negative
4090,KALKVENS CALQUENCE pokaza,Khagrid Morgan,Negative
4092,KALKVENS CALQUENCE pokaza,irina galushka,Negative
4093,KALKVENS CALQUENCE pokaza,Matvey,Negative
4094,KALKVENS CALQUENCE pokaza,Irina,Negative
4095,KALKVENS CALQUENCE pokaza,Ded Moroz,Negative
4096,KALKVENS CALQUENCE pokaza,Nikita Kanev,Negative
4097,KALKVENS CALQUENCE pokaza,Ruslan Lunov,Negative
4098,KALKVENS CALQUENCE pokaza,aaa,Negative
4099,KALKVENS CALQUENCE pokaza,Rikardo Dias,Negative
4101,KALKVENS CALQUENCE pokaza,Kolia,Negative
4102,KALKVENS CALQUENCE pokaza,Fnhdddnkjgf,Negative
4103,KALKVENS CALQUENCE pokaza,Inna Krosheva,Negative
4104,KALKVENS CALQUENCE pokaza,Sveta,Negative
4105,KALKVENS CALQUENCE pokaza,Muslim,Negative
4106,KALKVENS CALQUENCE pokaza,Jor,Negative
4107,KALKVENS CALQUENCE pokaza,Aleksandr Shevtsov,Negative
4108,KALKVENS CALQUENCE pokaza,Sergei,Negative
4109,KALKVENS CALQUENCE pokaza,Koretov,Negative
4110,KALKVENS CALQUENCE pokaza,Makim Koldomov,Negative
4111,KALKVENS CALQUENCE pokaza,Semen Frolov,Negative
4112,KALKVENS CALQUENCE pokaza,Fox Nice,Negative
4113,KALKVENS CALQUENCE pokaza,Alla Surtaeva,Negative
4114,KALKVENS CALQUENCE pokaza,Masha Liakh,Negative
4115,KALKVENS CALQUENCE pokaza,Vlad Krokanov,Negative
4116,KALKVENS CALQUENCE pokaza,yyvfy,Negative
4117,KALKVENS CALQUENCE pokaza,Maksim iosivich,Negative
4118,KALKVENS CALQUENCE pokaza,Fwefwe fwefwfwe,Negative
4119,KALKVENS CALQUENCE pokaza,Olia Kurbakova,Negative
4120,KALKVENS CALQUENCE pokaza,lina smith,Negative
4121,KALKVENS CALQUENCE pokaza,Histopov Loreon,Negative
4122,KALKVENS CALQUENCE pokaza,Artem BELOW,Negative
4123,KALKVENS CALQUENCE pokaza,Bond Den,Negative
4124,KALKVENS CALQUENCE pokaza,Irina Chernikova,Negative
4125,Ibrutinib Acalabrutinib Zanubrutinb,Judith Trotman,Postive
4126,KALKVENS CALQUENCE pokaza,Marcos Junior,Negative
4127,KALKVENS CALQUENCE pokaza,John Valent,Negative
4128,KALKVENS CALQUENCE pokaza,kot neadekvat,Negative
4129,two,MD Anderson Cancer Center,Postive
4130,KALKVENS CALQUENCE pokaza,Evgenii Shil'ko,Negative
4132,KALKVENS CALQUENCE pokaza,Ol'ga Surin,Negative
4133,KALKVENS CALQUENCE pokaza,torp ploas,Negative
4134,KALKVENS CALQUENCE pokaza,Nika Sushnyakova,Negative
4135,KALKVENS CALQUENCE pokaza,qplknco,Negative
4136,KALKVENS CALQUENCE pokaza,Aleksej Buss,Negative
4137,KALKVENS CALQUENCE pokaza,Fedorov,Negative
4138,KALKVENS CALQUENCE pokaza,Kirill Afanas'ev,Negative
4139,KALKVENS CALQUENCE pokaza,Viktoriia Azimova,Negative
4140,KALKVENS CALQUENCE pokaza,Aleksei Lunev,Negative
4141,KALKVENS CALQUENCE pokaza,Elena Popova,Negative
4142,KALKVENS CALQUENCE pokaza,Iurii Antonov,Negative
4143,KALKVENS CALQUENCE pokaza,Artem Polushin,Negative
4144,KALKVENS CALQUENCE pokaza,Katerina Dunaeva,Negative
4146,KALKVENS CALQUENCE pokaza,Sergei Petrov,Negative
4147,KALKVENS CALQUENCE pokaza,Viktor Vasil'ev,Negative
4148,KALKVENS CALQUENCE pokaza,diufghs,Negative
4149,KALKVENS CALQUENCE pokaza,Inna Golovina,Negative
4150,KALKVENS CALQUENCE pokaza,denis,Negative
4151,KALKVENS CALQUENCE pokaza,plx,Negative
4152,KALKVENS CALQUENCE pokaza,Makar Afanas'ev,Negative
4153,KALKVENS CALQUENCE pokaza,Crasybeardog,Negative
4154,KALKVENS CALQUENCE pokaza,Veronika Blum,Negative
4155,KALKVENS CALQUENCE pokaza,Alex,Negative
4156,KALKVENS CALQUENCE pokaza,Misha Sal'nikovv,Negative
4157,KALKVENS CALQUENCE pokaza,Nonna Chizhova,Negative
4158,KALKVENS CALQUENCE pokaza,Kristina Vol'fovskaia,Negative
4159,KALKVENS CALQUENCE pokaza,Nikita Kurkin,Negative
4160,KALKVENS CALQUENCE pokaza,Ol'ga Spiridonova,Negative
4162,KALKVENS CALQUENCE pokaza,kek kekov,Negative
4163,KALKVENS CALQUENCE pokaza,InstaPromoVideo,Negative
4164,KALKVENS CALQUENCE pokaza,BoiK,Negative
4165,KALKVENS CALQUENCE pokaza,Ivanov Sergei Petrovich,Negative
4166,KALKVENS CALQUENCE pokaza,Denchik,Negative
4167,KALKVENS CALQUENCE pokaza,Yarema Dyackiv,Negative
4168,KALKVENS CALQUENCE pokaza,miausy,Negative
4170,KALKVENS CALQUENCE pokaza,Artiom Kostiuchenko,Negative
4171,KALKVENS CALQUENCE pokaza,Petr Semenov,Negative
4172,KALKVENS CALQUENCE pokaza,Dima,Negative
4173,KALKVENS CALQUENCE pokaza,Aleksandr Berg,Negative
4174,KALKVENS CALQUENCE pokaza,Svetlana Plechistytsa,Negative
4175,KALKVENS CALQUENCE pokaza,Maks Panch,Negative
4176,KALKVENS CALQUENCE pokaza,Kamila Antonova,Negative
4177,KALKVENS CALQUENCE pokaza,Hacker,Negative
4178,KALKVENS CALQUENCE pokaza,Alisa Leonova,Negative
4179,KALKVENS CALQUENCE pokaza,Sergei Ivanov,Negative
4180,KALKVENS CALQUENCE pokaza,Nadiia Volodimirivna,Negative
4181,KALKVENS CALQUENCE pokaza,Nikolai,Negative
4182,KALKVENS CALQUENCE pokaza,Il'ia Kalashnikov,Negative
4183,KALKVENS CALQUENCE pokaza,Valentin Grevtcov,Negative
4184,KALKVENS CALQUENCE pokaza,Serioga Shatalov,Negative
4185,KALKVENS CALQUENCE pokaza,dmitrii uauya,Negative
4186,KALKVENS CALQUENCE pokaza,fghjk,Negative
4187,KALKVENS CALQUENCE pokaza,mediavlogster,Negative
4188,KALKVENS CALQUENCE pokaza,Stark,Negative
4189,KALKVENS CALQUENCE pokaza,Artiom Reznikov,Negative
4190,KALKVENS CALQUENCE pokaza,arkadi naftaliev,Negative
4192,KALKVENS CALQUENCE pokaza,Aniuta Tarasova,Negative
4193,KALKVENS CALQUENCE pokaza,Ekaterina Nesvetaeva,Negative
4194,KALKVENS CALQUENCE pokaza,nikolos keidzh,Negative
4195,KALKVENS CALQUENCE pokaza,Lovee,Negative
4196,KALKVENS CALQUENCE pokaza,Vlad Maliovanyi,Negative
4197,KALKVENS CALQUENCE pokaza,Anna Petrova,Negative
4198,KALKVENS CALQUENCE pokaza,abdul,Negative
4199,KALKVENS CALQUENCE pokaza,Ivan Romanov,Negative
4200,KALKVENS CALQUENCE pokaza,Roby wilams,Negative
4201,KALKVENS CALQUENCE pokaza,Knyazev,Negative
4202,KALKVENS CALQUENCE pokaza,Xoma feb,Negative
4203,KALKVENS CALQUENCE pokaza,Team FOETBT,Negative
4204,KALKVENS CALQUENCE pokaza,olwfkw fowmkfowmfw,Negative
4205,KALKVENS CALQUENCE pokaza,Zakhar Phylyppo,Negative
4206,KALKVENS CALQUENCE pokaza,Sobaka Kysaka,Negative
4209,KALKVENS CALQUENCE pokaza,Nikita Prohorow,Negative
4211,KALKVENS CALQUENCE pokaza,Alena Ivanova,Negative
4212,KALKVENS CALQUENCE pokaza,Sasha Marinich,Negative
4213,KALKVENS CALQUENCE pokaza,Johnny Dillinger,Negative
4214,KALKVENS CALQUENCE pokaza,regeter,Negative
4215,KALKVENS CALQUENCE pokaza,Fedia Galaktionov,Negative
4216,KALKVENS CALQUENCE pokaza,Aleksei Saigulov,Negative
4217,KALKVENS CALQUENCE pokaza,Vadimovna Dariia,Negative
4218,KALKVENS CALQUENCE pokaza,ANTON,Negative
4219,KALKVENS CALQUENCE pokaza,Anastasiia grudinina,Negative
4220,KALKVENS CALQUENCE pokaza,Zhenechka Kusakina,Negative
4223,KALKVENS CALQUENCE pokaza,Denix,Negative
4224,KALKVENS CALQUENCE pokaza,Dmitrii Lents,Negative
4225,KALKVENS CALQUENCE pokaza,Dasha Chizhova,Negative
4226,KALKVENS CALQUENCE pokaza,Iaroslav Chirkov,Negative
4227,KALKVENS CALQUENCE pokaza,Yernar Asirov,Negative
4228,KALKVENS CALQUENCE pokaza,Sonia Orlova,Negative
4229,KALKVENS CALQUENCE pokaza,Oksana Spirina,Negative
4230,KALKVENS CALQUENCE pokaza,Tsitaty,Negative
4231,KALKVENS CALQUENCE pokaza,Irina,Negative
4232,KALKVENS CALQUENCE pokaza,Dmitrii Stennikov,Negative
4233,KALKVENS CALQUENCE pokaza,"bot one thousand, seven hundred and twentyeight",Negative
4234,KALKVENS CALQUENCE pokaza,Echo Mars,Negative
4235,KALKVENS CALQUENCE pokaza,prvlogster,Negative
4236,KALKVENS CALQUENCE pokaza,marinavlogster,Negative
4237,KALKVENS CALQUENCE pokaza,Black Kingutu,Negative
4238,KALKVENS CALQUENCE pokaza,herhejhed,Negative
4239,KALKVENS CALQUENCE pokaza,Vladislav Vargasov,Negative
4240,KALKVENS CALQUENCE pokaza,Vsetlana Eliseeva,Negative
4241,KALKVENS CALQUENCE pokaza,Egor Dukhovnyi,Negative
4242,KALKVENS CALQUENCE pokaza,gekpaker,Negative
4243,KALKVENS CALQUENCE pokaza,balikesir byn,Negative
4244,KALKVENS CALQUENCE pokaza,Daniil Demidov,Negative
4245,KALKVENS CALQUENCE pokaza,Evgenii,Negative
4246,KALKVENS CALQUENCE pokaza,gwgrgrwgwrg,Negative
4247,KALKVENS CALQUENCE pokaza,Anton Diachenko,Negative
4248,KALKVENS CALQUENCE pokaza,Savelii Gradkov,Negative
4249,KALKVENS CALQUENCE pokaza,ArlNakru,Negative
4250,KALKVENS CALQUENCE pokaza,Antony Terras,Negative
4251,KALKVENS CALQUENCE pokaza,Andrey,Negative
4252,KALKVENS CALQUENCE pokaza,ozoz ozoz,Negative
4253,KALKVENS CALQUENCE pokaza,Andrei Martynenko,Negative
4254,KALKVENS CALQUENCE pokaza,ASUNWQ,Negative
4255,KALKVENS CALQUENCE pokaza,Volka,Negative
4256,KALKVENS CALQUENCE pokaza,Ivan Kozlov,Negative
4257,KALKVENS CALQUENCE pokaza,Mul'tiki dlia malen'kikh Detskii kanal,Negative
4258,KALKVENS CALQUENCE pokaza,lialia,Negative
4259,KALKVENS CALQUENCE pokaza,Kirill Shprotov,Negative
4260,KALKVENS CALQUENCE pokaza,Nikolai Gerom,Negative
4261,KALKVENS CALQUENCE pokaza,Volodia,Negative
4262,KALKVENS CALQUENCE pokaza,asfdf,Negative
4263,KALKVENS CALQUENCE pokaza,Kirill Ukolov,Negative
4264,KALKVENS CALQUENCE pokaza,Aleksandr Ivanov,Negative
4265,KALKVENS CALQUENCE pokaza,sdawdwad,Negative
4268,KALKVENS CALQUENCE pokaza,Soldatenkova tat'iana,Negative
4269,KALKVENS CALQUENCE pokaza,Andrey Mays,Negative
4270,KALKVENS CALQUENCE pokaza,jgfg bgvg,Negative
4271,KALKVENS CALQUENCE pokaza,Vasia,Negative
4272,KALKVENS CALQUENCE pokaza,Aleksei Trofimov,Negative
4273,KALKVENS CALQUENCE pokaza,kirillantonov,Negative
4274,KALKVENS CALQUENCE pokaza,Imperator Casino,Negative
4275,KALKVENS CALQUENCE pokaza,Vasyl,Negative
4276,KALKVENS CALQUENCE pokaza,Andrei Varkhinian,Negative
4277,KALKVENS CALQUENCE pokaza,Tat'iana Tuchkova,Negative
4278,KALKVENS CALQUENCE pokaza,Aleks Tikhii,Negative
4279,KALKVENS CALQUENCE pokaza,Kravtsova,Negative
4280,KALKVENS CALQUENCE pokaza,Alena Starkova,Negative
4281,KALKVENS CALQUENCE pokaza,Vasia Pupkin,Negative
4282,KALKVENS CALQUENCE pokaza,Maksim Medvedev,Negative
4283,KALKVENS CALQUENCE pokaza,Evkak,Negative
4284,KALKVENS CALQUENCE pokaza,Ivan,Negative
4285,KALKVENS CALQUENCE pokaza,Maksim Karlykov,Negative
4286,KALKVENS CALQUENCE pokaza,Radmir,Negative
4287,KALKVENS CALQUENCE pokaza,Iulia Pilipenko,Negative
4288,KALKVENS CALQUENCE pokaza,hjhjhjj,Negative
4289,KALKVENS CALQUENCE pokaza,carpooling,Negative
4290,KALKVENS CALQUENCE pokaza,Igor' Moskvin,Negative
4291,KALKVENS CALQUENCE pokaza,theonlyone,Negative
4292,KALKVENS CALQUENCE pokaza,Vlad Petrov,Negative
4293,KALKVENS CALQUENCE pokaza,Roman,Negative
4294,KALKVENS CALQUENCE pokaza,Nkita Berkut,Negative
4295,KALKVENS CALQUENCE pokaza,Djon EBLO,Negative
4296,KALKVENS CALQUENCE pokaza,Kirill Ivanov,Negative
4297,KALKVENS CALQUENCE pokaza,Natasha Popova,Negative
4298,KALKVENS CALQUENCE pokaza,turik azizov,Negative
4299,KALKVENS CALQUENCE pokaza,vfrcbv,Negative
4300,KALKVENS CALQUENCE pokaza,Jesionekk,Negative
4301,KALKVENS CALQUENCE pokaza,Mister Zubochistka,Negative
4302,KALKVENS CALQUENCE pokaza,Vlad,Negative
4303,KALKVENS CALQUENCE pokaza,Timur,Negative
4304,KALKVENS CALQUENCE pokaza,Caballeros de lujo,Negative
4305,KALKVENS CALQUENCE pokaza,Pashok,Negative
4306,KALKVENS CALQUENCE pokaza,Nataliia Kim,Negative
4307,KALKVENS CALQUENCE pokaza,Liudvig Aristarkhovich,Negative
4308,KALKVENS CALQUENCE pokaza,Savelii,Negative
4310,KALKVENS CALQUENCE pokaza,Slava Kirilov,Negative
4311,KALKVENS CALQUENCE pokaza,Andrei Kucher,Negative
4312,KALKVENS CALQUENCE pokaza,Vitalik Stepanov,Negative
4313,KALKVENS CALQUENCE pokaza,Madad Fada,Negative
4314,KALKVENS CALQUENCE pokaza,Dzheki Chan,Negative
4315,KALKVENS CALQUENCE pokaza,Sonya Kotova,Negative
4316,KALKVENS CALQUENCE pokaza,oleg stepanov,Negative
4317,KALKVENS CALQUENCE pokaza,Ivanna Lavrenteva,Negative
4318,KALKVENS CALQUENCE pokaza,Nikita Nikitin,Negative
4319,KALKVENS CALQUENCE pokaza,AndreySmoke,Negative
4320,KALKVENS CALQUENCE pokaza,Sergei Voron,Negative
4321,KALKVENS CALQUENCE pokaza,Oleg,Negative
4322,KALKVENS CALQUENCE pokaza,Serhii Ryzhenko,Negative
4323,KALKVENS CALQUENCE pokaza,aleksui ivanov,Negative
4324,KALKVENS CALQUENCE pokaza,sf srfsr,Negative
4325,KALKVENS CALQUENCE pokaza,hjnvb bgngh,Negative
4326,KALKVENS CALQUENCE pokaza,Catherine Lain,Negative
4327,KALKVENS CALQUENCE pokaza,Andrei Garkin,Negative
4328,KALKVENS CALQUENCE pokaza,Olenka,Negative
4329,KALKVENS CALQUENCE pokaza,aman zhaman,Negative
4330,KALKVENS CALQUENCE pokaza,Nikole Aniston,Negative
4331,KALKVENS CALQUENCE pokaza,Ksiusha Aleshchenko,Negative
4332,KALKVENS CALQUENCE pokaza,Andrei golubkov,Negative
4333,KALKVENS CALQUENCE pokaza,Egor Pluse,Negative
4334,KALKVENS CALQUENCE pokaza,Lada Martova,Negative
4335,KALKVENS CALQUENCE pokaza,Nina Petrenkova,Negative
4337,KALKVENS CALQUENCE pokaza,Julia Shocinx,Negative
4338,KALKVENS CALQUENCE pokaza,lena blinova,Negative
4339,KALKVENS CALQUENCE pokaza,Nikita Kalachev,Negative
4340,KALKVENS CALQUENCE pokaza,dima,Negative
4341,KALKVENS CALQUENCE pokaza,Ol'ga Abramovskaia,Negative
4342,KALKVENS CALQUENCE pokaza,Ed,Negative
4343,KALKVENS CALQUENCE pokaza,Sinopskaia Varvara,Negative
4344,KALKVENS CALQUENCE pokaza,Svetlana Dmitrieva,Negative
4345,KALKVENS CALQUENCE pokaza,Sergei Kuznetsov,Negative
4346,KALKVENS CALQUENCE pokaza,Magnify,Negative
4347,KALKVENS CALQUENCE pokaza,Madin Hadif,Negative
4348,KALKVENS CALQUENCE pokaza,shine lylz,Negative
4349,KALKVENS CALQUENCE pokaza,Sasha Motychko,Negative
4350,KALKVENS CALQUENCE pokaza,The Godfather Quotes,Negative
4351,KALKVENS CALQUENCE pokaza,Galina Savchuk,Negative
4352,KALKVENS CALQUENCE pokaza,Elena Obramova,Negative
4353,KALKVENS CALQUENCE pokaza,Iuan Groznyi,Negative
4354,KALKVENS CALQUENCE pokaza,Fylhtq,Negative
4355,KALKVENS CALQUENCE pokaza,Renat Akhmetzianov,Negative
4356,KALKVENS CALQUENCE pokaza,Kolia Moroz,Negative
4357,KALKVENS CALQUENCE pokaza,Kolia Bobik,Negative
4358,KALKVENS CALQUENCE pokaza,solomin,Negative
4359,KALKVENS CALQUENCE pokaza,Aton Anikovich,Negative
4360,KALKVENS CALQUENCE pokaza,Andrei Iaom nTik,Negative
4362,KALKVENS CALQUENCE pokaza,Happy,Negative
4365,KALKVENS CALQUENCE pokaza,Aleksandr,Negative
4366,KALKVENS CALQUENCE pokaza,OLGA,Negative
4368,KALKVENS CALQUENCE pokaza,Danila Burmistrov,Negative
4369,KALKVENS CALQUENCE pokaza,oleg,Negative
4370,KALKVENS CALQUENCE pokaza,Andrei Kuznetsov,Negative
4371,KALKVENS CALQUENCE pokaza,Nik Romashkinn,Negative
4373,BMO ABBV Mavyret Imbruvica Calquence Humira,dough,Negative
4374,KALKVENS CALQUENCE pokaza,afaf,Negative
4375,KALKVENS CALQUENCE pokaza,Onishchuk Ruslan,Negative
4376,KALKVENS CALQUENCE pokaza,miron,Negative
4377,KALKVENS CALQUENCE pokaza,Enedin,Negative
4378,KALKVENS CALQUENCE pokaza,Aleksei Starkov,Negative
4379,KALKVENS CALQUENCE pokaza,Artem Kononov,Negative
4380,KALKVENS CALQUENCE pokaza,Valeriia Kudriavtseva,Negative
4381,KALKVENS CALQUENCE pokaza,Ilona Vojnich,Negative
4382,KALKVENS CALQUENCE pokaza,Andrei Zadorozhnyi,Negative
4383,KALKVENS CALQUENCE pokaza,Trema Erema,Negative
4384,Colorectal Cancer Charity,Colorectal Cancer Charity,Negative
4385,KALKVENS CALQUENCE pokaza,Aleksandr Gusaruk,Negative
4386,KALKVENS CALQUENCE pokaza,Alice Cooper,Negative
4387,KALKVENS CALQUENCE pokaza,dfgthfhjjgyjyg,Negative
4388,KALKVENS CALQUENCE pokaza,Aleks,Negative
4389,KALKVENS CALQUENCE pokaza,MankinMikhail,Negative
4390,KALKVENS CALQUENCE pokaza,gjdscghktsngyuc,Negative
4391,KALKVENS CALQUENCE pokaza,AnnaGrigorenko,Negative
4392,KALKVENS CALQUENCE pokaza,Capt Nikolskiy,Negative
4393,KALKVENS CALQUENCE pokaza,OL'GA SALTANOVA,Negative
4397,two thousand and,Sylvia Joyner,Negative
4399,Headache,Medscape Education,Negative
4401,CLL,Medscape Education,Negative
4407,two thousand and eighteen fourteen million twentytwo thousand and eighteen USD one thousand five hundred DelveInsight Acalabrutinib Launch two thousand and eighteen Insight Acalabrutinib,Drug Delivery News,Negative
4409,Neil Kay MayoClinic CLL Kay OncLive,CLL Ireland,Negative
4411,Neil Kay MayoClinic ChronicLymphocyticLeukemia OncLive TV CLL,Mayo Clinic Cancer Center,Negative
4415,BTK TiansterZhang DukeCancer,Sumanta Pal,Postive
4417,ASH two thousand and Atlanta Richard Furman two YouTube,CLL Society Inc,Negative
4418,four,dokutazugeto,Negative
4421,Jerry one one Jerry year,Cancer Medicine,Postive
4422,CLL,Oncology Tube,Postive
4424,BTK,FabriceAndre,Negative
4426,two Study Efficacy Safety Acalabrutinib Subjects CLL Intolerant Ibrutinib Therapy CLLsm,Mike Thompson MD PhD FASCO,Negative
4428,NEJM CLLsm,Mike Thompson MD PhD FASCO,Negative
4430,two MCL,Lymphoma Hub,Negative
4431,INFOS TRAITEMENT Lymphome un,Ligue contre le cancer comite fiftyeight,Negative
4432,two week,The Lancet,Negative
4433,TheLancet Bruton,Adam Harris,Negative
4434,Linfoma del Manto Resultados de fase two sin rama control poco Plaquetas Ibrutinib al,Daniel Ernst,Negative
4435,two,Devona Williams,Negative
4436,nine ten Mantle Cell Lymphoma Patients Benefit Calquence AstraZeneca Reports,Leukemia Research Foundation,Negative
4437,FDA linfomas de celulas del manto,ASEPO Asociacion ES,Negative
4438,fourteen Calquence Acerta MSDNederland Life Sciences Industry,Kernteam Economie,Negative
4440,nine ten Mantle Cell Lymphoma Patients Benefit Calquence,Lymphoma News Today,Postive
4443,AstraZeneca Reports Boost In Friday four percent Imfinzi,Pharmacy News Research,Negative
4444,AstraZeneca Reports Boost In Friday four percent Imfinzi,Women Health News,Negative
4445,AstraZeneca Reports Boost In Friday four percent Imfinzi,Cancer News,Negative
4451,Mantle month,Alexis Rodriguez,Negative
4455,AstraZeneca BTK,Julie Lakeview,Postive
4456,AstraZeneca BTK,Jane Swift,Postive
4457,AstraZeneca BTK,About Medtech,Postive
4458,CLL CLL,Oncology Tube,Postive
4459,michaelwangmd Acalabrutinib,MD Anderson Cancer Center,Postive
4461,nine ten Mantle Cell Lymphoma Patients Benefit Calquence AstraZeneca Reports,BioNews,Negative
4462,New Post nine ten Mantle Cell Lymphoma Patients Benefit Calquence AstraZeneca Reports,Lymphoma News Today,Negative
4463,BTK PancreaticCancer Ibrutinib,Anirban Maitra,Negative
4465,New Molecularly,AACR Foundation,Negative
4467,MCL Owen OncLive,ColumbiaCancer,Negative
4468,FDA,Sheila Mayers,Postive
4469,FDA Calquence,National Cancer Institute,Negative
4470,kinase inhibitor MCL,ASH Clinical News,Postive
4471,FDA el tratamiento de adultos con linfoma de celulas del Aprenda ma,NCI en espanol,Negative
4473,CLL,Oncology Tube,Postive
4474,CLL,Oncology Tube,Postive
4476,two thousand and seventeen Lymphoma SnapShot,dtw Research Inc,Negative
4477,CLL TN ASH two thousand and seventeen Oral Abstract four hundred AgingData Aging,NACDA Program Aging,Negative
4478,Study JTCancercenter theLancet,JTCancerCenter,Postive
4479,FDA linfomas de celulas del manto,Vive ma,Negative
4481,CLL Oral Abstract four hundred Read,Lymphoma Hub,Negative
4482,CLL TN Oral Abstract four hundred Read,Lymphoma Hub,Negative
4483,MCL,CTOAM,Negative
4484,Ibrutinib MCL FingersCrossedAgain,Frank Zambrano,Negative
4485,Ibrutinib,Frank Zambrano,Negative
4487,CLL,Graham Collins,Negative
4488,CLL,Home Journal,Negative
4491,CLL SLL one hundred and thirtyfour Overall Response Rate,PANNA SHARMA,Negative
4492,The Food Drug Administration,GRACE,Negative
4496,Mantle Cell,Lampe Company,Negative
4498,BloodAdvances,Chan Cheah,Negative
4499,Calquence,AACR Foundation,Postive
4500,NHL,Blood Advances,Negative
4501,two,ALI ALAHMARI,Negative
4503,TheLancet,medwireNews,Negative
4504,Wang et al acalabrutinib MCL two Different forty CRR PFS AE AF one hundred Better,Graham Collins,Negative
4505,AstraZeneca,Gerry Post,Negative
4506,FDA Lymphoma,Oncology Times,Negative
4508,IRB FDA four hundred,Sandy Pond GCP,Negative
4509,Lawrence Kaplan MD UCSF,OncLive SOSS,Negative
4510,ASH two thousand and,Fatih Uckun,Negative
4511,two MCL Oral Abstract one hundred Read,Lymphoma Hub,Negative
4516,Clinic Acalabrutinib Previously Treated Mantle Cell Lymphoma,The ASCO Post,Negative
4517,NHL,Philip McCarthy,Negative
4518,Lymphoma,The ASCO Post,Negative
4519,Lymphoma,The Purple Society,Negative
4520,two HospitalLaFe HarmonynetEU EFPIA,Guillermo Sanz,Negative
4521,second FDA,AACR Foundation,Negative
4522,Hodgkin second Btk,Michael Makris,Negative
4524,BTK Calquence AstraZeneca CLL,Encore BioMed,Negative
4525,Astra Zeneca Calquence Business The Times The Sunday Times,Lymphoma Canada,Negative
4526,NHL,Blood Advances,Negative
4527,two,GoFIR,Negative
4530,FDA,Lambda Kappa Sigma,Negative
4533,two,Cancer Library VCC,Negative
4534,FDA Calquence,National Cancer Institute,Negative
4535,AstraZeneca Calquence,RANJAN BUDA,Negative
4536,AstraZeneca Calquence,RANJAN BUDA,Negative
4537,Yi Xue,Zhu Shi Hui She baioinpakuto,Negative
4538,Lancet Article Acalabrutinib two,Mahmoud Aljurf,Negative
4541,two,ARB,Negative
4545,First,AdisInsight,Postive
4546,two,Mahmoud Aljurf,Negative
4547,two,The Lancet,Negative
4548,thelancet lymphomedumanteau dans essai de phase two,Nicolas Zarjevski,Negative
4550,three six week MCL today TheLancet,AstraZenecaUS,Postive
4553,AstraZeneca CLL one AZN malaysia,Siti van der Meij,Negative
4554,AstraZeneca CLL one,Breaking News,Negative
4555,AstraZeneca Calquence,Yemen News,Negative
4556,FDA Lymphoma,Oncology Times,Negative
4557,AstraZeneca Calquence,Neth Corporate News,Negative
4559,AstraZeneca Calquence,lark,Negative
4560,AstraZeneca Calquence,Open Outcrier,Negative
4565,AstraZeneca Calquence,DWIB Leukaemia Trust,Negative
4566,AstraZenecas Calquence,Sverige,Negative
4567,AstraZeneca Calquence,Pharma News,Negative
4568,AstraZeneca Calquence Syria,Doha Insight,Negative
4573,AstraZeneca,Financial Buzz,Negative
4574,AstraZeneca Calquence,Financial Buzz,Negative
4575,AstraZeneca,EIN Presswire Pharmaceutical Newswire,Negative
4577,Astra Zeneca Calquence GoogleAlerts,CheckRare,Negative
4578,AstraZeneca Calquence,nyuseuwaieo,Negative
4579,AstraZeneca Calquence,nyuseuwaieo geongang,Negative
4580,AstraZeneca Calquence,nyuseuwaieo,Negative
4581,AstraZeneca Calquence,nyuseuwaieo geongang,Negative
4582,AstraZeneca,ANTELLIS,Negative
4583,AstraZeneca,Crwe World,Negative
4584,AstraZeneca Pharma today,Business,Postive
4585,AstraZeneca Calquence Pharma today,Business,Postive
4586,AstraZeneca,BusinessWireProducts,Negative
4587,AstraZeneca Calquence,BusinessWireProducts,Negative
4588,AstraZeneca,Business,Negative
4591,CLL Dr,Caner Saygin MD,Negative
4592,CLL today,AstraZenecaUS,Negative
4593,AstraZeneca,Stockboard Media Inc,Negative
4594,AstraZeneca,The Pharmaceutical Marketing Group,Negative
4595,AstraZeneca Calquence,The Pharmaceutical Marketing Group,Negative
4596,RR CLL eighty DOR Compare IR nineteen de novo RR Obino fifty,Erel Joffe,Negative
4597,AstraZeneca Calquence,Pharmaceuticals repo,Negative
4598,two MCL ab one hundred michaelwangmd lymsm,NE Live,Negative
4599,Astra Zeneca Calquence Acalabrutinib today CLL,CLL Ireland,Negative
4600,Astra Zeneca Calquence,Health Fitness Loveaffair,Negative
4602,AstraZeneca Calquence,Financial Buzz,Negative
4603,AstraZeneca Demonstrates Activity,Financial Buzz,Negative
4605,AstraZeneca,Maveric,Negative
4606,one hundred two CR forty,Clarivate Cortellis,Negative
4607,Drugs Pharma,Giuseppe Michieli,Negative
4608,AstraZeneca,EIN Presswire Pharmaceutical Newswire,Negative
4609,AstraZenecas forty,Renal Cell Carcinoma,Negative
4610,AstraZenecas Calquence forty,Renal Cell Carcinoma,Negative
4613,AstraZenecas Calquence forty,Drug Delivery News,Negative
4614,AstraZenecas forty,Drug Delivery News,Negative
4615,AstraZeneca Calquence,ANTELLIS,Negative
4616,Mantle Cell,Zachary McLellan,Negative
4617,AstraZenecas Calquence forty,Lung Cancer News,Negative
4618,AstraZenecas forty,Lung Cancer News,Negative
4619,Today,AstraZenecaUS,Negative
4620,AstraZeneca Demonstrates Activity,Crwe World,Negative
4621,AstraZeneca Demonstrates Activity Pharma,Business,Postive
4622,AstraZeneca Demonstrates Activity,BusinessWireProducts,Negative
4623,AstraZeneca Calquence Pharma,Business,Postive
4624,AstraZeneca Calquence,Business,Negative
4625,AstraZeneca Calquence,BusinessWireProducts,Negative
4627,AstraZenecas Calquence forty,Cancer News,Negative
4628,AstraZenecas forty,Cancer News,Negative
4629,Michael Wang MCL,Marek Trneny,Negative
4630,MCL,David Dahan PhD,Negative
4632,Wang et al BTK,Dr Katrina Farrell,Negative
4633,AstraZeneca Demonstrates Activity,The Pharmaceutical Marketing Group,Negative
4634,AstraZeneca Calquence,The Pharmaceutical Marketing Group,Negative
4635,Wang et al acalabrutinib MCL CRR Cheson CRR,Graham Collins,Postive
4636,AstraZeneca,Stockboard Media Inc,Negative
4638,DrMichaelWang MCL,Matthew Matasar MD,Postive
4639,DrMichaelWang nice MCL,Matthew Matasar MD,Negative
4640,MCL Dr Wang CR forty,Carla Casulo,Negative
4641,two twenty Median two Grade AE thirty,Erel Joffe,Negative
4642,DrMichaelWang two zero,Matthew Matasar MD,Negative
4643,MCL,Raul Cordoba MD PhD,Negative
4644,second,Ahmad Halwani,Negative
4645,Obat Baru,Majalah Farmasetika,Negative
4646,Calquence,AACR Foundation,Negative
4648,Calquence MCL Owen MD PhD OncLive,ColumbiaCancer,Negative
4649,one hundred Efficacy Safety Acalabrutinib Monotherapy two,Raul Cordoba MD PhD,Negative
4650,AstraZeneca Highlight Its Commitment Blood Cancers two thousand and seventeen American First US,Renal Cell Carcinoma,Postive
4651,AstraZeneca Highlight Its Commitment Blood Cancers two thousand and seventeen American First US,Drug Delivery News,Postive
4652,AstraZeneca Highlight Its Commitment two thousand and seventeen American First US,Cancer News,Negative
4653,FDA,AACR Foundation,Negative
4654,Chronic,Lampe Company,Negative
4656,Meet Peninsula,San Francisco Business Times,Negative
4659,Meet Peninsula,San Francisco Business Times,Negative
4660,US Efficacy Safety Acalabrutinib Monotherapy two,Michael Dickinson,Postive
4664,CLL,CancerWallonia,Negative
4665,FDA,The Hindu Patrika,Negative
4666,Lymphoma RX,Newhard Pharmacy,Negative
4670,michaelwangmd present two two ORR forty DOR NB AF,Chan Cheah,Negative
4673,The Delaney Clause You Were What You Ate nine hundred,Past Daily,Negative
4675,Wang et al ORR,Graham Collins,Negative
4679,FDA AstraZeneca Calquence,Hlthnews,Negative
4680,FDA AstraZeneca Calquence,Hlthnews,Negative
4681,Meet Peninsula,San Francisco Business Times,Negative
4683,CLL,Ethical Recruiters,Negative
4684,CLL,mediPr Yi Xue Zuo Jia Xiang Gang ,Negative
4685,FDA,Lymphoma News Today,Postive
4686,JR Brown CLL Hematology,Mussetti,Postive
4688,FDA AstraZeneca Calquence,Vignesh Sekar,Negative
4690,US FDA,Hematopoiesis News,Negative
4691,FDA,Carol Evans MD,Negative
4692,FDA Approves,Cancer Health,Negative
4698,Meet Peninsula,San Francisco Business Times,Negative
4699,FDA,OncologyNurseAdvisor,Postive
4701,BMO AZN Calquence Acalabrutinib MCL CLL,dough,Postive
4702,FDA AstraZeneca,Carolyn Thompson,Negative
4703,FDA FDAMedia,Cancer Health,Negative
4705,AstraZeneca BTK Calquence AZN,Olderpreneurs,Postive
4706,FDA,OncologyNurseAdvisor,Postive
4708,Linfoma de Celulas Manto Calquence,Medicsupply,Negative
4709,FDA Calquence,Hlthnews,Negative
4710,Meet Peninsula,San Francisco Business Times,Negative
4711,FDA Clears CBC Test Office Use Calquence,Dean Celia,Negative
4712,Mi FDA Liao Yao akaraburuchinibuwoCheng Ren  akaraburuchinibu,mikusuBian Ji Bu ,Negative
4713,Mi FDA Liao Yao akaraburuchinibuwoCheng Ren  akaraburuchinibu,MEDWAVE,Negative
4714,FDA Calquence Treatment Treatment Mantle Cell,CancerConnect,Negative
4718,Linfoma Mantellare Acalabrutinib AstraZeneca FDA,Salutedomani,Negative
4719,FDA AstraZeneca Calquence MCL,Pharma Journalist,Negative
4720,FDA News,Hlthnews,Postive
4721,FDA Approves Calquence Adults Mantle Cell,Hlthnews,Negative
4722,Them FDA Tuesday October Calquence Prexxartan Zegerid,Living Safely,Negative
4723,AstraZeneca BTK Calquence AZN,Truth Studio,Postive
4724,RxWiki,SchwietermanPharmacy,Postive
4725,RxWiki,tristatemedicalgroup,Postive
4726,RxWiki,PRINCE ADEKOYA,Postive
4727,The US Food Drug Administration FDA,Kaup Pharmacy,Postive
4728,RxWiki,Marcrom Pharmacy,Postive
4729,The US Food Drug Administration FDA,Bengal Rx,Postive
4730,The US Food Drug Administration FDA,Churchill Pharmacy,Postive
4731,The US Food Drug Administration FDA,Phipps Pharmacy,Postive
4732,RxWiki,Custom Compounding,Postive
4733,RxWiki,Horseshoe Health,Postive
4738,AstraZeneca BTK Calquence AZN,FancyFinancy,Postive
4740,Linfoma Mantellare Acalabrutinib AstraZeneca,Salutedomani,Negative
4741,AstraZeneca BTK Calquence AZN,Financial Carnivores,Postive
4742,US FDA AstraZeneca Calquence,Gilles Gallant,Negative
4743,AstraZeneca BTK Calquence AZN,ZC,Postive
4744,Linfoma Mantellare Acalabrutinib AstraZeneca FDA,Salutedomani,Negative
4745,Linfoma Mantellare Acalabrutinib AstraZeneca FDA,Salutedomani,Negative
4746,Linfoma Mantellare Acalabrutinib AstraZeneca FDA,Derma News OK,Negative
4747,Linfoma Mantellare Acalabrutinib AstraZeneca FDA,Antonio Caperna,Negative
4749,AstraZeneca BTK Calquence AZN,MySmallCap,Postive
4750,retweet apotheker Nieuws FDA,Northeast Apotheek,Negative
4751,PW FDA,Northeast Personeel,Negative
4752,Biologics,McKesson Corporation,Negative
4753,FDA,PW,Negative
4754,The US Food Drug Administration FDA,CDS ten Pharmacy,Postive
4755,RxWiki,The Medicine Shoppe,Postive
4756,RxWiki,Greenwood Drug,Postive
4757,CALQUENCE MCL Zhi Liao Yao Guo Shi Pin Yi Yao,MEDWAVE,Negative
4758,The US Food Drug Administration FDA,"Medicine Shoppe one thousand, eight hundred and twentytwo",Postive
4760,RxWiki,Medicine To Go,Postive
4763,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
4765,Meet Peninsula,San Francisco Business Times,Negative
4767,The US Food Drug Administration FDA,Joseph Pharmacy,Postive
4768,The US Food Drug Administration FDA,Greenhill Pharmacy,Postive
4769,The US Food Drug Administration FDA,Scott Pharmacy,Postive
4770,RxWiki,Greenbrier Pharmacy,Postive
4771,RxWiki,Sam Health Mart,Postive
4772,RxWiki,Brehme Drug,Postive
4773,RxWiki,Food City RX Marion,Postive
4774,RxWiki,Crown Pharmacy,Postive
4775,RxWiki,LibertyHillPharmacy,Postive
4776,RxWiki,Hopkinton Drug,Postive
4777,RxWiki,Delran Pharmacy,Postive
4778,RxWiki,Fox Drug Torrance,Postive
4779,The US Food Drug Administration FDA,Hartzells Pharmacy,Postive
4780,RxWiki,Cascade Custom RX,Postive
4781,RxWiki,Coastal Pharmacy,Postive
4782,The US Food Drug Administration FDA,Valley Pharmacy,Postive
4783,Congrats AstraZeneca FDA MCL,The Galien Foundation,Postive
4784,FDA BTK MCL,NatureRevClinOncol,Postive
4785,Calquence,Mike Thompson MD PhD FASCO,Postive
4786,approvalsWatch News Acalabrutinib FDA,medwireNews,Negative
4787,Pharma three EPVantage FDA AstraZeneca Calquence ThePharmaLetter,Evaluate Pharma,Negative
4788,l`lj ',ywsf shms ldyn,Negative
4789,PrecisionMedicine Congratulations Organon Kinase Immunology Team Gene GeneNominator BTK,NTRC,Postive
4790,FDA la aprobacion acelerada de acalabrutinib Calquence,APRHIFAC,Negative
4791,FDA Lymphoma,DOCTOR MENDOZA CANCER NEWS,Negative
4792,Zulassung Behandlung von Mantelzellenlymphomen bei Erwachsenen,INSIGHTHealth,Negative
4793,Zai Fa Nan Zhi Xing Bao rinpaZhong BTK Hai Yao Acalabrutinib,monitasanpuruShi shiDui ,Negative
4794,Zai Fa Nan Zhi Xing Bao rinpaZhong BTK,Yao Ji Shi niyusuPei Xin kun,Negative
4795,AstraZeneca Calquence BN,Sverige,Negative
4797,FDA la aprobacion acelerada de acalabrutinib Calquence,APRHIFAC,Negative
4798,MCL several month,OncLive SOSS,Negative
4799,three FDAgaCheng Bao rinpaZhong Su Cheng Ren,dokutazugeto,Negative
4803,FDA MCL,OncLive SOSS,Postive
4804,Ibruvica JNJ,Bursatil Biotech,Negative
4805,FDA,OncLive SOSS,Negative
4806,Meet Peninsula,San Francisco Business Times,Negative
4807,Cytokine Research Pharmacodynamics Similarity,Cytokine News,Negative
4808,AstraZeneca Calquence FDA,PharmaLeaders,Postive
4809,FDA Lymphoma,CancerWallonia,Negative
4810,AstraZeneca Calquence Imbruvica FiercePharma,Advera Health,Negative
4812,FDA AstraZeneca Calquence FDA,RxSpark,Negative
4813,AstraZeneca BTK Calquence AZN,Truth Studio,Postive
4815,FDA Lymphoma,VHSPL,Postive
4816,Tuesday FDA Calquence,Rare Disease Report,Negative
4822,AstraZeneca BTK Calquence AZN,FancyFinancy,Postive
4823,Meet Peninsula,San Francisco Business Times,Negative
4824,Calquence,Odi Bruckman,Negative
4825,AstraZeneca BTK Calquence AZN,Financial Carnivores,Postive
4826,FDA AstraZeneca Calquence,UKiwiS,Negative
4827,CIENCIASMEDICASNEWS Calquence Approved Mantle Cell,Victor Norberto Cerasale Morteo,Negative
4828,FDA,CBPartners,Negative
4829,AstraZeneca BTK Calquence AZN,Piggy Bank People,Postive
4830,AstraZeneca BTK Calquence AZN,Zack Capp,Postive
4831,AstraZeneca BTK Calquence AZN,Portfolio Penny,Postive
4833,AstraZeneca Calquence,Drug Store News,Postive
4834,FDA AstraZeneca Calquence CLL,Margaret Walker,Negative
4835,AstraZeneca FDA Calquence Drug Store News,MedFirst MedComms,Negative
4836,Calquence fda,European Pharmaceutical Review,Negative
4838,FDA Aprova Acalabrutinib Linfoma Folicular,Fernando Medina,Negative
4842,Meet Peninsula,San Francisco Business Times,Negative
4843,Mantle FDA,Galeri Haber,Negative
4844,Read Medscape FDA four Cancer TargetedTherapy,MyOncoPath,Negative
4846,AstraZeneca FDA Calquence David SalazarThe,Pharmacy News Research,Negative
4847,AstraZeneca FDA Calquence David SalazarThe,Lung Cancer News,Negative
4848,FDA Calquence kompanii AstraZeneca,ZdravMedInfo,Negative
4849,kanser onkoloji hematolog FDA,Mustafa Ozdogan MD,Negative
4850,FDA,Amer Coll Clin Pharm,Negative
4851,FDA Calquence,Farmacia Nenna,Negative
4853,Cancer Calquence FDA,Treatment Scores,Negative
4854,FDA,Home Journal,Negative
4855,AstraZeneca Calquence,Regulatory Jobs,Negative
4857,FDA AstraZeneca Calquence,David Ledger,Negative
4858,USA FDA Kemivarlden Kemisamfundet,Lars Ohrstrom,Negative
4859,La FDA un nuevo oncologico,Cristina Kroll,Negative
4860,La FDA un nuevo oncologico,PharmaBiz,Negative
4861,FDA Calquence kompanii AstraZeneca,Razvlekatel'nyi sait UWDESHKI,Negative
4864,AstraZeneca Zulassung fur Calquence,APOTHEKE ADHOC,Negative
4865,FDA Calquence kompanii AstraZeneca,Razvlekatel'nyi sait UWDESHKI,Negative
4866,Avella AstraZeneca CALQUENCE,Sudam Walekar,Negative
4867,FDA Lymphoma,dario pasqualini,Postive
4868,FDA,BioNews,Postive
4870,Imbruvica Calquence PharmaCompass,Riya Verma,Negative
4878,Meet Peninsula,San Francisco Business Times,Negative
4879,FDA AstraZeneca Calquence PharmaTimes,Digital Pharma,Negative
4881,FDA Lymphoma,balaji jegannathan,Negative
4882,Approved Mantle Cell,Josh Kunken,Negative
4883,Calquence ABBV Imbruvica,Jacob Bell,Negative
4884,Calquence ABBV Imbruvica,BioPharma Dive,Negative
4885,FDA,UKiwiS,Negative
4886,FDA AstraZeneca Calquence,Pharma Commons,Negative
4888,FDA Lymphoma,Encore BioMed,Negative
4889,FDA,UKiwiS,Negative
4890,FDA,Medical Microbiology,Postive
4891,two AstraZeneca BTK Calquence AZN,John Carroll,Postive
4893,Xin Zhao Ji Shi   FDA Approves Calquence Mantle Cel,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
4894,FDA,Lymphoma News Today,Postive
4895,FDA Lymphoma,Krishan Maggon,Postive
4896,OncoPharm Feedback,John Bossaer,Postive
4898,FDA MCL,Lalit Leonard Sehgal PhD,Postive
4899,FDA Calquence,MDedge Hematology Oncology,Postive
4900,one,Pharmacy News Research,Negative
4901,Snags Quick FDA,SDBN,Postive
4902,CALQUENCEA,Lung Cancer News,Negative
4903,AstraZeneca Calquence FDA,Sonali Prusty,Postive
4904,US FDA AstraZeneca Calquence,UKiwiS,Negative
4905,michaelwangmd lymsm,MD Anderson Cancer Center,Postive
4907,AstraZeneca Calquence,Regulatory Jobs,Negative
4909,one,Drug Delivery News,Negative
4910,one,Renal Cell Carcinoma,Negative
4912,MCL,Blue Matter,Negative
4913,Approved Mantle Cell Lymphoma Available,The Pharmaceutical Marketing Group,Negative
4914,Approved Mantle Cell Lymphoma Available,Business,Negative
4917,AstraZeneca Calquence Imbruvica,buzz lightyear,Negative
4919,Imbruvica AZN JNJ ABBV,Carly Helfand,Negative
4920,FDA BloodCancer,AstraZenecaUS,Postive
4921,Imbruvica,Martin JS Dyer,Negative
4922,Biologics,Biologics McKesson,Negative
4923,FDA AstraZeneca Calquence,Global Pharma News,Negative
4926,FDA AstraZeneca Calquence,World Pharma News,Negative
4927,AstraZeneca US,UKiwiS,Negative
4928,FDA AstraZeneca Calquence,UKiwiS,Negative
4929,Hours Calquence three,BioWorld,Negative
4930,AstraZeneca Snags Quick FDA,Pharma Commons,Postive
4931,FDA AstraZeneca Calquence,Pharma Commons,Negative
4932,FDA,Ethical Recruiters,Negative
4933,Meet Peninsula,SFBTRileyMcD,Negative
4934,Meet Peninsula,Riley Gutierrez McDermid,Negative
4935,Meet Peninsula,San Francisco Business Times,Negative
4936,SanJose,Julian Chen,Negative
4938,AstraZeneca Imbruvica,Salil Kallianpur,Negative
4939,Yesterday,Andre Goy,Postive
4940,AstraZeneca Snags Quick FDA,LucidQuest,Postive
4941,AstraZeneca Snags Quick FDA,Dr Timos Papagatsias,Postive
4942,AstraZeneca Snags Quick FDA,LucidQuest,Postive
4943,AstraZeneca Snags Quick FDA,Dr Timos Papagatsias,Postive
4946,FDA MantleCell,SSBMT lkhlyljdh`y@,Negative
4953,FDA MCL,Laura Nikolaides,Negative
4955,SF,Miles Frenzetta,Negative
4957,FDA,Talbot Research Library Media Services,Postive
4959,one,Les Yonemoto MD MBA,Postive
4961,FDA Cancer,TheSocialMedwork,Negative
4964,TGTX Excellent Interesting,Don van Vliet,Postive
4965,MCL AZN,MG,Negative
4967,AstraZeneca Snags Quick FDA BTK Potential Lymphoma Blockbuster Calquence BioSpace,Nathan Letts PhD,Postive
4969,AstraZeneca Snags Quick FDA,Biotech World,Postive
4970,Bao rinpaZhong,Hai Wai ganYi Liao Qing Bao rihuarensu,Negative
4971,FDA AstraZeneca Calquence AstraZeneca Calquence US,Davalyn Corporation,Negative
4972,AstraZeneca Snags Quick FDA,BioCalifornia,Postive
4973,AstraZeneca approbation de Calquence InvestingFrance,Buy Cryptocurrency,Negative
4974,AstraZeneca,France,Negative
4975,FDA BloodCancer,AstraZenecaUS,Postive
4976,Imbruvica Acerta,BioWorld,Negative
4977,APTO BTK,Grant Beasley,Postive
4978,AstraZeneca BTK Calquence ENDPOINTS NEWS,Uri Baruch,Postive
4981,FDA AstraZeneca Calquence,Barry Curry,Negative
4982,FDA AstraZeneca Calquence,Everything Pharma,Negative
4984,FDA AstraZeneca Calquence,PharmaTimes,Negative
4985,FDA AstraZeneca Calquence,Pharma Trader,Negative
4986,AstraZeneca BTK Calquence,Endpoints News,Postive
4987,AstraZeneca,pharmaphorum,Postive
4988,AstraZeneca,Richard Staines,Postive
4989,AstraZeneca,IPRX,Postive
4990,AstraZeneca Imbruvica Calquence,BioPharma Global,Negative
4991,AstraZeneca Imbruvica Calquence,Carolyn Thompson,Negative
4992,FDA MCL,Lymphoma Hub,Postive
4994,FDA,ehealthandfitness,Negative
4995,Calquence fda,European Pharmaceutical Review,Negative
4996,FDA,GEDEFO,Negative
4997,AstraZeneca Reuters Reuters Black Swan Intelligent,BlackSwan Analysis part Evaluate Pharma Ltd,Postive
4998,FDA,CancerWallonia,Negative
5001,AstraZeneca Article AMP Reuters,UCL TRO,Negative
5002,AstraZeneca Calquence FDA,pharmabr,Postive
5003,AstraZeneca Calquence FDA,PharmaLeaders,Postive
5005,FDA,Bronx Voice,Negative
5006,FDA NewsAssistant,News Assistant,Negative
5010,CR FDA,Pallawi Torka,Postive
5011,BTK Acalabrutinib ORR MCL,Allen,Negative
5012,AstraZeneca BTK Calquence,Endpoints News,Postive
5013,AstraZeneca Imbruvica Calquence FiercePharma,Digital Pharma,Negative
5014,FDA Acalabrutinib Mantle Cell,Medscape Pharmacists,Postive
5015,Congratulations AstraZeneca FDA MCL,Jackie Fairley,Postive
5016,Lymphoma TUESDAY two thousand and seventeen HealthDay News Calquence,Rocketnews,Negative
5019,Regulatory News FDA Tuesday October Calquence Prexxartan Zegerid,Living Safely,Negative
5021,CR MCL Revlimid Ibrutinib twenty Acal RR,MyelomaLymphoma,Negative
5022,AZN Calquence,BioPharmCatalyst,Negative
5025,FDA BTK,Philip McCarthy,Negative
5026,AstraZeneca,Reuters Health,Negative
5028,FDA Calquence take Imbruvica JNJ ABBV,FiercePharma,Negative
5030,FDA Approves Calquence Adults Mantle Cell,IntoxicatedTrader,Negative
5032,FDA Calquence,Coping Cancer,Negative
5033,BloodCancer,AstraZenecaUS,Negative
5034,Avella AstraZeneca,IntoxicatedTrader,Negative
5035,Lymphoma,Animal Lover,Negative
5038,FDA AZN Calquence,Hottest Stocks Now,Negative
5039,AstraZeneca,IntellaTurn LLC,Negative
5040,AstraZeneca US Reuters Black Swan Intelligent,BlackSwan Analysis part Evaluate Pharma Ltd,Postive
5042,US FDA,UKiwiS,Postive
5043,AstraZeneca plc US FDA AstraZeneca Calquence,UKiwiS,Negative
5045,FDA,osakahiro,Negative
5046,Breakingnews Avella AstraZeneca,Today News,Negative
5048,FDA,ACS Research,Negative
5050,AstraZeneca Imbruvica,Pharma Commons,Negative
5051,FDA Approves Calquence Adults Mantle Cell,New Drug Approvals,Negative
5054,Reuters,Eugenio,Negative
5055,AstraZeneca Reuters,Anna Loop,Negative
5057,Reuters,Fazeen DEAN,Negative
5058,AstraZeneca Reuters,Choonsik Yoo yucunsig,Negative
5059,FDA,AstraZenecaUS,Postive
5060,US FDA,IntoxicatedTrader,Postive
5061,AstraZeneca,The Briefing Room,Negative
5062,Reuters,Ron Bourne,Negative
5063,Reuters,JusticeOutcry,Negative
5064,Reuters,Martha Leah Nangalama,Negative
5065,AstraZeneca,Recommended For You,Negative
5066,AstraZeneca,Sorgitza,Negative
5067,Reuters,Himanish,Negative
5068,RT Reuters AstraZeneca,Tony De Vos,Negative
5069,AstraZeneca,Reuters,Negative
5070,BTK FDA,Anna Deveau,Negative
5072,AstraZeneca BTK,David Coleman,Postive
5073,AZN monthly Calquence,John Carroll,Negative
5074,AstraZeneca Imbruvica,Dr Maanane Fouad,Negative
5075,FDA AstraZeneca Calquence,Krishan Maggon,Negative
5076,FDA AstraZeneca Calquence,Krishan Maggon,Negative
5077,BTK,John Carroll,Postive
5080,Congrats Calquence Grace Guthrie Jane Huang Brian Lannutti Amy Peterson,Julie Papanek Grant,Postive
5081,Linfoma Fda,PharmaStar,Negative
5082,FDA Acalabrutinib Mantle Cell,Medscape Oncology,Postive
5083,AstraZeneca Imbruvica,BioPharma Investigator,Negative
5084,AstraZeneca Imbruvica Calquence FiercePharma,Pharmaceuticals repo,Negative
5085,FDA,UKiwiS,Negative
5086,FDA,UKiwiS,Negative
5087,FDA,UKiwiS,Negative
5088,FDA AstraZeneca Calquence,UKiwiS,Negative
5089,AstraZeneca US Reuters Black Swan Intelligent,BlackSwan Analysis part Evaluate Pharma Ltd,Postive
5090,FDA AstraZeneca CALQUENCE,Krishan Maggon,Negative
5091,AstraZeneca Imbruvica Calquence AZ,John Baresky Healthcare And Content Marketing Guy,Negative
5092,FDA Approves,Kazeem Olalekan,Negative
5093,FDA,Tom,Negative
5094,FDA BloodCancer,AstraZenecaUS,Postive
5095,FDA,CancerTherapyAdvisor,Negative
5096,FDA MCL,Simon Rule,Postive
5097,FDA Calquence,CancerCare,Negative
5098,US FDA,OncologyInfo,Negative
5099,FDA Calquence,Salutedomani,Negative
5100,FDA Calquence,Salutedomani,Negative
5102,FDA,PER,Negative
5103,BTK,Neil Sankar MPH,Negative
5104,FDA,Mens Sexual Health,Negative
5105,FDA,Pharm Digest,Negative
5106,AstraZeneca US Reuters Black Swan Intelligent,BlackSwan Analysis part Evaluate Pharma Ltd,Postive
5107,Aggressive Mantle Mantlecell BTK,Neil Sankar,Negative
5108,Second BTK MCL,Pavan Anne,Negative
5110,FDA Lymphoma,Junaid Hussain,Negative
5111,FDA AstraZeneca Calquence Reuters Health News Reuters,Prem Raj Shakya,Negative
5112,AstraZeneca Imbruvica,analyst land news,Negative
5113,AstraZeneca Calquence Approved By US Food amp Drug Administration Interactive Investor Black Swan,BlackSwan Analysis part Evaluate Pharma Ltd,Negative
5114,AstraZeneca,Ben Hirschler,Negative
5115,Halloween,Carly Helfand,Negative
5116,AstraZeneca Imbruvica,Dr Timos Papagatsias,Negative
5117,AstraZeneca Imbruvica,LucidQuest,Negative
5118,FDA,Medical HotSpot,Postive
5119,FDA AstraZeneca one,Milton Financial Market Research Institute,Negative
5120,FDA AstraZeneca Calquence Reuters The Food Drug Administration,Referral Kings,Negative
5121,FDA AstraZeneca one,Davalyn Corporation,Negative
5122,US FDA AstraZeneca Calquence MCL,Zahedi Mujawar,Negative
5123,FDA AstraZeneca one AZN malaysia,Siti van der Meij,Negative
5124,FDA AstraZeneca Calquence,Ida Sooks,Negative
5126,FDA AstraZeneca one,Breaking News,Negative
5127,today one,Michael Wang MD,Postive
5128,FDA Calquence take Imbruvica JNJ ABBV,FiercePharma,Negative
5129,US FDA AstraZeneca Calquence,Duncan Young,Negative
5131,FDA dans,oncohebdo,Negative
5132,FDA AstraZeneca Calquence,ali bajwa,Negative
5133,FDA AstraZenecas Calquence patienter med tidigare behandlad,Cision News,Negative
5136,FDA AstraZeneca Calquence Reuters The Food Drug Administration FDA,Medical Web Times,Negative
5137,FDA AstraZeneca Calquence Reuters The Food Drug Administration,Paul Devereaux,Negative
5138,HealthNews FDA AstraZeneca Calquence,Kevin Donaldson,Negative
5139,FDA AstraZeneca Calquence Grow Taller,Edward Miller,Negative
5141,FDA Lymphoma,Silas Inman,Negative
5142,FDA Calquence,Salutedomani,Negative
5143,BTK,ICI Research,Negative
5145,Calquence AstraZenecaUS,Healio,Postive
5146,Calquence AstraZenecaUS,HemOnc Today,Postive
5148,FDA AstraZeneca Calquence,News Emirates,Negative
5149,FDA Calquence,Antonio Caperna,Negative
5150,FDA Calquence,Salutedomani,Negative
5152,FDA Calquence,Derma News OK,Negative
5153,BREAKINGNEWS,Rare Disease Report,Negative
5154,AstraZeneca Calquence FDA,FirstWord Pharma,Negative
5155,AstraZeneca BTK,Brittany Meiling,Negative
5156,FDA AstraZeneca Calquence,Reuters Health,Negative
5157,FDA AstraZeneca Calquence,Vernell Lintner,Negative
5158,ORR CI month,Raul Cordoba MD PhD,Postive
5159,FDA Lymphoma,Raul Cordoba MD PhD,Negative
5160,FDA AstraZeneca Calquence,world CROs,Negative
5161,FDA AstraZeneca Calquence,Jonathan one Lawrence,Negative
5162,FDA AstraZeneca Calquence,Healthy And Yeah,Negative
5163,FDA AstraZeneca Calquence,Usta,Negative
5164,FDA AstraZeneca Calquence,Xeling,Negative
5165,FDA AstraZeneca Calquence,Cabbages King Mag,Negative
5166,FYI,Sarah Parks,Negative
5167,AstraZeneca BTK,Colinde,Postive
5168,FDA AstraZeneca Calquence Reuters Health News Reuters,Prem Raj Shakya,Negative
5172,FDA AstraZeneca Calquence,Imran Haque,Negative
5173,FDA AstraZeneca Calquence,Christine,Negative
5174,AstraZeneca BTK,John Carroll,Postive
5176,FDA AstraZeneca Calquence,Lorna BArnett,Negative
5177,FDA AstraZeneca Calquence,iQtipsy,Negative
5179,MCL,Matthew Matasar MD,Postive
5180,FDA,Mike van Dulken,Postive
5181,FDA Calquence,CancerWallonia,Negative
5182,FDA,Ned Pagliarulo,Negative
5183,BTK August Acalabrutinib US,Jacob Plieth,Negative
5185,FDA pharma,Donna Young,Negative
5187,FDA,Donna Young,Negative
5188,FDA AstraZeneca Calquence,Option Runners,Negative
5189,FDA AZN Brand Calquence Recall Imbruvica,Adam Feuerstein,Negative
5190,Calquence BTK,Jonathan Rockoff,Negative
5192,AstraZeneca,Lymphoma Canada,Negative
5194,five MCL NSCLC ATO CML CTCL,Encore BioMed,Negative
5195,VIDEO BTK CLL Peter Hillmen UniversityLeeds,VJHemOnc,Negative
5196,AstraZeneca,Khan BA,Negative
5199,Astra Zeneca,Neil Sankar MPH,Negative
5200,Astra Zeneca BTK,Neil Sankar MPH,Negative
5201,La etica de la industria AstraZeneca,Pedro Perdomo,Negative
5202,AstraZeneca,Elizabeth Ramirez,Negative
5203,AstraZeneca,Robert Orlowski,Negative
5204,AstraZeneca,Dr Amy mitchell,Negative
5205,AstraZeneca,Home Journal,Negative
5210,AstraZeneca,Ash Paul,Negative
5212,BTK Inhibition Acalabrutinib Tumor Control CLL,Marlowe Tessmer,Negative
5213,Ascerta,Sally Church,Negative
5214,Inhibition Acalabrutinib,Jerry Lee,Negative
5217,FDA Revisao da,Fernando Medina,Negative
5220,Susan UCIrvine CLL,Naveen Pemmaraju MD,Postive
5221,obinutuzumab checkpoint,Oncology Tube,Negative
5222,August Acalabrutinib Granted Priority Review,SUMIT SHARMA,Negative
5223,MRK ORR three,Andy Biotech,Negative
5224,US FDA FDA,American Preclinical,Negative
5225,New Combo Treatment UK,Lymphoma News Today,Negative
5228,Combination Acalabrutinib Vistusertib Subjects,Jason Rosenberg,Negative
5229,Combination Acalabrutinib Vistusertib Subjects,Salim Ali,Negative
5232,Proud Oxford,Graham Collins,Postive
5233,FDA Review,Lymphoma News Today,Postive
5234,Salute FDA Breakthrough Therapy Designation Priority Review,Salutedomani,Negative
5235,AstraZeneca Acalabrutinib FDA Breakthrough Therapy Designation,Pf Magazine,Negative
5240,Following PhIII BTK,Novateur Ventures,Postive
5241,New Combo Treatment UK,BioNews,Negative
5242,New Combo Treatment UK,Lymphoma News Today,Negative
5243,AstraZeneca Acalabrutinib FDA Breakthrough Therapy Designation,Parallel Learning,Negative
5245,AstraZeneca Acalabrutinib FDA Breakthrough Therapy Designation,Pf Magazine,Negative
5246,FDA Breakthrough Therapy Designation Cancer,Sue Mockus,Negative
5248,Lymphoma Treatment Acalabrutinib Receives,chadi nabhan MD MBA FACP,Negative
5249,FDA,Lymphoma News Today,Postive
5252,FDA,Hlthnews,Negative
5253,FDA,Lymphoma News Today,Postive
5254,FDA LCM,News Farma,Negative
5255,Linfoma,Giuseppe Spinnato,Negative
5256,Potential Mantle Cell,Lymphoma Canada,Postive
5258,US FDA Accepts Regulatory Submission Acalabrutinib Grants Priority Review,Hlthnews,Negative
5261,US FDA Priority Review,Krishan Maggon,Postive
5262,FDA Review,BioNews,Postive
5263,FDA Review,Lymphoma News Today,Postive
5265,Clinical Trials Acalabrutinib,Saleh Stevens,Negative
5269,AcertaPharma US FDA Priority Review NDA AstraZeneca,EuropaWire,Negative
5270,AstraZeneca Acalabrutinib FDA Breakthrough Therapy Designation,Pf Magazine,Negative
5272,US FDA Accepts Regulatory Submission Acalabrutinib Grants Priority Review,IntoxicatedTrader,Negative
5274,ClinicalTrials,SStevens,Negative
5279,US FDA Priority Review,David Ledger,Postive
5280,FDA Awards Acalabrutinib Priority Review,CancerWallonia,Negative
5281,FDA,CancerWallonia,Negative
5282,FDA Breakthrough Therapy Lymphoma,Anna Deveau,Negative
5283,BTK,OncLive SOSS,Negative
5284,US FDA,pharmatutor,Negative
5285,Linfoma FDA Breakthrough Therapy Designation Priority Review,Farmacia Nenna,Negative
5286,Oxford,Graham Collins,Postive
5288,NDA Priority Review,Lymphoma Hub,Negative
5292,US,Pharma Business Int,Negative
5293,US FDA,Global Pharma News,Postive
5296,US FDA Priority Review,World Pharma News,Postive
5298,WuXiAppTec US FDA,Pharmaceutical News,Postive
5299,WuXiAppTec US FDA,MedicalResearch News,Postive
5300,Linfoma,JobInPharma,Negative
5303,AstraZeneca pharma,SartoriusRoyston,Negative
5306,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
5310,Xin Zhao Ji Shi,Yao Ji Shi uotsuchi Xiang Hu huoro,Negative
5312,Gan Ran Zheng,Yi Liao niyusuSu Bao ,Negative
5316,PR TIMES,Yao Ji Shi niyusuPei Xin kun,Negative
5319,FDA BTK MCL BloodCancer,CBPartners,Negative
5321,This week Lymsm,Andre Goy,Postive
5323,FDA,MDedge Hematology Oncology,Negative
5324,AZ FDA Breakthrough Therapy Designation,AstraZenecaUS,Negative
5325,MCL Proud,Deborah Stephens,Postive
5326,FDA Awards Acalabrutinib Priority Review,Crwe World,Negative
5330,Breakthrough Therapy,Lymphoma Hub,Negative
5331,AstraZeneca Acalabrutinib FDA,Danvantri Farma,Negative
5332,AstraZeneca Acalabrutinib FDA Read AZN,Pharmaceutical News,Negative
5334,AstraZeneca Acalabrutinib FDA,PharmaLeaders,Negative
5335,AstraZeneca Acalabrutinib FDA,pharmabr,Negative
5336,AstraZeneca FDA Priority Review Pharma,Pharmafocus,Negative
5337,US FDA,timelivenews,Postive
5338,FDA Awards Acalabrutinib Priority Review Lai Zi,Hunan Huateng Pharmaceutical Ltd,Negative
5339,Linfoma Fda AstraZeneca,Francesca Bariggi,Negative
5340,NDA,SUMIT SHARMA,Negative
5341,FDA AstraZeneca,European Pharmaceutical Review,Negative
5343,AstraZeneca MDLinx,Bruce Berger,Negative
5346,Following PhIII AstraZeneca FDA BTK,Endpoints News,Postive
5349,FDA Awards Acalabrutinib Priority Review,mediPr Yi Xue Zuo Jia Xiang Gang ,Negative
5350,Pharma,Edwin van Bloois PhD,Negative
5351,Priority Review,BioCentury,Negative
5352,FDA,BioNews,Negative
5353,AstraZeneca Acalabrutinib FDA Breakthrough Therapy Designation,Pf Magazine,Negative
5354,Linfoma FDA Breakthrough Therapy Designation,Salutedomani,Negative
5355,Linfoma FDA Breakthrough Therapy Designation,Salutedomani,Negative
5356,Linfoma AstraZeneca,PharmaStar,Negative
5357,Following PhIII AstraZeneca FDA BTK,Sean McGrath,Postive
5359,US FDA Priority Review,AstraZenecaUS,Negative
5360,FDA Black Swan Intelligent,BlackSwan Analysis part Evaluate Pharma Ltd,Negative
5361,FDA,one Malati Invisibili,Negative
5362,Linfoma FDA Breakthrough Therapy Designation Priority Review,Salutedomani,Negative
5363,Linfoma FDA Breakthrough Therapy Designation Priority Review,Salutedomani,Negative
5364,Linfoma FDA Breakthrough Therapy Designation Priority Review,Salutedomani,Negative
5365,Linfoma FDA Breakthrough Therapy Designation Priority Review,Derma News OK,Negative
5367,Linfoma FDA Breakthrough Therapy Designation Priority Review,Antonio Caperna,Negative
5368,FDA,Lymphoma News Today,Negative
5369,US FDA,Lymphoma Canada,Negative
5370,FDA,Healio,Negative
5371,FDA,HemOnc Today,Negative
5372,Following PhIII AstraZeneca FDA BTK,cafepharma,Postive
5373,FDA AstraZeneca AZN,Share News,Negative
5375,AstraZeneca FDA Priority Review Pharma,Pharmafocus,Negative
5376,FDA NDA Priority Review,AstraZenecaUS,Negative
5380,WuXiAppTec Read Blog,MedicalResearch News,Negative
5381,WuXiAppTec Read Blog,Pharmaceutical News,Negative
5382,Following PhIII FDA BTK,Kara Jill Stancell,Postive
5383,AcertaPharma Read,Pharmaceutical News,Negative
5384,AstraZeneca InvestingFrance,Buy Cryptocurrency,Negative
5385,AstraZeneca,France,Negative
5387,AstraZeneca Radiology,Radiology BHIVE,Negative
5388,AstraZeneca Pediatrics,BHIVE Pediatrics,Negative
5389,AstraZeneca Neurology,Nephrology,Negative
5390,AstraZeneca FDA Accepts Acalabrutinib Filing Grants Priority Review More UK,iito Life Science,Negative
5391,Yesterday FDA Breakthrough Designation,AstraZenecaUS,Negative
5392,Clock FDA AstraZeneca,Pharmaceutical Market Europe,Negative
5393,Following PhIII AstraZeneca FDA BTK,world CROs,Postive
5394,AstraZeneca EmergencyMed,BHIVE EmergencyMed,Negative
5395,Following PhIII AstraZeneca FDA BTK,John Carroll,Postive
5396,Following PhIII AstraZeneca FDA BTK,Endpoints News,Postive
5397,US FDA Priority Review,Gary Skinner,Postive
5398,Clock FDA AstraZeneca,Gemma Jones,Negative
5399,FDA,Richard Staines,Negative
5400,FDA,Marco Ricci,Negative
5401,FDA,pharmaphorum,Negative
5402,FDA,IPRX,Negative
5403,PharmaTimes,BioInnoPlayground,Negative
5405,Clock FDA,ScienceSeeker Feed,Negative
5406,Clock FDA,Danvantri Farma,Negative
5407,FDA Astra Zenecas prioriterad,Sverige,Negative
5408,US FDA Priority Review,PressReleasePoint,Postive
5410,AstraZeneca US,Pharmaceutical News,Negative
5412,FDA AstraZeneca BTK,FirstWord Pharma,Negative
5413,Mantle Cell Lymphoma FDA Grants,Krishan Maggon,Negative
5415,pharma health,PharmaTimes,Negative
5420,AZN Acalabrutinib FDA Pipeline,WheelieDealer,Negative
5421,Another day BTK Acerta AZN,Jacob Plieth,Negative
5423,AstraZeneca Cardiology,BHIVE Cardiology,Negative
5424,FDA Lymphoma,Alan Tan,Negative
5425,AstraZeneca PLC AZ US,Pharmaceutical News,Negative
5426,US FDA,Cision News,Postive
5427,BTK,Brad Loncar,Negative
5428,US FDA,Cision News,Negative
5429,Nuevas Grants Acalabrutinib Breakthrough Therapy Designation,Luis Villela,Negative
5430,AstraZeneca Breakthrough Therapy,Ryan HamNer,Negative
5431,AstraZeneca Breakthrough Therapy,Ryan HamNer,Negative
5432,FDA,Crwe World,Negative
5433,AstraZeneca Breakthrough Therapy CLL,CLL Society Inc,Negative
5434,FDA,Silas Inman,Negative
5435,FDA,Graham Collins,Negative
5436,Lymphoma,The ASCO Post,Negative
5437,MYSTIC AstraZeneca two two day durvalumab lung acalabrutinib MCL,Pavan Anne,Negative
5438,AstraZeneca Breakthrough Therapy,lark,Negative
5439,FDA,CancerTherapyAdvisor,Negative
5440,Mantle Cell Lymphoma FDA Grants,BlackSwan Analysis part Evaluate Pharma Ltd,Negative
5441,US FDA,Sheila Crowe,Negative
5442,AstraZeneca Breakthrough Therapy,West sand,Negative
5443,AstraZeneca Breakthrough Therapy AZN malaysia,Siti van der Meij,Negative
5444,AstraZeneca Breakthrough Therapy,Breaking News,Negative
5445,AstraZeneca PLC,Pharmaceutical News,Negative
5446,MCL,Hatem Murad MD FAAN Htm mrd,Negative
5447,FDA,AstraZenecaUS,Negative
5448,US FDA acertapharma,Ida Sooks,Negative
5449,FDA,HemOnc Today,Negative
5450,FDA,Healio,Negative
5451,BreakthroughTherapy MCL,BluePrint Orphan,Postive
5452,FDA,Danvantri Farma,Negative
5453,FDA AstraZeneca,European Pharmaceutical Review,Negative
5454,FDA BTD NHL Watch DRGinsights AskDRGExperts,Andrew Merron,Negative
5455,Pharma Giant AstraZeneca PLC,Biotechnology,Negative
5456,Pharma Giant AstraZeneca PLC,Corixis,Negative
5457,Pharma Giant AstraZeneca PLC,Biotech World,Negative
5458,Pharma Giant AstraZeneca PLC,Pharmaceutical,Negative
5459,The Treatment Of Patients With Mantle Cell,OBR,Negative
5468,Yesterday LOXO REDX BTK today,Jacob Plieth,Negative
5469,dans,oncohebdo,Negative
5472,Zenecas ho FDA,Sverige,Negative
5473,FDA Breakthrough Therapy Designation Mantle Cell,WheelieDealer,Negative
5474,FDA,Odi Bruckman,Negative
5475,AstraZeneca Aktie,DER AKTIONAR,Negative
5477,AstraZeneca PLC Read AZN,Pharmaceutical News,Negative
5478,AstraZeneca US,Mike van Dulken,Negative
5479,US FDA,Cision News,Negative
5480,second two day Acerta BTK,Brad Loncar,Negative
5481,Ensayo Linfocitica Mas,MD Anderson Madrid,Negative
5483,MD Gaithersburg,Marketing Jobs,Negative
5486,Comparison Acalabrutinib Selective Bruton Tyrosine Kinase Inhibitor Ibrutinib,Jerry Lee,Negative
5489,ClinicalTrials US Acalabrutinib,Avery Hudson,Negative
5491,one Study Japanese,Renal Cell Carcinoma,Negative
5492,week June,Andy Biotech,Negative
5494,CLL,Cure Cancer Now,Negative
5495,Ensayo Linfocitica Mas,MD Anderson Madrid,Negative
5496,obinutuzumab checkpoint,Oncology Tube,Negative
5498,AstraZeneca Pharmaceuticals LP Global Brand Acala,JOBS EmploymentBoard,Negative
5504,obinutuzumab checkpoint,Oncology Tube,Negative
5506,obinutuzumab checkpoint,Oncology Tube,Negative
5509,Nuevo Linfocitica Mas,MD Anderson Madrid,Negative
5510,CLL,OncLive SOSS,Negative
5511,Andrew Zelenetz MD CLL,OncLive SOSS,Negative
5514,obinutuzumab checkpoint,Oncology Tube,Negative
5515,obinutuzumab checkpoint,Oncology Tube,Negative
5516,AstraZeneca Pharmaceuticals LP Global Medical Aff,JOBS EmploymentBoard,Negative
5517,DanaFarber,Jason Broderick,Negative
5518,CLL,Lymphoma Canada,Negative
5520,CLL,VJHemOnc,Negative
5521,obinutuzumab checkpoint,Oncology Tube,Negative
5522,BTK CLL,Oncology Tube,Negative
5523,AZN Acalabrutinib,JQ,Negative
5526,BTK CLL,Oncology Tube,Negative
5527,BTK CLL,Oncology Tube,Negative
5528,BTK CLL,Oncology Tube,Negative
5529,BTK Inhibitors CLL,Oncology Tube,Negative
5531,SRC CLL,Raul Cordoba MD PhD,Negative
5532,Comparison BTK CLL,Raul Cordoba MD PhD,Negative
5533,CLL,VJHemOnc,Negative
5534,BTK CLL,VJHemOnc,Negative
5535,Peter Hillmen CLL,VJHemOnc,Negative
5536,obinutuzumab checkpoint,Oncology Tube,Negative
5537,Comparison Bruton,TumorImmunoPapers,Negative
5538,Comparison Bruton,Cure Cancer Now,Negative
5539,obinutuzumab checkpoint,Oncology Tube,Negative
5541,BTK CLL,Oncology Tube,Negative
5543,BTK CLL,Oncology Tube,Negative
5545,CLL,VJHemOnc,Negative
5552,Acalabrutinib ASH,Jose Borbolla MD,Negative
5558,one BTKinhibitor CLL,MDedge Hematology Oncology,Negative
5559,AstraZeneca Early Data Demonstrate Clinical Activity Acalabrutinib,Pharmaceutical News,Negative
5560,AstraZeneca Early Data Demonstrate Clinical Activity Acalabrutinib,Pharmaceutical News,Negative
5561,AstraZeneca Early Data Demonstrate Clinical Activity Acalabrutinib,Pharmaceutical News,Negative
5562,AstraZeneca Early Data Demonstrate Clinical Activity Acalabrutinib,Pharmaceutical News,Negative
5563,Btk Imbruvica,BioCentury,Negative
5565,AstraZeneca PLC,Pharmaceutical News,Negative
5571,Early Data Demonstrate Clinical Activity Acalabrutinib,COPD News,Negative
5573,Acalabrutinib Safe Effective,HRA,Postive
5577,AstraZeneca PLC,Pharmaceutical News,Negative
5578,Early Data Demonstrate Clinical Activity Acalabrutinib,Diagnostics News,Negative
5585,AZN Astrazeneca plc Early Data Demonstrate Clinical Activity Acalabrutinib,ResearchPool,Negative
5588,Pharma CLL,AstraZenecaUS,Negative
5590,Dr Awan one CLL,Jacob Plieth,Negative
5592,AE Ibrutinib,Anthony Mato,Negative
5594,Grade five Looking,Matthew Matasar MD,Negative
5598,Dr Hillman three nine,Matthew Matasar MD,Negative
5599,BTK CLL,Oncology Tube,Negative
5600,Bruton BTK,Cure Cancer Now,Negative
5601,one CLL,Oncology Tube,Negative
5602,Obinutuzumab CheckpointInhibitor unisouthampton,Oncology Tube,Negative
5604,Shang Biao  CALQUENCE Chu Yuan Yao Ji,Shang Biao Su Bao bot,Negative
5605,one CLL,Oncology Tube,Negative
5606,BTK CLL,Oncology Tube,Negative
5610,Andrew Davies,VJHemOnc,Negative
5611,CLL two,chadi nabhan MD MBA FACP,Negative
5612,one CLL,Oncology Tube,Negative
5613,BGNE Acalabrutinib,Andy Biotech,Negative
5615,AstraZaneca Dutch,rob halkes,Negative
5616,jaar van naar MSD Oss FD,Hans Tenk,Negative
5617,VIDEO Davies,VJHemOnc,Negative
5618,BTK,Oncologiavet,Negative
5619,Obinutuzumab Checkpoint Inhibitor Lymphoma,Oncology Tube,Negative
5620,VIDEO Davies,VJHemOnc,Negative
5621,obinutuzumab checkpoint,Oncology Tube,Negative
5622,one CLL,Oncology Tube,Negative
5623,one CLL,Oncology Tube,Negative
5624,Hematology BTK MedicBoard,Hematology Board,Negative
5625,BTK CLL,Oncology Tube,Negative
5626,one CLL,Oncology Tube,Negative
5627,BTK CLL ScrippsHealth,Oncology Tube,Negative
5628,BTK CLL,Oncology Tube,Negative
5629,AstraZeneca six two thousand and Para hematologia,Raul Cordoba MD PhD,Negative
5631,BTK,CancerWallonia,Negative
5632,BTK,Oncologiavet,Negative
5633,MCL UK,TeamHaem,Negative
5634,one CLL,Oncology Tube,Negative
5635,BTK,CancerWallonia,Negative
5636,Hematology Overview Phase one MedicBoard,Hematology Board,Negative
5637,one CLL,Oncology Tube,Negative
5638,BTK CLL,Oncology Tube,Negative
5640,LEUCEMIA LINFATICA CRONICA,one Malati Invisibili,Negative
5641,Hematology News Acalabrutinib MedicBoard,Hematology Board,Negative
5642,CLL,Hematology News,Negative
5643,Pembro Acalabrutinib Durva Ibrutinib Acalabrutinib,Anirban Maitra,Negative
5644,one CLL,Oncology Tube,Negative
5645,CLL,ASH Clinical News,Negative
5646,one CLL,Oncology Tube,Negative
5647,BTK CLL,Maxim,Postive
5648,CLL,Oncology Practice,Negative
5649,LCC,Gaceta Medica,Negative
5650,AstraZeneca,dave chapman,Negative
5651,Richard Furman CLL,WCM Lymphoma,Negative
5652,EMA three,ComplexPharm,Negative
5653,CLL BTK TGTX,Michael Goodman,Postive
5654,TGTX,Allen,Negative
5655,AZN Acerta Pharma one hundred Aka Acalabrutinib,Sarcasm Bot,Negative
5657,Acerta,John Leonard MD,Negative
5659,Ibrutinib,CLL Society Inc,Postive
5662,simi CML,CMLHope,Negative
5664,AgingData OncLive,NACDA Program Aging,Negative
5665,simi CML,CMLHope,Negative
5670,one CLL,Oncology Tube,Negative
5671,USAN two thousand and CLL BTK,CancerWallonia,Negative
5672,BTK CLL,Oncology Tube,Negative
5674,BTK CLL,VJHemOnc,Negative
5676,BTK CLL,Ca Vi,Negative
5677,GaithersburgJobs Marketing Acalabrutinib Gaithersburg Jobs,Gaithersburg Jobs,Negative
5678,BTK CLL,Oncology Tube,Negative
5679,CLL,Avery Hudson,Negative
5680,BTK CLL,Oncology Tube,Negative
5682,La UE,EL GLOBAL,Negative
5683,BTK,Francesco Turturro,Negative
5684,La UE,Oncopharma,Negative
5685,La EMA three,Pedro Lendinez,Negative
5686,Europa Lee ma en,Visitador Medicos,Negative
5687,three Europa,Delos Clinical,Negative
5688,three Europa Lee ma en,Visitador Medicos,Negative
5690,Europa,Victor Norberto Cerasale Morteo,Negative
5691,EMA,ACAFARMUR,Negative
5692,La UE,El Farmaceutico Independiente,Negative
5693,La EMA,El Farmaceutico Independiente,Negative
5694,La EMA NewsCancer,de Cancer,Negative
5695,La EMA three,Susana Garcia,Negative
5696,La EMA NewsCancer,de Cancer,Negative
5697,La EMA three,Luis Pereira Lopez,Negative
5698,La,EL GLOBAL,Negative
5699,La EMA AstraZeneca,MedicinaTV,Negative
5700,La EMA su designacio,Victor Norberto Cerasale Morteo,Negative
5701,three,Crown Bioscience,Negative
5702,three Europa,PMFarma,Negative
5703,three Europa,onmedic,Negative
5705,La EMA ElGlobalnet,COF Pontevedra,Negative
5706,La EMA,El Farmaceutico Independiente,Negative
5707,La EMA AstraZeneca,El Farmaceutico Independiente,Negative
5708,Europa ActaSanitaria,Fundacion IDIS,Negative
5709,La EMA AstraZeneca,Ascol,Negative
5710,Europa,Acta Sanitaria,Negative
5711,La EMA three,IM Medico,Negative
5712,La EMA AstraZeneca,Clash Clans,Negative
5713,La EMA AstraZeneca NewsSalud,de Salud,Negative
5714,La EMA AstraZeneca NewsCancer,de Cancer,Negative
5715,La EMA AstraZeneca,Que se cuece,Negative
5716,La EMA AstraZeneca,Inter SEO Labs,Negative
5717,La EMA AstraZeneca three,Jedi Republicano,Negative
5718,BTK CLL,Oncology Tube,Negative
5719,Europe three Regulatory,Regulatory Jobs,Negative
5721,ESPERTI EMA RACCOMANDANO LA DI FARMACO ORFANO PER ACALABRUTINIB,one Malati Invisibili,Negative
5722,EU CLL,Paul Lane,Negative
5724,Europe three,Ira Kholmyansky,Negative
5725,Orphan three EU,European Pharmaceutical Review,Negative
5726,EU,Brian Uberig,Negative
5728,Orphan three,ACAFARMUR,Negative
5729,Orphan three EU,European Pharmaceutical Review,Negative
5730,EMA three,Hlthnews,Negative
5731,Ya estan los BTK de segunda EMA,Mariangel Gil,Negative
5732,EU PharmaTimes,Novateur Ventures,Negative
5733,AstraZeneca,Pharmaceutical News,Negative
5734,AstraZeneca,Tony Baller,Negative
5735,Europe three,Health,Negative
5737,Europe three,Global Pharma News,Negative
5739,Europe three,Mohammed Saied Faraj,Negative
5740,Europe three,SmartRx Systems,Negative
5741,Europe three AstraZeneca,Beyond Pill two thousand and fifteen,Negative
5742,Europe three AstraZeneca,Mktingfarmaceutico,Negative
5743,Europe three AstraZeneca,PISPOpharma,Negative
5744,Europe three,MyMexicanStore,Negative
5745,Europe three,World Pharma News,Negative
5746,Europe three AstraZeneca,David Ledger,Negative
5747,DTN Pharma News Acalabrutinib Europe three,DTN Pharma News,Negative
5748,BTK,MDedge Hematology Oncology,Negative
5749,EMA three,Danvantri Farma,Negative
5750,EMA three The European Medicines Ag,pharmabr,Negative
5751,Pharma News EMA three European,Pharma Industry News,Negative
5752,EU International Business Times India Edition,BlackSwan Analysis part Evaluate Pharma Ltd,Negative
5753,Europe three,Gunel Huseynova,Negative
5754,EU AstraZeneca,Archana,Negative
5755,EU,IBTimes,Negative
5756,Orphan Drug Europe three,Melody Davis,Negative
5758,Orpan three,Neil Sankar MPH,Negative
5760,Orphan three haem,SwanBio,Negative
5761,EU,MedSource,Negative
5762,EU,David Ledger,Negative
5764,Orphan Drug Europe three,Breaking News,Negative
5765,Orphan three,Danvantri Farma,Negative
5766,Protivoopukholevyi EMA,FarmAkta,Negative
5767,four Billion Acalabrutinib CLL SCL five year,JediPD,Negative
5768,EU,Danvantri Farma,Negative
5769,EU,Carsten Wenzel,Negative
5770,EU EU,Beyond Pill two thousand and fifteen,Negative
5771,EU EU,Mktingfarmaceutico,Negative
5772,EU EU,patientincluded,Negative
5773,EU EU,MedicalFactsEU,Negative
5774,EU,Everything Pharma,Negative
5776,Acerta Acalabrutinib Europe,Anirban Maitra,Negative
5777,EU,Pronounce Media Medical Pharmacutical News,Negative
5779,EU,PharmaTimes,Negative
5780,EU,Pharma Trader,Negative
5781,Orphan three,Pharmaceutical Mkt,Negative
5782,Orphan three EU,European Pharmaceutical Review,Negative
5783,AcertaPharma three,Pharmaceutical News,Negative
5784,AstraZeneca three,Pharmaceutical News,Negative
5785,AstraZeneca AZN PLC,Pharmaceutical News,Negative
5786,Europe,Pharmaceutical News,Negative
5787,Europe,Drug Delivery News,Negative
5788,Europe Acalabrutinib,Drug Delivery News,Postive
5790,EUROPE THREE,CMLHope,Negative
5791,Leukemia Leuk CML,CMLHope,Negative
5792,AstraZeneca PLC,RNS,Postive
5793,Europe Acalabrutinib,Sum,Negative
5794,Europe,Drug Delivery News,Negative
5795,EMA AstraZeneca CLL,Elsa Willebrand,Negative
5796,AstraZeneca February two thousand and sixteen,Pharmaceutical News,Negative
5798,Europe,Knowsis Healthcare,Negative
5799,Europe Acalabrutinib,Healthcare Industry,Negative
5800,AstraZeneca Acalabrutinib three,iito Life Science,Negative
5801,AstraZeneca AZN ACALABRUTINIB ORPHAN DRUG,Pharmaceutical News,Negative
5803,AstraZeneca AZN ACALABRUTINIB ORPHAN DRUG,Vox Markets Podcast,Negative
5806,Risultati BTK Pharmakon Feb eleven,Pharmakon,Negative
5807,New Leukemia,ColumbiaCancer,Negative
5808,Hai Ji Zhi Liao Quan katsuYou Xiao  gan,Hai Wai ganYi Liao Qing Bao rihuarensu,Negative
5810,one CLL,Oncology Tube,Negative
5811,LEUCEMIA LINFATICA CRONICA ARRIVA IL NUOVO PROMETTENTE INIBITORE ACALABRUTINIB,one Malati Invisibili,Negative
5814,BTK,MedChemExpress,Negative
5816,CLL,Richard Lehman,Negative
5818,Venetoclax,Richard Lehman,Negative
5822,CLL,Oncology Report,Negative
5825,BTK CLL,Oncology Tube,Negative
5826,ColumbiaMed,ivy science,Negative
5829,CLL Strong Responses,MedChem ONCo,Negative
5830,linfocitica,Dicaf,Negative
5832,John Imbruvica CLL,CURE Magazine,Negative
5833,Jacqueline Barrientos CLL,VJHemOnc,Negative
5834,BTK CLL,Oncology Tube,Negative
5836,one hundred,CancerWallonia,Negative
5837,one CLL,Oncology Tube,Negative
5839,Acaba Espana ya tenemos puertas otro inh generacion,Raul Cordoba MD PhD,Negative
5840,BTK three,MoJo,Negative
5843,CLL,CancerTherapyAdvisor,Postive
5845,Promise Acalabrutinib CLL,Francesco Bertoni,Negative
5849,Promise Acalabrutinib CLL,Silas Inman,Negative
5852,Promise Acalabrutinib CLL,FarmaOnco,Negative
5854,Promise Acalabrutinib CLL,PER,Negative
5855,Promise Acalabrutinib CLL,Oncology News Update,Negative
5856,Venetoclax Acalabrutinib Active CLL,Oncology,Negative
5857,nuevo farmaco Ojala,Lucas Pueyo,Negative
5859,BTK,FUJI,Negative
5863,CLL imbruvica ABBV AZN,zach,Postive
5866,CLL,Punjikasthala,Negative
5867,Venetoclax Acalabrutinib Active CLL,PracticeUpdate,Negative
5868,BTK CLL fourteen Followup NEJM,Philip McCarthy,Negative
5870,AstraZeneca seven billion Acerta Pharma three BTK,Krishan Maggon,Negative
5871,AstraZeneca fatia majoritaria Acerta US four Transacao,Negociando Agora Web,Negative
5872,AstraZeneca fatia majoritaria Acerta US four Transacao,Weverton Souza,Negative
5873,AstraZeneca fatia majoritaria Acerta US four Transacao,EXAME Negocios,Negative
5874,four Believes,JP Duvenhage,Negative
5875,four Believes,StartupStudio,Negative
5876,four Believes,Davies Wealth Management,Negative
5877,four Believes,Davies Wealth Management,Negative
5878,four Believes,Michel Francoeur,Negative
5879,Imbruvia First,Sukaina Virji,Negative
5880,four AstraZeneca,NNY,Negative
5881,AstraZeneca,Priti Arora,Negative
5882,Harry Potter,Kristen Hallam,Negative
5883,four AstraZeneca,StartupStudio,Negative
5884,four AstraZeneca,JP Duvenhage,Negative
5887,one,Dr Musa Fares Alzahrani,Negative
5888,NEJM CLL,Dr Musa Fares Alzahrani,Negative
5889,second BTK,Dr Musa Fares Alzahrani,Negative
5891,AstraZeneca Acerta Pharma five billion,Ghazi Tadmouri,Negative
5892,AstraZeneca Acerta Pharma,steve bagley,Negative
5894,StemCells News Acalabrutinib Shows,Stem Cell News,Negative
5895,Research News Acalabrutinib,Living Safely,Negative
5897,Amy Johnson PhD CLL,Targeted Oncology,Negative
5898,Acerta Pharma Btk Imbruvica AstraZeneca NEJM,Cormac Sheridan,Negative
5899,CLL Acerta Dutch AstraZeneca,Mike Ward,Negative
5900,New England Journal Medicine Demonstrates Acalabrutinib,Rx,Negative
5901,CLL NEJM,liz,Negative
5903,Amy Johnson PhD,Targeted Oncology,Negative
5905,Imbruvica ORR CLL,Joe Hedden,Negative
5906,New England Journal Medicine Demonstrates Acalabrutinib,Lindsey Summers,Negative
5907,BTKinhibitor CLL,MDedge Hematology Oncology,Negative
5911,BTK first CLL NEJM,Jeremy Warner MD MS FAMIA FASCO,Negative
5918,ASH Venetoclax Acalabrutinib Active CLL Two,Doctors Lounge,Postive
5921,ASH Venetoclax Acalabrutinib Active,Doctors Lounge,Negative
5924,New England Journal Medicine Demonstrates Acalabrutinib,Pharmicals,Negative
5925,Monday,NEJM,Negative
5926,CLL,tehmina tahir,Negative
5931,GMOfree,Melanie Johnson,Negative
5932,cacao US,Carole Johnson,Negative
5934,Glutenfree,Nadia Rice,Negative
5953,NEJM,Cancer Cell,Negative
5956,BTK CLL,Marc Gozlan,Postive
5958,New England Journal Medicine Demonstrates Acalabrutinib,Cancer Blog,Negative
5960,CLL NEJM,Nitin Jain,Negative
5961,New England Journal Medicine Demonstrates Acalabrutinib,Johnson Johnson,Negative
5962,New England Journal Medicine Demonstrates Acalabrutinib,DrugGenius,Negative
5963,New England Journal Medicine Demonstrates Acalabrutinib,Business,Negative
5964,CLL,NEJM,Negative
5966,CLL,RIOH,Postive
5968,Jacqueline Claudia NorthwellHealth,OncLive SOSS,Postive
5971,two Advances Management Register HemOnc CME CLLsm,MedscapeLIVE,Negative
5977,QUBBloodCancer AML CLL,QUB Blood Cancer Research,Postive
5978,CllSociety COVIDvaccine,Patient Power,Negative
5979,Learn CLL MDS AML,HARMONY Alliance,Negative
5980,BTK,Oncology Nursing News,Negative
5984,Ublituximab Plus Ibrutinib v Ibrutinib Alone Patients With Relapsed Refractory MD,PracticeUpdate,Negative
5985,Targeted Oncology Roundtable Daniel Persky MD,Targeted Oncology,Negative
5986,Submissions tomorrow CET Submit CLL,International Conference Malignant Lymphoma,Negative
5989,TY two week one two CLL GetVaccinated,Michele,Postive
5990,three Only seventeen AE Greater CLL,Nicolas Martinez,Postive
5991,two Lymphocytic,knowmedge,Negative
5992,twelve twelve,Cell Reports,Negative
5996,CLLSociety CDC March CDC Interim Recommendations Fully Neil Kay CLL Read,CLL Society Inc,Negative
5997,CLL Town Hall,Patient Power,Postive
5998,Shuo Ma MD Jennifer Boyer MSN APRN Deborah Stephens today Town Hall CLL,Lurie Cancer Center,Negative
5999,CLL CLL Town Hall,Patient Power,Negative
6000,COVIDvaccine CLL Town Hall,Patient Power,Negative
6001,CLL CLL,Lymphoma Hub,Negative
6002,Advocating Your Care intro CLL,Patient Power,Negative
6003,ten CLL Town Hall ClevelandClinic LurieCancer Learn,Patient Power,Postive
6004,Signaling Pathway,Eastern,Negative
6008,Oncology Eternal Oncternal Therapeutics mAb CLL,Garret,Negative
6014,Covid six week ago Monday one CLL,Tony Rothwell,Negative
6015,Haematology,ClinOwl Haematology,Negative
6017,one one thousand nine hundred Rai Sawitsky Cronkite Chanana Levy Pasternack BloodJournal CLLsm,Mike Thompson MD PhD FASCO,Negative
6018,discus update key study,OncLive SOSS,Postive
6020,March contribute international event CLL,International Conference Malignant Lymphoma,Postive
6021,skill grip edtech Cll,KidyGame,Postive
6022,CLL Many u bunker year MHQ,Jan Rynne,Negative
6023,median four year CLL CLL,Dr Rajesh Bollam Cancer Specialist Hyderabad,Negative
6025,CLL,The Oncologist,Negative
6027,CLL,CLLSA,Postive
6028,Friday Visit May BioAscend CLL,iwCLL,Postive
6029,CLL fourth CLLSupport LeukaemiaCareUK UkCll CLL,CLLSA,Negative
6030,Chronic Ibrunat,nine hundred and eightyfour pharmacy,Negative
6031,Chronic Incepta Ibrunat,GDMEDS,Negative
6036,CLL Pirtobrutinib BTK WaterfordMafia,Michael Rynne,Postive
6041,Study Tracks PatientPower,Michele,Negative
6044,Bociek MD,OncLive SOSS,Negative
6045,CLL Two Tuesday Susan CLL,Andrew Schorr,Negative
6046,Global Bridges Core Lecture Series Heme Malignancies Block BegnaKebede MayoClinic,Global Bridges,Negative
6050,AstraZeneca CLL,Pharmafocus,Negative
6051,myeloid one Learn CLL,Cancer Research Group,Negative
6052,twelve CLL BhatiaProgram twelve CLL,Hematopoiesis News,Negative
6053,Tuesday CLL DanaFarber,Patient Empowerment Network,Postive
6054,recent year James Gerson three Blood Cancer,David Henry,Negative
6055,Haematology,ClinOwl Haematology,Negative
6056,Bociek MD,OncLive SOSS,Negative
6057,UK today Hillmen CLL JanRynne EibhlinMulroe,CLL Ireland,Postive
6062,CLL twelve billion CLL,iHealthcareAnalyst,Negative
6063,CLL today UK CLL,CLLSA,Negative
6064,AstraZeneca CLL,Pharmafocus,Negative
6065,twelve,Oncology Machine Learning,Negative
6067,Bociek MD,OncLive SOSS,Negative
6068,one CLL one AZ six week ago Took one Covid Astra Zeneca CLL,Tony Rothwell,Negative
6069,CLL Saturday March twenty LurieCancer,Patient Power,Postive
6070,Saturday four hundred CLL Thanks Drs Shuo Ma Debbie Stephens CLL,Andrew Schorr,Negative
6071,SCT CLL ASOVASNA evening one,Lucrecia Yanez,Postive
6072,June two thousand and twentyone CC unmc CLL,BioAscend,Postive
6073,CLL CLLsm,Journal NCCN,Negative
6074,April fifteen two thousand Apply ESH GOLDMAN INTERNATIONAL RESEARCH AWARD Fund TFR MRD CML CLL AML,ESH Haematology,Postive
6077,Patient Education Council Love,Taylor Buss MSW,Postive
6079,CLL Umbralisib Ublituximab,Patient Power,Postive
6081,New week EHA three CML CLL MM HSCT,European Hematology Association,Negative
6082,Jose fourteen,Lymphoma Hub,Negative
6083,Learn Evaluating Leukemia,Medivizor,Negative
6085,CLL Heidi Yates CLL HeidiYates,Michele,Negative
6086,CLL,Rod,Negative
6087,NatureMedicine CLL,Satyen Gohil,Postive
6088,CLL Cohort four RachelMorrogh IrishCancerSoc JanRynne,Michael Rynne,Negative
6089,first AmbassadorsChallenges STEM CLL Humanities Arts Ambassadors,Briar Hill Primary School,Postive
6090,New BTK Inhibitor,CellworksLife,Negative
6091,discus update key study,OncLive SOSS,Postive
6092,twelve,Bhatia Program,Negative
6093,CLL,Patient Power,Negative
6094,Anthony Mato MD,CheckRare,Negative
6098,Noxxon dans Nephropathy NOX dans dans Chronic dans dans dans,MASSI,Negative
6099,CLL,CLLSA,Negative
6100,Chronic,Sarah Jones,Negative
6101,two thousand and twenty BTK,Lymphoma Papers,Negative
6103,District CLL NextMove HappyCustomers LoyaltyMatters,Lizbeth Leon,Postive
6105,Haematology,ClinOwl Haematology,Negative
6106,Chromosome Haematology,ClinOwl Haematology,Negative
6107,CLL CLL,Benlazar Amine,Postive
6109,CLL CLL,Blood Journal,Negative
6110,MKSAP Pearl Intravenous,Tom Curley MD,Negative
6111,Haematologica,Fleur Peters,Negative
6112,Just one week March CLL,International Conference Malignant Lymphoma,Negative
6113,CLL protocol least two year,Irish Cancer Society,Postive
6116,Jim Dornan Jamie Dornan Dornan CLL two thousand and five,Michael Rynne,Negative
6117,Imbruvica Plus Novel May Improve CLL BloodCancer,Patient Power,Postive
6118,CLL,CellworksLife,Negative
6119,Region LLSusa CLL DukeCancer Register,Duke Hematologic Malignancies Cellular Therapy,Negative
6120,Bociek MD,OncLive SOSS,Negative
6121,Blood Tanja Stankovic IcgsUob xenograft BloodCancer,CRUK Birmingham Centre,Negative
6122,mRNA Interesting CLL GNM,Sunny Sovereign,Negative
6124,last week one CLL,Kirstie Page,Postive
6126,obinutuzumab leusm,Targeted Oncology,Negative
6127,CLL,Yan Leyfman,Postive
6128,Pirtobrutinib CLL OncoAlert,Taylor Lab UM,Negative
6130,Bociek MD,OncLive SOSS,Negative
6132,UK CLL,Amit Sud,Negative
6133,Bociek MD,OncLive SOSS,Negative
6135,Worrisome CLL CLL Blood Cancer Patients Survivors Hesitate,CLL Society Inc,Negative
6137,CLL CLLsm HemOnc,Medscape Education,Negative
6139,EleniLadikou CLL AML,Sussex Cancer Fund,Postive
6141,thirteen one CLL,Mazyar Shadman MD MPH,Negative
6142,March GRUBHUB Gift Cards first fifty,Houston ONS,Postive
6144,Bispecific Antibody five,Cancer Papers,Negative
6145,Bispecific Antibody five,Jerry Lee,Negative
6151,today CLL The Leukemia Research Foundation webinar ConquerBloodCancers,Leukemia Research Foundation,Postive
6152,CLL,Patient Empowerment Network,Negative
6153,CLL CLL CLL,Patient Power,Negative
6154,Chromosome hvhebron hemat Text Haematologica,BibliotecaHUVH ICS,Negative
6155,Vit CLL three two thousand Shanafelt Drake et al MayoLeukemiaMDS BloodJournal CLLsm SuppOnc,Mike Thompson MD PhD FASCO,Negative
6162,The Truth Behind Aging CLL CLL PatientPower PatientReporter,Michele,Negative
6163,Haematology,ClinOwl Haematology,Negative
6164,CLL Register webinar March thirty DanaFarber,Health Content Collective HCC,Negative
6165,annual CLL two ten CLL Blood Journal two thousand and fourteen DisabilityInfo Zusia,Zusia Dr Jackie Volk,Negative
6166,CLL four mclsm cllsm,RedMedEd,Postive
6167,Steven Coutre MD StanfordMed,Patient Power,Negative
6168,AnthonyMatoMD,ASH Clinical News,Negative
6170,"twelve PM MT webinar Mississippi SB two thousand, seven hundred CLL",MJ Platform,Negative
6171,Meet Professor today PM ET Dr Steven Courtre Stanford University School Medicine Register,Research To Practice,Postive
6172,Yeahhhhh AMC Zooooo namelijk geen,Jolanda,Negative
6173,CLL day one,MyLeukemiaTeam,Negative
6180,Jacqueline Claudia NorthwellHealth,OncLive SOSS,Postive
6181,Zanubrutinib Selective Covalent Inhibitor,Lymphoma Papers,Negative
6182,CLL,Neal,Negative
6185,Zanubrutinib Selective Covalent Inhibitor,TYR Kinase paper,Negative
6188,Cheryl Missouri Please,Christian Healthcare Ministries,Postive
6189,CLL,Tom,Negative
6190,The Truth Behind Aging CLL Matt Davids Susan OBrien PatientPower CLL DanaFarber,Michele,Postive
6192,Zanubrutinib Selective Covalent Inhibitor,Lymphoma Papers,Negative
6193,CLL Carol Preston COVIDvaccine,Patient Power,Negative
6194,CLL,Carlos Salinas,Postive
6195,Rituximab,PharmaFactz,Negative
6196,one Brown JR Blood,paper link,Negative
6197,Led Jennifer Brown BrighamWomens CLL,Hematopoiesis News,Negative
6198,last year CLL Nicole Lamanna ColumbiaMed CancerPatients,Patient Power,Negative
6199,William Wierda PhD MD Anderson Cancer Center CLL Lymphoma Society,CheckRare,Negative
6200,Alan Ramsey CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
6201,Alexander Egle CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
6203,CLL CLL Allison Michie UofGlasgow,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
6204,UK CLL UkCll annual Inaki CLL Join day,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
6205,CLL Download CLL,AbbVie UK,Negative
6206,CLL,Toby Eyre,Postive
6207,Centret livslangt Norden,Bildningsalliansen,Negative
6210,CLL Register webinar March thirty DanaFarber CLLsm Register,Patient Empowerment Network,Postive
6211,Data,Ganjly Reliable Cannabis News,Negative
6212,DamsonEd WordAware NELI EYFS CLL,Yorkshire Endeavour English Hub,Postive
6213,Receiving BTK Inhibitor Treatment Considerations AdvancedPractitioners March AP CLL BTK,APSHO,Negative
6214,Gleevec protuberans,PharmaFactz,Negative
6215,CLL Danielle Roberts WinshipAtEmory CLLsm,Health Content Collective HCC,Postive
6216,Learn Illegal Dumping Fund,APWA,Negative
6217,eight,AstraZenecaUS,Negative
6221,Cathy Wu DanaFarber CLL CLL,Dr Rajesh Bollam Cancer Specialist Hyderabad,Postive
6222,TOMORROW Advances Management CLL two HemOnc CME CLLsm,Medscape Education,Negative
6223,Catherine Wu DanaFarber knockin mouse,Immune Regulation News,Negative
6224,CLL,Patient Power,Negative
6225,CLL Drug CLL,Taylor Lab UM,Negative
6226,March FLAIR STATIC CLL,CLLSA,Negative
6228,myeloid myeloid,Sarah Jones,Negative
6230,UNITEGlioblastoma DKFZ first AHR CLL,CeMOS,Negative
6232,IntermittentFasting CLL,Eleah Stringer RD,Negative
6236,one Mark June two thousand CLL,Michele,Negative
6238,Xueyan Cui,Centre Thrombosis Haemostasis Research OUS,Negative
6239,one Prostate Cancer Breast,When reason fails,Negative
6240,John Hayslip MD AbbVie Pharmaceuticals MURANO Lymphoma Society,CheckRare,Negative
6243,four month,David Almeida MD,Postive
6250,Webinar CLL AYA Webinar lymfatische leukemie YouTube,Lymfklierkanker VV vzw,Negative
6251,JanaChaaban chuanzhenzhao CLL,nanofabPOM,Postive
6252,seventy year old Leukemia MC,EM Board bomb,Negative
6254,CLL two,Mazyar Shadman MD MPH,Postive
6255,Saturday morning CLL,Anthony Mato,Negative
6256,Carlo Moreno CLL,Saudi Blood SSBD 'mrD ldm,Negative
6257,CLL Carlo Moreno CLL,Saudi Blood SSBD 'mrD ldm,Negative
6259,one CLL Carlo Moreno SSBD,Saudi Blood SSBD 'mrD ldm,Negative
6268,CLL,Benlazar Amine,Negative
6270,First CLL,Benlazar Amine,Negative
6271,CLL first,Benlazar Amine,Negative
6272,CLL,Benlazar Amine,Negative
6273,CLL,Benlazar Amine,Negative
6275,RareDisease Wildgroei CLL BHSnursing Stkstichting,De Munter,Negative
6276,Wildgroei webinar CLL,De Munter,Negative
6277,Just one week Abstracts LymphoidNeoplasms CLL,International Conference Malignant Lymphoma,Negative
6278,multiplex method four hundred Bruton Tyrosine Kinase,Lymphoma Papers,Negative
6279,Raquel three ma en el equipo CLL LacasaLitner Ortodoncia Valdemoro,Clinica Lacasa Litner,Negative
6280,NIH,CLL Society Inc,Negative
6281,Turmeric Natural Prevention Treatment Chronic,Kyle Norton,Negative
6282,Memorial Sloan Kettering Appreciate Alvaro Alencar CLL,Taylor Lab UM,Postive
6283,Imbruvica Imbruvica,CURE Magazine,Negative
6284,today RR CLL,Deborah Stephens,Postive
6285,Program Access Access Virtual Exhibition Area CLL,International Conference Malignant Lymphoma,Negative
6286,New Research Paper Published Using SCF Equipment Andrea Pepper Sussex Cancer Fund Read BloodCancer,Sussex Cancer Fund,Negative
6287,CLL Congrats al client Loxo,Josie,Postive
6288,CLLsm,Patient Empowerment Network,Negative
6289,Reaserch Advance Inhibitor Targeting Receptor,EurekaMag,Negative
6290,Digital Advocacy Health Equity CLL CLLsm,Patient Empowerment Network,Negative
6291,Memorial Sloan Kettering Appreciate Alvaro Alencar CLL,Taylor Lab UM,Postive
6292,Koln three,CheckRare,Negative
6293,ChronicLymphocyticLeukemia Learn CLL,Mayo Clinic Cancer Center,Negative
6294,Pirtobrutinib CLL MCL RoswellPark,Suchitra Sundaram,Postive
6295,CLL Research Ublituximab Ibrutinib Ibrutinib Alone CLL,Tom Henry MBA RPh CPh,Negative
6296,Tissue CLL,Wnt publication,Negative
6300,CLL Traduttori Vittoriale two thousand,Il Vittoriale,Negative
6301,Congrats Pirtobrutinib BRUIN CLL,Taylor Lab UM,Postive
6302,multiplex method four hundred Bruton Tyrosine Kinase,Lymphoma Papers,Negative
6304,FollicularLymphoma Hematology Review two thousand and eighteen two Click,touchONCOLOGY,Negative
6305,CLL SLL BTK Phase BRUIN TheLancet,Remy Dulery,Postive
6306,TheLancet Outstanding Pirtobrutinib CLL,Toby Eyre,Postive
6307,one Pirtobrutinib OUHospitals CLL,Toby Eyre,Postive
6308,CLL Fantastic Congrats Pirtobrutinib BRUIN,Toby Eyre,Postive
6309,Friday,Dr,Negative
6310,seventeen Scientists CLL,Dawn Ai Playin,Negative
6311,MCL CLL Congrats CLL,Pietro Di Ciaccio,Postive
6312,CLL,Chaitra Ujjani MD,Negative
6317,daily two hundred CLL BTK,Victor Lin,Negative
6319,Mississippi Initiative Thursday twelve PM MT CLL,MJ Platform,Negative
6320,LRF Christopher Flowers MD MS CLL BTK Click,Lymphoma Research Foundation,Negative
6321,Shuo Ma Jennifer Boyer Sat March Register PatientPower CLL,Lurie Cancer Center,Negative
6323,CLL,Journal NCCN,Negative
6324,MRD one one million AdaptiveBiotech Labcorp,CLL Society Inc,Negative
6325,three,Fragments,Negative
6326,March eleven CLL BTK Inhibitor AP,JADPRO,Negative
6331,CLL National Alliance Caregiving NAC LLSusa Stay,National Alliance Caregiving,Postive
6333,Jacqueline Claudia,OncLive SOSS,Postive
6334,two,Lymphoma Papers,Negative
6335,two,Cancer Papers,Negative
6337,Agence en centre ville de Toulouse Greve jour appel SNU CGT CLL SUD JalbertOlivier,SNU Pole Emploi FSU Occitanie,Negative
6338,CLL next week RSVP March,Phoebe Needles,Negative
6339,CLL today Leukaemia Care CLL,Nick,Postive
6340,FREE Patient Webinar CLL Two April NCCN CLLsm,UCSF Cancer Center,Postive
6341,Pharmacy Grand Rounds last two year Glad PGR CLL OncoPharm,Mikhaila Rice,Postive
6343,CLL CLL,Blood Advances,Negative
6344,NCCN one Register,MGH Cancer Center,Postive
6345,CLL Sandy Peterson CLLsm,Patient Empowerment Network,Postive
6346,March CLL DanaFarber,Patient Empowerment Network,Postive
6348,CLL COVIDvaccine Hematology Rocky Mountain Cancer Centers,Patient Power,Negative
6349,LeukaemiaCareUK LymphomaAction March CLL,CLLSA,Postive
6350,two,UVA Science Pubs,Negative
6354,Mikhaila Rice TwitteRx,Mayo Clinic Pharmacy Residency Programs,Negative
6355,two,Lymphoma Papers,Negative
6356,Amjad Hayat University Hospital Galway CLL Shane Coleman,CLL Ireland,Postive
6360,Shuo Ma Jennifer Boyer Sat March twenty Register CLL,Lurie Cancer Center,Negative
6367,Montana Cannabis Legalization Licensing MT CLL,Akerna,Negative
6368,CLL,medRxiv,Negative
6370,hvhebron hemat,BibliotecaHUVH ICS,Negative
6371,CLL today Input,Leukaemia Care,Postive
6372,March Registrations CLL,CLLSA,Negative
6373,CLL CLL PatientPower,Patient Power,Negative
6375,Check Evaluating,Medivizor,Negative
6376,Koln CLL UniCologne Lymphoma Society,CheckRare,Negative
6377,India CLL AML SLL Venetoclax Read,Name Patient Import,Postive
6379,one three Understanding CLL Progression Genetics,Tinu,Negative
6380,CLL,Deborah Stephens,Negative
6382,Dinner Docs CLL Rocky Mountain Cancer Centers Catch,Patient Power,Negative
6383,Receiving BTK Inhibitor Treatment Considerations AdvancedPractitioners March AP CLL BTK,APSHO,Negative
6386,CLL Learn one,Pharmacyclics AbbVie Company,Postive
6387,CLL,Patient Power,Negative
6392,CLL,Lymphoma Hub,Negative
6397,MURANO Duvelisib CLL SLL,VJHemOnc,Negative
6400,CLL one Brad Adams ChronicLymphocyticLeukemia two thousand and ten Fast PatientPower,Patient Power,Negative
6401,Damian Kovalovsky CLL,Matthew Cyr,Postive
6402,Damian Kovalovsky NCIResearchCtr CARTcells CLL CLL LeukemiaJnl,Cell Therapy News,Negative
6403,CLL,Silvers Antonio,Negative
6405,NEW Comparing,Medivizor,Negative
6406,MDS CLL AML JohnPLeonardMD GreatDebatesHem,Jessica Altman MD,Postive
6408,Advances Management CLL Bringing,Medscape Oncology,Negative
6409,GCLLSG CLL,Mazyar Shadman MD MPH,Negative
6411,Syed Ali Abutalib Jennifer Brown,The ASCO Post,Negative
6412,CLL winter Drs Goy Brown Cortes,Anthony Mato,Postive
6413,GCLLSG CLL UKKoeln UniCologne,Michael Hallek,Postive
6414,Norway CLL,Sigrid Skanland,Negative
6415,CLL first European Ireland,CLL Ireland,Negative
6416,The University Clinic Lymphoma MayoClinic theNCI,Mayo Clinic Cancer Center,Negative
6417,la pensee je deteste la distance et humiliation mon ennemi,Silvers Antonio,Negative
6418,CLL CLL tomorrow,CLL Society Inc,Postive
6419,Dr Brown,donnashort,Negative
6420,CLL,Elizabeth Fiala,Negative
6421,eight hundred van zeldzame ziektendag wil Evy Radiorgbe Getuigenis CLL YouTube,Lymfklierkanker VV vzw,Negative
6423,Quitter la maison le matin et rentree Dieux accorde,Silvers Antonio,Negative
6427,CLL two CLL,Blood Journal,Negative
6428,one day GI Vote CardioOnc ACCED,American College Cardiology,Negative
6429,CLL IO,Yan Leyfman,Negative
6430,ATTN Meeting Deadline May BioAscend CLL,iwCLL,Postive
6431,ActiveMonitoring BloodCancer LeukaemiaCareUK LymphomaAction MPNVoice CLLSupport MPN CLL,Zack,Negative
6433,Frontiers Phosphoinositide,Markus Vallaster,Negative
6435,Click CLL,Lymphoma Hub,Negative
6436,CLL,Dr Robert,Negative
6437,Haematology,ClinOwl Haematology,Negative
6438,CLL Ireland Shane Coleman Dr Gerard Crotty Consultant Dr Crotty CLL,CLL Ireland,Postive
6441,FREE Medifocus Guidebook,Cheryl Brigs,Postive
6445,York Advanced Practice Provider,Our Ability Inc,Postive
6446,one year obinutuzumab William Wierda CLL EndCancer,MD Anderson Cancer Center,Negative
6448,CLL Australasia,Journal NCCN,Negative
6449,Jacqueline Claudia NorthwellHealth,OncLive SOSS,Postive
6450,CLL,Klaus Okkenhaug,Negative
6451,PTCL,Journal NCCN,Negative
6452,seventy three month ago CardioOnc,American College Cardiology,Postive
6454,Florida CLL CLL Learn,Patient Power,Postive
6456,Moderated JohnPLeonardMD Cell Therapy Managing Patients Recurrent CLL CLL,Great Debates Hematologic Malignancies,Negative
6457,Anthony Mato MD MSCE one thousand four hundred,Targeted Oncology,Negative
6462,TODAY EST Advances Management CLL Bringing four HemOnc CME CLLsm,Medscape Education,Negative
6463,TGTX TG Therapeutics twelve February FDA UKONIQ three Ublituximab Ibrutinib RR,Biotech Pipeline Tracker,Postive
6464,two thousand and sixteen six month HepC one CLL today,Shouting people underpants,Postive
6466,Rossana Maffei,Human Immunology News,Negative
6467,BCR IKAROS SYK,TYR Kinase paper,Negative
6468,Learn AP CLL BTK,JADPRO,Negative
6469,AFib EKG Vote CardioOnc ACCED,American College Cardiology,Postive
6472,Epigenetic Trajectories Transition CLL,Benlazar Amine,Negative
6473,CME webinar February Strategies CMS,myCME,Negative
6474,Chronic Lymphocytic,Reality alone sanity,Postive
6476,CLL Connect Florida Cancer Specialists Research Institute,Patient Power,Negative
6477,NIH CLL CLLreporter,Michele,Negative
6478,LabMedjournal Smudge Cells,ASCP,Negative
6481,CLL TechnologyOffer LifeSciences Pharma NRWHIP,PROvendis GmbH,Negative
6482,COVIDVaccine CLL DonnellyStephen HSEImm,John Wall,Negative
6483,CLL four CllIreland,Jan Rynne,Negative
6484,Anna Puiggros,NK paper,Negative
6485,one Lymphoma Australia Ambassadors March Australia CLL FacebookWatch,Donna Gairns,Postive
6487,Mazyar Shadman MD,OncLive SOSS,Negative
6488,SCI Steven Coutre CLL,Steven Artandi MD PhD,Negative
6496,Docs CLL Florida Cancer Specialists Research Institute FL,Patient Power,Negative
6502,Register PFAS CLL,APWA,Negative
6503,one BloodJournal CLL,Ingo Ringshausen,Postive
6504,ESH GOLDMAN INTERNATIONAL RESEARCH AWARD two thousand TFR MRD April fifteen two thousand CML CLL AML,ESH Haematology,Postive
6506,TGTX TG Therapeutics Announces Publication Final Results Phase three Lancet,Stock Market Catalyst News,Negative
6507,TGTX TG Therapeutics Announces Publication Final Results Phase three The Lancet Haematology BioSpace,Biotech Tech Stock Focus,Negative
6508,TG Therapeutics Announces Publication three The Lancet Haematology TG,Dan Brickner,Negative
6510,TGTX TG Therapeutics Announces Publication Final Results Phase three,OTC Dynamics Inc,Negative
6511,TGTX TG Therapeutics Announces Publication Final Results Phase three,Stock News Bot,Negative
6512,TG Therapeutics Announces Publication three,Crwe World,Negative
6513,TGTX TG Therapeutics Announces Publication Final Results Phase three,Stock Titan,Negative
6515,CLL el diagnostico Paolo Ghia Lydia Scarfo Barbara Eichhorst Moritz Furstenau,Alberto Lopez Garcia,Negative
6526,JA Kipps James DF Mongan,NK paper,Postive
6527,three CLL,The Lancet Haematology,Negative
6529,PubMed Memory,Memory,Negative
6530,William Wierda CLL EndCancer,MD Anderson Cancer Center,Postive
6531,James Essell healthcare professional amp Zoom Essell CLL Register today,OHC,Negative
6534,tomorrow EHA Endorsement myESMO Clinical Practice Guidelines Diagnosis Treatment CLL today,European Hematology Association,Postive
6535,CLL,Lymphoma Hub,Negative
6536,Advances Management CLL Bringing Data Life Thursday ICYMI HemOnc CME CLLsm,Medscape Education,Negative
6537,akaraburuchinibu CLL,ganpurasu,Negative
6538,thirteen CLL two Dolphins last two day,Jack Lydon,Negative
6539,BloodJournal May two thousand and twenty,Felipe Pena Munoz,Negative
6542,transcription BRAF fourteen,Cancer epigenetics paper,Postive
6545,articulo del nuevo modulo BloodJournal CLL CLL Tycho Baumann Score asintomaticos drjdelaserna art,Alberto Lopez Garcia,Negative
6551,UK US,ABNewswire,Negative
6552,CLL ScrippsHealth,Anthony Mato,Postive
6554,one Calgary Banff CLL Jasper,Kelly,Negative
6555,Jacqueline Claudia NorthwellHealth,OncLive SOSS,Postive
6567,CLL Anything,Albert Sloan,Negative
6568,Bispecific Antibody Boosts Autologous,Cure Cancer Now,Negative
6570,CLL BloodCancerAwareness,RIOH,Negative
6571,CLL PatientPower,JanssenUS,Postive
6572,CLL PatientPower,Pharmacyclics AbbVie Company,Postive
6573,John Allan CLL,WCM Lymphoma,Negative
6574,five February OracleHealthSci,DIA,Postive
6575,William Wierda CAPTIVATE,Targeted Oncology,Negative
6576,Neil Kay MD MayoClinic CLL,Clin Adv Hem Onc,Negative
6577,April Free Richard Rosenquist Brandell Matthew Davids,Sigrid Skanland,Postive
6578,CLL,Shouting people underpants,Negative
6579,David Ozor five Million Naira Kindly RT Elcrucifixio DONJAZZY,Samuel Olaiya Afolaranmi,Negative
6580,one week Great Debates three day myeloid,Joseph Mikhael,Postive
6581,NEW ARTICLE,CMRO Journal,Negative
6582,CLL,International Conference Malignant Lymphoma,Negative
6585,one one Patient Power nineteen Pharmacyclics Pharmacyclics Pharmacyclics AbbVie Company,CheckRare,Postive
6586,Bendamustine Haematologica,Dr Comeau MD,Negative
6587,CLL,Benlazar Amine,Postive
6588,Don WeillCornell Richard Furman CLL BioAscend CME lymsm,WCM Lymphoma,Negative
6589,Mazyar Shadman OncLive CancerPatients CLL,SeattleCancerCareAlliance,Negative
6590,CLLtreatment CLL,Health Content Collective HCC,Postive
6591,CLL Steven Coutre StanfordMed next week,Andrew Schorr,Negative
6593,CLL Zoom March,Phoebe Needles,Negative
6595,CLL Florida Cancer Specialists Research Institute,Patient Power,Negative
6596,CLL splenomegaly TLS Updated,Amber Koehler,Postive
6597,two thousand,Ryan Smith,Postive
6602,Venetoclax Rituximab Ibrutinib CLL,CureHuntr,Negative
6603,Venetoclax Rituximab Ibrutinib,TrialBulletin,Negative
6604,Ophthopedia Update Chronic,Ophthopedia,Negative
6605,Fan two thousand International Journal Cancer,Krishan Maggon,Negative
6607,CLL,Seema Ali Bhat,Negative
6608,COVIDVaccine CLL CLLReporter,Michele,Negative
6612,attendee doc one CLL Myeloma WinshipAtEmory More,Patient Power,Negative
6613,Mein Mann von chronischlymphatischerLeukamie CLL Asthmatikerin Ehefrau Impfung Er kann nicht Homeoffice,Pilgrim,Negative
6614,CLL CLL,Benlazar Amine,Postive
6615,Friday CLL Society LLS LivingWithCLL,LLS National Capital,Postive
6616,PathTwitter MedTwitter,Sami Talibi MD,Negative
6617,Imbruvica,Tom Lamb,Negative
6618,CLL BloodCancer Cancer,Coping Cancer,Negative
6619,CLL StanfordMed new webinar CLL Join one week,Patient Power,Postive
6620,one hourly CLL,neilgolemo,Postive
6621,February CLL PatientPower,JanssenUS,Negative
6622,Our Small Things Big Difference CLL,AbbVie UK,Negative
6623,PostdocPosition TumourImmunology OMICS CRISPR CLL,Anna Kabanova,Negative
6628,February PST CLL PatientPower,Pharmacyclics AbbVie Company,Negative
6629,CLL Friday CME FREE,BioAscend,Postive
6631,one week CLL CLL Florida Cancer Specialists First FREE Florida,Patient Power,Negative
6632,Jim Allen CLL Jim,Blood Cancer UK,Negative
6634,NCCN Brukinsa,CURE Magazine,Negative
6636,one hundred CLL,Bobby Martin,Negative
6637,Hark Thursday Gribben Registration TheEBMT CLL AML BigData,Kimmo Porkka,Postive
6638,myeloid,defeatHIV,Negative
6639,LeukaemiaCareUK CLL Facebook CLL,LymphomaAction,Postive
6640,DisabledWorld,Disability DATA,Negative
6641,June two thousand Lugano CLL,International Conference Malignant Lymphoma,Postive
6642,Douala Nairobi Lagos Nacala Georgia Idaho,The Indian Pharma,Negative
6644,Advances Management CLL Bringing tomorrow jonathonbcohen ICYMI HemOnc CME CLLsm,Medscape Education,Negative
6645,LeukaemiaCareUK TODAY Monday February CLL Register,LymphomaAction,Postive
6648,Lymphocytic IDRA MGNK ADRO XCUR ArtKrieg CpG kortylmt,Oligotherapeutics,Negative
6653,one six Advances Management CLL Tuesday CME NurseTwitter,Medscape Nurses,Negative
6654,Envy Chronic,StarSeekerDragon,Negative
6655,five hundred CLL Morabito American Journal Hematology,Benlazar Amine,Negative
6656,The Spike Protein Endoplasmic Reticulum Shelterin Complex MIMIC Chronic,Walter Chesnut,Negative
6657,Research Project Identification Learn,Pine Biotech,Negative
6658,one CLL Brazil Healthcare FC Chlorambucil Rituximab Alentuzumab Int Access Healthcare Acala Venetoclax thecancergap cllsm,Thiago Carneiro,Negative
6659,LeukaemiaCareUK Monday February CLL Register,LymphomaAction,Postive
6660,three CLL two thousand and ten Australia,CLL Ireland,Postive
6662,US Veterans Health Administration System,Lymphoma Papers,Negative
6663,CLL SWOG,Mazyar Shadman MD MPH,Negative
6664,February twenty MPN MM AML CLL moasc,MOASC,Postive
6665,first SYK CLL CLL,Adam Kittai,Negative
6666,CLL,Michele,Negative
6667,five February OracleHealthSci,DIA,Postive
6669,New Research Paper Published Using SCF Equipment Andrea Pepper Sussex Cancer Fund Read BloodCancer,Sussex Cancer Fund,Negative
6670,CLL Nicole Lamanna MD CLL Learn,Patient Power,Postive
6671,CLLsm CLL,Journal NCCN,Negative
6672,First CRISPR CLL today Laura TumourImmunology FondazioneTLS,Anna Kabanova,Postive
6673,CLL,AbbVie UK,Negative
6674,one CLL CML,Journal Blood Disorders Treatment,Negative
6681,CLL Ireland EibhlinMulroe,CLL Ireland,Postive
6682,two thousand and ten CLL two thousand and twenty Ireland DonnellyStephen,Michael Rynne,Negative
6683,Cerebral Invasive Aspergillosis Case Chronic,TYR Kinase paper,Negative
6684,myeloid myeloid Hodgkin NHL,Leukemia,Negative
6685,Houston CLL NatRevImmunol,Nitin Jain,Negative
6686,Saturday Today,pro diet coke button,Negative
6687,CLL UTSWnews Lamanna next week,Andrew Schorr,Postive
6688,February,myCME,Postive
6689,US Veterans Health Administration System,Lynn Crismon,Postive
6691,Today one hundred and thirty CLL ChildhoodCancer,HARMONY Alliance,Negative
6692,US Veterans Health Administration System,Chris Frei,Negative
6694,healthcare resource Ibrutinib Bendamustine Rituximab,Lymphoma Papers,Negative
6695,Afternoon WhatsApp,Brown Emmanuel,Postive
6701,CLL Andrea Visentin UniPadova,VJHemOnc,Negative
6702,CLL Winter Hematology Update Listen Friday,Anthony Mato,Postive
6703,DYK year old CLL,BeiGene,Negative
6706,Lymphocyte CLL,Nagy Akos,Negative
6707,one week CLL Nicole Lamanna MD UTSWNews CLL Learn,Patient Power,Negative
6709,today PM ET CLL Claim Oncology ClinicalXchange,Clinical Care Solutions,Negative
6714,The Design Inhibitors Treating Chronic Leukemia Shiyu Wang ScientificChallenge,BioSolveIT,Postive
6715,Florida CLL one PatientPower Hematologists PatientPower CLL CLLFlorida,Michele,Negative
6716,First Past Post,Habib Olapade,Negative
6718,Tomorrow Join Lymphoma Research Foundation Update Oral Therapies Lymphoma February two pm ET Jonathon Cohen Emory University CLL Helpline,CLL Society Inc,Negative
6719,eight,Francis Jenkins RE,Negative
6720,ERIC IG CLL Maria Teresa Daniele Calistri,Biosciences Laboratory IRST,Postive
6729,LeukaemiaCareUK Monday February CLL Register,LymphomaAction,Postive
6730,US,Aptitude Health,Negative
6731,CLL CLL REGISTER ClinicalXchange,Clinical Care Solutions,Negative
6732,CLL CLLsm,Journal NCCN,Negative
6733,BloodJournal AKT RT CLL CLL,Victor Lin,Negative
6734,CONGRESS Bishop Uchicago TRANSCEND CLL four CLL,Lymphoma Hub,Negative
6736,Michael Bishop UChicago CLL,VJHemOnc,Negative
6737,CLL,Blood Journal,Negative
6739,CLL PrecisionMedicine MassSpectrometry,alberto santos,Postive
6740,Three CLL CLLsm,Journal NCCN,Negative
6741,fifty today nine hundred daysinn wyndham,DaysInnBryanCS,Postive
6742,UK CLL Forum Annual Scientific Day March Registration CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
6744,Advances Management CLL Bringing,Medscape Oncology,Negative
6745,CLL,StressMarq,Negative
6746,rituximab regimen,Lymphoma Papers,Negative
6747,This week LearningMondays Prof Gunnar Larfors,European Hematology Association,Negative
6748,myeloid,PharmaFactz,Negative
6751,Advances Management CLL Bringing Six February sixteen HemOnc CME CLLsm,Medscape Education,Negative
6752,akaraburuchinibu CLL,ganpurasu,Negative
6754,One CLL,AACR Foundation,Negative
6756,CLL LungCancer,Liz Samander,Negative
6758,CLLSociety Brian CNN Drs Chaitra Ujjani Sharon CLL EladSharon,CLL Society Inc,Negative
6762,Join Lymphoma Research Foundation Update Oral Therapies Lymphoma February two pm ET Jonathon Cohen Emory University CLL Helpline,CLL Society Inc,Negative
6763,CLL,FindACurePanel,Postive
6771,Chelsea Chelsea CLL,Aurileus FC,Negative
6773,LeukaemiaCareUK Monday February CLL Register,LymphomaAction,Postive
6774,fifty Bleed five HTN Infections Diarrhea CVS forty ten CLL,Hammad,Negative
6775,one CLL CML,Journal Blood Disorders Treatment,Negative
6776,Robert Figlin MD Mazyar Shadman ASH two thousand and twenty OBR OBRtweets,Mazyar Shadman MD MPH,Negative
6778,Susan MD UCIrvine CLL Aditi Robert Galamaga Phoenix Stephen Goldfarb DO Sierra Vista AZ,BioAscend,Postive
6779,CLL CllSociety,Chaitra Ujjani MD,Negative
6780,JustIn SCCA CNN CLL,SeattleCancerCareAlliance,Negative
6781,CLL,Chaitra Ujjani MD,Postive
6790,two thousand and,Industry Today,Negative
6792,one six Advances Management CLL Bringing Data Life HemOnc CME NurseTwitter,Medscape Nurses,Negative
6793,This year,Larissa Nelson,Negative
6795,CLLsm,Patient Empowerment Network,Negative
6796,CLL four today mclsm cllsm,RedMedEd,Negative
6797,ten year,designated dilf fucker,Negative
6798,Arzerra Kesimpta Ofatumumab CLL,PharmaFactz,Negative
6799,Op Wereldkankerdag CLL six,Lymfklierkanker VV vzw,Negative
6800,CLLsm,Patient Empowerment Network,Negative
6802,WorldCancer Day one CLL one one,Deb Amlen,Negative
6803,Jeff CLL Discover Jeff,WEGO Health,Negative
6804,Idelalisib Is Not Associated With Increased Bleeding Risk Patients With,Oncology,Negative
6805,ten billion one,Riddle Brantley,Negative
6806,one CLL,Anna Stewart,Negative
6807,CLLSociety WorldCancerDay Telling CLL,CLL Society Inc,Negative
6808,fri verden WorldCancerDay cml cmml lymfekraeft,LyLe Foreningen,Postive
6809,CLLSociety Today ASH two thousand and twenty Comes You Mato Wierda ASH two thousand and CLL,CLL Society Inc,Negative
6810,LeukaemiaCareUK Monday February CLL Register,LymphomaAction,Postive
6811,CLL,Blood Cancer UK,Postive
6812,CLL,Leukaemia Care,Negative
6813,James Gerson,OncLive SOSS,Negative
6814,UK CLL Email LeukaemiaCareUK UkCll LymphomaAction,Nick,Postive
6815,HARMONY one hundred CLL MMSM ChildhoodCancer CML,HARMONY Alliance,Postive
6816,Today CLL Core Outcome Sets AcuteLeuk LeukaemiaCareUK CllIreland,CLL Advocates Network,Postive
6819,CLLSociety Today ASH two thousand and twenty Comes You Includes Mato Wierda TRANSCEND CLL,CLL Society Inc,Negative
6820,Today CLL,CLL Ireland,Negative
6821,Today CLL CcoHse,Michael Rynne,Negative
6822,Today CLL JanRynne,Michael Rynne,Negative
6823,UK CLL Email,CLLSA,Postive
6824,Today CLL CLLAdvocates,CLL Advocates Network,Negative
6826,Kudos CLL,Amber Koehler,Negative
6827,CLL CLL,Michael Bayerl MD,Postive
6828,CLL Philip Thompson,Patient Power,Negative
6830,Chronic CLL PI CLLsm,Aurora Cancer Care,Negative
6831,CLL,PeerView,Negative
6832,CLL Sandy Peterson CLLsm,Patient Empowerment Network,Postive
6833,Bispecific Antibody Boosts Autologous CLL,CellworksLife,Negative
6834,CLL CLL,CLLSA,Postive
6835,Bispecific Antibody Boosts Autologous,Cure Cancer Now,Negative
6836,one,Lymphoma Papers,Negative
6837,Journal Experimental Medicine Rockefeller University Press,Ariakas Enoreth,Negative
6841,CLL,Anthony Mato,Negative
6842,BTK CLL TRAEs Start HemOnc CLLsm,Medscape Education,Negative
6844,Acute Lymphoblastic Leukemia Patients Chronic Lymphocytic Leukemia Treated Lenalidomide Haematology,ClinOwl Haematology,Negative
6845,Spanish CLL,Journal NCCN,Negative
6846,February CLL AcuteLeuk LymphomaAction,CLL Advocates Network,Negative
6847,Bendamustine Haematologica CLL,Benlazar Amine,Postive
6848,Krakow Poland CLL,BioAscend,Postive
6849,CLL CLLsm,Patient Empowerment Network,Negative
6850,CACHE EYE nine fourteen CLL,Early Years LSC FE VocEd EYFS,Negative
6851,CLLsm,Patient Empowerment Network,Negative
6852,Cancer Institute,CURE Magazine,Negative
6853,CLL NCFF,Laila Kjaerbaek,Negative
6854,TheBethesdaLabs NIHClinicalCntr CLL Call Office Patient FightBloodCancer,NHLBI Bethesda Labs,Negative
6855,UK CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
6856,LeukaemiaCareUK Monday February CLL Register,LymphomaAction,Postive
6860,Koln CLL UniCologne Lymphoma Koln The Leukemia Lymphoma Society,CheckRare,Negative
6861,Bcells ChronicLymphocyticLeukemia CLL LupusErythematosus,TU Munchen,Negative
6864,Advances Management CLL Bringing Six February sixteen HemOnc CME CLLsm,Medscape Education,Negative
6867,CLL,Raymond DuBois,Negative
6868,John Pagel Top Tips,Patient Empowerment Network,Negative
6869,two PatientPower,Patient Power,Negative
6870,million CLL,AstraZeneca,Negative
6872,James Gerson,OncLive SOSS,Negative
6874,Elliott CLLSupport CLL,CLLSA,Postive
6876,Acute Lymphoblastic Leukemia Patients Chronic Lymphocytic Leukemia Treated Lenalidomide BloodJournal,BibliotecaHUVH ICS,Negative
6877,Bruton Waldenstrom,Bio Cancer Care,Negative
6880,CLL,Orchard Primary Academy Nursery,Postive
6881,CLL,VJHemOnc,Negative
6882,Crusader Barrientos CLL NorthwellHealth Alumnus YaleIMed WeillCornell WomenInMedicine MedTwitter,Kristine Olson,Negative
6884,Check Comparing,Medivizor,Negative
6889,Check Comparing,Medivizor,Negative
6898,One CLL,Mazyar Shadman MD MPH,Negative
6899,CLL Mark Silverstein CarePartner Nelia,Patient Power,Postive
6900,CLL Current Perspectives Treatment Chronic April six Leusm,SeattleCancerCareAlliance,Negative
6902,OncoAlert CLL,Raul Cordoba MD PhD,Negative
6903,CLL Venetoclax Don MCThompsonMD Check HemOnc,VJHemOnc,Negative
6904,John Allan CLL TargetedOnc,WCM Lymphoma,Postive
6905,One CLL one PeterHillmen CLL,Nicolas Martinez,Postive
6906,Fastest Lancet CLL,Kevin Paul Ferraris,Postive
6907,CLL,Toby Eyre,Postive
6914,Venetoclax CLL Ian Flinn,VJHemOnc,Negative
6916,two thousand CET two Prof Eichhorst Prof Ghia EHA,European Hematology Association,Postive
6917,CLL CllSociety,Mazyar Shadman MD MPH,Negative
6919,rituximab CLL FL al NVAX NVAX,Biotech Jim,Postive
6920,CLL,Nicolas Martinez,Postive
6921,Order CLL today,Breaking Data,Negative
6922,Rhapsody Music Notes,RhapsodyMusicLessons,Negative
6923,CLL Register,BioAscend,Negative
6924,CLL four today,RedMedEd,Negative
6929,CLL,Toby Eyre,Negative
6930,Watch Feb Think You Resilient See Real Resilience,Michele,Negative
6932,CLL CME,PeerView,Postive
6933,next week CLL CancerPatients,Michele,Negative
6934,COVIDVaccine Safety CLL,Michele,Negative
6936,Squirrels EYmatters EAD CLL,Ashbridge Nursery Maxy Farm,Postive
6937,Comparing Medivizor,Paul Wright,Negative
6938,Comparing Medivizor,Lynne Mac Lean,Negative
6939,New Medivizor Comparing Leukemia,Medivizor,Negative
6942,BTK CLL TRAEs Start CLLsm,Medscape Education,Negative
6943,today Copying CLL,Orchard Primary Academy Nursery,Negative
6944,John Allan CLL CC OncLive,WCM Lymphoma,Negative
6946,CLL Randall Davis,Comprehensive Cancer Center UAB,Postive
6947,CLL,Ana Bacelar,Negative
6948,BloodJournal second DOR IMO CLL,chadi nabhan MD MBA FACP,Postive
6949,FDA rituximab biosimilar CLL,Journal NCCN,Negative
6950,MRD CLL webinar Swedish,ACCC,Negative
6952,ASH two thousand and twenty Lots CLL,Toby Eyre,Postive
6953,CLL,RedMedEd,Postive
6956,two Study Zanubrutinib SLL Estimated Primary,ClinicalTrialsData,Negative
6962,Zeal CLL EndCancer MedEd HCCwebinar mmsm realworldevidence,Hematology Cancer Consortium,Postive
6963,James Gerson,OncLive SOSS,Negative
6964,CLL ten NMA five CIT two Amazing,Mazyar Shadman MD MPH,Postive
6965,Willliam Wierda PhD CancerNetwrk,Lisa Palacios,Postive
6966,Man Xing Xie Bing CLL,gannabiTong Xin ,Negative
6967,CLL Man Xing,gannabiTong Xin ,Negative
6969,CLL two thousand and nineteen CLL ninety fifty year,Zusia Dr Jackie Volk,Negative
6971,JCOGO,ASCO Publications,Negative
6976,Earn CME CLL January,myCME,Postive
6977,Learn Evaluating,Medivizor,Negative
6978,Cancer Humor CancerSurvivor CLL,Coping Cancer,Negative
6979,Marc Hoffman CLL,KU Cancer Center,Negative
6980,leukemiaMan Xing,Yi Xue Ying Dan Yu bot,Negative
6982,cll wwierda MDAndersonNews OncLiveSOSS,donnashort,Negative
6983,CLL,RedMedEd,Negative
6984,CLL William Wierda PhD,Lisa Palacios,Negative
6986,NCCN CLL,Amber Koehler,Negative
6987,MRD CLL webinar Swedish,ACCC,Negative
6988,CACHE EYE fifteen EYP fourteen BTEC CPLD six Supporting Emergent Literacy CLL,Early Years LSC FE VocEd EYFS,Negative
6989,CLL,The EY Tagteam,Negative
6990,January Molecular Diagnostics CLL Email,CLLSA,Postive
6991,RedTalk Many CLL CAR,Jordan Gauthier,Postive
6992,three,Dr Comeau MD,Negative
6994,NoxxonPharma Novartis Marche de la leucemie Une NoxxonPharma MedImmune,HAM,Negative
6995,DRG one hundred and seventy two thousand and thirty,DRG Epidemiology,Negative
6996,Drs Verstovsek Neelapu Mechanisms,donnashort,Negative
6997,MDAndersonNews,donnashort,Negative
6998,Don Year Review tonight ET Dr Love Drs MatthewDavids Jennifer Woyach,Research To Practice,Postive
7000,CLL ASH two thousand and,VJHemOnc,Negative
7002,CLL CLLsm Leusm,Memej,Negative
7008,David Ozor five Million Naira Kindly RT Elcrucifixio DONJAZZY,Samuel Olaiya Afolaranmi,Negative
7009,DRG United States two thousand,DRG Epidemiology,Negative
7010,Kerry Rogers MD,Targeted Oncology,Negative
7011,MD Anderson CLL,Michele,Negative
7012,BloodAdvances CLL one,chadi nabhan MD MBA FACP,Negative
7013,Proud Nick Immunotherapy ImmunoOnc CLL,Dr Alan Ramsay,Postive
7014,MRD CLL webinar Swedish,ACCC,Negative
7016,ERA PerMed CLL KjetilTasken ManuelaZucknick,Sigrid Skanland,Negative
7017,CLL Commentary Epigenetic Trajectories Transition,Blood Cancer Discovery,Negative
7018,CLL John Pagel CLLsm,Patient Empowerment Network,Postive
7019,CLL,Blood Journal,Negative
7030,Chemotherapy CLL MAURITIUS,The Indian Pharma,Negative
7031,DRG one hundred and seventy two thousand and thirty DRGinsights NHL,DRG Epidemiology,Negative
7032,ipc covid Young,donnashort,Negative
7034,CLL Learn JADPRO Review Article,APSHO,Negative
7035,CLL,Patient Empowerment Network,Negative
7036,mushy CLL OrchardPrimaryA,Orchard Primary Academy Nursery,Postive
7037,CLL Watch CME today,PeerView,Postive
7038,CLL Kerry Rogers CLL,Patient Power,Postive
7039,Anthony Mato MD Lymphoma Society,CheckRare,Negative
7040,MBL CLL,Influenza News,Negative
7041,David Ozor five Million Naira DONJAZZY,Samuel Olaiya Afolaranmi,Negative
7043,DRG two thousand and NHL,DRG Epidemiology,Negative
7044,James Gerson MD,OncLive SOSS,Negative
7045,BPK Symbasis Sign MOU Develop CLL ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
7046,David Ozor five Million Naira DONJAZZY,Samuel Olaiya Afolaranmi,Negative
7047,Freddie Fantastic CLL,Orchard Primary Academy Nursery,Postive
7049,CLL CME Event today,myCME,Postive
7052,Thousands year Access AML NHL CLL MyelodysplasticSyndrome,Breaking Data,Postive
7053,BTK CLL TRAEs Start CLLsm,Medscape Education,Negative
7054,CLL,CellworksLife,Negative
7055,two Study Zanubrutinib SLL Estimated Primary,ClinicalTrialsData,Negative
7056,Superb Free TheEBMT ISEHSociety CLL AML BigData,Kimmo Porkka,Postive
7057,La ten,Symag BNP Paribas PF,Negative
7059,CLLSociety Official Triage,CLL Society Inc,Negative
7060,CLL,CLL Society Inc,Negative
7068,VaccineStrategy,Anna Deveau,Negative
7069,James Gerson MD PennCancer,OncLive SOSS,Negative
7070,afternoon one Idelalisib,Dr Vicky Forster,Negative
7071,Quickie Tremfya guselkumab MAB MAB one MS two,PharmacyPhunQuiz,Negative
7072,two one two CLL,Seema Ali Bhat,Negative
7074,CLL Sessions John Gribben Tedeschi MCThompsonMD,VJHemOnc,Negative
7083,Blood Advances American Society Hematology,ac,Negative
7085,Begs CLL,Chaitra Ujjani MD,Postive
7087,GEP Niamh Appleby WGS CLL Richters,Genomics Education,Negative
7088,NHL Read MedicalCollege Wisconsin MCL CLL CARTcell,Lymphoma Hub,Negative
7089,Clinical Cancer Research CLL CSO Hans Vliet MD PhD CLL,LAVA Therapeutics,Negative
7090,CLL,Blood Advances,Negative
7093,nnnnntknnnnsla olimpodebe nnnnnnn un la Nnn lasnVB,Asdrubal Perez,Negative
7094,BloodJournal CLL,LYMPHOMA MYELOMA CONNECT,Negative
7095,Bruton,Benlazar Amine,Postive
7096,Brander Targeted Oncology,Targeted Oncology,Negative
7097,James Gerson,OncLive SOSS,Negative
7098,American Society Hematology thirty two thousand and,Shouting people underpants,Negative
7099,Lymphocytic Myeloid Leukemia Cells Steve Martin,jorge gonzalez,Negative
7100,CLL,TessEunkyoung Yoo,Negative
7101,vaccinationCovid CLL Bood,Mazyar Shadman MD MPH,Postive
7102,OncoAlert Vaccinations CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
7103,CLL CLL,Kate Cwynarski,Negative
7104,Haematology James Rozario John Seymour Venetoclax Rituximab Watch,MDBriefCase,Negative
7105,CLL Experts AdamKittai Susan Leclair PhD MRD,Patient Power,Negative
7106,first,NotTheMacAnon,Negative
7108,Health Canada three FDA EMA,Lymphoma Hub,Postive
7109,Library Highlight Reading Construction,APWA,Negative
7110,ONCT,Beck,Negative
7111,CLL first Ibrutinib,Walz Lab,Negative
7112,CLL,CellworksLife,Negative
7113,BTK CLL TRAEs Start CLLsm,Medscape Education,Negative
7114,Ibrutinib CLL Oct,TAP Clinical Trial Network,Negative
7121,Lesen Sie Beitrag Zulassung Leukamie Chemotherapie IQWiG Studie Immuntherapie CLL,JOURNAL ONKOLOGIE,Negative
7123,Targeted Oncology Peer Perspectives,Targeted Oncology,Negative
7125,CLL Clinical Trials Explained,Patient Empowerment Network,Negative
7126,CLL BTK CLL,NatureRevClinOncol,Negative
7127,Health Canada Approves Plus Rituximab Treatment Patients Chronic CLL,Alicia Bell IFBB Pro,Negative
7128,CLLsm,Patient Empowerment Network,Negative
7129,John Gribben Tedeschi MCThompsonMD HemOnc Leusm Leukemia,VJHemOnc,Negative
7130,Research Project Identification Learn,Pine Biotech,Negative
7131,eight,AstraZenecaUS,Negative
7132,Chronic,hematologist,Negative
7133,CLL CLL PatientPower,Patient Power,Negative
7134,William Wierda PhD MD Anderson Cancer Center CLL Lymphoma Anderson Cancer,CheckRare,Negative
7137,today eight AM CST Call EndCancer MedEd CLL,Lisa Palacios,Negative
7145,CLL PatientExperience CLL PatientJournal OxfordHaem,Oxford Centre Haematology,Negative
7146,Canada Jean Lachaine Catherine Beauchemin,Current Oncology,Negative
7147,three CLL,OncLive SOSS,Negative
7148,Blood Advances American Society Hematology,Aloysius Pendergast,Negative
7150,Among Mazyar Shadman UWMedicine FredHutch OncLive,UW Medicine Newsroom,Negative
7153,CLL Treatment Approach,Patient Empowerment Network,Negative
7154,CLL,Anthony Mato,Negative
7155,Blood Advances Anthony Mato,Sigrid Skanland,Negative
7156,OncoAlert CLL American Society Hematology,Raul Cordoba MD PhD,Negative
7157,Digital Advocacy Health Equity CLL Patients,Patient Empowerment Network,Negative
7158,Idelalisib Does Increase Risk Bleeding Patients With,Oncology Publishers Feed,Negative
7159,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
7160,Pearl Immune SLE,Tom Curley MD,Negative
7161,CLL,PeerView,Negative
7163,Don CLL John Gribben Tedeschi MCThompsonMD,VJHemOnc,Negative
7164,Blanca Espinet Anna Puiggros Barcelona Spain Chronic CLL Saphyr ten twelve CLL Cytoscan BNGO BionanoSymposium,Bionano Genomics Inc,Negative
7165,Bu aksam KLL CLL,Fevzi Altuntas,Negative
7166,CLL EHA Scientific Working Group Research Initiative CLL,European Hematology Association,Negative
7167,William Wierda PhD eight MedEd,Lisa Palacios,Postive
7168,CLL three hour MCThompsonMD,VJHemOnc,Negative
7169,CLL,ESMO Eur Oncology,Negative
7175,Nguyen DimHien MSSO UKK,Daniel Bachurski,Postive
7176,CLL,Haematologica,Negative
7177,night CLL,Mazyar Shadman MD MPH,Postive
7178,one Jane CLL two thousand and twelve,Leukaemia Foundation,Negative
7179,VEGF VEGF Dr Steve Martin,jorge gonzalez,Negative
7180,Ibrutinib CLL PriteshMunot KNJobanputra CRST OncoAlert,Cancer Research Statistics Treatment,Negative
7181,one month CME John Burke MD Manuel Santiago MD,Oncology CE,Postive
7182,Super day The Gruffalo woodland bird song CLL,Orchard Primary Academy Nursery,Postive
7183,Jan Burger EndCancer,Lisa Palacios,Negative
7184,Condition Summary Lymphocytic SLL,TrialBulletin,Negative
7185,John Hayslip MD AbbVie Pharmaceuticals MURANO Lymphoma Society,CheckRare,Negative
7186,three minute one US,AstraZenecaUS,Negative
7190,four Gene Mutations three,Trip Database,Negative
7191,FREE EYFS CLL,Jerry Clay English Hub,Postive
7192,Lydia Scarfo TrialUpdate,VJHemOnc,Negative
7193,ChronicLymphocyticLeukemia Learn CLL,NCI Cancer Stats,Negative
7194,Tanya Siddiqi MD,OncLive SOSS,Negative
7195,FDA rituximab biosimilar,Lymphoma Hub,Negative
7199,one hundred CLL CllSociety,Mazyar Shadman MD MPH,Negative
7200,Hairy CLL,Blood Journal,Negative
7201,CLL ImmunoOnc,VJHemOnc,Negative
7202,one month CME John Burke MD Manuel Santiago MD,Vindico Medical Education,Postive
7203,CLL English German Spanish Greek,CLL Advocates Network,Negative
7204,twelve,Lymphoma Papers,Negative
7207,RIP Tres Luxembourg Emile Hemmen LeCNL FICE CLL,Calmus,Negative
7208,GC Follicular,ImmuneGCPapers,Negative
7209,Colorado CLL Dinner Docs Rocky Mountain Cancer Centers Registration first FREE,Patient Power,Negative
7211,FollowFriday CLL,The Match Advocacy,Negative
7213,Follicular,Lymphoma Papers,Negative
7221,BloodJournal CLL,Sussex Haematology,Negative
7222,CLL Congratulations,Ingo Ringshausen,Postive
7223,Lymphocytic Blood American Society Hematology,Michie Lab,Negative
7224,Blood Michael Chowen,Chris Pepper,Postive
7226,akaraburuchinibu CLL,ganpurasu,Negative
7227,The American Journal Forensic Medicine Pathology,American Journal Forensic Medicine Pathology,Negative
7229,two thousand International Workshop Chronic today CLL BioAscend,iwCLL,Negative
7230,Medicare George two thousand Medicare,PAN Foundation,Postive
7232,CLL,ChampionsOncology,Negative
7234,ICYMI Experts Share Advice two thousand two thousand and,Patient Power,Negative
7238,two thousand and twenty Leukemia CLLsm,Mike Thompson MD PhD FASCO,Negative
7239,CLL CLLAdvocates IPPOSI HRCIreland BloodCancerIRL,CLL Ireland,Negative
7240,Latest CLLAdvocates nine CLL,CLL Advocates Network,Postive
7241,Annals Hematology SEHH VHIO CLL,Francesc Bosch,Postive
7242,Zanubrutinib CLL TrialUpdate,VJHemOnc,Negative
7243,Checkpoint Blockade Melanoma Patients With Underlying Chronic Lymphocytic,Melanoma MRV,Negative
7244,LenucciMarcello,Elsevier Biotech,Negative
7245,NCCN Recommends Zanubrutinib Therapy Learn,AJMC,Negative
7246,CLL,StressMarq,Negative
7247,CLL MayoClinic,Blood Cancer Discovery,Negative
7248,CLL John Pagel Swedish CLLsm CLL,Patient Empowerment Network,Postive
7249,Jonathon Cohen MD MS TargetedOnc,Winship Cancer Institute Emory University,Negative
7251,CLL four thousand three hundred,CLLSA,Negative
7253,CLL Jay Blatt Nicole Lamanna PatientPower,Patient Power,Negative
7254,September CLL,BioAscend,Negative
7255,Lymphocytic CLL,Shouting people underpants,Negative
7257,CLL Purchase,Aptitude Health,Negative
7263,kontakt egen,LyLe Foreningen,Postive
7270,CLL ImmunoOnc CTSM TrialUpdate,VJHemOnc,Negative
7271,CARTCellTherapy Size Surpass two thousand,MarketStudyReport,Negative
7272,CLL,Shouting people underpants,Negative
7273,Global Chronic Lymphocytic Leukemia Treatment Market Production Capacity Revenue Forecast,Depp Gaikwad,Negative
7274,Rituximab CLL Hinweis Zusatznutzen Allgemeinzustand Kombination verlangert da Gesamtuberleben Fur Studiendaten,idw Nachrichten,Negative
7275,BTK CLL,MDEdge,Negative
7276,BTK CLL,MDedge Hematology Oncology,Negative
7278,CLL CME,Jen Silverman,Negative
7280,ScienceDirect,Bion,Negative
7282,Neil Kay,Lucien Lab,Postive
7284,CLL,IQWiG,Postive
7285,Rituximab CLL Hinweis Zusatznutzen Allgemeinzustand Kombination verlangert da Gesamtuberleben Fur Studiendaten,IQWiG,Negative
7286,CLL CLL,David Henry,Negative
7288,seventy Days CLL one CLL,Shouting people underpants,Negative
7290,PsoriasisPhase two two CYCC Fadraciclib Chronic CLL one,Aleksandar Starcevic,Negative
7291,one Teach first saglife,Aaron,Negative
7292,two thousand and twenty three mmsm,Targeted Oncology,Postive
7293,Lymphocytic CLL,Blood Cancer Uncensored,Negative
7300,Tanya Siddiqi MD,OncLive SOSS,Negative
7301,three one LGL two three Aggressive LGL Large azurophilic reniform,Aaron Goodman Papa Heme,Negative
7302,Salil Panchal Harsha Asha,Clinical Oncology,Negative
7310,CLL CllSociety,Mazyar Shadman MD MPH,Postive
7311,Annual Focus CLL,Benlazar Amine,Negative
7312,Young Adults Chronic,Oncology Times,Negative
7313,two thousand Nicole Lamanna Jennifer Brown DanaFarber CLL two thousand and twenty PatientPower,Patient Power,Postive
7314,APTO four today two thousand and twentyone year AML CLL six,Joe,Postive
7315,Abreu MM Ko Jewett Gouvea,NK paper,Negative
7318,CLL PracticalNeurol Last paper year,Chinar Osman,Negative
7319,one CLL HemOnc ImmunoOnc,VJHemOnc,Negative
7322,Riabni Lymphoma,OncologyNurseAdvisor,Negative
7324,Check Evaluating,Medivizor,Negative
7332,CLL,MDEdge,Negative
7334,CLL CLL,Coping Cancer,Negative
7335,DART molecule treatment CLL,Benlazar Amine,Negative
7336,CLL,Benlazar Amine,Negative
7338,Idelalisib ROS ADCC Bcells Read CLL,Cancer Immunology Research,Negative
7346,Gene Expression Profiling Predicts Sensitivity,TumImmTxpapers,Negative
7349,LiveStream Package CLL CLL CryptoLiveLeakToken,CryptoLiveLeak,Negative
7352,La un de Dieu Quand avon la chance etre heureux CLL Bon,Carmel La Lumiere,Negative
7353,LenucciMarcello,Elsevier Biotech,Negative
7357,CLL four Tanya Siddiqi HemOnc,VJHemOnc,Negative
7358,CLL,IMPharma News,Negative
7368,CLL,MDedge Hematology Oncology,Negative
7369,Tanya Siddiqi MD,OncLive SOSS,Negative
7371,First Duration Therapy Effective UniCologne,Oncology Times,Negative
7372,ASH two thousand and twenty,Oncology,Negative
7373,ASH two thousand and twenty,Oncology,Negative
7374,CLL ASH two thousand and twentyone PM AM,VJHemOnc,Postive
7375,BCCancer Victoria CLL three month,Shouting people underpants,Negative
7376,New Data Highlights Venetoclax,Oncology Times,Negative
7378,Salil Panchal Harsha Asha,Clinical Oncology,Negative
7380,Young Adults Chronic,Oncology Times,Negative
7383,FDA Riabni Amgen Riabni two thousand and nineteen Lymphoma Wegener Pharma,Mihir,Negative
7384,ASH two thousand and twenty Promising Option Chronic,Oncology,Negative
7385,two thousand and twenty John Allan WeillCornell,VJHemOnc,Negative
7386,CLL,Seema Ali Bhat,Negative
7391,Further,screen name currently taken,Negative
7394,CLL,Victor Lin,Negative
7396,CLL,Blood Journal,Negative
7397,Leukemia Maharaj,Cells MDPI,Negative
7398,Dicamba,GMO Free USA,Negative
7399,CLL Drug Trial Anthony Mato,Michele,Negative
7400,CLL,Michael Hallek,Postive
7404,PubSaludMurcia Clinical European,BVirtual Murciasalud,Negative
7405,Ireland England Scotland Wales COVID CLL,CLL Ireland,Negative
7406,CLL Wiestner,CLL Society Inc,Negative
7408,one,crafti,Postive
7410,CLL ACCME CLL,Health,Negative
7411,CLL StayHome Join PatientPower Quote Tweet,Michele,Negative
7413,CLL myeloid CLL,Blood Advances,Negative
7415,CLL,Tweemol,Negative
7417,first CLL CLLSupport LeukaemiaCareUK,AbbVie UK,Postive
7418,European,Biblioteca CHT,Negative
7419,European Text,BibliotecaHUVH ICS,Negative
7422,CLL MRD CllSociety JanRynne,CLL Ireland,Postive
7423,CLL CLL CLL BTK,CCO Infectious Disease,Negative
7424,Ri Ben hamadaWei Cheng Ren CLL,ganpurasu,Negative
7425,BTK Jacqueline Barrientos ZuckerSoM NorthwellHealth,CCO Infectious Disease,Postive
7426,one Chinese CLL,Shouting people underpants,Postive
7427,Sara Tinsley MURANO CLL one hundred,JADPRO,Negative
7428,CLLsm,Patient Empowerment Network,Negative
7430,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
7431,FDA,Targeted Oncology,Negative
7432,FDA five CLL,MDLinx,Negative
7433,Gleason three PSA PSAD Staging CT Chronic CLL,Felipe de Galiza,Negative
7434,September two thousand CLL,BioAscend,Negative
7435,CLL,Blood Advances,Negative
7436,Monday CLL,Health,Postive
7437,MRD PatientPower,Patient Power,Negative
7438,MPN Myeloma CLL,Marc Braunstein MD PhD FACP,Postive
7439,Norah CLL Download one,AbbVie UK,Postive
7440,three MURANO Haematology,ClinOwl Haematology,Negative
7442,two thousand and twenty Leukemia CLLsm two thousand and twenty CFR thirteen,Mike Thompson MD PhD FASCO,Negative
7445,Obinutuzumab Plus,Oncology,Negative
7446,CDC,Andrew Schorr,Postive
7447,thirtythree CLL,Erick Lansigan,Negative
7448,FCR DFCR CLL Leukemia,Benlazar Amine,Negative
7449,CLL,Seema Ali Bhat,Negative
7450,Researchers National Institutes Health,Report,Negative
7451,First Duration Therapy Effective UniCologne,Oncology Times,Negative
7453,ClevelandClinic,OncLive SOSS,Negative
7454,CLL two thousand and twentyone year JanRynne CllSociety CLLAdvocates,CLL Ireland,Postive
7455,CLL,Toby Eyre,Postive
7456,Twitter two thousand and CLL two thousand,Anthony Mato,Postive
7457,CLL LYLE Det Blodkraeft CLLAdvocates Network Lymphoma Coalition,LyLe Foreningen,Negative
7459,Thor year CLL,AbbVie UK,Postive
7460,Obinutuzumab Ibrutinib Venetoclax Kerry Rogers OhioState,VJHemOnc,Negative
7461,statin,Lymphoma Papers,Negative
7462,Seymour MD BTK,OncLive SOSS,Negative
7463,CLL Jan twelve two thousand and twentyone PM AM EST,VJHemOnc,Negative
7465,CLL four year ago Norah thirty year John CLL,AbbVie UK,Postive
7466,al VR PD AE Interrupt AE Tox Rx VenR PFS CLL,Toby Eyre,Negative
7467,HCCWebinar Speakers Anderson TX Today HemeMalignancies,Nikita Mehra,Postive
7468,CLL MathewsVikram,Nitin Jain,Negative
7469,"ninety minute Webinar ID eight hundred eight thousand, six hundred four thousand, six hundred Passcode eight hundred and thirtytwo thousand five hundred CLL EndCancer MedEd HCCwebinar mmsm",Hematology Cancer Consortium,Postive
7470,Antonella Santoro Elisa Laurenti CLL American Society Hematology,Ingo Ringshausen,Postive
7474,New Medivizor Comparing Leukemia,Medivizor,Negative
7476,CLL,ALynn,Negative
7478,One Year CLL,IMPharma News,Negative
7481,CLLsm,Patient Empowerment Network,Negative
7482,FDA biosimilar rituximab treatment adult,Targeted Oncology,Postive
7484,CovidVaccine DanaFarber CLL Doc CLL,Michele,Negative
7485,statin,Oncology Machine Learning,Negative
7486,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
7487,CLL Richard Furman,WCM Lymphoma,Negative
7488,CLL CLL PatientPower,Patient Power,Postive
7489,FDAOncology Amgen,Home Journal,Negative
7492,Mabtas RA Injection nine billion eight hundred and thirtyseven million six hundred and five thousand seven hundred GenericMedicines Exporter,MCare Exports,Postive
7499,CLL Stories four CLL Nick Norah John Liz CLLSupport LeukaemiaCareUK,AbbVie UK,Postive
7500,CLL,Anju,Negative
7501,one CLL,Magic Whitney PetPro,Negative
7502,FDA two,CURE Magazine,Negative
7503,FDA,Oncology Nursing News,Negative
7504,CLL,Benlazar Amine,Negative
7505,New Data Highlights Venetoclax,Oncology Times,Negative
7506,OncoAlert CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
7507,Dr twenty year CLL Lost Mom one seventeen,Kathleen Casey,Negative
7508,CLL Danielle Roberts WinshipAtEmory CLLsm,Patient Empowerment Network,Postive
7509,CLL Stacey Gray MassEyeAndEar UTSWNews CLL PatientPower,Patient Power,Negative
7510,two CLL,Journal NCCN,Negative
7511,TGTherapeutics CLL John Gribben MD,HemOnc Today,Postive
7512,CLL,Seema Ali Bhat,Negative
7519,Man Xing Xie Bing CLL,ziyoukaibon,Negative
7520,Man Xing Xie Bing CLL,ziyoukaibon,Negative
7522,NEW Research Chronic,Oncology Times,Negative
7524,two journey healthcare provider CLL,JanssenUS,Postive
7526,CLL Network White CLL,Patient Empowerment Network,Negative
7527,Don CLL FREE today CLL Lamanna Brown,Andrew Schorr,Postive
7528,MURANO Venclexta Rituxan,CURE Magazine,Postive
7529,MayoClinic Swedish HopkinsMedicine MRD CLLSociety,ACCC,Postive
7530,VACCINE CLL today UK CLLSupport JanRynne,CLL Ireland,Postive
7531,CLL John Gribben Tedeschi Meghan Thompson Matthew Davids two thousand and twentyone PM AM,VJHemOnc,Negative
7532,CLL John Gribben Tedeschi Meghan Thompson Matthew Davids two thousand and twentyone PM AM,VJHemOnc,Negative
7533,CLL ClinicalTrials,Memej,Negative
7534,CLL Allan WeillCornell ASH two thousand and twenty CLL,Patient Power,Negative
7535,WednesdayWisdom CLL,Health,Negative
7536,The EVOLVE Study Testing Newly Diagnosed Asymptomatic Patients Chronic Lymphocytic Lymphocytic Lymphoma CTSU,Cancer Trials Support Unit,Negative
7539,Lymphoid one Lymphocytic Leukemia Soliman Siveen KS,NK paper,Negative
7541,Allison Winter MD ClevelandClinic,OncLive SOSS,Negative
7542,Young Adults Chronic,Oncology Times,Negative
7543,three John Pagel MD,Oncology Tube,Negative
7546,CLL UK CLL CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
7547,three CLL,Targeted Oncology,Negative
7548,CLL Physician Roberts WinshipAtEmory CLLsm,Patient Empowerment Network,Negative
7555,ASH Highlights ASH Annual Meeting sixteen December two thousand and twenty CLL Lymphome,MEDtalks CH,Negative
7556,Handy LeukaemiaCareUK CLL,CLLSA,Negative
7557,CLL Immunchemotherapie Welche Kombination Nebenwirkungsprofil Wie Die zusammengefasst Leukamie,MedMedia,Negative
7558,two thousand and twentythree,Depp Gaikwad,Postive
7559,Dr Love CLL,Nitin Jain,Postive
7560,Dr Barrientos,donnashort,Negative
7561,Ublituximab Doublet Bests Chemoimmunotherapy Chronic,Oncology Board,Negative
7563,YouTube CLL,Kenneth Garofalo,Negative
7564,CLL AttentionMining,CLL CryptoLiveLeak Token,Negative
7565,CLL PhilippStaber MCThompsonMD,Sigrid Skanland,Negative
7566,MRD CLL Learn DukeCancer Swedish,ACCC,Negative
7567,Young Adults Chronic,Oncology Times,Negative
7568,Nitin Jain MD NitinJainMD CLL,Lisa Palacios,Negative
7569,William Wierda PhD EndCancer,Lisa Palacios,Negative
7570,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Postive
7571,CLL Clinical Trials Explained CLL CLLsm,Patient Empowerment Network,Negative
7572,New AI Learn,HeartcoR Solutions,Negative
7573,CLLsm,Patient Empowerment Network,Negative
7576,Canada Canadian CLL December CLL,Survivor Network CA,Negative
7579,seven IST Join webinar CLL,Hematology Cancer Consortium,Postive
7580,CLL,Kathleen Hoffman,Negative
7582,Imbruvica four year,CURE Magazine,Negative
7584,Israel,Lymphoma Papers,Negative
7585,Yvonne Gomez,PSJA Jefferson TSTEM,Postive
7586,CLL NitinJainMD CLL,Patient Power,Negative
7587,AML SOC,Bubbafox,Postive
7588,Check Evaluating,Medivizor,Negative
7589,Paul Barr TargetedOnc,Wilmot Cancer Institute,Negative
7590,Novel Agents,Timesnest,Negative
7591,Download Kindle Medifocus,Emily Grahamb,Negative
7595,REGISTER CLL Jan twelve two thousand and twentyone PM AM EST,VJHemOnc,Postive
7596,CIT thirty FISH CLL,Pietro Di Ciaccio,Postive
7597,Analysis seven,Psychiatry Intel,Negative
7601,Jan Burger MD PhD American Society Hematology,Home Journal,Negative
7606,"Join SatishShanbhagMD CLL six thousand, six hundred and ten",CCO Education,Postive
7612,CLL Telemedicine Watch CLL John Pagel CLL CLLsm,Patient Empowerment Network,Postive
7614,three year CLL MRD,OncologyNurseAdvisor,Negative
7617,Streamline CLL Watch CLL SureSeq,OGT,Negative
7619,Oral Adherence Hematological Oncology Agents,TrialBulletin,Negative
7621,Checkpoint Blockade Melanoma Patients With Underlying Chronic Lymphocytic,Ingentium Melanoma,Negative
7622,CLL four CLL,Cary Presant,Negative
7623,ASH Annual CLL Myeloma,Patient Power,Negative
7624,three Learn,SpecialtyPTimes,Postive
7625,MRD CLL DukeCancer MayoClinic CLLSociety,ACCC,Negative
7627,CLL,Kathleen Hoffman,Negative
7628,CLL Learn,AbbVie,Negative
7629,New Data Highlights Venetoclax,Oncology Times,Negative
7630,CLL William Wierda PhD EndCancer,Lisa Palacios,Negative
7631,HallekMichael CLL Viktoria Amazing,Hien Nguyen,Postive
7633,Hematologia,Biosimilar Today iMagazine,Negative
7634,NEW Research Chronic,Oncology Times,Negative
7637,BNTX Phase one Pilot,ClinicalTrialsData,Negative
7638,January CLL,CLLSA,Negative
7639,Venetoclax,Lymphoma Papers,Negative
7643,CLL Society Cells Richter Transformation Umbralisib Ublituximab Prognostic Biomarker Testing CLL,CLL Society Inc,Postive
7646,year CLL AML US eleven,AbbVie,Postive
7647,John Gribben MD,MedPage Oncology,Negative
7648,John Allan MD American Society Hematology CLL,Home Journal,Negative
7649,John Burke Manuel Santiago Complete CME,Oncology CE,Postive
7650,anthonymatomd CLL CLLsm,Patient Empowerment Network,Negative
7651,Cancer News Philip Thompson Fauci CLL,Patient Power,Negative
7652,Idelalisib ROS ADCC Bcells Learn CLL,Cancer Immunology Research,Negative
7653,CLL next year,AbbVie US,Negative
7654,CARTCells,Targeted Oncology,Negative
7655,linfocitica pequeno lograria respuesta global sixtytwo luego de serian,investigando,Negative
7656,two DecodingCancer JanRynne CLL CLLSupport,CLL Ireland,Negative
7657,Jacqueline Barrientos Feinstein Institutes Medical Research CLL Watch,Lymphoma Hub,Negative
7658,Roche Venclexta CLL,American Pharma Outsourcing,Negative
7659,CLL CLL,The France Foundation,Negative
7661,CLL Hematology CLL,Massive Bio Inc,Negative
7662,Clinical Relevance Residual Persistent,Calyx,Negative
7663,Daten CLL diese Leitlinie Rezidiv Therapien Von ASHToday,medtoday Germany,Negative
7666,Hamatologen UKKoeln Universitatsmedizin Gottingen HamburgEppendorf CLL MultiplesMyelom HodgkinLymphom,Kompetenznetz Maligne Lymphome,Negative
7667,CLL Review,Medscape Education,Postive
7668,Der nine Tracks AML Schwerpunkt FL CLL Studien zusammengefasst von Machen Sie,medtoday Germany,Negative
7669,Clin Med,IUOPA,Negative
7670,CLL Wierda TRANSCEND CLL four one,LYMPHOMA MYELOMA CONNECT,Negative
7671,LenucciMarcello,Rajeev Singla,Negative
7672,three,IMPharma News,Negative
7673,CLL AML Precision Medicine Combination Therapies,KrisA,Postive
7674,one PhD CLL,Dr Anya Hotinski,Negative
7675,ASHKudos cll lymsm,Lymphoma Hub,Negative
7676,Roche Venclexta CLL two Venclexta Imbruvica Imbruvica,Bionest Partners,Postive
7677,Constantine Tam MD PeterMacCC CLL,Pharmacyclics AbbVie Company,Postive
7678,James MD CLL,Pharmacyclics AbbVie Company,Negative
7679,James MD CLL,Pharmacyclics AbbVie Company,Negative
7680,Check Technical Advance JLB Heitmann Muller Bcell CLL,Journal Leukocyte Biology,Negative
7681,CLL Protecting Leading People During Reopening Government sixteen,APWA,Postive
7682,CLL Important,CLL Society Inc,Negative
7683,Subcutaneous Masses Unusual Manifestation Relapse Case Atypical Chronic,EurekaMag,Negative
7684,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
7685,MRD CLL Learn DukeCancer Swedish,ACCC,Negative
7686,Jay Blatt Nicole Lamanna PatientPower,Patient Power,Postive
7687,CLL UK,CLL Ireland,Negative
7688,today CLL afternoon,Michael Rynne,Postive
7689,CLL JanRynne IPPOSI,CLL Ireland,Negative
7690,REGISTER CLL HemOnc Leusm,VJHemOnc,Negative
7692,CLL John Allan,WCM Lymphoma,Postive
7693,CLL,Nicolas Martinez,Negative
7694,CLL PatientPower,Patient Power,Postive
7695,one CLL,AstraZenecaUS,Postive
7696,NEWS Genetic CLL Ferran Nadeu,HemOnc Today,Negative
7697,one CLL anthonymatomd CLLsm,Patient Empowerment Network,Negative
7698,LundJenny CLL NCI Medicare frailty earlier year,Shakira Grant MBBS,Negative
7699,plasma severely ill,Immunology Infectious Disease News,Negative
7703,Loxo Oncology Lilly Announces,Pharma News,Negative
7704,today CLL today,Patient Power,Postive
7705,RWD IgG CLL,Flatiron Health,Negative
7706,today CLL Scotland Irish JanRynne HSELive,CLL Ireland,Postive
7708,anthonymatoMD CLL CLL Caveats Rec,Kate Cwynarski,Postive
7711,Carla CLL October Carla Head,Blood Cancer UK,Postive
7712,ten billion NHL CLL Roundup two minute,Select Justice,Postive
7713,CLL Scotland The Scottish Medicines Consortium SMC NHSScotland,CLLSA,Postive
7714,Cornishlithium Lepidico CLL,Things Stuff,Negative
7716,Loxo Oncology Lilly Announces,IMPharma News,Negative
7719,LenucciMarcello,Elsevier Biotech,Negative
7721,Imbruvica Two,PharmaShots Incisive news three shot,Negative
7722,two thousand and twentythree,Depp Gaikwad,Postive
7723,BTK,Targeted Oncology,Negative
7724,one CLL,Canadian Stocks Market,Negative
7725,TGTX Phase Study CLL,Tom Silver,Negative
7727,Loxo BTK PharmaScrip,Alaric DeArment,Negative
7729,ICYMI TG Therapeutics,Home Journal,Postive
7730,CLL CLL,AstraZeneca,Postive
7731,CLL MCL Learn,AstraZeneca,Negative
7732,Wonderful CLL,Krishna Komanduri MD FASTCT,Postive
7733,CLL,Lymphoma Hub,Negative
7734,Constantine Tam MD PeterMacCC CLL,Pharmacyclics AbbVie Company,Postive
7735,CLL,Seema Ali Bhat,Negative
7737,New Data Demonstrate Benefit,Company News HQ,Negative
7738,CONGRESS RNA Goal CLL,Lymphoma Hub,Postive
7739,three MURANO genentech Arnon Kater PhD,HemOnc Today,Postive
7740,Venetoclax Rituximab Sustains five Years CLL CancerNetwrk,SSBMT lkhlyljdh`y@,Negative
7741,Loxo Oncology Lilly Announces,Investor News,Negative
7742,Richard Furman CLL,WCM Lymphoma,Postive
7743,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
7744,Venclexta Rituxan five year Rituxan,CURE Magazine,Negative
7745,today CLL CLL,Lili Wang Lab,Negative
7746,Ibrutinib Bruton CLL,MDedge Hematology Oncology,Negative
7747,CLL,Jennifer Crombie MD,Negative
7748,Key CLL Treatment,Patient Empowerment Network,Negative
7749,Young Adults Chronic,Oncology Times,Negative
7751,UBCIMP CLL British Columbia BC Canada American Society Hematology,Paul Winston MD,Postive
7752,CLL today,Anthony Mato,Negative
7754,CLL Watch anthonymatomd CLLsm,Patient Empowerment Network,Negative
7755,three CLL,HCPLive,Negative
7756,Zanubrutinib Intolerant BTKis Today BeiGeneUSA CLL,Mazyar Shadman MD MPH,Negative
7757,twelve CLL IGVH,Deborah Stephens,Postive
7758,CLL NEWS PatientPower Join three CLL WeillCornell NorthwellHealth CLL,Michele,Negative
7760,Two Luckily one CLL AbdelWahablab,Taylor Lab UM,Postive
7761,Stefano Molica five MURANO first one,EmatoInfo,Negative
7762,TGTherapeutics CLL today ASHKudos Gribben Zinzani TGTX,LaVoieHealthScience,Negative
7763,CONGRESS CLL CLL,Lymphoma Hub,Negative
7764,CLL,Taylor Lab UM,Negative
7765,CLL,Pharmacyclics AbbVie Company,Negative
7766,Anthony Important CLL SylvesterCancer,Taylor Lab UM,Postive
7767,Tanya Siddiqi CLL UUtah,Deborah Stephens,Postive
7768,CONGRESS Tanya Siddiqi eighteen TRANSCEND CLL four DOR fifteen MRD CLL,Lymphoma Hub,Negative
7769,LLY Lilly Announces SLL Data ASH,Biotech Tech Stock Focus,Negative
7770,Umbralisib Ublituximab CLL Watch John Gribben,VJHemOnc,Postive
7771,CONGRESS nine PD three three NE Neutropenia CLL,Lymphoma Hub,Negative
7772,CONGRESS TRANSCEND CLL four nineteen CLL ORR CR seventeen CRS NE MTD CLL,Lymphoma Hub,Negative
7773,Gribben TN CLL,TG Therapeutics,Negative
7774,CLL Friday,PeerView,Postive
7775,CLL fifteen twelve NA,Toby Eyre,Postive
7776,CONGRESS three ORR ND CLL AEs CLL,Lymphoma Hub,Negative
7777,William Wierda PhD Transcend CLL four Cohort Lisocabtagene Maraleucel Combination Ibrutinib Lymphocytic,Lisa Palacios,Negative
7778,BTK CLL two LOXO,Chaitra Ujjani MD,Postive
7779,LLY Loxo Oncology Lilly Announces,OTC Dynamics Inc,Negative
7781,Loxo Oncology Lilly Phase BRUIN CLL Learn,Eli Lilly Company,Postive
7782,CONGRESS Phase BRUIN ORR CLL,Lymphoma Hub,Negative
7783,anthonymatomd et al one hundred and seventy CLL three four AF one ORR,Toby Eyre,Negative
7784,LOXO,Bio,Negative
7785,LLY Loxo Oncology Lilly Announces,Stock Titan,Negative
7786,Jennifer Crombie MD JenCrombieMD present SLL,News,Negative
7787,CLL PeterMacCC,Michael Dickinson,Postive
7789,Venetoclax UK CLL,LymphomaAction,Negative
7791,CLL four Cohort Lisocabtagene Maraleucel Combination Ibrutinib Lymphocytic,Lisa Palacios,Negative
7792,Das ASHToday Satellitensymposium mit Meet von Von Uhr gibt Expertendiskussion uber CLL CLL,medtoday Germany,Negative
7793,two thousand and twenty Global Analysis Forecast two thousand Market Research Report,Industry Today,Negative
7794,ABBV,CHItraders,Negative
7795,plasma severely ill,One Health India,Negative
7797,ABBV,Investor News,Negative
7803,von Uhr Daten CLL Schwerpunkt DLBCL Machen Sie MPNsm,medtoday Germany,Negative
7804,Jan morningecfm CLL,CLL Ireland,Negative
7806,AbbVie Imbruvica,Gordon Gekko,Negative
7807,AbbVie Imbruvica ABBV,Investor News,Negative
7808,Imbruvica,Breaking News,Negative
7810,MD Magazine,Cun Jing  Cheng Si ,Negative
7817,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7818,three,The Political Hedge,Negative
7819,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7821,Janssen Reports Imbruvica Leukemia Pharmashot,PharmaShots Incisive news three shot,Negative
7822,CLL,Suvir Singh,Postive
7825,CLL,Robert Albero Gallego,Negative
7826,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7827,three,NwokeAgulu,Negative
7828,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7829,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7830,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7831,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7832,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7833,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7834,BTK CLL Threshold plasma one BTK two fifty Next night,Joe,Negative
7835,CLL,Seema Ali Bhat,Negative
7836,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7837,CLL Monday seven PST Exciting CART RWE Gribben Benjamini Siddiqi,Mazyar Shadman MD MPH,Negative
7838,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7839,CLL Society ASH two thousand and twenty Day Anthony Fauci Koffman,CLL Society Inc,Negative
7840,CLL DukeCancer MayoClinic,ACCC,Postive
7841,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7842,obinutuzumab rx CLL,Ash Alizadeh,Postive
7843,ClevelandClinic,OncLive SOSS,Negative
7844,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7845,Regimen Fixed Duration Treatment Patients Chronic,Investor Press Releases,Negative
7846,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7847,three CLL,HCPLive,Negative
7849,three Biomar Related Tickers ABBV,Quant Data,Negative
7850,three,Company News HQ,Negative
7851,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7852,BeiGene Announces two three Annual,Pharmacutical Daily,Negative
7853,MRD CLL,knowMRD,Negative
7854,Seymour MD BTK BTK,OncLive SOSS,Negative
7855,CLL MRD CLL MM,clonoSEQ,Negative
7856,BGNE BeiGene Announces two three Annual,Biotech Tech Stock Focus,Negative
7857,New Data Demonstrate Benefit,NwokeAgulu,Negative
7858,CLL Check,Ferran Nadeu,Postive
7859,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7860,two three CLL today,JanssenUS,Negative
7861,New Data Demonstrate Benefit,mednetnews,Negative
7862,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7863,New Data Demonstrate Benefit,Stock Market News,Negative
7864,CLL today,Janssen Global,Negative
7865,New Data Demonstrate Benefit,lnshr publisher,Negative
7866,CLLsm,VJHemOnc,Negative
7867,New Data Demonstrate Benefit,IMPharma News,Negative
7868,today CLL CLL,Lili Wang Lab,Postive
7869,three,OTC Dynamics Inc,Negative
7870,BGNE BeiGene Announces two three Annual,OTC Dynamics Inc,Negative
7871,three,Paper News Network,Negative
7872,LucaDezzani CLL ASHTogether,Michele,Postive
7873,three,Stock Market News,Negative
7874,CLL,Jessica Okosun,Postive
7875,Intellasia East Asia News BeiGene Announces two three Annual,PressNewsAgency,Negative
7876,Today CLL,Pharmacyclics AbbVie Company,Negative
7877,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7878,three,Crwe World,Negative
7879,three,Stock Titan,Negative
7880,Dr Lipsky WT CLL,Nitin Jain,Postive
7881,BGNE BeiGene Announces two three Annual,Corporate News,Negative
7882,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7883,BeiGene Announces two three,Crwe World,Negative
7884,BGNE Announces Data two three,Bio,Negative
7885,BeiGene Announces two three Annual,Latest News Business Wire,Negative
7886,BGNE BeiGene Announces two three Annual,Stock Titan,Negative
7887,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7888,Kerry Rogers OhioState Phase Ib Lanalumab plus Ibrutinib OncoAlert,VJHemOnc,Negative
7889,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7890,NEWS Venetoclax JanssenGlobal Pharmacyclics William Wierda PhD,HemOnc Today,Negative
7891,Jim Dean CLL,Pharmacyclics AbbVie Company,Postive
7892,Jim Dean CLL,Pharmacyclics AbbVie Company,Postive
7893,today Prajish Prajish MayoClinic CLL,Lili Wang Lab,Negative
7894,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7895,ASH Roche Venclexta CLL Venclexta Imbruvica CLL ABBV RHHBY pharma CLL,Helix BioPharma,Postive
7896,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7897,Terry CLL,JanssenUS,Negative
7898,Congrats CLL,Anthony Mato,Postive
7899,Today CLL CLL,Lili Wang Lab,Postive
7900,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7901,Day one Lymphocytic CLL obinutuzumab lanalumab MRD,Prescient Healthcare Group,Negative
7902,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7903,CLL,Seema Ali Bhat,Negative
7904,CLL,Seema Ali Bhat,Negative
7905,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7906,five hundred William Wierda PhD MD Session six hundred CLL,Lisa Palacios,Negative
7907,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7908,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7909,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7910,CLL,HARMONY Alliance,Postive
7911,CLL CLL Celebrating,Jessica Okosun,Postive
7912,one CLL,Toby Eyre,Postive
7913,CLL,Raul Cordoba MD PhD,Negative
7914,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7915,CLL Nicole Lamanna,Kate Cwynarski,Postive
7916,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7920,Andrew Roberts Therapeutic lymsm CLL,Raul Cordoba MD PhD,Negative
7921,CLL,lnshr publisher,Negative
7922,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7923,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7924,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7925,Five Years OncLive December five two thousand and twenty,globalfirstnews,Negative
7926,CLL,MasdelMedio,Negative
7927,Regimen Fixed Duration Treatment Patients Chronic,MasdelMedio,Negative
7928,One Year CLL,MasdelMedio,Negative
7930,five Reuters Abbvie Inc,Towelie,Negative
7931,one CLL Zero IMHO,chadi nabhan MD MBA FACP,Negative
7932,CLL,Seema Ali Bhat,Negative
7933,Presents Extended Data For Fixed Duration Treatment Venclextavenclyxto Venetoclax CLL,Biotech Tech Stock Focus,Negative
7934,first CLL Australia,Pietro Di Ciaccio,Negative
7935,CLLsm,VJHemOnc,Negative
7937,CLL,Cindy Pabon MD,Postive
7938,BTK CLL chaligneRonan AnnaEnim WCMLymphoma Columbiacancer six hundred,Andrew Lipsky,Postive
7939,Janssen CLL,Mark Wildgust,Postive
7940,CAPTIVATE CLL ITT MRD PB MRD MRD,Nitin Jain,Negative
7941,CLL,Chaitra Ujjani MD,Postive
7942,CONGRESS Nicole Lamanna ColumbiaMed DukeCancer CLL CLL,Lymphoma Hub,Negative
7943,Today two three,LYMPHOMA MYELOMA CONNECT,Negative
7944,One Year CLL,NwokeAgulu,Negative
7945,Regimen Fixed Duration Treatment Patients Chronic,IMPharma News,Negative
7946,anthonymatomd tablet CLL Richters,Toby Eyre,Negative
7947,Genentech,Pharmacutical Daily,Negative
7948,Regimen Fixed Duration Treatment Patients Chronic,mednetnews,Negative
7949,CLL one PatientPower,Patient Power,Postive
7950,del mut CLL,Benlazar Amine,Negative
7951,CLL,Benlazar Amine,Negative
7952,del mut CLL,Benlazar Amine,Negative
7953,CLL CLL,WCM Lymphoma,Negative
7954,Ibr twelve four uMRD PB BM uMRD IBR MRD CLL,Toby Eyre,Negative
7955,Mabs CIT CLL,Benlazar Amine,Negative
7956,CLL,Toby Eyre,Negative
7957,CLL,Benlazar Amine,Postive
7958,CLL,Chaitra Ujjani MD,Postive
7959,First CLL,Benlazar Amine,Postive
7960,LRF LRFGrantee Jacob Soumerai ASHTogether,Lymphoma Research Foundation,Negative
7961,CLL Venetoclax Today three pm Piers Blombery CLL,Mission Bio,Negative
7962,four Time twenty four CLL,Krish Patel,Postive
7963,Genentech Announces New Data Reinforcing Benefit Combination People With Relapsed Refractory,Corporate News,Negative
7964,Algorithm CLL,Benlazar Amine,Negative
7965,Algorithm CLL,Benlazar Amine,Negative
7967,five Murano Kater nineteen uMRD PD CLL CLL,Krish Patel,Postive
7968,CLL,Eduardo Flavio Oliveira Ribeiro,Postive
7969,four year GCLLSG Dr CLL,Nitin Jain,Postive
7970,CLL,Benlazar Amine,Postive
7971,MURANO twentyfive month MRD reappearance clinical progression gt MRD two MRD Ven twentyfive month CLL,Mazyar Shadman MD MPH,Postive
7972,CLL,Benlazar Amine,Negative
7973,anthonymatomd discus OncoAlert CLL,VJHemOnc,Negative
7974,Changing Landscape CLL,Benlazar Amine,Negative
7975,Chronic,Company News HQ,Negative
7976,CLL,Hottest Stocks Now,Negative
7977,today CLL,chadi nabhan MD MBA FACP,Postive
7978,Genentech,Parent Security,Negative
7979,Genentech,Gregory Evans,Negative
7980,Today CLL,JanssenUS,Negative
7981,Genentech,Crwe World,Negative
7982,Chronic,Crwe World,Negative
7983,CLL,chadi nabhan MD MBA FACP,Negative
7984,CLL,OTC Dynamics Inc,Negative
7985,RHHBY Genentech,OTC Dynamics Inc,Negative
7986,CLL,Lisa Palacios,Negative
7987,RHHBY ROG,Roche,Postive
7988,Genentech,Stock Market News,Negative
7989,Regimen Fixed Duration Treatment Patients Chronic,Stock Market News,Negative
7990,CLL Captivate RR TAP Clarity,Eduardo Flavio Oliveira Ribeiro,Negative
7991,MURANO CLL,chadi nabhan MD MBA FACP,Negative
7992,Issued Press Release December five CLL,Flash Alert,Negative
7993,RHHBY Genentech,Biotech Tech Stock Focus,Negative
7994,Regimen Fixed Duration Treatment Patients Chronic,lnshr publisher,Negative
7995,CLARITY CLL MRD,chadi nabhan MD MBA FACP,Postive
7996,CLL,DrItirDemiriz,Negative
7998,CLL,Lisa Palacios,Negative
7999,CLL ASHKudos,Lisa Palacios,Negative
8000,RHHBY Issued Press Release December five Genentech,Flash Alert,Negative
8001,CLARITY CLL VincentRK,chadi nabhan MD MBA FACP,Postive
8002,Genentech,Latest News Business Wire,Negative
8003,MCL,Toby Eyre,Negative
8004,two,Genentech,Negative
8005,wwierda LeukemiaMDA MRD two OncoAlert OncoAlert CLL,VJHemOnc,Negative
8007,CLL,Stock Titan,Negative
8008,one one CLL,chadi nabhan MD MBA FACP,Postive
8009,two CLL,Pharmacyclics AbbVie Company,Negative
8010,Regimen Fixed Duration Treatment Patients Chronic,NwokeAgulu,Negative
8011,Impressive CLL,chadi nabhan MD MBA FACP,Negative
8012,CLL,chadi nabhan MD MBA FACP,Negative
8013,CAPTIVATE CLL,chadi nabhan MD MBA FACP,Negative
8014,Fraser et al HELIOS Ibrutinib RB CLL five hundred CLL,Alexander Luchinin,Negative
8015,One Year CLL,Stock Titan,Negative
8016,CLL,chadi nabhan MD MBA FACP,Negative
8017,Today PM ET CLL,Janssen Global,Negative
8018,William Wierda PhD Session six hundred CLL,Lisa Palacios,Negative
8019,CLL Drs Barrientos Moreno Mato CllIreland,CLL Society Inc,Postive
8020,CLL,Anthony Mato,Negative
8021,Don Education Session DukeCancer CLL,Duke Hematologic Malignancies Cellular Therapy,Negative
8022,CLL one pm four pm EST Thompson,Patient Power,Negative
8023,CLL,Adam Kittai,Negative
8024,SEQUOIA BTK,BeiGene,Negative
8025,Seymour MD BTK BTK,OncLive SOSS,Negative
8026,Club Success Mantra association Student Activities Leadership SAL Center Aptitude Quiz Competition Register NCU,THE NORTHCAP UNIV,Postive
8027,CLL Toxicity Notable,Toby Eyre,Postive
8028,Lymphoma Learn BeiGene lymsm cllsm,BeiGene,Negative
8029,Kirsten Fischer five Education Book HallekMichael CLL,Toby Eyre,Postive
8030,today CLL CLL CllSociety,Chaitra Ujjani MD,Postive
8040,OncoAlert Approaches CLL Hematology American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
8041,CLL LRoekerMD CllSociety,Anthony Mato,Postive
8042,CLL Algorithms CLL,Anthony Mato,Postive
8043,CLL Algorithm,Anthony Mato,Negative
8044,TGTX TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,Mellalta Meets,Negative
8045,MDAnderson CLL,Mark Wildgust,Negative
8046,CLL Susan Brien John Pagel Ian Flinn CLL,Raj Gauba,Postive
8047,MRD CLL,Tiffany De Sadier,Postive
8048,CLL CLL RocheInnovation,Roche,Negative
8049,Doris CLL,Pharmacyclics AbbVie Company,Postive
8050,CLL,Nicola,Negative
8051,Richard Furman CLL Access,WCM Lymphoma,Negative
8052,CONGRESS Symposia MRD CLL MRD PB Excellent NitinJainMD,Lymphoma Hub,Postive
8053,Chronic Lymphocytic Lymphocytic The American Journal Surgical Pathology,Anju,Negative
8054,past three year CLL,CLL Advocates Network,Negative
8056,ASH CLL MediHumdani BldCancerDoc,sganguly,Negative
8058,Attendees Subscribe Insights Newsletter MedEd CLL,Lisa Palacios,Postive
8059,CLL,Eduardo Flavio Oliveira Ribeiro,Postive
8060,one hundred William Wierda PhD six hundred CLL,Lisa Palacios,Negative
8061,today,BeiGene,Negative
8062,CLL year NovantHealth,Alan Skarbnik,Postive
8063,CLL Nicole Lamanna,Patient Power,Postive
8064,CLL Learn,AbbVie US,Negative
8066,ClevelandClinic,OncLive SOSS,Negative
8067,MEI,MEI Pharma,Negative
8069,CLL Weirda,Hayder Saeed MD,Negative
8070,CLL CLLsm,Patient Empowerment Network,Negative
8071,first first Twitter,Danielle Brander,Postive
8072,CLL AML,AbbVie US,Negative
8073,CLL last decade,Cindy Pabon MD,Negative
8074,one FCR CLL Jeremy Abramson one,Hayder Saeed MD,Negative
8075,Jeremy Abramson CLL,Erick Lansigan,Postive
8076,CLL,PeerView,Postive
8077,CLL,Kathleen Hoffman,Negative
8078,CLL,PeerView,Postive
8080,Today John Gribben CLLSociety Peerivew two thousand and twenty CLL Register CLLSociety CLL,CLL Society Inc,Negative
8083,four CLL,Janssen EMEA,Negative
8085,CLL,CLLSA,Postive
8086,TODAY Join CLL,Medscape Education,Postive
8087,Lamanna BTK CLL,Andrew Lipsky,Postive
8088,CLL Review ASHFromHome,chadi nabhan MD MBA FACP,Negative
8089,CLL,chadi nabhan MD MBA FACP,Negative
8090,ASH CLL daily Saturday PatientPower CLL,Michele,Negative
8091,UK CLL Dr one hundred thousand Genomes Project four hundred CLL WGS CLL,Nick,Negative
8092,CLL CLL,CLL Ireland,Negative
8093,five day SMDH,Stephanie,Negative
8094,CLL DukeCancer MayoClinic,ACCC,Postive
8095,OnlineFirst CLL MayoClinic,Blood Cancer Discovery,Negative
8097,More two hundred Saturday Ask Me Anything ASH Anderson CLL Phil Thompson CLL,Andrew Schorr,Negative
8098,PST Mapping Philip Thompson MB MS,Lisa Palacios,Negative
8099,PST Application Individualized Treatment Novel Agents Combinations William Wierda MD PhD,Lisa Palacios,Negative
8103,PeerView,PeerView,Negative
8104,TG Therapeutics TGTherapeutics,Home Journal,Postive
8106,Education Program Session CLL Sunday,Thomas LeBlanc MD MA MHS FAAHPM,Negative
8107,CLL CllSociety LeukaemiaCareUK,CLL Advocates Network,Postive
8108,New Twitter MCThompsonMD CLL Twitter Twitter CLL,Anthony Mato,Negative
8111,CLL,Deirdre,Negative
8112,CLL SLL,Ilera tv,Negative
8113,Leukemia,Medivizor,Negative
8114,Tomorrow John Gribben CLLSociety Peerivew two thousand and twenty CLL Register Peerview CLLSociety CLL,CLL Society Inc,Negative
8117,Philip Thompson MB MS LeukemiaMDA join CLL EndCancer,Lisa Palacios,Negative
8118,Friday seven AM,PeerView,Negative
8119,Five year ago one four CLL San Bernardino,Gregizona,Negative
8120,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
8121,CME CLL BTKinhibitors CLL CLL,PeerView,Postive
8122,ClevelandClinic,OncLive SOSS,Negative
8123,CME CLL BTKinhibitors CLL CLL,PeerView,Postive
8125,CARTcell CLL,Benlazar Amine,Negative
8126,CLL Anthony Monday PST BTK CLL,Taylor Lab UM,Negative
8127,CLL Watch Pagel CLLsm,Patient Empowerment Network,Postive
8128,TGTX two BTK,InvestorsObserver,Negative
8129,TG Therapeutics Announces Publication two CLL,AlphaBronze,Negative
8130,NFCMonth,AstraZenecaUS,Negative
8131,TGTX TG Therapeutics Announces Publication Phase two,Biotech Tech Stock Focus,Negative
8135,TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,Tina Witte,Negative
8136,TG Therapeutics Announces Publication two,Pharmacutical Daily,Negative
8137,two,Mazeraski,Negative
8138,TGTX TG Therapeutics Announces Publication Phase two,Jodie Insights,Negative
8139,TGTX TG Therapeutics Announces Publication Phase two,OTC Dynamics Inc,Negative
8140,TG Therapeutics Announces Publication two,IMPharma News,Negative
8142,TG Therapeutics Announces Publication two,Stock Market News,Negative
8143,TG Therapeutics Announces Publication two,Crwe World,Negative
8144,TG Therapeutics Announces Publication two,Investor News,Negative
8145,TGTX TG Therapeutics Announces Publication Phase two,Stock Titan,Negative
8147,CLL AML,AbbVie US,Negative
8149,CLL two thousand and twenty CllSociety LLSNatCap,Anthony Mato,Postive
8150,nine DEZ twenty Themen CLL Myelom iNHL aNHL HodgkinLymphom moderiert von Anmeldung,Kompetenznetz Maligne Lymphome,Negative
8151,CLL UK,CLLSA,Negative
8152,ATM CLL Jennifer Brown one four CLL ATM,CLL Society Inc,Negative
8153,Clinical BTK CLL,Anthony Mato,Postive
8155,ClevelandClinic Cleveland Clinic CLL,OncLive SOSS,Negative
8156,TGTX Food amp Drug Administration,MAISA,Postive
8157,umbralisib BCRi intol anthonymatomd two Reasons eighteen AF twelve AE Important Ix CLL,Toby Eyre,Negative
8158,Watch CLL John Pagel CLLsm,Patient Empowerment Network,Negative
8159,Drs Flinn Brien four Friday ASH Meeting Exposition CCO CLL,CCO Education,Negative
8161,Sponsored Medscape,Pharm Exec Magazine,Negative
8162,CLL Treatment Approach,Patient Empowerment Network,Negative
8163,BLA,Targeted Oncology,Negative
8164,CLL HSCT Webinar CLL Saudiblood,Saudi Blood SSBD 'mrD ldm,Negative
8165,TGTX TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,Biotech Tech Stock Focus,Negative
8167,TGTX Initiates Rolling Submission Biologics License Application,Mazeraski,Negative
8168,Top Abstract CLL,Lymphoma Hub,Postive
8169,TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,IMPharma News,Negative
8170,CLL,BSI UK,Postive
8171,TGTX TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,Jodie Insights,Negative
8172,TGTX TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration Leukemia TG Therapeutics,dough,Negative
8173,TGTX Initiates Rolling Submission BLA Ublituximab Combination Umbralisib Treatment Patients Chronic BLA,Bio,Negative
8174,TGTX TG Therapeutics Initiates Rolling Submission Biologics License Application Food Drug Administration,Stock Titan,Negative
8180,German CLL Study Group UniCologne OncoAlert OncoAlert,VJHemOnc,Negative
8182,CLL COVID Access Remote CMOIreland,CLL Ireland,Negative
8184,CLL,cheryta jones,Postive
8185,Covid Vaccines CLL Brian Koffman CllSociety,Shouting people underpants,Postive
8186,CLL CLL,The France Foundation,Negative
8188,BeiGene seven BTK Waldenstrom Hodgkin,BeiGene,Negative
8189,John Burke Manuel Santiago Complete CME,Vindico Medical Education,Postive
8190,CLL Learn LLSusa NFCMonth,AstraZenecaUS,Negative
8191,CLL CLL Bob Susan CLL Watch,Diverse Health Hub,Postive
8192,CLL today Friday December Drs Gribben Tedeschi Thompson,PeerView,Negative
8194,CME CLL BTKinhibitors CLL CLL,PeerView,Postive
8197,del CLL,Lymphoma Hub,Postive
8198,November CLL,CLLSA,Negative
8200,CLL,StressMarq,Negative
8201,Incorporating Shared CLL Care CLL,PRIME Education,Postive
8202,CLL,Kathleen Hoffman,Negative
8203,CLL,CLL Advocates Network,Negative
8204,CLL UKKoeln OncoAlert OncoAlert,VJHemOnc,Negative
8205,CLL six foot,CLL Society Inc,Negative
8206,next week CLL MURANO Fixed Tx,chadi nabhan MD MBA FACP,Postive
8207,CLL Observational two thousand and twenty,chadi nabhan MD MBA FACP,Negative
8208,CLL,chadi nabhan MD MBA FACP,Negative
8209,CLL,Felipe de Galiza,Negative
8210,CLL Pre ASH two thousand and twenty JanRynne MarieKeating IrishCancerSoc,CLL Ireland,Postive
8211,two GIBB,Lymphoma Papers,Negative
8212,NHL CLL,Medscape Oncology,Negative
8213,Australia Drug Deborah Sims CLL Australian CllSociety,CLL Advocates Network,Postive
8214,two thousand and twenty eJHaem Wiley Online,Benlazar Amine,Negative
8215,CLL Australia Australian DonnellyStephen MaryLouMcDonald RoisinShortall,CLL Ireland,Postive
8216,CLL,Patient Power,Negative
8217,Davids,Targeted Oncology,Negative
8218,Leusm Lymsm,VJRegenMed,Negative
8219,Barbara Eichhorst UniklinikUlm Clemens Wendtner von der CLL Daten de prasentieren,medtoday Germany,Negative
8223,CLL Learn CLLAdvocates,HARMONY Alliance,Negative
8225,CLL MayoClinic,chadi nabhan MD MBA FACP,Negative
8226,two GIBB CLL,Benlazar Amine,Negative
8229,CLL December four,PeerView,Negative
8230,CLL John Gribben OncoAlert,VJHemOnc,Negative
8231,BOTH CLL,Chris Cogbill MD,Negative
8232,ErleneSeymour discus kinase BTK BTK,OncLive SOSS,Negative
8233,BloodJournal CLL CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
8234,New Research Method Analysis past twenty year TME,Frontiers Immunology,Negative
8235,CLLSociety Invest CLL two thousand and twenty,CLL Society Inc,Negative
8237,CLL,CLLSA,Negative
8241,two thousand CLL,CLLSA,Postive
8242,CLL,CLLSA,Postive
8243,four hundred CLL,CLLSA,Postive
8244,CLL CLL,CLLSA,Postive
8245,Global Chronic Lymphocytic Leukemia Treatment Market Expected Experience Immense Growth two thousand and twenty two thousand and twentythree,Depp Gaikwad,Negative
8246,Oncology Neil Dr John Pagel Cancer Institute Watch,Research To Practice,Negative
8247,Ibrutinib first CLL Dr Paul Barr five year first Ireland,Michael Rynne,Negative
8248,CLL Ibrutinib Dr Brian Koffman Paul Barr JanRynne,CLL Ireland,Negative
8249,healthcare,Dr Timos Papagatsias,Postive
8250,CLL,Seema Ali Bhat,Negative
8251,FL two Sent,NoShtickJewishChick,Negative
8252,Davids Lymsm,Targeted Oncology,Negative
8253,CLL CLL,The France Foundation,Negative
8256,MURANO CLL rituximab Undetectable MRD,chadi nabhan MD MBA FACP,Negative
8259,Lymphocytic,Mellalta Meets,Negative
8260,Lymphocytic,The Political Hedge,Negative
8261,Lymphocytic,mednetnews,Negative
8262,Lymphocytic,ArthurPotatoeHammer,Negative
8263,Lymphocytic,IMPharma News,Negative
8264,Inhye Ahn MD Perspective Lindsey Roeker MD,HemOnc Today,Negative
8265,BTK Davids,Targeted Oncology,Postive
8266,Fannie Mae Freddie Mac two thousand Read two thousand MA FannieMae FreddieMac CLL,South Shore REALTORS,Negative
8267,ChronicLymphocyticLeukemia CLL Paolo Caimi UHhospitals Brian Hill ClevelandClinic CLL BTK,Patient Power,Postive
8268,Join Drs Gribben Tedeschi Thompson December four PST CLL BTK CME,PeerView,Negative
8269,tomorrow Wednesday CLL,Saudi Blood SSBD 'mrD ldm,Negative
8270,CLL CLL John Pagel CLL,Diverse Health Hub,Postive
8271,one NEGATIVE CLL one,Mike ForThePeople,Negative
8272,UK CLL UK CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
8273,CLL,Journal NCCN,Negative
8274,RCT CLL,Anthony Mato,Negative
8275,New Medivizor Comparing,Medivizor,Negative
8281,Seymour,Targeted Oncology,Negative
8283,Global Chronic Lymphocytic Leukemia Treatment Market Research Report two thousand and twenty two thousand and twentythree,Depp Gaikwad,Negative
8284,Lymphoid,Sanjeev Sethi,Negative
8285,CLL,Kathleen Hoffman,Negative
8286,Week eight,UC Davis CLL,Postive
8287,CLL Daniel Catovsky Matutes,Kate Cwynarski,Postive
8289,CLL Jennifer Woyach CLLsm,Patient Empowerment Network,Negative
8290,CLL Robin Foa CLL,VJHemOnc,Negative
8293,CLL AdamKittai Hematologist Susan Leclair,Andrew Schorr,Postive
8294,Leukemia Hematology Blood Antioxidants OxidativeStress ReactiveOxygenSpecies InfectiousDiseases Infections CLL,Gaman,Negative
8295,CLL Experts ClevelandClinic UHhospitals PatientPower,Patient Power,Negative
8296,BreakingData AML NHL CLL Get RapidImpactReport,Breaking Data,Postive
8298,CLL,Alfredo,Postive
8299,CLL couple day ago BloodJournal CIBERONC,Ferran Nadeu,Negative
8300,French,Lymphoma Papers,Negative
8302,one Matt trap January two thousand and seventeen,Just Jen,Negative
8303,CLL,Naveen Pemmaraju MD,Negative
8304,CLL TOMORROW CLL Susan Leclair AdamKittai Register,Patient Power,Negative
8305,UK,Anthony Mato,Postive
8307,CLL,CLL Ireland,Negative
8309,CLL Dimitar Efremov OncoAlert OncoAlert CLL,VJHemOnc,Negative
8311,NovantHealth BTK,OncLive SOSS,Negative
8316,PubMed Memory,Memory,Negative
8318,CLL CLL seventy day Brian Koffman,CLL Society Inc,Negative
8319,five CLL,Talha Badar,Negative
8320,CADTH Venetoclax Venclexta Obinutuzumab Chronic,CADTH,Negative
8321,Jan Burger PhD CLL EndCancer,Lisa Palacios,Negative
8322,five year OncoAlert OncoAlert CLL,VJHemOnc,Negative
8323,CLLsm,Patient Empowerment Network,Negative
8324,two CLL,Journal NCCN,Negative
8325,Join Drs Gribben Tedeschi Thompson Friday December CLL,PeerView,Negative
8326,CLL anthonymatomd CLLsm,Patient Empowerment Network,Negative
8327,Monday Nov CLL Susan Leclair CLL AdamKittai Register,Patient Power,Negative
8328,CLL CLL,The France Foundation,Negative
8339,William Wierda MD MD Anderson Leukemia CLL,Lisa Palacios,Negative
8340,Chronic Lymphocytic,Kristen Fernandes,Negative
8343,Raghuveer Ranganathan Ranganathan,Lymphoma Research Foundation,Negative
8344,CLL,CancerTherapyAdvisor,Negative
8345,CME,Oncology CE,Postive
8346,CLL John Allan WCMCLymphoma Join,Andrew Schorr,Postive
8347,Jeff Folloder CLL,Patient Power,Postive
8348,CLL Watch CLL John Pagel CLLsm,Patient Empowerment Network,Postive
8349,Bill Wierda CLL,Michael Hallek,Negative
8350,CLL,Kathleen Hoffman,Negative
8351,ESH CLL nine Chairs Jennifer Boston Michael Hallek,ESH Haematology,Negative
8352,eight Clonal Chairs Davide John Seymour Live CLL,ESH Haematology,Negative
8353,BTK,Targeted Oncology,Negative
8354,CLL,Sigrid Skanland,Negative
8355,BTK CLL CME,Medscape Education,Negative
8356,Dr Moles PhD CLL yesterday Elaine Willmore UniofNewcastle Maggie Harnett,Michie Lab,Postive
8357,last Day last three Meet The Expert Sessions Seats Access ESHCONFERENCES,ESH Haematology,Negative
8358,Targeted Oncology Case Based Peer Perspective,Targeted Oncology,Negative
8360,WGS UK Richters BloodJournal CLL DVVavoulis Jenny,Toby Eyre,Negative
8361,CLL Panel,Michael Hallek,Postive
8362,The Mithralog Induces Chronic,Biblioteca HUCA,Negative
8363,Diwali Getting CLL SpeakingandListening EYTagteam,Manisha Patel,Postive
8364,Watch CLL John Pagel CLL,Patient Empowerment Network,Negative
8365,CLL Jennifer Woyach CLLsm,Health Content Collective HCC,Negative
8366,UTSWNews,OncLive SOSS,Negative
8368,seven Efficacy Chairs Barbara Cologne Javid Moslehi,ESH Haematology,Negative
8369,CLL Matthew Davids Peter Dreger Peter Hillmen ESHCONFERENCES,ESH Haematology,Negative
8370,December four CLL Friday ASH Meeting Exposition CCO CLL,CCO Education,Postive
8371,December four,PeerView,Negative
8372,six two CLL Dreger Access,ESH Haematology,Negative
8373,CLL lifestyle Join TOMORROW John Allan Register,Patient Power,Postive
8374,November CLL,CLLSA,Negative
8375,CLL Management two thousand and twenty Webinar November two thousand and twenty GMT Health CLL,Saudi Blood SSBD 'mrD ldm,Postive
8376,Arnon Kater CLL,Michael Hallek,Negative
8377,CLL Hypoxia,Michael Hallek,Negative
8378,five Chairs Silvia Deaglio Adrian Wiestner Live,ESH Haematology,Negative
8379,Article Title Bilateral EdoriumJournals Chroniclymphocyticleukemia Chylothorax Chylouseffusion Article URL,EDORIUM JOURNALS,Negative
8384,Check Evaluating,Medivizor,Negative
8385,The ESH Translational Research CLL Access ESHCONFERENCES,ESH Haematology,Negative
8386,Norwegian,Lymphoma Papers,Negative
8387,Method Analysis,Lymphoma Papers,Negative
8388,CLL Check,Francesca Perutelli,Postive
8389,"Ian Flinn MD CLL six thousand, six hundred and ten",CCO Education,Negative
8390,one month habit five hundred CLL,God Nothing,Negative
8399,today Grand Rounds Presentation,Rush Pharmacy,Postive
8400,David Spaner CLL Chronic Lymphocytic Toronto CLL David Spaner,Shouting people underpants,Postive
8401,CLL Learn CAR,Patient Empowerment Network,Postive
8402,tomorrow Register ESHCONFERENCES,ESH Haematology,Negative
8403,two CLL Watch,JanssenUS,Negative
8404,ESH CLL,Sigrid Skanland,Negative
8405,two CLL Watch,Pharmacyclics AbbVie Company,Negative
8406,WALK Leaders Alexey Danilov Davide Agenda Register ESHCONFERENCES,ESH Haematology,Negative
8407,Lindsey Roeker New York CLL,Michael Hallek,Negative
8408,four Outside Clinical Trials Chair,ESH Haematology,Negative
8409,CLL,Gail Williams,Negative
8410,CLL OncoAlert CLL,VJHemOnc,Negative
8411,LeukaemiaCareUK CLL,CLL Ireland,Postive
8412,Bad News CLL seventy day RNA one hundred and,Billy Bostickson,Negative
8413,CLL CLL,Diverse Health Hub,Postive
8421,John Pagel CLL CLL Watch,Diverse Health Hub,Negative
8422,Lymphocytosis AMPath Molpath CLL,Michael Bayerl MD,Negative
8423,Ireland CLL,Gearoid Crotaigh CareCantWait,Negative
8424,CLL two BTK Leukemia,Michael Hallek,Postive
8425,CLL CLL WVCancer,Patient Power,Negative
8426,three CLL Michael Hallek,ESH Haematology,Negative
8427,RELEASED Salud Hematology CLL,Raul Cordoba MD PhD,Negative
8429,"Lunch Learn SatishShanbhagMD CLL six thousand, six hundred and ten",CCO Education,Negative
8430,WALK Leaders Matthew Davids Tedeschi Agenda Access live Register ESHCONFERENCES,ESH Haematology,Negative
8431,BCR CLL Paolo Kostas Hassan Jumaa Andrew Steele Anthony Mato Oppezzo ESHCONFERENCES,ESH Haematology,Negative
8432,today two thousand and CLL Login GenQA CLL,GenQA Genomics Quality Assessment,Negative
8433,CLL First today,Michael Hallek,Postive
8434,two BCR CLL Paolo,ESH Haematology,Negative
8435,first ESH CLL CLL,ESH Haematology,Negative
8436,England CLL,CLL Ireland,Postive
8437,England CLL,Blood Cancer UK,Negative
8438,one CLL Chairs Brown,ESH Haematology,Negative
8440,CLL CLL,AstraZeneca,Negative
8441,Hellenic Group CLL,CLL Advocates Network,Postive
8442,Wednesday CLL Speakers Dominic Pivonka Rob Coster,CLLSA,Negative
8443,Venetoclax Untreated CLL,Cancer Clinical Trials All,Postive
8444,one one one thousand nine hundred,Philip Brooks,Postive
8445,CLL one one one thousand nine hundred,Philip Brooks,Postive
8446,tomorrow CLL,Michael Hallek,Negative
8447,Brown Ghia HallekMichael tomorrow ESHCONFERENCES,ESH Haematology,Postive
8448,BTK tomorrow Translational Research Conference Chronic,Anthony Mato,Negative
8449,Leukemia,Medivizor,Negative
8451,Applying Data Practice four,Medscape Education,Negative
8453,Buen un Federico Paz YouTube,Gimena do Santos,Negative
8454,four year Watch Wait Time Treatment week Link Bio sll,Living Busy Life With Cancer,Postive
8455,obinutuzumab CLL,Benlazar Amine,Postive
8456,two THE LIVE PROGRAMME REGISTER NOW,ESH Haematology,Negative
8457,Leukaemia Care CLLSupport CLL next month Complete CLL,Leukaemia Care,Negative
8458,Medivizor,Chocolatiere Phys,Negative
8462,Applying Data Practice four,Medscape Education,Negative
8463,two,Targeted Oncology,Negative
8464,Ennio hour,Kirk Kirlin,Negative
8466,Lin et al eJHaem CLLsm,Mike Thompson MD PhD FASCO,Negative
8467,CLL CLL,AstraZeneca,Negative
8468,anthonymatomd detail phase CLL CLLsm,Patient Empowerment Network,Negative
8469,two year forty,Targeted Oncology,Negative
8470,Leukaemia Care CLLSupport CLL next month Complete CLL,Leukaemia Care,Negative
8471,Abtract Hematologia,Biosimilar Today iMagazine,Negative
8472,one UNITY CLL,Toby Eyre,Postive
8473,CLL,Lymphoma Hub,Negative
8474,CLL ChronicLymphocyticLeukaemia Read,European Pharmaceutical Review,Postive
8476,Translational Research CLL Register two thousand and Paolo Ghia HallekMichael,ESH Haematology,Negative
8478,CLL Open CLL SLL,CLLSA,Negative
8483,Mumbai Hematology Group Details webinar,Rajesh Sharma,Negative
8484,Haematologica two thousand and twenty one hundred and five nine Julio Elias Campo,Jose Queizan,Negative
8485,two,Targeted Oncology,Negative
8486,Primary Care Providers tomorrow Guest Expert Facilitator Mark Kristjanson Register,CancerCare Manitoba,Negative
8488,CLL,Patient Empowerment Network,Negative
8489,CLL CLL Richard Furman BTK,Patient Power,Negative
8490,CLL Register today CME December four Drs Gribben Tedeschi Thompson,PeerView,Negative
8491,CLL CME two thousand and twenty Annual four,PeerView,Negative
8492,four CLL BTK,PeerView,Negative
8494,CLL,Patient Empowerment Network,Postive
8497,Recordatorio Algoritmo de Tratamiento Leucemia Linfatica CLL,Hematologia Salamanca,Negative
8498,Recordar el algoritmo de tratamiento de CLL,Hematologia Salamanca,Negative
8499,Marco Gonzalez Jefe de Servicio HematoCAUSA Guias CLL,Hematologia Salamanca,Negative
8500,CLL,Kathleen Hoffman,Negative
8501,today CLL,Sigrid Skanland,Postive
8503,Nitib Capsule Chronic nine billion eight hundred and thirtyseven million six hundred and five thousand seven hundred GenericMedicines Exporter,MCare Exports,Postive
8505,morning four PSE UTW Maths,Ashbridge Nursery Maxy Farm,Negative
8506,UK,CLL Society Inc,Postive
8507,Lin et al eJHaem CLLsm,Mike Thompson MD PhD FASCO,Negative
8508,This eighteen year ago VeteransDay two Vietnam,Matt Phillippi,Negative
8509,CLL ESHaematology,Michael Hallek,Negative
8510,CLL,Lymphoma Hub,Negative
8512,Translational Research CLL Experts Register Chairs,ESH Haematology,Negative
8513,APTO CC CLL one one ASH AML,Joe,Postive
8515,Blood American Society Hematology,Mraz Lab,Postive
8520,NICEComms CLL,CLLSA,Postive
8521,NICE CLL,LYMPHOMA MYELOMA CONNECT,Postive
8522,LLY APTO Announces Details Presentations BTKin CLL MCL NHLs ORAL,Helen Ong,Negative
8523,CLL Tune PatientPower Stacey Gray,Mass Eye Ear,Negative
8524,APTO CLL,Joe,Negative
8525,CLL,Nicolas Martinez,Postive
8526,CLL NICE obinutuzumab CLL,Toby Eyre,Postive
8527,English CLL SLL Venetoclax Ibrutinib obinutuzumab Scotland FCR,Deirdre,Postive
8528,CLL BTK MRD Brian Hill ClevelandClinic Watch Here,Patient Power,Negative
8534,CLL,Michele,Postive
8535,Great News CLL NICE CLLSupport UkCll LymphomaAction CllIreland CllSociety,CLL Advocates Network,Postive
8536,Irish CLL today UK,Michael Rynne,Negative
8537,CLL UK Nice Venetoclax JanRynne IPPOSI,CLL Ireland,Postive
8538,New Epcoritamab Genmab CLL,Lambrechts,Negative
8539,Leukemia Kirkland seventy day one hundred and five day,ChristosArgyropoulos,Postive
8541,Genetic Epigenetic RNA Laia Coll Cancer Epigenetics Group Bistue Functional Cytomics Group,Petriz Lab,Negative
8542,MHG Shifting Treatment Paradigm Management CLL Friday November two thousand and twenty seven nine Canada,Rajesh Sharma,Negative
8543,CLL CLL CLL Visit PatientPower,Patient Power,Negative
8545,kornacki khaki,Jeff Neurman,Negative
8547,CLL Thanks Kerry Rogers,Andrew Schorr,Postive
8548,CLL,Patient Power,Postive
8549,CLL,Christopher Steer,Negative
8550,CLL CLL John Pagel,Diverse Health Hub,Negative
8551,CLL Stacey Gray Register Today,Andrew Schorr,Postive
8552,week Life Goes Link Bio sll,Living Busy Life With Cancer,Negative
8553,Zur Anmeldung Bei Chronischen Lymphatischen Leukamie CLL Anderungen Erstlinientherapie Spannende Diskussion Webinar CLL Medizin Krebs CLL,MedMedia,Negative
8554,Learn CLL CLL,Diverse Health Hub,Negative
8555,Robin Weinick SVP November ten Solving Patient Diversity Problem Registration,DIA,Postive
8556,Great BIOSSFreiburg rituximab CLL,Prof John,Postive
8557,CLL,CLLSA,Negative
8558,Learn Comparing Leukemia,Medivizor,Negative
8559,Man Xing Xie Bing Xie Bing  cllHuan Zhe Jia Zu noHui Dou Bing  Gan Ran Yu Fang,SUMICA,Negative
8560,Zanubrutinib Plus,Oncology,Negative
8561,two thousand and twenty,Current Oncology,Negative
8562,VIDEO Treatment CLL Stevenson OncoAlert OncoAlert,VJHemOnc,Negative
8563,CLL,Kathleen Hoffman,Negative
8564,Congrats Keep CLL AML,Helix BioPharma,Postive
8565,one Covid,Persephone,Negative
8566,CLL Attiah Hossameldin Zoom two,ALLAB PSU,Negative
8569,Barbara Eichhorst OncoAlert CLL,VJHemOnc,Negative
8570,two thousand and,MMIT Network,Negative
8571,BloodJournal Ibrutinib CLL,chadi nabhan MD MBA FACP,Negative
8572,y'ty lywm AML CLL,ltthqyf,Postive
8573,CLL,chadi nabhan MD MBA FACP,Postive
8574,Key CLL Treatment Factors,Patient Empowerment Network,Negative
8575,Giacopelli Brian Global Epigenetics CLL,New OhioLINK ETDs,Negative
8582,GeneReviews,NCBI Bookshelf,Negative
8583,monthly eight pm ET five pm PT CLL CureLeukaemia LeukaemiaAus LLSAdvocacy EPCALM,AnCan,Postive
8584,DanaFarber,OncLive SOSS,Negative
8585,CLL CME December four,PeerView,Negative
8586,Efficacy Ibrutinib CLL,Benlazar Amine,Negative
8588,CLL Nathan Tirey,Heartland Cancer Foundation,Postive
8589,Last week Jessica Marini Oncology Resident Novel,MUSC Pharmacy Residency,Negative
8590,CME,Vindico Medical Education,Postive
8591,CLL AML,AbbVie US,Negative
8592,CLL AML,AbbVie,Negative
8593,The European Society Medical Oncology CLL LymphomaMatters,LymphomaAction,Negative
8594,November CLL UKlockdown,CLLSA,Negative
8596,Pharmacokinetics Venetoclax Patients,CureHuntr,Negative
8597,CLL CLL CllSociety CllSociety,CLL Advocates Network,Postive
8598,CLL HemOnc OncoAlert OncoAlert,VJHemOnc,Negative
8601,Christmas two thousand and twenty quarintena,Face To Face Market,Negative
8602,BTK CME,PeerView,Negative
8603,CLL,Health Content Collective HCC,Postive
8604,Kerry Rogers MD OhioState,HemOnc Today,Negative
8605,ASH,Jordan,Negative
8606,Bo Zhang,Lili Wang Lab,Negative
8607,Wu CLL,Lili Wang Lab,Negative
8608,CLL anthonymatomd et al median four ORR,Toby Eyre,Postive
8610,Hispanic Black Americans Cancer Zusia,Zusia Dr Jackie Volk,Negative
8614,ChronicLymphocyticLeukemia Hill ClevelandClinic CLL,Patient Power,Negative
8615,three CLL ELISA plasma inhibitor activity PIA,Joe,Negative
8617,FCR Binet CLL three,palliativewise,Negative
8622,VIDEO Relapse Catherine Wu DanaFarber OncoAlert,VJHemOnc,Negative
8623,two thousand and twentythree,Depp Gaikwad,Postive
8625,CLL Haematologica,Benlazar Amine,Negative
8626,Robin Weinick SVP November ten Solving Patient Diversity Problem Registration,DIA,Postive
8628,AML CLL PatientPower CureLeukaemia Cancers,AnCan,Postive
8630,Pallasch lab University hospital Cologne MPI Metabolism AKT CLL CLL,Christian Pallasch,Negative
8631,Miami one Chronic,Joe Dowdell,Postive
8632,CLL,CLLSA,Negative
8642,CLL,Kathleen Hoffman,Negative
8643,lymsm CLL CME today,RedMedEd,Postive
8645,WeillCornell ChronicLymphocyticLeukemia Richard Furman PatientPower second CARTCellTherapy CLL,WCM Lymphoma,Negative
8646,biologic drug,Maddy GlobalData Healthcare,Negative
8653,one hundred CLL,Bachar Samra MD,Negative
8654,five CLL Smaller,Toby Eyre,Postive
8655,CLL,Benlazar Amine,Negative
8656,Seymour MD CLL,OncLive SOSS,Negative
8657,New Targeted Agents Treatment Chronic,EurekaMag,Negative
8658,Brander,Targeted Oncology,Negative
8659,three MURANO rituximab CLL Arnon Kater Read CLL,Lymphoma Hub,Negative
8660,today one halloween,Jeff Neurman,Negative
8661,KurtinSandra AM EDT CLL AP,JADPRO,Negative
8662,Join KurtinSandra AM EDT CLL,APSHO,Negative
8666,CLL CLLsm,Patient Empowerment Network,Negative
8667,Farrukh Awan CLL,UTSW Simmons Comprehensive Cancer Center,Postive
8669,CLL Don lymsm,RedMedEd,Negative
8670,Ross Salvaris CLL,Future Oncology,Negative
8671,CLL,BioPharm Insight,Negative
8681,Robin Weinick SVP November ten Solving Patient Diversity Problem Registration,DIA,Postive
8682,Brander,Targeted Oncology,Negative
8683,Join Drs Gribben Jacbos Tedeschi Thompson December four PST CLL BTK,PeerView,Negative
8686,SEHHJoven CLL,Ana Bacelar,Negative
8688,Vitamin CLL CLL JECCR Full,Walaa,Negative
8693,Comparison Bruton CLL,Eduardo Flavio Oliveira Ribeiro,Negative
8694,dysphagia,Lymphoma Papers,Negative
8695,Blood American Society Hematology,Cytof Manchester,Negative
8696,Frontiers Method Analysis,Cytof Manchester,Negative
8699,CLLsm,Patient Empowerment Network,Negative
8700,CLL Begum Alankus Jurgen Ruland Leukemia Lymphoma,JExpMed,Negative
8701,Slab CLL,Concrete Logistics,Negative
8702,Read ShaiIzraeli Myeloma CLL,Public Cord Blood Bank Crete,Negative
8703,day La LEGEND CLL,CHELSEA DAKAR SUPPORTERS CLUB,Negative
8704,CLL October,Lymphoma Hub,Negative
8706,rituximab NonHodgkins,TBRC,Negative
8707,CLL,Kathleen Hoffman,Negative
8708,ARQL PR CLL fifteen APTO ASH one,Joe,Postive
8711,CLL,Blood Journal,Negative
8712,ten minute Jennifer Woyach,Patient Empowerment Network,Postive
8714,PM ET MRD BTK BTK Register,Research To Practice,Negative
8715,September CLL GioraSharf,CML AdvocatesNetwork,Negative
8716,BloodCancer COVID Recent international CLL,CLL Ireland,Negative
8717,CLL PaulMcauliffe Paschald josephamadigan SimonHarrisTD,Michael Rynne,Negative
8718,October AgentOrangeAwareness month two thousand and twelve CLL VietnamVets May,Courtney,Negative
8719,October ChronicLymphocyticLeukemia CLL,Patient Power,Negative
8720,CLL,Patient Empowerment Network,Negative
8721,CLL Watch CLL Pagel,Patient Empowerment Network,Negative
8722,little month Alexey Danilov CLL MedEd,LYMPHOMA MYELOMA CONNECT,Negative
8723,three Neil Love three Register,Research To Practice,Negative
8724,TG Therapeutics CLL,Ozmosi,Negative
8725,CLL Watch,Patient Empowerment Network,Negative
8726,ChronicLymphocyticLeukemia CLL CLL Chris ClevelandClinic,Patient Power,Negative
8727,Venetoclax Ibrutinib Patients Chronic Lymphocytic HOVON Erasmus MC,Kazem Nasserinejad,Postive
8728,Gastrointestinal Involvement,Balkan Medical Journal,Negative
8731,VIDEO Retrospective CLL Lydia Scarfo OncoAlert CLL,VJHemOnc,Negative
8734,two thousand and twenty To two thousand and twentythree,Depp Gaikwad,Postive
8735,CLL monthly Blood American Society Hematology,Talha Badar,Negative
8736,Davids,Targeted Oncology,Negative
8737,CLL,CellworksLife,Negative
8738,CLL MDS,CLL Advocates Network,Negative
8744,CardioOnc mclsm lysm CLL,Jose Sandoval MD FACP,Negative
8745,cll Bob Levis,donnashort,Postive
8746,Medivizor,HHF,Negative
8747,sll five year Dr Bryan,donnashort,Postive
8748,CLL,StressMarq,Negative
8749,CME Learn John Burke MD Manuel Santiago MD,Oncology CE,Negative
8750,Leukemia Acute Myeloid AML Acute Lymphocytic Myeloid Leukemia CML,Jacinto Convit World Organization,Postive
8751,Japanese,Lymphoma Papers,Negative
8758,CLL FCR three year,Dude,Negative
8759,Lymmcare thirteen CLL CLLsm,Yvonne van Batenburg,Negative
8761,FNCE two thousand and twenty FNCE two thousand CLL,Linda Gigliotti,Postive
8762,Katy Rezvani CLL,Patient Power,Negative
8763,ITP ITP Viral CLL,bluestatestuff,Negative
8764,two eighteen twenty one VHR CLL two Homeschool,Jan Rynne,Negative
8765,CLL Register webinar Jennifer Woyach CLLsm Register,Patient Empowerment Network,Negative
8766,CLL NOTCH Transformation Barr WilmotCancer,Patient Power,Negative
8767,one hundred CLL ninety fourteen twentyeight day,Literature Surveillance Team,Negative
8770,one one one John Allan ChronicLymphocyticLeukemia CLL OncLive,WCM Lymphoma,Postive
8771,CLL FluShot,Lauren Evoy Davis,Negative
8772,CLL Register webinar Jennifer Woyach CLLsm,Health Content Collective HCC,Negative
8773,Peggy thirteen year CLL two thousand and eight CLL,CancerCareMBFdn,Negative
8774,one one CLL,Berto,Negative
8775,CLL Tetrahedron unibirmingham OpenAccess,JSF Group,Negative
8776,CLL DNAmethylation Work JGW Patterson Foundation,CLL Epigenetics,Negative
8777,Blood American Society Hematology,Izaskun Zeberio,Negative
8778,ESH Translational Research Chronic,Didi Jasmin,Negative
8780,GC,ImmuneGCPapers,Negative
8781,three Leukemia Richard Furman WeillCornell,Lymphoma Leukemia Myeloma Congress,Negative
8782,Christinekw ZachBreeding CLL FNCE,Mindy Hermann,Postive
8784,BTK,Lymphoma Papers,Negative
8790,CLL CllIreland,Jan Rynne,Negative
8791,today CLL,Jan Rynne,Postive
8792,CLL,Clarence Thomas,Negative
8793,Dap two,Health Life Sci Research Teesside University,Negative
8794,CLL,Kathleen Hoffman,Negative
8795,OncoAlert Prognostic CLL three four two hundred and fifty CLLsm,Raul Cordoba MD PhD,Negative
8797,TGTX Umbralisib Learn,Wainwright Co,Negative
8798,John Seymour Andrew Roberts two thousand and twenty Ramaciotti Medal Excellence Venetoclax CLL,Leukaemia Foundation,Postive
8799,GGAL CLL,oxfe,Negative
8800,CLL American Society Hematology,Benlazar Amine,Negative
8801,APTO Inhibit BTK CLL AML,Joe,Postive
8802,TG Therapeutics FDA CLL regulatoryaffairs,BioPharma Global,Negative
8803,Blood American Society Hematology,Eduardo Flavio Oliveira Ribeiro,Negative
8804,CLL Blood Advances American Society Hematology CLL,Michael,Negative
8805,CLL,Blood Advances,Negative
8806,Sandra Kurtin PhD today CLL,JADPRO,Negative
8807,CLL FightCancer,Michael Hallek,Postive
8808,November two thousand and twenty Chairs Jennifer Michael Hallek ESHCONFERENCES,ESH Haematology,Negative
8809,TG Therapeutics FDA CLL,BioTuesdays,Negative
8810,CLL,AlphaBronze,Negative
8811,Mantle Cell WhatsApp,Shifa Drug,Negative
8812,one CLL two CNE one,RedMedEd,Postive
8813,CLL Barbara Eichhorst KjetilTasken,Sigrid Skanland,Postive
8815,CLL Ireland,CLL Ireland,Negative
8821,ErleneSeymour discus kinase BTK BTK,OncLive SOSS,Negative
8822,CLLSociety John Pagel ASH two thousand and nineteen Sameer Parikh Monoclonal MBL five age forty MBL CLL,CLL Society Inc,Negative
8823,two hour CML AML CLL,Bioevents Sharing Biomed Knowledge,Postive
8826,Zanubrutinib Zanubrutinib FL,Mahmoud Aljurf,Negative
8827,CDC,sandi wear mask save someone anyone,Negative
8828,TGTherapeutics Roche,HemOnc Today,Negative
8829,Novel Agents,The Oncologist,Negative
8830,FDA,Raymond DuBois,Negative
8832,FDA,Targeted Oncology,Negative
8833,Susan Brien CLL,Patient Empowerment Network,Negative
8835,TGTX TG Therapeutics Announces Fast Track Designation Granted FDA Ublituximab TGTX CLL,BiopharmIQ Amp,Negative
8836,CLL,CellworksLife,Negative
8837,one Chronic one Canada month US SaraGideon SenatorCollins,Bill Both,Postive
8839,Only eight hour Leukemia CLL BloodCancer,Larry Updike,Negative
8840,Ross Salvaris CLL,Future Oncology,Negative
8841,CLL BloodJournal Belfast City Hospital CLL Follow,QUB Blood Cancer Research,Negative
8843,TGTX TG Therapeutics Announces Fast Track Designation Granted FDA Ublituximab,Biotech Tech Stock Focus,Negative
8844,Begum Alankus Jurgen Ruland Leukemia Lymphoma,JExpMed,Negative
8845,CLL,Journal NCCN,Negative
8846,TG Therapeutics Reports,Quant Data,Negative
8847,klarer sig tiden KraeftensBekaempelse AML CLL,LyLe Foreningen,Postive
8848,USFDA CLL three,TG Therapeutics,Postive
8850,NASDAQ TGTX Protagonist TG Therapeutics Announces Fast Track Designation Granted FDA Ublituximab Combination Umbralisib Treatment Adult Patients Chronic,Preticks,Negative
8851,TGTX FDA CLL,BondJamesBond,Negative
8852,TGTX TG Therapeutics Announces Fast Track Designation Granted FDA Ublituximab Leukemia TG Therapeutics,dough,Negative
8853,TGTX October,Flash Alert,Negative
8854,TGTX Announces Fast Track Designation Granted FDA Ublituximab Combination Umbralisib Treatment Adult Patients Chronic,Bio,Negative
8855,TGTX TG Therapeutics Announces Fast Track Designation Granted FDA Ublituximab,Stock Titan,Negative
8856,Catherine Geneva PEEK Study Neil Mathews CLL Leukemia LeukemiaOz Peter Hillman LeedsHospitals,Julie McCrossin AM,Negative
8857,Sharon Winton PBS Lymphocytic CLL tonight,Julie McCrossin AM,Postive
8858,MC webinar tonight UK Australian CLL Peter Hillman LeedsHospitals,Julie McCrossin AM,Negative
8862,AML CLL,LyLe Foreningen,Postive
8866,one,hematologist,Negative
8867,CLL Cll,Mazyar Shadman MD MPH,Negative
8868,half Haematologica Journal Foundation Zusia,Zusia Dr Jackie Volk,Negative
8869,chr,Medivizor,Negative
8870,ChronicLymphocyticLeukemia CLL CLL MicheleNadeemB Robin Katz LurieCancer,Patient Power,Postive
8871,Grab Mask one Chronic one Thanksgiving Cancer Research Help,Show Me Nourish,Negative
8872,Leukemia,Medivizor,Negative
8873,Onc,DESIREE CLEGG,Negative
8875,Venetoclax Venex Venclyxto CLL SLL myeloid AML,David Wang,Postive
8876,New Article Alert Chronic Malignanc,Journal American Society Cytopathology,Negative
8877,Shuo Ma MD BTK,OncLive SOSS,Negative
8878,two CML AML CLL,Bioevents Sharing Biomed Knowledge,Postive
8879,CLL,Haematologica,Negative
8891,rituximab VenR CLL,OncologyNurseAdvisor,Negative
8892,CLL Checkout Michele CLL FacebookWatch PatientPower CLL GeneticTesting,Michele,Negative
8894,CLL today,PeerView,Postive
8895,CLL Andreas Agathangelidis OncoAlert OncoAlert CLL,VJHemOnc,Negative
8896,Richard Furman ChronicLymphocyticLeukemia CLL CC PatientPower,WCM Lymphoma,Negative
8898,CLL OncoAlert,Mariana Brandao,Negative
8899,CLL,Annals Oncology,Negative
8900,kun Vaer LyLe,LyLe Foreningen,Postive
8901,next webinar Friday October Samir Agrawal QMUL BartsHospital London Register CLL,CLLSA,Postive
8902,two three Better Than one,EurekaMag,Negative
8903,Matthew Davids MD DanaFarber Ibrutinib Umbralisib CLL CLLsm MCLsm hemeonc,Journal NCCN,Negative
8904,CLL CLL CLL Leslie Powell Robin Katz LurieCancer,Patient Power,Postive
8905,VIDEO Current CLL Lydia Scarfo OncoAlert CLL,VJHemOnc,Negative
8906,Nathan CLL Nathan one,David Cohn MD MBA,Postive
8907,Join Oct ET CLL Nicole Lamanna ColumbiaMed Send Questions,Patient Power,Negative
8908,one Tuesday BP,Coach Bill,Negative
8909,Seymour MD CLL,OncLive SOSS,Negative
8910,CLL,Kathleen Hoffman,Negative
8911,Novel Agents,Oncology Board,Postive
8912,CLL HemOnc OncoAlert OncoAlert CLL,VJHemOnc,Negative
8914,Novel Agents,HAM,Negative
8915,Yi Lu Lin Ba Yan   Lymphoma Luchshii CLL ystkhdm hdh ldw lGdd,World Cancer medicine,Negative
8916,VIDEO CLL Dimitar Efremov HemOnc OncoAlert OncoAlert CLL,VJHemOnc,Negative
8917,Pulmonary,Cardio Medicine,Negative
8918,Tatjana European Research Initiative CLL ERIC International Meeting October twenty CLL Ericllorg,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
8919,Anticancer ER CLL,Journal Cancer Research,Negative
8920,CLL Jan Burger MDAndersonNews OncoAlert OncoAlert CLL,VJHemOnc,Negative
8922,Shuo Ma MD LurieCancer NorthwesternMed Developing,Lurie Cancer Center,Negative
8924,three Haematologica,Mahmoud Aljurf,Negative
8925,Seema MD CLL,OncLive SOSS,Negative
8926,Read NHLBI ClinicalTrial Hematology,NIH NHLBI,Negative
8928,Protein Kinase two,Northumbria University Open Research,Negative
8929,CLL ScienceDaily,Cytiva,Negative
8930,Zanubrutinib CLL,Benlazar Amine,Negative
8931,five eight nine ten fifteen sixteen EYP eight fourteen CLL EYTagteam,Early Years LSC FE VocEd EYFS,Negative
8932,CLL CLL,VJHemOnc,Negative
8934,TBT five year ago Mets WorldSeries one CLL POCUS TimeFlies,Sameer Khanijo,Postive
8935,Seema MD BTK CLL BTK,OncLive SOSS,Negative
8936,Webinar CLL,Patient Empowerment Network,Postive
8937,week Sort Plan Link Bio sll,Living Busy Life With Cancer,Negative
8940,STAIRWAYTOHEAVEN COWANLIEBOWITZ CLL,Cowan Liebowitz,Negative
8941,Annual National Patient Conference Lymphoma CLL LymphomaCanada,AbbVie Canada,Negative
8942,two week ago,isaac,Negative
8944,Save KIM CLL,Concrete Logistics,Negative
8945,cll,Seema Ali Bhat,Negative
8946,John Allan ChronicLymphocyticLeukemia CLL OncLive Peer Exchange,WCM Lymphoma,Negative
8947,zur CLL de CIO Koln Referentin Barbara Eichhorst Oberarztin Klinik,Kompetenznetz Maligne Lymphome,Negative
8948,CLL OncoAlert OncoAlert CLL,VJHemOnc,Negative
8950,Ibrutix Ibrutinib Mantle Cell WhatsApp,Shifa Drug,Negative
8951,MRD CLL MRD CLL MM,clonoSEQ,Negative
8953,CNE CME Gameshow CLL,RedMedEd,Postive
8954,CLL Catherine Wu DanaFarber OncoAlert OncoAlert CLL,VJHemOnc,Negative
8958,CLL,CellworksLife,Negative
8959,Alankus Ruland CLL RANKL CLL,Rockefeller Press,Negative
8960,Begum Alankus Jurgen Ruland CLL RANKL CLL,JExpMed,Negative
8962,Dr Neil John Pagel Cancer Institute Register,Research To Practice,Negative
8963,CLL Ibrutinib,chadi nabhan MD MBA FACP,Postive
8964,Tx CLL Ibrutinib,chadi nabhan MD MBA FACP,Negative
8966,Healthcare Medicare,Lymphoma Papers,Negative
8968,CLL one two hundred and fifty PFS two Reproducible CLL,Toby Eyre,Postive
8969,CLL,Journal NCCN,Negative
8974,CLL Stevenson OncoAlert OncoAlert CLL,VJHemOnc,Negative
8975,Key CLL Treatment Factors,Patient Empowerment Network,Negative
8976,Time Next Treatment Health Care Resource Utilization Veterans,STATinMED Research,Negative
8978,CLL NB eighteen AF Ibrutinib uMRD Blood ASH,Toby Eyre,Negative
8979,Leukemia,Medivizor,Negative
8980,CLL,Kathleen Hoffman,Negative
8981,This month twelve five CLL Discover cll,OGT,Negative
8984,Targeted Oncology Case Based Peer Perspective,Targeted Oncology,Negative
8986,MD Thursday CLL CLL,CCO Education,Postive
8987,first BloodJournal,ASH Clinical News,Negative
8988,Stephan Stilgenbauer Susan Brien CLL,ASH Clinical News,Negative
8989,Three first CLLsm,ASH Clinical News,Negative
8990,first BloodJournal,ASH Clinical News,Negative
8991,seven five year CLL,ASH Clinical News,Postive
8992,CLLsm,ASH Clinical News,Negative
8993,Jeff one CLL Connect,WEGO Health,Postive
8994,Khan Targeted Oncology Case,Targeted Oncology,Negative
8995,CLL Tuesday CLL CLLsm Register,Patient Empowerment Network,Postive
8996,BTK CME today,PeerView,Postive
8997,SCIENTIFIC RATIONALE FOR LOWER DOSE OF,Hematology,Negative
8998,CLL Learn ChronicIllness Healthcare,Ohio Infusion Services,Negative
8999,SOHO State Art Updates Next Questions Clonal Evolution,Lymphoma Papers,Negative
9002,CLL Barbara Eichhorst OncoAlert OncoAlert CLL,VJHemOnc,Negative
9003,Matthew Davids CLL DanaFarber,Mazyar Shadman MD MPH,Negative
9004,Hodgkin CLL UUtah,Deborah Stephens,Postive
9005,CLLSociety Invest CLL Society CLL Society two thousand and twenty,CLL Society Inc,Negative
9006,CLL,Mazyar Shadman MD MPH,Negative
9008,CLL Treating Patients With Chronic Lymphocytic two thousand and twenty,Srujana Joga,Postive
9009,MD,Srujana Joga,Negative
9010,Suggests ABVD Rx Hodgkin CLL Richters,Toby Eyre,Postive
9014,CLL,Anthony Mato,Negative
9015,CLL Robin Foa CLL,VJHemOnc,Negative
9017,CME Learn John Burke MD Manuel Santiago MD,Vindico Medical Education,Negative
9018,Seema MD,OncLive SOSS,Negative
9019,three Study Awesome one,Eduardo Flavio Oliveira Ribeiro,Postive
9023,CLL Saturday October two thousand and twenty CLL Hosted Dr Brian Koffman JanRynne,CLL Ireland,Postive
9024,next week CLL,CLL Ireland,Postive
9026,CLL Cassin Hematological Oncology,Benlazar Amine,Negative
9027,CLL,Journal NCCN,Negative
9030,two,UTSW Simmons Comprehensive Cancer Center,Negative
9031,one ChronicLymphocyticLeukemia CLL Richard Furman MRD PatientPower,WCM Lymphoma,Negative
9033,Langerhans,Dendritic Cell Papers,Negative
9034,CLL Oncology,INDoximity,Negative
9036,CLL MRD CllSociety JanRynne,CLL Ireland,Postive
9039,New Research Genetic CLL,Frontiers Immunology,Negative
9040,cll,Seema Ali Bhat,Negative
9041,one nonhodgkinslymphoma sll,Living Busy Life With Cancer,Negative
9043,fifteen TLS Very Brave CLL,Toby Eyre,Postive
9044,Cancer Rituximab,Cancer Stat Essential News Research Analysis,Negative
9045,CLL,Blood Advances,Negative
9047,CLL CLL Richard Furman WeillCornell,Patient Power,Negative
9048,today CLL CLL,Patient Empowerment Network,Postive
9049,APTO today APTO first CLL AML,Joe,Postive
9050,CLL,Kathleen Hoffman,Negative
9056,week CLL OncoAlert Leusm Leukemia,VJHemOnc,Negative
9057,today CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
9058,Schongewusst Bestimmte Risikofaktoren Therapieerfolg Lebenserwartung von Menschen Leukamie kurz CLL,AbbVie Deutschland,Negative
9059,Versus Chlorambucil Combined With,TrialBulletin,Negative
9060,Zanubrutinib,Lymphoma Papers,Negative
9062,CLL three four Clinical Advances Hematology Oncology Zusia,Zusia Dr Jackie Volk,Negative
9064,CLL three two thousand and Tribune Remember Dear Abby Ever CLL Society Ask Doctors Ask Lab Scientist Ask Pharmacist Ask Hospice Click,CLL Society Inc,Negative
9065,John Allan ChronicLymphocyticLeukemia OncLive Peer Exchange,WCM Lymphoma,Negative
9068,Troll EYFS CLL EYFSAdventures,Manisha Patel,Negative
9069,first CLL CLL Hematologia,Biosimilar Today iMagazine,Negative
9070,Pete Read Pete,JanssenUS,Negative
9071,Ibrutinib,BSH Haematology,Negative
9078,rituximab young CLL CLL,OncLive SOSS,Negative
9079,CLL,Michael Rynne,Postive
9080,CLL,CLL Advocates Network,Negative
9081,cme,PRIME Education,Postive
9082,Zanubrutinib,Blood Advances,Negative
9083,MURANO Trial Venetoclax Plus,The ASCO Post,Negative
9084,CLL,Patient Worthy,Negative
9085,Zanubrutinib CLL Blood Advances lymsm,Benlazar Amine,Negative
9086,obinutuzumab,OncologyNurseAdvisor,Negative
9089,CARTcell NMEDclinical,Nature Medicine,Postive
9090,CLL CLL,Patient Empowerment Network,Postive
9091,CLL several year,Patient Empowerment Network,Negative
9092,CLL,Patient Empowerment Network,Negative
9093,CLL,Patient Empowerment Network,Negative
9094,fifteen minute,Patient Empowerment Network,Negative
9095,Rituximab Riximyo Non,Trip Database,Negative
9096,Susan Brien CLL,Patient Empowerment Network,Negative
9097,CLL CLLsm,Patient Empowerment Network,Negative
9098,ma veterana acaba de cumplir five nosotros Blanca Por ma en el equipo CLL LacasaLitner,Clinica Lacasa Litner,Negative
9099,CLL Pete CureToday,Pharmacyclics AbbVie Company,Postive
9100,Betty journey,JanssenUS,Negative
9103,MURANO Trial Venetoclax Plus,Aloysius Pendergast,Negative
9104,Betty CLL TheMighty,Pharmacyclics AbbVie Company,Postive
9105,CLL Register tomorrow six,Health Content Collective HCC,Negative
9108,This year National Patient Conference Lymphoma CLL Learn LymphomaCanada,AbbVie Canada,Negative
9109,NOTCH Transformation Host CLL Paul Barr WilmotCancer,Patient Power,Negative
9110,CLL SPDP,PedagoCLL,Negative
9111,Project Orbis May two thousand and nineteen EMEA two thousand and nineteen three eight one,David Firn,Postive
9113,two,ClinicalTrialsData,Negative
9119,Vitamin one Vit several year CLL,Michael,Negative
9120,ErleneSeymour BTK,OncLive SOSS,Negative
9122,CLL CLL COVID Corona,PharmAnt,Negative
9124,Acromioclavicular Damage Trichosporon,Quaglee Dragontacos,Negative
9126,CLL,Kathleen Hoffman,Negative
9127,cll,Seema Ali Bhat,Negative
9128,today CLL today,Patient Power,Negative
9129,Town Hall CLL three hundred and one ClevelandClinic UHhospitals CLL FDA,Patient Power,Negative
9130,Town Hall CLL MRD,Patient Power,Negative
9131,CLL Treatments Town Hall CLL CLL Tune Facebook,Patient Power,Negative
9132,Ulrich EHA EU next week HemOnc OncoAlert,VJHemOnc,Postive
9133,The ERIC CLL Database HemOnc OncoAlert,VJHemOnc,Negative
9134,CLL,Michael Hallek,Negative
9135,US CLL,VJHemOnc,Negative
9136,OncoAlert CLL,VJHemOnc,Postive
9137,Second,VJHemOnc,Negative
9138,nine pm ET ClevelandClinic CLL Register Now,Patient Power,Negative
9139,CME,Jen Silverman,Negative
9140,HallekMichael John Seymour Florence Cymbalista George Follows Alessandra Tedeschi Jennifer Woyach,VJHemOnc,Negative
9141,Global Chronic Lymphocytic Leukemia Treatment Market Recent Trends Growth Opportunities Forecast By Application two thousand and twentythree,Depp Gaikwad,Postive
9146,Gaidano CLL,Benlazar Amine,Negative
9147,CLL,Benlazar Amine,Negative
9149,Acala CLL,Benlazar Amine,Negative
9150,Acala CLL,Benlazar Amine,Negative
9151,CLL,Benlazar Amine,Postive
9152,IR FCR CLL,Benlazar Amine,Postive
9153,CLL,Benlazar Amine,Negative
9154,CLL today,CLL Advocates Network,Negative
9155,CLL today PatientPower,CLL Ireland,Postive
9156,twelve ET Join ClevelandClinic UHhospitals Register CLL,Michele,Negative
9158,obinutuzumab CLL,Hematology Advisor,Negative
9159,ClevelandClinic UHhospitals tomorrow CLL,Andrew Schorr,Negative
9160,Dave Memoriam CLL ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9161,one uMRD EOT two year ClinicalTrials CLL,Nicolas Martinez,Negative
9162,CLL,AJMC,Negative
9163,CLL Paul Barr WilmotCancer,Patient Power,Postive
9164,Friday October sixteen Saturday October Annual This year CLL FREE,Lymphoma Canada,Postive
9165,EXCEPT,committee,Negative
9166,one Ibrutinib CLL,God Nothing,Negative
9167,Leukemia,Annette Hay,Postive
9168,CERTHellas HemOnc OncoAlert,VJHemOnc,Postive
9169,CLL,VJHemOnc,Postive
9170,Chronic,Cure Cancer,Negative
9171,one Chronic,Steve Krasinski,Negative
9172,Hematology Lablogatory CLL,ASCP,Negative
9173,CLL Jan Burger MDAndersonNews Watch OncoAlert,VJHemOnc,Negative
9174,HemOnc OncoAlert CLL,VJHemOnc,Postive
9177,CLL Check,VJHemOnc,Negative
9178,Sportskred CLLlacrosse Sportskred CLL Lacrosse NewPartnership Sportskred,Sportskred,Postive
9179,Day two Stephan Stilgenbauer,VJHemOnc,Negative
9180,End week Drs Neil William Wierda MD Anderson Register,Research To Practice,Postive
9184,Lymphoid Leukemia CLL Sarka Pospisilova Jitka Malcikova Ericllorg WomenInScience,CEITEC Connect,Negative
9186,OncLiveSOSS,Seema Ali Bhat,Negative
9187,Idelalisib EBMT,Oncology Publishers Feed,Negative
9189,Cowan Liebowitz Latman Alumna Shira Appointed Register Copyrights,Cowan Liebowitz,Negative
9190,tonight eight pm Eastern Info Moderated Tom Henry AML MultipleMyeloma CLL,AnCan,Postive
9191,Kater al JCO Updated CI MRD CLL Little ORR one hundred VEN,Toby Eyre,Postive
9193,Susan Brien CLL CLLtreatment,Patient Empowerment Network,Negative
9197,Panagiotis Baliakas CHIP second myeloid OncoAlert CLL,VJHemOnc,Negative
9198,RichterTransformation HemOnc CLL,VJHemOnc,Negative
9199,Canadian Lacrosse League Sportskred CLL,Javier,Postive
9200,Catherine Wu DanaFarber OncoAlert CLL,VJHemOnc,Negative
9201,Robin Foa SapienzaRoma CLL OncoAlert,VJHemOnc,Negative
9202,CLL,Journal NCCN,Negative
9203,Andrew Rawstron LeedsHospitals CLL OncoAlert CLL,VJHemOnc,Negative
9204,MBL CLL Lydia Scarfo OncoAlert CLL,VJHemOnc,Negative
9205,Catch OncoAlert CLL,VJHemOnc,Negative
9206,Freda Stevenson CLL OncoAlert CLL,VJHemOnc,Negative
9207,Paolo Ghia Catch OncoAlert CLL,VJHemOnc,Negative
9208,CLL,Kate Freeman,Negative
9209,two Supporting CLL,Kate Freeman,Postive
9210,Leukemia Soniya,Soniya Singh,Negative
9212,Leukemia,Medivizor,Negative
9213,Hill,Targeted Oncology,Negative
9214,three,ClinOwl Haematology,Negative
9215,Nathan Tirey one American CLL,The James,Negative
9216,CLL,Tina,Negative
9217,eight RS CLL,Benlazar Amine,Negative
9218,three,Miriam Lopez Perez,Negative
9219,ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9220,three,Juan Marquet,Negative
9222,three,ALI ALAHMARI,Negative
9223,Blood Advances American Society Hematology CLL,Benlazar Amine,Negative
9224,NEW STANDING DATE Bones Virtual Support Group one pm Eastern AML CLL LeukaemiaAus,AnCan,Postive
9225,SLL CLL,Cancer Support Community,Negative
9226,second,OpenSourcePPEMakers,Negative
9227,TheWistar,Medical Xpress,Negative
9229,ERIC two thousand and Virtual Meeting start Stay CLL OncoAlert Leusm Leukemia,VJHemOnc,Negative
9230,BloodCancerAwarenessMonth CLL Healthgrades,Ankur Parikh,Negative
9231,three,ClinOwl,Negative
9235,Jose Sandoval Sus MD,Targeted Oncology,Negative
9236,three,JAVIER DE LA SERNA,Negative
9237,CML AML CLL,Bioevents Sharing Biomed Knowledge,Postive
9238,Latest CLL Research,Garrey Faller,Negative
9239,VenR v BR CLL Venetoclax Plus Rituximab three,Benlazar Amine,Postive
9240,Noah Ark CLL ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9241,three,filippo masini,Negative
9242,CLL Michele Nadeem Talks Ibrutinib FacebookWatch CLL Ibrutinib,Michele,Negative
9243,Susan Brien CLL,Patient Empowerment Network,Negative
9244,first Fashion Law Institute year Friday September cll,Cowan Liebowitz,Postive
9245,CLL three,Journal NCCN,Negative
9246,two thousand and twentythree,Depp Gaikwad,Negative
9247,CLL,CellworksLife,Negative
9255,Only day ERIC two thousand and twenty Virtual Meeting OncoAlert CLL,VJHemOnc,Negative
9256,three,INDoximity,Negative
9257,two,INDoximity,Negative
9258,ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9259,next Tuesday six CLL Register CLL CLLsm,Patient Empowerment Network,Negative
9260,Susan Brien CLL,Patient Empowerment Network,Postive
9261,CLL CLL,Riverside Healthcare,Negative
9262,CME CLL,RedMedEd,Negative
9263,two thousand and twenty CLL GenQA ERIC,GenQA Genomics Quality Assessment,Negative
9264,Second CLL,NIHR BTRU Stem Cells,Postive
9267,Learn Chronic Bhargava Director,Fortis Healthcare,Negative
9268,HemaSphere,Benlazar Amine,Negative
9270,two thousand and twentythree,Depp Gaikwad,Negative
9271,four day OncoAlert CLL,VJHemOnc,Negative
9273,CLL,Kathleen Hoffman,Negative
9274,This day nine year ago Jan CLL three sick year UK Thankfully today today,Michael Rynne,Negative
9275,tomorrow CLL Click OncoAlert Leusm Leukemia,VJHemOnc,Negative
9277,ThanksCoach CLL CoquitlamReds one,MammaMarcus,Postive
9278,seven Myths About Chronic,Mary Rack,Negative
9279,Hill,Targeted Oncology,Negative
9282,Chornobyl Experimental,Yuval Avnir,Negative
9289,cll,Arthur,Negative
9290,Classic Chemoimmunotherapy Chronic Lymphocytic,SAGE Clinical Med,Negative
9291,Juravinski Cancer CLL CLL Canada Secure,Education,Negative
9292,Tuesday September PM ET two CLL,Pharmacyclics AbbVie Company,Negative
9293,Leukemia ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9294,CLL AML NHL,HEORO,Postive
9295,George Watch George,PAN Foundation,Postive
9296,CLL CLLsm,Patient Empowerment Network,Negative
9297,Zhong Da Zhu Su noCLLtsute,karupatsuchiyo,Negative
9298,Dual Inhibitor,Oncology Times,Negative
9299,CLL MRD MRD CLL MM,clonoSEQ,Negative
9300,Tuesday September PM ET two CLL,JanssenUS,Negative
9301,The Hawaii Society Clinical Oncology three couple hour,Oncology State Societies ACCC,Postive
9302,CLL David Macdonald OttawaHospital Jonathan Stevens SJRHFoundation,RIOH,Postive
9303,CLL October two thousand and twenty Registration CLL,Toby Eyre,Postive
9304,Quality Life Hematologia,Biosimilar Today iMagazine,Negative
9305,Arnon Kater CLL OncoAlert,VJHemOnc,Negative
9309,CLL AML NHL,HEORO,Postive
9311,Oxidative CLL,MDedge Hematology Oncology,Negative
9312,webinar CLL Laurie Sehn CLL,IMPACT Medicom,Negative
9313,MayoClinic,Mayo Clinic Fellowship,Negative
9314,ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
9315,OncoTracker BCMA MultipleMyeloma CLL HaemOnc,DDNews Online,Negative
9317,CLLsm BCAM,Patient Empowerment Network,Negative
9318,Don,Cowan Liebowitz,Negative
9319,two three,OncologyNurseAdvisor,Negative
9320,CLL,Journal NCCN,Negative
9322,ERIC two thousand and twenty Virtual Meeting CLL OncoAlert,VJHemOnc,Negative
9323,libertano e compromiso de one hundred primaria cll huarazperu Huaraz,Antony Cuper,Negative
9325,BloodCancerAwareness Month UCI Health Susan Brien,UCI Health,Negative
9326,undiacomohoy degustacion CLL,Vivian Malachwskyj,Negative
9327,Congratulations Clive Zent BloodJournal ChronicLymphocyticLeukemia CLL,Wilmot Cancer Institute,Postive
9330,Mark Read ChronicLymphocyticLeukemia LymphomaCanada CLL BloodcancerAwarenessMonth,AbbVie Canada,Negative
9331,Every three minute US BloodCancer Learn AML CLL,Patient Empowerment Network,Postive
9332,ErleneSeymour BTK,OncLive SOSS,Negative
9333,three BloodCancers MEI FollicularLymphoma,MEI Pharma,Negative
9334,Implications Patients CLL tomorrow CLL CCO CLL,CCO Education,Postive
9335,TODAY Join Drs Neil Click Zoom,Research To Practice,Postive
9337,Collega Denise Carolien van Carolien Lees CLL bloodcancerawarenessmonth,Janssen Nederland,Negative
9339,Alessandra Ferrajoli CLL OncoAlert Leukemia Leusm OncoAlert,VJHemOnc,Negative
9340,CLL Don REGISTRATION DEADLINE September twenty Click OncoAlert Leusm Leukemia,VJHemOnc,Negative
9344,CLL,Kathleen Hoffman,Negative
9345,one,Paul Hampel,Postive
9346,CLL Healthgrades,Cancer Treatment Centers America CTCA,Negative
9347,CLL,CellworksLife,Negative
9348,cll,Bell Mig,Negative
9349,cll,Bell Mig,Negative
9350,two thousand,Ryan Smith,Postive
9351,CLL,NACE CME,Negative
9353,CLL SLL Imbruvica Venclexta CLL,CONQUER patient voice,Negative
9359,Aged Monoclonal Antibody Encephalitis Patients Chronic,Quaglee Dragontacos,Negative
9360,Blood Advances American Society Hematology,Sameer Parikh,Negative
9362,September BloodCancerAwarenessMonth Hawaii Society Clinical Oncology UNMC Friday,Oncology State Societies ACCC,Postive
9363,tomorrow Imbruvica Register,SPA,Postive
9364,rituximab BR,OncologyNurseAdvisor,Negative
9365,Janssen Pharmacyclics CLL,dtw Research Inc,Negative
9366,two thousand and eighteen United States,Zusia Dr Jackie Volk,Negative
9367,obinutuzumab CLL,Journal NCCN,Negative
9368,CELG Phase three,ClinicalTrialsData,Negative
9369,Saturday November ChronicLymphocyticLeukemia,Michele,Negative
9370,CLL CLL WeillCornell PatientPower,Patient Power,Negative
9372,Phillip Thompson CLL CLL CLLsm,Patient Empowerment Network,Negative
9374,John CLL twenty year ago OurExpresssions,Syros Pharma,Negative
9375,Sorigue two thousand and Cytometry Part Clinical Cytometry,gilbert faure,Postive
9376,Janssen Research first one,Beacon Targeted Therapies,Negative
9377,CLL CLL,Dyslexior Jaime Mejia MD APCP,Postive
9379,BloodCancer,Coping Cancer,Negative
9382,BroadResearchRoundup New CLL,Broad Institute,Negative
9384,Partner Schools two next week SSP CLL CLL,Jerry Clay English Hub,Postive
9385,two thousand and twenty,filippo masini,Negative
9387,Blood Advances American Society Hematology,Krishan Maggon,Negative
9388,APRIL Chronic,Turkish Journal Medical Sciences,Negative
9389,CLL,Bell Mig,Negative
9390,one plerixafor rituximab,Lymphoma Papers,Negative
9395,CLL BloodJournal,chadi nabhan MD MBA FACP,Negative
9396,two week CLL Treatments Town Hall CLL ClevelandClinic UHhospitals Learn Register,Patient Power,Negative
9398,Isurus Oxyrhincus,Adam Curtis Bot,Negative
9399,Turmeric Natural Prevention Treatment Chronic,The Curable Recipes,Negative
9400,Wildflower Biopharma first Efficacy,Thomas Roy Webb,Postive
9401,CLL Bruton,HEORO,Negative
9403,CLL,Journal NCCN,Negative
9404,PeerView BTK CLL BTK,PeerView,Negative
9405,PeerView BTK CLL BTK,PeerView,Negative
9406,Blood Advances American Society Hematology,ALI ALAHMARI,Negative
9407,Drs Myung Sun Kim US FDA Bruton Potential,ACS Journal Cancer,Postive
9408,cll,Bell Mig,Negative
9409,CLL,Bell Mig,Negative
9410,CLL,Bell Mig,Negative
9422,Lymphoma Leukemia Hematology Oncology,Hematology Advisor,Negative
9423,CLL Bruton,HEORO,Negative
9424,Imbruvica earlier last month Imbruvica,SPA,Negative
9425,Learn Comparing Leukemia,Medivizor,Negative
9426,CLL Drs Carolina Miguel Pavlovsky Fundaleu Buenos Aires Latin America Excellent,Michael Hallek,Postive
9427,AlphaTherapy OranoMed NordicNanovector CLL,Savepig Invest GotSilver,Negative
9429,Only two week CLL two thousand and Virtual Meeting HemOnc OncoAlert,VJHemOnc,Negative
9430,BTK five thousand four hundred six hundred,OncoKB,Negative
9432,nineteen US CLL Visit CancerdotNet,Sumanta Pal,Negative
9433,CLL,StressMarq,Negative
9434,CLL,Bell Mig,Negative
9435,CLL,Bell Mig,Negative
9436,Zatta CLL RutgersCancer TeleMedicine two thousand and nineteen,Andy Evens,Negative
9437,CllSociety CLL COVID,Mark Wildgust,Negative
9438,CLLsm,Patient Empowerment Network,Negative
9439,Jeffrey Zatta RutgersCancer Andrew Evens Community Medical Center Chirag Shah,RutgersCancerInstNJ,Negative
9441,two Register CLL OncoAlert Leusm Leukemia,VJHemOnc,Negative
9442,Ivanova Saint Petersburg,XIV Raisa Gorbacheva Memorial Meeting,Negative
9447,Chronic CLL MCL Marginal MZL Waldenstrom,worldwide medicine,Negative
9449,Chronic CLL MCL Marginal MZL Waldenstrom,KOLKATA RAVI SPECIALITIES PHARMA,Negative
9451,Oncology Nurses tomorrow CLL ONSBridge,CEC Oncology,Negative
9452,DanaFarber Cathy Wu Congrats,Rizwan Romee,Postive
9453,Leukemia CLL Hematology,Hematology Advisor,Negative
9454,CLL KharchenkoLab,Satyen Gohil,Negative
9456,CLL,Kathleen Hoffman,Negative
9457,CLL David Porter PennCancer OncoAlert ImmunoOnc Leukemia Leusm,VJHemOnc,Negative
9458,Party,Jeff Neurman,Negative
9459,Tuesday CLLsm,Patient Empowerment Network,Negative
9460,today one pm Northwestern LCSW LesliePowell NorthwesternMedical CLL,Michele,Negative
9461,Acute Lymphoblastic Leukemia ALL Acute AML CLL MLS,Laboratory Career,Postive
9462,Robin Katz LurieCancer NorthwesternMed Register PatientPower CLL,Lurie Cancer Center,Postive
9463,Tuesday CLLsm BCAM CancelBloodCancer,Patient Empowerment Network,Negative
9464,Friday CLL,Lymphoma Hub,Negative
9466,Earlier year CLL CLL,Lisa Dawley PhD,Negative
9468,CLL Deborah Sims Australia CLL Deborah BLLPHD CllSociety,CLL Ireland,Postive
9469,Brian Koffman CLL AbbVieUS,CLL Society Inc,Postive
9470,Rituximab Ruxience CLL Rheumatoid Arthritis,Trip Database,Negative
9471,HEMATOLOGIA Scarfo ERIC European Research Initiative CLL two thousand and,MUVBBvirtual,Negative
9472,BloodCancerAwareness Month UCI Health Susan Brien,UCI Health,Negative
9473,Register Our Upcoming CLL Webinar How Can You Access Latest,Patient Empowerment Network,Negative
9475,tomorrow eight CST MedEd CLL,MD Anderson Leukemia,Negative
9476,AML Myeloma Lymphoma CLL MPN,sohoitaly,Postive
9477,One CLL Barr WilmotCancer,Patient Power,Postive
9478,Brewery Industry Insight Different Parties Breweries,Cowan Liebowitz,Negative
9479,CLL TOMORROW Robin Katz LurieCancer Register,Patient Power,Postive
9481,bendamustine rituximab alternative CLL,CancerTherapyAdvisor,Negative
9488,CLL,Lauren Evoy Davis,Negative
9489,This World Lymphoma Awareness Day CLL,CLL Advocates Network,Postive
9490,Sept World Lymphoma Awareness Day World CLL CllIreland,Nick,Postive
9491,CLL,Hematology Advisor,Negative
9492,Liverpool UK,Katie Griffee,Postive
9493,Today EYFS,Norman Pannell Reception,Postive
9494,First Years Ed Spuzello ChronicLymphocyticLeukemia one thousand nine hundred Ed Ed,Patient Power,Postive
9495,APTO CLL,Joe,Negative
9496,nineteen September KSA Time SSBMT Webinar Chronic Leukemia Arnon Kater University Amsterdam John Gribben Cancer Institute SaudiHematology,SSBMT lkhlyljdh`y@,Negative
9498,MRD CLL NeoGenomics CLL MRD CLL,NeoGenomics,Negative
9500,CLL,PeerView,Postive
9501,several decade CLL UkCll abrimvarghese IMBRUVICAUSHCP,Sunitha Daniel,Negative
9502,CLL,limbic,Negative
9503,CLL Society Virtual Patient Educational John Clinical Trials Well CLL FIRST,CLL Society Inc,Postive
9504,Venetoclax obinutuzumab v chlorambucil CLL three uMRD,Michael Hallek,Negative
9505,obintuzumab v PFS CK MRD four one CLL,Toby Eyre,Negative
9506,WhatsApp,osicent,Negative
9507,CLL,Kathleen Hoffman,Negative
9510,The American Cancer Society Cancer Action Network Hope Home Bismarck ND These LightsofHope,Ellen Schafer,Negative
9511,Jan Burger HematologyAdv CLL EndCancer,MD Anderson Cancer Center,Postive
9512,Last couple day today last night Zoom CLL tomorrow,Wendy Dance,Postive
9513,CLL,MDEdge,Negative
9514,MRD William Wierda PhD Daily News,MD Anderson Leukemia,Negative
9515,CLL,MDedge Hematology Oncology,Negative
9517,CLL OncoAlert,VJHemOnc,Negative
9518,LK Hoh HY Kipps JC Mulligan Kay NE JC Lal ID Dean,NK paper,Postive
9525,Kudos Reebok Wonder Women Fabulous CLL,Michele,Postive
9526,CONGRESS Elizabeth Shpall CLL,Lymphoma Hub,Negative
9527,NEW The FDA MRD CLL,Patient Power,Negative
9528,PhD today CLL Epigenetics,Charlotte McDonald,Postive
9529,Brian Koffman MD CLL Society,Oncology Tube,Negative
9530,John Pagel Cancer Institute,Oncology Tube,Negative
9531,CLL OncoAlert NHLsm HodgkinLymphoma CLLsm,VJHemOnc,Negative
9532,Swedish CLL,Journal NCCN,Negative
9533,one CLL,ASH,Negative
9534,Steering Committee Astrid Pavlovsky CLL,Lymphoma Hub,Negative
9535,Tina Leukemia CLL,Michael Hallek,Postive
9536,INDEPENDENT SATELLITE SYMPOSIUM four Achieving Innovation CLL Care BTK Inhibitors Selection Safety Sequencing Across Continuum William Wierda MD PhD Philip Thompson MB MS,MD Anderson Leukemia,Postive
9537,six William Wierda PhD,MD Anderson Leukemia,Negative
9540,CONGRESS William Wierda Philip Thompson BTK CLL,Lymphoma Hub,Negative
9541,CLL,PeerView,Postive
9542,CLL,PeerView,Postive
9545,Ibrutix Ibrutinib WhatsApp,World Cancer medicine,Negative
9546,Xie Bing   CLL,gannabiTong Xin ,Negative
9547,one HallekMichael decade AntiCancer HematologyPharmacists Cll,Tina Crosbie,Postive
9549,four Acute Acute AML CLL CML Learn,UI Holden Comprehensive Cancer Center,Negative
9550,CONGRESS John Michael Hallek BTK CLL,Lymphoma Hub,Postive
9551,Nitin CLL,Michael Hallek,Postive
9552,CME,PeerView,Negative
9553,KNOW,La maliiila,Postive
9554,CLL two thousand and twenty Nitin Jain MD eight MedEd,MD Anderson Leukemia,Postive
9555,CONGRESS three BTK CLL Paolo Ghia,Lymphoma Hub,Negative
9556,CLL AboulafiaMd Chaudhry Check,Binaytara Foundation Advocate Educate Innovate,Negative
9557,Review Lynn Wang Jimmy Lee UChicago FREE,Mol Diagnostics,Postive
9558,one thousand nine hundred four year Joseph Flynn Norton Medical Group Norton Cancer Institute,Norton Healthcare,Negative
9560,William Wierda PhD Leukemia Measuring Residual Disease Clinical Implications ten PM CST Session six CLL EndCancer,MD Anderson Leukemia,Negative
9561,CLL Register webinar nine CLLsm Register,Patient Empowerment Network,Negative
9562,John Burke MD Manuel Santiago MD CME today,Oncology CE,Postive
9563,September half CLL,wAIHA Warriors,Postive
9565,CLL Lymphocytic LymphomaCanada LLSCanada,AbbVie Canada,Negative
9567,Katrine Melvold today Vitro Sensitivity Targeted,Sigrid Skanland,Postive
9568,Janssen Imbruvica European Commission,Amit Dang,Postive
9576,ERIC two thousand and twenty Virtual Meeting three week CLL OncoAlert,VJHemOnc,Negative
9577,BloodCancerAwarenessMonth World Susan AllTrials DemandDiversity DiversityMatters,Teckro,Negative
9578,Claudia Maria Teresa Gonzalez ChronicLymphocyticLeukemia CLL NGS,International Journal Cancer,Negative
9579,CLL Colorectalcancer SidYadavMD Register,Binaytara Foundation Advocate Educate Innovate,Postive
9580,CLL Tom Henry AML CLL,AnCan,Postive
9581,HallekMichael CLL German Catch OncoAlert OncoAlert Leukemia Leusm,VJHemOnc,Negative
9584,first CLL BloodJournal,ASH Clinical News,Negative
9585,Three first CLL,ASH Clinical News,Negative
9586,CLL,ASH Clinical News,Negative
9587,eight pm EDT BloodCancerAwarenessMonth AML CLL CureLeukaemia LeukaemiaAus,AnCan,Postive
9588,CLL,Deborah Stephens,Negative
9589,BloodCancerAwarenessMonth Susan UCIrvine Check CLL,MJH Life Sciences,Negative
9590,Summary Judgement Costco Trademark Infringement Vacated Appeal,Cowan Liebowitz,Negative
9592,Small Lymphocytic Lymphoma Parameswaran Venugopal RushMedical Wednesday sixteen two thousand and,Leukemia Research Foundation,Postive
9593,MTP Session Seymour Park Ferrajoli,MD Anderson Leukemia,Negative
9594,Janssen Announces EuropeanCommission Decision Expanded Use Combination Rituximab CLL JanssenGlobal,Plexus Ventures,Negative
9595,September LeicesterRoyalInfirmary Ben Kennedy CRCTU RichtersSyndrome CLL,TAP Clinical Trial Network,Negative
9596,MTP Session nine CLL Thompson Jain NitinJainMD Join,MD Anderson Leukemia,Negative
9598,one month CLL Click OncoAlert Leusm Leukemia,VJHemOnc,Negative
9606,CLL second Othman CLL,Seema Ali Bhat,Postive
9607,Study Participants With Lymphoma CLL,CureHuntr,Negative
9608,Pharma Designation FDA Ascentage FDA CLL,FSTP,Postive
9609,Alessandra Ferrajoli BTK Inhibitor Toxicities nine AM CST MTP XIX CLL Register,MD Anderson Leukemia,Negative
9610,OncoAlert American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
9611,Nitin Jain MD NitinJainMD BTK nine AM CST MTP nine CLL Register,MD Anderson Leukemia,Negative
9612,Philip Thompson MB BS Leukemia nine CLL Register,MD Anderson Leukemia,Negative
9613,CLL EYFS AaronEarlyYears StJamesIDerby,DEYTS,Negative
9614,CLL one CLL CLLsm,Patient Empowerment Network,Negative
9615,CLL HPV CLL,Tina Kaczor ND FABNO,Postive
9616,Janssen Imbruvica Rituximab Receives EC Marketing Authorization Previously Untreated,Claude Waddington,Negative
9617,EU Imbruvica CLL CLL CLL,Recruitment,Negative
9618,William Wierda Philip Thompson MB MS BTKinhibitors CME Friday September eleven AM,PeerView,Negative
9619,FDA Grants Orphan Drug Designation Novel CLL,Raymond DuBois,Negative
9620,FDA Orphan Drug,Targeted Oncology,Negative
9622,Priti Patel Heroes Among Us CLL BloodCancerAwarenessMonth,AstraZenecaUS,Negative
9623,Janssen Imbruvica Rituximab Receives EC Marketing Authorization Previously Untreated,PharmaShots Incisive news three shot,Negative
9624,CLL myeloid AML BloodCancerAwarenessMonth,Patient Empowerment Network,Postive
9626,Bruton Tyrosine Kinase Ghoshdastidar BTK,Pharmacology Research Perspectives,Negative
9627,Janssen Imbruvica CLL,The PMI Pharmaceutical Managers Institute,Negative
9628,Arzerra CLL CLL,KOLKATA RAVI SPECIALITIES PHARMA,Negative
9629,Arzerra CLL CLL,worldwide medicine,Negative
9630,Japan,Lymphoma Papers,Negative
9633,CLL,Haematologica,Postive
9634,CLL Learn CLLAdvocates,HARMONY Alliance,Negative
9636,JanssenUS EC IMBRUVICA rituximab treat CLL,ExpPharma,Postive
9637,Answers Please Sept nine eight pm ET Support Group Richard Farmer CLL,Michele,Postive
9638,MRD MRD CLL MRD CLL MM,clonoSEQ,Negative
9639,maryland OrphanDrug,Aspen Biosciences,Negative
9641,Michele Kenny Richard Bones Blood Cancers Virtual Support Group Sep nine pm Eastern AML CLL,AnCan,Postive
9643,Leukemia BioSpace,Jessi,Negative
9644,European Commission JNJNews Imbruvica Roche MabThera JNJ ROG,Market Intelligence Healthcare,Negative
9652,CELLFOOD,Cellfood SA,Negative
9653,four myeloid,CARF,Negative
9654,CLL,Kathleen Hoffman,Negative
9655,CLL EYFS Phonics,Kirstie Page,Postive
9658,two year later BloodCancerAwarenessMonth BloodCancer,Danielle,Negative
9659,New Medivizor,Medivizor,Negative
9660,The Virtual Congress Hematology October two thousand and twenty Chaired Pia Raanani CLL,Bioevents Sharing Biomed Knowledge,Postive
9661,CLL CLL tomorrow morning Register FREE,Binaytara Foundation Advocate Educate Innovate,Postive
9663,Highlights role Alloa Allogeneic Blood Advances American Society Hematology,Shankara Paneesha,Negative
9664,Paul Hampel Molecular Tumor Board CLL tomorrow AM PST AM CST Nepal Excellent CLL,Sid Yadav MD FACP,Postive
9665,VIDEO CLL GREEN Veronique OncoAlert,VJHemOnc,Negative
9666,CLL,Leonardo Mejia,Negative
9667,CLL JCO,ASCO Publications,Negative
9668,Randomized Dose Optimization Study Chimeric Antigen Receptor bagalbp,Albeena Nisar,Negative
9669,Roger Strair RutgersCancer Seth Cohen RWJBarnabas Health CLL,Patient Power,Negative
9670,CLL two thousand and,Leonardo Mejia,Negative
9671,CLL,Leonardo Mejia,Negative
9672,CLL,Leonardo Mejia,Negative
9673,Lymphoma Chronic WhatsApp,Shifa Drug,Negative
9674,CLL Allogeneic Blood Advances American Society Hematology,Toby Eyre,Postive
9682,CLL CLL,Remy Dulery,Negative
9683,Meet Our Faculty Oncology Fellow MayoClinic CLL CLL Register,Binaytara Foundation Advocate Educate Innovate,Negative
9684,September BTK Register Now,Medscape Education,Negative
9685,CLL SpotLeukemia Fatigue Leukemia,Baker,Negative
9686,next week FragileNucleosome Seminars Giacomo Corleone CLL,Ben Martin,Negative
9687,today CLL ten million CLLSupport,CLL Advocates Network,Postive
9688,BTK CLL Learn More,Oncology Learning Network,Negative
9689,Randomized Dose Optimization Study Chimeric Antigen Receptor,Chimeric Antigen Receptor,Negative
9690,CLL Society CLL MichealMartinTD DonnellyStephen,Michael Rynne,Negative
9691,Irish CLL Forgottenfamilies SocDems JanRynne CllIreland CllSociety,CLL Ireland,Postive
9692,DYK CLL NHL Learn,BeiGene,Negative
9693,CLL,Blood Journal,Negative
9694,CLL CLL Leukemia Oncology Hematology,Hematology Advisor,Negative
9695,CLL AML MPN PatientPower,Esther Schorr,Negative
9698,CLL,Blood Journal,Negative
9699,CLL CLL every year CLL,Lymphoma Coalition,Postive
9700,Lymphocytic SLL DM,God Nothing,Postive
9701,CLL CLL Anthony Mato,Patient Power,Negative
9702,TODAY Join Dr Neil Kerry Rogers Ohio State University Register CME,Research To Practice,Postive
9703,Acute,KOLKATA RAVI SPECIALITIES PHARMA,Negative
9704,Ed Durham Team EYFS CLL EYFS,Kirstie Page,Postive
9705,September CLL,Katharine Parker,Negative
9706,Acute,worldwide medicine,Negative
9707,Ben je opmerkelijk vaak verkouden moe heb je opgezette lymfeklieren Ga je controleren leukemie cll maarikbenernog,Jolanda,Negative
9708,Heidi Yates CLL,Patient Power,Postive
9710,two thousand and twenty Size Share,Swapna Supekar,Postive
9711,SpotLeukaemia Matt GP Two week later Chronic CLL,MerMer Goodburn,Negative
9712,BloodJournal one CLL,chadi nabhan MD MBA FACP,Postive
9713,Haematologica CLL,Benlazar Amine,Negative
9714,CLL Carsten Niemann Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
9715,Cancer EHA Scientific Working CML AML CLL Europe Learn,European Hematology Association,Postive
9716,Today CLL JanRynne CllIreland CllSociety,Michael Rynne,Postive
9717,CLL,Doctors Overseas,Negative
9718,Steven Treon BTK CLL,Journal NCCN,Negative
9719,HEMATOLOGIA Mattsson et al Increasing,MUVBBvirtual,Negative
9720,OncoAlert CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
9721,OncoAlert Outcomes CLL American Society Hematology,Raul Cordoba MD PhD,Negative
9722,Emili Montserrat CLL CLL Blood American Society Hematology,Toby Eyre,Negative
9723,CLL Blood Advances,Hematology Advisor,Negative
9724,Phillip Thompson CLL,MD Anderson Leukemia,Negative
9725,MD ASCO,MedPage Oncology,Negative
9728,September eleven AM CLL William Wierda Philip Thompson MB MS,PeerView,Negative
9730,Relates CLL CllSociety,CLL Ireland,Negative
9731,CLL DNAmethylation Early View Haematologica,Environmental Epigenetics,Negative
9732,today CLL,BSI UK,Postive
9733,Haematologica,Maria Jose Calasanz,Negative
9734,nationale genom forskningscenter starter arbejdet CLL,LyLe Foreningen,Negative
9736,Case Report,Medical Dialogues,Negative
9737,MolecularTumorBoard CLL MayoClinic VirginiaMason Chaudhry SummitCancerCen Register,Binaytara Foundation Advocate Educate Innovate,Negative
9738,CLL,Journal NCCN,Negative
9739,CLL,Seema Ali Bhat,Negative
9740,Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive,Cytof Manchester,Negative
9741,Finalist PatientAdvocate CLL BloodCancerAwarenessMonth PatientPower,Michele,Postive
9742,Watch,Medscape Oncology,Postive
9744,Adaptive Biotechnologies Receives Expanded FDA Clearance,Oncology Tube,Negative
9745,Adaptive Biotechnologies Receives Expanded FDA Clearance Chronic,Oncology Tube,Negative
9746,Adaptive Biotechnologies Receives Expanded FDA Clearance John Pagel MD,Oncology Tube,Negative
9747,Adaptive Biotechnologies Receives Expanded FDA Clearance,Oncology Tube,Negative
9748,Adaptive Biotechnologies Receives Expanded FDA Clearance FDA CLL,Oncology Tube,Negative
9749,Adaptive Biotechnologies Receives Expanded FDA Clearance Brian Koffman MD CLL Society CllSocie,Oncology Tube,Negative
9750,Mazyar Shadman Deborah Stephens CLL,Journal NCCN,Negative
9752,Barr BTK,Targeted Oncology,Negative
9753,BTK,Lymphoma Papers,Negative
9754,CLL,Michael Rynne,Negative
9759,CLL,The Lancet Oncology,Negative
9760,CLL,Kathleen Hoffman,Negative
9762,MRD MRD CLL Furman WeillCornell,Patient Power,Negative
9764,half CLL,Patient Power,Negative
9765,Join PTCE tomorrow CLL Learn More,Pharmacy Times,Postive
9766,CLL Order,Patient Resource,Postive
9767,September eleven AM,PeerView,Postive
9768,CLL,CancerTherapyAdvisor,Negative
9769,Arzerra Patient Access Novartis Oncology,CURE Magazine,Negative
9770,September clinician Manitoba CLL,RIOH,Postive
9771,Food Industry Insight Overcoming Trademark Genericism Ingenuity Le Creativity Languages,Cowan Liebowitz,Negative
9772,bloodcancerawarenessmonth,LyLe Foreningen,Postive
9773,CLL two thousand and Koffman Koffman CLL fourteen CLL,CLL Society Inc,Negative
9774,CLL Society BIG Global Virtual Educational Forum October ten CLL CLL,CLL Society Inc,Postive
9775,September CME CLL,RedMedEd,Negative
9777,Olivier Tournilhac two thousand and nine two thousand and eighteen CLL EBMT idelalisib lymsm,Lymphoma Hub,Negative
9781,CLL Richard Rosenquist Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
9782,CLL Nitin Jain PatientPower EndCancer,MD Anderson Cancer Center,Postive
9783,CLL two thousand and Patient Survey Help CLLSociety CLL MRD Testing Limited Duration Smarter Patients,CLL Society Inc,Postive
9784,CLL,CancerTherapyAdvisor,Negative
9785,Dual Inhibitor,Oncology Times,Negative
9786,CLL PatientPower,Patient Power,Negative
9788,Credit Steve Gschmeissner,SciencePhotoLibrary,Negative
9789,PGX CLL xenograft,mygenomerx,Negative
9790,Neil Love three Register,Research To Practice,Postive
9791,one CLL MEDICARE,Elmer Puddpucker,Negative
9793,Speaking Out Susan CLL,CURE Magazine,Negative
9794,Leukemia,Medivizor,Negative
9795,Barr BTK,Targeted Oncology,Negative
9797,Blood Advances American Society Hematology,British Society Blood Marrow Transplantation,Negative
9799,Blood Advances American Society Hematology,Hernandez Mohedo,Negative
9802,OncoAlert Longitudinal CLL two thousand and twenty eJHaem CLLsm,Raul Cordoba MD PhD,Negative
9803,CLL Peter Hillmen UniversityLeeds Oncoalert EHAtrending OncoAlert,VJHemOnc,Negative
9804,CLL Furman WeillCornell,Patient Power,Postive
9805,yesterday CLL two,Andy Evens,Postive
9806,one CLL MEDICARE,Elmer Puddpucker,Negative
9807,Japanese,Lymphoma Papers,Negative
9816,Portell,Targeted Oncology,Negative
9817,CLL JanRynne DonnellyStephen,CLL Ireland,Negative
9818,Donnchadhol carlobrien JanRynne CLL,Michael Rynne,Negative
9819,Learn Courtney DiNardo PatientPower EndCancer,MD Anderson Cancer Center,Postive
9820,Scott,Janet,Negative
9821,Will CLL,Gamer Kitteh,Postive
9822,Randomized Dose Optimization Study Chimeric Antigen Receptor,filippo masini,Negative
9823,CLL AML Courtney DiNardo,Esther Schorr,Negative
9824,CLL,Lymphoma Hub,Negative
9825,International Ultman Chicago Lymphoma Symposium CLL,Krishna Komanduri MD FASTCT,Postive
9826,one Leukemia MPN EndCancer,Focused Health,Negative
9827,PatientPower Founder Courtney DiNardo MD discus,MD Anderson Leukemia,Negative
9830,Leukemia COVID,Benlazar Amine,Negative
9831,Verb Verbs CLL,Kirstie Page,Negative
9833,Adherence two thousand and eighteen,Fight Cancer Team,Negative
9839,one,MerMer Goodburn,Postive
9840,Tumor Lysis Syndrome Chronic,EurekaMag,Negative
9841,CLL tonight,Kristin Ferguson DNP RN OCN,Postive
9842,one one one Today one day,EllenStefancik,Negative
9843,CLL,Blood Advances,Negative
9844,today CLL Answers one pm pm EST Barr WilmotCancer Register Here PatientPower,Patient Power,Negative
9845,Phase Study Oral Patients Previously Treated Chronic,Michael Wang MD,Negative
9848,CLL,CancerTherapyAdvisor,Negative
9849,CLL Mato Watch More,Patient Power,Negative
9851,CLL,AbbVie US,Negative
9852,The CLL Society CLL Stay Limit Download,CLL Society Inc,Negative
9853,Obinutuzumab Ibrutinib Venetoclax,The ASCO Post,Negative
9854,today,CURE Magazine,Negative
9855,Blood Advances American Society Hematology,Saudi Leukemia Net,Negative
9856,BSI Learn today CLL,BSI UK,Postive
9857,EHA two thousand and CLL Oncoalert EHAtrending OncoAlert CLL,VJHemOnc,Negative
9860,Jennifer Brown Florence Cymbalista Two mmsm bmtsm mdssm,Society Hematologic Oncology SOHO,Negative
9861,CLL,Kathleen Hoffman,Negative
9862,two Obinutuzumab Ibrutinib Venetoclax,Andrew Johns MD,Postive
9863,Blood Advances American Society Hematology,Marcel van den Brink,Negative
9864,Led Dr Wei Wang MD Anderson Cancer CLL,Human Immunology News,Negative
9865,Jan Burger Leukemia Reviews BTK TargetedOnc CLL,MD Anderson Leukemia,Negative
9866,CLL,Flow Paradigm,Postive
9867,CLL Steven Coutre FISHtest,Patient Empowerment Network,Negative
9868,William Wierda Philip Thompson MB MS September eleven AM BTKinhibitors CLL,PeerView,Negative
9870,CLL past two decade,Ron Grunsby,Negative
9872,CLL Join one pm pm ET Paul Barr Register,Patient Power,Negative
9873,CLL Market Report FTSE CLL,Proactive,Negative
9874,TOMORROW Register,Karmanos Cancer Institute,Postive
9879,akaraburuchinibu CLL,ganpurasu,Negative
9880,Burger,Targeted Oncology,Negative
9881,Allo CLL NRM thirteen cll,Alan Skarbnik,Postive
9882,RR CLL NA NA PFS CLL,Toby Eyre,Postive
9883,webinar Chronic CLL CLL Learn More,PharmacyTimesCE,Postive
9884,OncoAlert CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
9885,Blood Advances American Society Hematology,ALI ALAHMARI,Negative
9887,Richard Furman WeillCornell BTKInhibitors CLL,Patient Power,Negative
9888,CLL Kostas Stamatopoulos Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
9889,CLL Paul Barr WilmotCancer Thursday,Andrew Schorr,Postive
9890,FDA first MRD CLL one million Read OncoAlert HemeOnc,VJHemOnc,Negative
9896,CLL ten CLL MRD,CLL Society Inc,Negative
9897,Coming week Dr Neil Love three Register LeciaSequist,Research To Practice,Negative
9898,Lisa Leukemia CLL Great,BinderLab,Postive
9899,European Research Initiative CLL,EurekaMag,Negative
9900,CLL Learn Program Paul Barr Thursday one PM PM EST,Patient Power,Negative
9902,Phillip Thompson three CLL FishTest,Patient Empowerment Network,Negative
9905,OncoAlert The Impact Age Survival CLL,Raul Cordoba MD PhD,Negative
9907,Davids three,Targeted Oncology,Negative
9910,one CLL one one,Deborah Reynolds,Postive
9911,RWD CLL,COTA Inc,Negative
9912,California Irvine CLL Listen,Lymphoma Hub,Negative
9913,Wenserski Bolz Schliffke Simnica,NK paper,Negative
9917,two,Philip McCarthy,Negative
9919,CLL,Kathleen Hoffman,Negative
9922,CLL EHA two thousand and twenty Peter Hillmen UniversityLeeds Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
9924,undiacomohoy degustacion CLL,Vivian Malachwskyj,Negative
9925,FCR CLL FCR Congrats,Mazyar Shadman MD MPH,Postive
9926,Oncology Alliance Medical Oncologist CLL September twenty Learn,Binaytara Foundation Advocate Educate Innovate,Negative
9927,EducatedPatient Webinar Learn today,CURE Magazine,Negative
9928,Paul Barr WilmotCancer CLL next week,Andrew Schorr,Negative
9929,CLL,Fiona,Postive
9934,noon Neil Love Brad Kahl CME,Research To Practice,Postive
9935,Genmab Announces Plan Transition ofatumumab,Pharma News,Negative
9936,SchonGewusst Die Deutsche Gesellschaft Hamatologie und Medizinische Onkologie Onkopedia Leitlinie CLL Untersuchungen Risikofaktoren Einleitung Therapie Mehr,AbbVie Deutschland,Negative
9937,FDA Clears First Chronic,ALI ALAHMARI,Negative
9938,Genmab Announces Plan Transition ofatumumab,Pharmacutical Daily,Negative
9939,CLL Jason Butler,Lymphoma Australia,Postive
9941,GMAB NVS Genmab,Biotech Tech Stock Focus,Negative
9943,Genmab Announces Plan Transition ofatumumab,Genmab,Negative
9944,Genmab Announces Plan Transition ofatumumab,IMPharma News,Negative
9945,GMAB Genmab,OTC Dynamics Inc,Negative
9946,Genmab Announces Plan Transition ofatumumab,Crwe World,Negative
9948,GMAB Novartis Arzerra Genmab thirty million NVS,Bio,Negative
9950,CLLsm,Targeted Oncology,Negative
9951,John Burke MD Manuel Santiago MD CME today,Vindico Medical Education,Postive
9952,McRaven Chronic one,Dark Horse Duo Plan,Postive
9953,NEJM LTE CLL Read,NHLBI Bethesda Labs,Negative
9954,CLL Watch Susan Brien CLLsm,Patient Empowerment Network,Negative
9956,IVO CLL,Adam Kittai,Postive
9957,Susan MD Chao Family Chronic,The Leukemia Lymphoma Society,Negative
9958,September Key Dr Satarupa Choudhuri Consultant Royal Oldham Hospital CLL Chair Marc Auckland Register,CLLSA,Negative
9959,Sunday September two thousand and twenty CLL VirginiaMason Chaudhry SummitCancerCen Register,Binaytara Foundation Advocate Educate Innovate,Postive
9960,MRD CLL MM,clonoSEQ,Negative
9962,FRIDAY noon Neil Love Brad Kahl Register CME,Research To Practice,Postive
9964,two thousand and twenty CLL,Lymphoma Research Foundation,Postive
9965,BTKinhibitors Learn William Wierda Philip Thompson MB MS CME September eleven AM,PeerView,Postive
9966,Coutre first,Targeted Oncology,Negative
9967,two,Cancer Papers,Negative
9968,Dual Inhibitor,Oncology Times,Negative
9974,CR FCR Chlorambucil Phase two,Martin JS Dyer,Negative
9975,Bezeichnungen mit der Leukamie kurz CLL Dieser Artikel GemeinsamGrenzenVerschieben Onkologie,AbbVie Deutschland,Negative
9976,three hundred and sixty,Amparo Santamaria Ortiz MD PhD,Negative
9977,LLNI Cll,Dr Effie Kostareli,Postive
9978,CLL Kostas Stamatopoulos CERTHellas Oncoalert EHAtrending,VJHemOnc,Negative
9980,BTK Learn William Wierda Philip Thompson MB MS CME,PeerView,Postive
9981,Learn William Wierda Philip Thompson MB MS BTK CME September eleven,PeerView,Negative
9983,two Acute Leukemia AML,Emily Bell,Negative
9984,CLL,Raffaella Ravinetto,Negative
9985,Explored CLL,Toby Eyre,Negative
9987,CLL CLL,HealthWellOrg,Negative
9988,CLL second Tune,Patient Empowerment Network,Negative
9989,Susan CLL Watch CLLsm,Patient Empowerment Network,Negative
9990,DYK CLL Susan CLLsm,Patient Empowerment Network,Negative
9991,Susan Brien CLL CLLsm,Patient Empowerment Network,Negative
9992,WEBINAR CLLsm,Patient Empowerment Network,Negative
9993,Register CLLsm,Patient Empowerment Network,Negative
9994,CLL Marty Read,MEI Pharma,Postive
9995,two,Benlazar Amine,Negative
9996,CLL Phillip Thompson,Patient Empowerment Network,Negative
9997,CLL one thousand nine hundred,Hematology Advisor,Negative
9998,today Webinar Sign couple hour CLL Register,Patient Empowerment Network,Postive
9999,CLL,Fish Chromosomes,Postive
10000,today eleven,Mayo Clinic Pharmacy Residency Programs,Postive
10008,CLL CLL,amber,Postive
10009,Leukemia,Claire Saxton,Negative
10011,September two thousand and twenty FREE Register Here,Binaytara Foundation Advocate Educate Innovate,Postive
10012,Brighton Sussex Medical School BioFlux hundred CLL,Fluxion Biosciences,Negative
10013,Quality Life Significantly Lower,Kimberly Curseen,Negative
10014,CLL,Lymphoma Australia,Negative
10015,Davids three,Targeted Oncology,Negative
10017,CLL Steven Coutre CLL CLLsm,Patient Empowerment Network,Negative
10018,Paolo Ghia Peter Anglin Southlake Regional Health Centre CLL,Education,Negative
10020,CLL,CellworksLife,Negative
10021,JT Played CLL,Aurileus FC,Postive
10022,Bone Marrow Transplantation CLL,Benlazar Amine,Negative
10023,Join Erlene Seymour CLL Register,Karmanos Cancer Institute,Postive
10025,Principia Biopharma BTKinhibitors,Recruitment,Negative
10027,Das Vorliegen Nichtvorhandensein von Merkmalen CLL dem Krebs Therapie Hier,AbbVie Deutschland,Negative
10028,CLL tomorrow morning CllSociety DanaFarber ALLGtrials,Lymphoma Australia,Postive
10029,CLL Society Lymphoma Australia Virtual Conference Our Brian Koffman Matt Davids Jason Butler four PM PT Aug seventeen nine AM Aug eighteen Melbourne Australia CLL Australia,CLL Society Inc,Negative
10031,CLL,Kathleen Hoffman,Negative
10034,Blocs September Numberblocs EYFS CLL,Lea,Negative
10035,ten CLL,Zusia Dr Jackie Volk,Negative
10037,VIDEO Umbralisib Ibrutinib CLL MCL DanaFarber Oncoalert EHAtrending,VJHemOnc,Negative
10038,One CLL CLL,Read Spell TTRS,Postive
10040,pasamos al dia CLL,Emaa,Negative
10041,CLL,MedStudent,Negative
10046,CLL,Cochrane UK,Negative
10047,Register CLL Susan,Patient Empowerment Network,Postive
10048,one hundred Lyphocytic CLL,Say It Forward,Negative
10050,Today CLL MRD CLL Find Join CLL Society August Webinar,CLL Society Inc,Negative
10051,CLL,CellworksLife,Negative
10053,Recent Advances Hematology Review two thousand and eighteen fourteen two BcellMalignancies,touchONCOLOGY,Negative
10057,CLL MRD CLL Find Join CLL Society August Webinar Drs Anthony Mato,CLL Society Inc,Negative
10059,first,OncologyNurseAdvisor,Negative
10060,Dual Inhibitor,Oncology Times,Negative
10061,William Wierda Philip Thompson MB MS BTKinhibitors CME September eleven AM,PeerView,Negative
10062,APTO IND AML AML CLL month amp month,Joe,Postive
10063,APTO ARQL drug BTK CLL,Joe,Negative
10064,first,OncologyNurseAdvisor,Negative
10066,Request,CLL Society Inc,Postive
10067,CLL,The Cochrane Library,Negative
10069,one NHL AML Malignancies,Joe,Postive
10072,CLARITY CLL month CRCTU,TAP Clinical Trial Network,Postive
10073,CLL Society Lymphoma Australia Virtual Conference Our Brian Koffman Matt Davids Jason Butler four PM PT Aug seventeen nine AM Aug eighteen Melbourne Australia CLL Australia,CLL Society Inc,Negative
10074,Schongewusst Genabschnitt CLL Vergleich Mehr Leukamie Onkologie,AbbVie Deutschland,Negative
10075,HOVON one hundred and nine,Physician Weekly,Negative
10077,William Bensinger Swedish Venugopal RushCancer CLL,Binaytara Foundation Advocate Educate Innovate,Negative
10078,eight pm Eastern Blood Cancer Free AML CLL,AnCan,Postive
10079,one CalebLareau LeifLudwig CLL NatureBiotech,Satyen Gohil,Postive
10080,Chronic,Oncology Times,Negative
10081,Tanya Siddiqi,City Hope Orange County,Postive
10082,Italy Campus CLL,Blood Journal,Negative
10085,Watch,SpecialtyPTimes,Postive
10086,VIDEO CLL Tanya Siddiqi Oncoalert EHAtrending,VJHemOnc,Negative
10087,GEORGE THOROGOOD Delaware one dollar Badder Than Ever Leukemia Lymphoma Society Canada CLL,Elmer Puddpucker,Postive
10088,Jonathon Cohen HemOnc Oncology,Targeted Oncology,Negative
10089,Dual Inhibitor,Oncology Times,Negative
10090,one CLL Today Register Leusm WeillCornell,Patient Power,Postive
10091,CLL CLL,healthbook,Negative
10092,week MRD CLL CRCTU,TAP Clinical Trial Network,Negative
10093,August Diploma Quality Management Find today CLL,BSI UK,Postive
10094,Leukemia Leukemia four Acute Acute AML Chronic CLL CML,ZenOncoIO,Negative
10095,CLL Nitin Jain MRD MRD,CLL Society Inc,Negative
10096,Haematology,ClinOwl Haematology,Negative
10099,Schongewusst Bei Leukamie kurz CLL Risikofaktoren den Krankheitsverlauf den Therapieerfolg Lebenserwartung von Patienten GemeinsamGrenzenVerschieben Onkologie,AbbVie Deutschland,Negative
10100,CLL,Kathleen Hoffman,Negative
10102,Chinese ZTE Network CLL,Pune Samachar,Negative
10103,Arvind Chaudhry CLL August two thousand and twenty Learn,Binaytara Foundation Advocate Educate Innovate,Negative
10104,Immunoglobulin lgG Primary Immune Deficiency Disease Chronic Lymphocytic Kroger Specialty Pharmacy,Kroger Specialty Pharmacy,Postive
10105,next Tuesday Aug eighteen CLL CLLsm,Patient Empowerment Network,Negative
10106,Earlier year CLL Small Lymphocytic Lymphoma Katy one August Katy,Cheyenne Leigh Photography,Postive
10108,summer CLL Congrats Julio Ferran Dolors,JAVIER DE LA SERNA,Postive
10114,AIM CLL Cello Health PLC Scheme Arrangement,AIM Alerts,Negative
10115,PTCMA Virtual CPD August two thousand and twenty,SAMA,Negative
10117,two thousand FUNDSWIFT,FundSwift,Negative
10118,CLL September VirginiaMason Clinic FREE,Binaytara Foundation Advocate Educate Innovate,Postive
10119,Kenny BloodCancers Virtual Support Group twelve pm Eastern AML CLL,AnCan,Postive
10120,CLL Nitin Jain MRD MRD,CLL Society Inc,Negative
10121,last Wednesday Rang CLL one tonight,Tony Rothwell,Postive
10123,CART CellTherapy Phase one,ASGCT,Negative
10124,YoungIndiansGAO Cll YiTweets,Aman Pawar,Negative
10125,CLL Society Adaptive Biotechnologies FDA MRD CLL,CLL Society Inc,Negative
10126,CLL Join,RedMedEd,Postive
10127,MassiveBio Leuekemia Chronic FDA AI CLL,Cagatay CULCUOGLU,Negative
10128,Chronic FDA AI CLL Clinical Trials,Massive Bio Inc,Negative
10129,AIM CLL Cello Health PLC Relevant Securities Issue,AIM Alerts,Negative
10132,ICYMI MRD,OncLive SOSS,Negative
10135,Check Zanubrutinib,Medivizor,Negative
10136,AIM CLL Cello Health PLC Exercise Options,AIM Alerts,Negative
10138,CLL CLL LCL,Fernando Martin Moro,Negative
10139,September two thousand and twenty second Virtual CLL Learn,Binaytara Foundation Advocate Educate Innovate,Postive
10147,CLL CLL ASCO EHA John Gribben Susan Barbara Eichhorst OncoAlert,VJHemOnc,Negative
10149,three HELIOS CLL,Benlazar Amine,Negative
10150,FDAOncology,Home Journal,Negative
10151,MRD Nitin Jain USA,Rajesh Sharma,Negative
10154,CLL,Kathleen Hoffman,Negative
10155,CLL,Oncology,Negative
10156,SPA Arvind Chaudhry Come Imbruvica,SPA,Postive
10157,Treated CLL,MerMer Goodburn,Negative
10158,Lee MRD MRD CLL MM,clonoSEQ,Negative
10159,thirty two thousand and twenty Burger NEJM CLLsm,Mike Thompson MD PhD FASCO,Negative
10160,AIM CLL Cello Health PLC Court Sanction Scheme,AIM Alerts,Negative
10161,FDA,OncLive SOSS,Negative
10162,Learn,SpecialtyPTimes,Negative
10163,AIM CLL Cello Health PLC,AIM Alerts,Negative
10164,Adaptive Biotechnologies Receives Expanded FDA Clearance Media Snippet,ArthurPotatoeHammer,Negative
10166,two August CLL,BSI UK,Negative
10168,PTCMA Virtual CPD August two thousand and twenty,SAMA,Negative
10169,Leukemia CLL Cancers,ProteoGenix,Negative
10171,dia comenze trabajar CLL,Jose Chinchilla,Negative
10172,MRD CLL MRD CLL,CLL Society Inc,Negative
10173,Dual Inhibitor,Oncology Times,Negative
10174,FDA Clears First Chronic CLL,Raymond DuBois,Negative
10176,CLL Chronic Lymphocytic Leukemia Patient Management,National Comprehensive Cancer Network NCCN,Negative
10178,Scan Stochastic Buy Signal FUL RESI ARS,SwingTradeBot UK,Negative
10179,Learn MRD Lymphocytic CLL MRD CLL MM,clonoSEQ,Negative
10180,one CLL Register Leusm WeillCornell,Patient Power,Postive
10181,CLL Kostas Stamatopoulos CERTHellas Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
10182,Adaptive CLL three CLL,Theresa Nicoletto,Postive
10183,CLL Richard Furman PatientPower twelve ET Learn,WCM Lymphoma,Postive
10184,ClonoSeq CLL,Ted Kaminski,Postive
10185,Adaptive Biotechnologies Receives Expanded FDA Clearance Chronic,Pharmacutical Daily,Negative
10186,CLL Leukemia NEJM,MD Anderson Leukemia,Negative
10187,CLL,Mazyar Shadman MD MPH,Negative
10188,Volunteer Network CLL,Patient Empowerment Network,Postive
10189,PTCMA Virtual CPD August two thousand and twenty,SAMA,Negative
10190,one APTO CLL AML,Joe,Postive
10191,CLL MRD CLL MM,clonoSEQ,Negative
10192,Adaptive Biotechnologies Receives Expanded FDA Clearance,Investor News,Negative
10193,Adaptive Biotechnologies Receives Expanded FDA Clearance Chronic,IMPharma News,Negative
10195,CLL Society ASH two thousand and nineteen Paul Barr Ibrutinib MRD,CLL Society Inc,Postive
10197,Chronic,OTC Dynamics Inc,Negative
10198,Adaptive Biotechnologies Receives Expanded FDA Clearance Chronic,Ariel Herzog,Negative
10199,Chronic,BW Capital,Negative
10200,Chronic,Stock Titan,Negative
10201,HemaSphere Leukemia CLL,Michael Hallek,Postive
10204,CLL MRD MRD,Enrique Colado,Negative
10211,OncoAlert,Raul Cordoba MD PhD,Negative
10213,CLL Jan Burger,Talha Badar,Postive
10214,CLL August VIRTUAL Seattle Lymphoma July thirty two thousand and Lymphoma Research Foundation,Mazyar Shadman MD MPH,Postive
10216,fifty today PDZ PNL CNS,SwingTradeBot UK,Negative
10219,BTK CllSociety LIVE Monday today,CancerCoachLive,Postive
10220,Tuesday CLL CLLsm Register,Patient Empowerment Network,Negative
10222,August two thousand and George Duke Frank Zappa Los Angeles one thousand nine hundred Duke,Psychedelic Jukebox,Negative
10223,Today two thousand and George Duke,All Jazz Radio,Negative
10224,IMO APTO APTO CLL AML month month,Joe,Postive
10225,Today two thousand and George Duke,Uncle Duke,Negative
10226,two CLL NEJM HematologyOncology MedEd,NEJM Resident three hundred and sixty,Negative
10227,APTO yesterday CLL three CLL BTK,Joe,Negative
10234,Temadag two thousand and twenty Se Jer cml cmml lymfekraeft fasvarpasporgsmal BlodcancerDk,LyLe Foreningen,Postive
10235,CLL John Gribben Susan Barbara Eichhorst OncoAlert OncoAlert,VJHemOnc,Negative
10236,Supports CLL MRD,Michael Hallek,Postive
10237,Jan Burger Anderson Cancer CLL,Michael Hallek,Negative
10238,RNA,mitopapers,Negative
10239,yesterday one three year Christianity CLL,Shouting people underpants,Negative
10240,Aspergillus,Quaglee Dragontacos,Negative
10241,CLL CLL,Cancer Papers,Negative
10242,CLL,Hematology Advisor,Negative
10244,Flechere Fortin Genomic first NGS CNV,OGT,Postive
10245,Review Article Chronic,NEJM,Negative
10247,thirty two thousand and twenty Burger NEJM CLLsm,Mike Thompson MD PhD FASCO,Negative
10248,Norah Grant Radio four Today Programme Saturday August one August CLL,CLLSA,Postive
10249,Venetoclax,Lymphoma Papers,Negative
10257,John Gribben Susan Barbara Eichhorst OncoAlert,VJHemOnc,Negative
10258,one CLL COVID JanRynne CllIreland,Michael Rynne,Postive
10259,two August BSI CLL,BSI UK,Negative
10260,September AML CLL CllSociety CllIreland,CLL Advocates Network,Postive
10262,one month September AML CLL,Zack,Postive
10264,New Zanubrutinib,Medivizor,Negative
10265,SidYadavMD SirohiBhawna Yan first Lymphocytic Leukemia,Binaytara Foundation Advocate Educate Innovate,Postive
10266,New Medivizor Reviewing,Medivizor,Negative
10267,CLL,Journal NCCN,Negative
10268,Bruce Raphael MD,OncLive SOSS,Negative
10269,Primer dia de doctorado en RitaUria Feliz emocionada toda PhD,Gimena do Santos,Negative
10271,CLL NEJM CLL,Joseph Shatzel,Postive
10272,one hundred CLL,Say It Forward,Negative
10274,CLL YOU Register Is It Time Treat Your CLL eighteen Susan Brien CLLsm Register,Patient Empowerment Network,Postive
10276,JohnPLeonardMD Richard Furman Bruton BTK CLL Listen,WCM Lymphoma,Postive
10277,August Matthew Davids MD Anthony Mato MD MSCE BTK Register Questions,OMedLive,Postive
10278,three hour The CLL Sessions John Gribben Susan Barbara Eichhorst CLL ASCO EHA OncoAlert,VJHemOnc,Negative
10279,AIM CLL Cello Health PLC Results Court,AIM Alerts,Negative
10280,CLL,Tinu,Negative
10283,BTK CLL Florence Cymbalista Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
10284,CLL CLL,Brave Is,Negative
10286,Goodbye Boston two brilliant year DanaFarber CLL,Satyen Gohil,Postive
10287,Learn Reviewing Leukemia,Medivizor,Negative
10288,seventeen two year,NEJM,Negative
10290,RNA,Happy Scientist,Negative
10291,NEW Reviewing,Medivizor,Negative
10294,two CLL,Xenia Schmidt,Negative
10295,Only twentyfour hour CLL Sessions ASCO EHA John Gribben Susan Barbara Eichhorst Register ASCO Leusm OncoAlert,VJHemOnc,Negative
10296,The New England Journal Medicine Search Results,AGD Biomedicals,Negative
10297,Somatic Hypermutation NGS CLL NGS CLL,Sanjeev Gupta,Negative
10298,Healthcare Jennifer Woyach CLL Monday noon,The James,Postive
10299,CLL CLL,Anthony Mato,Negative
10300,CLLSociety CLL Koffman CLL CLL,CLL Society Inc,Negative
10301,twelve ASCO four CLL,CLL Society Inc,Negative
10302,Pelotonia one,Harold Paz MD,Postive
10304,PGR one ADE OncPharm MayoPharmRes,Mikhaila Rice,Postive
10305,CLL,Vivian Malachwskyj,Negative
10311,CLL Cochrane CLL,Cochrane Haematology,Negative
10312,LYMPHOCYTIC CLL,chetan padghan,Negative
10313,CLL Sessions John Gribben Susan Barbara Eichhorst CLL ASCO EHA OncoAlert,VJHemOnc,Negative
10314,OncoAlert Chronic International Journal Cancer CLLsm,Raul Cordoba MD PhD,Negative
10315,TatPremiers ten four FoxMemorial CLL Glenora Rugby League Football Club one thousand nine hundred,Te Atatu Roosters Rugby League,Negative
10316,CLL,Kathleen Hoffman,Negative
10317,THREAD CLL,Shouting people underpants,Negative
10318,CLL Sessions CLL ASCO EHA John Gribben Susan Barbara Eichhorst Register OncoAlert,VJHemOnc,Negative
10319,Tuesday,Patient Empowerment Network,Negative
10320,Technological Innovation Leading Key Players Roche Johnson Johnson Services Medic Report,FancyFinancy,Negative
10321,Clinical Pearls MedEd,NEJM Resident three hundred and sixty,Negative
10322,Technological Innovation Leading Key Players Roche Johnson Johnson Services Medic Report,Financial Carnivores,Negative
10323,Today CLL,Patient Power,Negative
10324,CLL,CONQUER patient voice,Negative
10326,PennMedicine BLLPHD CLL,Krishna Komanduri MD FASTCT,Negative
10329,publiHUCA Hematology,Biblioteca HUCA,Negative
10330,CLL Boomer Buy Setup Pocket Pivot Bullish,SwingTradeBot UK,Negative
10331,CLL Burger NEJM week CanerSaygin AdamKittai SherraineMD,Andrew Johns MD,Postive
10332,Technological Innovation Leading Key Players Roche Johnson Johnson Services Medic Report,Robo Schmobo,Negative
10333,Scan today CLL JESC TPOU UKML,SwingTradeBot UK,Negative
10334,Scan Hammer Candlestick today ADAM CLL UTLF,SwingTradeBot UK,Negative
10335,CLL,CancerTherapyAdvisor,Negative
10336,MRD CLL Lydia Scarfo Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
10337,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10340,CLL one CLL,AbbVie US,Negative
10346,Vitamin,Lymphoma Papers,Negative
10354,Technological Innovation Leading Key Players Roche Johnson Johnson Services Medic Report,BioPharmaDevice,Negative
10355,two CLL,BSI UK,Negative
10356,Saturday,Te Atatu Roosters Rugby League,Negative
10359,NEJM CLL,ATOPP Summit,Negative
10360,CLL,Jabatan Perubatan Keluarga di,Negative
10362,CLL Friday July,Patient Power,Negative
10363,CLL CLL,Toby Eyre,Negative
10364,Kerry Rogers OSUWexMed Danielle Jill Vershel MS,CURE Magazine,Negative
10365,CLL,Journal Clinical Pathways,Negative
10366,chr,Medivizor,Negative
10369,Study Subjects Hematological Malignancies Philip Thompson AML CLL,MD Anderson Leukemia,Postive
10370,VSTM Duvelisib Chronic two thousand and,Daniel,Negative
10371,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10379,Challenges CLL Management Webinar YouTube CLL,Saudi Blood SSBD 'mrD ldm,Negative
10380,CLL Sessions CLL ASCO EHA John Gribben Susan Barbara Eichhorst August ASCO,VJHemOnc,Negative
10381,Jul two thousand and fourteen Whitaker CLLsm IDonc,Mike Thompson MD PhD FASCO,Negative
10382,two thousand and fourteen Whitaker CLLsm IDonc,Mike Thompson MD PhD FASCO,Negative
10383,one Months week CLL,Adam Kittai,Negative
10384,CLL,Elaine Schattner,Postive
10385,CLL Haitham Khogeer CLL,Saudi Blood SSBD 'mrD ldm,Negative
10386,Diagnostic CLL Khogeer CLL,Saudi Blood SSBD 'mrD ldm,Negative
10387,CLL Riad El CLL,Saudi Blood SSBD 'mrD ldm,Negative
10388,Ibrutinib Mervet Mattar CLL,Saudi Blood SSBD 'mrD ldm,Negative
10389,CLL Mervat Mattar CLL,Saudi Blood SSBD 'mrD ldm,Negative
10390,UK CLL two thousand and Peter Hillmen CLL,Saudi Blood SSBD 'mrD ldm,Negative
10391,Milestones CLL,Saudi Blood SSBD 'mrD ldm,Negative
10392,Hillmen Talk CLL,Saudi Blood SSBD 'mrD ldm,Negative
10393,CLL,Saudi Blood SSBD 'mrD ldm,Negative
10394,CLL FRIDAY CLL Please cllsm cll,Andrew Schorr,Postive
10395,CLL Webinar August one PM Eastern ten AM PT twelve PM CT,Patient Empowerment Network,Negative
10396,CllSociety BTK Chronic CLL Register,CancerCoachLive,Negative
10397,CLL DistillingIndustry SpiritsIndustry,Cowan Liebowitz,Negative
10399,AIM CLL Cello Health PLC Notification,AIM Alerts,Negative
10400,Don July five Register today,CURE Magazine,Negative
10413,CLL Ibrutinib Paolo Ghia Oncoalert EHAtrending OncoAlert,VJHemOnc,Negative
10415,Check Clinical Updates CLL,NACE,Negative
10416,summer CLL,Easterwood Airport,Negative
10417,CLL,Kathleen Hoffman,Negative
10423,AbbVie Genentech Reddy Venclexta three,Laura Smalley,Negative
10424,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10425,mdpijcm SpecialIssue Advances March two thousand and twentyone,JCM MDPI,Negative
10426,CLL,ganpurasu,Negative
10429,MedscapeEdu Bruton BTK Drs Jeff Sharman WVCancer,Medscape Education,Negative
10430,Test Before Treat,CLL Society Inc,Postive
10433,Patient Influencer CLL one,Michele,Postive
10434,obinutuzumab venetoclax v obinutuzumab Othman UniCologne HemOnc Oncoalert EHAtrending,VJHemOnc,Negative
10435,CLL,Victor Lin,Postive
10437,eighteen six FoxMemorial TatProud TatPremiers CLL Jack Colvin Park,Te Atatu Roosters Rugby League,Negative
10440,Educated Webinar today,CURE Magazine,Negative
10441,JackColvinPark today Enjoy CLL Te Atatu Roosters,Te Atatu Roosters Rugby League,Postive
10442,Gene Repertoire Chronic Lymphocytic CLL Agathangelidis et al Haematologica CLLsm,Mike Thompson MD PhD FASCO,Negative
10443,MBL CLL eleven two thousand and fifteen Strati Shanafelt BloodJournal CLLsm,Mike Thompson MD PhD FASCO,Negative
10444,CLL Lorna Warwick,AstraZenecaUS,Negative
10445,Updates American Society Hematology two thousand and annual,Current Oncology,Negative
10446,Join CllSociety August Anthony Mato MD CLL Register today,Lymphoma Research Foundation,Negative
10447,Janssen EMA Imbruvica Imbruvica two thousand and,Punit,Postive
10448,Jenn,Cancer Support Community,Negative
10449,CAR,Chimeric Antigen Receptor,Negative
10450,UK CLL UK CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
10451,CLL REVIEW MedscapeEdu,Medscape Education,Negative
10456,One day Acute Acute myeloid,nZyrh,Negative
10458,Saturday CLL FoxMemorial Jack,Te Atatu Roosters Rugby League,Negative
10459,Fortunate DukeFellows year ago DukeCancer,Danielle Brander,Postive
10463,New Research Increased Expression CLL,Frontiers Endocrinology,Negative
10464,Cannabis Industry Insight Trademark Registrations Continue Denied Foods Dietary Supplements,Cowan Liebowitz,Negative
10465,Leukemia,Anthony Mato,Negative
10466,Pleural CLL,Journal NCCN,Negative
10467,half,CURE Magazine,Negative
10469,four MTGCLL MTGO MTGLegacy CLL,Community Legacy League,Postive
10470,Comparison Access Novel Drugs India United States,Lymphoma Papers,Postive
10471,BSI,BSI Philippines,Negative
10472,CLL,Journal NCCN,Negative
10473,Dressler CLL Dog Cancer Answers,Dog Cancer Help,Negative
10474,CLL,Darko Antic,Postive
10475,Challenges CLL Management Webinar July two thousand and four CLL Challenges,Saudi Blood SSBD 'mrD ldm,Postive
10476,VIDEO BTK CLL Ibrutinib Lydia Scarfo Oncoalert EHAtrending OncoAlert,VJHemOnc,Negative
10477,CLL CLL Coutre StanfordMed,Patient Empowerment Network,Negative
10478,buscando un curso de ISO Conozca la guia BSI CLL BSIMexico,BSI Mexico,Negative
10479,Brian Marie,AstraZeneca Canada,Postive
10480,CLL,Kathleen Hoffman,Negative
10481,Comparison Access Novel Drugs India United States,Bloodbytes,Postive
10482,two thousand and twenty Read BSIUK CLL,BSI UK,Negative
10484,Herbalmedicines Cancer AML CLL,Saarumsciences,Negative
10485,eighteen August Join CLL Matt Davids Dana Farber Institute USA Brian Koffman CLL Society USA CLL Register,Lymphoma Australia,Negative
10486,weekend FoxMemorial Saturday CLL,Te Atatu Roosters Rugby League,Postive
10487,one Leukaemia BloodCancer CLL RoyalMarsden CancerCarer,MerMer Goodburn,Negative
10488,CLL CFR Tx BloodJournal Glad,chadi nabhan MD MBA FACP,Postive
10489,Expert Review Hematology zero CLL,Benlazar Amine,Negative
10490,CLL MRD CllSociety MRD CLL CLL,Michele,Postive
10491,CLL BloodJournal today JanRynne,CLL Ireland,Negative
10492,Combo Leads Better Outcomes Patients CLL,Patient Worthy,Negative
10494,Leukemia,Medivizor,Negative
10495,AIM CLL MILLENNIUM,AIM Alerts,Negative
10496,CLL,Duke Hematologic Malignancies Cellular Therapy,Negative
10497,Nicole Lamanna MD BTKInhibitors CLL Hematology CME CE MedEd ASCO,CCO Education,Postive
10498,Educated Webinar Wednesday July five ET Learn,CURE Magazine,Negative
10499,AIM CLL Cello Health PLC Total Voting Rights,AIM Alerts,Negative
10504,CLL today,Anthony Mato,Negative
10505,Leukemia,CancerEpiPapers,Negative
10506,CLL BloodJournal Equiv,Toby Eyre,Negative
10507,TGTX Phase two Evaluate Efficacy Safety Patients With Chronic,ClinicalTrialsData,Negative
10509,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10511,CLL,Mazyar Shadman MD MPH,Negative
10514,two thousand and twenty Venclexta Genentech Gazyva Venclexta CLL,dtw Research Inc,Negative
10515,July,Duke Cancer,Negative
10516,Glenn Sabin RadicalRemission CLL,Radical Remission,Negative
10519,AIM CLL MILLENNIUM,AIM Alerts,Negative
10520,Cody Steeves CLL Watch,Biologics McKesson,Postive
10523,CLL five bltwqyt lshrqy,khaleel Saeed,Negative
10525,Read second CLL,BSI UK,Postive
10526,chr,Medivizor,Negative
10528,Drs John Burke Manuel Santiago,Oncology CE,Negative
10529,Nancy Torres Sharon Clive Zent CLL WilmotCancer,URHemOncFellows,Negative
10530,HarvardCatalyst,Oncology Times,Negative
10531,CLL Joseph DiGiusepp,Dr Abdulsalam,Negative
10535,CLL,CLLSA,Postive
10537,CLL,Seema Ali Bhat,Negative
10542,Howick eighty metre TatReserves TatProud CLL The Howick Hornets,Te Atatu Roosters Rugby League,Negative
10543,CLL,Fact Minute,Negative
10544,Imbruvica,Alisyn Gayle,Negative
10545,one CLL,Tinu,Negative
10547,CLL Watch,SpecialtyPTimes,Postive
10549,Three first,ASH Clinical News,Negative
10550,CLL,Kathleen Hoffman,Negative
10557,CLL Othman UniCologne Oncoalert EHAtrending OncoAlert ImmunoOnc Leusm,VJHemOnc,Negative
10561,CARTcell,Muzaffar Qazilbash,Negative
10564,CLL MCL,Patient Worthy,Negative
10565,MD MURANO ASCEND CLL,MedPage Oncology,Negative
10566,autoimmune CLL,Reumatologia Xalapa,Negative
10567,AIM CLL Cello Health PLC Form Cello Health,AIM Alerts,Negative
10568,CLL Steven Coutre Btkinhibitor CARTcell CLLsm,Patient Empowerment Network,Negative
10569,CLL,deFacto Research,Negative
10570,CLL US approximately one third,AbbVie US,Negative
10572,Jacob Soumerai MD two CLL ASCO,MedPage Oncology,Negative
10579,Katelyn Brown Anything,Snaggle Tooth,Postive
10580,TatPremiers Howick FoxMemorial BeThere CLL Paparoa Park Home Of The Howick Hornets,Te Atatu Roosters Rugby League,Negative
10581,Thursday sixteen thirty Irish PatientPower CLL JanRynne DonnellyStephen,CLL Ireland,Postive
10582,CLL,CauseISaidSo,Postive
10584,This Saturday Waipareira TatPremiers FarrellyPhotos five FoxMemorial CLL GraemeMurdoch,Te Atatu Roosters Rugby League,Negative
10585,obinutuzumab CLL,Journal NCCN,Negative
10586,CLL Brian Koffman twelve Picks ASCO two thousand and seven,CLL Society Inc,Negative
10587,South NewJersey CLL Docs doc RutgersCancer RWJbarnabas,Patient Power,Negative
10588,CLL Brian Koffman twelve Picks ASCO two thousand and Number eight CL,CLL Society Inc,Negative
10589,AIM CLL Cello Health PLC Update,AIM Alerts,Negative
10590,California Irvine CLL Listen,Lymphoma Hub,Negative
10591,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10593,Zhong Mu Hei Hao Hua Jin Shi Long Er   Bao Si,ryuji,Negative
10594,CLL node,Fact Minute,Negative
10595,CLL Brian Koffman twelve Picks ASCO two thousand and Number nine CLL,CLL Society Inc,Negative
10596,Lazio Region Previous,Frontiers Oncology,Negative
10597,Rituximab HSCT CLL,Michael Maris,Negative
10598,Alert Supreme Court The Supreme Court CLL,Cowan Liebowitz,Postive
10599,South NewJersey CLL Docs doc RutgersCancer RWJbarnabas,Patient Power,Negative
10600,CLL,Medical Xpress,Negative
10601,AIM CLL Cello Health PLC Form Cello Health,AIM Alerts,Negative
10602,MedscapeEdu Bruton BTK Drs Jeff Sharman WVCancer,Medscape Education,Negative
10607,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10608,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10609,Leukemia,Medivizor,Negative
10610,CLL Brian Koffman twelve Picks ASCO two thousand and ten zanubrutinib obinutuzumab venetoclax,CLL Society Inc,Negative
10611,CLL Brian Koffman twelve Picks ASCO two thousand and eleven cirmtuzumab combination,CLL Society Inc,Negative
10612,Duvelisib CLL SLL,CrozrX,Negative
10613,RWJBarnabas RWJSomerset Community Oncology CLL Central NewJersey PatientPower,Andy Evens,Postive
10614,CLL Docs doc RutgersCancer RWJbarnabas,Patient Power,Negative
10616,BTK CLL CME,PeerView,Postive
10617,medtwitter mondaythoughts HarvardCatalyst,Oncology Times,Negative
10619,USouthFlorida TGTherapeutics Treg,Renee Fonseca,Postive
10620,AIM CLL MILLENNIUM,AIM Alerts,Negative
10621,md lymfekraeft,LyLe Foreningen,Postive
10622,CLL Brian Koffman twelve Picks ASCO two thousand and twelve CLL US Veterans Health Administration,CLL Society Inc,Negative
10623,CLL,Adrian Warnock,Negative
10626,AIM CLL BARCLAYS PLC,AIM Alerts,Negative
10627,Check Reviewing,Medivizor,Negative
10628,AML CLL,Sapien Biosciences Pvt Ltd,Negative
10629,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10630,AIM CLL Cello Health PLC Publication Scheme Document,AIM Alerts,Negative
10631,CLL,Kathleen Hoffman,Negative
10632,CLL,Andrew Schorr,Negative
10633,one TatPremiers Saturday FoxMemorial TatProud TatPremiers CLL Richmond Lynn Park,Te Atatu Roosters Rugby League,Negative
10635,Davids,Targeted Oncology,Negative
10636,CLL three CLL APTO eight hundred and six,Helen Ong,Negative
10637,CLL last year PatientPower JanRynne,CLL Ireland,Postive
10639,CLL TapKadia,Naveen Pemmaraju MD,Negative
10641,one two eight eleven CLL,JAMA Oncology,Negative
10642,Scarfo ERIC European Research Initiative CLL CLL,paper link,Negative
10645,BTK CLL,OncLive SOSS,Negative
10650,US Food Drug Administration Bruton Potential,Lymphoma Papers,Negative
10651,TatPremiers twenty sixteen FoxMemorial TatProud TatPremiers CLL Lynn Park,Te Atatu Roosters Rugby League,Negative
10652,NJ CLL RutgersCancer RWJBarnabas doc Sign UberEats CLL Register,Karen Kobleur,Postive
10653,Scan today OOUT MRL KWG,SwingTradeBot UK,Postive
10654,Scan Hammer Candlestick today AAVC ACC IIT JWNG NFX SRB,SwingTradeBot UK,Negative
10655,today TatPremiers Round four FoxMemorial Roosters CLL,Te Atatu Roosters Rugby League,Negative
10656,next week three CLL RWJBarnabas Dinner RutgersCancer,Andy Evens,Negative
10657,one two thousand and twenty summer year one one last year,Jeff Neurman,Negative
10658,two thousand,akonter,Negative
10659,EHA HemOnc CLL,VJHemOnc,Negative
10660,US FDA Bruton Potential,ACS Journal Cancer,Negative
10662,AIM CLL BARCLAYS PLC,AIM Alerts,Negative
10666,Davids,Targeted Oncology,Negative
10667,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10669,weekend TatPremiers CLL Richmond Bulldogs Grey Lynn Park,Te Atatu Roosters Rugby League,Negative
10670,Click,Home Journal,Negative
10671,six month today Numbers one six month,David Garrison,Postive
10672,CLL ERIC CLL Campus,Jaksic,Negative
10674,tonight Sign Tumor Board Series Click,Home Journal,Negative
10675,Today UCSDHealth,Andrew Schorr,Postive
10676,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10678,BTK CLL,Blood Journal,Negative
10679,WGS Check Fantastic Ferran Nadeu Elias Campo NHL CLL,Francesco Maura,Postive
10680,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
10681,two thousand and fourteen Tammi third Tammi today Webcast EDT Register today,LLSCanada,Postive
10689,TatReserves TatPremiers FoxMemorial BeThere Saturday CLL,Te Atatu Roosters Rugby League,Postive
10690,Tonight,Community Legacy League,Negative
10691,Bruce Raphael MD,OncLive SOSS,Negative
10693,fourteen tonight MTG CLL four,Community Legacy League,Negative
10694,Sign Tumor Board Series Click,Home Journal,Negative
10695,Davids,Targeted Oncology,Negative
10696,Davids,Targeted Oncology,Negative
10697,Rituximab MABLE,FarmaciaHUAP,Negative
10698,TF seven CTCF,Victor Lobanenkov,Negative
10699,Davids umbralisib lymsm,Targeted Oncology,Negative
10700,CLL,Blood Advances,Negative
10702,CLL North Central South NewJersey doc Register,Patient Power,Negative
10703,CLL JohnPLeonardMD DrMDavids,BioAscend,Negative
10704,Drs Andrew Evens Kathy Toomey Seth Cohen Robert Grossman,RutgersCancerInstNJ,Negative
10705,TGTherapeutics Treg CLL Treg,DDNews Online,Negative
10707,three one,Journal Medical Surgical Pathology,Negative
10708,CLL,AAROnJHILL,Negative
10709,CLL,deFacto Research,Negative
10712,Virtual MRD,healthbook,Negative
10713,CLL,Kathleen Hoffman,Negative
10714,TGTX TG Therapeutics Engages CLL NHL MS BRB Weekly,Ian McMillan CMT,Negative
10715,next week Rutger CINJ,Karen Kobleur,Postive
10716,one CLL April one realized morning one,Yvonne Evans,Negative
10717,one two hundred mile one Cancer Research UK,Alison Fox,Negative
10719,Tumor Board Series Click,Home Journal,Negative
10720,CLL,Journal NCCN,Negative
10723,Canada,Current Oncology,Negative
10728,Bruce Raphael MD,OncLive SOSS,Negative
10729,India JCOGO,ASCO Publications,Negative
10730,HPV CLL,Journal NCCN,Negative
10731,Virtual Support Group July eight pm EDT AML CLL,AnCan,Postive
10732,Davids,Targeted Oncology,Negative
10733,fifty today HWG CLL,SwingTradeBot UK,Negative
10734,CME BTKinhibitors CLL,PeerView,Postive
10735,CLL fourteen Drs Andrew Evens Kathleen Toomey Seth Cohen Robert Grossman Register,RU Cancer Patient Education,Negative
10736,AIM CLL Cello Health PLC Form Cello Health,AIM Alerts,Negative
10738,Barriers Proceeding Stem Cell,Leukemia,Negative
10740,last Today day first two thousand and twenty season EQA NTRK CLL EQA,GenQA Genomics Quality Assessment,Negative
10741,July Register CLL,CLLSA,Negative
10745,Mum March Tomorrow one,Claire,Negative
10746,CLL WeillCornell Oncoalert EHAtrending OncoAlert Leusm,VJHemOnc,Negative
10747,CLL,CLL Society Inc,Postive
10750,CLL Watch Astrid PDF,Lymphoma Hub,Negative
10751,CLL CLL Montserrat,Centro Medico Teknon,Negative
10753,three,Targeted Oncology,Negative
10756,twenty year Venetoclax twenty year Walter Eliza Hall Institute,STEMLORD,Negative
10757,MRD CLL August,Anthony Mato,Postive
10758,Leukemia,Medivizor,Negative
10764,Tumor Lysis Syndrome With Inhibition After CAR Therapy Chronic Phari,Chimeric Antigen Receptor,Negative
10765,MolecularTechniques Myeloid CML Acute AML Acute Lymphocytic,Jacinto Convit World Organization,Postive
10766,Prognostic Predictive Molecular Biomarkers Chronic MolDx Molpath,Pathology Alerts Guidelines Reviews,Negative
10767,CLL,Kathleen Hoffman,Negative
10768,Tumor Board Series,Home Journal,Negative
10769,New Jersey CLL Community three Docs Limited fifty UberEats NewJersey RutgersCancer RWJBarnabas,Patient Power,Negative
10771,CLL JohnPLeonardMD CLL,BioAscend,Negative
10772,Bruce Raphael MD,OncLive SOSS,Negative
10779,AIM CLL Cello Health PLC eight OPD Cello Health,AIM Alerts,Negative
10780,Michael Choi,OncLive SOSS,Negative
10781,Turmeric Natural Prevention Treatment Chronic,Kyle Norton,Negative
10783,WEGO Health Awards,Michele,Postive
10784,Between March April two thousand and twenty seven CLL rituximab obinutuzumab ibrutininb FCR five two,Michael Hallek,Negative
10785,one Dad Grandpa JulyBirthday LLS CLL MDS,Katie Scherhaufer,Postive
10786,CLL Learn,SpecialtyPTimes,Negative
10787,two CllSociety Tribune today CLL,Shouting people underpants,Postive
10789,Thursday July two CLL UCSDHealth Fixed Duration Therapy Other Leusm,Patient Power,Negative
10790,Mazyar Shadman,CURE Magazine,Postive
10791,Leukemia,Medivizor,Negative
10796,AIM CLL Cello Health PLC eight Cello Health,AIM Alerts,Negative
10797,Central Southern Northern NewJersey RutgersCancer CLL RWJBarnabas PatientPower Only two week,Andy Evens,Negative
10798,two thousand and,Stock Market News,Negative
10799,OncoAlert CLL twelve ATM CLLsm,Raul Cordoba MD PhD,Negative
10800,Davide Rossi MD Oncology Institute Southern,HemOnc Today,Negative
10801,Mark,RWJBarnabas,Negative
10802,Expansion Breakout today HAYD CLL,SwingTradeBot UK,Negative
10803,Scan Signal Line Cross today CLL,SwingTradeBot UK,Postive
10804,Scan Week Closing High today HAYD CLL BVC IGG,SwingTradeBot UK,Negative
10805,Scan Above fifty DMA today CLL SUMO,SwingTradeBot UK,Negative
10807,fourteen Drs Andrew Evens Kathy Toomey Seth Cohen Robert Grossman Register,RutgersCancerInstNJ,Negative
10808,CLL,Blood Journal,Negative
10809,CLL obinutuzumab venetoclax,Blood Journal,Negative
10810,one CLL morning thirteen one,John,Postive
10812,CLL CLL,Proactive,Postive
10814,CLL Market Report FTSE one hundred eight year CLL,Proactive,Negative
10819,CLL one,Sigrid Skanland,Negative
10820,CLL Cello Health CLL,Proactive,Negative
10821,one CLL one,WheelieDealer,Postive
10822,Marice Alcantara PhD FionaElseyCRI Dr Alcantara City Hope,Federation University,Postive
10827,FDA Orphan Drug mclsm lymsm,Targeted Oncology,Negative
10828,FDA Orphan cirmtuzumab v mantle cell BreastCancer CanaleComm,DDNews Online,Negative
10829,David Lauterstein Nasty Pig two thousand and twenty PRIDE LGBTQ CLL COWANLIEBOWITZ,Cowan Liebowitz,Postive
10830,Orphan Drug Designations ODD Cirmtuzumab Mantle Cell,BioPharma Global,Negative
10831,New Reviewing,Medivizor,Negative
10833,four CME CLL Lots lymsm,RedMedEd,Negative
10834,VIDEO Sequence CLL DanaFarber Oncoalert EHAtrending,VJHemOnc,Negative
10835,Tumor Board Series,Home Journal,Negative
10836,Assay,MyJournals,Negative
10839,ONCT Oncternal Therapeutics Announces Orphan Drug,OTC Dynamics Inc,Negative
10840,one one one CLL,Amber Koehler,Postive
10842,three first Mazyar Shadman,CURE Magazine,Negative
10843,ONCT June,Flash Alert,Negative
10844,UTSWNews BTK,OncLive SOSS,Negative
10845,Covid two thousand and Analysis By Global Industry Revenue Share Size Status Growth Rate Services two thousand and twentythree,Swapna Supekar,Postive
10846,Bruce Raphael MD,OncLive SOSS,Negative
10847,MayoClinic CLL,Mayo Clinic Cancer Center,Negative
10848,Michael Choi,OncLive SOSS,Negative
10850,CLL Checalo,Ivan Gonzalez,Negative
10851,Thursday July two CLL UCSDHealth Fixed Duration Therapy Other Leusm,Patient Power,Negative
10852,PhD Anne Martens CLL,Fleur Peters,Negative
10853,today CLL David Allsup CLL Helen Knight UkCll CLLSupport,Nick,Negative
10854,CLL Lydia Scarfo Oncoalert EHAtrending,VJHemOnc,Negative
10855,Venetoclax Lucius Pharma CLL,MedsDots,Negative
10858,CLL,Kathleen Hoffman,Negative
10859,Nicole Lamanna MD BTKInhibitors CLL Hematology CME CE MedEd ASCO,CCO Education,Postive
10861,CLL JanRynne,CLL Ireland,Postive
10862,CLL tomorrow CLL webinar gt,Leukaemia Care,Negative
10863,CLL Society ASH two thousand and nineteen ASH two thousand and nineteen John Pagel Alexey Danilov Danilov CLL,CLL Society Inc,Postive
10864,Lymphoma June two thousand and twenty,Michele,Negative
10865,Coronavirus Risks People With Chronic CLL,MoonAngelWings NO DM,Negative
10866,MRD CLL,MDedge Hematology Oncology,Negative
10868,four CLL,CURE Magazine,Negative
10870,CLL CLL,Toby Eyre,Negative
10876,Niemann RWD CLL,Kimmo Porkka,Postive
10878,one Montanans Daines ACA,Olivia Bercow,Negative
10879,DART molecule treatment CLL Journal,Benlazar Amine,Negative
10880,CLL,Targeted Oncology,Negative
10881,CLL Watch,SpecialtyPTimes,Negative
10883,CLL,Journal NCCN,Negative
10884,CLL,How Much Do Make,Negative
10885,DART molecule treatment,Lymphoma Papers,Negative
10890,August New England Journal Medicine NEJM CLL three MercuryRetrograde,AstrologyNewsNetwork,Negative
10892,CLL,Journal NCCN,Negative
10899,BTK,Targeted Oncology,Negative
10904,OncoAlert CLL obinutuzumab venetoclax American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
10905,OncoAlert Genetics CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
10906,MRD CLL,MDEdge,Negative
10907,Steven Coutre StanfordMed CLL,Patient Empowerment Network,Negative
10908,Five CLL,`bdllh bn `ly lsrHny Dr AL Serhani,Negative
10909,Five CLL,`bdllh bn `ly lsrHny Dr AL Serhani,Negative
10910,CLL,Cowan Liebowitz,Negative
10912,CLL Connections Docs Central NJ,MyelomaTeacher Cindy Chmielewski,Negative
10922,BJH Unexpected two,BSH Haematology,Negative
10923,CLL Mary Ann Anderson John Seymour CLL,Thomas Eliot Lew,Postive
10926,Mosaic ninety CLL,Marwan Shinawi,Postive
10927,BTK CLL,Blood Journal,Negative
10928,one,Jeff Neurman,Negative
10929,Cllstrong,Brave Is,Negative
10930,Charlie Rogers,CONQUER patient voice,Negative
10932,CLL,bio technerd,Negative
10936,Healthy Korean Individuals With two thousand and twenty forty five Korean Society Laboratory Medicine,Annals Laboratory Medicine,Negative
10937,Blood American Society Hematology CLL,Toby Eyre,Negative
10938,Links CACHEORG EYE fifteen CLL EYtwittertagteam EYTagteam,Early Years LSC FE VocEd EYFS,Postive
10939,CLL,How Much Do Make,Negative
10942,CLL,Kathleen Hoffman,Negative
10943,Bruton,SpecialtyPTimes,Negative
10944,CLL,Rajesh Sharma,Negative
10945,Therapeutics Market Tremendous Growth Near Future two thousand and twenty two thousand,Priti Sharma,Negative
10946,two two thousand and twenty ASCO,Home Journal,Negative
10947,SNSS BTK two CLL,MAISA,Negative
10948,Read Oncology CLL,ecancer,Negative
10952,Drs John Burke Manuel Santiago,Vindico Medical Education,Negative
10953,BTK,OncLive SOSS,Negative
10956,two thousand,Nita Sonwane,Postive
10957,CLL CLL Coutre StanfordMed,Patient Empowerment Network,Negative
10958,ONCT Oncternal Therapeutics get FDA Orphan Drug Designation Cirmtuzumab,TradeHawk,Negative
10959,Restaurant Industry Insight Registering Descriptive Restaurant Name,Cowan Liebowitz,Negative
10961,Matt The Wednesday CLL,MerMer Goodburn,Postive
10962,Virtual Annual,Cancer Medicine,Negative
10963,Nikos Sousos MF LPD Rapid Emergence,Adam Mead,Negative
10964,Dra Adriana Scheliga CLL,hemomeeting,Negative
10966,CLL,Garbine Lizeaga,Negative
10967,Michael Choi MD,OncLive SOSS,Negative
10968,Immunoglobulin Gene Analysis,Fabrice Leclerc,Negative
10969,Immunoglobulin Gene Analysis,SeqComplete,Negative
10970,Immunoglobulin,CompBiolPapers,Negative
10971,two first CLL Much IgHV Interestingly HallekMichael,chadi nabhan MD MBA FACP,Postive
10972,CLL CLL,Dr Effie Kostareli,Postive
10974,Bruton CLL,JTH,Negative
10976,CLL,Oncology Publishers Feed,Negative
10981,RA Chronic CLL,India Oncology,Negative
10983,ALS ALS,Captain Syn,Negative
10984,CLL two thousand and twenty Summarize Congrats Moreno,linfopedia,Postive
10985,Immunoglobulin Leukemia,Richard Rosenquist Brandell,Negative
10986,Hairy McClary CLL EYtwittertagteam EYTagteam,The EY Tagteam,Postive
10987,CllIreland EHA CLL,SeqComplete,Negative
10988,Gabriela Forestieri Institute Oncology Research IOR CLL CLL,Lymphoma Hub,Negative
10989,Sonali Sharma MasarykUni University Hospital CLL,Lymphoma Hub,Negative
10990,Fabienne CLL,Lymphoma Hub,Negative
10991,Andy Rawstron UniversityLeeds CLARITY CLL,Lymphoma Hub,Negative
10992,Michallet CLL,Lymphoma Hub,Negative
10993,CLL Carsten Niemann,VJHemOnc,Negative
10994,ERIC Mutations CLL Relapsing Ibrutinib,CLL Advocates Network,Negative
10995,Ibrutinib CLL,CLL Advocates Network,Negative
10996,Othman UniCologne CLL fifty uMRD two year,Lymphoma Hub,Negative
10997,CLL View EHA,VJHemOnc,Negative
10998,Venetoclax CLL Arnon Kater View EHA,VJHemOnc,Negative
10999,Next Generation CLL Dcollinsflynn,Michael Rynne,Postive
11000,Carsten Niemann Rigshospitalet CLL,Lymphoma Hub,Negative
11001,EHA CLL,CLL Ireland,Negative
11004,CLL JanRynne,CLL Ireland,Negative
11005,Gianluca Gaidano University Eastern Piedmont today CLL,Lymphoma Hub,Negative
11006,CLL,Lymphoma Hub,Negative
11007,CLL today Answering Carol Moreno CllSociety CllSociety,CLL Advocates Network,Negative
11008,CLL Tools CLL LeukaemiaCareUK CllSociety JanRynne CllIreland,CLL Advocates Network,Negative
11009,Tanya Siddiqi CLL CAPTIVATE CLL,VJHemOnc,Postive
11010,leuke medivizor,Medivizor,Negative
11011,Venetoclax CLL VENICE one Arnon Kater,VJHemOnc,Negative
11012,First EHA Venetoclax Obinutuzumab Ibrutinib Venetoclax Impressive LornaWarwick CllIreland,CLL Advocates Network,Postive
11023,three CLL Othman UniCologne Watch,VJHemOnc,Negative
11024,BTK CLL Ibrutinib Lydia Scarfo,VJHemOnc,Negative
11025,Today CLL HARMONY View CLLAdvocates Ericllorg,HARMONY Alliance,Postive
11026,CLL Irish JanRynne CllSociety CLLSupport,Michael Rynne,Negative
11027,Tumor Lysis Syndrome,Lymphoma Papers,Negative
11029,CLL,Guillermo,Negative
11030,Bad Blood annual Thursday night,Nancy Zurawski,Negative
11032,CLL Steven Coutre StanfordMed,Health Content Collective HCC,Negative
11033,CONGRESS Carol Moreno HospitalSantPau CLL,Lymphoma Hub,Negative
11034,CLL,Journal NCCN,Negative
11035,CONGRESS Stuart UniCologne AKT CLL,Lymphoma Hub,Negative
11036,Secondary School Research CLL SOC JCMM,Petr Taus,Negative
11038,CLL MRD,Biologics McKesson,Negative
11039,CLL Care Finally Returning Normal,Brave Is,Negative
11040,five Richters CR,Adam Kittai,Postive
11041,CONGRESS Junyan Lu CLL,Lymphoma Hub,Negative
11042,Meets CLL Limited Evidence Offers Some Hope Good Outcomes Cancer Therapy,Oncology Publishers Feed,Negative
11043,two,Targeted Oncology,Negative
11045,Next Webinar Wednesday July Ben Kennedy CLL,CLLSA,Postive
11047,CLL,Garbine Lizeaga,Negative
11048,New Medivizor Leukemia,Medivizor,Negative
11049,CLL,Journal NCCN,Negative
11050,CLL month CLL CLLsm,Raul Cordoba MD PhD,Negative
11051,OncoAlert BTK CLL CLLsm,Raul Cordoba MD PhD,Negative
11052,Seema MD two Venetoclax ASCO CLL,MedPage Oncology,Negative
11054,two thousand and twenty NCCN Virtual Annual,Targeted Oncology,Negative
11055,Scan Stochastic Sell Signal BVIC IQE CLL,SwingTradeBot UK,Negative
11056,Learn Zanubrutinib Leukemia,Medivizor,Negative
11057,Otto Trautz Vermont June two thousand and UVM Medical Center,VTDigger,Negative
11058,CLL David Allsup CLL Helen Knight UkCll CLLSupport,Nick,Negative
11059,one one one Leukaemia BloodCancer CLL,MerMer Goodburn,Negative
11060,CONGRESS Lydia Scarfo BTK CLL ERIC BTK,Lymphoma Hub,Negative
11061,Constriction Pain agg Blood Leukemia Anemia,Maria Marta,Negative
11062,Matutes Holding Matutes CLL,Benlazar Amine,Postive
11064,CONGRESS Tanya Siddiqi SLL MRD,Lymphoma Hub,Negative
11065,CLL Join NitinJainMD Alexy Danilov CLL CLL,Patient Power,Negative
11066,Henriette Huber CLL CI,Lymphoma Hub,Negative
11067,Today Register CLL Society Virtual Community Meeting June eighteen Kimberly Hanson Susan Leclair,CLL Society Inc,Negative
11068,leuke via,Medivizor,Negative
11071,one one MERVENDALPS,MerMer Goodburn,Negative
11073,CLL,Kathleen Hoffman,Negative
11077,Tomorrow CLL Join NitinJainMD Alexy Danilov CLL CLL,Patient Power,Negative
11078,CLL Dr Brian Koffman JanRynne,CLL Ireland,Negative
11079,BTKInhibitors CLL,PeerView,Postive
11080,thirty year ACRCaseinPoint,ACR Radiology,Negative
11081,Tomorrow Register CLL Society Virtual Community Meeting June eighteen Kimberly Hanson Susan Leclair,CLL Society Inc,Negative
11091,Hetero Healthcare Launches,Hetero Healthcare,Negative
11093,CLL Watch,SpecialtyPTimes,Negative
11094,Congress Coverage Focus CLL Morschhauser Witzig Ansell Eichhorst Rummel PL Zinzani,Raul Cordoba MD PhD,Postive
11095,Andrew Ip Susan Brien MD CLL Register today,MJH Life Sciences,Negative
11096,BTKInhibitors CLL,PeerView,Postive
11097,BTKInhibitors CLL,PeerView,Postive
11100,Safety Preliminary Efficacy Study Combination,CureHuntr,Negative
11102,ERIC CLL CLL,GenQA Genomics Quality Assessment,Postive
11103,two thousand,Market Research,Negative
11104,Tirabrutinib Combination Idelalisib Entospletinib Previously Treated Chronic,ScottWaudbyHaemResLeics,Negative
11105,Covid two thousand and twentythree,Swapna Supekar,Negative
11106,European Hematology Association Australia CLL,Lymphoma Australia,Negative
11107,CLL,Blood Journal,Negative
11108,Steve Watch,Cancer Support Community,Negative
11109,Lynn Chronic CLL,Cancer Support Community,Negative
11111,Jenn Leukemia Learn CLL,Cancer Support Community,Negative
11112,CLL CLL Steve Lynn Learn Chronic,Cancer Support Community,Negative
11113,Flag Day Greetings flagday,Cowan Liebowitz,Negative
11114,al zanubrutinib obinutuzumab ZanuO MRD two BM mFup PB uMRD Rx Impressive CLL,Toby Eyre,Negative
11115,BTKinhibitors CLL twelve PM EDT CEST,PeerView,Negative
11116,AIL ASSOCIAZIONE ITALIANA LE,Pacientes LMC,Negative
11117,Marsden next week one Matt Leukaemia BloodCancer CLL,MerMer Goodburn,Negative
11120,CLL NHS Ibrutinib Venetoclax CLARITY,TAP Clinical Trial Network,Postive
11122,CLL Recommendations Gianluca Gaidano University Eastern Novara COVID lymsm,Jennifer Smith,Negative
11123,twentyfour hour Please RT CLL FuckCancer Donate Myelofibrosis Leukemia,CurlieCutiePie,Postive
11124,CLL CLL andrewschorr MicheleNadeemB DanaFarber,Patient Power,Negative
11125,Janice Gabrilove IcahnMountSinai,The Tisch Cancer Institute,Negative
11126,Ibrutinib Venetoclax CLL twelve month CllSociety LornaWarwick,CLL Advocates Network,Postive
11127,CLARITY Ibrutinib CLL,CLL Ireland,Postive
11128,CLL REVIEW MedscapeEdu,Medscape Education,Negative
11129,Rawstron al MRD UK CLARITY CLL two two month MRD MRD CLL,Toby Eyre,Postive
11130,Lydia Scarfo Leukemia CLL,VJHemOnc,Negative
11131,Scarfo al BTK ERIC fifty BTK BTK sixteen Ix CLL,Toby Eyre,Negative
11132,Michallet Response BM MRD obinutuzumab CLL FC,Toby Eyre,Postive
11133,Check Zanubrutinib,Medivizor,Negative
11134,Hodgkin,Lymphoma Papers,Negative
11136,second Mantle Cell day,Luis Villela,Negative
11137,Aktuelle CLL Myelom iNHL aNHL moderiert von Anmeldung,Kompetenznetz Maligne Lymphome,Negative
11138,Lab Apr ten,Author Curator,Negative
11139,CLL OncologyTrials,Michele,Negative
11141,Tanaan,Suomi Lacrosse,Negative
11142,CLL,Seema Ali Bhat,Negative
11143,New Medivizor,Medivizor,Negative
11151,BTKis CLL,Thomas Eliot Lew,Postive
11152,one hundred Spanish,Pavithran,Negative
11153,Lee,Targeted Oncology,Negative
11154,today CLL EHA Prof Gribben CllSociety CllIreland,CLL Advocates Network,Negative
11155,CLL EHA CLL EHA Prof Gribben JanRynne,CLL Ireland,Postive
11158,Unbelievable CLL,George,Postive
11159,ten,Tong,Negative
11160,Arnon Kater VENICE one three CLL,LYMPHOMA MYELOMA CONNECT,Negative
11161,CLL MRD TheUSONetwork,Patient Power,Negative
11162,CLL,Hematology Advisor,Negative
11163,Heute Abend Ihnen Beginn de hematologytoday Clemens Wendtner von der Sein Thema CLL Jetzt regsitrieren hematology,medtoday Germany,Negative
11164,Sonali Sharma EHA CLL,Mraz Lab,Postive
11165,CLL CLLsm,Janssen EMEA,Postive
11166,CLL,Kathleen Hoffman,Negative
11167,APTO CLL seven lymphocyte count week,Joe,Postive
11169,Sidnavigare DrRaulCordoba spanish CLL BritSocHaem,Toby Eyre,Negative
11172,Wednesday Peter Hillmen CLL,CLLSA,Negative
11176,six Datos CLL el anciano de la leucemias de Gumprecht de celulas,Prometheus Trainee,Negative
11177,three BTK,Targeted Oncology,Postive
11178,Leukemia,Medivizor,Negative
11179,first BTKinhibitors CLL June twelve PM EDT,PeerView,Negative
11180,Scan Centerline Cross today CMCX VRS RWA GHT,SwingTradeBot UK,Negative
11181,OncoAlert Novel CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
11183,Matthias Bottcher Mougiakakos CLL,Alessandro Donada,Postive
11184,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
11185,CLL,RedMedEd,Negative
11186,CLL,linfopedia,Negative
11187,GCLLSG,linfopedia,Negative
11189,Spanish,Lymphoma Papers,Negative
11194,CLL PeerView CME,Alicia Enrico,Negative
11195,One Chronic two thousand and eleven,Deborah Reynolds,Postive
11196,CLL Jennifer Woyach,Adam Kittai,Postive
11199,Jennifer Woyach ten Award Learn Woyach Chronic ten TopTen,Clinical Research Forum,Postive
11200,CLL,RedMedEd,Negative
11201,Spanish,Garbine Lizeaga,Negative
11202,CarersWeek one CLL,AbbVie UK,Postive
11203,three,James Kerwin,Negative
11204,Btk ARQL LOXO SNSS CLL,BiopharmIQ Amp,Negative
11206,CALISMASI REJIMININ UZUN DONEM kll kroniklenfositiklosemi memorialatasehirhematoloji obinutuzumab profdrhisari,Ismail Sari,Negative
11207,CLL,Jill Lykon PharmD BCOP,Negative
11208,June ten pm Eastern AML CLL CureLeukaemia,AnCan,Postive
11211,Paraneoplastic Pemphigus An Indication Treatment Chronic,Cureus,Negative
11212,Nicole Lamanna MD BTKInhibitors CLL Hematology CME CE MedEd ASCO,CCO Education,Postive
11214,CLL SLL eight billion one hundred and thirty million two hundred and ninety thousand nine hundred and fifteen China Cambodia Indonesia canada Malaysia Thailand Vietnam Hong Kong UAE Ireland Barbados Estonia,The Indian Pharma,Negative
11217,NEW Zanubrutinib,Medivizor,Negative
11223,UkCll CLLSupport CLL third CLL,Leukaemia Care,Negative
11224,LYMPHOCYTIC CLL,Pearl David,Negative
11226,China Brukinsa,China Science,Negative
11227,Leukemia,Medivizor,Negative
11228,Oxford Gene Technology SureSeq CLL CNV NGS,Clinical Lab Products Magazine,Negative
11229,One one CLL,linfopedia,Postive
11231,CME BTK CLL June eight AM CEST,PeerView,Negative
11232,Minutes Ed Bradley Thursday Mount Sinai Hospital Manhattan,Nancy,Negative
11234,CLL Dr Brian Koffman CLL Virtual Community JanRynne,CLL Ireland,Postive
11235,RNA International Natural,Fabrice Leclerc,Negative
11236,CLL,Kathleen Hoffman,Negative
11237,Randomized Dose Optimization Study Chimeric Antigen Receptor,INDoximity,Negative
11238,CRBIOTECH Phytochemicals,International Natural Product Sciences Taskforce,Negative
11241,one August two thousand and twelve two thousand and seventeen one Keep,Bennia Johnson,Negative
11242,CLL one year Chart,WheelieDealer,Postive
11243,CLL Comparable AE two CLL,Marta MD,Negative
11244,autoimmune hemolytic anemia association,EurekaMag,Negative
11245,Ken Hill Pinehurst FirstHealth CancerSurvivors,FirstHealth,Negative
11247,Ed Bradley Thursday Mount Sinai Hospital Manhattan Ed Bradley Dead CBSNews,Patricia Limbacher,Negative
11250,CLL JanRynne CllSociety,CLL Ireland,Postive
11253,BloodJournal CLL HallekMichael,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
11257,Assessing Minimal Residual Disease Generation Sequencing Minimize Exposure People,TrialBulletin,Negative
11258,Popular Research Chronic,Oncology Times,Negative
11259,Imbruvica MCL CLL,CURE Magazine,Negative
11260,CLL CLL Clinically BCR FNBrno,Bryjalab,Negative
11263,fourteen twenty Aktuelle CLL Myelom iNHL aNHL moderiert von Anmeldung,Kompetenznetz Maligne Lymphome,Negative
11265,two thousand and twelve Tait Shanafelt StandfordWellMD burnout two thousand and twenty ColumbiaMed MIND BLOWN one CLL,Katrina Sondermann,Postive
11266,Scan Signal Line Cross today MPH,SwingTradeBot UK,Negative
11267,FDA Update Ibrutinib,Oncology Times,Negative
11268,Mike Boston Patient Power AndrewSchorr CAR,Patient Power,Postive
11269,Today CLL WCMCLymphoma WeillCornell,Patient Power,Negative
11271,Updates American Society Hematology two thousand and annual,Lymphoma Papers,Negative
11272,CLL,Lymphoma Papers,Negative
11279,eBook two thousand and nineteen,AplusA World,Postive
11281,CLL,Joslyn Rudoni PharmD BCOP,Postive
11283,CLL,Kathleen Hoffman,Negative
11284,CLL,Jeff Baron PharmD BCOP,Negative
11287,Leukemia Watch Alessandra Ferrajoli CLL,Patient Power,Negative
11288,three CLL BloodJournal,GEDEFO,Negative
11289,Tomorrow CLL WeillCornell,Patient Power,Negative
11290,CLL Lots,Blood Cancer Uncensored,Postive
11291,Nationwide Epidemiological Study Leukemia Lymphoma Vol six Advanced Binet,Izaskun Zeberio,Negative
11293,CLL REVIEW MedscapeEdu,Medscape Education,Negative
11295,BeiGene Announces Approval Of BRUKINSA In Mantle Cell,Quant Data,Negative
11296,BGNE BeiGene,Stock Titan,Negative
11300,CLL Constantine Tam PeterMacCC HemOnc,VJHemOnc,Negative
11302,Register CLL,LLSCanada,Negative
11303,Nicole Lamanna MD BTKInhibitors CLL Hematology CME CE MedEd ASCO,CCO Education,Postive
11304,tomorrow CLL one hundred DM,Community Legacy League,Postive
11305,New Medivizor Zanubrutinib,Medivizor,Negative
11308,Leukemia Radar,Leukemia,Negative
11309,BTK,OncLive SOSS,Negative
11310,CLL,Blood Cancer Uncensored,Negative
11311,AI ML CLL Read Virtual Scientific Program,IQVIA,Postive
11312,NIH GMWatch,GMO Free USA,Negative
11315,UK LeukaemiaCareUK CLLSupport CLL,CLL Advocates Network,Negative
11316,CLL,Oncology Times,Negative
11317,CLL,Jake Soumerai,Postive
11318,CLL Chronic CLL MCL BCR,LiteratureFeed,Negative
11319,Annual CLL,Lymphoma Hub,Postive
11322,CLL Guardians LeukemiaJnl,Klaus Okkenhaug,Postive
11323,Zanubrutinib obinutuzumab CLL first two MRD,Taylor Lab UM,Negative
11325,mab CLL,Toby Eyre,Postive
11326,CONGRESS Cirmtuzumab mAb Hun Ju Lee CLL,Lymphoma Hub,Negative
11327,one one Heme CLL MPNsm,Taylor Lab UM,Negative
11329,CONGRESS three CLL,Lymphoma Hub,Negative
11330,CONGRESS three WVCancer CLL ORR PFS,Lymphoma Hub,Negative
11334,CLL CLL Ibrutinib fifty CR five CLL,Mariam Alasfour,Negative
11335,Catching Nice Venetoclax CLL fifty CR two Great,Taylor Lab UM,Postive
11336,first day two thousand and twenty Virtual Annual Meeting,Lymphoma Hub,Negative
11337,first MURANO two thousand and eighteen Venclexta rituximab,Managed Healthcare,Postive
11338,CLL AdamKittai one one Twitter,Amber Koehler,Negative
11339,Scan Stochastic Buy Signal CLL,SwingTradeBot UK,Negative
11340,Scan today CLL,SwingTradeBot UK,Negative
11341,Chronic,EurekaMag,Negative
11342,CLL LRF Financial Assistance Grant,Lymphoma Research Foundation,Postive
11344,Carlos Carrasco,Fuzzy,Negative
11345,CLLSupport UkCll CLL first two,Leukaemia Care,Negative
11346,Hematologia,Biosimilar Today iMagazine,Negative
11347,Chronic CLL,Patient Power,Negative
11349,TG Therapeutics Announces Final Results GENUINE Phase three,Pharmacutical Daily,Negative
11350,TG Therapeutics Announces Final Results GENUINE Phase three,Pharmacutical Daily,Negative
11351,CONGRESS CLL,Lymphoma Hub,Negative
11352,CLL Tune PatientPower June four EST CLL John Allan,WCM Lymphoma,Negative
11353,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,OTC Dynamics Inc,Negative
11354,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,Stock Titan,Negative
11355,TG Therapeutics Announces Final Results GENUINE Phase three Ibrutinib Previo,Crwe World,Negative
11357,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,dough,Negative
11358,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,Jake,Negative
11359,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,The Stock Sniper,Negative
11360,TG Therapeutics Announces Final Results GENUINE Phase three,TraderZ,Negative
11361,TGTX TG Therapeutics Announces Final Results GENUINE Phase three,Amp Trades,Negative
11368,two thousand and nineteen twelve one two hundred and three,Wnt publication,Negative
11369,CLL SLL,Journal NCCN,Negative
11370,Check Reviewing,Medivizor,Negative
11372,CLL March one,Amber Koehler,Postive
11374,CLL,Kathleen Hoffman,Negative
11378,Today March two thousand and sixteen one Leukaemia CLL BloodCancer,MerMer Goodburn,Negative
11379,Unermudlichen Krebsforschung Massstabe Vor three Jahren HallekMichael Deutschen Krebspreis Zum Blick Forscherleben,Krebsgesellschaft,Negative
11380,CLL Download,AbbVie UK,Negative
11382,It week half CLL,MerMer Goodburn,Postive
11383,Clinical Kidney Journal,manuel macia hera,Negative
11384,CLL,Blood Journal,Negative
11385,CLL,Blood Journal,Negative
11386,VIDEO Horizon CLL Constantine Tam PeterMacCC ImmunoOnc,VJHemOnc,Negative
11388,FDA Imbruvica Pharmacyclics CLL SLL,Great Debates Hematologic Malignancies,Negative
11389,NuRD,Nucleosome paper,Negative
11390,Chemokuur three Dankbaar Corona CLL,Heleen Stuifzand,Negative
11392,Leukemia CKJ KidneyCancer kdjhaveri LeukemiaRF,CKJ,Negative
11393,transcription Edelmann al Haematologica two thousand and twenty May,WikiPathways,Negative
11394,CAR CLL CME CancerNetwrk,PER,Postive
11395,Scan Hammer Candlestick today GHH CLL ACC,SwingTradeBot UK,Negative
11396,two thousand,Ryan Smith,Postive
11397,ASCO one,Bubble Boy Finance,Negative
11399,CLL Download,AbbVie UK,Postive
11400,CLL,Lymphoma Papers,Negative
11402,CLL Lymphocytes ChronicLymphocyticLeukemia CLLTreatment MedicalTourismIndia HealingTouristry,Healing Touristry,Negative
11404,one hundred four hundred thousand four hundred,fendy wahab,Negative
11407,Blood American Society Hematology,filippo masini,Negative
11409,Gleevec CML Philadelphia,PharmaFactz,Negative
11410,CLL,Kathleen Hoffman,Negative
11411,CLL Ireland CLL,CLL Ireland,Negative
11412,CLL Cirmtuzumab twelve twelve CLL Efficacy ORR CR Efficacy CLL ORR TN three CR,Toby Eyre,Negative
11413,MURANO Short CLL,Toby Eyre,Negative
11415,Data BOVen CLL MRD,Anthony Mato,Negative
11416,Drs Brown Skarbnik BTK,Targeted Oncology,Negative
11417,CllSociety Brian,CURE Magazine,Negative
11419,CLL,Tina,Postive
11420,Remdesivir Checkout,Michele,Negative
11421,CLL CLL,Toby Eyre,Negative
11422,one CLL DukeCancer,Patient Power,Negative
11424,BJH Article Protective Role BTK Inhibitors Patients Chronic Lymphocytic,BSH Haematology,Negative
11426,CLL Tregs,Blood Advances,Negative
11429,Today CLL Register DanaFarber,Patient Power,Negative
11433,Blood American Society Hematology,Dr Comeau MD,Negative
11435,April BTK CLL,Taylor Lab UM,Negative
11436,CLL,MerMer Goodburn,Negative
11437,COVIDnCancer Great CLL Risks,Taylor Lab UM,Postive
11438,one hour Understanding Impact Care Patients Chronic Lymphocytic Leukemia Research To Practice,Matthew Davids MD MMSc,Postive
11439,OncoAlert International CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
11440,AML CLL,Blood Journal,Postive
11441,John CLL,Aurileus FC,Negative
11442,Cloud Lunch Learn Victor Rodrigues Azure IoT Central PowerBI Save May two thousand and twenty twelve UTC CLL,Hugo Barona,Postive
11443,CLL twelve,Chris Cogbill MD,Negative
11444,Tomorrow CLL Register DanaFarber,Patient Power,Negative
11445,four CME CLL Lots,RedMedEd,Negative
11446,CLL,CLLSA,Postive
11451,CLL Download AbbVieUK YouTube Oncology,AbbVie UK,Postive
11452,CLL three year ago CLL,CauseISaidSo,Negative
11454,fifty PB uMRD venG MRD EOT ten CLL,Toby Eyre,Postive
11455,eight CLL Protective Role BTK Inhibitors,Toby Eyre,Negative
11456,tomorrow PM CLL Register today three,Research To Practice,Postive
11458,CLL Register,The Leukemia Lymphoma Society,Postive
11461,AIM CLL Cello Health PLC Result,AIM Alerts,Negative
11462,CLL CLL,Proactive,Postive
11463,Cello CLL Cello Health first half,Calisto Portfolio,Postive
11464,CLL first half CLL,Ruth Gemmell,Postive
11465,CLL first half CLL,Proactive,Postive
11466,CLL Update Cello Signal Virus Small Division one,WheelieDealer,Negative
11467,Cello Health CLL,Share Prophets,Postive
11468,AIM CLL Cello Health PLC AGM Statement,AIM Alerts,Negative
11470,Dressler CLL Dog Cancer Answers,Dog Cancer Help,Negative
11471,Haematology,ClinOwl Haematology,Negative
11472,New Research Evaluation Somatic Hypermutation Status chronic celldevbio,Frontiers Cell Developmental Biology,Negative
11473,CLL one one one,Amber Koehler,Postive
11474,Frontiers Evaluation Somatic Hypermutation Status Chronic,Yuval Avnir,Negative
11475,Richters CLL Spanish CLL Study Group BJH,Toby Eyre,Negative
11476,MentalHealthAwarenessWeek CLL,AbbVie UK,Postive
11477,first,Targeted Oncology,Negative
11478,Leukemia,healthbook,Postive
11479,BTK two CavetJim,Christie Library,Negative
11484,CLL,Kathleen Hoffman,Negative
11487,Scan Bearish Centerline Cross today,SwingTradeBot UK,Negative
11488,CLL,Reed Rowell,Postive
11489,ASCO Journal Clinical Oncology CART,ASGCT,Negative
11490,The EQA Summary Report Individual Laboratory Report ILR Chronic CLL CLL CLL,GenQA Genomics Quality Assessment,Negative
11491,ISPOR HEALTHCARE RESOURCE UTILIZATION,Anthony Mato,Negative
11492,CLL Ian Flinn one,Patient Power,Negative
11493,ACP CLL Nationale Zorggids,Nationale Zorggids,Negative
11494,CLL one four last year,Jan Rynne,Postive
11495,Shielding,Tina,Postive
11496,Jennifer Woyach MD,OncLive SOSS,Negative
11497,Ian Flinn Hematology Review two thousand and eighteen two,touchONCOLOGY,Negative
11499,CLL CLL,Mazyar Shadman MD MPH,Postive
11501,BTK,Targeted Oncology,Negative
11508,CLL DukeCancer,Patient Power,Postive
11511,Friday May two thousand and twenty Please Current Evidence Management CLL Future Direction CLL,Hematology Cancer Consortium,Postive
11512,one hundred,Lymphoma Papers,Negative
11513,cll,Seema Ali Bhat,Negative
11514,GMWatch,GMO Free USA,Negative
11515,one CLL CLL Heath Center,Patient Empowerment Network,Negative
11516,CLL Learn More,Oncology Learning Network,Negative
11518,CLL,Mahmoud Aljurf,Negative
11525,CLL,Kathleen Hoffman,Negative
11526,NHS Watch amp Wait two CLL,CLLSA,Negative
11527,next Thursday CME CLL Drs,Research To Practice,Postive
11528,One nine Supporting Emergent Literacy EYtwittertagteam CLL,Early Years LSC FE VocEd EYFS,Postive
11529,nine Supporting Emergent Literacy CLL,Early Years LSC FE VocEd EYFS,Negative
11530,michieCLLlab CLL,Kristina Kirschner,Negative
11531,one one one Listen AML CLL CureLeukaemia,AnCan,Postive
11532,John Burke MD Manuel Santiago MD Earn CME today,Oncology CE,Postive
11533,today TeachingPoint,Arkana Laboratories,Negative
11534,CLL,Joe Fournet,Negative
11536,Webinar CLL,Raul Cordoba MD PhD,Postive
11537,Today ChronicLymphocyticLeukemia,ERN EuroBloodNet,Negative
11540,combinatorial drug Marina ThorstenZenz,Britta Velten,Postive
11546,Association Expression Severity Chronic,EurekaMag,Negative
11547,BrittaVelten Marina Lukas Thorsten,Wolfgang Huber,Negative
11548,Bruce Raphael MD,OncLive SOSS,Negative
11549,GENIUNE Phase three CLL ninety twenty v five seven UTX,SY Investing,Negative
11550,VIDEO Eastern Free CLL CureLeukaemia LeukaemiaAus,AnCan,Postive
11552,Scan Bearish Signal Line Cross today TRI PET CLL BWY SCLP,SwingTradeBot UK,Negative
11554,FDA,Cancer Health,Negative
11555,GRACE Blood Cancer Video Joshua Brody CLL BTK cancerGRACE,GRACE,Negative
11556,CLL Jan seventeen two thousand and twenty BloodJournal,Mike Thompson MD PhD FASCO,Negative
11558,tomorrow ChronicLymphocyticLeukemia Register RareDiseases,ERN EuroBloodNet,Negative
11559,BTK two,Lymphoma Papers,Negative
11563,Michael Choi,OncLive SOSS,Negative
11566,Bones Blood Cancers Virtual Support Group May thirteen pm Eastern AML CLL,AnCan,Postive
11567,Health Canada Approves Biosimilar Rituximab Riximyo CherylKoehn AHPAconnect SPONDYLITISCA,JointHealth,Negative
11568,Jing Fan Chris Fletcher,Schieke Lab,Negative
11569,rituximab Tait Shanafelt,Steven Artandi MD PhD,Postive
11571,NHL Virtual Meeting Learn CancerNetwrk,PER,Negative
11572,CME CLL four four,RedMedEd,Postive
11573,Deborah Kirkland RN MPH The Hoffberger Breast Center Mercy CLL The Evolving Role Patient Navigator,MDMercy Media,Postive
11576,Today CLL NorthwellHealth Register,Patient Power,Negative
11578,Exciting Karsten Rippe KarstenRippe,Michael Boutros,Negative
11580,CLL Drs Jennie Crews MedscapeEdu,Medscape Education,Negative
11583,three,Lymphoma Hub,Postive
11584,Thursday ChronicLymphocyticLeukemia Provided Prof Dominique Bron,ERN EuroBloodNet,Negative
11588,Ophthopedia Update Ophthalmic one hundred Ophthalmology Eye Ophthotwitter,Ophthopedia,Negative
11589,NutriSci Jing Fan Metabolic,Nutri Sci,Postive
11590,CLL Watch CLL SarahCannonDocs,Patient Power,Postive
11591,CLL,Blood Journal,Negative
11592,CLL,Blood Journal,Negative
11593,lHlt New Prognostic Tool Determine,Molecular Biology MEMBS mjtm` lbywlwjy ljzyy'y@,Negative
11594,VIDEO CLL MRD HemeOnc,VJHemOnc,Negative
11595,CLL,Journal NCCN,Negative
11596,Tomorrow CLL NorthwellHealth Register,Patient Power,Negative
11597,two thousand,Ryan Smith,Postive
11598,CLL,Journal NCCN,Negative
11599,CLL CLL,Patient Power,Negative
11600,radon,Radon Done,Negative
11601,CME CLL,RedMedEd,Postive
11603,Subcutaneous Masses Unusual Manifestation Relapse Case Atypical Chronic,Lymphoma Papers,Negative
11609,obinutuzumab plus chlorambucil three,Targeted Oncology,Negative
11611,CLL,Kathleen Hoffman,Negative
11613,CLL FieldofDreams,Reed Rowell,Negative
11614,Abbaspour Rostami Faranoush Ghahramanfard Pak Barati,NK paper,Negative
11625,Chronic People Are Talking three CLL,Patient Power,Negative
11626,Laura Michaelis,The ASCO Post,Negative
11627,Chronic Lymphocytic Leukemia Treatment Professional Version National Cancer Institute,Interesting Weird Facts,Negative
11628,seven Myths About Chronic,NurseGroups,Negative
11629,BigData nuestros cursosonline masterdigitales con los que un FormacionOnline CLL one hundred Digital,datahack,Negative
11632,two thousand and one CLL,Amber Koehler,Negative
11633,three,Home Journal,Negative
11635,CLL LymphomaCanada,AbbVie Canada,Negative
11636,Cancer Edition one four month one day,Mike ForThePeople,Negative
11637,Ian Flinn SarahCannonDocs,CURE Magazine,Negative
11638,TGTherapeutics Announces UNITYCLL Phase three Umbralisib Ublituximab Combination Demonstrates Efficacy LymphocyticLeukemia,TrialSite News,Negative
11639,Battle Thermopylae three hundred Spartans obinutuzumab Xerxes,EurekaMag,Negative
11640,Chronic Sydney Hester CLL SarahCannonDocs,Patient Power,Postive
11641,This week CLL,Blood Journal,Negative
11642,US National Institutes Health Study,GMWatch,Negative
11643,CLL one Lower CRS two,Adam Kittai,Negative
11644,Impulsa tu carrera ma eficiente popular para memoria lo Comenzamos Junio Mas FormacionOnline CLL one hundred Digital,datahack,Negative
11649,July two thousand and twenty Translational Research Conference CLL November two thousand and twenty Chairs Brown,ESH Haematology,Negative
11651,Barriers Proceeding Stem Cell,Leukemia,Negative
11652,Thursday Webinar How ChronicLymphocyticLeukemia Bron,ERN EuroBloodNet,Negative
11653,CLL The Venetoclax BTK Inhibitor CLL,Toby Eyre,Negative
11655,First hemeonc lymsm nca MedTwitter,Faheema Hasan,Negative
11657,OncoAlert CARTcell CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
11658,OncoAlert CARTcell CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
11659,FDAOncology,Home Journal,Negative
11660,CLL Blood American Society Hematology,Benlazar Amine,Negative
11661,LeukaemiaCareUK CLL,CLL Advocates Network,Postive
11662,Canada CLL leukemia year,AbbVie Canada,Negative
11665,CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
11666,CLL CLL SarahCannonDocs,Patient Power,Negative
11667,Swedish one thousand two thousand and seven,Fish Chromosomes,Negative
11669,CLL Watch,Leukaemia Care,Postive
11670,CLL LIVE Join,Leukaemia Care,Postive
11671,Thks,MDSUK PatientSupport,Negative
11672,Chronic CLL,John Austin,Negative
11674,Trump million acre Dicamba Researchers National Institutes Health,GO GREEN,Negative
11676,JanRynne first CLL Ireland,CLL Ireland,Negative
11677,DYK CLL one,AbbVie Canada,Negative
11678,eight PM ET Chronic CLL,Asembia,Postive
11681,obinutuzumab plus chlorambucil,Targeted Oncology,Negative
11682,ICYMI CLL CLLSupport tomorrow London Marc Auckland CLL Zoom day,Leukaemia Care,Negative
11688,EPA NIH,Extinction Crisis,Negative
11689,first webinar Farukh Awan UTSWNews,CURE Magazine,Negative
11690,CLL CLLSupport Thursday May London Marc Auckland CLL day,Leukaemia Care,Negative
11691,CLL CLL CLL,CLEVER Network,Postive
11692,TGTherapeutics umbralisib ublituximab CLL Trial obinutuzumab chlorambucil comparator,DDNews Online,Negative
11693,three hundred and sixty Ibrutinib CLL,National Comprehensive Cancer Network NCCN,Negative
11694,Cationic,EurekaMag,Negative
11695,Health Canada Obinutuzumab ABBV,JHC,Postive
11696,Health Canada Obinutuzumab Related Tickers ABBV,Quant Data,Postive
11697,Health Canada Approval Combination Obinutuzumab Patients,Alicia Bell IFBB Pro,Negative
11698,Kerry Rogers CLL OhioHealth,Patient Power,Postive
11699,TG Therapeutics Announces three,Redington Inc,Postive
11700,TGTX USD three,MAISA,Postive
11701,Pascal Lefevre UniversityLeeds CLL,Molecular Oncology,Negative
11702,Read Download,yeongji,Negative
11703,Today Congrats two TGTX,Amy Cavers,Postive
11704,Today Congrats,Amy Cavers,Postive
11705,TGTX PM TG three CLL Met PFS,SY Investing,Postive
11706,Today Health Canada CLL,AbbVie Canada,Negative
11707,Chronic CLL Wed May six eight PM ET Learn,Asembia,Postive
11710,tgtx TG Therapeutics Announces three,Behavioral Finance,Postive
11711,decade CLL Antibodies,Cancer Sci Ther,Negative
11712,TGTX PM Positive CLL,Scott Spencer,Postive
11713,CLL CancerSucks,Drive Show,Postive
11714,TG Therapeutics three TGTX,JHC,Negative
11715,TG Therapeutics three Related Tickers TGTX,Quant Data,Negative
11716,Health Canada Approval Combination Obinutuzumab Patients,Matt Fanning,Negative
11717,TGTX three obinutuzumab plus chlorambucil,Palmer,Postive
11718,TG Therapeutics Announces three,Quant Data,Negative
11719,TGTX TG Therapeutics Announces Positive three,Jake,Postive
11720,TGTX TG Therapeutics Announces Positive three,Day Trading Alerts,Postive
11721,TGTX TG Therapeutics Announces Positive three,Swing Trading,Postive
11722,Health Canada Approval Combination Obinutuzumab Patient,Crwe World,Negative
11723,TGTX TG Therapeutics Announces Positive three Leukemia Nasdaq TGTX,dough,Postive
11725,TGTX TG Therapeutics Announces Positive three,Michelle Solly,Postive
11726,TGTX Announces Positive Topline Results Phase three,Michel Doepke,Postive
11727,TGTX Announces Positive Topline Results Phase three,Bio,Postive
11728,TGTX TG Therapeutics Announces Positive three,Amp Trades,Postive
11729,TGTX TG Therapeutics Announces Positive three,TradeXchange,Postive
11730,Indian,Lymphoma Papers,Negative
11732,CLL Highlights Paneeshas ImmunologyUoB,Helen Parry,Negative
11734,one CLL fifteen May,Abhilash,Postive
11735,AIM CLL Cello Health PLC Issue,AIM Alerts,Negative
11736,JCI,fadra tedesco,Negative
11738,Michal Smida CLL ATM,Ferran Fece de la Cruz,Negative
11740,NIH,Nathan Donley,Negative
11741,Hematologic Data Summaries Ash Research Collaborative CLL,Taylor Lab UM,Postive
11743,MRD Watch discus lymsm,Lymphoma Hub,Negative
11745,CLL CLL SarahCannonDocs Tennessee Oncology,Patient Power,Negative
11746,CAR CLL,ASCO Publications,Negative
11747,Godspeed Duvelisib Copiktra CLL,CrozrX,Negative
11748,CLL,Toby Eyre,Negative
11753,Paul He CLL Living,Mark Noblet,Postive
11754,Jennifer Woyach MD,OncLive SOSS,Negative
11757,CLL,Kathleen Hoffman,Negative
11758,two thousand and first,satirewriter,Negative
11760,ScientificData CLL,Deyan Yosifov,Negative
11764,anthonymatomd discus three obinutuzumab,OncLive SOSS,Negative
11765,Jackie Broadway UNC UCSF Skills Challenge Clinical Pearls,Medscape Education,Postive
11766,Skills Challenge Clinical Pearls fifteen,Medscape Education,Negative
11767,Skills Challenge Clinical Pearls fourteen Myalgia,Medscape Education,Negative
11768,Skills Challenge Clinical Pearls thirteen,Medscape Education,Negative
11769,Skills Challenge Clinical Pearls twelve,Medscape Education,Negative
11770,Skills Challenge Clinical Pearls eleven Hypertension,Medscape Education,Negative
11771,Skills Challenge Clinical Pearls ten Atrial Fibrillation,Medscape Education,Negative
11772,Skills Challenge Clinical Pearls nine,Medscape Education,Negative
11773,Skills Challenge Clinical Pearls eight Fungal Infections,Medscape Education,Negative
11774,Skills Challenge Clinical Pearls seven CLL,Medscape Education,Negative
11775,Skills Challenge Clinical Pearls six,Medscape Education,Negative
11776,Skills Challenge Clinical Pearls five,Medscape Education,Negative
11777,Skills Challenge Clinical Pearls two,Medscape Education,Negative
11778,Optimizing Use BTK Inhibitors Skills Challenge Clinical Pearls fifteen one two BTK Inhibitors CLL,Medscape Education,Negative
11779,FDA CLL,CellworksLife,Negative
11780,Learn,COTA Inc,Negative
11781,menos para comenzar de nuevo Estamos CLL Guadalajara GuadalajaraEspana Centro Las Lomas,Centro Las Lomas,Negative
11782,twelve Inpts BTKis four CLL,Toby Eyre,Postive
11787,Stromal Tumor Microenvironment,Leukemia,Negative
11788,CllSociety CLL,Mazyar Shadman MD MPH,Postive
11789,one CLL CAP,Sara Javidiparsijani MD FCAP,Postive
11790,Scan today ROL RDT RB CLL NTEA,SwingTradeBot UK,Negative
11791,first,CURE Magazine,Postive
11792,Copyright Developments Supreme Court CLL,Cowan Liebowitz,Postive
11793,Postdoc Siena CLL Please,Anna Kabanova,Postive
11794,Coronavirus Turmoil Take Toll Growth,Pharma News,Negative
11796,DNAmethylation ChronicLymphocyticLeukemia CLL,Scientific Data,Negative
11797,Herbal Turmeric Natural Prevention Treatment Chronic,The Curable Recipes,Negative
11798,rituximab chronic CLL FDAOncology,NCI CTEP Clinical Research,Negative
11799,Infections,EurekaMag,Negative
11800,CME CLL Four today,RedMedEd,Postive
11801,Webinar CLL May UK CLL Please,CLLSA,Postive
11802,NHL,Home Journal,Negative
11803,BigData nuestros cursosonline masterdigitales con los que un FormacionOnline CLL one hundred Digital,datahack,Negative
11804,FDA rituximab chronic,Jean Zhao,Negative
11805,Michael Choi,OncLive SOSS,Negative
11811,CLL BJH CLL,Ariez BV,Negative
11813,FDA Imbruvica Plus Rituximab Treatment Patients Chronic CLL,NewExpressNews,Negative
11814,Haematology,ClinOwl Haematology,Negative
11815,BCR Haematology,ClinOwl Haematology,Negative
11817,CLL SarahCannonDocs,Patient Power,Negative
11819,CLL,Teresa Martin,Negative
11820,CLL,Kathleen Hoffman,Negative
11822,EHA CLL Myelom iNHL aNHL,Kompetenznetz Maligne Lymphome,Negative
11823,care seventythree year old Chronic Lymphocytic CHO Anuba Lohe Phek Village Phek,Health Wellness Center Nagaland,Negative
11824,CLL BTK CLL,Paul DeSantis PharmD,Postive
11825,Michael Choi,OncLive SOSS,Negative
11826,two thousand and nineteen American CLLsm,Targeted Oncology,Negative
11829,FDAOncology,Home Journal,Negative
11831,CLL today Irish Dr Brian Koffman Register JanRynne CllIreland,Michael Rynne,Postive
11832,Today CLL Neil Kay Brian Koffman April PDT EDT,CLL Society Inc,Postive
11833,nearly month ICU seventeen day Mary Hernandez yesterday one Read Mary,MD Anderson Cancer Center,Postive
11834,Learn,Lankenau Institute,Negative
11835,Genmab CDC CLL mAbs rituximab ofatumumab obinutuzumab GMAB Blood Cancer Journal,Lambrechts,Negative
11836,first Blood ballpark long time first CLL,Taylor Lab UM,Postive
11843,cll,Seema Ali Bhat,Negative
11844,Katy Rezvani MD CAR CLL Learn More MedTwitter Oncology Medical,Oncology Learning Network,Negative
11846,pharmacy drug update FDA Pemazyre Imbruvica CLL SLL Trodelvy,Ian Mackey Parnigoni,Negative
11847,CAPTIVATE Imbruvica Venclexta CLL Leusm,Patient Power,Negative
11848,Drs Joshua Richard Bakst Amir Steinberg MD CLL joshuabrodyMD IcahnMountSinai,The Tisch Cancer Institute,Negative
11850,New Medivizor Leukemia,Medivizor,Negative
11851,CLL CLL Society Tuesday April Webinar Neil Kay Brian Koffman,CLL Society Inc,Negative
11852,Bruton,Targeted Oncology,Negative
11853,Myeloid,Cancer Papers,Negative
11854,Myeloid,Hematopoiesis,Negative
11855,John Burke MD Manuel Santiago MD Earn CME today,Vindico Medical Education,Postive
11856,CLL Alison Mulholland Amy Sheldrick,Patient Power,Negative
11857,CLL two thousand and twenty ArijitBishnu SujayRainchwar DigambarPanchal,Nihar Desai,Negative
11862,CLL first,Lorna Warwick,Negative
11863,HealtheVoicesLIVE HUGE TY DavinaConner CathyKramer Gratitude Breakout Insightful CLL,Michele,Postive
11864,FDA IMBRUVICA Rituximab,Cord Blood News,Negative
11865,HealtheVoicesLIVE CLL,Michele,Postive
11866,two thousand and nineteen European Medicines Agency CLL one GCLLSG,Michael Hallek,Postive
11868,HealtheDinner Middle Eastern Lots CLL,Michele,Negative
11869,rituximab CLL,Toby Eyre,Negative
11876,CLL,Kathleen Hoffman,Negative
11877,CLL,Journal NCCN,Postive
11878,Earlier week BTK Imbruvica CLL SLL Cancer Leukemia GeneOnline,GeneOnline,Negative
11879,Earn CE May two Join Jackie Broadway MDAndersonNews BTK CLL REGISTER,Medscape Education,Postive
11881,OncoAlert one CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
11883,CLL,Oncology Learning Network,Negative
11884,Randomized Dose Optimization Study Chimeric Antigen Receptor,Hernandez Mohedo,Negative
11886,FDAOncology,Home Journal,Negative
11887,next week CLL,Lymphoma Hub,Negative
11888,April two thousand and twenty Lymphomtherapien Arzte Anmeldung UKKoeln,Kompetenznetz Maligne Lymphome,Negative
11895,Lymphocytic Leukemia CLL Earn CMEcredits Click Oncology,Paradigm Med Comm,Negative
11896,one CLL Blood American Society Hematology CLL,Benlazar Amine,Negative
11897,one CLL,Blood Journal,Negative
11898,AbbVie Imbruvica CLL FDA Imbruvica CLL,Bionest Partners,Negative
11899,FDA rituximab chronic,StemExpress,Negative
11900,Chaitra Ujjani MD two CLL,Oncology Tube,Negative
11901,three Cancer Research Group National Cancer Institute CLL,Cancer Research Group,Negative
11903,Docs CLL CME CLL,RedMedEd,Negative
11906,UK CLL JanRynne CllIreland,Michael Rynne,Postive
11907,today CLL SpotLeukaemia,Leukaemia Care,Postive
11909,FDA IMBRUVICA CLL,PressReleasePoint,Negative
11910,CLL SLL FDA rituximab chronic,Leukemia Research Foundation,Postive
11911,FDA,BioSpace,Negative
11912,FDA Plus Rituximab Treatment Patients Chronic,Company News HQ,Negative
11913,Tirabrutinib Combination Idelalisib Entospletinib Previously Treated Chronic,CellworksLife,Negative
11914,CLL PI,Erin Hickey PharmD BCOP,Negative
11915,Laura Patrussi Nagaja Capitani,Cancers MDPI,Negative
11916,CLL rituximab ibrutinib FDA rituximab chronic,Adam Kittai,Postive
11917,FDA Pharmacyclics Imbruvica ProjectOrbis CLL FDA,Headwaters Communications,Negative
11918,FDA,BioCalifornia,Negative
11919,FDA CLL three,JanssenUS,Postive
11920,CLL,CLLSA,Negative
11922,Learn MayoClinic ChronicLymphocyticLeukemia CLL,Mayo Clinic Cancer Center,Negative
11923,CarnivalCruise CLL June,Edsel Talbert,Negative
11926,FDA rituximab chronic,The Oncologist,Negative
11927,CARTcell CLL Median CR CR one month,Thomas LeBlanc MD MA MHS FAAHPM,Postive
11929,Aktuelle Therapiekonzepte bei Lymphomen HallekMichael,idw Nachrichten,Negative
11932,JanRynne CLL nearly six week,Michael Rynne,Negative
11933,VIDEO CLL View ImmunoOnc HemeOnc,VJHemOnc,Negative
11934,FDA rituximab chronic,Baha Alrfaei bh,Negative
11935,FDA FDA CLL,Saadvik Raghuram,Negative
11936,CLL SLL Read,The Leukemia Lymphoma Society,Postive
11937,Check Ibrutinib,Medivizor,Negative
11938,April twentyone two thousand and twenty FDA Imbruvica combination rituximab CLL SLL PI,Bichoy Gabra,Negative
11939,FDA Plus Rituximab Treatment Patients Chronic CLL,BuxMont Forum,Negative
11940,NEWS The FDA CLL,Janssen Global,Negative
11941,FDA Plus Rituximab Treatment Patients Chronic The Delaware County Daily Times,NwokeAgulu,Negative
11943,April twentyone two thousand and Food Drug Administration IMBRUVICA combination rituximab CLL,Society Immunotherapy Cancer,Negative
11944,FDA UPDATE April twentyone two thousand and Food Drug Administration IMBRUVICA combination rituximab CLL SLL,Lymphoma Research Foundation,Negative
11945,FDA CLL seven one FDAOncology LalehAmiri TargetedOnc,Javid Moslehi,Negative
11946,Learn FDA rituximab chronic CLL SLL Tait Shanafelt StanfordMed lymsm CancerNews,Sarah Williams,Negative
11947,Today FDAOncology Learn,AACR Foundation,Negative
11948,FDA,Targeted Oncology,Postive
11949,Imbruvica rituximab Rituxan,Oncology Nursing News,Negative
11950,FDA rituximab chronic,Philip McCarthy,Negative
11951,Today CLL,AACR,Postive
11952,Ennio hour,Kirk Kirlin,Negative
11953,FDA rituximab chronic,Guillaume Andrieu,Negative
11954,FDA rituximab chronic FDA,Kevin Wolcott,Negative
11955,FDA RareDisease,Rare Disease Report,Postive
11956,New Drug Application FDA Learn CLL,Pharmacyclics AbbVie Company,Negative
11957,FDA CLL,Brian Kenney,Postive
11958,FDA IMBRUVICA combination rituximab ProjectOrbis,FDA Oncology,Negative
11959,FDA CLL SLL,Kerri Wachter,Negative
11960,Douglas Leukemia Survivor LLS LLSusa LLSVolunteer CLL TuesdayMotivation,Cellectar Biosciences,Postive
11961,CllSociety CLL,Mazyar Shadman MD MPH,Postive
11962,MRD,Oncology Tube,Negative
11963,BDFACSMatters webinar Register,BD Biosciences,Negative
11964,Brenda Eichelberger earlier month many year,PSU School Business,Postive
11965,CARES Act Summary Coronavirus SmallBusiness CLL,Cowan Liebowitz,Postive
11966,Impulsa tu carrera ma eficiente popular para memoria lo Comenzamos Junio Mas FormacionOnline CLL one hundred Digital,datahack,Negative
11973,CLL CLL CLL SLL UK,CLLSA,Negative
11974,CLL HallekMichael two HallekMichael UKKoeln,CLL Advocates Network,Negative
11976,AIM CLL Cello Health PLC Annual,AIM Alerts,Negative
11977,Learn Ibrutinib Leukemia,Medivizor,Negative
11978,CLL CLL,Hematology Advisor,Negative
11979,Rod Humerickhouse CLL iwCLL International Workshop Chronic CLL,CheckRare,Postive
11980,two Chronic,ClinicalTrialsData,Negative
11984,CLL,Kathleen Hoffman,Negative
11985,ChronicLymphocyticLeukemia,Mayo Clinic Cancer Center,Negative
11986,Venetoclax CLL TLS Really CLL,Thomas Lofaro,Negative
11989,Herpes Simplex Necrotic Lymphadenitis,Lymphoma Papers,Negative
11990,New Ibrutinib,Medivizor,Negative
11991,The Connect CLL Registry one thousand four hundred one hundred US CLL,Blood Advances,Negative
12000,Michael Choi,OncLive SOSS,Negative
12001,CLL OSUCCC,Seema Ali Bhat,Negative
12002,Join May two Tune UNC BTK CLL REGISTER,Medscape Education,Negative
12003,Lymphocytic Leukemia CLL CMEcredits Oncology,Paradigm Med Comm,Negative
12004,CLL Venetoclax Ibrutinib,Dr Boominathan PhD,Negative
12005,Therapy PCAT CLL Ibrutinib,Dr Boominathan PhD,Negative
12006,CLL Venetoclax,Dr Boominathan PhD,Negative
12007,CLL Venetoclax Ibrutinib,Dr Boominathan PhD,Negative
12010,EyeForPharma CLL,WEGO Health,Postive
12011,Cytokine EFPVirtual CLL CytokineStorm,WEGO Health,Negative
12012,CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
12013,Randomized Dose Optimization Study Chimeric Antigen Receptor,Hayder Saeed MD,Negative
12014,Congrats PennCancer CLL,Anthony Mato,Postive
12015,ERC Consolidator,AcademicTransfer,Negative
12016,CLL,Adam Kittai,Negative
12020,BSI Connected Leaning Live CLL,BSI UK,Postive
12021,AIM CLL Cello Health PLC,AIM Alerts,Negative
12022,CLL,CLL Ireland,Negative
12023,CELG Phase two Chronic,ClinicalTrialsData,Negative
12024,CLL CllSociety today CLL CllSociety JanRynne ODonovanCiara,Michael Rynne,Negative
12025,Duvelisib,Lymphoma Papers,Negative
12027,Michael Choi,OncLive SOSS,Negative
12028,Randomized Dose Optimization Study Chimeric Antigen Receptor Kymriah,Bruce Levine,Negative
12029,CLL webinar Tuesday April Register,STTR Cancer,Negative
12030,New Medivizor Ibrutinib,Medivizor,Negative
12031,ICYMI Researchers,Home Journal,Negative
12032,Congrats Pfizer EMA,Brand Institute Inc,Postive
12040,CLL three Study DOESNOT,Pallawi Torka,Negative
12043,WEBINAR Epigenetic Tools Blood Cancer Research CLL,Epigenetics Podcast,Negative
12044,Chronic Lymphocytic Leukemia Treatment Version,Interesting Weird Facts,Negative
12045,CLL,Seema Ali Bhat,Negative
12046,Awesome Christine Ryan PJP CLL DanaFarber Low,Matthew Cheng,Negative
12047,CLL,Blood Journal,Negative
12048,AdvancedPractitioners CLL Read JADPRO,APSHO,Negative
12049,Leukemia CLL,MD Anderson Leukemia,Negative
12050,CLL,CLLSA,Negative
12051,CLL,Coping Cancer,Negative
12052,first CLL CLL Haematology,ClinOwl Haematology,Negative
12059,NCA CLL,Ind Med Ped Oncology,Negative
12060,one one,ClinicalTrialsData,Negative
12061,two,ClinicalTrialsData,Negative
12062,ASH two thousand and nineteen Mato Sequencing CLL Venetoclax CLL Society,Brave Is,Negative
12063,CLL CLL Society CLL Friday April seventeen two thousand and twenty eleven AM PT twelve PM one PM two PM ET Register,CLL Society Inc,Negative
12064,CLL,Benlazar Amine,Negative
12065,The Connect CLL Registry one thousand four hundred one hundred US American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
12066,Profiling Bioinformatics Analyses,Transcriptomes,Negative
12068,Lymphoma Acute Lymphocytic Leukemia AVM,Sound Choice,Postive
12069,CLL CLL,Ex Dividend Date,Negative
12070,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
12071,EyeForPharma CLL,WEGO Health,Negative
12072,CLL,Cowan Liebowitz,Negative
12073,Lymphoma Acute Lymphocytic,AVM Biotechnology,Postive
12074,CLL two three CLL previous two decade,David Henry,Negative
12081,ERIC Haematology,ClinOwl Haematology,Negative
12082,CLL Love,Mazyar Shadman MD MPH,Postive
12083,first Leukemia CLL CLL,Hoffmann,Negative
12084,CLL,Michele,Negative
12085,CLL,Kathleen Hoffman,Negative
12086,FREE six week HSE NHS UK CLL Session Tuesday,CLL Ireland,Postive
12087,Check Ibrutinib leuke via,Medivizor,Negative
12088,Rai CLL SujayRainchwar HarshitThole,Nihar Desai,Negative
12089,Leukemia,Medivizor,Negative
12090,three,Clinical Lab Manager,Negative
12091,International Prognostic Score Asymptomatic Chronic American,Eduardo Anguita MD PhD,Negative
12094,EJhaem BritSocHaem Pevonedistat Clin CLL RoswellPark Mucho Hernandezlab SSundaramMD Cheers,Pallawi Torka,Postive
12097,Cancer Learning,Francis Chartier,Negative
12102,ICYMI Researchers,Home Journal,Negative
12103,CLL Easter,CLL Ireland,Postive
12104,one thousand nine hundred two thousand and,Drugs Caps,Negative
12105,Duvelisib Promising SLL,Drugs Caps,Negative
12106,FDA,Drugs Caps,Negative
12107,Jeff Sharman CLL,Patient Power,Negative
12108,New Coronavirus Webinars week Doctors MPN Mon,Patient Power,Negative
12110,CLL International Prognostic Score Asymptomatic Chronic American,Toby Eyre,Negative
12111,ERIC,CompBiolPapers,Negative
12120,OncoAlert CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
12121,Comparative ERIC,Richard Rosenquist Brandell,Negative
12122,Observational Trial Treatment Utilization Effectiveness,TrialBulletin,Negative
12124,CLL,Kathleen Hoffman,Negative
12126,BTK CLL,CURE Magazine,Negative
12127,Check Bendamustine,Medivizor,Negative
12129,International Prognostic Score Asymptomatic Chronic,ClinOwl Haematology,Negative
12130,sa kontakt pa el Tlf zero cml cmml lymfekraeft leukaemi md,LyLe Foreningen,Postive
12131,The Connect CLL Registry one thousand four hundred one hundred US,Cancer Papers,Negative
12132,Observational Trial Treatment Utilization Effectiveness Duvelisib,CrozrX,Negative
12133,CLL Nicole Lamanna HICCC ColumbiaMed PatientPower,ColumbiaCancer,Negative
12135,Klanova Pavel CLL,Cancers MDPI,Negative
12136,CLL Blood,giacomo paoletti,Negative
12140,International Prognostic Score Asymptomatic Chronic,Hoffmann,Negative
12142,Chronic Lymphocytic Leukemia Version April three two thousand and,CLL Advocates Network,Negative
12144,LOXO CLL,Toby Eyre,Postive
12145,CLL BloodAdvances,chadi nabhan MD MBA FACP,Negative
12146,CLL UK,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
12147,Wei Ding ChronicLymphocyticLeukemia CLL MayoClinic,Mayo Clinic Cancer Center,Negative
12148,The Connect CLL Registry one thousand four hundred one hundred US,Young Hematologists,Negative
12149,one CLL Bloodjournal International Prognostic Score Asymptomatic American,Adam Kittai,Postive
12151,Learn Bendamustine Leukemia,Medivizor,Negative
12152,CLL,CancerTherapyAdvisor,Negative
12153,CLL half Mexican VincentRK DavidSteensma DrMiguelSanz mvmateos mpdrc,Guillermo,Negative
12154,International Prognostic Score Asymptomatic Chronic American,Richard Rosenquist Brandell,Negative
12162,tonight eight pm Click CLL,AnCan,Postive
12164,International Prognostic Score Asymptomatic Chronic American,Juan Marquet,Negative
12165,International Prognostic Score Asymptomatic Chronic American,ALI ALAHMARI,Negative
12166,ICYMI Medicare,Home Journal,Negative
12167,AsktheExpert Nicole Lamanna CLL AV,Patient Power,Negative
12168,The ILLINOISsocialwork Community Learning Lab CLL Take,ILLINOIS Social Work,Negative
12169,BloodJournal CLL,ASH,Negative
12171,Less thirty minute Chris Fegan CLL Keep,Leukaemia Care,Postive
12172,NIH CLL NCI Contact NIH CC Office Patient Recruitment Refer,NIH Clinical Center,Negative
12173,CLL UK,CLLSA,Postive
12175,CARTcells CLL Read ImmunoOnc HemOnc,VJHemOnc,Negative
12177,CancerNetwrk,NCI Media Relations,Negative
12180,OncoAlert BTK CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
12181,Cello CLL,Investor Champion,Postive
12182,April eight pm EDT Free AML CLL,AnCan,Postive
12183,CLL Cello Health PLC CLL,Ruth Gemmell,Negative
12184,Trademark Law Alert CARES Act Patent Trademark Office Extends Various Filing Fee Deadlines Applicants Affected USPTO CLL,Cowan Liebowitz,Postive
12185,Cello Health PLC,Andrew Scott,Negative
12186,CLL Cello Health PLC CLL,Proactive,Negative
12188,China,Odi Bruckman,Negative
12194,CLL Mark Lesney,The Lancet Haematology,Negative
12195,CLL Cello Health first CLL,Proactive,Negative
12196,AIM CLL Cello Health PLC Update,AIM Alerts,Negative
12198,BloodCancer kennycapps CLL,Michele,Postive
12199,CLL Wednesday CLL UK Registrants Register,CLLSA,Postive
12200,Chronic Acute Chronic,Lab Test,Negative
12201,OncoAlert FCR Lacks Evidence Change Standard Watch CLLsm,Raul Cordoba MD PhD,Negative
12202,DRG United States Western Europe DRGinsights CLL Roche,DRG Epidemiology,Negative
12203,CLL Listen GillSaar PennMedicine Tanya Siddiqi HemOnc ImmunoOnc MRD,VJHemOnc,Negative
12204,Leukemia,Medivizor,Negative
12206,CLL CancerMoonshot,MD Anderson Cancer Center,Negative
12207,one webinar one CllSociety,Tom Henry MBA RPh CPh,Negative
12210,First,Streetwise Reports,Negative
12211,First,Life Sciences Report,Negative
12212,BTK,Oncology,Negative
12214,Venetoclax Review,Lymphoma Papers,Negative
12216,New Ibrutinib,Medivizor,Negative
12218,FCR Binet,Targeted Oncology,Postive
12220,Haematologica CLL,Benlazar Amine,Negative
12221,ICYMI,Home Journal,Negative
12222,obinutuzumab,Medivizor,Negative
12223,The European Commission rituximab biosimilar Ruxience NHL CLL EC,CellworksLife,Negative
12225,BloodJournal BTK CLL thirtyfour fortytwo month,Victor Lin,Negative
12226,CLL seventeen,isthisreal,Negative
12228,CLL,Kathleen Hoffman,Negative
12229,CLL CLL,Shouting people underpants,Negative
12230,next week AML CLL,AnCan,Negative
12231,Check Bendamustine,Medivizor,Negative
12232,CLL,Hematology Advisor,Postive
12233,Astrid Pavlovsky Fundaleu CLL Listen,Lymphoma Hub,Postive
12234,DRG United States Western Europe DRGinsights CLL,DRG Epidemiology,Negative
12235,one month one year,Cancer clinical trial,Negative
12236,April CLL,CLLSA,Negative
12237,Today Lamanna ColumbiaMed CLL,Patient Power,Negative
12238,five one first three,Palmer,Negative
12239,Pfizer EU MabThera NHL CLL GPA MPA Haematology,Recruitment,Postive
12246,CLL CLL JanRynne WaterfordMafia,CLL Ireland,Negative
12247,Connected Learning Live CLL Automotive fourteen April CLL,BSI UK,Negative
12252,CLL,Seema Ali Bhat,Negative
12253,six first one first three,Palmer,Negative
12254,Irish CLL,CLL Ireland,Postive
12255,OncoAlert CLL Binet German CLL CLLsm,Raul Cordoba MD PhD,Negative
12256,Dr Amir Steinberg Rich Bakst TischCancer Americans CLL,Joshua Brody MD,Postive
12257,Turmeric Natural Prevention Treatment Chronic,The Curable Recipes,Negative
12258,Bruton,NCI Media Relations,Negative
12259,CLL Questions April one two thousand and twenty Drs Mazyar Shadman Michael Hallek Anthony Mato CLL,Michael Hallek,Negative
12260,Relax CLL,Carlos Loinaz,Negative
12261,Michael Choi,OncLive SOSS,Negative
12262,CLL,Amber Koehler,Negative
12263,CllSociety,CURE Magazine,Negative
12265,Jennifer Woyach MD,OncLive SOSS,Negative
12266,two,The ASCO Post,Negative
12268,Bloodjournal Great Woyach CLL,Adam Kittai,Postive
12278,UK UK CLL CLL,Toby Eyre,Postive
12279,UK CLL UK CLL CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
12280,Journal,Krishan Maggon,Negative
12281,CLL Key CLL ASH,Anthony Mato,Negative
12282,CllSociety,Anthony Mato,Negative
12283,CLL,Mustaqeem Siddiqui,Postive
12284,Cll,Laik Manifesto,Negative
12285,today CLL,secamimom,Negative
12286,three hundred and sixty,Jocelyn MS,Negative
12287,CLL five year Complement one three,Toby Eyre,Negative
12288,Acute Pancreatitis,Cancer Papers,Negative
12289,Chase Birthday next week April two thousand and eighteen Chase last month Chase,Veterinary Cancer Group,Postive
12290,The next couple week First,Sarah,Negative
12291,four,Benyam Muluneh,Postive
12293,CLL,Navneet Majhail MD MS,Negative
12294,Rod Humerickhouse CLL Fight CLL International,CheckRare,Postive
12301,four thousand eight hundred Landlord one half half one Chronic Lymphocytic Leukemia,Brad Hoylman,Negative
12302,ICYMI,Home Journal,Negative
12303,two Copiktra Venclexta,CONQUER patient voice,Negative
12304,CLL,Prof John,Postive
12305,DRG United States Western Europe DRGinsights CLL Roche,DRG Epidemiology,Negative
12306,CLL Society Round Two Answers CLL Society Virtual Community Meeting Friday April three two thousand and twenty,CLL Society Inc,Negative
12307,American CLL Medicare CLL,HealthWellOrg,Negative
12308,thirty day two,Still Buying Baker Mayfields Nick Chubbs,Negative
12309,Canada Ask Doctor three Ritux Venetoclax,Shouting people underpants,Postive
12310,CLL,Kathleen Hoffman,Negative
12311,CLL,CLLSA,Negative
12312,Bruce Raphael MD,OncLive SOSS,Negative
12313,CLL,The Lancet Haematology,Negative
12316,leuke medivizor,Medivizor,Negative
12319,AIM CLL Cello Health PLC,AIM Alerts,Negative
12321,CLL,Taylor Lab UM,Negative
12322,leuke via,Medivizor,Negative
12324,Japan Remdesivir Duvelisib Copiktra CLL SLL NFL Lymphoma NHL,CrozrX,Negative
12325,CLL GP Monday thirty March GP,CLLSA,Negative
12328,today RTE News Now Main CLL FergalBowers,Michael Rynne,Negative
12330,Imbruvica Waves Imbruvica AML CLL,dtw Research Inc,Postive
12331,CLL,Biotech Feed,Negative
12334,CLL UK CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
12336,CLL Orlaodo,Michael Rynne,Negative
12341,Ibrutinib Imbruvica Bone CLL SLL MCL,CrozrX,Negative
12342,one today,Eye,Negative
12343,obinutuzumab,Medivizor,Negative
12344,CLL CLL,Ex Dividend Date,Negative
12345,CLL Society Virtual Community Meeting two Anthony Mato John Pagel Susan Leclair Pharmacist Thomas Henry Register,CLL Society Inc,Negative
12346,Lancet one CLL,Shouting people underpants,Negative
12347,CLL,Lymphoma Papers,Negative
12355,ForMyDad CancerSucks CLL one John Chemo Medication,Marisa Allton Reptiles More,Negative
12356,CLL,ASH Clinical News,Postive
12358,Lymphoma CLL,PatientView,Negative
12359,Medicare,ASH Clinical News,Negative
12360,MedscapeEdu Bruton BTK Drs Jeff Sharman WVCancer,Medscape Education,Negative
12361,CLL CLL CLL SLL,CLLSA,Negative
12363,CLL,CLL Advocates Network,Negative
12365,Discovery,UCL Discovery,Negative
12366,morning CLL,Mayflower Primary School,Negative
12367,New OfficialNIHR,Europe PMC article,Negative
12368,CLL Tom Henry tomorrow CLL Society Virtual Community Meeting Register,CLL Society Inc,Negative
12369,ICYMI Jennifer Woyach MD,Home Journal,Negative
12370,American one hundred age twenty CLL five year,Beloved Foundation,Negative
12371,Acute Philadelphia Philadelphia CML,ANTARES,Negative
12372,CLL NHL CLL,Adam Kittai,Negative
12375,JanRynne CLL today,CLL Ireland,Negative
12376,Thomas Baxter March Vancouver Gen Hospital six Chronic,Derren Brown,Postive
12377,obinutuzumab,Medivizor,Negative
12379,European EPAR Gazyvaro Date nine Agenparl Cycle Cycles Reactions Treatment,Agenparl,Negative
12381,First China CLL one,Amber Koehler,Negative
12383,Cll IrishMed JanRynne,CLL Ireland,Negative
12384,CLL,Michael Rynne,Negative
12385,one,Winn Schott,Negative
12389,Sam Matheny,Lodge two hundred and eighty,Negative
12390,CllSociety CLL,Danielle Brander,Postive
12391,CLL,Cancer News,Negative
12392,Susan Brien MD Stephan Stilgenbauer CLL,ASH Clinical News,Negative
12393,obinutuzumab Leukemia,Medivizor,Negative
12395,Sat Tennessee CLL Worldwide Town hall SarahCannonDocs Tennessean,Andrew Schorr,Negative
12396,Chronic Lymphocytic Leukemia Treatment Health Professional Version PubMed CLL,CancerWallonia,Negative
12399,CLL,Lymphoma Hub,Negative
12400,obinutuzumab,Medivizor,Negative
12404,twelve week one,Nikki Greenwood,Negative
12405,CLL Society Virtual Community Meeting CLL Drs Anthony Mato Susan Leclair Pharmacist Tom Henry CLL Brian Koffman Register,CLL Society Inc,Negative
12406,Global Chronic Lymphocytic Forecasts two thousand,Investor News,Negative
12407,Global Chronic Lymphocytic Forecasts,Investor News,Negative
12410,CLL Times Sean Neill CLL Ireland Please SimonHarrisTD,Michael Rynne,Negative
12414,Two CLL,Leukemia one Fine,Negative
12416,CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
12420,Saturday CLL March CLL Register,Patient Power,Negative
12421,one one Chronic one PTSD one nine,baseballgodx laugh,Negative
12422,two thousand and one one CLL WHNFT,Adam Kittai,Postive
12424,MedscapeEd Mollie Moran MSN CNP Shilpa Paul,Medscape Education,Negative
12425,CLL German CLL Study Group,Lymphoma Papers,Negative
12430,CLL UK,CLLSA,Negative
12431,Sean The Times UK CLL CllSociety LornaWarwick,CLL Advocates Network,Negative
12432,BTK Inhibitors Transform Treatment CLL Macroglobulinemia Constantine Tam MD BTK Waldenstr,COPD News,Negative
12434,NIH CLL Contact NIHClinicalCntr Patient Recruitment Refer Lymphomaleukemia,NIH Clinical Center,Postive
12436,monthly CLL March,Lymphoma Hub,Negative
12437,Crohns MS RA,Michele,Negative
12438,BSI Connected Learning Live VirtualLearning CLL,BSI UK,Negative
12439,CLL LeoVaradkar,Michael Rynne,Negative
12440,CLL Northern Ireland JanRynne CllIreland LeukaemiaCareUK,Michael Rynne,Negative
12441,WHO CLL,CLL Ireland,Negative
12442,one one one,Mandy Mitchell,Postive
12444,European Commission Approval,Thomas Keefe,Negative
12446,Bay Area Mark DeSaulnier four,San Francisco Chronicle,Negative
12448,CLL Please,CLLSA,Negative
12454,JanRynne CLL IrishCancerSoc,Aishling Deegan,Postive
12455,one CLL,Oistein Jansen,Postive
12456,two thousand and thirtyfour two thousand nine hundred,COPD News,Negative
12457,CLL,Seema Ali Bhat,Negative
12458,CLL Webinar PatientPower,Taylor Lab UM,Negative
12459,CLL first JanRynne,CLL Ireland,Negative
12460,CLL,Kathleen Hoffman,Negative
12461,Replays week,Andrew Schorr,Negative
12462,CLL Carol Butler John discus second,Patient Power,Negative
12463,today CLL tomorrow United,Danielle Brander,Postive
12464,Ibrutinib FCR CLL Mindful Brien ten year FCR,JR Quan MD,Postive
12465,Lee Greenberger,CURE Magazine,Negative
12466,CLLStrong CLL PatientPower,Brave Is,Negative
12472,twentyone year,COPD News,Negative
12475,CLL,Mazyar Shadman MD MPH,Negative
12477,CLL Brad Kahl BTK,COPD News,Negative
12478,Latest Advice On Coronavirus For People Affected By Blood Cancer,The Thinker,Negative
12479,March FDA,ASH Clinical News,Negative
12480,one fifty zero,Lee Humphrey,Negative
12481,CLL,Anthony Mato,Postive
12482,BTK CLL Important CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
12483,CLL VEN Reason VEN,Toby Eyre,Negative
12484,UMass,Patient Power,Negative
12485,ICYMI Eviti Read,NantHealth,Negative
12486,DRG United States Western Europe DRGinsights CLL Roche,DRG Epidemiology,Negative
12487,Head NHL,Lymphoma Hub,Postive
12488,Last day Great Benign Hematology Watching CLL WHNFT,Adam Kittai,Postive
12489,BioTechniques EMBL Heidelberg EMBL,Karla Plevova,Postive
12495,Leukemia,Medivizor,Negative
12497,Seattle Cancer Care Alliance myeloid,Cowford Ball American Cancer Society,Negative
12498,CLL,Patient Power,Negative
12499,DTHSTR,DTHSTR,Negative
12508,transcript Nature Communications,Yungang Xu Xu Yun Gang ,Negative
12509,Mum today four CLL Mum,Pippa Jones,Negative
12511,two thousand and twenty,The ASCO Post,Negative
12512,CLL,Christopher DeBoever,Postive
12514,Please CLL,Taylor Lab UM,Postive
12516,CLL CLL,Lymphoma Hub,Negative
12517,two today CLL Drs Justin Taylor Farrukh Awan Nina Shaw Larry Anderson CLL,Andrew Schorr,Postive
12518,one three Please one CLL,Michele,Negative
12519,eleven AM PM CllStrong Cancer,Patient Power,Negative
12520,Read,NantHealth,Negative
12521,Today PM PM ET Cancer,Patient Power,Negative
12522,CLL,PRIME Education,Negative
12523,transcript MIT DanaFarber ILeukemia LeukaemiaCareUK MayoClinic,Gianluigi Zangari del Balzo,Negative
12524,transcript,Happy Scientist,Negative
12525,CLL CLL,Ruth Gemmell,Postive
12527,CLL Cello Health CLL,Proactive,Negative
12529,AIM CLL Cello Health PLC,AIM Alerts,Negative
12530,two thousand and thirtyfour two thousand nine hundred,DrugGenius,Negative
12531,Acute AML CLL CML year,Leukemia one Fine,Postive
12532,CLL LRoekerMD dbranderMD,Anthony Mato,Postive
12533,RT PhysRelations Leukemia Therapy CLL OncLive,Robert Orlowski,Negative
12534,BTK,Oncology Tube,Negative
12535,CLL SLL next twelve week,CLLSA,Negative
12537,CLL March CLL Register,Patient Power,Negative
12538,Leukemia Therapy CLL OncLive,MD Anderson Leukemia,Negative
12539,JanRynne today CLL,CLL Ireland,Negative
12540,last year ICU,Michelle St John,Negative
12541,CLL,Cancer Papers,Negative
12542,CLL,Lymphoma Papers,Negative
12547,CLL Next week NHS England,CLLSA,Negative
12548,JanRynne CLL SelfIsolation StephenAMcMahon IrishCancerSoc,Michael Rynne,Negative
12550,three CLL CLLsm,Bachar Samra MD,Negative
12551,Learn Undetectable Leukemia,Medivizor,Negative
12552,Investigators Pursue LessToxic,COPD News,Negative
12553,obinutuzumab CLL,Blood Journal,Negative
12554,twelve week two CLL,Nic,Negative
12556,five hundred CLL Jennifer Woyach HemeOnc,VJHemOnc,Negative
12557,CME CME,Oncology CE,Postive
12559,CLL,Kathleen Hoffman,Negative
12560,European EPAR Mabthera rituximab Agenparl Chemotherapy Combination Patients Treatment,Agenparl,Negative
12562,chr,Medivizor,Negative
12563,CLL,Dr Sylvia Benjamin,Negative
12564,Venclyxto Europe EuropeanCommission EC CLL first EU,Recruitment,Postive
12565,one CLL eight year UK one StayHome CllIreland,Jan Rynne,Postive
12566,Story Pharmacyclics Janssen Oncology USATODAY,CLL Society Inc,Negative
12567,Leukemia,Medivizor,Negative
12570,Coronavirus Update Andrew Schorr Jeff Sharman CLL WVCancer,Patient Power,Negative
12571,UK CLL NorthernIreland UK Ireland UK,CLL Ireland,Negative
12572,Mitochondrial Respiration Correlates Prognostic Markers,Lymphoma Papers,Negative
12576,Coronavirus,Peter Higgins conker,Postive
12577,two thousand and seventeen CllIreland CLL JanRynne CLL,Ciara masking friend,Postive
12578,eighty twenty CLL,CLL Ireland,Postive
12579,one Hep,Sarah Sterner,Negative
12582,one one one one Trum,Patricia,Postive
12583,one one one,Patricia,Negative
12585,CLL,Seema Ali Bhat,Negative
12586,two thousand and twenty Drs Susan Stephan Stilgenbauer Ranges From Treatment Options Current Role Chemotherapy,The ASCO Post,Negative
12587,Jennifer Woyach MD three Alliance,OncLive SOSS,Negative
12589,Precision Medicine Management,Lymphoma Papers,Negative
12593,AML Bonemarrowtransplant MultipleMyeloma,linfopedia,Postive
12594,CLL CLL CLL,CLLSA,Negative
12597,MRK Phase two Study Evaluate Safety Preliminary Efficacy,ClinicalTrialsData,Negative
12598,The Number Signaling Pathways Altered Driver,Jerry Lee,Negative
12599,two thousand and twenty,Nita Sonwane,Postive
12601,European Commission Approval,LLZ Consulting,Negative
12608,Chronic AML nine three,Lymphoma Papers,Negative
12610,CLL,CLLSA,Negative
12612,Coronavirus Personalized CLL Care,jneed,Negative
12615,New UK CLL LeukaemiaCareUK CLLSupport CllSociety,CLL Advocates Network,Negative
12616,UK CLL CLL,Michael Rynne,Negative
12617,CLL,Gearoid Crotaigh CareCantWait,Postive
12618,CLL JanRynne PaulKeane BernifloodBerni WaterfordMafia,CLL Ireland,Negative
12619,European Commission,Roche,Negative
12620,CLL,CLL Ireland,Negative
12621,European Commission Approval,Oncology Tube,Negative
12623,CLL UK CLL today CLL,Toby Eyre,Postive
12624,New UK CLL CLL CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
12625,Jennifer Woyach MD,Home Journal,Negative
12626,Matthew Davids MD two thousand and nineteen Annual,COPD News,Postive
12627,CLL The European Commission,COPD News,Postive
12628,one two half BorisJohnson NicolaSturgeon,Susan Fleming,Negative
12629,European Commission Approval,Company News HQ,Negative
12630,CLL Coronavirus Personalized CLL Care,Brave Is,Postive
12632,News Medical Independent Sales Representatives Medical Distributors AbbVie European Commission,HSMN,Negative
12634,CLL,MD Anderson Leukemia,Negative
12635,European Commission RHHBY ROG,Roche,Postive
12636,ABBV Thursday European Commission EC Venclyxto CLL,Anna Deveau,Postive
12637,European Commission Approval,Pharma News,Negative
12638,Learn CLL,AbbVie,Negative
12640,EC Approval VENCLYXTO Combination Regimen Patients With Chronic Lymphocytic,Bio,Negative
12641,European Commission Approval,Crwe World,Negative
12650,CLL Jacqueline Barrientos,The Patient Channel,Postive
12651,first CLL,palliativewise,Negative
12652,Didn Tampa four Friday NSCLC CLL thirty day CLL,CEC Oncology,Negative
12654,Jennifer Woyach CLL CancerNetworkAabout,COPD News,Negative
12655,CLL UK tomorrow Wishing CLL next month,UK Chronic Lymphocytic Leukaemia CLL Forum,Negative
12658,ICYMI,Home Journal,Negative
12659,CLL Scharff EinsteinMed Chiorazzi NorthwellHealth Labs,Immunogenetics Lab,Negative
12660,Precision Medicine Management Andrea Patriarca al CLL,Cancers MDPI,Negative
12661,CLL Ibrutinib CLL,RIOH,Negative
12662,CLL Eugen Tausch MD Department Internal Medicine three Ulm University Germany,Great Debates Hematologic Malignancies,Negative
12665,CLL,Kathleen Hoffman,Negative
12666,Haematology,ClinOwl Haematology,Negative
12667,one two eight eleven CLL,JAMA,Negative
12670,two,Lymphoma Papers,Negative
12671,Congratulations Alexey Danilov,Martin JS Dyer,Postive
12672,Pleural,GPII Eco,Negative
12676,CLL,COPD News,Negative
12678,twelve year old,Clin Path Cornell,Negative
12679,Rod Humerickhouse CLL iwCLL International Workshop Chronic Lymphocytic Leukemia Living CLL,CheckRare,Postive
12680,Ill PancreaticCancer CLL,Gary,Postive
12681,CLL shareastoryeveryday,Orchard Primary Academy Nursery,Postive
12682,PubMed Memory,Memory,Negative
12687,NEW Venetoclax,Medivizor,Negative
12689,Blood,Official Kaplan Edupac Indonesia HQ,Negative
12690,US CLL Saturday March,FLASCO,Negative
12691,Patient Power CLL Experts,Michele,Negative
12692,Seattle Cancer Care Alliance,emily nunn,Negative
12693,CLL HemeOnc,VJHemOnc,Negative
12694,CLL,Blood Advances,Negative
12695,CLL,Orchard Primary Academy Nursery,Postive
12696,CLL Learn FightBloodCancer ResearchMatters,NHLBI Bethesda Labs,Negative
12697,CLL Learn,AbbVie US,Negative
12698,Seattle Cancer Care Alliance,Trustwell Law Group LLP,Negative
12699,Check Ibrutinib,Medivizor,Negative
12700,CLL CLL PeterMacRes,Prof John,Negative
12701,Turmeric Natural Prevention Treatment Chronic,Chantel Martiromo,Negative
12702,Tcell EpsteinBarr,Lupus News,Negative
12703,JanRynne CLL,CLL Ireland,Negative
12705,two thousand and Majors Dodgers CLL Claremont American Little League,Amy Ramos,Negative
12707,JOHN TERRY CLL,BEARDED FRENCH MAN,Negative
12709,Krazyhorse Farmhouse Indian Classic BeLegendary,undead viking zombie,Negative
12712,Cancer Research CLL,CLL Ireland,Negative
12716,CLL Read,CLLSA,Negative
12717,Check Ash CLL SadafFazeli,sadaf fazeli,Negative
12718,Ace Cafe Next indian,undead viking zombie,Negative
12724,New Medivizor Ibrutinib,Medivizor,Negative
12725,UK CLL March two thousand and twenty,CLLSA,Negative
12727,one CO mid April,Winifred Council,Negative
12728,one CLL,Brave Is,Negative
12729,forty AVG FOUR ten,Tong,Negative
12730,CLL,Blood Journal,Negative
12731,CLL,Blood Journal,Negative
12732,The Debate Over Early Intervention Chronic Lymphocytic,CONQUER patient voice,Negative
12737,AML CLL Venetoclax,Blood Journal,Postive
12738,CLL,CONQUER patient voice,Negative
12739,one CLL Specialist PatientPower CllStrong,Brave Is,Negative
12740,CLL,Kathleen Hoffman,Negative
12741,Blood American Society Hematology,Eduardo Anguita MD PhD,Negative
12742,Saudi Arabia CLL,Carrie Thompson MD,Postive
12744,CLL,Marc Braunstein MD PhD FACP,Negative
12745,Watch Lynn CLL,Cancer Support Community,Negative
12747,Blood American Society Hematology,Eduardo Flavio Oliveira Ribeiro,Negative
12748,OncoAlert Multiple CLL American Society Hematology,Raul Cordoba MD PhD,Negative
12749,CLL Regimens Bruce Raphael MD,COPD News,Negative
12750,today Going Bearhunt CLL,NET The Ferns Primary Academy,Postive
12751,ICYMI Medicare,Home Journal,Negative
12752,CLL,CLLSA,Negative
12753,CLL Drs Lamana Koffman CllSociety,Tom Henry MBA RPh CPh,Negative
12754,Join Drs Adrian Chris Pleyer CLL April eighteen FightBloodCancer ResearchMatters,NHLBI Bethesda Labs,Negative
12755,CLL Clown,Dario Antilen,Negative
12756,BeLegendary indian,undead viking zombie,Postive
12757,YouTube,Brave Is,Negative
12762,Download eBook,AplusA World,Postive
12764,BioTechniques Karla Plevova CLL,BioTechniques,Negative
12765,Ron Keller Lincoln Illinois SIU Press SIU Illinois Lincoln CLL Twitterstorians,SIU Press,Negative
12767,Nitin Jain MD Texas Houston Listen,Oncology Learning Network,Negative
12768,Learn Venetoclax Leukemia,Medivizor,Negative
12769,ChronicLymphocyticLeukemia Learn CLL,Mayo Clinic Cancer Center,Negative
12770,TOMORROW March CLL Expert Register,Patient Power,Negative
12771,Sdq Ahmed sixtyfour year old WBC second,one,Negative
12772,one nearly forty million Americans one Mary,AstraZenecaUS,Postive
12773,CLL Eugen Tausch MD Department Internal Medicine three Ulm University Germany,Lymphoma Leukemia Myeloma Congress,Negative
12774,Bendamustine Haematology,ClinOwl Haematology,Negative
12775,one BeLegendary,undead viking zombie,Negative
12778,PhD Rebecka Svanberg Carsten Niemann Copenhagen week CLL,Sigrid Skanland,Negative
12779,Hemati Mir Mohammadkhani,NK paper,Negative
12781,FCR Binet CLL three,ALI ALAHMARI,Negative
12782,CLL NCCN ACPE,CEC Oncology,Postive
12783,CLL CLL,Pharmacyclics AbbVie Company,Postive
12784,Haematologica twelve CLL,Maria Tsagiopoulou,Negative
12785,CLL two thousand and twenty DukeCancer,Duke Hematologic Malignancies Cellular Therapy,Negative
12786,CLL today Wash Wash,Adam Kittai,Postive
12787,New Ibrutinib,Medivizor,Negative
12788,CLL Town Hall Nashville March CLL Register,Patient Power,Negative
12789,CLL,CLLSA,Negative
12790,Karina Chronic Karina Karina,Runway Hope,Postive
12791,ASH two thousand and sixteen two Update New Chronic Leukemia Drugs two thousand and sixteen two Update New Chronic,Oncology Tube,Negative
12792,Learn Ibrutinib Leukemia,Medivizor,Negative
12794,Ace Cafe Iconic Brighton Burn later year BeLegendary,undead viking zombie,Negative
12795,BTK one CLL,MedChemExpress,Negative
12801,CLL CLLSpecialist,Meli Rockhold,Negative
12802,Michael CLL,CLL Ireland,Negative
12803,Check Venetoclax,Medivizor,Negative
12804,Chronic CLL,Vitaly Terushkin MD FACMS,Negative
12806,CLL,Hematology Advisor,Negative
12808,CLL,Joe Fournet,Negative
12809,New Venetoclax,Medivizor,Negative
12811,two thousand and twenty two thousand Fortune Business Insights Come Analysis Market Size Growth,Nita Sonwane,Negative
12813,BTK,Targeted Oncology,Postive
12814,Venetoclax,noel cole,Negative
12815,Venetoclax,Medivizor,Negative
12816,CLL,Cristina Ibanez,Negative
12817,one Hypertrophic Cardiomyopathy HOCM Chronic,Susan RetiredProgrammer Greenberg,Negative
12818,ASH two thousand and sixteen three two thousand and sixteen three,Oncology Tube,Negative
12819,CLL,Kathleen Hoffman,Negative
12820,Venetoclax,Medivizor,Negative
12821,Indian BeLegendary indian,undead viking zombie,Postive
12824,Gareth Auckland CLL JustGiving,CLLSA,Postive
12825,Check Venetoclax,Medivizor,Negative
12826,CAR,Home Journal,Negative
12828,CLL MajorsDodgers Claremont American Little League,Amy Ramos,Negative
12829,CLL Seattle,Mazyar Shadman MD MPH,Negative
12830,"SWOG one thousand, nine hundred CLL Anticipate May two thousand and twenty one CllSociety UUtah",Harsh Shah,Negative
12831,CLL Tx,Jose Sandoval MD FACP,Negative
12832,Andy CLL,Andy Evens,Postive
12833,Check Ibrutinib,Medivizor,Negative
12834,monthly July two thousand and nineteen CLL,Lymphoma Hub,Negative
12835,COMPLEMENT two,Lymphoma Papers,Negative
12842,This week one today,Shark Lexy,Negative
12843,three,The Beacon Newspapers,Negative
12844,CAR CRS CLL,Oncology Learning Network,Negative
12845,CLL HemeOnc,VJHemOnc,Negative
12846,CLL,CONQUER patient voice,Negative
12847,CLL,Lymphoma Hub,Negative
12848,one CLL Starwars CLL Clones,Adam Kittai,Postive
12849,CLL one Leukemia Cancer CancerDiagnosis,Coping Cancer,Negative
12850,RT EuropeanCancer RT February Newsletter EUCancerPlan Lymphoma Coalition Global Patient Survey Lymphomas CLL,BlackSwan Analysis part Evaluate Pharma Ltd,Negative
12851,Doug Olson first CART nine year ago,Parexel,Negative
12856,Leeds March CLL SLL CLL,CLLSA,Negative
12857,February Newsletter EUCancerPlan Lymphoma Coalition Global Patient Survey Lymphomas CLL,ERN EuroBloodNet,Negative
12858,ERIC Israeli CLL Haematology,ClinOwl Haematology,Negative
12859,Venetoclax,Medivizor,Negative
12860,Only two week CLL JanRynne CllIreland,Michael Rynne,Negative
12861,CLL EAD,NET The Ferns Primary Academy,Negative
12862,cll tunisia JLL,Amna Snene,Negative
12863,March CLL Voices Faith,Phoebe Needles,Negative
12864,Second CLL,CancerTherapyAdvisor,Negative
12865,Time,Michele,Negative
12867,Ian Flinn Oncology Hematology Review two thousand and eighteen fourteen two,touchONCOLOGY,Negative
12872,ISHBT CLL CLL,Gaurav Prakash,Negative
12873,seven,Insights VUMC,Negative
12875,New Medivizor Venetoclax Leukemia,Medivizor,Negative
12876,one MedEd CLL Check CLL,Amber Koehler,Negative
12878,CLL,Kathleen Hoffman,Negative
12880,CLL CLL two year,Journal Clinical Pathways,Postive
12881,CLL one thousand nine hundred Patient Resilience,Brave Is,Negative
12882,The University Clinic Lymphoma MayoClinic theNCI,Mayo Clinic Cancer Center,Negative
12883,CLL Jay Blatt,Patient Power,Negative
12884,CLL British Columbia,Alicia Bell IFBB Pro,Negative
12885,CLL YahooFinance,SC,Negative
12886,Translational Research Conference Chronic CLL Hematology Haematology,ESH Haematology,Negative
12887,CLL TLS,NHLBI Bethesda Labs,Negative
12888,ERIC Israeli CLL,Cancer Papers,Negative
12890,BeLegendary indian,undead viking zombie,Postive
12891,Unilateral Blurred Vision Sole Presenting Symptom,Brandon Lujan MD,Negative
12900,Bruce Raphael MD CLL Hematologic Malignancies,OncLive SOSS,Negative
12901,CME CME,Vindico Medical Education,Postive
12902,Nitin Jain MD CLL Listen,Oncology Learning Network,Negative
12903,Diop CLL FCR Haematologica,Krizsan Szilvia MD,Negative
12904,Leukemia OncLive,MD Anderson Leukemia,Negative
12905,CLL Town Hall Nashville March CLL Register,Patient Power,Negative
12906,New Combination Therapies Treatment,SpecialtyPTimes,Negative
12907,HL Chronic Lymphocytic Leukemia Lymphoma HL,Oncology Tube,Negative
12908,Clinical Trials Leukemia Lymphoma Society,Brave Is,Postive
12909,one thousand nine hundred two thousand and seventeen,Pacylex Pharmaceuticals Inc,Negative
12912,VEGF VEGF Steve Martin,jorge gonzalez,Negative
12914,Lake District Scotland BeLegendary,undead viking zombie,Postive
12919,The Very Hungry Caterpillar This morning CLL UTW,Miss Nolan,Postive
12920,Leukemia Minimal,IUOPA,Negative
12921,CLL CLL,CLLSA,Negative
12922,DISCO Application Improvement Financial Outcomes Patients With Hematologic Cancer Status,TrialBulletin,Negative
12923,CLL Haematologica,chadi nabhan MD MBA FACP,Postive
12924,future Join u The International Workshop Chronic Sept two thousand Krakow Poland CLL,iwCLL,Negative
12925,CAR,Home Journal,Negative
12926,CLL,Reed Rowell,Postive
12927,CLL Join u March AM PM Eastern,Patient Power,Postive
12930,"early one thousand, eight hundred BeLegendary",undead viking zombie,Negative
12932,CLL,Lymphoma Hub,Negative
12933,day celebrate day fourteen year ago one,Stephen Brown,Postive
12934,CLL,Lymphoma Hub,Negative
12935,Medivizor,Chocolatiere Phys,Negative
12937,one CLL,chadi nabhan MD MBA FACP,Negative
12940,Lori Leslie MD John Theurer Hackensack Meridian Health CLL ASCO,Oncology Tube,Negative
12941,ICYMI,Home Journal,Negative
12942,CLL Miami Jennifer Woyach,Taylor Lab UM,Negative
12944,Paul Barr Cancer Institute CLL,Oncology Tube,Negative
12952,Rode Don one BeLegendary,undead viking zombie,Postive
12953,Rahmen de Deutschen Krebs Kongresses Krebsaktionstag Betroffene Angehorige Informationen Menschen mit CLL,AbbVie Deutschland,Negative
12954,CLL CLL,CLLSA,Postive
12956,Hemato Oncology Key Points eBook two thousand and nineteen,AplusA World,Postive
12957,LuchaLibre pisoton,Lenko Sins,Negative
12958,CAR NHL CLL,Home Journal,Negative
12964,CLL,Kathleen Hoffman,Negative
12965,This year CLL USAToday,Pharmacyclics AbbVie Company,Negative
12966,Invivoscribe LabPMM Shanghai Supporting MRD Flow MRD later year mm Bioinformatics,Jeffrey Miller,Postive
12969,AE CLL,Adam Kittai,Postive
12971,BritSocHaem CLL CelentyxLtd,Prof John,Postive
12973,Haematologica CLL,Benlazar Amine,Negative
12974,Scotland BeLegendary indian,undead viking zombie,Postive
12975,CLL,Lymphoma Hub,Negative
12976,SMUDGE CELLS CLL Smudge,Baby,Negative
12977,Los Motto Zielgerichtet Wirksam Neue Kombinationen CLL,Christoph Habel,Negative
12979,Potential Milestone CLL FDA IND FDA,Michele,Negative
12980,CLL,Michele,Postive
12981,atsuvui Man Xing rinpaXing Bai Xie,onkoro,Negative
12983,CLL,Blood Journal,Negative
12984,ABNORMAL,`ly `bdllh lkhlyf@,Negative
12985,Lee Greenberger,CURE Magazine,Negative
12986,CLL Pushing Through Cancer year one hundred,Shouting people underpants,Negative
12987,CLL,Patient Empowerment Network,Negative
12988,CLL NGS CLL CLL,OGT,Negative
12989,FREE WEBINAR Carolyn Owen CLL annual American Society Hematology December,Lymphoma Canada,Postive
12990,US UK CLL,Anthony Mato,Negative
12991,four hundred and thirtythree CLL LRoekerMD lymsm CLL,Toby Eyre,Negative
12992,Rod Humerickhouse CLL Lymphoma Hub,CheckRare,Postive
12996,Read,Comprehensive Cell Solutions New York Blood Center,Negative
12997,CLL Infections,CLLSA,Negative
13000,mshadman today one hundred Clinical Outcomes CLL Patients Relapsed Refractory Disease Tcellrx,Jordan Gauthier,Negative
13001,CLL,Daniela Hermelin MD,Negative
13002,CLL,Lymphoma Hub,Postive
13003,Andrew Esther Schorr Vietnam,Patient Power,Negative
13004,Raman UCLouvain CHUUCLNamur,Anal Bioanal Chem,Negative
13005,CLL,NHLBI Bethesda Labs,Negative
13006,Jennifer Specht CLL two,Lymphoma Hub,Negative
13008,LuchaLibre puntadiamante pisoton AAA,Lenko Sins,Negative
13009,FDA Priority Review Read,Comprehensive Cell Solutions New York Blood Center,Negative
13010,Misa PhD BristolUni Ziva one CLL Congrats,Bryjalab,Postive
13011,OncoAlert FCR Binet CLL FCR,Raul Cordoba MD PhD,Postive
13012,FCR Binet CLL three,Garbine Lizeaga,Negative
13017,Check Ibrutinib,Medivizor,Negative
13019,CLL Town Hall Nashville March CLL Register,Patient Power,Negative
13020,CLL CLL,AbbVie US,Postive
13021,Checkout HealthMonitorMagazine CLL Healthmonitor,Michele,Negative
13022,Hematopoietic,Brave Is,Postive
13023,Will Grateful Patient Power CLL,Brave Is,Negative
13024,CLL,Brave Is,Negative
13025,Ofatumumab May Prolong Survival,Brave Is,Negative
13026,Netherlands,Brave Is,Negative
13028,Venetoclax Obinutuzumab,Brave Is,Negative
13029,New Medivizor Ibrutinib Leukemia,Medivizor,Negative
13031,Chronic,Dr Shibley,Negative
13033,BTK,Targeted Oncology,Postive
13034,HighRisk Chronic,Lung Cancer News,Negative
13035,CLL Join u March AM PM Eastern,Patient Power,Postive
13037,CLL,Patient Worthy,Negative
13042,Geloof cll,Jolanda,Negative
13043,CLL,Kathleen Hoffman,Negative
13044,Check Ibrutinib,Medivizor,Negative
13045,Annu Rev Pathol,IUOPA,Negative
13046,anthonymatomd discus three,OncLive SOSS,Negative
13047,Learn Ibrutinib Leukemia,Medivizor,Negative
13048,NEW Ibrutinib,Medivizor,Negative
13049,new drug,Stanford Medicine Magazine,Negative
13051,CLL,Blood Journal,Negative
13052,three,ClinOwl Haematology,Negative
13053,MedCram,Michele,Negative
13054,twelve Noon CLL,Prof John,Negative
13055,BeLegendary indian,undead viking zombie,Negative
13058,Indian MCN FTR one thousand two hundred warmup BeLegendary,undead viking zombie,Postive
13060,Carole Nash Motorcycle today BeLegendary,undead viking zombie,Negative
13073,Leukemia Treatment Breakthroughs,Ritesh Patil,Negative
13074,fridaythoughts,Oncology Times,Negative
13075,Scan today GHH ANCR RECI NWT NXR STCK AV CLL,SwingTradeBot UK,Negative
13076,OncoAlert Achieving CLL American Society Hematology,Raul Cordoba MD PhD,Negative
13077,one BeLegendary indian,undead viking zombie,Postive
13078,Haploidentical Blood Marrow Leukemia Mi el Javier Bolanos JohnsHopkins,Xavier Tello,Negative
13079,Venetoclax Obinutuzumab,Jenn,Negative
13080,CLL,Adam Kittai,Negative
13081,Lisa CLL ValentinesDay Lisa,Leukaemia Care,Postive
13082,DRG United States Western Europe DRGinsights CLL,DRG Epidemiology,Negative
13083,Un linfocitica cronica Bajos los ultimos el indice de en persona con esta enfermedad,TenS Holanda,Postive
13088,Idelalisib Treatment Relapsed Follicular,ALI ALAHMARI,Negative
13090,Three BTK CLL John Allan,WCM Lymphoma,Negative
13091,Scan Centerline Cross today SWG KGF FUL HFG CLL TMKS ZIN,SwingTradeBot UK,Negative
13092,CLL CLL Bone Marrow CR PR BM Ibr PRs,Paul DeSantis PharmD,Postive
13093,Remarkable CLL CLL NCRI,Toby Eyre,Postive
13094,American,Mustafa,Negative
13095,obinutuzumab,Barry Shrier,Negative
13097,CLL Brian Hill Matthew Davids Nicole Lamanna DanaFarber ClevelandClinic,Patient Power,Negative
13098,Spreadex UK Sold CLL KAZ RR,John,Negative
13099,two CLL AML,Taylor Lab UM,Postive
13100,Jennifer Woyach MD,OncLive SOSS,Negative
13101,Early last week FDA IND NHL CLL,Beacon Targeted Therapies,Negative
13102,Leukemia Healio,Living Safely,Negative
13106,CLL,John,Postive
13107,Paula Soler CLL MCL,Marcius Lab,Negative
13108,Lymphoma Coalition Global Patient Survey Lymphomas CLL nineteen Webinar CutaneousLymphoma RareDiseases ERNeu,ERN EuroBloodNet,Negative
13109,CLL recent year Learn,AplusA World,Negative
13111,Rachel Thilssen CLL Venetoclax LorneCancer,Mohamed Saad,Negative
13112,two thousand and twenty WeillCornell CLL,FEDERICO GAITI,Postive
13113,MRD CLL,knowMRD,Negative
13114,CLL Charles Berry Geriatric Clinic DrTacara CancerMoonshot,MD Anderson Cancer Center,Postive
13115,CLL Woyach Rogers WomenInScience,Gretchen McNally PhD AOCNP,Postive
13116,FlappyCrypto Google Bitcoin CLL Ethereum Tezos Chainlink NEO Cosmos,FlappyCrypto,Negative
13117,IBM CLL SLL,Journal Clinical Pathways,Negative
13118,Pulse Access Pulse,Lymphoma Research Foundation,Postive
13119,Chemotherapy Learn CLL,AbbVie,Negative
13120,first CLL lymphocyte count indication treatment,David Kahn MD,Negative
13121,CLL BloodJournal DavidSteensma,chadi nabhan MD MBA FACP,Negative
13122,Great day BeLegendary indian,undead viking zombie,Postive
13123,European EPAR Mabthera rituximab,Agenparl,Postive
13126,DIAGNOSTIC PANEL BASIC HOME COLLECTION FACILITY eight billion seven hundred and fifty million five hundred five hundred and twentyseven million two hundred and thirtythree thousand five hundred Shop No Paramount Spectrum Market Crossings Republik Ghaziabad,Dr Lalpath Lab Crossings Republik,Negative
13127,obinutuzumab,Medivizor,Negative
13128,Drs Woyach Rogers Bhat,Adam Kittai,Postive
13129,obinutuzumab,Medivizor,Negative
13131,MDAnderson Novel Immunotherapy Produces Results CLL NHL,TrialSite News,Negative
13132,CLL,CLL Ireland,Postive
13133,obinutuzumab,Medivizor,Negative
13134,James Dean MD Sr Medical CLL Pharmacyclics Pharmacyclics AbbVie Company,CheckRare,Postive
13135,CLL,Patient Power,Negative
13136,obinutuzumab,Medivizor,Negative
13137,PhD two thousand and twenty Glasgow CLL,Michie Lab,Postive
13138,Duvelisib sll,CrozrX,Negative
13139,Lymphoid Leukemia Sarka Pospisilova Jitka Malcikova MasarykUni Ericllorg CLL WomenInScience,CEITEC Connect,Negative
13140,obinutuzumab,Medivizor,Negative
13141,PatientPower CLL Promising CLL Research MicheleNadeemBaker NicoleLamanna,Michele,Postive
13142,CLL,Patient Empowerment Network,Negative
13143,obinutuzumab,Medivizor,Negative
13144,CLL Hematology Haematology,ESH Haematology,Negative
13145,MRD CLL,ASH Clinical News,Negative
13146,CLL,AbbVie US,Negative
13147,obinutuzumab,Medivizor,Negative
13148,The European Medicines Agency two month ChildhoodCancer CLL Read gt LymSM,LymphomaAction,Postive
13149,CLL rituximab CLL,Shouting people underpants,Postive
13150,CLL,Kathleen Hoffman,Negative
13151,CAR,Home Journal,Negative
13152,obinutuzumab,Medivizor,Negative
13157,obinutuzumab Leukemia,Medivizor,Negative
13158,Super three morning CLL,Orchard Primary Academy Nursery,Postive
13159,CLL SLL three March twelve Feb Submit CLL,Lymphoma Australia,Negative
13160,CLL,Gift Child,Negative
13162,CLL CLL CLL,Christian Pallasch,Negative
13163,CLL CLL,Blood Journal,Negative
13164,CLL,NHLBI Bethesda Labs,Negative
13168,Paolo Tambaro CLL Free,The Lancet Haematology,Negative
13170,forty Caligaris el segundo el Rojo CLL two CDMKJ,Club Deportivo Moto Kart Jovita,Negative
13171,CLL CLL Le Tian,"one thousand, one hundred and fortyseven one",Negative
13172,Joni Casalis al Rojo CLL zero one CDMKJ,Club Deportivo Moto Kart Jovita,Negative
13173,CLL Sheila Hoff,Patient Power,Negative
13174,yesterday BeLegendary,undead viking zombie,Postive
13175,Prognostic Testing Treatment,Lymphoma Papers,Negative
13177,Lew et al BloodAdvances CLL Broadly uMRD PB BM uMRD Value BM,Toby Eyre,Negative
13178,Chronic,DanielNewmae,Negative
13179,Cumplimos el tenemos el one Ahora CLL,Fran,Negative
13180,Expression,Enrique,Negative
13182,TX USA Utilizing Cancer,Aftab Ahmad PhD,Negative
13183,Neil Kay Mayo Clinic CLL Venetoclax Measurement MRD CLL,Rafael Fonseca MD,Negative
13184,Jennifer Woyach MD three Alliance CLL,OncLive SOSS,Negative
13185,nonHodgkin CAR,Renal Cell Carcinoma,Negative
13186,HematonNL Bart van Echteld beterwordenisnietvoorwatjes,Yvonne van Batenburg,Negative
13187,CLL Nicole Lamanna MD ColumbiaMed OncLive,ColumbiaCancer,Negative
13188,CLL,MD Anderson Leukemia,Negative
13191,Lymphoma Coalition Global Patient Survey two thousand and CLL nineteen,Natacha Bolanos,Postive
13192,CLL,Sherry Sherry,Negative
13193,fridaythoughts,Oncology Times,Negative
13194,Lymphocytic CLL November,karla,Negative
13195,ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
13196,Apply John Goldman Award two thousand and twenty Deadline March one CML CLL AML TFR,Didi Jasmin,Postive
13197,three Learn More,PharmacyTimesCE,Postive
13198,CLL,Phronetik,Negative
13199,CLL Netherlands,Hematology Advisor,Negative
13200,Drs Matthew Fraser CLL,Education,Negative
13201,two thousand and twenty Lymphoma CLL PatientExperience,Lorna Warwick,Postive
13203,ACCC CLL,Adam Kittai,Negative
13204,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
13211,CLL CLL CLL Bcell,iReceptor Plus,Negative
13212,CLL NKcells CelentyxLtd,Prof John,Postive
13213,CLL,Kathleen Hoffman,Negative
13214,CLL Haematologica UoSResearch,CLL Epigenetics,Negative
13215,ACCC Quality Improvement Workshops Address Need Improved Chronic,CLL Society Inc,Postive
13216,Pharma Break RodneyGillespie BlueCarpet PatientsMatter CLL ProstateCancer,Michele,Postive
13217,CLL thirty BCMA,Raj Chakraborty,Negative
13218,CLL,CancerTherapyAdvisor,Negative
13220,Hematology Oncology,Targeted Oncology,Negative
13221,today MPAC BUR HUR yesterday CLL Pulsar,John,Negative
13222,CLL,Flow Paradigm,Negative
13223,one,Home Journal,Negative
13224,Hematology Today CLL Western Countries,Malgorzata Osmola,Negative
13225,CLL,Lymphoma Hub,Negative
13226,Venetoclax CLL,Benlazar Amine,Negative
13227,Venetoclax CLL,Benlazar Amine,Negative
13228,Practice Leukemia Healio,Living Safely,Negative
13229,EPIC,Biblioteca EASP,Negative
13230,Katy Rezvani CancerMoonshot,MD Anderson Cancer Center,Negative
13234,CLL,Benlazar Amine,Negative
13235,Acala CLL,Benlazar Amine,Negative
13236,CLL,Benlazar Amine,Negative
13237,CLL Cello Health Acess Intelligence Pulsar CLL,Proactive,Negative
13238,AIM CLL Cello Health PLC Settlement Access Intelligence,AIM Alerts,Negative
13241,Study Katy Rezvani MD,HemOnc Today,Negative
13242,Scan Centerline Cross today ARK SYNC GRI TIGT,SwingTradeBot UK,Negative
13248,James Beebe Ralph Williams two week later Read Ralph Story,Beebe Healthcare,Negative
13249,AMSSpringboard newPI CLL MHLSQUB,Dr Effie Kostareli,Postive
13250,medicare un PBM,Bijoy Telivala,Negative
13251,Philip Thompson CLL cll,Patient Power,Negative
13252,tonight Venetoclax CLL Great,Anthony Mato,Postive
13253,superb day CLL first Another good day,John,Postive
13254,CLL Watch PatientPower CLL Allesanda Ferrajoli,Michele,Negative
13255,RNAseq,BlueBee,Negative
13256,Google Search,TSmrecansky,Negative
13257,CLL NHL Novartis,Beacon Targeted Therapies,Negative
13260,CLL fifteen IcgcArgo,EGA archive,Negative
13262,Australia CLL CLL Learn,AbbVie Australia,Negative
13263,Autoimmune Focus Molecular Aspects Autoimmune ITP,Frontiers Oncology,Negative
13264,one hundred and thirty Read CeMM Ibrutinib,Genomics,Negative
13265,Roundup Options Legal Center Alabama,EIN Presswire Press Releases,Postive
13266,nhl cll steinberg legalhelp classaction massaction,Roundup Options,Negative
13268,Lymphoma Large Diffuse Follicullar Lymphoma Cutaneous Anapalastic Chronic,Matthews Associates,Negative
13269,CLL Brad Kahl,Tarsheen Sethi MD MSCI,Postive
13270,CLL Watch CLL Steve Lynn CLL,Cancer Support Community,Negative
13271,Hundreds Roundup NHL CLL,Matthews Associates,Negative
13272,US Watch Dr Adam Olszewski,AJMC,Postive
13273,one CLL,AbbVie,Negative
13274,EYFSculturalcapital CLL,Bishopton Primary School,Postive
13275,CLL two,Kerry,Negative
13276,Today CLLAdvocates,LyLe Foreningen,Postive
13277,two thousand CLL Cancer,Ali Ansari,Negative
13278,michieCLLlab CLL,Michie Lab,Postive
13279,Congratulations Stuart Blakemore Leukemia ATM CLL,Christian Pallasch,Postive
13280,Super Blossom CLL,Orchard Primary Academy Nursery,Postive
13281,Chronic Reddit,Nikhil Upadhyay,Negative
13282,Breakthroughs CLL James Ohio State John Byrd SPON,Local,Negative
13283,Chronic Leukaemia Blood Cancer,Lighthouse Naturopathy,Negative
13284,Today CLL,CLL Ireland,Negative
13285,CLL CLL CLL,CLLSA,Postive
13286,CLL,Ten ni,Postive
13287,February four two thousand and twenty CancerSpecialist CLL Brustkrebs WHOUNOIO,Konigin Connie Zuckerberg von der Schweiz QUEENIE,Negative
13288,CLL,Michael Hallek,Negative
13289,one MDAnderson Chemotherapy CLL,Michele,Negative
13290,EYFS EYFS LanguageDevelopment CLL,Jerry Clay English Hub,Postive
13292,Read,Pfizer Inc,Negative
13293,CLL,chadi nabhan MD MBA FACP,Negative
13294,Scripps Research,Scripps Research,Negative
13295,CLL Oncology PracticeChanging Advances OncLive,PER,Negative
13296,MD Anderson Alessandra Ferrajoli MD Patient Power CLL cll,Patient Power,Negative
13297,March CLL,Sigrid Skanland,Negative
13298,CLL,Kathleen Hoffman,Negative
13299,CLL Help Prevent Colds Flu Viruses Wash,Michele,Postive
13302,CLL CAR Cell Meeting two thousand and twenty,Lymphoma Hub,Postive
13303,CLL,Michael Hallek,Negative
13304,CLL,Michael Hallek,Negative
13306,CLL thirty CLL,COPD News,Postive
13308,Ibrutinib one,Jeremy Lorber,Negative
13309,ten CLL,Andy Evens,Negative
13311,OnkoLogisch Das Teil Manner Von Leukamie CLL Manner Mehr Fakten CLL,AbbVie Deutschland,Negative
13317,Venetoclax Venetoclax Venex CLL,AtoZ Drugs Bangladesh,Negative
13318,CLL CLL IPI,Deepesh Lad,Negative
13319,Haematologica,CancerEpiPapers,Negative
13321,CLL andrewschorr,Patient Power,Negative
13322,CLL Learn CLL four,JAAPA,Negative
13323,new drug,Stanford Medicine Magazine,Negative
13326,TLS CLL hemeonc,Faheema Hasan,Negative
13331,Kollegerna har producerat denna Snyggt,Majlen Saarinen,Negative
13335,first,Clinical Lab Manager,Negative
13337,YouTube CLL SaudiBlood,Saudi Blood SSBD 'mrD ldm,Postive
13338,Venetoclax obinutuzumab CLL Brazil Tx Nice Brazil Interesting,Phillip Scheinberg,Postive
13339,MedscapeOnc Medscape,Northstream Global Partners,Postive
13340,CLL Grand Rounds Resistance CLL Great talk Woyach,Adam Kittai,Postive
13341,News Medical Independent Sales Representatives Medical Distributors AbbVie Receives Positive CHMP,HSMN,Postive
13344,Learn CLL,AbbVie,Postive
13346,first ECM,Professione Oculista,Negative
13348,four year,David Henry,Negative
13357,OnkoLogisch Nicht two Drittel CLL einem spateren Zeitpunkt Beobachten Mehr Infos,AbbVie Deutschland,Negative
13358,Japan PhD UofGlasgow CLL,Michie Lab,Postive
13362,Leukemia,Medivizor,Negative
13364,CLL,SNN,Negative
13365,The Number Signaling Pathways Altered Driver,Cure Cancer Now,Negative
13367,CLL Fig scRNAseq,Arash Davari Serej,Postive
13368,Lymphoma Chronic People Lymphoma CLL Feel Lymphoma Coalition,Chiara,Negative
13370,Michael Taylor,Ginny McLean,Postive
13373,one andrewschorr,Patient Power,Negative
13374,LLSusa CLL Register Leukemia CLL,SeattleCancerCareAlliance,Negative
13375,VEGF,jorge gonzalez,Negative
13376,Chicago Jeff CLL,MyelomaTeacher Cindy Chmielewski,Postive
13377,CLL BTK,Adam Kittai,Postive
13378,Translational Research Conference Chronic Paris France CLL,ESH Haematology,Negative
13379,Chronic,Austrian Academy Sciences,Negative
13380,CLL,Kathleen Hoffman,Negative
13389,CLL Free,The Lancet Haematology,Negative
13390,nhl cll legalhelp classaction massaction,Roundup Options,Negative
13391,New Premedication,Medivizor,Negative
13392,Finale Ergebnisse Ofatumumab CLL,Onko Community,Negative
13393,John CLL,The James,Negative
13395,last week Elena Georgieva,CLL Advocates Network,Negative
13397,CLL one CLL,Cancer Support Community,Negative
13398,CLL,Patient Empowerment Network,Negative
13399,Lilly Presents Interim Clinical Data Dose Escalation American,Oncology Tube,Negative
13400,theNCI CLL Contact NIHClinicalCntr Office Patient Recruitment Refer Lymphomaleukemia,NIH Clinical Center,Negative
13401,CLL,Sigrid Skanland,Negative
13402,CLL NatureComms,Medical Xpress,Negative
13403,nursery morning Goldilocks CLL,Orchard Primary Academy Nursery,Negative
13404,European CLL,Lymphoma Hub,Negative
13406,CLL,Hematology Advisor,Negative
13407,CLL CLL,JanssenUS,Negative
13408,Chronic CLL Ref CCL,Arash Davari Serej,Negative
13409,CLL Lymphoma Ireland,CLL Ireland,Postive
13414,CeMM Christoph Bock Group NatureComms CLL,idw News,Negative
13415,CeMM Christoph Bock Group NatureComms CLL,CeMM,Negative
13416,obinutuzumab Blood,Hematologia ICO Hospitalet,Negative
13417,Un bienvenidas la opiniones,Jesus Sierra,Negative
13418,Que lo bueno tiene el al placer de ganar Cuando,Fran,Negative
13419,CLL last ten year Alessandra Ferrajoli PatientPower,MD Anderson Cancer Center,Negative
13422,Anderson CLL second,Andrew Schorr,Negative
13424,CLL one CLL,AbbVie US,Negative
13425,FerrumCollege Delia Heck,Phoebe Needles,Negative
13426,CLL Call Office Patient,NHLBI Bethesda Labs,Negative
13427,obinutuzumab Blood American Society Hematology,Juan Marquet,Negative
13433,three CLL,Orchard Primary Academy Nursery,Negative
13434,recent year ago CharityTuesday CLL,LymphomaAction,Postive
13438,New Medivizor Comparing,Medivizor,Negative
13439,ma asi LuchaLibre NoMasShowFamiliar xnl,Lenko Sins,Negative
13440,CLL,CLL Epigenetics,Negative
13442,Watchful CLL Steve,Cancer Support Community,Postive
13450,CLL,RIOH,Negative
13451,one thousand nine hundred two thousand and seventeen,Christopher Walker,Negative
13452,CLL,Patient Empowerment Network,Negative
13453,CLL,Pharmacyclics AbbVie Company,Negative
13454,CLL one,CURE Magazine,Postive
13455,one thousand nine hundred two thousand and seventeen,Olderpreneurs,Negative
13457,Idelalisib CLL,Lymphoma Hub,Negative
13459,today three CLL,Orchard Primary Academy Nursery,Postive
13460,Chronic Lymphocytic Leukemia Treatment Version,Chocolatiere Phys,Negative
13461,CLL Drs Jennie Crews MedscapeEdu,Medscape Education,Negative
13463,EBioMedicine Genmab Bcells CLL,Prof John,Negative
13465,CLL early year EEF CLL,Jerry Clay English Hub,Negative
13466,todasparami diadelamujerhondurena cll,This way,Negative
13469,Deborah Sims CLL one Prof John Gribben JanRynne CllSociety,CLL Ireland,Postive
13471,OncoAlert CLL twenty four hundred Netherlands one thousand nine hundred two thousand and sixteen,Raul Cordoba MD PhD,Negative
13472,Hofland Endstra Gomes CKP de Boer de Weerdt one five Riedl JA Heukers Smit MJ,NK paper,Negative
13481,CLL,linfopedia,Postive
13482,Haematologica,CancerEpiPapers,Negative
13483,CLL,Toby Eyre,Negative
13484,CLL Vocabulary,Jerry Clay English Hub,Postive
13485,Venetoclax Rituximab CLL Spain MoreOptionsMoreChances,Raul Cordoba MD PhD,Postive
13486,two thousand and nineteen CLL,Shouting people underpants,Negative
13487,CLL,Kathleen Hoffman,Negative
13490,yesterday Chris Fegan Janice Rees John Perkins CLL,CLLSA,Negative
13496,two thousand and nineteen two thousand View More Amgen Roche AmecoResearch,Rohit,Negative
13497,nhl cll surgeon nurse,Roundup Options,Negative
13498,Russ MLW CLL NGEN LuchaLibre Luchador Santiago Chile,Zenshi,Negative
13499,CLL,Benlazar Amine,Negative
13500,Therapy Supporting Evidence Value Considerations,Heidi Fleming,Postive
13501,CLL,Toby Eyre,Negative
13502,CLL,Patient Empowerment Network,Negative
13503,CLL LeukaemiaCareUK LornaWarwick LymphomaAction CLLSupport CLLAdvocates Leukaemia,Zack,Postive
13504,one Columbus Ohio,TSmrecansky,Negative
13505,Venetoclax one one Ibrutinib Afib,Shouting people underpants,Postive
13506,first one Radon,Sun Man,Negative
13510,Arabinoxylan Curcumin,Lovisa Bray,Postive
13512,CLL,Benlazar Amine,Negative
13513,fifty Bearish List today CLL SPO TERN,SwingTradeBot UK,Negative
13515,CLL,Patient Power,Postive
13517,AIM CLL Cello Health PLC Block Interim Review,AIM Alerts,Negative
13518,CLL CLL next two year NatureComms one,Pearson Lab,Postive
13519,CLL,Oncology Learning Network,Negative
13520,myeloid one,vashti,Negative
13521,tomorrow Prof Chris Fegan CLL,CLLSA,Negative
13522,CLL Roche CLL,Vladimir Strugov,Postive
13523,Erweiterung Imbruvica Janssen Anwendung Rituximab Behorden Kombitherapie CLL,APOTHEKE ADHOC,Negative
13524,English CLL CREATIVITY,Jorge Sette,Postive
13527,CLL Kanduri CLL,CLL Epigenetics,Negative
13528,Planned Purposeful Talk afternoon HeyPobble CLL,Miss Marsh,Postive
13529,EMA Imbruvica rituximab CLL JanssenGlobal,Plexus Ventures,Negative
13530,LymphomaAction,CLL Advocates Network,Postive
13532,CLL Learn USAToday,JanssenUS,Negative
13533,CLL Learn USAToday,Pharmacyclics AbbVie Company,Negative
13535,Super time morning CLL,Orchard Primary Academy Nursery,Postive
13537,CLL CLL,Nuclear Medicine Molecular Oncologic Imaging,Negative
13538,one six month today one CLL today BloodCancer Leukemia CancerCure Immune BBC News,RJW,Negative
13540,twenty four hundred Netherlands one thousand nine hundred two thousand and sixteen CLL,Benlazar Amine,Negative
13542,Ofatumumab CLL,Hematology Advisor,Negative
13543,CLL One ZPWLC,Nick,Postive
13544,postdoc Please TaskenLab GregVladimer,Sigrid Skanland,Postive
13545,Rendeiro Christoph Bock CeMM PhD today,CeMM,Postive
13546,CLL,Prof John,Negative
13547,CLL,Kathleen Hoffman,Negative
13548,CLL BHSnursing cancernurseEU,De Munter,Negative
13549,John Seymour PeterMacCC Royal Melbourne Hospital ASH two thousand and nineteen Murano Venetoclax rituximab CLL,Lymphoma Australia,Negative
13550,one CLL zero Doesn like week,Maxwell Ivey,Negative
13551,Cascade NWAC NW Athletic Center,NW Athletic Center,Negative
13553,fifty LanguageDevelopment CLL,Jerry Clay English Hub,Negative
13554,Venclexta Imbruvica Bruton BTK CLL Oncology,PER,Negative
13555,Medicare,Home Journal,Negative
13556,Blood,Hematologia ICO Hospitalet,Negative
13557,CLL Progression Persistence Link Subclone Diversity CLL,Taylor Lab UM,Postive
13558,CLL MRD ClinicalTrials,Blood Advances,Negative
13560,NEUTROPHILIC,Michelle Holder,Negative
13561,Blood American Society Hematology,Michie Lab,Negative
13565,OncoAlert Multiple CLL American Society Hematology CLLsm,Raul Cordoba MD PhD,Negative
13566,obinutuzumab CLL Barbara Eichhorst ImmunoOnc HemeOnc,VJHemOnc,Negative
13568,NGS,CAP TODAY MAGAZINE,Negative
13569,Annual Orlando,Tu Salud Magazine,Negative
13570,CLL CLL CLL,Toby Eyre,Negative
13573,CLL Indolent Lymphomas Hear Marc Hoffman MD,KU Cancer Center,Negative
13577,CLL,Taylor Lab UM,Postive
13578,CLL Justin Taylor,Patient Power,Negative
13579,CLL Wojciech CLL,Lymphoma Hub,Negative
13580,CLL Follow Mato,Memorial Sloan Kettering Cancer Center,Postive
13586,Adaptive Genentech three Study,ArthurPotatoeHammer,Negative
13587,DrTacara CLL Charles Berry Geriatric Clinic CancerMoonshot,MD Anderson Cancer Center,Postive
13588,one Bcellmalignancies CLL,Science Translational Medicine,Negative
13589,ATH five day week three day ATH five day eight Reduced BLIN CLL ten RCH CSP VTY ten,Tong,Postive
13590,two PhD Peter Napper CLL Tues HWB GreatScience Research Seminar,DCG Seminar Series,Postive
13591,CLL nearly die year RareDisease ChronicLymphocyticLeukemia,Michele,Postive
13592,CLL two thousand and nineteen CLL ninety CLL age fifty year Memorial Sloan,Zusia Dr Jackie Volk,Negative
13593,CLL,Lymphoma Hub,Negative
13594,CLL,Health,Negative
13596,MedTech PrecisionMedicine MachineLearning,The Royal Vox Post,Negative
13598,OnkoLogisch Genabschnitt CLL sein kann Der Status Vergleich,AbbVie Deutschland,Negative
13599,CLL,Prof John,Negative
13600,CRUKCambridge CLL,CRUK Cambridge Centre Haematological Malignancies,Negative
13601,SCICambridge CLL,Prof John,Negative
13602,twelve five CLL,LabPulse,Negative
13603,ImmunoOncology Comprehensive CLL,Michele,Negative
13604,CLL Diagnostics,Michele,Negative
13605,CLL Hai Yao,ganpurasu,Negative
13606,MN two thousand and twenty spring CLL,Amber Koehler,Postive
13608,Steve,Cancer Support Community,Negative
13609,Check Jenn,Cancer Support Community,Negative
13610,CLL Jennifer Woyach CLL,Patient Power,Negative
13611,Jennifer Woyach MD BTK,OncLive SOSS,Negative
13612,Read,Comprehensive Cell Solutions New York Blood Center,Negative
13615,one today CancerSupport BloodCancer CLL,LymphomaAction,Postive
13616,Lindsey Roeker CLL CLL Click,Lymphoma Research Foundation,Negative
13617,Read CRUKCambridge CLL,CRUK Cambridge Centre Haematological Malignancies,Postive
13618,today Feast PPIX DBOX,Hybridan,Negative
13619,Daratumumab Ibrutinib Treatment Relapsed Refractory CLL Genmab GMAB JNJ MayoClinic,Lambrechts,Negative
13620,CLL CNV Panel CLL NGS,OGT,Negative
13623,one UkCll DrTonyLetai CLL,Ingo Ringshausen,Postive
13624,CLL six Signal one,WheelieDealer,Postive
13625,The Lymphoma Coalition two thousand and twenty eleven March LymphomaMatters CLL,LymphomaAction,Postive
13626,CLL six One Brexit year,John,Negative
13627,CLL Signal Cello Health CLL AndrewScottTV,John Harrington,Postive
13628,CLL Cello Signal CLL AndrewScottTV,Proactive,Negative
13629,AIM CLL Cello Health PLC Trading Statement,AIM Alerts,Negative
13630,one Raphael,Suzie Siegel,Negative
13632,Michele CLL two thousand and nineteen American Society Hematology Annual,Patient Power,Negative
13633,CLL,Cancer Health,Negative
13634,Adaptive Genentech three Study,gilbert faure,Negative
13635,CLL,Meghan MacMillan,Negative
13640,CLL,Kathleen Hoffman,Negative
13643,OncoAlert two thousand and Lymphoma Coalition Global Patient Survey Lymphoma CLL YoungSIOG,Raul Cordoba MD PhD,Postive
13644,OncoAlert two thousand and Lymphoma Coalition Global Patient Survey Lymphoma CLL,Raul Cordoba MD PhD,Postive
13645,nonhodgkinslymphoma nhl cll,Roundup Options,Postive
13646,CLL,Patient Empowerment Network,Negative
13647,CLL,AbbVie US,Postive
13648,Warthin Involvement HemePath SurgPath,Lisa Rooper,Negative
13650,ChadRobbins AdaptiveBiotech CLL Adaptive FDA,Linda Stotsky,Postive
13651,CLL Progression Persistence Link Subclone Diversity,Michele,Negative
13652,CLL Drs Jennie Crews MedscapeEdu,Medscape Education,Negative
13653,SureSeq CLL CNV Panel NGS CLL cnv,OGT,Negative
13658,Blood American Society Hematology,Krishan Maggon,Negative
13660,CME San Diego Join Drs Stephen Ansell Jennifer Brown Nitin Jain today,Oncology CE,Postive
13661,AdaptiveBiotech genentech CLL LiquidBiopsy CLL NGS MRD,DDNews Online,Negative
13664,CLL Genetic Testing Explained,Patient Empowerment Network,Negative
13665,SFBN Feed Adaptive Genentech three Study SEATTLE thirteen two thousand and twenty BayArea Biotech,San Francisco Biotechnology Network,Negative
13666,Russell Powell Read,Jefferson Health,Negative
13667,one thousand nine hundred two thousand and seventeen CLL,PracticeUpdate,Negative
13669,Adaptive Genentech three Study SEATTLE thirteen two thousand and twenty GLOBE NEWSWIRE Adaptive,COPD News,Negative
13670,three Study,Mr Bentley Onelly,Negative
13671,three Study Multi year Venetoclax,Michelle Solly,Negative
13672,Adaptive Genentech,Crwe World,Negative
13673,European EPAR Blitzima,Agenparl,Negative
13674,Adaptive Biotechnologies Receives,ArthurPotatoeHammer,Negative
13675,Tanya Siddiqi USA CLL ASH Dr Siddiqi one CLL,Lymphoma Australia,Negative
13676,Cardiac HFpEF cell dyscrasia CLL Lymphoma,Nihar Desai,Negative
13678,CLL Philadelphia Lymphoma Rounds See link Please,Anthony Mato,Postive
13679,Mayo Nov two thousand and ten CLL,Shouting people underpants,Postive
13681,OnkoLogisch Ein Fehlen Fortschreiten CLL Funktionsverlust de Eiweisses Zellteilung Tumorwachstum,AbbVie Deutschland,Negative
13682,NitinJainMD CLL LeukemiaMDA,Katrina Sondermann,Postive
13683,one CLL Genentech tomorrow Anniversary Jamaica Jeopardy AA First Class,Jessica Efron Sauer,Postive
13685,Super CLL ksondermann,Nitin Jain,Postive
13686,Zydelig,CURE Magazine,Negative
13687,Tam two,Targeted Oncology,Negative
13688,CLL,Medscape,Postive
13696,CLL,Kathleen Hoffman,Negative
13698,New Medivizor Ofatumumab,Medivizor,Negative
13699,Review CellCellPress Snapshot Adrian Krainer AbdelWahablab CLL,Taylor Lab UM,Negative
13700,CLL Brian Hill CLL second,Patient Empowerment Network,Postive
13701,New Ofatumumab,Medivizor,Negative
13702,CLL Mayo Clinic Hematologist,Mayo Clinic,Negative
13705,Learn PAN CLL,AA MDSIF,Postive
13706,Check Ofatumumab leuke via,Medivizor,Negative
13707,Ofatumumab,Medivizor,Negative
13709,Ofatumumab,Medivizor,Negative
13712,OnkoLogisch Blutzellen au dem Knochenmark Bei CLL Lymphozyten WorldCancerDay,AbbVie Deutschland,Negative
13713,Ofatumumab,Medivizor,Negative
13717,The Number Signaling Pathways Altered Driver,Cure Cancer Now,Negative
13718,Association COMPLEMENT Mech Will Novel CLL,Toby Eyre,Negative
13719,The Number Signaling Pathways Altered Driver,Richard Rosenquist Brandell,Negative
13720,MPAC CLL GAN one ISA,John,Negative
13721,Adaptive two thousand and twenty,MedTech Dive,Postive
13722,OncoAlert Idelalisib Treatment Relapsed Follicular,Raul Cordoba MD PhD,Negative
13723,Sandra Kurtin PhD CLL US,JADPRO,Postive
13724,CLL monthly,Lymphoma Hub,Negative
13725,USD billion two thousand USD billion two thousand and nineteen,Jimi Richards,Negative
13727,CLL Jennifer Woyach MedscapeEdu,Medscape Education,Negative
13730,Chronic Lymphocytic Leukemia CLL,Brian Uherek,Postive
13731,CLL,CRUK Cambridge Centre Haematological Malignancies,Negative
13732,CLL,Freddy Pizart,Postive
13734,Adaptive Biotechnologies Receives,Investor News,Negative
13736,Reward Ad AttentionMining CryptoLiveLeakToken CLL CLL,CLL CryptoLiveLeak Token,Postive
13737,one UkCll London CLL Friday,Ingo Ringshausen,Postive
13738,Scan Stochastic Sell Signal,SwingTradeBot UK,Negative
13739,HL CLL today TED RBD AGFX,John,Postive
13740,CLL AML CML first LLSCanada LymphomaCanada,AbbVie Canada,Postive
13742,CLL Mike Boston Seattle,Andrew Schorr,Negative
13744,CLL,John,Negative
13745,Cello Health CLL three Outlook,John,Postive
13746,Adaptive Biotechnologies Receives,Crwe World,Negative
13749,CLL,Medscape,Postive
13752,one doc Swedish today every six month one Bizarre,AAROnJHILL,Negative
13753,FL CLL,Health,Negative
13755,today IBT,SwingTradeBot UK,Negative
13756,CLL CLL Javier,Patient Empowerment Network,Negative
13757,CLL Javier,Patient Empowerment Network,Negative
13758,Trabectedin CLL,Shouting people underpants,Postive
13759,CLL Ian Flinn SarahCannonDocs two thousand and nineteen,HemOnc Today,Postive
13760,CLL Please January two thousand and twenty CLL EQA,GenQA Genomics Quality Assessment,Negative
13765,Bob Azopardi,Andrew Schorr,Negative
13766,one CLL twenty week ago Today one next thirtytwo week one one Truly,Mike ForThePeople,Postive
13768,Expansion Breakout today MNO AVAP UNG CGNR SPR ARC GGP,SwingTradeBot UK,Negative
13769,CLL,Andrew Schorr,Postive
13770,Danielle Brander CLL,Patient Empowerment Network,Negative
13771,Ryan Jacobs CLL,MedPage Oncology,Negative
13772,SUBMIT four Paris,ESH Haematology,Negative
13773,Amy Pierre three CLL,JADPRO,Negative
13774,Blossom CLL,Orchard Primary Academy Nursery,Negative
13775,CLL,Kathleen Hoffman,Negative
13776,CLL,Freddy Pizart,Postive
13777,PatientPower al Leusm,Navneet Majhail MD MS,Postive
13778,PatientPower al Leusm,Navneet Majhail MD MS,Postive
13780,ICYMI,Home Journal,Negative
13781,Strati et al Post CR Nice one CLL,Toby Eyre,Negative
13782,CLL,Patient Power,Negative
13783,CLL,Medscape Med Student,Postive
13785,CLL,Medscape,Postive
13786,CLL,Medscape Oncology,Postive
13787,Trabectedin,Candice Limper,Postive
13788,CLL,Patient Power,Postive
13789,one thousand nine hundred two thousand and seventeen,MUA,Negative
13791,first trabectedin,Luisa Torres PhD,Negative
13792,one two thousand and nineteen ASH Review NewJersey two thousand and myeloid CART CLL REGISTER,Andy Evens,Negative
13793,International Advisory Board Many TheLancet CLL,Raul Cordoba MD PhD,Postive
13795,CLL DanaFarber CLL CLLsm,Patient Empowerment Network,Postive
13796,CLL Kerry Rogers CLLsm,Patient Empowerment Network,Negative
13797,The Year CLL two thousand and nineteen Inhye Ahn MD William Archibald Nicole Lamanna MD Ian Flinn MD,HemOnc Today,Negative
13798,Jeff Sharman MD WVCancer ASH Annual Meeting Exposition,Home Journal,Negative
13803,CLL,Kathleen Hoffman,Negative
13804,LEUCEMIA Trabectedin Targets Leukemic Cells Restores Immune Cell pharmamar trabectedin,Pharma Jonpi,Postive
13805,Nicole Lamanna MD MURANO CLL,MedPage Oncology,Negative
13806,Jennifer Woyach MD Alliance ASH Annual Meeting Exposition,Home Journal,Negative
13808,Jennifer Woyach The Ohio State University Comprehensive Cancer Center Alliance ASH Annual Meeting Exposition,Cancer News,Negative
13812,DYK CLL Learn,AbbVie US,Negative
13813,Trabectedin,CancerTherapyAdvisor,Postive
13817,AmericanCancer CLL two thousand and nineteen,DelveInsight,Negative
13819,New Year two thousand and twenty two thousand and nineteen Crypto Blockchain Tezos CLL CLL,CryptoLiveLeak,Postive
13820,one thousand nine hundred two thousand and seventeen,Robo Schmobo,Negative
13821,CLL Susan Leclair andrewschorr cll,Patient Power,Postive
13822,one thousand nine hundred two thousand and seventeen,Pacylex Pharmaceuticals Inc,Negative
13823,one thousand nine hundred two thousand and seventeen CLL,Oncology,Negative
13829,CLL two thousand and twenty LornaWarwick CllSociety,CLL Advocates Network,Postive
13830,NY Lymphoma Rounds CLL,Anthony Mato,Postive
13831,NewYear ten year one thousand nine hundred Polynesian Samoan one seven Samoan,ron white,Negative
13832,one thousand nine hundred two thousand and seventeen,Portfolio Penny,Negative
13833,CLL Michael Keating William Wierda CLL CLL Global Research Foundation andrewschorr wwierda,Patient Power,Negative
13834,one thousand nine hundred two thousand and seventeen,Financial Carnivores,Negative
13835,Hematologia,Biosimilar Today iMagazine,Negative
13838,CLL two thousand and twenty,CLL Ireland,Postive
13839,one thousand nine hundred two thousand and seventeen,CarnivoresHealth,Negative
13840,LyLe Godt Nytar fremtiden Vi Vi cmml,LyLe Foreningen,Postive
13843,Last day two thousand and nineteen two thousand and twenty CLL,Anthony Mato,Postive
13844,CNS,Pooja,Negative
13845,today,SwingTradeBot UK,Negative
13846,three two thousand and eighteen Original,Roland Wolff,Negative
13847,Richard Furman CLL TargetedOnc,WCM Lymphoma,Negative
13848,Anthony Daniyan Award,Conquer Cancer ASCO Foundation,Postive
13850,Don Scholarships CLL Haematology Hematology,ESH Haematology,Negative
13851,Susan three CLL,Lymphoma Hub,Negative
13852,CNS,New Scientist Zone,Negative
13853,New Year two thousand and twenty CLL one MRD,Taylor Lab UM,Postive
13855,Supporting Emergent Literacy nine CLL,Early Years LSC FE VocEd EYFS,Negative
13856,CLL Leukamie Onkologie Hamatologie,Onko Community,Negative
13857,One Anna DeVeaux,An Deveaux,Negative
13858,CLL one,Patient Power,Negative
13859,one annually,Welty,Postive
13860,CLL,CLL Ireland,Postive
13861,CLL,Kathleen Hoffman,Negative
13862,CLL,Benlazar Amine,Negative
13863,Prognostic Value Baseline Total Metabolic CLL,Benlazar Amine,Negative
13865,Herbal Turmeric Natural Prevention Treatment Chronic,The Curable Recipes,Negative
13866,CLL,Lymphoma Hub,Negative
13868,Lymphoma CLL Patients Geroge Follows CancerTreatment,The Patient Channel,Negative
13872,today FIVE CPG,SwingTradeBot UK,Negative
13873,Scan Stochastic Sell Signal BHI IGR SMJ LSRG CLL BRWM PRTC SYNT FGT,SwingTradeBot UK,Negative
13875,one Lymphoma one Chronic three week one one,Tai,Negative
13876,CLL Continue Leukemia Lymphoma,Taylor Francis Medicine Health,Negative
13877,German CLL Study Group,Richard Rosenquist Brandell,Negative
13879,Tanya Siddiqi TRANSCEND CLL four CLL,Lymphoma Hub,Negative
13883,one thousand nine hundred two thousand and,FA Technologies,Negative
13884,one thousand nine hundred two thousand and,Mazen,Negative
13885,integrin mouse Blood Advances American Society Hematology CLL,Benlazar Amine,Negative
13886,CLL,CancerDotNet,Negative
13887,one thousand nine hundred two thousand and,Medical Xpress,Negative
13888,CLL Nicole Lamanna CLL,Patient Power,Negative
13891,Global Chronic Lymphocytic Leukemia Treatment Market two thousand LymphocyticLeukemia Read More,Report consultant,Negative
13892,Science News Chronic two thousand and twenty two thousand,Global News Report,Negative
13896,CLL Christian,Patient Power,Negative
13898,CLL SLL,ganpurasu,Negative
13899,quickly nine year nine year ago one four Non Hodgkins TON,Joe Lehr,Postive
13900,three CLL lymsm,Benlazar Amine,Negative
13901,CLL,Biren Sahoo,Postive
13904,one Japanese,Lymphoma Papers,Negative
13909,Fungal Infections Chronic Lymphocytic Leukemia Treatment,National Aspergillosis Centre,Negative
13911,Medical Care Chronic Teresa Smrecansky,TSmrecansky,Postive
13912,CLL Dave Kasanicky Lynnda,Patient Power,Negative
13914,Winter Recess tomorrow Thursday two CLL,ESCofNJ,Postive
13915,Brian Koffman Hidden Forces Demetri Kofinas Please CLL CLLsm,CLL Society Inc,Postive
13916,CLL,Teresa Martin,Postive
13919,BTK TwitteRx,Dave Hughes,Negative
13920,Thoracic,Lymphoma Papers,Negative
13921,CLL,Kathleen Hoffman,Negative
13924,van Oers et al Blood Cancer Journal CLL CLL Follicular,Toby Eyre,Negative
13925,TLS CLL two TLS CLL,Toby Eyre,Postive
13927,CLL two thousand and nineteen,DelveInsight,Negative
13931,CLL,MDEdge,Negative
13932,CLL MCL Patient Power,Patient Power,Negative
13933,CLL BTK CLL Immunology,Elaine Schattner,Negative
13937,OncoAlert Idelalisib Treatment Relapsed Follicular,Raul Cordoba MD PhD,Negative
13938,Shouldn,Kenny Price,Negative
13939,CLL Xin Yao,Xing Xie niya,Negative
13940,Medicare FL CLL idelalisib rituximab,JAMA Oncology,Negative
13941,CLL,Mahmoud Aljurf,Negative
13942,Idelalisib Treatment Relapsed Follicular CLL,Benlazar Amine,Negative
13943,CLL,MDedge Hematology Oncology,Negative
13947,Idelalisib Treatment Relapsed Follicular Medicare,Lymphoma Papers,Negative
13948,one Leukemia,Carm,Negative
13950,CLL,Myrtle Newsam,Negative
13951,ASH two thousand and sixteen two Update New Chronic Leukemia Drugs two thousand and sixteen two Update New Chronic,Oncology Tube,Negative
13952,NuView Academy CLL CLL Frosty Snowman,ESCofNJ,Postive
13953,TRANSCEND CLL four Lymphoma Hub,Benlazar Amine,Negative
13955,CLL,MDedge Hematology Oncology,Negative
13956,Siempre serum la mia tambien lloras tambien Vivan los payasos CLL ChileLuchaLibre,Dario Antilen,Negative
13957,one CLL Kerry Rogers CLL CLL CLLsm,Patient Empowerment Network,Negative
13958,one Doug CLL CARTcell,Patti Cuevas,Negative
13959,NHL CLL,Matthews Associates,Negative
13961,Lymphoma Large Diffuse Follicullar Lymphoma Cutaneous Anapalastic Chronic,Matthews Associates,Negative
13963,two,EurekaMag,Negative
13964,two thousand and twenty Scholar Award WeillCornell CLL ASHAwards CLL,FEDERICO GAITI,Postive
13965,CLL Chart two year Triangle Breakout Level fourteen three Divvy,WheelieDealer,Negative
13966,CLL,Benlazar Amine,Negative
13967,chromatin accessibility transcription CLL,Xuan Shirley Li,Negative
13968,IDEL Idelalisib Treatment Relapsed Follicular CLL,Elaine Schattner,Negative
13970,Rigtig Glaedelig Jul og Mange md cml cmml Plolaeger,LyLe Foreningen,Postive
13974,Translational Research Conference Chronic March two thousand and twenty Haematology Hematology CLL,ESH Haematology,Negative
13976,CLL,MDEdge,Negative
13977,Idelalisib Treatment Relapsed Follicular,ClinOwl,Negative
13978,Congrats AndreaSitlinger CLL ExerciseOncology,Duke Hematologic Malignancies Cellular Therapy,Postive
13979,Lilly Presents Interim Clinical Data Dose Escalation American,Oncology Tube,Negative
13980,two thousand and twenty Scholar Award DukeCancer DukeGeriatrics ASHAwards CLL ExerciseOncology,David Bartlett PhD,Postive
13981,CLL,Patient Empowerment Network,Negative
13987,CLL,Kathleen Hoffman,Negative
13990,five year Molica Hematological Oncology Wiley Online,Francesco Bertoni,Negative
13991,Anthony Mato MD MSCE,COPD News,Negative
13992,one CLL,Andrew Schorr,Postive
13993,ASH three CLL Brian Hill Matthew Davids Nicole Lamanna CLL,Esther Schorr,Postive
13994,one,CURE Magazine,Negative
13995,Efficacy Safety Tenalisib CLL,CureHuntr,Negative
13996,CLL,Alicia Bell IFBB Pro,Negative
13998,Pharmaceutical Alliance pCPA Combination With Rituximab Treatment Patients With Chronic CLL,Simple Charts,Postive
13999,CLL tomorrow,The Tisch Cancer Institute,Negative
14000,two thousand and nineteen Cunningham,Oncology,Negative
14001,BTK CLL,Maria Badillo MSN RN OCN CCRP,Negative
14002,one thousand and twelve,Biosimilar Today iMagazine,Negative
14003,Tony Pogo CLL Clown,Dario Antilen,Negative
14004,Neha Godiwala Goyal CLL Learn CLL,AbbVie US,Negative
14006,LeukaemiaResearch Andrew Steele Lab BCR,Helgason Lab,Postive
14011,MedlinePlus,Carolyn Matyjanka,Negative
14012,Charles Berry NASA CLL DrTacara Geriatric Clinic CancerMoonshot,MD Anderson Cancer Center,Negative
14014,Cationic,Frontiers Oncology,Negative
14015,Scan today PPC USFP BMV VIN FSTA CLL,SwingTradeBot UK,Negative
14016,MRD CLL DanaFarber CLL CLLsm,Patient Empowerment Network,Negative
14017,CLL Genetics CLL,BeiGene,Negative
14018,CLL Kerry Rogers CLL CLLsm,Patient Empowerment Network,Negative
14019,CLL William Wierda Anderson Cancer Center Patient Power ASH Orlando andrewschorr wwierda,Patient Power,Negative
14020,one Leukaemia CLL,MerMer Goodburn,Negative
14021,de mi ventana Ya CLL Texas Oncology Plano Presby,Francis Camacho,Negative
14022,Center Lifelong Learning annual Winter Concert Winter Dreams Check CLL,ESCofNJ,Postive
14028,CERTHellas CLL Kostas Stamatopoulos CERTHellas,eos,Negative
14029,van hacer enanos cuando regrese wrestler,Lenko Sins,Negative
14030,CLL WBC one thousand mm ICU one CLL,Joseph Shatzel,Negative
14032,Matt The Royal Marsden today SpotLeukaemia,MerMer Goodburn,Negative
14033,CLL Catherine Coombs,Shonali Midha,Negative
14034,Jonathan Ferland,Cegep de Levis,Negative
14036,CLL SLL,LLS Sacramento,Negative
14037,Kanti Rai CLL Rai Hematology IcahnMountSinai,The Tisch Cancer Institute,Postive
14038,CLL TY u,Michele,Postive
14039,Zanubrutinib CLL,Mazyar Shadman MD MPH,Postive
14040,CLL one Listen Lynn Story CLL,Cancer Support Community,Negative
14041,Sara Tinsley BTK CLL SCT Video APs,JADPRO,Negative
14044,Venetoclax,Carlo Franzini,Negative
14045,Messy CLL,Orchard Primary Academy Nursery,Negative
14047,Lymphoma,Taylor Francis Medicine Health,Negative
14048,CLL,Kathleen Hoffman,Negative
14053,BCR,Lung Cancer News,Negative
14055,Medivizor,Chocolatiere Phys,Negative
14057,two thousand and nineteen two thousand twentyfour million USD one thousand five hundred two thousand and nineteen,CRO Contract Res,Negative
14059,Medivizor,Paul Wright,Negative
14060,Recomendamos el Kari Vega futbol campeona CLL,Revista El Repollero,Negative
14062,MondayNightIBD Elderly Crohns CLL two,MondayNightIBD,Negative
14063,MondayNightIBD Elderly Crohns CLL one,MondayNightIBD,Negative
14067,Medivizor,Lynne Mac Lean,Negative
14072,OncoAlert CLL Bone Marrow CLLsm,Raul Cordoba MD PhD,Negative
14073,el ultimo vento del ano CLL ChileLuchaLibre,Giannina,Negative
14074,two thousand and nineteen two thousand twentyfour million USD one thousand five hundred two thousand and nineteen,Renal Cell Carcinoma,Negative
14077,CLL,AbbVie US,Negative
14080,CLL HallekMichael ASkarbnik NitinJainMD,Mazyar Shadman MD MPH,Negative
14082,rick simpson,CP DA DON,Negative
14083,one CLL Orlando,Jessica Okosun,Postive
14084,CLL,Benlazar Amine,Negative
14085,CLL Research James Kaye,RTI Health Solutions,Negative
14087,CLL,ACS Journal Cancer,Negative
14088,Cationic,Transporters Solute carrier,Negative
14089,Sara Tinsley BTKinhibitors CLL HSCT,APSHO,Postive
14090,CLL coming day,Lymphoma Hub,Negative
14091,CLL Alexey Danilov PHOENIX one TN MURANO MedEd Watch,LYMPHOMA MYELOMA CONNECT,Negative
14093,Karyotypes MBL twelve Nuclei zero seven CLL,Grup de Recerca Translacional,Negative
14094,Battle Thermopylae three hundred Spartans obinutuzumab Xerxes,Lymphoma Papers,Negative
14095,Battle Thermopylae three hundred Spartans obinutuzumab Xerxes Najera MJ Feliu,NK paper,Negative
14102,Book Appointment DrManojKumarSharma Oncologist CancerSpecialist,Manoj Sharma,Negative
14104,UK CLL Forum George Follows,VJHemOnc,Negative
14106,CLL Kerry Rogers CLL CLLsm,Patient Empowerment Network,Negative
14107,Scan Bearish Centerline Cross today,SwingTradeBot UK,Negative
14108,American,Oncologiavet,Negative
14110,AmericanCancer CLL CLL Medicare,HealthWellOrg,Negative
14111,Sandra Kurtin PhD CLL United States,APSHO,Negative
14112,News Data James Kay RTIHS Medicare JamesGersonMD PennMedicine,HemOnc Today,Negative
14113,CLL,Toby Eyre,Postive
14114,Otis Chapman February two thousand and three Roundup one thousand nine hundred two thousand and four,GMO Free USA,Negative
14116,one age forty US Listen CLL,Cancer Support Community,Negative
14118,DYK CLL,BeiGene,Negative
14119,CLL,CellworksLife,Negative
14120,one,Esther Schorr,Postive
14121,Pipaon FANCA Leukemia TodosconFanconi,Paula Rio,Negative
14122,Vet American,Stefano Cattaneo DVM,Negative
14127,Don SUBMIT March two thousand and twenty CLL,ESH Haematology,Negative
14128,American Society Hematology Orlando myeloma mmsm mpnsm hemophilia,Yasin Murat Yigit,Negative
14129,The Centre Lifelong Learning CLL MREI Register Now,Manav Rachna,Negative
14130,Las Gumarelas consagran campeonas tambien del Clausura two thousand and nineteen En La Huerta un nuevo titulo lo ganaron de punta punta chicas CLLPY CLL,Revista El Repollero,Negative
14131,SpringerOpen,Nutritional Epigenetic News,Negative
14132,CLL,Donna Gairns,Postive
14133,rituximab,Home Journal,Postive
14134,CLL,CONQUER patient voice,Negative
14135,one,Cancer Support Community,Negative
14136,Texas HongKong LRD AUS CLL GRK,ToppsMuchoBB,Postive
14137,CLL Constantine Tam PeterMacCC HemeOnc,VJHemOnc,Negative
14138,one one November one,Maggie Holben,Postive
14139,CLL Kerry Rogers CLL CLLsm,Patient Empowerment Network,Postive
14142,Pamela Crilley Chair OncologyTimes one CLL,Cancer Treatment Centers America CTCA,Negative
14143,Jeff Folloder CLL Edward Faber CLL,Patient Power,Negative
14144,Communique Intersyndical National de Organisations Syndicales SNU CGT FO et SUD SOLIDAIRES de CFDT CFTC CLL,SNU Pole Emploi FSU Occitanie,Negative
14145,OhioState CLL SCL John COP,Ohio State Pharmacy,Postive
14149,CLL LRoekerMD,Satyen Gohil,Postive
14150,January Join CLL Wales,CLLSA,Postive
14151,CLL ImmuneSuppression Read ImmuneModulation Macrophages MDAndersonNews,Cancer Immunology Research,Negative
14152,Catherine Gutierrez Cathy Wu CLL,News,Negative
14153,January Chris Fegan CLL,CLLSA,Postive
14155,MRD kemofri patienter sundpol dksund BlodcancerDk,LyLe Foreningen,Negative
14156,Leukemia Ibrutinib,Hawkins Gay MD MPH,Negative
14157,two American,Turmeric,Negative
14163,CLL annual,MDEdge,Postive
14164,transcript,Hard Lock,Negative
14165,CLL MURANO,AbbVie,Negative
14166,Amal Saidi Texas NordicNanovector,Savepig Invest GotSilver,Postive
14167,Memorial Sloan,Zusia Dr Jackie Volk,Negative
14168,CLL,Lymphoma Hub,Postive
14169,CLL,Benlazar Amine,Negative
14170,BloodJournal CLL,Nicolas Gendron,Negative
14171,Health Monitor one,Stephen Brown,Postive
14172,today FIF UKCM SHB AMER CLL,SwingTradeBot UK,Negative
14173,DMA AAS RHIM ARK DOTD MRW GVC,SwingTradeBot UK,Postive
14174,CLL Scrip,john davis,Negative
14175,Orlando der Erstmals Reihe LymphomKompetenz KOMPAKT Videoberichten von Kongress Lymphome Myelom CARTCells,idw Nachrichten,Negative
14176,Mrs Foley Paris two thousand and nineteen CLL,St Maurice Modern Languages,Postive
14178,CLL annual,MDedge Hematology Oncology,Postive
14179,Learn CLL,AbbVie,Negative
14180,DanaFarber CLL,News,Negative
14181,CLL two Read,AbbVie,Negative
14182,Highlights Amy Pierre CLL Obinutuzumab Venetoclax,APSHO,Negative
14183,CLL,Kathleen Hoffman,Negative
14185,Marie Benz MD,ScienceSeeker Feed,Negative
14186,CLL,JanssenUS,Negative
14187,CLL,SSBMT lkhlyljdh`y@,Negative
14188,cll Anna DeVeaux,An Deveaux,Negative
14189,MBL CLL Gonzalo Blanco CLL,Hospital del Hematology,Negative
14192,Gene Expression Cytokine American Society Hematology,gilbert faure,Negative
14193,American,Lymphoma Papers,Negative
14196,SA god kommer CLL BlodcancerDk,LyLe Foreningen,Negative
14197,AmericanCancer ChronicLymphocyticLeukemia two thousand and nineteen,DelveInsight,Negative
14198,Genentech READ Genentech Venclexta MURANO CLL Rituxan,Mateen Dalal,Negative
14199,Merck ArQule Merck ArQule five hundred,Market Intelligence Healthcare,Negative
14201,CLL,Chaitra Ujjani MD,Postive
14202,Stop Hall Level two four thousand two hundred Blanca Espinet Bionano WholeGenomeImaging CLL,Bionano Genomics Inc,Negative
14204,CLL,Seema Ali Bhat,Negative
14205,CLL,CLL Society Inc,Negative
14206,The Aurora Research Institute two Learn,Aurora Health Care,Postive
14207,Hall,Takeda Oncology,Negative
14208,CLL Clare Gould Piers Blombery four thousand two hundred and ninety tonight Wilson,Michael Dickinson,Negative
14209,two CLL,Milos Miljkovic,Negative
14210,attendee Join u Hall four thousand two hundred six hundred Bionano WholeGenomeImaging CLL Blanca Espinet,Bionano Genomics Inc,Negative
14211,CLL Video Shadman CLL,SeattleCancerCareAlliance,Negative
14212,today CLL SmilowCancer YaleMed,Yale Cancer Center,Negative
14213,CLL,Jeff Szer,Negative
14214,CLL,BeiGene,Negative
14215,BloodCancer Jim,AstraZenecaUS,Postive
14216,CLL AML,AbbVie,Postive
14217,CLL Prognosis Treatment Options TargetedOnc,Mustafa,Negative
14218,MRK ARQL great news great biopharma story Read CLL LOXO,BiopharmIQ Amp,Postive
14219,CLL,AbbVie,Negative
14221,MSK CLL Click year,Memorial Sloan Kettering Cancer Center,Negative
14222,AML MDS CLL,Stock Sharks,Postive
14223,SEQUOIA,Targeted Oncology,Negative
14224,FollicularLymphoma CLL SLL BTK,MEI Pharma,Negative
14225,New Data Continues Demonstrate Survival Overall Survival Benefits,LLZ Consulting,Negative
14226,two CLL,Pharmacyclics AbbVie Company,Negative
14228,CLL,The Political Hedge,Negative
14230,Fantastic BloodJournal Tanja IcgsUob CLL,Prof John,Postive
14231,CLL,Scott Spencer,Postive
14232,seventy year MedicalSecrets,Elsevier Med Students,Negative
14233,CAR Tcell CLL,Bruce Levine,Negative
14234,MURANO VenR CLL Arnon Kater CLLsm HemeOnc,VJHemOnc,Negative
14235,Update From Video Newsletter Alexey Danilov Jessica Okosun CLL Register MedEd,LYMPHOMA MYELOMA CONNECT,Negative
14237,CLL SCL FDAMedWatch,The Ohio State University College Medicine,Postive
14238,James Kaye today,RTI Health Solutions,Negative
14239,Johnson Johnsons Imbruvica Sales Beat Roches Rituxan two thousand and,Daniel Kovach,Negative
14240,Hear Betty USAToday,Pharmacyclics AbbVie Company,Negative
14241,CLL,Dr Effie Kostareli,Negative
14242,CLL,Seema Ali Bhat,Negative
14243,Combination Therapy Data Two ASH two thousand and nineteen,HEDGE,Negative
14245,morning DanaFarber Elisa Ten Hacken CLL,Mission Bio,Negative
14246,CLL,CellworksLife,Negative
14247,Constantine Tam PeterMacCC Sequioa,Lymphoma Hub,Negative
14248,Bruton rituximab,Vall Hebron Institute Oncology VHIO,Negative
14249,CLL,ASH Clinical News,Negative
14250,Duvelisib Venetoclax CLL Jennifer Crombie,News,Negative
14251,Stick Man one one MAN Super today Stick CLL Roleplay juliadonaldson,Orchard Primary Academy Nursery,Postive
14254,four CLL CLLsm,Janssen EMEA,Postive
14255,Blossom CLL,Orchard Primary Academy Nursery,Postive
14256,APTO Inhibitor Exhibits Broad Signaling Inhibition Chronic,Grant Beasley,Negative
14257,Yue Lynn Wang WATCH CLL,medwireNews,Negative
14258,AbbVie Korea Biomedical Review,Saeed Valadbaygi,Negative
14262,VIDEO Frontline CLL Danielle Brander CLLsm Leusm,VJHemOnc,Negative
14263,four thousand seven hundred and sixteen An Innovative Telemedicine Platform Provide Expert Access Patients Chronic Lymphocytic two thousand and nineteen six eight PM tonight Orlando,CLL Society Inc,Postive
14264,Nordic CLL,Sigrid Skanland,Negative
14265,ASH Time Discovery CLL,Michael Hallek,Postive
14266,Danielle CLL,Duke Hematologic Malignancies Cellular Therapy,Negative
14267,BGNE BRUKINSA CLL SLL BeiGene,Hottest Stocks Now,Negative
14268,CLL,Deborah Stephens,Negative
14269,CLL,Amber Koehler,Postive
14270,CLL,Adriana Bello,Negative
14271,The end day two Lots Seth Karol AML Yue Lynn Wang CLL,medwireNews,Postive
14273,TorneoClausura SolDeAmerica,Club Libertad Limpeno,Negative
14274,Kitchen Tip,Eann Olsson,Negative
14275,TorneoClausura CLL ST,Club Libertad Limpeno,Negative
14276,TorneoClausura CLL Liza Larrea Karina Vega,Club Libertad Limpeno,Negative
14277,TorneoClausura Stephanie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14278,TorneoClausura CLL ST,Club Libertad Limpeno,Negative
14279,CR CLL Siddiqi one TRANSCEND CLL,Amber Koehler,Negative
14280,LOXO ten ORR Responses BTK,Kevin Wolcott,Negative
14281,TorneoClausura CLL twelve,Club Libertad Limpeno,Negative
14282,Imbruvica,Mary Caffrey,Negative
14283,CLL RoswellPark,Pallawi Torka,Postive
14284,TorneoClausura CLL five,Club Libertad Limpeno,Negative
14285,one CLL,Taylor Lab UM,Negative
14286,TorneoClausura CLL Inicio el ST Griselda Garay Yanina Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14287,CLL,Kate Whitaker,Postive
14288,CLL,Toby Eyre,Negative
14289,BeiGene Announces Clinical Data Zanubrutinib American Society Hematology two,Diagnostics News,Negative
14290,CLL,Toby Eyre,Negative
14291,anthonymatomd BTK CLL ORR,Amber Koehler,Postive
14292,Anthony Mato CLL,Mayur Narkhede,Negative
14293,BeiGene Announces Clinical Data Zanubrutinib American Society Hematology ASH Annual two Stockmarketnews,Trading News,Negative
14294,TorneoClausura CLL,Club Libertad Limpeno,Negative
14295,TorneoClausura CLL,Club Libertad Limpeno,Negative
14296,TorneoClausura CLL,Club Libertad Limpeno,Negative
14297,Today genentech two MURANO CLL,ATOPP Summit,Negative
14298,Zanubrutinib CR Grade three CLL,Taylor Lab UM,Negative
14299,BTK CLL Prof Tam petermacCC,Michael Dickinson,Negative
14300,three BTK CLL,Mayur Narkhede,Negative
14301,BTK CLL today,BeiGene,Negative
14302,TorneoClausura SolDeAmerica,Club Libertad Limpeno,Negative
14303,Tam SEQUOIA two ORR CLL AE,Amber Koehler,Negative
14304,Zanubrutinib CLL ORR thirty Grade three,Taylor Lab UM,Negative
14305,TorneoClausura CLL,Club Libertad Limpeno,Negative
14306,Zanubrutinib CLL ORR Dr Tam CLL,Barbara Pro,Postive
14307,TorneoClausura SolDeAmerica CLL,Club Libertad Limpeno,Negative
14308,TorneoClausura CLL eighteen Nairelis Gutierrez Laurie Cristaldo,Club Libertad Limpeno,Negative
14309,Session six hundred CLL BTK,Taylor Lab UM,Negative
14310,TorneoClausura SolDeAmerica ten,Club Libertad Limpeno,Negative
14311,TorneoClausura CLL,Club Libertad Limpeno,Negative
14312,Benjamin Lampson MD PhD ATM one four CLL,News,Negative
14315,New Data Continues Demonstrate Survival Overall Survival Benefits,Saeed Valadbaygi,Negative
14317,Roche two,Roche,Negative
14318,CLL TGTherapeutics,Hottest Stocks Now,Negative
14319,Tues Vegas BREAKING CLL BTK NCCN ACPE,CEC Oncology,Postive
14321,CLL Edward Faber CLL,Patient Power,Negative
14322,cll,Seema Ali Bhat,Negative
14323,cll,Seema Ali Bhat,Negative
14324,CLL Mechanisms Response,Katrina Sondermann,Postive
14325,Jennifer Woyach MD OhioState CLL,SpecialtyPTimes,Negative
14326,CLLsm CLL Jennifer Woyach,Shonali Midha,Negative
14327,CLL Distinct Acala Ibru Don MRD daily,Fernando Martin Moro,Postive
14328,CLL Barbara Eichhorst GCLLSG Leusm,Bachar Samra MD,Postive
14329,CLL Barbara Eichhorst,Sigrid Skanland,Negative
14330,MRD Barbara Eichhorst,VJHemOnc,Negative
14331,CLL,VJHemOnc,Negative
14332,MRD CLL,Amber Koehler,Negative
14333,New Data Continues Demonstrate Survival Overall Survival Benefits,Crwe World,Negative
14334,RR CLL Barbara Eichhorst UniCologne,VJHemOnc,Negative
14335,Lori Leslie MD John Theurer Hackensack Meridian Health CLL ASCO,Oncology Tube,Negative
14336,Eichorst CLL,Amber Koehler,Postive
14337,New Data Demonstrate,Pharmacutical Daily,Negative
14338,New Data Demonstrate,Pharmacutical Daily,Negative
14339,CLL Presented Jennifer Woyach,Sigrid Skanland,Negative
14340,CLL Dr Jennifer Woyach CTSM Leusm CLLsm,VJHemOnc,Negative
14341,CLL,Lucrecia Yanez,Negative
14342,CLL Woyach first one VincentRK,Amber Koehler,Postive
14343,CLL Dr Jennifer Woyach CTSM Leusm CLLsm,VJHemOnc,Negative
14344,two Stop Hall CLL,BeiGene,Negative
14345,CLL Catherine Wu,Sigrid Skanland,Negative
14346,Impressive CLL,Toby Eyre,Postive
14347,CLL,chadi nabhan MD MBA FACP,Negative
14348,CLL three thousand Avelumab one thousand five hundred Drop three thousand and today,Milos Miljkovic,Negative
14349,Wu CLL,Amber Koehler,Negative
14350,CLL,Milos Miljkovic,Negative
14351,MRD CLL,Vinicius Molla,Postive
14352,CLL CLL WomenInMedicine,Xenia Schmidt,Postive
14353,CLL,Seema Ali Bhat,Negative
14354,CLL,MD Anderson Leukemia,Negative
14355,CLL Paul Barr,Sigrid Skanland,Negative
14356,BTK CLL one year GI CLL,Amber Koehler,Negative
14357,CyteirInfo CLL,Tamar Aprahamian,Negative
14358,CLL,Sigrid Skanland,Negative
14359,Dr Rai Alexa CLL,Eduardo Flavio Oliveira Ribeiro,Negative
14360,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,Stock Market News,Negative
14361,RHHBY New Data Demonstrate,OTC Dynamics Inc,Negative
14362,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,Simple Charts,Negative
14363,uMRD one CLL,Amber Koehler,Negative
14364,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,MasdelMedio,Negative
14365,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,pressdaily,Negative
14366,New Data Demonstrate,Saeed Valadbaygi,Negative
14367,CLL MURANO,AbbVie,Negative
14368,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,Pharma News,Negative
14369,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,Pharma News,Negative
14370,Roche two RHHBY ROG,Roche,Negative
14371,New Data Continues Demonstrate Survival Overall Survival Benefits CLL,Simple Charts,Negative
14372,New Data Demonstrate,Stock Market News,Negative
14373,RHHBY Issued Press Release December eight New Data Demonstrate,Flash Alert,Negative
14374,New Data Demonstrate,Latest News Business Wire,Negative
14375,This morning CLL Hall three hundred,Genentech,Negative
14376,afternoon CLL,Toby Eyre,Negative
14379,Combination Data Show High Rates Disease Clearance Previously Untreated Patients,Saeed Valadbaygi,Negative
14380,Combination Data Show High Rates Disease,Company News HQ,Negative
14381,CLL,MD Anderson Leukemia,Negative
14383,CLL Nitin Jain speaks lymphomahub lymsm,Lymphoma Hub,Negative
14384,tomorrow BTK CLL,BeiGene,Negative
14385,Treatment Combo Achieves,SpecialtyPTimes,Negative
14386,RT PhysRelations RT MDAndersonNews CLL OncLive,Robert Orlowski,Negative
14387,CLL,Seema Ali Bhat,Negative
14388,CLL Receptor Signal Transduction Inhibitors,Memorial Sloan Kettering Cancer Center,Negative
14389,CLL Medicare,Thomas LeBlanc MD MA MHS FAAHPM,Negative
14390,CLL fourteen Fixed,PRAJAK BARDE,Negative
14391,RT PhysRelations Jain one PI NitinJainMD CLL,Robert Orlowski,Postive
14392,This morning CLL Watch,Pharmacyclics AbbVie Company,Negative
14393,CLL CllIreland CLLAdvocates,Michael Rynne,Postive
14394,CLL,Seema Ali Bhat,Negative
14395,first,Jeremy Lorber,Postive
14396,two thousand four hundred Sunday,SeattleCancerCareAlliance,Negative
14397,FCR pm EST CLL,Michele,Negative
14398,CLL Hypertension Patients Treated With Ibrutinib Chronic,Anatoly Anatolii,Negative
14399,IMBRUVICA CLL SLL,Hottest Stocks Now,Negative
14400,Combination Therapy Data Two ASH two thousand and nineteen,Saeed Valadbaygi,Negative
14401,CLL,AbbVie,Negative
14402,Deyi Zhang CLL,NIH NHLBI,Negative
14403,APTO Expect Can Become Highly Differentiated AML,Joe,Postive
14404,CLL CllIreland CllSociety JanRynne,Michael Rynne,Postive
14405,Jain one PI NitinJainMD CLL,Katrina Sondermann,Postive
14406,APTO Key one two CLL BTK,Joe,Negative
14407,CLL,Seema Ali Bhat,Negative
14408,CLL CLL,Marie Hu MD,Postive
14409,CLL MCL,chadi nabhan MD MBA FACP,Negative
14410,Today CLL Read iNHL,Verastem Oncology,Negative
14411,CLL hour,Pallawi Torka,Negative
14413,Combination Data Show High Rates Disease Cleara,Crwe World,Negative
14414,CLL,AstraZenecaUS,Postive
14415,CLL two Read,AbbVie,Negative
14416,morning CLL BTK CLL LombardiCancer NitinJainMD,Ayushi Chauhan,Negative
14417,CLL,Simple Charts,Negative
14418,Combination Data Show High Rates Disease Clearance Previously Untreated Patients CLL,Simple Charts,Negative
14419,CLL MRD,Jiajia Liu,Negative
14420,Kirsten CLL MRD MRD BM,The Lancet Haematology,Negative
14421,CLL,chadi nabhan MD MBA FACP,Negative
14422,CLL fourteen Fixed Fischer HallekMichael,chadi nabhan MD MBA FACP,Negative
14423,CLL,Toby Eyre,Negative
14424,CLL fourteen German,chadi nabhan MD MBA FACP,Negative
14425,PatientPower MRD CLL Ibrutinib Venetoclax,Michele,Negative
14426,BTK Lampson CLL,Ayushi Chauhan,Negative
14427,Combination Data Show High Rates Disease Clearance Previously Untreated Patients CLL,Newswire,Negative
14428,German CLL HallekMichael,chadi nabhan MD MBA FACP,Negative
14429,First CAPTIVATE CLL,Sigrid Skanland,Negative
14430,Constantine Tam first CLL,The Lancet Haematology,Negative
14431,CLL,Michele,Negative
14432,MRD CLL,Miguel Canales,Negative
14433,NitinJainMD IHGV CLL,Amber Koehler,Postive
14434,Time CLL,Toby Eyre,Negative
14435,Tam CLL,chadi nabhan MD MBA FACP,Negative
14436,MRD CLL,chadi nabhan MD MBA FACP,Negative
14437,NitinJainMD CLL,Sairah Ahmed MD,Postive
14438,CAPTIVATE CLL,chadi nabhan MD MBA FACP,Negative
14439,mab CLL MRD lymsm,Toby Eyre,Negative
14441,BM Neutropenia fifty CLL,Amber Koehler,Negative
14442,CLL EAOnc NCTN IMBRUVICAUSHCP EurekAlert,Cancer Research Group,Postive
14443,CLL EAOnc NCTN IMBRUVICAUSHCP EurekAlert,Cancer Research Group,Postive
14444,Con Tam CAPTIVATE CLL Ibrutinib TLS MRD CLL,Michael Dickinson,Negative
14445,BTK FCR FCR Cheson LombardiCancer CLL,Ayushi Chauhan,Negative
14446,FCR CLL,Toby Eyre,Negative
14447,MRD CLL NitinJainMD,chadi nabhan MD MBA FACP,Negative
14449,Tait month rituximab PFS FCR CLL,The Lancet Haematology,Negative
14450,Frontline CLL Ibrutinib NitinJainMD Older,chadi nabhan MD MBA FACP,Negative
14451,three Read,Pharmacyclics AbbVie Company,Negative
14452,four CLL achieve VictoriesOverCancer,Janssen EMEA,Negative
14453,Ibrutinib CLL,Miguel Canales,Postive
14454,FCR CLL one,chadi nabhan MD MBA FACP,Negative
14455,Conclusions Shanafelt CLL today,chadi nabhan MD MBA FACP,Negative
14456,CLL,dough,Postive
14457,CLL,Carmine DeLuca,Negative
14458,IR CLL IgHV,chadi nabhan MD MBA FACP,Negative
14459,Dr Lampson TN CLL four three Acala CLL,Krish Patel,Postive
14460,Combination Data Show High Rates Disease Clearance Previously Untreated Patients CLL,pressdaily,Negative
14461,CLL,pressdaily,Negative
14462,Combination Therapy Data Two ASH two thousand and nineteen,pressdaily,Negative
14463,Today two CLL,Pharmacyclics AbbVie Company,Negative
14464,Known Fly,flylemurs,Negative
14465,CLL,Carmine DeLuca,Negative
14466,IR CLL,chadi nabhan MD MBA FACP,Negative
14467,CLL Tait Shanafelt,chadi nabhan MD MBA FACP,Negative
14468,Benjamin BTK CLL Response MRD eight,The Lancet Haematology,Postive
14469,CLL OncLive,MD Anderson Cancer Center,Negative
14470,CLL,Miguel Canales,Negative
14471,CLL,chadi nabhan MD MBA FACP,Negative
14472,Today three Click,JanssenUS,Negative
14473,This morning MRD CLL,Genentech,Negative
14474,CLL,chadi nabhan MD MBA FACP,Negative
14475,CLL MRD,chadi nabhan MD MBA FACP,Negative
14476,CLL,chadi nabhan MD MBA FACP,Negative
14477,CLL,Simple Charts,Negative
14478,Combination Data Show High Rates Disease Clearance Previously Untreated Patients CLL,Simple Charts,Negative
14479,Lampson DanaFarber CLL,chadi nabhan MD MBA FACP,Negative
14480,CLL CLLsm,Michael Dickinson,Postive
14481,Cheson CLL,chadi nabhan MD MBA FACP,Postive
14482,CLL,Carmine DeLuca,Negative
14483,CLL,chadi nabhan MD MBA FACP,Negative
14484,CLL morning,chadi nabhan MD MBA FACP,Negative
14485,CLL First mab CLL,Toby Eyre,Postive
14486,CLL,chadi nabhan MD MBA FACP,Negative
14488,CLL OncoAlert morning,chadi nabhan MD MBA FACP,Negative
14489,CLL morning,chadi nabhan MD MBA FACP,Negative
14490,CLL,chadi nabhan MD MBA FACP,Negative
14491,CLL morning OncoAlert Oncoalert,chadi nabhan MD MBA FACP,Negative
14501,RT PhysRelations RT CancerFrontline Venetoclax Philip Thompson Phase two CLL,Robert Orlowski,Negative
14502,Venetoclax Philip Thompson Phase two CLL,Cancer Frontline,Negative
14503,AML CLL Learn,Genentech,Postive
14504,tomorrow one CLL SLL one thousand seven hundred,Verastem Oncology,Postive
14506,CLL,Benlazar Amine,Negative
14507,CLL December two thousand and nineteen CLL,Benlazar Amine,Negative
14508,CLL December two thousand and nineteen CLL,Benlazar Amine,Negative
14509,Drs jonathonbcohen Danielle Brander Philip Thompson,Medscape Education,Postive
14510,CLL five BTK Inhibitors CLL,Medscape Education,Negative
14511,CLL four Philip Thompson,Medscape Education,Negative
14513,CLL three BTK Inhibitors DukeHealth,Medscape Education,Negative
14514,CLL two BTK CLL Development Partial DukeHealth,Medscape Education,Negative
14515,CLL one CLL,Medscape Education,Negative
14516,CLL one CLL daily pm EST Saturday,Michele,Negative
14517,CLL,Medscape Education,Negative
14518,AlasdairRankin CLL next year,ABPI,Postive
14519,This morning CLL Watch,Pharmacyclics AbbVie Company,Negative
14520,weekend,Pharmacyclics AbbVie Company,Postive
14521,weekend,Pharmacyclics AbbVie Company,Postive
14522,one MedscapeLIVE Expert Philip Thompson,Medscape Education,Negative
14523,Orlando one hundred and fifteen,BeiGene,Negative
14524,anthonymatomd CLL,Oscar Lahoud,Negative
14525,Ofatumumab Blood Cancer Journal,Vincent Rajkumar,Negative
14526,CLL,Kathleen Hoffman,Negative
14527,CLL PeerView,VIP,Negative
14528,BTKinhibitors CLL,VIP,Negative
14529,Richard Furman MD BTKinhibitors CLL,PeerView,Negative
14530,Richard Furman CLL PeerView,Carmine DeLuca,Negative
14531,early tomorrow CLL,Roche,Postive
14534,early tomorrow CLL two hundred and three,Roche,Postive
14535,CLL Clinical AlasdairRankin,ABPI,Negative
14537,MRD CLL Arnon Kater,VJHemOnc,Negative
14538,Almost eight year CLL Work,chadi nabhan MD MBA FACP,Negative
14539,RT PhysRelations William Wierda CLL OncLive,Robert Orlowski,Negative
14540,Monoclonal CLL,An Deveaux,Negative
14541,RT PhysRelations Philip Thompson,Robert Orlowski,Negative
14542,RT PhysRelations CLL,Robert Orlowski,Negative
14543,William Wierda CLL OncLive,MD Anderson Leukemia,Negative
14544,LuchaLibre xnl CHILEANSWRESTLER,Lenko Sins,Negative
14548,Orlando Don CLL,Lymphoma Hub,Negative
14549,CLL,MD Anderson Leukemia,Negative
14550,Philip Thompson,MD Anderson Leukemia,Negative
14551,eight AM Obinutuzumab Del NitinJainMD CLL,MD Anderson Leukemia,Negative
14552,CLL Call Office Patient,NHLBI Bethesda Labs,Negative
14553,Venetoclax fourteen two thousand and nineteen,Mike Thompson MD PhD FASCO,Negative
14554,Anna DeVeaux PML Rituximab,An Deveaux,Negative
14555,two thousand and nineteen Speak CLL today CLL CLLsm,CLL Society Inc,Postive
14556,Lymphoma AML CLL CARTtherapy CellularTherapy,VJHemOnc,Postive
14557,LevineCancer Ryan Jacobs MD later week HemOncToday,Levine Cancer Institute,Postive
14558,one United States CLL CLL,Cancer Support Community,Negative
14559,BTK CLL,BeiGene,Postive
14560,first one Cardiovascular Ibrutnib,Bijoy Telivala,Negative
14561,SE,Will,Negative
14562,CLL,Toby Eyre,Negative
14563,AE CLL Ibrutinib,chadi nabhan MD MBA FACP,Postive
14564,Lindsey Roeker Hypertension Patients Treated With Ibrutinib Chronic,Anthony Mato,Negative
14566,TorneoClausura CLL,Club Libertad Limpeno,Negative
14567,TorneoClausura CLL CDC Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14568,TorneoClausura CLL,Club Libertad Limpeno,Negative
14569,IgHV CLL DrRaulCordoba,chadi nabhan MD MBA FACP,Negative
14570,TorneoClausura CLL CDC ST Larrea Karina Vega,Club Libertad Limpeno,Negative
14571,TorneoClausura CLL CDC sixteen ST,Club Libertad Limpeno,Negative
14572,seventeen,Enfermeria Seguridad del Paciente,Negative
14573,TorneoClausura CLL CDC four Liz Pena,Club Libertad Limpeno,Negative
14574,TorneoClausura CLL CDC three,Club Libertad Limpeno,Negative
14575,TorneoClausura CLL CDC Empezo,Club Libertad Limpeno,Negative
14576,TorneoClausura CLL,Club Libertad Limpeno,Negative
14577,TorneoClausura CLL,Club Libertad Limpeno,Negative
14578,TorneoClausura CLL CDC,Club Libertad Limpeno,Negative
14579,TorneoClausura CLL CDC,Club Libertad Limpeno,Negative
14580,TorneoClausura CLL CDC eighteen,Club Libertad Limpeno,Negative
14581,TorneoClausura CLL CDC nine,Club Libertad Limpeno,Negative
14582,CLL,Benlazar Amine,Negative
14583,TorneoClausura CLL CDC Inicia el,Club Libertad Limpeno,Negative
14584,Scan Stochastic Sell Signal SWEF PHP MNZS MTC TPT IGAS CLL MHN UTLF EAI,SwingTradeBot UK,Negative
14586,VIDEO Predicting CLL Danielle Brander,VJHemOnc,Negative
14587,CLL approximately one third,AbbVie US,Negative
14588,CLL ARQL APTO LLY APTO AML drug Interesting,Joe,Postive
14589,CLL AML Miami one Orlando,Felix Keller,Postive
14590,CLL,MD Anderson Leukemia,Negative
14591,Chronic CLL,Janssen EMEA,Negative
14600,one CLL,Liz Brem,Negative
14603,CLL one one thousand nine hundred,Jeff Szer,Negative
14605,CLL Richard Furman OncLive,WCM Lymphoma,Negative
14606,CLL CLL,Suchitra Sundaram,Postive
14607,Blood Advances American Society Hematology,Dr Comeau MD,Negative
14608,CLL CLL,Cancer Support Community,Postive
14609,Mitochondria one EM CLL ResearchMatters,RIOH,Postive
14610,Farrukh Awan International Workshop CLL Awan CLL,Patient Power,Postive
14611,Attending Discover Verastem Oncology six hundred and one,Verastem Oncology,Negative
14612,Kerry Rogers CLL CLLsm,Patient Empowerment Network,Negative
14613,Andrew Roberts,Mazyar Shadman MD MPH,Negative
14614,AIM CLL Cello Health PLC,AIM Alerts,Negative
14616,today CLL,Ysgolllanbedr,Negative
14617,today CLL,Orchard Primary Academy Nursery,Negative
14618,Steering Committee CLL,Lymphoma Hub,Negative
14619,James Kaye,RTI Health Solutions,Negative
14620,first ClinicalEpigenetics FCR CLL,Maria Tsagiopoulou,Negative
14621,CLL Carol Moreno,VJHemOnc,Negative
14622,REVIEW MDS CLL,Mathias,Negative
14623,New Medivizor Leukemia,Medivizor,Negative
14624,one Study Combining Inhibitor Venetoclax Inhibitor Treat Relapsed Refractory CLL William Wierda six hundred CLL,khmerxbxboi Sot Ali,Negative
14626,Guest ASH,CLL Society Inc,Negative
14628,two thousand and nineteen two thousand twentyfour million USD one thousand five hundred two thousand and nineteen CLL,CRO Contract Res,Negative
14630,CLL,Benlazar Amine,Negative
14632,CLL,Pacientes LMC,Negative
14633,CLL,El tal Toni JoActuo LlibertatPresosPolitics,Negative
14634,CLL DanaFarber CLL CLLsm,Patient Empowerment Network,Postive
14635,CLL Kerry Rogers CLLsm,Patient Empowerment Network,Negative
14636,USAToday Florida CLL,Pharmacyclics AbbVie Company,Negative
14637,CLL Read Florida CLL USAToday,JanssenUS,Negative
14638,two thousand and ten Taliban Afghanistan Navy US,Melissa Palomo Ramon,Negative
14639,CLL NGS,Blood Journal,Negative
14640,today many year Greece Follow MedThread CLL,AstraZenecaUS,Negative
14641,CLL,Blood Journal,Negative
14642,Mark Read ChronicLymphocyticLeukemia LymphomaCanada,AbbVie Canada,Negative
14643,DRG United States Western Europe DRGinsights CLL AstraZeneca,DRG Epidemiology,Negative
14644,Sponsored Join CLL six PM EST anthonymatomd chadinabhan MDedgeChats,MDedge Hematology Oncology,Negative
14645,David RIP James BloodCancer,LymphomaAction,Postive
14646,cll rituximab medium Anna DeVeaux,An Deveaux,Negative
14651,Orlando CLL CllSociety LornaWarwick,CLL Ireland,Negative
14652,al Longer FCR CLL CLL FCR,Toby Eyre,Negative
14653,OncoAlert Ibrutinib Rituximab,Raul Cordoba MD PhD,Postive
14654,CLL Society Giving Tuesday GivingTuesday CLL CLLsm,CLL Society Inc,Postive
14655,CLL,MDEdge,Negative
14656,Serologic Response New Recombinant Adjuvanted,Shingles Resources,Negative
14657,Rai NorthwellHealth,Targeted Oncology,Negative
14658,CLL,Kathleen Hoffman,Negative
14659,TorneoClausura DvoCapiata CLL FINAAAL,Club Libertad Limpeno,Negative
14660,TorneoClausura DvoCapiata CLL forty ST,Club Libertad Limpeno,Negative
14661,TorneoClausura DvoCapiata CLL Liz Pena,Club Libertad Limpeno,Negative
14662,TorneoClausura DvoCapiata CLL ST,Club Libertad Limpeno,Negative
14663,TorneoClausura CDC CLL ST Neily Carrasquel Damia Cortaza,Club Libertad Limpeno,Negative
14664,TorneoClausura CDC CLL ST Angeles Portillo Karina Vega,Club Libertad Limpeno,Negative
14665,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14666,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14667,TorneoClausura CLL eight Nairelis Gutierrez Laurie Cristaldo,Club Libertad Limpeno,Negative
14668,TorneoClausura DvoCapiata CLL six Karina Vega UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14669,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14670,BionanoGenomics one hundred,Bionano Genomics Inc,Negative
14671,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14672,TorneoClausura DvoCapiata CLL Stephanie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14673,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14674,TorneoClausura DvoCapiata CLL eighteen,Club Libertad Limpeno,Negative
14675,TorneoClausura DvoCapiata CLL thirteen Stephanie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14676,TorneoClausura DvoCapiata CLL twelve,Club Libertad Limpeno,Negative
14677,TorneoClausura DvoCapiata CLL INICIO,Club Libertad Limpeno,Negative
14679,Nicolas,VJHemOnc,Negative
14680,ATM first Rx CLL,Thomas Lofaro,Negative
14681,CLL,MDedge Hematology Oncology,Negative
14685,Trump Love,Daniel Baranowski,Postive
14689,Canada Sweden CLL,Matthews Associates,Negative
14691,CLL Kostas Stamatopoulos CERTHellas CLLsm Leusm,VJHemOnc,Negative
14692,CLL William Wierda Anderson Cancer Center International Workshop CLL,Patient Power,Negative
14693,Pairs ETH,CLL CryptoLiveLeak Token,Negative
14694,Varicella Zoster,Shingles Resources,Negative
14695,CLL Leusm,MSKHemOncTrials,Negative
14696,CLL Murano,Mansour,Postive
14697,CLL Genome Discovery,Dr Boominathan PhD,Negative
14698,one Velindre Cancer Centre Very Chronic daily Outlander,Leslie,Negative
14699,CLL Bone WeizmannScience,Prof John,Negative
14700,CLL Johnson Johnson,four hundred and twenty Ag,Negative
14701,Renee Beekman,Antonia five,Negative
14702,Keine Moglichkeit Kurze MultiplesMyelom Hodgkin NonHodgkin CARTcells,Kompetenznetz Maligne Lymphome,Negative
14703,European EPAR Rixathon rituximab Lymphoma Arthritis Rheumatoid,Agenparl,Postive
14704,Irene Lopez Lymphocytic,Centre Genomic Regulation CRG,Negative
14708,CLL KitRidout UniofOxford CLLsm Leusm,VJHemOnc,Negative
14709,HappyThanksgiving Thanksgiving Rootstock Vine,Zenshi,Negative
14711,ClinicalUpdates Review AML CLL Drs Delgado Eichhorst SapienzaRoma,Medscape Education,Postive
14712,Fludarabine PO BuFlu four four PO Obs four Paraguay PO CLL BMT,Cristobal Frutos,Negative
14713,CLL Treatment New Options More Hope CLL LLSCanada,RIOH,Postive
14714,CLL,Kathleen Hoffman,Negative
14716,Review Article CLL two three,Blood Journal,Negative
14718,CLL recent year,Jonathan Pearce,Negative
14719,Clive James CLL Ibrutinib One Ibrutinib CllSociety,Michael Rynne,Negative
14720,CliveJames CLL Ibruitinib two Ibrutinib two,Deirdre,Negative
14721,CLL,MerMer Goodburn,Negative
14722,monthly CLL November lmsm,Lymphoma Hub,Negative
14723,FDA International Program ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
14724,OhioStateUniversity Developed Drug Receives SLL healthcare,TrialSite News,Negative
14725,Jennifer Brown PhD CLL CLL,Expert Perspectives Oncology,Negative
14726,LymphomaResearch CLL,LymphomaAction,Postive
14730,Listening Resources Shop CLL,Early Years Resources,Postive
14731,today ninety minute CLL,Ian Hazzard,Negative
14732,la mimo la puedo CLL Clown,Dario Antilen,Negative
14733,TorneoClausura CLL,Club Libertad Limpeno,Negative
14734,TorneoClausura CLL GralDiaz,Club Libertad Limpeno,Negative
14736,TorneoClausura CLL GralDiaz,Club Libertad Limpeno,Negative
14737,TorneoClausura CLL Karina Vega Griselda Garay Angelica,Club Libertad Limpeno,Negative
14738,TorneoClausura CLL thirty,Club Libertad Limpeno,Negative
14739,TorneoClausura CLL,Club Libertad Limpeno,Negative
14740,FDA second,Prime Care Health Solutions,Negative
14741,Ublituximab CLL,Blood Journal,Negative
14742,CLL DanaFarber CLL CLLsm,Patient Empowerment Network,Negative
14743,one Husband Jay Maureen Ruth Schorr CLL CLL,Esther Schorr,Negative
14744,Annual Meeting Visit u Booth six hundred and one,Verastem Oncology,Negative
14745,Few week CLL Hope one evening,chadi nabhan MD MBA FACP,Negative
14746,CLL,chadi nabhan MD MBA FACP,Negative
14747,ClinicalTrials HealthResearch,Monterey Holistic,Negative
14749,two three Better Than one,Lymphoma Papers,Negative
14762,FDA second,Rajesh Vagh,Negative
14763,FDA Approves,Cancer Health,Negative
14764,CllIreland,Jan Rynne,Negative
14765,two PhD,Janina Nett,Negative
14766,one About ten CLL,Hematodata,Negative
14767,CME,Oncology CE,Postive
14768,CLL Thanksgiving Pie Day Thanksgiving Day CLL,ESCofNJ,Postive
14769,Advertising CLL CryptoLiveLeakToken CLL AttentionMining Reward Users Advertising Campaigns Impressions Views Clicks CTR Cost CLL,CLL CryptoLiveLeak Token,Postive
14770,CLL Read CLL USAToday,Pharmacyclics AbbVie Company,Negative
14771,FDA second,Michelle Petersen,Negative
14772,NewMonographMonday Truxima,epocrates,Negative
14773,CLL Ublituximab CLL Nice BloodJournal NebraskaMed WinshipAtEmory TGTherapeutics,Prof John,Postive
14774,CLL FCR,The Lancet Haematology,Postive
14775,CLL Kerry Rogers CLL CLLsm,Patient Empowerment Network,Negative
14776,Florida Read Betty CLL USAToday,JanssenUS,Postive
14778,SCIG CLL IgG twenty,Matthew Cheung,Negative
14781,two thousand and twentyseven twenty million one hundred and twelve thousand and eighteen USD three thousand five hundred Chronic Lymphocytic Leukemia Epidemiology Forecast CLL International Statistical Classification,Renal Cell Carcinoma,Negative
14783,FDA Approves,Cancer Health,Negative
14784,Chronic,Ashley Caneup,Postive
14785,AstraZeneca Leverages SLL CLL Drug AstraZeneca,TrialSite News,Negative
14786,Leukemia,Pete Herbert,Negative
14787,Jamie three,closed,Postive
14788,Application Artificial Neural Network Diagnosis,EurekaMag,Negative
14789,Dec eight two thousand and nineteen Join u second daily six PM EST Sunday December eight CLL,Patient Power,Negative
14791,Adherence two thousand and eighteen,Fight Cancer Team,Negative
14792,Turmeric Natural Prevention Treatment Chronic,Kyle Norton,Negative
14793,Monthly Watch Alessandra Ferrajoli CLL,Lymphoma Hub,Negative
14794,TorneoClausura CLL,Club Libertad Limpeno,Negative
14795,TorneoClausura CLL ST,Club Libertad Limpeno,Negative
14796,TorneoClausura CLL ST,Club Libertad Limpeno,Negative
14797,TorneoClausura CLL Liz Pena,Club Libertad Limpeno,Negative
14798,TorneoClausura CLL Stephanie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14799,TorneoClausura CLL ST Claudia Romero Griselda Garay,Club Libertad Limpeno,Negative
14800,TorneoClausura CLL Nairelis Gutierrez Laurie Cristaldo,Club Libertad Limpeno,Negative
14801,TorneoClausura CLL Karina Vega,Club Libertad Limpeno,Negative
14802,TorneoClausura CLL,Club Libertad Limpeno,Negative
14803,TorneoClausura CLL Liz Pena,Club Libertad Limpeno,Negative
14804,TorneoClausura CLL Joana Galeano,Club Libertad Limpeno,Negative
14805,TorneoClausura CLL fifteen ST,Club Libertad Limpeno,Negative
14806,TorneoClausura SolDeAmerica CLL ten,Club Libertad Limpeno,Negative
14807,TorneoClausura CLL,Club Libertad Limpeno,Negative
14808,TorneoClausura CLL,Club Libertad Limpeno,Negative
14809,TorneoClausura SolDeAmerica CLL,Club Libertad Limpeno,Negative
14810,TorneoClausura CLL Karina Vega,Club Libertad Limpeno,Negative
14811,TorneoClausura SolDeAmerica CLL,Club Libertad Limpeno,Negative
14812,TorneoClausura CLL twenty,Club Libertad Limpeno,Negative
14813,TorneoClausura CLL thirteen,Club Libertad Limpeno,Negative
14814,TorneoClausura CLL,Club Libertad Limpeno,Negative
14815,CLL last year JanRynne,CLL Ireland,Negative
14819,Adherence two thousand and eighteen,Lymphoma Papers,Negative
14820,CLL,Benlazar Amine,Negative
14822,Sao Paolo CarlosChiattone,Stefano Luminari MD,Postive
14823,two thousand and nineteen Chemotherapy Foundation Symposium Richard Furman CLL TargetedOnc,Weill Cornell Medicine,Negative
14824,CLL BloodCancer,AstraZenecaUS,Postive
14825,trastuzumab rituximab CLL,VJ Oncology,Negative
14826,CLL Jay Connolly Maureen Connolly,Patient Power,Negative
14827,Betty CLL Read Betty USAToday,Pharmacyclics AbbVie Company,Negative
14828,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
14829,Lymphoma Large Diffuse Follicullar Lymphoma Cutaneous Anapalastic Chronic,Matthews Associates,Negative
14830,Spanish el Mensaje Periodistico,Fernando LEON SOLIS,Postive
14831,CLL Annual CLL CllSociety LLSusa next year,Deborah Stephens,Postive
14832,Hundreds Roundup NHL CLL,Matthews Associates,Negative
14833,FDA Takes Second Action Under International Collaboration Approves New Treatment Option Patients With CLL,Oncology Times,Negative
14835,FDA PML MAB CLL,An Deveaux,Negative
14842,CLL CLL MorphologyMonday CLL,Anas Nasir,Negative
14843,FDA second,Claire Telford,Negative
14844,ChronicLymphocyticLeukemia two thousand and nineteen,DelveInsight,Negative
14846,FDAapproves,WuXi AppTec,Negative
14847,CLL,Kathleen Hoffman,Negative
14849,FDA second SLL,Mask Up damn nose please,Negative
14850,PML CLL,An Deveaux,Negative
14851,CLL Alcalabrutinib DrMDavids PatientPower,Michele,Postive
14852,FDA second FDA,matiere,Negative
14853,CLL SLL,The Leukemia Lymphoma Society,Postive
14854,EYE nine Supporting Emergent Literacy CLL EYtwittertagteam harlowcollegeEY,Early Years LSC FE VocEd EYFS,Negative
14855,FDA second,Crwe World,Negative
14856,FDA second,Liseth Parra PhD,Negative
14857,Justin Taylor Susan Leclair CLL MRD,Patient Power,Negative
14858,FDA second,carlota bernal,Negative
14859,FDA second,Renovatio Biomedica,Negative
14860,FDA CLL,eyeonfda,Negative
14861,FDA second Project Orbis TGAgovau,Media Affairs,Negative
14862,FDA second,Cayte Truza,Negative
14863,FDA second,LLZ Consulting,Negative
14864,FDA second,Kaushik,Negative
14865,Read Betty CLL USAToday,JanssenUS,Negative
14866,FDA second,Pharma Regulatory,Negative
14867,FDA second,FDA Daily,Negative
14868,GP module acute AML last week FREE CLL Myeloma SpotLeukaemia RcgpFaculties,Nick,Postive
14869,FDA FDA second,FederalGov News,Negative
14870,Today New Health Article Herbal Turmeric Natural Prevention Treatment Chronic,Kyle Norton,Negative
14871,BPTH Holdings Announces Clearance Investigational New Drug Application one Clinical Trial Evaluate Ability Targeting Protein Treat Lymphoma Chronic,HODOR,Postive
14872,BPTH Holdings Announces Clearance Investigational New Drug Application one Clinical Trial Evaluate Ability Targeting Protein Treat Lymphoma Chronic,quantumup,Postive
14877,Today Systematic Synthetic Phonics nine Supporting Emergent Literacy CLL,Early Years LSC FE VocEd EYFS,Negative
14878,BiomedChrom MassSpec,BioMassSpec,Negative
14880,Rai,Targeted Oncology,Negative
14881,TorneoClausura CLL Olimpia UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14882,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14883,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14884,TorneoClausura CLL Olimpia Karina Vega,Club Libertad Limpeno,Negative
14885,TorneoClausura CLL Olimpia Griselda Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
14886,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14887,TorneoClausura CLL Olimpia twenty,Club Libertad Limpeno,Negative
14888,TorneoClausura CLL Olimpia seventeen,Club Libertad Limpeno,Negative
14889,TorneoClausura CLL Olimpia eight,Club Libertad Limpeno,Negative
14890,TorneoClausura CLL Olimpia juega el segundo,Club Libertad Limpeno,Negative
14891,CLL,TrialSite News,Negative
14892,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14893,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14894,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14895,TorneoClausura CLL Olimpia fifteen,Club Libertad Limpeno,Negative
14896,TorneoClausura CLL Olimpia ten,Club Libertad Limpeno,Negative
14897,TorneoClausura CLL Olimpia,Club Libertad Limpeno,Negative
14898,today CLL LXI KGH,SwingTradeBot UK,Negative
14899,far week eyfs eyfstwitterpals rhyme,Tishylishy,Postive
14900,GENIUNE CLL TargetedOnc,PER,Postive
14901,CLL two Dr Goede,Joana Koury,Negative
14902,CLL,MDedge Hematology Oncology,Negative
14903,CLL,MDEdge,Negative
14904,CLL,Wilmot Cancer Institute,Postive
14906,Impressive CLL,labi lab innsbruck,Postive
14909,Halfway CLL SLL Texas Oncology Plano Presby,Francis Camacho,Negative
14910,today CLL,SwingTradeBot UK,Negative
14912,Monthly CLL FCR,Lymphoma Hub,Negative
14913,Meu Rap de Blumenau CLL,Charles Uller,Negative
14914,CLL Molica,LYMPHOMA MYELOMA CONNECT,Negative
14915,Zou Zhu HY XT Xia Miao Zhao SS Wu YJ Wang Xu Li JY,NK paper,Negative
14922,CLL FIVE ON Molica Hematological Oncology,Francesco Bertoni,Negative
14923,FabienneMackay CLL,Alina Lam,Postive
14924,CLL Leukamie Onkologie,Onko Community,Negative
14925,AttentionMining WordPress DM,CLL CryptoLiveLeak Token,Negative
14926,CME,Vindico Medical Education,Postive
14927,CLL two Dr Goede CLL,Joana Koury,Postive
14930,The Light Chain Defines New Poor Prognostic Subgroup Chronic,papersformax,Negative
14931,CLL MF,MDEdge,Negative
14932,CLL MF,MDedge Dermatology,Negative
14934,SCT CLL,Joana Koury,Postive
14935,week,Bernadette,Postive
14936,CLL Genome Discovery,Dr Boominathan PhD,Negative
14938,Paolo Ghia CLL Hematology Alexion Oslo,Sigrid Skanland,Postive
14939,CLL,Kathleen Hoffman,Negative
14940,three year old Humpties afternoon,Nic Hall,Postive
14941,Translational Research Conference Chronic March two thousand and Paris France Ghia HallekMichael Submit,ESH Haematology,Negative
14942,Susan Brien MD CLL,Expert Perspectives Oncology,Postive
14943,Study Rituximab,James Kerwin,Negative
14944,CLL Wizyta Prosze pana tu nic Niechaj,Jacek Kalinowski,Negative
14945,Rayen Waaaaw google three KEY CLL,Mahmoud Turki,Negative
14946,CLL FIVE CLL,Benlazar Amine,Negative
14947,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14948,TorneoClausura DvoCapiata CLL forty ST,Club Libertad Limpeno,Negative
14949,TorneoClausura DvoCapiata CLL ST UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
14950,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14951,TorneoClausura DvoCapiata CLL thirteen Liz Pena,Club Libertad Limpeno,Negative
14952,TorneoClausura DvoCapiata CLL twelve,Club Libertad Limpeno,Negative
14953,TorneoClausura DvoCapiata CLL five,Club Libertad Limpeno,Negative
14954,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14955,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14956,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14957,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14958,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14959,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14960,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14961,TorneoClausura DvoCapiata CLL eighteen,Club Libertad Limpeno,Negative
14962,TorneoClausura DvoCapiata CLL eleven,Club Libertad Limpeno,Negative
14963,TorneoClausura DvoCapiata CLL eight,Club Libertad Limpeno,Negative
14964,TorneoClausura DvoCapiata CLL,Club Libertad Limpeno,Negative
14965,Concannon Cancrr CLL CANCER CCW,Helen Greally,Negative
14968,Kanti Rai CAHON CLL Raicriteria,Tian Zhang MD MHS,Postive
14970,Haploidentical Blood Marrow Leukemia Allogeneic CLL,COPD News,Negative
14971,Louise Concannon GalwayCancer CLL,CLL Ireland,Postive
14972,Canadian,Current Oncology,Negative
14973,Amjat Hayat Galway University Hospital CLL Ireland,CLL Ireland,Negative
14974,CLL Maria Jose Terol,MoJo,Negative
14982,TorneoClausura CLL,Club Libertad Limpeno,Negative
14983,TorneoClausura CLL el segundo,Club Libertad Limpeno,Negative
14984,TorneoClausura CLL,Club Libertad Limpeno,Negative
14985,two thousand and twenty American Journal Hematology two thousand and nineteen Nov ninetyfour eleven,zahera Fahed,Negative
14986,TorneoClausura CLL,Club Libertad Limpeno,Negative
14987,Brian Koffman CllSociety Ireland CLL,CLL Ireland,Postive
14988,Center Lifelong Learning five hundred CLL CLL,ESCofNJ,Negative
14989,CLL,Blood Journal,Negative
14990,Friday last week Association Corporate Counsel The Bitter End Rock CLE FBF ACC,Cowan Liebowitz,Negative
14991,Venetoclax Deborah Stephens Blood two thousand and nineteen one hundred and thirtyfour,Jose Queizan,Negative
14992,nhl cll,Roundup Options,Negative
14993,CLL DanaFarber Leukemia,Dropworks,Postive
14994,CCO December six Orlando Take nine AML BetaThalassemia CLL PTCL,CCO Education,Postive
14995,CLL,CLL Society Inc,Postive
15005,Listening Resources Shop CLL,Early Years Resources,Postive
15006,Venclexta Rituximab Chronic,Trip Database,Negative
15007,Venetoclax CLL BloodJournal,Sagar Patel MD,Negative
15008,Venetoclax Blood American Society Hematology,Dr Comeau MD,Negative
15009,Federal Bar Council Intellectual Property Committee NFL Intellectual Property Counsel FEDERALBARCOUNCIL NATIONALFOOTBALLLEAGUE CLL,Cowan Liebowitz,Postive
15010,Venetoclax fourteen two thousand and nineteen,Mike Thompson MD PhD FASCO,Negative
15011,CLL BloodJournal,Raj Chakraborty,Negative
15012,Fatigue one CLL,Zack,Negative
15013,today KGH CLL,SwingTradeBot UK,Negative
15014,CLL two thousand and twenty UniofOxford CLLsm CLL Leusm,VJHemOnc,Negative
15015,FDA Dollar Tree CLL FDAPatientinfo PatientPower CllSociety CLLAdvocates CLL,Michele,Negative
15016,CLL Venetoclax BloodJournal UtahIMCMRs,Prof John,Postive
15017,Laboratory Leukemia GreenTea,Health Services LLC,Negative
15020,CLL uMRD Lots MDAndersonNews,Amber Koehler,Postive
15021,Barbara Eichhorst Carol Moreno Nicholas Chiorazzi,Sigrid Skanland,Negative
15022,two thousand and nineteen two thousand and twentythree,Kiran Bhole,Postive
15023,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
15024,LYMPHOCYTIC,Ezzy,Negative
15025,LYMPHOCYTIC sixteen,Ezzy,Negative
15026,Haploidentical Blood Marrow,ALI ALAHMARI,Negative
15027,RutgersCancer,Rutgers Biomedical Health Sciences,Postive
15028,CLL,Kathleen Hoffman,Negative
15029,AttentionMining Advertising Platform Ad CLL CLL CryptoLiveLeakToken Advertisement,CLL CryptoLiveLeak Token,Negative
15030,today CLL ITV,SwingTradeBot UK,Negative
15031,Teva Pharmaceuticals,WEGO Health,Negative
15032,today Teva Pharmaceuticals,WEGO Health,Negative
15033,CLL Teva Pharmaceuticals,WEGO Health,Negative
15034,Prepare Teva Pharmaceuticals,WEGO Health,Negative
15035,Users AttentionMining CLL,Kenneth Garofalo,Negative
15036,fourteen Step Guide CLL CLL CryptoLiveLeakToken AttentionMining,CryptoLiveLeak,Negative
15037,today Ad Space CLL,CLL CryptoLiveLeak Token,Negative
15039,Polish Lymphoma Research Group Analysis,Lymphoma Papers,Negative
15043,AIM CLL Cello Health PLC,AIM Alerts,Negative
15044,one Brian Hill ClevelandClinic CLLsm SLL,Patient Empowerment Network,Negative
15045,Chris Stevick Roundup last month CLL GroundWarDoc Monsanto,Ground War,Negative
15046,FL BloodJournal,chadi nabhan MD MBA FACP,Negative
15047,Hossein Khiabanian HKhiabanian Translational Award TheVFoundation Cancer Research,RutgersCancerInstNJ,Negative
15048,Jennifer Brown PhD del CLL,Expert Perspectives Oncology,Negative
15049,LYMPHOCYTIC fifteen,Ezzy,Negative
15050,LYMPHOCYTIC fourteen,Ezzy,Negative
15051,LYMPHOCYTIC thirteen,Ezzy,Negative
15052,LYMPHOCYTIC twelve,Ezzy,Negative
15053,LYMPHOCYTIC eleven,Ezzy,Negative
15054,LYMPHOCYTIC nine,Ezzy,Negative
15055,LYMPHOCYTIC eight,Ezzy,Negative
15056,LYMPHOCYTIC six,Ezzy,Negative
15057,LYMPHOCYTIC four,Ezzy,Negative
15058,LYMPHOCYTIC three,Ezzy,Negative
15059,CLL,Club Libertad Limpeno,Negative
15060,Janssen Announces Health,Alicia Bell IFBB Pro,Negative
15061,Haematologica,Dr Comeau MD,Negative
15062,two thousand and twenty Hallek two thousand and nineteen American Journal Hematology Wiley Online,Dr Comeau MD,Negative
15063,Download eBook,AplusA World,Postive
15065,European EPAR Imbruvica Lymphoma Leukemia Lymphocytic,Agenparl,Negative
15066,three Dr Karmali Dr Shammo First Waldenstroms RushUniversity LurieCancer,donnashort,Negative
15067,CLL,Michele,Postive
15068,New Drug Application FDA seventy year,Targeted Oncology,Negative
15070,BloodAdvances MartinJSDyer,Toby Eyre,Postive
15072,LYMPHOCYTIC two,Ezzy,Negative
15073,LYMPHOCYTIC one,Ezzy,Negative
15074,AbbVie FDA IMBRUVICA Rituximab CLL CLL,Plexus Ventures,Negative
15075,PNAS week,GenomeWeb Daily Scan,Negative
15076,CLL Brian Hill ClevelandClinic CLLsm,Patient Empowerment Network,Negative
15077,IgM,James Kerwin,Negative
15078,CLL Learn,AbbVie US,Negative
15079,SoC CLL,Lymphoma Hub,Negative
15081,CRISPR CLL FNCE nevillesanjana Neville,Kim Kirchherr,Negative
15089,Canadian,Lymphoma Papers,Negative
15090,CLL Ireland JanRynne,CLL Ireland,Postive
15091,Signaling Bcells BCR,Prof John,Negative
15092,New Options Treatment ChronicLymphocyticLeukemia Cancer Institute DanaFarber CLL,Michele,Negative
15094,two thousand and nineteen Speak CLL today CLL CLLsm,CLL Society Inc,Postive
15095,today CLL ITV QTX MRCH ARR,SwingTradeBot UK,Negative
15096,CLL CLLsm,Patient Empowerment Network,Postive
15098,CLL Brian Hill ClevelandClinic CLLsm,Patient Empowerment Network,Negative
15099,CllIreland JanRynne today IPPOSI CLL Jan IPPOSI,CLL Ireland,Postive
15101,Jennifer Brown PhD CLL,Expert Perspectives Oncology,Negative
15102,Monthly CLL,Lymphoma Hub,Negative
15103,APTO AML BTK CLL NHL AML Precision,Joe,Postive
15106,CLL,Benlazar Amine,Negative
15107,two GIBB Study Previously Untreated CLL,Benlazar Amine,Negative
15109,CLL,Benlazar Amine,Negative
15110,CLL,Benlazar Amine,Postive
15111,UK SCT one hundred and nine CLL Dr,Toby Eyre,Negative
15112,TorneoClausura CLL,Club Libertad Limpeno,Negative
15113,TorneoClausura CLL el ST UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15114,CLL CLL Saturday Galway Lookin JanRynne,Michael Rynne,Negative
15115,TorneoClausura Cortaza Liz Pena,Club Libertad Limpeno,Negative
15116,CLL,CellworksLife,Negative
15117,Less week Saturday November afternoon Galway CLL CLL Amjad Hayat Galway Ardilaun Hotel,CLL Ireland,Negative
15118,TorneoClausura SP CLL,Club Libertad Limpeno,Negative
15119,two Chronic,ClinicalTrialsData,Negative
15128,Roeker CLL CLL,Toby Eyre,Postive
15130,CLL Genomics England Pilot WGS,Liz Tseng,Negative
15131,KR year Over fifty CLL,Genome Biology,Negative
15132,CLL,Ri Ben Ren Xiang keUSMLEDui Ce bot,Negative
15133,CSE Occitanie SNU CFDT FO thirteen CGT SUD CFTC UNSA CLL,SNU Pole Emploi FSU Occitanie,Negative
15134,Prof Con Tam SEQUOIA ORR one Richters one CLLsm,Chan Cheah,Negative
15135,La Lucha AGUANTE LUCHAN Sobre los de primera linea CLL ChileLuchaLibre,Dario Antilen,Negative
15136,LYMPHOCYTIC five,Ezzy,Negative
15144,Core,Mayo Clinic Pathology,Negative
15145,median nineteen month eight fourteen CI four,Targeted Oncology,Negative
15146,New Drug Application FDA Learn,Pharmacyclics AbbVie Company,Negative
15147,CLL,Club Libertad Limpeno,Negative
15148,Koffman Expert Access CLL CLLsm,CLL Society Inc,Postive
15149,New Drug Application FDA CLL,Janssen Global,Negative
15150,second CLL Koffman CllSociety,Patient Empowerment Network,Negative
15152,HSMN Janssen Announces Submission Supplemental New Drug Application FDA IMBRUVICA Combination Rituximab,HSMN,Negative
15153,acala CLL,Toby Eyre,Postive
15156,Rituximab Lymphoma,Trip Database,Negative
15157,CLL,Kathleen Hoffman,Negative
15159,CLL,chadi nabhan MD MBA FACP,Negative
15160,Chronic today,TSmrecansky,Negative
15161,New Ibrutinib,Medivizor,Negative
15164,CLL,Katrina Sondermann,Negative
15165,CLL one LornaWarwick,CLL Advocates Network,Postive
15166,today,SwingTradeBot UK,Negative
15167,Scan Centerline Cross today CLL,SwingTradeBot UK,Negative
15168,Scan Signal Line Cross today FOG,SwingTradeBot UK,Negative
15169,CLL CllSociety CLLSupport,CLL Advocates Network,Postive
15170,Brian Koffman CllSociety UMRD CLL,Patient Empowerment Network,Negative
15179,Bendamustine Rituximab Combination With Copanlisib Treatment rituximab combination copanlisib,Lung Cancer News,Negative
15180,CLL Javier CLL CLLsm,Patient Empowerment Network,Negative
15181,RNA Sequencing Characterizes Impairment Cells Derived From Patients With CLL,David,Negative
15182,RNA CLL,CancerTherapyAdvisor,Negative
15183,MedTweetorial MedEd Specialties Nephrology Renal Neph Oncology CLL,MedTweetorials,Negative
15184,LymphoidNeoplasia,Blood Advances,Negative
15185,today forty year five mile SCI CLL,Mark Jahdoh,Postive
15187,CLL next month one CLL,Michele,Negative
15188,Jennifer Brown PhD Bruce Cheson Susan Brien MD CLL CLL,Expert Perspectives Oncology,Negative
15194,Venetoclax Effective Against CLL,Cure Cancer,Negative
15195,Young,Rap Name Bot,Negative
15196,obinutizumab CLL,AV MD,Negative
15197,four today Find BTK Droplet Digital PCR,EMEA,Negative
15198,Principal Life Insurance Company Principal,Kantor Kantor LLP,Negative
15199,CLL,ESCofNJ,Negative
15200,Sunday eatrightFNCE CLL,Chris Weithman,Postive
15201,Problems Cancer,Anas Saad,Negative
15202,APTO CLL two IMO,Joe,Negative
15203,LeukaemiaCareUK CLL Richters,Oxford Centre Haematology,Negative
15204,CLL three hundred BTKis NovantHealth CLL,Alan Skarbnik,Negative
15205,CLL Javier MoffittNews CLL CLLsm,Patient Empowerment Network,Postive
15206,one decade one CLL Keating CLL,Michael Wang MD,Postive
15207,MRD CLL Watch,AbbVie US,Negative
15208,four CLL SLL,Verastem Oncology,Negative
15209,VEN intol gt anthonymatomd Great CLL,Toby Eyre,Postive
15210,APTO,Joe,Negative
15211,Jennifer Brown DanaFarber CLL Grand,Sanam Loghavi MD,Postive
15213,The Mithralog Induces Chronic,Biblioteca HUCA,Negative
15214,Prof Sebastian Kobold four CLL al sitcancer WICouncil,Bernard Fox,Negative
15215,Dr Rai RichardFurmanMD philtalamo,donnashort,Negative
15216,two thousand and nineteen WeillCornell,donnashort,Postive
15217,one CLL two one five one four,Mike ForThePeople,Postive
15218,ATM LeukemiaJnl UniCologne CLL,Prof John,Negative
15219,NZ Robert Weinkove five year,Sarah,Negative
15221,Eddie Robinson Cherokee County Cherokee Northside,Northside Hospital,Negative
15222,APTO Clinical Responce CLL ARQL six first APTO Mcap ARQL Mcap APTO,Joe,Negative
15223,APTO Early Evidence Clinical Response CLL Second Dose Level,Joe,Negative
15225,The Mithralog Induces Chronic,Transcriptomes,Negative
15226,today CLL STX,SwingTradeBot UK,Negative
15227,Scan Hammer Candlestick today ATY BMV CRWN,SwingTradeBot UK,Negative
15228,Paul Barr Cancer Institute CLL,Oncology Tube,Negative
15229,epilepsy causing CLL CancerPatients Epilepsy ImmuneDisorders,Michele,Negative
15230,Chronic Dallas,Crowdfunding Center,Negative
15231,Risk Second Primary Malignancy,Oncology,Negative
15232,NCIDrDougLowy THE FLU SHOT FightFlu FluShot CLL,Michele,Negative
15233,CLL Danielle Brander CLLsm,Patient Empowerment Network,Negative
15234,CELG Phase two Chronic,ClinicalTrialsData,Negative
15235,two Bologna Postgraduate CLL Conference Kicking Con Tam Great Twitter CLL Zinzani ERCongressi HallekMichael,Amy Cavers,Postive
15236,CELG Phase two,ClinicalTrialsData,Negative
15237,Laboratory Leukemia GreenTea,Staffing LLC,Negative
15239,CLLSupport LeukaemiaCareUK CLL,Zack,Postive
15240,CLL CLL,CLLSA,Postive
15241,CLL CLL,CLLSA,Postive
15242,CLL CLL,CLLSA,Postive
15243,UK CLL CLL,CLLSA,Postive
15244,Today exciting day two thousand and four Forum CLL,CLLSA,Postive
15245,Henlius Ascentage Pharma Collaborate Evaluate Combination Therapy Chronic China,PharmaShots Incisive news three shot,Negative
15246,CLL Genome Discovery,Dr Boominathan PhD,Negative
15247,CLL Genome Discovery,Dr Boominathan PhD,Negative
15248,The Mithralog Induces Chronic,NK paper,Negative
15253,CLL,Lymphoma Papers,Postive
15254,MichaelKeating CLL,Krishna Komanduri MD FASTCT,Negative
15256,couple day four PCR webinar Droplet Digital PCR,EMEA,Negative
15257,two Twitter CLL Zinzani ERCongressi HallekMichael,Amy Cavers,Postive
15258,New Medivizor Ibrutinib,Medivizor,Negative
15260,Cll Dr Cohen SagarLonialMD OncLiveSOSS,donnashort,Negative
15261,Health Monitor Magazine Stay Kate,Stephen Brown,Postive
15262,Oncologists Earn Orlando six Danielle DukeHealth,Medscape Education,Negative
15263,Venetoclax CLL,Benlazar Amine,Negative
15264,CLL,LYMPHOMA MYELOMA CONNECT,Negative
15265,CLL Open House one Independence Cafe CLL,ESCofNJ,Postive
15266,Comparison Time Next Treatment Health Care Resource Utilization,Lymphoma Papers,Negative
15268,CLL CLL Brian Koffman CLLsm,Patient Empowerment Network,Negative
15269,CLL Corroborates CLL,Toby Eyre,Postive
15270,one CLL CLL,Deborah Stephens,Negative
15271,CLL Bologna CLL,Deborah Stephens,Postive
15272,Nearly ten year CLL Mark,Lymphoma Canada,Postive
15273,de Marc Lisez LymphomaCanada CLL,AbbVie Canada,Negative
15274,Mark journey ChronicLymphocyticLeukemia LymphomaCanada CLL,AbbVie Canada,Negative
15275,CLL Bologna John Seymour Melbourne CLL,Michael Hallek,Postive
15276,Angela Brooks UCSC,Nicolas Robine,Negative
15277,CLL,Teresa Martin,Postive
15279,KitRidout WGS CLL AI,Dr Philippa Brice,Postive
15280,CLL Davide Rossi,Michael Hallek,Postive
15281,Check Ibrutinib,Medivizor,Negative
15282,CLL,Kathleen Hoffman,Negative
15284,CLL Fatigue one Cure Magazine JanRynne,CLL Ireland,Negative
15285,second,Medivizor,Negative
15286,Michael Keating,COPD News,Negative
15287,TorneoClausura RP CLL,Club Libertad Limpeno,Negative
15288,TorneoClausura RP CLL Angelica Vazquez,Club Libertad Limpeno,Negative
15289,TorneoClausura RP CLL Angeles Portillo,Club Libertad Limpeno,Negative
15290,TorneoClausura RP CLL,Club Libertad Limpeno,Negative
15291,TorneoClausura RP CLL Neily Carrasquel,Club Libertad Limpeno,Negative
15292,TorneoClausura RP CLL Karina Vega,Club Libertad Limpeno,Negative
15293,TorneoClausura RP CLL Yanina Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15294,TorneoClausura RP CLL Yanina Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15295,TorneoClausura RP CLL Angelica Vazquez,Club Libertad Limpeno,Negative
15296,TorneoClausura RP CLL Karina Vega,Club Libertad Limpeno,Negative
15297,TorneoClausura RP CLL el,Club Libertad Limpeno,Negative
15298,TorneoClausura RP CLL,Club Libertad Limpeno,Negative
15299,TorneoClausura RP CLL Paola Genes UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15300,TorneoClausura RP CLL Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15301,TorneoClausura RP CLL Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15302,TorneoClausura RP CLL,Club Libertad Limpeno,Negative
15303,TorneoClausura RP CLL Karina Vega,Club Libertad Limpeno,Negative
15304,TorneoClausura RP CLL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15305,TorneoClausura RP CLL sixteen Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15306,TorneoClausura RP CLL eight Karina Vega Liz Pena,Club Libertad Limpeno,Negative
15307,TorneoClausura RP CLL,Club Libertad Limpeno,Negative
15308,CLL first two thousand and eleven Paschald Please Irish,Michael Rynne,Negative
15309,rituximab three year rituximab maintenance,Juan Marquet,Negative
15310,one Congress one four Washington,San Francisco Chronicle,Negative
15311,NHL CLL one hundred MZL,Lymphoma Hub,Negative
15312,Hazel Thomas Chronic past nineteen year journey chosen Today Read Hazel,CARTI Arkansas,Postive
15313,SaturdayMotivation Colorado FastTVNetwork FolloMe ColoradoMountains cll NeverGiveUp,Coffee Bullet,Postive
15314,Wayne Campbell MickeyRubin FNCE,Kim Kirchherr,Postive
15315,CLL HematoLaFe EFPIA IISLaFe JanssenESP jangeissler BolanosNat BloodJournal,Guillermo Sanz,Negative
15318,CLL,Hematology Advisor,Negative
15319,RNA PCR,Fragments,Postive
15321,CLL Kerry Rogers CLLsm,Patient Empowerment Network,Negative
15322,rituximab three year rituximab maintenance,JAVIER DE LA SERNA,Negative
15326,Mark one CLL,Michelle St John,Postive
15327,Clinical Jeanne Schaffer one two three,Patient Power,Negative
15329,second CLL,Medical Xpress,Negative
15330,Hundreds Roundup CLL,Matthews Associates,Negative
15331,CLL November,Schlesinger Group UK,Negative
15332,kan vi gore kan vi gore cml md cmml,LyLe Foreningen,Postive
15333,ho patienter Qol md livskvalitet,LyLe Foreningen,Postive
15334,Leukemia,SkillAcquire,Negative
15335,CLL HappyHalloween,MD Anderson Leukemia,Negative
15336,CLL Halloween party ESCNJ CLL HappyHalloween,ESCofNJ,Postive
15337,CLL rituximab three year rituximab maintenance,Benlazar Amine,Negative
15338,second,Medivizor,Negative
15339,Impressive Greece ERIC,Fredrik Ohrn,Postive
15340,Daniel Addison MACE CardioOncology CLL OhioStateMed,Sarah Williams,Negative
15341,two thousand and nineteen Comparing CLL MRD John Seymour PeterMacCC CLLsm HemOnc BTK,VJHemOnc,Negative
15342,Polish Adult Leukemia Study Group,Lymphoma Papers,Negative
15343,van rebre la subvencio de per la investigacio de CLL VHIO Gracies,Hematologia Hospital Universitari Vall,Negative
15344,November CLL,The Lancet Oncology,Negative
15346,PCR webinar Droplet Digital PCR,EMEA,Negative
15347,OncoAlert CLL,Raul Cordoba MD PhD,Negative
15348,CLL last September European Jewish thirty percent Native,Ashley Caneup,Negative
15350,Scan Bearish Centerline Cross today CNE PIN MKS OMU CLL FOUR HAT,SwingTradeBot UK,Negative
15352,CCO December six Orlando Take nine AML BetaThalassemia CLL PTCL,CCO Education,Postive
15353,Farrukh Awan International Workshop CLL two thousand and nineteen CLL CLL CLL,Esther Schorr,Postive
15354,Nicole Lamanna Patient Power International Workshop CLL two thousand and nineteen CLL,Esther Schorr,Negative
15355,Learn,Esther Schorr,Negative
15356,Today CLL Francesc Bosch Sidnavigare,Marta Crespo,Postive
15357,CLL Nicole Lamanna Patient Power International Workshop CLL two thousand and nineteen Edinburgh,Patient Power,Negative
15358,CLL CurrentOncology,RIOH,Negative
15359,CLL TBC GVAsanitat HospitalLaFe,Guillermo Sanz,Negative
15360,CLL,Kathleen Hoffman,Negative
15361,LLSusa Living Well CLL Charlotte CLLsm CLL NovantHealth,Alan Skarbnik,Postive
15362,Brian Koffman HiddenForcesPod week CLL Society Please CLL,CLL Society Inc,Postive
15364,CLARITY MRD CLL,Michael Wang MD,Postive
15366,CLL four CLL,Andrew Schorr,Postive
15367,FNCE Really CLL,Kim Kirchherr,Postive
15369,CLL Philip Thompson two thousand and Edinburgh Scotland Watch Thompson CLL MDAndersonNews,Patient Power,Postive
15370,One MeatVP FNCE CLL,Kim Kirchherr,Negative
15371,EPA FNCE CLL,Kim Kirchherr,Negative
15372,MeatVP FNCE CLL,Kim Kirchherr,Postive
15373,FNCE CLL,Kim Kirchherr,Postive
15374,USDA FNCE CLL,Kim Kirchherr,Negative
15375,FNCE CLL,Kim Kirchherr,Negative
15376,FNCE CLL,Kim Kirchherr,Postive
15377,one FNCE CLL,Kim Kirchherr,Postive
15378,MickeyRubin Boom FNCE CLL,Kim Kirchherr,Postive
15379,Tratamiento CLL Dra Baltasar,Miguel Canales,Negative
15380,MickeyRubin FNCE CLL,Kim Kirchherr,Postive
15381,DYK DYK NHANES MickeyRubin FNCE CLL,Kim Kirchherr,Postive
15382,MickeyRubin FNCE CLL,Kim Kirchherr,Negative
15383,One noon MickeyRubin one hundred and fifteen FNCE CLL,Kim Kirchherr,Negative
15384,CLL November,Schlesinger Group UK,Negative
15385,second Medivizor,Chocolatiere Phys,Negative
15386,Barbara Eichhorst CLL two Friday CLLsm Leusm CTSM HemOnc,VJHemOnc,Negative
15387,morning CLL,Nadia Naumova MD,Negative
15388,CLARITY CLL CIT ORR CR BM PB CLL,Lymphoma Hub,Postive
15390,Brown Ghia Hallek ESH Translational Research Conference Chronic CLL Haematology,ESH Haematology,Negative
15392,FDAfood FNCE CLL,Kim Kirchherr,Negative
15393,Peter Hillmen MD Leeds Institute Medical Research James England ASCO Venclexta CLL,MedPage Oncology,Negative
15394,FNCE CLL,Kim Kirchherr,Postive
15395,two hundred and eleven FDAfood FNCE CLL,Kim Kirchherr,Negative
15396,FNCE CLL,Kim Kirchherr,Negative
15397,FNCE,Kim Kirchherr,Postive
15398,CLL,Shinigami,Negative
15399,Venn FNCE CLL PS,Kim Kirchherr,Postive
15400,Michael Hallek ESH Scientific Committee,Didi Jasmin,Negative
15401,October Month Center Lifelong Learning month CLL,ESCofNJ,Negative
15402,second,Medivizor,Negative
15403,CLL John Allan MemberMondays,ACCC,Negative
15404,eight John Terry UTC CLL,The Lion Shed,Postive
15405,Jennifer Brown PhD Bruce Cheson Susan Brien MD CLL CLL,Expert Perspectives Oncology,Negative
15406,CLL One,AbbVie US,Negative
15407,Jeff Neurman,Coping Cancer,Negative
15408,PIM,EurekaMag,Negative
15409,second,Medivizor,Negative
15410,second,Medivizor,Negative
15411,BTK Droplet Digital PCR Here,EMEA,Negative
15412,second Medivizor,Lynne Mac Lean,Negative
15413,second,Medivizor,Negative
15415,One nevillesanjana FNCE CLL,Kim Kirchherr,Negative
15416,Love nevillesanjana FNCE CLL,Kim Kirchherr,Postive
15417,nevillesanjana FNCE CLL,Kim Kirchherr,Postive
15418,CRISPR nevillesanjana FNCE CLL,Kim Kirchherr,Negative
15419,nevillesanjana love FNCE CLL,Kim Kirchherr,Postive
15420,Microsoft nevillesanjana CRISPR FNCE CLL,Kim Kirchherr,Negative
15421,one hundred and one nevillesanjana FNCE CLL,Kim Kirchherr,Negative
15422,FNCE CLL,Kim Kirchherr,Postive
15423,Don Be FNCE CLL,Kim Kirchherr,Postive
15424,two,Kim Kirchherr,Negative
15427,CLL,Kim Kirchherr,Postive
15428,Team al Junior Cloud,ICS Think Safe Think ICS,Negative
15429,CTaylorRD FNCE CLL,Kim Kirchherr,Negative
15430,Nutrition respect Balance CTaylorRD FNCE CLL,Kim Kirchherr,Negative
15431,FNCE CLL,Kim Kirchherr,Negative
15432,FNCE CLL,Kim Kirchherr,Postive
15433,CLL,Kathleen Hoffman,Negative
15434,CLL one,Lymphoma Hub,Negative
15435,HopeBarkoukis Cooking Wellness Sustainability Food Agriculture It FNCE CLL,Kim Kirchherr,Postive
15437,Dietitians CLL FNCE,Kim Kirchherr,Negative
15438,dietitian FNCE CLL,Kim Kirchherr,Negative
15439,shout morning FNCE,Kim Kirchherr,Negative
15440,CLL FNCE,Kim Kirchherr,Negative
15441,one FNCE one one CLL,Kim Kirchherr,Postive
15442,CLL INSERM,Prof John,Negative
15443,Besserung Kobi Kuhn Bei CLL Innovative Therapien Linderung,Felix Keller,Negative
15446,today Cll,linfopedia,Negative
15447,Monthly Ibrutinib three CLL,Lymphoma Hub,Negative
15449,CLL one,Mike ForThePeople,Negative
15450,CLL Stefano Casola CLL,VJHemOnc,Negative
15451,one,Sonali Bracken,Negative
15452,MRD CLL Lecture Javier Pinilla,Joana Koury,Negative
15454,Ublituximab Plus Ibrutinib Results Show PFS Benefit CLL TargetedOnc,Benlazar Amine,Negative
15455,Credit Steve Gschmeissner,SciencePhotoLibrary,Negative
15456,CLL London Manchester today Lymphoma Research,LymphomaAction,Postive
15458,Eosinophilic,JAAD Journals,Negative
15459,CLL,CLL Society Inc,Negative
15460,CLL,UK Chronic Lymphocytic Leukaemia CLL Forum,Postive
15462,CLL anthonymatomd,LYMPHOMA MYELOMA CONNECT,Negative
15463,Myloid Leukemia CLL AML,Jemrath Bikombo,Postive
15465,two thousand and nineteen Cell Persistent Lymphocytic,Unidrugscom,Negative
15466,one Coping With Cancer,Jeff Neurman,Negative
15467,two thousand and nineteen,Unidrugscom,Negative
15468,two thousand and nineteen,Unidrugscom,Negative
15469,CLL Treatment Moves Toward Combo Approaches CAR William Wierda,Renal Cell Carcinoma,Negative
15470,two thousand and nineteen two thousand twentyfour million USD one thousand seven hundred two thousand and nineteen,Renal Cell Carcinoma,Negative
15471,CLL Jitka Malcikova MasarykUni CLL,VJHemOnc,Negative
15472,Hemato Oncology Key Points eBook earlier year,AplusA World,Postive
15474,August michieCLLlab,POG Research,Postive
15475,Maria Tsagiopoulou PhD Chronic Lymphocytic,RDA Europe,Postive
15476,TGTX Announces Final Results From Phase three,YGLDMETG,Negative
15477,TG Therapeutics Announces three Ublituximab Co,Crwe World,Negative
15478,CLL GUcancersci MichaelMoles Jen Cassels Check Video Article,Michie Lab,Postive
15479,VIDEO Geographic CLL African Norah Akinola CLL,VJHemOnc,Negative
15480,Myeloid CLL AML,Jemrath Bikombo,Negative
15481,second CLL,Hematology Advisor,Negative
15482,JoVEdongyeongsang Subcellular Fractionation Primary jove nonmun,poseuteg bagtaejunhagsuljeongbogwan,Negative
15483,CLL LymphoidNeoplasia,Blood Advances,Negative
15484,HL Chronic Lymphocytic Leukemia Lymphoma HL,Oncology Tube,Negative
15485,CLL Cells ROR Ahead Through Constitutive Signalling SacklerMed Bcells,Prof John,Postive
15486,NEWS Verastem Oncology five CLL SLL,Verastem Oncology,Negative
15487,Philip Thompson CLL,MD Anderson Leukemia,Negative
15488,QotW Wie Offseason Question Week un Antworten CLL,Coach Alex,Negative
15490,one Slime CLL,Orchard Primary Academy Nursery,Postive
15491,VIDEO CLL Nitin Jain CLL,VJHemOnc,Negative
15492,one one CAR CLL OncLive,MD Anderson Cancer Center,Negative
15493,CLL,Targeted Oncology,Negative
15494,Scan Hammer Candlestick today GHE JARA,SwingTradeBot UK,Negative
15495,Umbralisib pembrolizumab,Targeted Oncology,Negative
15496,CLL CLL,AbbVie US,Postive
15497,CLL ORR CLL,Lymphoma Hub,Negative
15498,CLL,Kathleen Hoffman,Negative
15499,CMC CLL CLL AttentionMining,CryptoLiveLeak,Negative
15500,AttentionMining CLL one,CLL CryptoLiveLeak Token,Negative
15501,Tuesday night Frankly Speaking Cancer Chronic Read Martha Garcia,Gilda Club QC,Negative
15502,Orlando six CLL jonathonbcohen WinshipAtEmory REGISTER,Medscape Education,Negative
15503,CLL Stefano Casola CLL,VJHemOnc,Negative
15504,Notch CLL Read Cancer,Oncogene Journal,Negative
15505,lymphomahub interview wwierda CLL BTK,Lymphoma Hub,Negative
15507,The EQA Summary Report Individual Laboratory Report ILR two thousand and nineteen CLL,GenQA Genomics Quality Assessment,Negative
15508,three SLL five year three,Prof John,Postive
15509,Wierda,Targeted Oncology,Negative
15510,Paolo Ghia CLL,VJHemOnc,Negative
15511,two week AskAlex CTOAM PrecisionOncology Alex Rolland Lymphoma CLL Follicular,CTOAM,Negative
15514,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15515,LibertadoresFem CLL ST,Club Libertad Limpeno,Negative
15516,LibertadoresFem CLL Joana Galeano Liz Pena,Club Libertad Limpeno,Negative
15517,LibertadoresFem CLL Liz Pena,Club Libertad Limpeno,Negative
15518,LibertadoresFem CLL twenty,Club Libertad Limpeno,Negative
15519,LibertadoresFem CLL sixteen,Club Libertad Limpeno,Negative
15520,LibertadoresFem CLL ten Fiorella Martinez Laurie Cristaldo,Club Libertad Limpeno,Negative
15521,LibertadoresFem CLL six,Club Libertad Limpeno,Negative
15522,LibertadoresFem CLL el segundo,Club Libertad Limpeno,Negative
15523,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15524,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15525,LibertadoresFem CLL forty,Club Libertad Limpeno,Negative
15526,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15528,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15529,LibertadoresFem CLL eighteen,Club Libertad Limpeno,Negative
15530,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15531,LibertadoresFem CLL five,Club Libertad Limpeno,Negative
15532,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15533,CLL Jitka Malcikova MasarykUni CLL,VJHemOnc,Negative
15536,The Roundup Options Legal Center Minnesota,EIN Presswire Press Releases,Postive
15539,Last month Sharon Information Support Team CLL Horizons CLL LymphomaMatters,LymphomaAction,Postive
15540,David Maloney CLL,Lymphoma Hub,Negative
15541,November CLL Busting Bad Thinking Andrea Miller,Phoebe Needles,Negative
15542,UCLAJCCC UCLAstemcell UCLA UCLAHealth,CIRM,Negative
15543,one PolishPattycake one sdf louisville Easterwood Airport,Amanda Roberts Mather,Negative
15544,Lymphocytic Leukemia Click,LLS Students Year Eastern Iowa,Postive
15545,afternoon CLL MDAndersonNews,Patient Power,Negative
15546,two PrecisionOncology Alex Rolland Lymphoma CLL Follicular,Liquid Biopsy Labs,Negative
15549,CLL,Kathleen Hoffman,Negative
15550,CLL Leukamie Onkologie Hamatologie,Onko Community,Negative
15551,CLL,Benlazar Amine,Postive
15552,CLL Access,AbbVie Australia,Negative
15553,Australian CLL Access,AbbVie Australia,Negative
15554,FDA Panel Thumbs Up Cefiderocol Urinary Tract Infections CLL,Michele,Negative
15555,el partido en CLL Natalia Griselda,Radio La Red,Negative
15556,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15557,Neily Carrasquel CLL,Radio La Red,Negative
15558,Se adicionan four NANvsCLL Claudia Romero Joana Galeano CLL Yanina Natalia Pena CLL Tifanny Villamar Kerlly Corozo NAN,Radio La Red,Negative
15559,LibertadoresFem CLL ST,Club Libertad Limpeno,Negative
15560,NAN jugadora menos CLL NANvsCLL Grecia Vega Kaira Houser NAN Carina NAN,Radio La Red,Negative
15561,sixty NAN el campo CLL la desatenciones defensivas de su el marcador NANvsCLL,Radio La Red,Negative
15562,LibertadoresFem CLL fifteen ST,Club Libertad Limpeno,Negative
15563,fiftytwo de CLL Griselda Lopez remato cruzado abajo para NANvsCLL,Radio La Red,Negative
15564,LibertadoresFem CLL NANAS seven Griselda Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15565,fifty CLL Farissa Cordoba la llevo Fabiola Sandoval NANvsCLL Farissa Cordoba NAN,Radio La Red,Negative
15566,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15567,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15568,el primer CLL Natalia,Radio La Red,Negative
15569,fortythree de CLL Natalia se encontro un del area Cordoba NANvsCLL,Radio La Red,Negative
15570,LibertadoresFem CLL LIZ,Club Libertad Limpeno,Negative
15571,thirtyseven de CLL Natalia Galeano un costado de Cordoba NANvsCLL,Radio La Red,Negative
15572,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15573,CLL Zambrano Bailey la arquera estuvo atenta para evitar el tanto NANvsCLL,Radio La Red,Negative
15574,thirty emparejo NAN CLL los ultimos NANvsCLL,Radio La Red,Negative
15575,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15576,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15577,fifteen NAN la pelota en su CLL NANvsCLL,Radio La Red,Negative
15578,LibertadoresFem CLL twelve,Club Libertad Limpeno,Negative
15579,ten CLL Angelica Vasquez un centro la Stephanie Lacoste la Cordoba su izquierda para evitar la caida de su arco NANvsCLL,Radio La Red,Negative
15580,LibertadoresFem CLL five,Club Libertad Limpeno,Negative
15581,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15582,Open House Friday two tomorrow,ESCofNJ,Negative
15583,Cardiology Regional Grand Rounds DarrylLeong Cardiology one Braley Research Institute,PHRI Population Health Research Institute,Negative
15584,Paul Barr CLL,Oncology Tube,Negative
15585,CLL last year,Catherine Velazquez,Postive
15586,Lack Patient Understanding,Michele,Negative
15587,Plasma Maturation Antigen Levels Elevated Correlate Disease Activity Patients Chronic CLL,Targeted Oncology,Negative
15588,Joanne Lee Cancer Immunoengineering,Madison Taylor,Negative
15589,Mayo CLL weekly CLL,Amber Koehler,Postive
15591,CLL,AbbVie US,Negative
15592,two thousand and nineteen Now CLL today CLL CLLsm,CLL Society Inc,Postive
15593,CLL twentyone month,Hematologia ICO Hospitalet,Negative
15594,CLL,Manoj Raghavan,Negative
15595,CLL,Michael Wang MD,Negative
15596,one CLL Twitter June three Yesterday Next April,AskThisCatholic,Postive
15597,CLL CLLsm,Patient Empowerment Network,Postive
15598,two thousand and nineteen Now CLL today CLL CLLsm,CLL Society Inc,Postive
15599,CLL,Taylor Lab UM,Postive
15600,CLL Danielle Brander DukeCancer CLLsm,Patient Empowerment Network,Negative
15601,DYK AmericanCancer CLL two thousand and nineteen Learn CLL NationalHealthEducationWeek,Pharmacyclics AbbVie Company,Negative
15602,CLL CLL,NCI CCR Med Onc Service,Negative
15603,AskAlex CTOAM PrecisionOncology Alex Rolland Lymphoma CLL Follicular,CTOAM,Negative
15605,William Wierda PhD Emerging Combinations Shift CLL OncLive,Cancer Medicine,Negative
15607,SarahCannonDocs,Oncology Times,Negative
15608,CLL Manchester London Lymphoma Research BloodCancer,LymphomaAction,Postive
15610,GenQA two Chronic CLL CLL Register Feb CLL,GenQA Genomics Quality Assessment,Postive
15612,SALT CLL,STEF EDWARDS,Postive
15614,Wierda,Targeted Oncology,Negative
15616,quand pour le jfrobergeQc ce partenariat rendra accessibles trois qui un CLL Recherche,PedagoCLL,Negative
15617,qui CLL Pedagogie,PedagoCLL,Negative
15618,two CLARITY CLL MRD,LYMPHOMA MYELOMA CONNECT,Postive
15619,Tuesday October Cedar Rapids Davenport,Iowa Cancer Consortium,Negative
15620,two thousand and nineteen,Benlazar Amine,Negative
15621,William Wierda PhD Role Rituximab Biosimilar Evolving OncLive,MD Anderson Leukemia,Negative
15622,CLL first,MD Anderson Cancer Center,Negative
15626,Cancer Cell,Sophie,Negative
15627,CLL Only two Cancer,Mike ForThePeople,Postive
15629,Aus CLL Prof Lichtenberg,Tania Jayesuria,Negative
15630,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15631,LibertadoresFem CLL forty ST,Club Libertad Limpeno,Negative
15632,LibertadoresFem CLL Liza Larrea Karina Vega,Club Libertad Limpeno,Negative
15633,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15634,LibertadoresFem CLL Nairelis Gutierrez Carmen Benitez,Club Libertad Limpeno,Negative
15635,LibertadoresFem CLL Liz Pena Yanina Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
15636,LibertadoresFem CLL eleven,Club Libertad Limpeno,Negative
15637,LibertadoresFem CLL AmericaDeCali EMPIEZA EL,Club Libertad Limpeno,Negative
15638,LibertadoresFem CLL,Club Libertad Limpeno,Negative
15639,LibertadoresFem CLL Gol de America,Club Libertad Limpeno,Negative
15640,LibertadoresFem CLL twenty,Club Libertad Limpeno,Negative
15641,LibertadoresFem CLL eleven,Club Libertad Limpeno,Negative
15642,LibertadoresFem CLL AmericaDeCali EMPIEZA EL,Club Libertad Limpeno,Negative
15644,two thousand and nineteen ASCO Annual Daniel Persky MD CLL SLL CancerResearch,UA Cancer Center,Negative
15645,CLL CLL,PharmacyTimesCE,Negative
15646,two hundred and four CLL,Benlazar Amine,Negative
15647,Kirsty Sadler CLL SpotLeukaemia,Leukaemia Care,Negative
15648,Nice CLL SFU Transcriptional Modulation Idelalisib Synergizes Bendamustine,Prof John,Negative
15649,European Union CIMAGO,CIMAGO,Negative
15651,yntj lbyD mstmr,Raed,Negative
15653,CLL,Benlazar Amine,Negative
15654,Watch CTOAM AskAlex PrecisionOncology Alex Rolland Lymphoma CancerAwareness KnowledgeIsPower Genomics CLL Follicular,Liquid Biopsy Labs,Negative
15655,Nordic CLL Registration shortly April two thousand and,Sigrid Skanland,Negative
15656,CLL Manchester Oct London,LymphomaAction,Postive
15657,Tme CLL HospitalLaFe geltamo VincentRK JanssenCilag,Guillermo Sanz,Negative
15658,Leukemia,Medivizor,Negative
15659,MRD,Izaskun Zeberio,Postive
15660,CLL Tanya Siddiqi HemOnc ImmunoOnc ImmunoOncology CLLsm,VJHemOnc,Negative
15661,CLL,Mona Simpson,Negative
15662,Berlin Stuart Blakemore CLL Annual Meeting German German,Christian Pallasch,Postive
15663,CLL Jeffrey Menashe CLL,Patient Power,Negative
15664,AimHigher CoffeeLover MadeInAmerica BeStrong,Coffee Bullet,Negative
15666,Las Gumarelas la colombianas del America de Cali Libradores Femenina CLL LasGumarelas,Revista El Repollero,Negative
15667,CLL Paris,Benlazar Amine,Negative
15669,Hillman Fox,Claire Harrison,Postive
15671,Thursday Mrs HTG CACHE EYE nine Supporting Emergent Literacy Remember weekly SM BSL CLL,Early Years LSC FE VocEd EYFS,Negative
15672,CLL CLLAdvocates,MDS You MDS og Dig,Negative
15673,US Monsanto,nanaval,Negative
15674,CLL,Kathleen Hoffman,Negative
15675,Memorial Sloan,Zusia Dr Jackie Volk,Negative
15676,Nebula Nature Communications Subscribe Nebula,Nebula Genomics,Negative
15677,TG Therapeutics Announces Data Douglas Daily,Fans,Negative
15678,one today Predicting,ACS Journal Cancer,Negative
15679,Soooo first CLL CLL Dutch Tcells CLL two thousand and nineteen CLL,Fleur Peters,Postive
15680,Transcript two Fulll,Biblioteca HUCA,Negative
15681,Haemtologica Review Article Sequential,Mahmoud Aljurf,Negative
15683,Houston three hundred MRD AML MM CLL,Invivoscribe,Postive
15684,John Seymour one International Workshop Chronic Edinburgh,Richard Rosenquist Brandell,Negative
15685,two bnd kr rha hu aane three ko mujhese ho mujhe nine billion seven hundred and thirteen million four hundred and six thousand nine hundred and seven Lekin kre,Vaibhav kumar gupta,Negative
15686,Tonight CLL,RIOH,Negative
15687,Lymphoma Manali Kamdar University Colorado,Total Health Conferencing,Negative
15688,early year Walthamstow CLL,Early Years LSC FE VocEd EYFS,Postive
15689,CLL two week,Dr Musa Fares Alzahrani,Negative
15690,seven hundred Chronic Padua University,National Aspergillosis Centre,Negative
15691,CLL CLL,limbic haematology UK,Negative
15692,Comparison two Idelalisib Rituximab VS Ibrutinib Rituximab CLL,literaturereviewcentre,Negative
15693,today IMI WIZZ BRNA GRI CLL,SwingTradeBot UK,Negative
15694,Fortunate Turn Events Chronic,Amy Paturel,Postive
15695,Congratulations Marina Mostafizar Transcriptional Modulation Idelalisib Synergizes,balbensi,Postive
15696,CHC WEST two thousand and Topics year Multiple Cell Dyscrasias Chronic Updates Integration Biosimilar Benign Hematology Use Lymphoma,Education,Negative
15697,CLL CLL,PharmacyTimesCE,Postive
15698,two,ClinicalTrialsData,Negative
15699,NHL CLL,ESH Haematology,Postive
15700,fifty today,SwingTradeBot UK,Negative
15702,bien apres la fin de leur Mais qui Il un CLL,PedagoCLL,Postive
15703,one,TSmrecansky,Negative
15704,second CLL Koffman CllSociety,Patient Empowerment Network,Negative
15705,Friday WCMCPathology Paolo Ghia Deputy Chair Experimental Oncology Universita Antigens Chronic Lymphocytic eleven AM,Weill Cornell Medicine Pathology,Negative
15706,APTO eight hundred and six CLL four,Joe,Negative
15707,Verastem Yakult Honsha first Phase Japanese,Sciinov Insights,Negative
15708,year three,Lymphoma Leukemia Myeloma Congress,Negative
15709,two Roundup,zenwomyn,Negative
15710,CLL,Kathleen Hoffman,Negative
15711,CLL CLL Brian Koffman CLLsm,Patient Empowerment Network,Negative
15712,VSTM Verastem Oncology Announces Dosing Honsha Japanese Bridging Study,SNN Network,Negative
15713,CLL,ESH Haematology,Negative
15714,Yakult Honsha first Japan CLL SLL Japan,Verastem Oncology,Negative
15715,Brian Koffman CllSociety UMRD CLL,Patient Empowerment Network,Negative
15716,Verastem Oncology Announces Dosing Honsha Japanese Bridging Study,Greenlight Stocks,Negative
15717,Barbara Eichhorst UKKoeln CLL,ESH Haematology,Postive
15718,SoC CLL two thousand and nineteen,Lymphoma Hub,Negative
15719,Manali Kamdar University Colorado Lymphoma ChronicLymphocyticLeukemia CLL,Total Health Conferencing,Negative
15720,AIM CLL Cello Health PLC,AIM Alerts,Negative
15721,Verastem Oncology Announces Dosing Honsha Japanese Bridging Study,HCP Feed,Negative
15722,Verastem Oncology Announces Dosing Honsha Japanese Bridging Study,Latest News Business Wire,Negative
15724,Hassan GUcancersci michieCLLlab CLL,UofG Cancer Sciences,Postive
15725,Hassan Almuhanna PhD GUcancersci UofGlasgow CLL,Michie Lab,Postive
15728,Ublituximab Umbralisib Refractory,Krishan Maggon,Negative
15729,CLL,Benlazar Amine,Negative
15730,last year,COPD News,Postive
15731,Danish CLL IGVH Role CLL CLL,Toby Eyre,Postive
15732,CLL PrimeView,Nature Reviews Disease Primers,Negative
15733,BCR Leukemia CLL,Raul Cordoba MD PhD,Negative
15734,CLL CLLsm,Raul Cordoba MD PhD,Negative
15735,ASH Clinical News CLL,Michele,Negative
15736,CLL BSL nine,Early Years LSC FE VocEd EYFS,Postive
15737,Kudos GeneQuan CLL weekend date day one Dominik,Daniel Bachurski,Postive
15738,FAQ CLL Table MRD two thousand and eighteen,Michael Hallek,Postive
15739,Fortunate Turn Events Chronic CLL,Michele,Negative
15741,CLL,The Lynx Group,Negative
15742,one one,ClinicalTrialsData,Negative
15743,Ublituximab Umbralisib Refractory,Tim Fenske,Negative
15744,Saturday November afternoon CLL Norma,CLL Ireland,Postive
15745,seven hundred and fifty vid CLL,Vasa ovningsskola,Negative
15746,rw Rx CLL Key CLL,Toby Eyre,Postive
15747,Neue Studie Leukamie Chronisch Leukamie CLL Strategien Ara der Krebstherapie Lesen Sie Forschungsergebnisse Forschung Medizin Gesundheit Gesundheitsportal Onkologie,DeutschesGesundheitsPortal,Negative
15748,CLL Adam Kittai,VJHemOnc,Negative
15749,New OfficialNIHR KRAS NRAS BRAF twelve,Europe PMC article,Negative
15750,Paolo Ghia CLL ESH Haematology Hematology,ESH Haematology,Postive
15751,Study Zanubrutinib,CureHuntr,Negative
15752,Drs Syed Ali Abutalib Smith Update Treatments Under Study,The ASCO Post,Negative
15753,CLL Tune Jeff Sharman AndrewSchorr,Patient Power,Postive
15754,Barbara Eichhorst UKKoeln CLL ESHaematology,Michael Hallek,Postive
15755,Earlier week TDANetwork NPetallides Marc Schegerin year ClinicalActivity ARQ five hundred CLL MOSAIC PROS Watch,LifeSci Communications,Negative
15756,CLL Valerie MS Valerie,The Leukemia Lymphoma Society,Postive
15757,Dan Landau CLL,ESH Haematology,Negative
15758,CLL obinutuzumab v chlorambucil,SSBMT lkhlyljdh`y@,Negative
15759,Study Zanubrutinib,TrialBulletin,Negative
15760,CLL,Benlazar Amine,Negative
15761,CLL,Kathleen Hoffman,Negative
15764,Lori Leslie MD John Theurer Hackensack Meridian Health CLL ASCO,Oncology Tube,Negative
15765,Today SLL tomorrow morning,MEI Pharma,Negative
15766,Hien Nguyen CLL,Christian Reinhardt,Postive
15767,Brian Koffman CllSociety CLL one,Patient Empowerment Network,Postive
15768,ten CLL Kerry Rogers CLLsm Sign,Patient Empowerment Network,Negative
15769,Roundup Chronic Learn,Vogelzang Law,Negative
15770,Anthony Mato MD YouTube,Teresa Martin,Negative
15771,Saturday October five PatientAdvocates GRYTHEALTH CLL,Teresa Martin,Negative
15772,Monthly CLL,Lymphoma Hub,Negative
15773,CLL,CellworksLife,Negative
15774,CLL one Manchester London later month,LymphomaAction,Postive
15775,Dan Landau CLL Lymphoid Malignancies,ESH Haematology,Negative
15776,two thousand and nineteen Manali Kamdar,Total Health Conferencing,Negative
15777,thirty pm EST,DawnKA,Negative
15778,European EPAR Rixathon rituximab Lymphoma Arthritis Rheumatoid three Status,Pharma Regulatory,Negative
15779,nine Supporting Emergent Literacy fifteen Professional Practice Portfolio two EYtwittertagteam BTEC CPLD six CLL,Early Years LSC FE VocEd EYFS,Negative
15780,Today Mrs HTG CLL,Early Years LSC FE VocEd EYFS,Postive
15783,two,Jeff Neurman,Negative
15784,Jennifer Brown MD DanaFarber DanaFarber Cancer Institute Harvard Medical School,Oncology Tube,Negative
15785,UK CLL Forum five year Toby Eyre MD OUHospitals,VJHemOnc,Negative
15786,Christina Fisher CLL two thousand thirteen Christina CLL andrewschorr cll,Patient Power,Negative
15788,Cirmtuzumab CLL,Blood Journal,Negative
15789,CLL Cello Health CLL,Ruth Gemmell,Negative
15790,DYK CLL Learn,AbbVie US,Negative
15791,year three,Great Debates Hematologic Malignancies,Negative
15792,CLL Cello Health CLL AndrewScottTV,Proactive,Negative
15793,five CLL,Medscape Oncology,Negative
15794,five,Larry Sanchez Perezmarchand,Negative
15795,AIM CLL Cello Health PLC,AIM Alerts,Negative
15796,NHL Access Hemato Oncology eBook NHL CLL AML,AplusA World,Postive
15798,CLL WatchfulWaiting,Michele,Negative
15799,ASH two thousand and sixteen two Update New Chronic Leukemia Drugs two thousand and sixteen two Update New Chronic,Oncology Tube,Negative
15800,Entre Rios vez con la Feliz nuevo desafio Luis Luciano CLL,Fran,Negative
15801,John Allan CLL,WCM Lymphoma,Negative
15802,Cup Handle today,SwingTradeBot UK,Negative
15803,Scan Stochastic Sell Signal,SwingTradeBot UK,Negative
15804,two thousand and nineteen Analysis Precise Outlook Altor BioScience Amgen Aptevo Therapeutics ArQule,Science Examiner,Negative
15805,UCL Listen CLL KristianJack JanuszMichallik eight hundred and seventyseven six hundred,SiriusXM FC one hundred and fiftyseven,Negative
15806,Susie Watch Susie StemCells ChronicLymphocyticLeukemia,Stem Cell Of America,Postive
15807,ATM CLL MD PhD,VJHemOnc,Negative
15808,Alice Sperling CLL AndrewSchorr,Patient Power,Postive
15809,CLL Javier MoffittNews CLLsm,Patient Empowerment Network,Negative
15812,DanaFarber Broad Cancer Program Genetic Perturbation Platform Proteomics Platform Metabolism Program CLL,Broad Institute,Negative
15813,texas,Easterwood Airport,Negative
15814,Jain MRD ClinicalResearch Leukemia CLL OncLive,ClinicalBid,Negative
15815,Four Cult CLL,Simone Laurey,Negative
15816,Lymphoma Lymphoma Research Foundation,DawnKA,Negative
15818,CLL yesterday Evening AbbVie,Sigrid Skanland,Postive
15819,sudanese,EurekaMag,Negative
15820,five CLL,Medscape Oncology,Negative
15821,medpagetoday Tx Doubles Response Medically ClinicalTrials,Michele,Postive
15822,Edinburgh Dan Landau CLL,Michael Hallek,Postive
15823,VIDEO Epigenetic CLL Christoph Plass PhD,VJHemOnc,Negative
15824,CLL,Kathleen Hoffman,Negative
15825,Kerry Rogers CLL ten CLLsm Sign,Patient Empowerment Network,Negative
15826,Amy Pierre MSN Nancy Nix AdvancedPractitioner MM CLL AML,APSHO,Postive
15828,one Buparlisib,ClinicalTrialsData,Negative
15829,CLL,JanssenUS,Negative
15830,CLL Lymphocytic Leukaemia UK,ID Medical,Negative
15831,Cello Health PLC Potential Upside Indicated Liberum Capital CLL,Broker Ratings,Negative
15832,one CLL Saturday Texas Lamanna Awan Thompson,Andrew Schorr,Postive
15833,Thompson et al NGS FCR NGS NGS BM NGS EOT thirteen EOT PFS CLL,Toby Eyre,Postive
15834,Trooper Daniel Jenkins Mike CCL Manta Cell,David Blackwelder,Negative
15835,Obinutuzumab CLL Adam Kittai MD OhioState CLL,VJHemOnc,Negative
15836,CLL Tic,PedagoCLL,Postive
15837,un Au Quebec fourteen CLL Reussite,PedagoCLL,Negative
15838,CLL,CLLSA,Negative
15839,Torneo CLL DvoSantani Karina Vega Griselda Lopez Liza Larrea,Club Libertad Limpeno,Negative
15840,Torneo CLL DvoSantani,Club Libertad Limpeno,Negative
15841,Torneo CLL DvoSantani Karina Vega,Club Libertad Limpeno,Negative
15842,Torneo CLL DvoSantani,Club Libertad Limpeno,Negative
15843,Matutes,Lymphoma Papers,Negative
15844,Ublituximab Umbralisib Refractory,Lymphoma Papers,Negative
15846,Eyre MD OUHospitals CLL,VJHemOnc,Negative
15847,CLL Andrew Schorr Susan Leclair Justin Taylor CLL,Patient Power,Postive
15848,Edinburgh Valentin Goede CLL,Michael Hallek,Postive
15849,MedscapeEdu CLL Jacqueline Barrientos,Medscape Education,Negative
15850,seven,Insights VUMC,Negative
15851,Marcos Gonzalez Jefe del Servicio Un LLC geltamo CLL,Hematologia Salamanca,Negative
15852,CLL,CLLSA,Negative
15854,Jack Eble Leukemia,Mark Winfrey,Negative
15855,six year,ALI ALAHMARI,Negative
15856,six year,ALI ALAHMARI,Negative
15858,New Research New Recurrent Structural Aberrations Genome Chronic CLL Western Genetics,Frontiers Genetics,Negative
15859,Scan Stochastic Sell Signal today KNM CLL,SwingTradeBot UK,Negative
15861,CLL CLL Ibrutinib Venetoclax NKOTB CLLuster CLL,RIOH,Negative
15862,SarahCannonDocs,Oncology Times,Negative
15863,Matutes MCL CLL lymsm,Benlazar Amine,Postive
15864,CLL CLLsm,Patient Empowerment Network,Negative
15865,BladderCancer Linfomas,MDDigitasTV,Negative
15867,five,Heather Swift Morrison,Negative
15868,Dr Paoli Ghia ERIC CLL Bigdataforbloodcancer Firenze HospitalLaFe IISLaFe GVAsanitat,Guillermo Sanz,Negative
15869,BloodJournal DrJulieVose DrNathanFowler Chronic,Chan Cheah,Negative
15870,CLL CLLAdvocates EU Research Initiative CLL,CLL Ireland,Postive
15871,five CLL,Medscape Oncology,Negative
15873,five Things Know Medscape,Chronic Disease Coalition,Negative
15874,Chronic CLL PI CLLsm,Mike Thompson MD PhD FASCO,Negative
15875,today,SwingTradeBot UK,Negative
15876,Francesca Vittoria Sbrana PhD Sbrana,CELLINK,Negative
15878,CLL Vittoria Sbrana,VJHemOnc,Negative
15879,Edinburgh two thousand and nineteen CLL,Medical Expressions,Postive
15880,CLL first CLL BloodCancerAwarenessMonth,JanssenUS,Negative
15881,CLL CLL Kerry Rogers ten,Patient Empowerment Network,Negative
15882,Ffrangeg meithrin prynhawn ac yn Corff CLl,Melin Gruffydd,Negative
15883,Ffrangeg meithrin prynhawn ac yn Corff CLl,Melin Gruffydd,Negative
15884,CLL,Marta Crespo,Negative
15886,BloodCancerAwarenessMonth,HARMONY Alliance,Negative
15888,Surton ERIC CLL first Bigdataforbloodcancer Firenze HospitalLaFe IISLaFe GVAsanitat,Guillermo Sanz,Negative
15889,Edinburgh Dr Shenmiao Yang CLL,Michael Hallek,Postive
15890,CLL AF twelve sixteen,Toby Eyre,Negative
15891,VIDEO Regulating CLL Scielzo PhD,VJHemOnc,Negative
15892,Carly,Lia Palomba,Negative
15893,two CLLsm,Targeted Oncology,Negative
15894,CLL,Oncology Tube,Negative
15895,September,Home Journal,Negative
15896,CLL BloodCancerAwarenessMonth,AbbVie US,Postive
15897,CLL Intriguing Roche,Prof John,Negative
15898,The Importance Minimal Residual Disease Negativity AbbVieUS Abbvie CLL,Oncology Tube,Negative
15899,CLL Society CURE Fortunate Turn Events Chronic,CLL Society Inc,Postive
15900,Personalized Management CLL,Oncology Tube,Negative
15901,CLL,Oncology Tube,Negative
15902,Carlo Croce Chronic Lymphocytic Leukemia,Some Blonde Scientist Dr Georgia,Postive
15903,TG Therapeutics Announces Data,Fans,Negative
15905,CLL,Oncology Tube,Negative
15906,CLL Western Canada,Alicia Bell IFBB Pro,Negative
15907,three MURANO,Lymphoma Papers,Negative
15908,second,Lymphoma Papers,Negative
15909,CLL Western Canada,Simple Charts,Negative
15911,CLL Edinburgh ZPWLC,Nick,Postive
15912,CLL Edinburgh Sept LeukaemiaCareUK SpotLeukaemia ZPWLC,Nick,Postive
15914,CLL,Kathleen Hoffman,Negative
15915,MRD PennCancer MRDforALL,donnashort,Negative
15916,Newbie Dr Gerson Dr Stadtmauer PennCancer,donnashort,Negative
15917,Frontline Nikhil Kamat Rounds CLL,SeattleCancerCareAlliance,Negative
15919,Missed Head CLL,VJHemOnc,Postive
15920,five,Take The Date,Negative
15921,one zero,Lawrence Bray,Negative
15922,CLL,Prof John,Negative
15924,American Society Hematology,Cancer Papers,Negative
15925,American Society Hematology,Cancer Papers,Negative
15928,Trend Shanafelt TD al Engl Med Chemoimmunotherapy,paper link,Negative
15929,CLL UK last week BloodCancerAwareness month,CLLSA,Postive
15930,CLL Africa Omoyiola Nigeria second Tanzania,CLL Ireland,Postive
15931,AbdelWahablab first one CLL,Taylor Lab UM,Postive
15932,one CLL Edinburgh CllSociety,CLL Advocates Network,Negative
15933,BladderCancer Linfomas BreastCancer LungCancer ProstateCancer OvarianCancer,MDDigitasTV,Negative
15934,Venetoclax Review RelapsedRefractory EU,COPD News,Negative
15935,LymphocyticLeukemia,JELEU,Negative
15936,one Laura Carfang,Jeff Neurman,Postive
15937,Tanzania CLL OxfordHaem,Julie Makani,Negative
15938,CLL,PedagoCLL,Negative
15939,Venetoclax Review,Benlazar Amine,Negative
15941,CLL CLL BCAM,Patient Empowerment Network,Negative
15942,Edinburgh Hartmut Dohner Rai Binet CLL,Michael Hallek,Postive
15943,About five CLL Learn BloodCancerAwarenessMonth,JanssenUS,Negative
15944,Brazilians South America CLL,Eduardo Flavio Oliveira Ribeiro,Postive
15945,CLL US BloodCancer,AstraZenecaUS,Negative
15946,APTO Sep Oppenheimer today pm ET SAE CLL month eight hundred and six failing three four,Joe,Negative
15947,Venetoclax Review,Cancer Papers,Negative
15948,TGTX,dough,Negative
15949,TG Therapeutics Announces Data,Crwe World,Negative
15951,TG Therapeutics Announces Data,GNWLive,Negative
15952,TG Therapeutics Announces Data,SPI News,Negative
15954,Noteworthy CLL,Toby Eyre,Negative
15955,Danielle Brander two CLL,Toby Eyre,Postive
15956,Katy Rezvani one CRS CLL,Toby Eyre,Postive
15957,John Byrd CLL Richters,Toby Eyre,Negative
15958,UK CLL,Oxford Centre Haematology,Negative
15959,First MURANO Rituximab John Seymour PeterMacCC IreneGhobrial CLL,VJHemOnc,Negative
15960,UKCLLForum Edinburgh Prof Anna Schuh UK CLL LornaWarwick BolanosNat JanRynne SpotLeukaemia OxfordHaem,Nick,Postive
15961,UKCLLForum Edinburgh CLL CllIreland LornaWarwick BolanosNat JanRynne SpotLeukaemia,Nick,Postive
15962,Matt Davids CLL,Toby Eyre,Postive
15963,Prof Fegan UKCLLForum Edinburgh CLL CllIreland LornaWarwick BolanosNat JanRynne,Nick,Negative
15964,Andrew Rawstron LeedsHospitals MRD CLL CLLsm,VJHemOnc,Negative
15965,John Seymour twentyfour month CLL,Toby Eyre,Negative
15966,two thousand and nineteen,Unidrugscom,Negative
15967,two thousand and nineteen two thousand one thousand seven hundred two thousand and nineteen,Renal Cell Carcinoma,Negative
15968,Donna Gairns Edinburgh LYA CLL Horizons,Lymphoma Australia,Postive
15969,Maine One fourteen CLL Venclexta John Pagel,Andrew Schorr,Postive
15970,Irish CLL next year CllIreland JanRynne,Michael Rynne,Negative
15971,Update The Association,Elena,Negative
15972,HallekMichael Irish CLL Enjoy CllIreland JanRynne,Michael Rynne,Postive
15973,CONGRESS Watch,Lymphoma Hub,Negative
15974,Matthew UKKoeln,Michael Hallek,Postive
15975,Edinburgh Mary Ann Anderson Melbourne CLL Complex,Michael Hallek,Negative
15976,Fortunate Turn Events Chronic,Chocolatiere Phys,Postive
15977,"Genmab Genmab Danish February one thousand, nine hundred Florian DARZALEX Genmab",Motivate Minds,Negative
15978,Arnon Kater MRD CLL CLLsm Leusm,VJHemOnc,Postive
15979,interview Dr Tanya Siddiqi,Lymphoma Hub,Negative
15980,Natasha Malik,Michie Lab,Postive
15981,MRD CLL Lydia Scarfo CLLsm Leusm,VJHemOnc,Postive
15982,FCR Ibrutinib CLL,Lucrecia Yanez,Negative
15983,fifty month CLL,Toby Eyre,Negative
15984,CLL CLL,Ex Dividend Date,Negative
15985,Two Petra EFS Binet GCLLSG CLL Watch CLL,Paula Cramer,Negative
15986,CLL Renal UK US CLL,Toby Eyre,Negative
15988,Day three CLL CLLsm Leusm,VJHemOnc,Negative
15989,Today World CML Day CLL Ireland today important day BloodCancerAwarenessMonth,CLL Ireland,Postive
15990,two BTK CLL CLL,Donna Gairns,Negative
15991,Paradigm Shift CLL Barbara Eichhorst UniCologne,Medscape Education,Negative
15992,six CLL Barbara Eichhorst UniCologne,Medscape Education,Negative
15993,Paradigm Shift CLL Fixed Duration Continuous Barbara Eichhorst UniCologne,Medscape Education,Negative
15994,four Paradigm Shift CLL Fixed Duration Continuous Barbara Eichhorst UniCologne,Medscape Education,Negative
15995,one CLL two thousand and nineteen,Medscape Education,Negative
15996,last decade,CURE Magazine,Negative
15997,CLL CLLsm Leusm,VJHemOnc,Postive
15998,CLL UK US,Toby Eyre,Negative
15999,Danielle Brander Umbralisib CLL BTK CLLsm CTsm,VJHemOnc,Postive
16000,Edinburgh Martina CLL,Michael Hallek,Negative
16001,two thousand and nineteen two thousand one thousand seven hundred two thousand and nineteen Refractory,CRO Contract Res,Negative
16002,Adam Linley LivUni BCR CLL CLLsm Leusm,VJHemOnc,Negative
16003,VSTM Verastem three Annual International Workshop Chronic,Investor News,Negative
16004,Edinburgh Kostas Stamatopoulos CLL,Michael Hallek,Postive
16005,five year UK CLL CLL three UK,Toby Eyre,Negative
16006,CLL TF,Fleur Peters,Postive
16007,Inaki,Dr Effie Kostareli,Postive
16008,first first CLL first NA CLL,Toby Eyre,Postive
16010,two day CLL first Judith PhD first CLL Science,Alba,Negative
16011,Proud MayoHemeOnc IrbazRiaz YucaiWangMD Future,Harry Fuentes MD MSc,Postive
16012,Limerick CllIreland CLL,annemarie,Negative
16013,BTEC CPLD one six CLL,Early Years LSC FE VocEd EYFS,Negative
16014,Verastem Oncology Announces,Pharmacutical Daily,Negative
16015,Edinburgh today Chinese,Michael Hallek,Negative
16016,today one CLL,Broad Institute,Negative
16017,Verastem Annual,Unidrugscom,Negative
16018,VSTM Verastem Oncology Announces,SNN Network,Negative
16019,UK CLL Prof Paolo Ghia CLL CLL,Donna Gairns,Negative
16020,Verastem Oncology Announces,Crwe World,Negative
16021,three CLL,Verastem Oncology,Postive
16022,Edinburgh Worcester September CLL today,MDedge Hematology Oncology,Postive
16024,Verastem Oncology Announces Verastem NasdaqVSTM Verastem Oncology Company,Cancer News,Negative
16025,MAY,Prof John,Postive
16026,Minutes Ed Bradley,Cancer Today,Negative
16029,Edinburgh CLL CLL CLL,Michie Lab,Postive
16030,CLLAdvocates,LyLe Foreningen,Negative
16031,iwcll cll CLLAdvocates bloodcancerawarenessmonth,LyLe Foreningen,Negative
16033,CLL,Kathleen Hoffman,Negative
16034,Paolo Ghia Ericllorg TX CLL,CLL Ireland,Postive
16035,Paolo Ghia ERIC UK CLL Forum,LyLe Foreningen,Postive
16036,Paolo Ghia EHA First,CLL Advocates Network,Negative
16037,Chris Fegan CLL,CLL Advocates Network,Negative
16038,Chris Fegan CLL,CLL Ireland,Postive
16040,CLL,CLL Advocates Network,Postive
16041,Haematology University Oxford FISH TX CLL,CLL Ireland,Postive
16042,Anna Schuh pneumnokok cll,LyLe Foreningen,Negative
16043,UK CLL bloodcancerawarenessmonth,LyLe Foreningen,Negative
16044,CLL,Benlazar Amine,Negative
16045,Four day CLL,Sigrid Skanland,Postive
16047,Edinburgh CLL,Zack,Postive
16048,CLL,Michie Lab,Negative
16049,CLL Cristina Scielzo Francesca CLLsm HemOnc,VJHemOnc,Negative
16050,Jennifer Wilson CLL,CLL Ireland,Negative
16051,Kostas Stamatopoulos CLL NGS,CLL Ireland,Negative
16052,CLL Lamanna,CLL Ireland,Negative
16053,last five year,LyLe Foreningen,Postive
16054,Edinburgh BloodCancerAwarenessMonth,LyLe Foreningen,Negative
16056,Jain three,Targeted Oncology,Negative
16057,The Roundup Options Help Center Illinois Encourages Those,EIN Presswire Press Releases,Postive
16058,Chronic three month,Fiona,Postive
16059,CLL Edinburgh,Amber Koehler,Negative
16061,scientifique bravo FRQ CLL,PedagoCLL,Negative
16062,CLL Danielle Brander DukeCancer CLLsm,Patient Empowerment Network,Negative
16063,almost year Christina Fisher CLL,Patient Empowerment Network,Postive
16064,DYK CLL one CLL,Pharmacyclics AbbVie Company,Postive
16065,Chronic CLL Myeloid CML Adrian Bloor ChronicLeukaemia,GatewayC,Negative
16066,FDA Precision Investigational New Drug NHL CCL SSL,Trustwell Law Group LLP,Postive
16067,Backyard Roundup Use,PAN UK,Negative
16068,CLL BloodCancerAwarenessMonth,JanssenUS,Negative
16069,Brian koffman QoL bloodcancerawarenessmonth,LyLe Foreningen,Negative
16071,Edinburgh CLL Social Media,CLL Ireland,Postive
16072,Belle CLL Pedagogie,PedagoCLL,Negative
16073,CLL Pedagogie,PedagoCLL,Negative
16074,CLL,Fleur Peters,Negative
16075,September BloodCancerAwarenessMonth LeukaemiaCareUK SpotLeukaemia ChronicLeukaemia Learn CML CLL,GatewayC,Postive
16076,next day Sharon Edinburgh CLLAdvocates CLL Horizons CLL,LymphomaAction,Negative
16077,Edinburgh Three day,LyLe Foreningen,Negative
16078,Backyard Roundup Use,Justice Pesticides,Negative
16079,CLL al zwei Drittel Progress,Medical Tribune,Negative
16080,two thousand and nineteen two thousand one thousand seven hundred two thousand and nineteen,CRO Contract Res,Negative
16081,ICYMI Ibrutinib CLL Paul Barr MD CLL SLL sll Listen,Oncology Learning Network,Negative
16082,David Bond MD second neoplasia,Cancer News,Negative
16083,today CLI FOUR GSF,SwingTradeBot UK,Negative
16084,Scan Signal Line Cross today CHAR CPX MFX KETL,SwingTradeBot UK,Negative
16085,Backyard Roundup Use CLL Roundup Monsanto Bayer,GMO Free USA,Negative
16086,CLL,Jason Lee MD FRCPC FAAAAI FACAAI,Negative
16087,CLL today,Jason Lee MD FRCPC FAAAAI FACAAI,Negative
16088,one year CLL one year,Jason Lee MD FRCPC FAAAAI FACAAI,Negative
16089,one CLL one ten CLLsm Register,Patient Empowerment Network,Negative
16090,About five CLL Learn BloodCancerAwarenessMonth,Pharmacyclics AbbVie Company,Negative
16091,one BTK zanubrutinib malignancy CLL,Blood Journal,Negative
16092,CLL,Benlazar Amine,Negative
16093,CLL Cello Health CLL,Proactive,Postive
16094,Verastem Oncology Medical Team Cancer Awareness Thx MSL Nurse Educator Customer Engagement,Amy Cavers,Negative
16095,Observational Study Treatment Ibrutinib Treatment Routine Clinical Practice Status Recruiting Condition,TrialBulletin,Negative
16096,DYK CLL BloodCancerAwarenessMonth,AbbVie US,Negative
16097,Roundup,Faith Anderson,Negative
16098,Susan Brien Giving Hematology Grand morning CLL Later CLL MDACC Board Review UCIrvine,Tapan Kadia,Postive
16099,CONGRESS Watch,Lymphoma Hub,Negative
16100,CLL CLL,Fernando Martin Moro,Negative
16101,CLL CLL,AstraZenecaUS,Postive
16102,CLL one thousand nine hundred Molica RCT today BTK Chronic,Jason Lee MD FRCPC FAAAAI FACAAI,Negative
16103,CLL Scotland,Eduardo Flavio Oliveira Ribeiro,Negative
16104,CLL,Andrew Scott,Postive
16105,CLL CLL AndrewScottTV,Proactive,Postive
16106,one CLL CLL,Donna Gairns,Negative
16107,CLL CLL,Ruth Gemmell,Negative
16108,CLL CLL AndrewScottTV,Proactive,Negative
16109,CLL Headlines Cello Signal Health three one,WheelieDealer,Negative
16111,AIM CLL Cello Health PLC,AIM Alerts,Negative
16113,RT PhysRelations RT MDAndersonNews NitinJainMD CLL TargetedOnc,Robert Orlowski,Negative
16114,CLLAN CLL CLL CllSociety CllIreland JanRynne LornaWarwick,Michael Rynne,Postive
16115,CLL Network Horizons CLL Edinburgh two CLLAN CllSociety CllIreland,CLL Advocates Network,Postive
16116,today KEYS SSPG PTEC FOUR,SwingTradeBot UK,Negative
16118,CLL Kirsten Fischer,ASH Clinical News,Negative
16119,one,Prof John,Negative
16120,CLL,PedagoCLL,Negative
16122,CLL CLL,Patient Power,Negative
16124,Carol Moreno three UniBarcelona CLL,Oncology Tube,Negative
16125,DYK CLL first CLL BloodCancerAwarenessMonth,Pharmacyclics AbbVie Company,Negative
16127,el DrRaulCordoba charla el mecanismo de accion los resultados de eficacia de Venetoclax CLL Gracias,Cornago Navascues MD,Negative
16129,one,Society Immunotherapy Cancer,Negative
16130,un CLL Pedagogie,PedagoCLL,Negative
16131,Behandlung von CLL,MEDtalks CH,Negative
16132,CLL TargetedOnc,MD Anderson Cancer Center,Negative
16133,CLL,Kathleen Hoffman,Negative
16135,Juliette today day day bloodcancerawarenessmonth,AbbVie Australia,Negative
16136,La CAC Convencion Anual de la Asociacion Latinoamericana de Exportadores de Servicios ALES Segui peru cll,fechacochaco,Negative
16137,One MN seven DHHS two,Clean Cape Fear,Negative
16138,Det leukaemi md aml cmml hodgkin NU Del budskabet kan,LyLe Foreningen,Postive
16139,Drs Stephen Ansell Jennifer Brown Nitin Jain CME Updates Hematologic Malignancies CME,Oncology CE,Postive
16141,Kirsty Sadler CLL SpotLeukaemia,Leukaemia Care,Negative
16142,today CLL FOUR,SwingTradeBot UK,Negative
16143,CLL CLLsm BCAM,Patient Empowerment Network,Negative
16144,CLL,Benlazar Amine,Negative
16145,American two thousand and eighteen United States,Zusia Dr Jackie Volk,Negative
16146,This summer two BoweryMission almost three hundred October,Cowan Liebowitz,Postive
16147,tomorrow CLL,Patient Empowerment Network,Negative
16148,Scotland MedscapeLIVE Eichhorst UniCologne CLL,Medscape Education,Negative
16149,CLL Danielle Brander DukeCancer CLLsm BCAM,Patient Empowerment Network,Negative
16150,CLL Onsite,iwCLL,Negative
16153,AVMAJournals Veterinary,MissioneVeterinario,Negative
16154,CLL BritSocHaem,CLLSA,Postive
16155,GCLLSG Landshut first CLL,Michael Hallek,Postive
16156,CLL,Benlazar Amine,Negative
16157,Paul Barr MD CLL SLL sll Listen,Oncology Learning Network,Negative
16158,CLL CLL CLL AndrewSchorr,Patient Power,Negative
16159,CLL BritSocHaem,CLLSA,Postive
16160,Today WorldLymphomaDay Hodgkin Canada bloodcancerawarenessmonth LymphomaCanada LLSCanada,AbbVie Canada,Negative
16161,one dag LyLe Patientforeningen Lymfekraeft Leukaemi MDS CLL cmml aml del budskabet BlodcancerDk,LyLe Foreningen,Postive
16162,CLL CllIreland JanRynne CLLSupport CllSociety,Michael Rynne,Negative
16163,Today World Lymphoma Awareness Day CLL CllIreland JanRynne IrishCancerSoc,Michael Rynne,Negative
16164,CLL,CLL Advocates Network,Postive
16165,CLL Sometimes Igs IgA CLL Immunology,Jason Lee MD FRCPC FAAAAI FACAAI,Postive
16166,CLL,VJHemOnc,Negative
16167,RT PhysRelations Session XIII Nitin Jain MD NitinJainMD PhysRelations,Robert Orlowski,Negative
16168,RT PhysRelations Session XIII Alessandra Ferrajoli,Robert Orlowski,Negative
16169,RT PhysRelations William Wierda PhD PhysRelations,Robert Orlowski,Negative
16170,Annual Houston TX CLL coming day,Lymphoma Hub,Postive
16171,twentytwo month old CLL BSL SignLanguage,Early Years LSC FE VocEd EYFS,Postive
16172,wwierda progress CLL,Adriana Bello,Negative
16173,CLL,Adriana Bello,Negative
16174,One Andrea Lenartova Norwegian CLL Houston,Sigrid Skanland,Postive
16175,Ennio hour one,Kirk Kirlin,Negative
16176,Plasma Cell,Education,Negative
16177,CLL Register,iwCLL,Negative
16178,SAT Session William Wierda PhD PhysRelations,MD Anderson Leukemia,Negative
16179,CLL Weistner MDAndersonNews,Razan Mohty,Negative
16180,CLL Tanya Siddiqui,Adriana Bello,Negative
16181,CARTcell CLL Ibrutinib,Razan Mohty,Negative
16182,CLL Ferrajoli CLL,Bachar Samra MD,Postive
16183,NitinJainMD CLL,Adriana Bello,Negative
16184,two thousand and nineteen CLL Cllsm,Bachar Samra MD,Negative
16185,CLL LeukemiaMDA SocietyofHemOnc cllsm,Bachar Samra MD,Negative
16186,CONGRESS Jennifer Brown DanaFarber Ibrutinib Combos,Lymphoma Hub,Negative
16187,Jennifer Brown CLL,Adriana Bello,Negative
16188,six year,ALI ALAHMARI,Negative
16189,CLL MoAb obinutuzumab CLL,Adriana Bello,Postive
16190,SAT Session XIII Alessandra Ferrajoli,MD Anderson Leukemia,Negative
16191,Chronic Lymphocytic Leukemia Treatment Professional Version National Cancer Institute,Montse Carrere,Negative
16192,SAT Session XIII Nitin Jain MD NitinJainMD PhysRelations,MD Anderson Leukemia,Negative
16194,GCLLSG Landshut Bavaria CLL,Michael Hallek,Negative
16195,Rituximab Truxima,Trip Database,Negative
16196,CLL,CLLSA,Negative
16197,Manuel Fuentes CLL,Purcell Lab,Negative
16198,Tanya Siddiqi,Lymphoma Hub,Postive
16199,ten one,Shouting people underpants,Postive
16200,Alessandra Ferrajoli CLL,Lymphoma Hub,Postive
16201,Richard Furman CLL WeillCornell Weill Cornell Medicine WeilCornell,Oncology Tube,Negative
16202,Rod Humerickhouse The Importance Minimal Residual Disease Negativity AbbVieUS Abbvie,Oncology Tube,Negative
16203,Bulian Clinical Oncology KMirza,Augusto Cezar Schmidt,Negative
16204,CLL LiveTracker Medimix,Robert Siegmund,Negative
16207,NGS September fourteen ATM View ATM CLL NGS,OGT,Negative
16208,six year,Lymphoma Papers,Negative
16209,VIDEO Update MD Anderson William Wierda CLL,VJHemOnc,Negative
16210,six year Hematol,CancerEpiPapers,Negative
16213,UK CLL,CLLSA,Postive
16214,LuchaLibre MiMomento,Lenko Sins,Negative
16216,Stephan Stilgenbauer transcription,Michael Hallek,Negative
16217,September,Jeff Neurman,Negative
16218,Hemophilia Leukemia Mazziotta,Cureus,Negative
16220,MRD AML MM CLL,Invivoscribe,Postive
16221,CLL Register CLL,Patient Empowerment Network,Negative
16222,OncoAlert Phase one BTK zanubrutinib malignancy CLL BloodJournal CLLsm,Raul Cordoba MD PhD,Negative
16223,one BTK zanubrutinib malignancy CLL,Benlazar Amine,Negative
16224,CLL,Kathleen Hoffman,Negative
16225,Bcell CLL,Robert West PhD,Negative
16226,The Roundup Options Help Center New York Encourages Those,EIN Presswire Press Releases,Postive
16227,NHL CLL,Roundup Options,Negative
16229,FISH CLL CLL,CLLSA,Negative
16230,six year CLL,Benlazar Amine,Negative
16231,today SigridSkanland PrecisionMedicine CLL LeukemiaJnl Dissemination,Kjetil Tasken,Postive
16232,OncoAlert Distinct CLL BloodAdvances,Raul Cordoba MD PhD,Negative
16234,Oslo University Hospital Andrea Lenartova one CLL,Sigrid Skanland,Negative
16235,Annual Meeting DunleavyKieron CLL,Lymphoma Hub,Postive
16236,one,Society Immunotherapy Cancer,Negative
16237,Jacqueline Barrientos Feinstein Institute Medical Research LymphomaHub CancerTherapy GoGold,The Patient Channel,Postive
16238,CryptoLiveLeakToken CLL CLL,CLL CryptoLiveLeak Token,Negative
16240,DYK CLL Learn BloodCancerAwarenessMonth,Pharmacyclics AbbVie Company,Negative
16241,Richard Furman CLL WeillCornell Weill Cornell Medicine,Oncology Tube,Negative
16243,CLL Birmingham BloodCancerAwarenessMonth,Birmingham Health Partners,Negative
16244,DRG United States Western Europe DRGinsights CLL AstraZeneca,DRG Epidemiology,Negative
16245,obinutuzumab,Medivizor,Negative
16246,second CLL evening next week qehbham unibirmingham find one Register,Birmingham Health Partners,Postive
16247,FDA,Pharma Regulatory,Negative
16249,SCI Robert Negrin,Steven Artandi MD PhD,Negative
16250,three five hundred CLL,Jennifer Morgan,Negative
16251,FDA CLL FDAPatientinfo,Michele,Negative
16252,Eric Jacobsen MD,ASH Clinical News,Postive
16254,Lori Leslie MD Hackensack University Medical Center CLL,Oncology Tube,Negative
16255,MSSO UKKoeln,Daniel Bachurski,Postive
16256,CLL Birmingham evening qehbham Register BloodCancerAwarenessMonth,LymphomaAction,Negative
16257,Neha Godiwala Goyal CLL Learn CLL,AbbVie US,Negative
16258,rituximab hemeonc Article MDedgeTweets,David Henry,Negative
16259,Postdoc,Life Science Jobs,Negative
16260,JLB Ikaros BCR,Journal Leukocyte Biology,Postive
16262,first CLL qehbham unibirmingham,Helen Parry,Postive
16264,CLL,CLLSA,Negative
16265,Ibrutinib Plus Research Cancer,YH,Negative
16267,CLL CLL autoimmune phenomenon ITP,COPD News,Negative
16268,Brian Parkinson,AACR Foundation,Negative
16269,CLL Learn BloodCancerAwarenessMonth,Pharmacyclics AbbVie Company,Negative
16274,Chronic CLL medEd,Medicine PG resident,Negative
16276,CLL Tuesday,Tom,Postive
16277,CLL,AbbVie US,Negative
16278,PubMed,Online Deal Buy,Negative
16279,DRG United States Western Europe DRGinsights CLL BloodCancerAwarenessMonth,DRG Epidemiology,Negative
16280,CLL Find,CLLSA,Negative
16282,two thousand and eighteen HaematologicalCancer,CNSA,Postive
16283,Torneo CCP CLL,Club Libertad Limpeno,Negative
16284,Torneo CCP CLL Liz Pena,Club Libertad Limpeno,Negative
16285,Torneo CCP CLL,Club Libertad Limpeno,Negative
16286,Torneo CCP CLL ST,Club Libertad Limpeno,Negative
16287,Torneo CCP CLL CAMBIO Claudia Romero Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16288,Torneo CCP CLL Carmen Benitez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16289,Torneo CCP CLL nineteen ST UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16290,Torneo CCP CLL four Karina Vega,Club Libertad Limpeno,Negative
16291,Torneo CCP CLL,Club Libertad Limpeno,Negative
16292,Torneo CCP CLL de la primera,Club Libertad Limpeno,Negative
16293,Torneo CCP CLL,Club Libertad Limpeno,Negative
16294,Torneo CCP CLL,Club Libertad Limpeno,Negative
16295,Torneo CCP CLL sixteen,Club Libertad Limpeno,Negative
16296,DanaFarber Catherine Wu,Harvard Medical School,Negative
16297,CLL Alison Moskowitz,VJHemOnc,Negative
16298,Obinutuzumab CLL,Benlazar Amine,Negative
16299,CLL,Benlazar Amine,Negative
16300,BTK Inhibitors Treatment CLL Oncology Times,Benlazar Amine,Negative
16301,MRD CLL,chadi nabhan MD MBA FACP,Negative
16302,CLL,Kathleen Hoffman,Negative
16303,Ibrutinib rituximab v chemoimmunotherapy,Medivizor,Negative
16305,CLL,CLLSA,Postive
16306,Professors Farrukh Awan UTSWNews John Allan WeillCornell MedscapeLIVE,Medscape Education,Postive
16307,obinutuzumab,Medivizor,Negative
16308,five BTK Farrukh Awan UTSWNews,Medscape Education,Negative
16309,four,Medscape Education,Negative
16310,three BTK Farrukh Awan UTSWNews,Medscape Education,Negative
16311,two John Allan WeillCornell,Medscape Education,Negative
16312,BTK CLL Farrukh Awan UTSWNews,Medscape Education,Negative
16313,Ibrutinib rituximab v chemoimmunotherapy,Medivizor,Negative
16314,Friesian,Reda Mohamed Guessoum DVM,Negative
16315,Friesian,AVMA Journals,Negative
16316,second today Jhe Chaldean one hundred Locus Coeruleus nine,Jhe Russell,Postive
16317,CLL IcahnMountSinai MountSinaiNYC The Mount Sinai Hospital Icahn School Medicine Mount Sinai,Oncology Tube,Negative
16320,Leader So Legend CLL,Aurileus FC,Negative
16321,CLL Dublin JanRynne Great,Michael Rynne,Postive
16322,Duvelisib Rituximab,Lymphoma Papers,Negative
16324,CLL,CLLSA,Postive
16325,obinutuzumab,Medivizor,Negative
16326,obinutuzumab,Medivizor,Negative
16327,ACCC Educational Opportunities Addressing Disease States NSCLC CLL Myeloma ASU,Oncology Tube,Negative
16328,Check Ibrutinib rituximab v chemoimmunotherapy,Medivizor,Negative
16329,Roundup Lymphoma,Matthews Associates,Negative
16330,CLL FondazioneTLS,Anna Kabanova,Postive
16331,CLL,Benlazar Amine,Negative
16332,Minutes Ed Bradley,Cancer Today,Negative
16334,September six Week,Contemporary Clinic,Negative
16335,CLL,Eric Whitman MD,Negative
16336,Melanoma Associated CLL four hundred six hundred MSL CLL,Melody Davis,Negative
16337,CLL,Early Years Resources,Negative
16338,CLL More half People CLL first,CLLSA,Negative
16340,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16341,CLL,CLL Ireland,Negative
16343,Edinburgh two week CLL forty year CLL,iwCLL,Negative
16345,Joshua Brody,Icahn School Medicine Mount Sinai,Negative
16346,one,Society Immunotherapy Cancer,Negative
16347,Cancer Therapy Advisor Researchers,Folks,Negative
16348,Torneo NACIONAL CLL,Club Libertad Limpeno,Negative
16349,Torneo CLL ST,Club Libertad Limpeno,Negative
16350,Torneo NACIONAL CLL Karina Vega,Club Libertad Limpeno,Negative
16351,Torneo NACIONAL CLL ST,Club Libertad Limpeno,Negative
16352,Torneo NACIONAL CLL CAMBIO Liz Pena,Club Libertad Limpeno,Negative
16353,Torneo NACIONAL CLL CAMBIO Gutierrez Laurie Cristaldo,Club Libertad Limpeno,Negative
16354,Torneo CLL thirteen,Club Libertad Limpeno,Negative
16355,Torneo CLL five,Club Libertad Limpeno,Negative
16356,Torneo NACIONAL CLL,Club Libertad Limpeno,Negative
16357,Torneo CLL,Club Libertad Limpeno,Negative
16358,Torneo NACIONAL CLL,Club Libertad Limpeno,Negative
16359,Torneo CLL,Club Libertad Limpeno,Negative
16360,Torneo CLL Griselda Garay,Club Libertad Limpeno,Negative
16361,Torneo NACIONAL CLL Fabiola Sandoval,Club Libertad Limpeno,Negative
16362,Torneo NACIONAL CLL ST,Club Libertad Limpeno,Negative
16363,Torneo NACIONAL CLL EN MARCHA UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
16364,CLL,Prof John,Postive
16365,New Ibrutinib,Medivizor,Negative
16366,CLL SelfRegional SunriseLasVegas,ACCC,Postive
16367,Torneo CLL,Club Libertad Limpeno,Negative
16368,Torneo CLL,Club Libertad Limpeno,Negative
16369,CLL two CLARITY OLN,Oncology Learning Network,Postive
16370,rituximab v chemoimmunotherapy,Medivizor,Negative
16371,CLL Arlington Texas three CLL Lamanna Thompson,Andrew Schorr,Negative
16372,CLL six hundred,Children Melanoma,Negative
16373,CLL six hundred,SunAWARE,Negative
16374,one CLL five year June one first This week Oslo Trondheim Thankful,Sigrid Skanland,Postive
16375,Hayslip CLL,AbbVie,Postive
16376,The Roundup Options Help Center California Encourages Those,EIN Presswire Press Releases,Postive
16377,obinutuzumab,Medivizor,Negative
16379,pladser Temadag Aarhus Kom,LyLe Foreningen,Negative
16380,September BloodCancerAwareness month CLL,ecancer,Postive
16381,CLL,COPD News,Negative
16382,CLL ASCO,VJHemOnc,Negative
16383,CLL The Binet Staging System,CLLSA,Negative
16384,eight year ago NVRQT JonLester,Mikkel Bossow,Negative
16385,Judy Zhu Malu Chinese English,Lilian Wong,Negative
16386,Ibrutinib rituximab v chemoimmunotherapy Medivizor,Chocolatiere Phys,Negative
16387,Ibrutinib rituximab v chemoimmunotherapy,Medivizor,Negative
16388,CLL six hundred,Casey Foster,Negative
16390,CLL BMT,Benlazar Amine,Negative
16391,Ireland CLL BloodCancerAwarenessMonth,CLL Ireland,Negative
16393,CLL Five Years Counting CLLSupport,Tina,Negative
16394,Rod Humerickhouse The Importance Minimal Residual Disease Negativity CLL AbbVieUS,Oncology Tube,Negative
16395,Chronic CLL,Patient Empowerment Network,Negative
16397,JCO Editorial OSU CLL,Kerri Wachter,Negative
16398,Paul MD,Oncology Tube,Negative
16399,CLL CLLsm,Patient Empowerment Network,Negative
16400,CLL,chadi nabhan MD MBA FACP,Negative
16401,CLL ChronicLymphocyticLeukaemia RaiseAwareness,Tina,Negative
16403,CLL,CLLSA,Negative
16404,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16408,CLL,Kathleen Hoffman,Negative
16409,CLL MRD,Frontiers Oncology,Postive
16410,Jul six two thousand and Archibald et al CLLsm,Mike Thompson MD PhD FASCO,Negative
16411,four BTK CLL John Allan WeillCornell,Medscape Education,Negative
16412,Scan Bearish Centerline Cross today ADT WIL CLL JOUL KMK,SwingTradeBot UK,Negative
16413,Melanoma Associated CLL,SpecialtyPTimes,Negative
16414,September Month one eleven year ago CLL three,lacey vega,Negative
16415,John Pagel Swedish,Oncology Tube,Negative
16416,week CLL one four mid September,Mike ForThePeople,Postive
16417,Leukemia Research CLL six hundred,Melanoma Research Foundation,Negative
16419,JR Kim HT Armand Cutler five,Total Well Being,Negative
16420,Scotland MedscapeLIVE Barrientos ZuckerSoM CLL,Medscape Education,Negative
16421,two thousand and nineteen Chronic CLL Covering CLL Fund Learn,HealthWellOrg,Postive
16422,Verastem Oncology four Society Hematologic Oncology two thousand and Annual September two thousand and nineteen Houston CLL,Verastem Oncology,Negative
16423,September Leukemia Awareness four AML CLL CML,AACR Foundation,Postive
16424,Jonathon Cohen MD jonathonbcohen CLL,Winship Cancer Institute Emory University,Negative
16425,Lymphoma Large Diffuse Follicullar Lymphoma Cutaneous Anapalastic Chronic,Matthews Associates,Negative
16427,one one Elephants Tea Magazine,Jeff Neurman,Negative
16429,CLL,Prof John,Postive
16430,CLL CLL OsloCancer,Prof John,Postive
16432,Statin Canada,Jerry Lee,Negative
16433,UK CLL Blood ten Ireland CLL forty CllIreland JanRynne,Michael Rynne,Negative
16434,CLL CLL UK CLL CLL,CLLSA,Negative
16435,CLL,CancerWallonia,Negative
16437,Dr Bond two second CLL BTK,Targeted Oncology,Negative
16438,Read Jay Connolly,Patient Power,Negative
16439,Plasma Maturation Antigen Levels Elevated Correlate Disease CLL,Benlazar Amine,Negative
16440,CLL,iwCLL,Negative
16441,Hematology Review two thousand and eighteen ChronicLymphocyticLeukemia BcellLymphoma FollicularLymphoma,touchONCOLOGY,Negative
16442,one CLL,Fleur Templeton,Postive
16443,CLL,CLLSA,Negative
16444,Today BloodCancer Awareness Month CLL,CLL Ireland,Postive
16445,Jacqueline Barrientos Feinstein Institute Medical Research LymphomaHub,The Patient Channel,Postive
16446,September two thousand and sixteen Light Night,Kerry,Negative
16447,September BloodCancerAwarenessMonth CLL,Mask Up damn nose please,Negative
16448,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16450,Today mark start bloodcancerawareness Month Our CLL,CLLSA,Negative
16451,Torneo CLL SanLorenzo CLL San Lorenzo UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16452,CLL CLL,Benlazar Amine,Negative
16453,Torneo CLL CAMBIO Angelica Stephenie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16454,Torneo CLL SanLorenzo,Club Libertad Limpeno,Negative
16455,Torneo CLL SanLorenzo,Club Libertad Limpeno,Negative
16456,Torneo CLL CAMBIO Claudia Romero Griselda Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16457,Torneo CLL,Club Libertad Limpeno,Negative
16458,Torneo CLL Karina Vega,Club Libertad Limpeno,Negative
16459,Torneo CLL SanLorenzo,Club Libertad Limpeno,Negative
16460,Torneo CLL SanLorenzo,Club Libertad Limpeno,Negative
16461,Torneo CLL Karina Vega,Club Libertad Limpeno,Negative
16462,Torneo CLL SanLorenzo Karina Vega fifteen Paola Genes,Club Libertad Limpeno,Negative
16463,Torneo CLL SanLorenzo EN MARCHA UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
16464,VIDEO CLL,VJHemOnc,Negative
16465,Comparison Time Next Treatment Healthcare Resource Utilization Costs Patients Chronic,Anthony Mato,Negative
16466,one,Lymphoma Papers,Negative
16467,Tait Shanafelt,Stanford Department Medicine,Negative
16468,Paul Barr MD Opinion Ibrutinib Line CLL WilmotCancer,Oncology Tube,Negative
16469,CLL Register September CLL MoffittNews,Patient Empowerment Network,Negative
16470,today Poundland Baby Shower LANGUAGE CLL,Early Years LSC FE VocEd EYFS,Postive
16471,CLL,Sigrid Skanland,Postive
16472,The Roundup Options Help Center Texas Encourages Those,EIN Presswire Press Releases,Postive
16473,Venetoclax CllSociety RoswellPark CLL,Tom Henry MBA RPh CPh,Negative
16474,Califolink Logistics Office Storage Containers Rent CLL Solutions,iContactLanka,Negative
16475,CLL,Kathleen Hoffman,Negative
16477,CLL CLLsm,Mike Thompson MD PhD FASCO,Negative
16478,CLL,Oxford Nanopore,Negative
16480,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16481,JA Brien Evolution CLL Nat Rev Clin two thousand and eighteen Ches,Total Well Being,Negative
16482,CLL,Benlazar Amine,Negative
16484,Chicago IL Explore BTK CLL John Allan WeillCornell,Medscape Education,Negative
16485,New JITC Research Phase one,Society Immunotherapy Cancer,Negative
16486,BCR CLL,Benlazar Amine,Negative
16487,Brian Koffman CLL StJude LEUsm,VJHemOnc,Negative
16488,HL CLL,Oncology Tube,Negative
16489,CLL SelfRegional SunriseLasVegas,ACCC,Postive
16490,one,Oncology Nursing News,Negative
16491,European EPAR Gazyvaro eight,Pharma Regulatory,Negative
16492,September article month CLL AML,The Lancet Haematology,Postive
16494,CLL,Prof John,Postive
16495,GOssenkoppele Read Medicom Conference Portal Medical Publishers Conference Hematology AML CLL CART EHA Hematology,Medicom Medical Publishers,Postive
16496,Obinutuzumab,Garbine Lizeaga,Negative
16497,Obinutuzumab Robak Montserrat Ghia Hillmen Hallek,Total Well Being,Negative
16498,BCell two thousand and nineteen,Unidrugscom,Negative
16499,OncoAlert Obinutuzumab CLL,Benlazar Amine,Negative
16500,New Medivizor Immunoglobulin Leukemia,Medivizor,Negative
16501,Pros Cons CLL,Toby Eyre,Postive
16502,CLL,Blood Journal,Negative
16503,Venetoclax first,Diagnostics News,Negative
16504,Association PubMed NCBI,Alyssa,Negative
16505,CLL Register CLL,Patient Empowerment Network,Negative
16506,OncoAlert CLL three UK CLLsm,Raul Cordoba MD PhD,Negative
16508,CLL CLLsm,Patient Empowerment Network,Negative
16509,European EPAR Imbruvica Lymphoma Leukemia Lymphocytic fourteen,Pharma Regulatory,Negative
16510,one Mahadevan,UoW BioMed Research,Negative
16511,CLL,CLL Society Inc,Negative
16514,CLLsm,Patient Empowerment Network,Negative
16515,obinutuzumab CLL Cancer Oncology,VJHemOnc,Negative
16518,Zanubrutinib Ibrutinib CLL Tam PeterMacCC,VJHemOnc,Negative
16519,Hypothesis CLL Subset WT HallekMichael,Toby Eyre,Negative
16521,Xiao rinpaQiu Xing rinpaZhong   CLL,She Hui Bao Xian Yan Jiu Suo ,Negative
16522,Tuesday day Sea Sea,Vivian Cain,Postive
16523,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16527,Torneo CLL GralCaballero,Club Libertad Limpeno,Negative
16528,Torneo CLL CAMBIO Angeles Portillo Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16529,Torneo CLL GralCaballero,Club Libertad Limpeno,Negative
16530,Torneo CLL,Club Libertad Limpeno,Negative
16531,Torneo CLL GralCaballero Liz Pena,Club Libertad Limpeno,Negative
16532,Torneo CLL GralCaballero sixteen ST GOOL Fabiola Sandoval,Club Libertad Limpeno,Negative
16533,Torneo CLL CAMBIO Claudia Romero Damia Cortaza,Club Libertad Limpeno,Negative
16534,Torneo CLL GralCaballero seven ST GOOL,Club Libertad Limpeno,Negative
16535,Torneo CLL five,Club Libertad Limpeno,Negative
16536,Torneo CLL GralCaballero,Club Libertad Limpeno,Negative
16537,Torneo CLL GralCaballero,Club Libertad Limpeno,Negative
16538,Torneo CLL GralCaballero GOOL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16539,Torneo CLL GralCaballero GOOL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16540,Torneo CLL GralCaballero GOOL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16541,Torneo CLL GralCaballero GOOL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16542,Torneo CLL,Club Libertad Limpeno,Negative
16543,Torneo CLL GralCaballero nineteen,Club Libertad Limpeno,Negative
16544,Torneo CLL GralCaballero thirteen fourteen GOOL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16545,Torneo CLL GralCaballero ten,Club Libertad Limpeno,Negative
16546,Torneo CLL GralCaballero seven,Club Libertad Limpeno,Negative
16548,CLL,Kathleen Hoffman,Negative
16549,month Hot Topic Curt Hanson CLL,Iranian American Medical Association IAMA,Postive
16550,CLL,SpecialtyPTimes,Negative
16551,CLL French Florence Cymbalista,The Patient Channel,Negative
16552,Mayo Clinic,Mayo Clinic Pathology,Negative
16553,Langerhans Chronic Lymphocytic Lymphocytic,Dendritic cell,Negative
16555,Langerhans Chronic Lymphocytic Lymphocytic,Fragments,Negative
16556,Monthly freJordandhutch CLL,Lymphoma Hub,Negative
16557,Intense Uptake Liposomal Curcumin Multiple Myeloma Cell,Lovisa Bray,Negative
16558,Langerhans Chronic Lymphocytic Lymphocytic,Lymphoma Papers,Negative
16559,MYC,Lymphoma Papers,Negative
16560,Dr Bond two second BTK,Targeted Oncology,Negative
16561,CLL Barbara Eichhorst UniCologne,VJHemOnc,Negative
16562,nineteen one thousand nine hundred two thousand and eighteen CLL one hundred and fortysix one thousand nine hundred two thousand and eighteen two thousand and six two thousand and seven two thousand and fifteen two thousand and sixteen,CLL Society Inc,Postive
16563,rituximab patient,CenterForBiosimilars,Postive
16564,Chicago IL MedscapeLIVE Bruton BTK CLL REGISTER,Medscape Education,Negative
16565,today TFW BIFF STVG,SwingTradeBot UK,Negative
16566,Scan today,SwingTradeBot UK,Negative
16568,HL CLL,Oncology Tube,Negative
16569,Plasma Cell Dyscrasias CLL,Education,Negative
16570,month Hot Topic Curt Hanson CLL,Mayo Clinic Labs,Negative
16571,Scotland CLL,Patient Worthy,Negative
16572,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16574,European EPAR Venclyxto Leukemia Lymphocytic BCell Date four million one hundred and twentytwo thousand and sixteen Revision eight European EPAR Venclyxto,Renal Cell Carcinoma,Negative
16575,European EPAR Venclyxto Leukemia Lymphocytic eight,Pharma Regulatory,Negative
16576,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
16577,The Roundup Options Help Center Encourages,EIN Presswire Press Releases,Postive
16578,nonhodgkinslymphoma nhl cll,Roundup Options,Negative
16580,CLL CLL Navigator,Patient Empowerment Network,Negative
16581,CLL SelfRegional SunriseLasVegas,ACCC,Postive
16582,two thousand and,Society Immunotherapy Cancer,Negative
16583,CLL,SpecialtyPTimes,Postive
16584,CLL Danielle Brander DukeCancer CLLsm,Patient Empowerment Network,Negative
16585,Today one year one,Philly Sports Guy SC,Postive
16586,OncoAlert Hematological Oncology CLLsm,Raul Cordoba MD PhD,Negative
16587,Peripheral Lymphoma Arising Patients With Chronic,Lymphoma Papers,Negative
16588,FNCE Full,Kim Kirchherr,Negative
16589,DRG United States Western Europe DRGinsights CLL AstraZeneca,DRG Epidemiology,Negative
16590,CLL Cancer,CLL Ireland,Negative
16591,Canadian,Bibliosaude,Negative
16592,one Mighty Cancer Party One,Jeff Neurman,Negative
16593,Dr Bond two second BTK,Targeted Oncology,Negative
16594,first CLL Week one week,Mike ForThePeople,Postive
16595,Sravanti Teegavarapu CLL CancerNetwrk,BCM Media Relations,Negative
16596,today,Patient Empowerment Network,Negative
16597,CLL CLL CLL CLLsm,Patient Empowerment Network,Negative
16598,VIDEO Primary Barbara Eichhorst CLL,VJHemOnc,Negative
16600,one one hundred three,Justin Decker,Negative
16601,CLL approximately one third,AbbVie US,Negative
16603,CLARITY,Home Journal,Negative
16604,Cello Health PLC Potential Upside CLL,Broker Ratings,Negative
16605,Library Tours Maura today CLL,CLL Warwick Uni,Negative
16606,HL,Oncology Tube,Negative
16607,CLL Kombination Ibrutinib,Onko Community,Negative
16608,CLL CologneBonnMsso UKKoeln,Christian Reinhardt,Negative
16610,Chinese Han,microRNApapers,Negative
16611,rituximab chronic,Hematology Advisor,Negative
16612,THE LITERATURE Roland Wolff,Roland Wolff,Negative
16613,one PatientPower Susan Leclair CLL Video,Taylor Lab UM,Postive
16614,Koffman,CLL Society Inc,Negative
16615,Zou Hematological Oncology,Francesco Bertoni,Negative
16616,CLL Rates,two Minute,Negative
16617,CLL Tweeps Binet WT CLL CI CLL HallekMichael,Toby Eyre,Negative
16619,Global Chronic Lymphocytic Leukemia Treatment Market Analysis Size Share Outlook Study,HAM,Negative
16620,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16623,CLL,Kathleen Hoffman,Negative
16624,European EPAR Zydelig Lymphoma Leukemia Lymphocytic fifteen Status,Pharma Regulatory,Negative
16626,CLL,Benlazar Amine,Negative
16628,obinutuzumab VenG CLL,Oncology Tube,Negative
16630,almost year Christina Fisher CLL,Patient Empowerment Network,Postive
16631,CLL year Chronic,AstraZeneca,Negative
16634,two minute,David,Negative
16635,Matthew Davids Anthony Mato five CLL,PRIME Education,Negative
16636,Trend Shanafelt TD al Engl Med Chemoimmunotherapy,paper link,Negative
16637,CLL one,Mike ForThePeople,Postive
16638,Tomorrow morning first CLL one one tonight thirty,Mike ForThePeople,Negative
16640,SpringerLink CLL,Benlazar Amine,Negative
16641,Brian Koffman CllSociety CLLAdvocates CLL,CLL Advocates Network,Negative
16642,BloodJournal,ASH,Negative
16643,CLL Leukemia Cancer Oncology,VJHemOnc,Negative
16644,Torneo CLL Guarani de Liza Larrea los,Club Libertad Limpeno,Negative
16645,Torneo CLL ST,Club Libertad Limpeno,Negative
16646,Torneo CLL Guarani CAMBIO Liz Pena,Club Libertad Limpeno,Negative
16647,Torneo CLL Guarani CAMBIO Natalia Angelica Vazquez,Club Libertad Limpeno,Negative
16648,Torneo CLL CAMBIO Liza Larrea Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16649,Torneo CLL ST Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16650,Torneo CLL Griselda Garay nineteen ST UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
16651,Torneo CLL eight,Club Libertad Limpeno,Negative
16652,Torneo CLL Guarani DE LA,Club Libertad Limpeno,Negative
16653,Torneo CLL Liz Pena,Club Libertad Limpeno,Negative
16654,Torneo CLL Liz Pena,Club Libertad Limpeno,Negative
16655,Torneo CLL,Club Libertad Limpeno,Negative
16656,Torneo CLL seven Carmen Benitez,Club Libertad Limpeno,Negative
16657,Torneo CLL,Club Libertad Limpeno,Negative
16658,Torneo CLL Natasha Martinez Carmen Benitez Laurie Cristaldo Joana Galeano Cortaza Liz Pena,Club Libertad Limpeno,Negative
16659,obinutuzumab VenG CLL,Oncology Tube,Negative
16661,OncoAlert Prognostic Score Cytogenetic Risk Classification Chronic CLLsm,Raul Cordoba MD PhD,Negative
16662,Complex CLL,Benlazar Amine,Negative
16664,Prognostic Score Cytogenetic Risk Classification Chronic CLL,Benlazar Amine,Negative
16665,VIDEO Current CLL John Gribben CLL Cancer Oncology VJOncology,The Patient Channel,Negative
16666,ASH two thousand and sixteen two Update New Chronic,Oncology Tube,Negative
16667,CLL,Kathleen Hoffman,Negative
16669,Roundup Weed Killer Roundup,Harry Moritz,Negative
16672,OncoAlert Zou Hematological Oncology Wiley Online CLL,Benlazar Amine,Negative
16673,Temadag Det md cmml BlodcancerDk,LyLe Foreningen,Postive
16675,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16676,Immunoglobulin,Medivizor,Negative
16677,CME WEB Participate Oncology VideoWebinars CMEcredits Click Melanoma CLL,Paradigm Med Comm,Negative
16678,ATM,OncologyNurseAdvisor,Negative
16680,OncoAlert CLL,Benlazar Amine,Negative
16681,today CLL,SwingTradeBot UK,Negative
16682,CLL CLLsm,Patient Empowerment Network,Postive
16683,Imbruvica,BioNews,Negative
16684,CLL SelfRegional SunriseLasVegas,ACCC,Postive
16685,Read Connected Learning Live CLL,BSI America,Negative
16686,CLL CLLsm,Raul Cordoba MD PhD,Negative
16687,CLL Nicole Lamanna AndrewSchorr ColumbiaMed,Patient Power,Postive
16688,SCI Steve Coutre rituximab alone StanfordCancer,Steven Artandi MD PhD,Negative
16689,Today twelve CLL ISS QRT SOLG,Ryan Kia,Negative
16690,BCR Bcells CLL,Prof John,Negative
16691,Today last day CLL FMLA,Mike ForThePeople,Postive
16692,CLL,Benlazar Amine,Negative
16695,PubMed,Eva Montane,Negative
16696,EQLS CLL,Andrew Scott,Negative
16697,CLL Cello Health US US ISS CLL AndrewScottTV,Proactive,Negative
16698,CLL,MEDWAVE,Negative
16699,CLL Innovative Science Solutions US Consultancy specialising Legal Regulatory Healthcare CLL one,WheelieDealer,Postive
16700,Quantium Cast Episode twelve QRT CLL SOLG,Ryan Kia,Negative
16701,Quantium Cast Episode twelve QRT CLL SOLG,Quantium Research,Negative
16702,Cello Health CLL Innovative Science Solutions,Share Prophets,Postive
16703,CLL Genome Discovery,Dr Boominathan PhD,Negative
16704,AIM CLL Cello Health PLC Acquisition,AIM Alerts,Negative
16705,ASH two thousand and sixteen three,Oncology Tube,Negative
16707,two thousand and,Brian Barrett,Postive
16708,two thousand and,Brian Barrett,Postive
16709,two thousand and nineteen,Brian Barrett,Postive
16711,HL,Oncology Tube,Negative
16712,Classy Athletics CLL TeamCanada,Jon Lundquist,Postive
16713,CLL three,Benlazar Amine,Negative
16714,today CBOX NXR ATS SREI GTLY PHNX,SwingTradeBot UK,Negative
16715,CLL Danielle Brander DukeCancer CLLsm,Patient Empowerment Network,Negative
16716,OncoAlert Recommendations CardioOnc CLL CLLsm,Raul Cordoba MD PhD,Negative
16718,OncoAlert CLL three BloodJournal CLLsm,Raul Cordoba MD PhD,Negative
16719,HL CLL,Oncology Tube,Negative
16720,annual CLL two ten CLL Blood Journal two thousand and fourteen DisabilityInfo Zusia,Zusia Dr Jackie Volk,Negative
16721,CLL CLL AndrewSchorr,Patient Power,Postive
16722,one CLL,Tom Cloyd,Negative
16723,CLL Nicole Lamanna,Esther Schorr,Postive
16724,CLL,Cowan Liebowitz,Negative
16725,SpringerLink CLL lymsm,Benlazar Amine,Negative
16726,FCR CLL,Benlazar Amine,Negative
16727,Petra CLL,ASH Clinical News,Negative
16728,New Medivizor Combination Leukemia,Medivizor,Negative
16729,Scotland New CLL Venclyxto Mabthera Rixathon Scotland CLL,BCAwareness,Negative
16731,Prognostic Score Cytogenetic Risk Classification Chronic,Jerry Lee,Negative
16732,two thousand and,Krishan Maggon,Negative
16734,Chemoimmunotherapy Chronic,Urso,Postive
16735,New Immunoglobulin,Medivizor,Negative
16736,Tedeschi et al Haematologica Cross Ibrutinib two CLL No RCT IBR forty nineteen Diff Mutated CLL,Toby Eyre,Negative
16737,CLL Danielle Brander DukeCancer CLLsm,Patient Empowerment Network,Negative
16738,TN CLL,OncologyNurseAdvisor,Negative
16739,Denise United States Chronic Leukemia Way,Southland Transportation Group,Postive
16740,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16743,European JNJCares Waldenstrom,Cancer Stem Cell News,Negative
16744,Biotechnology Lifesciences Medicalscience,Eduard Alberts PhD,Negative
16745,rituximab CLL,Health,Negative
16746,two Europe Imbruvica CLL Waldenstrom,GESDAT GmbH,Negative
16747,Chronic Lymphocytic CLL,Prof John,Negative
16748,one CLL,Thiago Carvalho,Negative
16752,Immunoglobulin,Medivizor,Negative
16753,Rituximab Patients Previously Treated CLL Trial Site News,TrialSite News,Negative
16755,Willima Wierda CLL Venclexta,Dene Peters,Negative
16757,Immunoglobulin,Medivizor,Negative
16758,ATM,OncologyNurseAdvisor,Negative
16759,Roger Anne Boeve Massey Anne,VCU Massey,Postive
16760,CLL CLL,ASCO,Postive
16761,Read Connected Learning Live CLL,BSI America,Negative
16762,CLL,CLL Society Inc,Negative
16763,Oncologist Thursday,Dena Kirkland,Negative
16764,CLL Isabel Cunningham,Oncology,Negative
16765,Linda Karlsen PrecisionMedicine CLL TaskenLab,Sigrid Skanland,Postive
16766,San Zhong Xian  Yi Shi Shi  Yi Shi   Kong kiJia Yi Shi Xue Huang Xue Da Xue,Takahiro Chishima,Negative
16767,San Zhong Xian  Yi Shi Shi  Yi Shi   Kong kiJia  Hou Sheng Yi Shi Xue Huang Xue Da Xue,yamadamiraiLab,Negative
16769,Therapy PCAT CLL Genome Discovery,Dr Boominathan PhD,Negative
16771,Time,Jeff Neurman,Negative
16772,Covaris Diop,Covaris,Negative
16776,One week one CLL night,Mike ForThePeople,Negative
16777,CLL,Kathleen Hoffman,Negative
16778,OncoAlert HemaSphere CLLsm,Raul Cordoba MD PhD,Negative
16779,CLL,Birep Aygun,Negative
16781,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16782,Nature Communications,Daniel Castellano,Negative
16784,Lymphocy HemaSphere CLL,Benlazar Amine,Negative
16785,NatureComms,Behav Ecol Papers,Negative
16786,Statin statin,CLL Society Inc,Negative
16787,NatureComms,Muin Khoury,Negative
16788,Harry Potter,Potter Papers,Negative
16790,three HELIOS,Lymphoma Papers,Negative
16793,tonight CLL,Mike ForThePeople,Postive
16794,Second,Lou DiVito,Negative
16795,Myeloma two thousand and eighteen,Oncology Tube,Negative
16797,CLL today CLL CLLsm,CLL Society Inc,Postive
16798,SelfRegional SunriseLasVegas CLL,ACCC,Postive
16799,Susahnya tengok keadaan Pada Chronic Leukemia Semoga mempermudahkan kami Amin,roseXxxx,Negative
16801,New Medivizor,Medivizor,Negative
16802,CLL,Aigenpulse,Negative
16803,CLL,two Minute,Negative
16806,HOULSTON Nice CLL,Prof John,Negative
16807,Tanja Jo CRUKresearch CLL,Prof John,Negative
16808,CLL Genetics NatureComms,Houlston Lab ICR,Negative
16809,ChronicLymphocyticLeukemia CLL SYK,MedChemExpress,Negative
16810,July two thousand and nineteen FDA,Targeted Oncology,Negative
16811,CLL,iwCLL,Negative
16812,OncoAlert CLL BloodJournal,Raul Cordoba MD PhD,Negative
16813,OncoAlert CLL BloodJournal CLLsm,Raul Cordoba MD PhD,Negative
16814,New JITC Review CAR two thousand and,Society Immunotherapy Cancer,Negative
16815,CLL,Blood Journal,Negative
16816,CLL,Blood Journal,Negative
16817,ASH two thousand and sixteen three,Oncology Tube,Negative
16818,One,CLL Society Inc,Negative
16819,one zero one Except,Raucous,Negative
16820,CLL,Kathleen Hoffman,Negative
16821,two thousand and Angela Howes Imbruvica,pharmavoice,Negative
16822,Lymphoma Hub Satellite Symposium LymHubSS Click CLL,Lymphoma Hub,Negative
16823,Leukemia Healio,Living Safely,Negative
16824,Check Comparing,Medivizor,Negative
16825,versus rituximab three,Lymphoma Papers,Negative
16826,CLL,Early Years LSC FE VocEd EYFS,Postive
16827,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16829,one quarterly July CLL one three,Maggie Holben,Postive
16830,HL John Kuruvilla CLL,Oncology Tube,Negative
16831,CLL FCR One Jennifer Brown Cancer Institute CLL Harvard Harvard Medical School,Oncology Tube,Negative
16832,Progress,ACS Journal Cancer,Negative
16833,CLL SLL,CancerTherapyAdvisor,Negative
16834,StanfordMed NEJM Drug,Hematopoiesis News,Negative
16836,NEJM Nicole Lamanna ColumbiaMed,ColumbiaCancer,Postive
16837,UniBirmingham,Health,Negative
16838,First Exciting GCLLSG CLL MDAndersonNews,Eric Singhi MD,Negative
16839,England Wales nine CLL Reading Bookstart EYtwittertagteam EYMatters,Early Years LSC FE VocEd EYFS,Postive
16840,StanfordMed rituximab two,Vall Hebron Institute Oncology VHIO,Postive
16843,Tumor Microenvironment,paper,Negative
16845,APTO CLL rituximab idelalisib two day,Joe,Negative
16846,CLL,Benlazar Amine,Negative
16848,CLL,Cancer Care,Negative
16849,CLL IcahnMountSinai Icahn School Medicine Mount Sinai The Mount Sinai Hospital,Oncology Tube,Negative
16851,CLL,Hematology Advisor,Negative
16852,today CLL,Patient Empowerment Network,Negative
16853,today CLL two pm ET,Patient Empowerment Network,Postive
16854,CCRAdvance CCR,NCI Center Cancer Research,Negative
16855,Tait Shanafelt SCI Steven Coutre two two week StanfordCancer CLL,Steven Artandi MD PhD,Postive
16856,CLL Learn,AbbVie US,Negative
16857,two thousand and nineteen two thousand and twentythree Reuters,Kiran Bhole,Postive
16858,two thousand and nineteen two thousand and Chronic,lalit pachpande,Postive
16859,AIM CLL Cello Health PLC,AIM Alerts,Negative
16861,August six eleven AM PM Eastern Connect CLL LIVE Ask Expert,Patient Power,Negative
16864,CLL,isangweon,Negative
16865,CLL John Sangwon,isangweon,Negative
16866,Love ASCO,Noopur Raje,Postive
16867,European EPAR Blitzima seven,Pharma Regulatory,Negative
16868,Association Institutional Review Board,Total Well Being,Postive
16869,CLL recent year Learn,AplusA World,Negative
16871,one CLL two week first one two day one,Mike ForThePeople,Negative
16872,Debbie Appelwick four Metastatic,Rhonda Flagstad,Postive
16875,CLL,Medscape Oncology,Negative
16876,two thousand George Duke US four decade,The Hot Mammas,Negative
16877,Original Article Chemoimmunotherapy Chronic,NEJM,Negative
16878,tomorrow CLL webinar Susan LeClair Justin Taylor Register,Patient Empowerment Network,Negative
16879,New JCOCCI Weymann BCCancer four CLL,ASCO Publications,Negative
16880,CLL rituximab first Ireland,Gearoid Crotaigh CareCantWait,Negative
16881,two thousand thirteen GeorgeDuke TWIMH onthisday,Teddy Ruxspizzle,Negative
16882,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16885,Today two thousand and George Duke,Uncle Duke,Negative
16887,CLL five Nice Work Bloodwise,Prof John,Negative
16888,Bruce Cheson MD FACP MedStarGUH LombardiCancer,Expert Perspectives Oncology,Postive
16889,Two,The Scientist,Negative
16891,myRockworld Day George Duke American thirty,myRockworld,Negative
16892,StanfordMed The Answer Appears To Be Unequivocally Rituximab CLL,Prof John,Negative
16895,New Medivizor Comparing,Medivizor,Negative
16896,CLL,Christian Capitini,Negative
16897,mshj`@ lf`ly@ khlT@ dwy@,Hr,Negative
16899,CLL,Medscape Oncology,Negative
16900,SpringerLink CLL OncoAlert,Benlazar Amine,Negative
16902,Diop al NFkB CLL two hundred UVA BIRC HR MVA FCR,Toby Eyre,Negative
16905,Linfomas BreastCancer LungCancer ProstateCancer OvarianCancer bestmedicalnews dermatolgy,MDDigitasTV,Negative
16908,CLL,Benlazar Amine,Negative
16909,LymphocyticLeukemia Tait Shanafelt,Stanford Medicine,Postive
16912,CLL,Kathleen Hoffman,Negative
16913,CLL,COPD News,Negative
16914,rituximab ChronicDisease Oncology,two Minute,Negative
16915,CLL Michele summer,Patient Power,Postive
16918,Prognostic Predictive Effect IGHV Mutational,Lymphoma Papers,Negative
16919,Patrick Thornton EHA two thousand and nineteen CLL Ireland HallekMichael,Michael Rynne,Negative
16920,HallekMichael CLL two thousand and nineteen,CLL Ireland,Negative
16921,Haematologica,CancerEpiPapers,Negative
16922,CLL French Florence Cymbalista HopitalAvicenne MRD,The Patient Channel,Negative
16923,two thousand and nineteen CLL,Hematologia Hospital Clinic,Negative
16926,CLL Genome Discovery,Dr Boominathan PhD,Negative
16927,LeukemiaMDA join William Wierda World Expert EndCancer PatientPower CLLSociety MDAndersonNews CLLAdvocates,Michele,Negative
16930,Rituximab Chemoimmunotherapy CLL NEJM,Florian Slimano,Negative
16931,Two,The Scientist,Negative
16932,CLL,CLL Advocates Network,Postive
16933,HallekMichael CLL CllIreland JanRynne CllSociety CLLSupport,Michael Rynne,Postive
16934,FDA,Cancer Today,Negative
16935,Scan Above fifty DMA today USG TGP,SwingTradeBot UK,Negative
16936,two five hundred LymphocyticLeukemia,Stanford Medicine,Postive
16939,Ibrutinib Rituximab,leo uzych,Negative
16941,Researchers University CLL,Brian Lawenda MD,Negative
16945,ERK twelve CLL,Renal Cell Carcinoma,Negative
16946,Josh Winfield Age Nickname Winners Job Landscaper one hundred Representative Hons,Newbury Blues,Postive
16947,three,AJMC,Negative
16948,Macroglobulinemia Mantle Cell Lymphoma Marginal Zone,TrialBulletin,Negative
16949,South American Stanganelli Hematological Oncology OncoAlert CLL,Benlazar Amine,Negative
16950,CLL,MD Anderson Leukemia,Negative
16953,CLL CLL,Benlazar Amine,Postive
16955,Zanubrutinib Bcell CLL,The Lancet Oncology,Negative
16956,CLL Kombination Zytostatikum verbessert Therapieergebnisse,Kingreen MD,Negative
16957,CLL Kombination Zytostatikum Therapieergebnisse Palo Alto Eine Kombination,Deutsches Arzteblatt,Negative
16958,OncoAlert Chronic CLL two thousand and nineteen CLLsm,Raul Cordoba MD PhD,Negative
16959,CLL Chronic two thousand and nineteen Hallek American Journal Hematology,Michael Hallek,Negative
16961,Shanafelt TD al Engl Med Chemoimmunotherapy,paper link,Negative
16963,CNAG CRG JobOpening Bioinformatics Analyst Synergy BCLLatlas CLL six,Centre Genomic Regulation CRG,Negative
16969,CLL Article,Jennifer Smith,Negative
16970,Drug Combo,ManagedCareMag,Negative
16971,ICYMI NEJM theNCI three CLL,Pharmacyclics AbbVie Company,Negative
16972,CLL Median ALLIANCE IR one seven ALLIANCE Atrial ALLIANCE CLL,Toby Eyre,Negative
16974,rituximab FCR seventy year NEJM CLL,Marko Skelin MPharm PhD,Negative
16975,twelve MRD CLL,Toby Eyre,Negative
16976,three five hundred CLL,Healthy Life Pro,Negative
16977,FCR CLL Unmut Time two Mut CLL,Toby Eyre,Negative
16978,CLL,SpecialtyPTimes,Negative
16979,three five hundred CLL,onlydiscounted,Negative
16981,SarahCannonDocs,Oncology Times,Negative
16982,CLL August Susan Leclair Justin Taylor,Patient Empowerment Network,Postive
16985,CLL,Hematology Advisor,Negative
16986,today Shanafelt StanfordMed CLL,Cancer Research Group,Postive
16987,FDAoncology Rituxan rituximab,The Cancer Letter,Negative
16988,two two week,Verdi Oncology,Negative
16989,two two week,Horizon Oncology,Negative
16991,SelfRegional SunriseLasVegas CLL,ACCC,Postive
16993,CLL Tune Jain,Patient Power,Negative
16994,Ibrutinib Rituximab,Rodney DeKoter,Postive
16996,CLL Sept Edinburg Scotland Press,iwCLL,Negative
16998,Practice Ibrutinib Rituximab Leukemia Healio,Living Safely,Negative
16999,winterbournehg CLL,JSF Group,Negative
17000,CLL Biopsy one BP two three four,BJD,Negative
17005,OncoAlert Chemoimmunotherapy Chronic CLL CLLsm,Raul Cordoba MD PhD,Negative
17008,CLL,Afshine Emrani MD FACC,Negative
17012,CLL,Adriana Aguilar,Negative
17014,Today three CLL NEJM,Pharmacyclics AbbVie Company,Negative
17015,NEJM,Benlazar Amine,Negative
17019,Mayo CLL Chemoimmunotherapy Chronic,Keith Stewart,Negative
17020,one hundred chance journal club month Chemoimmunotherapy Chronic,John Bossaer,Negative
17024,Venetoclax CLL Italian Innocenti British Journal Haematology,Benlazar Amine,Negative
17025,CLL Watch Jennifer CLL,Oncology Tube,Negative
17026,Treating CLL PDF,chadi nabhan MD MBA FACP,Postive
17027,Italian one fifteen two four fiftyseven one v two CLL,Toby Eyre,Negative
17029,MRD CLL Watch,AbbVie US,Negative
17030,Crassini British Journal CLL,Benlazar Amine,Negative
17031,two thousand and nineteen Hallek American Journal Hematology Wiley Online Library CLL,Benlazar Amine,Negative
17035,CLL CLL,Vitaly Terushkin MD FACMS,Negative
17036,Paul Barr,Oncology Tube,Negative
17037,New Medivizor Combining,Medivizor,Negative
17039,MRD CLL NEJM,ASH Clinical News,Negative
17040,CLL Braggio Mayo Clinic CLL,Mission Bio,Negative
17041,one BTK CLL,Amber Koehler,Negative
17042,Richard Furman Leukemia HematologicMalignancies,Oncology Tube,Negative
17043,Rituxan five eighteen,AIS Health,Postive
17044,one hundred and seventyseven ANSWER Chronic Lymphocytic Lymphocytic NeuroRad HNRad DWIForTheWin Learn IURadiology COTD IUCOTD YouTube,Nicholas Koontz,Negative
17045,August six eleven AM PM Eastern Connect CLL LIVE Ask Expert,Patient Power,Negative
17046,TrialTuesday Alliance Jennifer Woyach MD Alliance Learn,Alliance Clinical Trials Oncology,Negative
17047,CLL CLLsm,CLL Society Inc,Postive
17050,one BTK CLL,Prof John,Postive
17052,VIDEO CLL David Maloney,VJHemOnc,Negative
17053,CLL,Kathleen Hoffman,Negative
17054,CLL AML CML,Cancer Health,Postive
17055,today,Patient Empowerment Network,Negative
17056,GoHealio Ryan Jacobs,Levine Cancer Institute,Negative
17057,CLL,Health,Negative
17061,van Bruggen JAC al Blood CAR,paper link,Postive
17062,Federal Register Kite GILD SGMO ZF Kymriah Yescarta Bcell CLL,Marty Chilberg,Negative
17063,Edinburgh September,Hematopoiesis News,Negative
17065,Nicola two half year CLL One Nicola one July,Leukaemia Care,Postive
17066,SarahCannonDocs,Oncology Times,Negative
17067,microscopy mathematical BCR,Cell Reports,Negative
17068,CLL three Venetoclax Read CLL ClinicalTrials,LymphomaAction,Postive
17069,eighty CLL Cincinnati PatientPower,Theresa Clementi Doan,Negative
17070,Live Cincinnati CLL,Patient Power,Negative
17071,one plerixafor rituximab,Benlazar Amine,Negative
17073,CLL Enjoy CLLsm,CLL Society Inc,Postive
17074,ICYMI FDA rituximab biosimilar CLL CLL,Oncology Learning Network,Postive
17075,NEW HemOnc Times Read,Oncology Times,Negative
17076,New Combination,Medivizor,Negative
17077,Scan Centerline Cross today ADT BAB,SwingTradeBot UK,Negative
17078,Lori Leslie MD Trial Outcomes JTCC John Theurer CLL,Oncology Tube,Negative
17079,Scan Hammer Candlestick today TRT STM ROL CLL,SwingTradeBot UK,Negative
17080,Jacqueline Barrientos CLL CLL,Oncology Tube,Negative
17081,CADTH Venclexta Rituximab CLL,CADTH,Negative
17082,CLL Jonathon Cohen jonathonbcohen,Winship Cancer Institute Emory University,Postive
17083,August CLL two,The Lancet Haematology,Negative
17084,Global Chronic Lymphocytic Leukemia Treatment Market two thousand and nineteen AB Science SA Amgen Celgene Corporation Dynavax Technologies Corporation Eisai,HAM,Negative
17085,une musique quand je ecoute CLL kikroll sourie MDR,JU,Negative
17086,SDMS Leadership Advisory Team OneTribe CLL,Amanda Cagle,Postive
17087,CLL,Cancer Stem Cell News,Negative
17090,John Kuruvilla CLL Lymphoma Leukemia,Oncology Tube,Negative
17091,Verastem Oncology Sanofi Russia Turkey East Africa VSTM,Verastem Oncology,Negative
17092,BloodJournal one BeiGene BTK Read,BeiGene,Negative
17093,Joshua Brody MD CLL MountSinai Icahn School Medicine Mount Sinai,Oncology Tube,Negative
17095,today CLL one One Doc,Mike ForThePeople,Negative
17096,BTK,Oncology Nursing News,Negative
17097,Young Investigator CLL Edinburgh,Sigrid Skanland,Postive
17098,Mutations Bruton,MDedge Hematology Oncology,Negative
17099,Ansatz Unterstutzung PD CLL,Universitat Ulm,Negative
17100,PML Progressive CLL Leusm,Anna Deveau,Negative
17102,Leukemia Ziegler Kim Piersanti Argyropoulos van den,Super Res Microscopy,Negative
17103,CLL one,CLL Warwick Uni,Postive
17106,CLL,Kathleen Hoffman,Negative
17107,Unsolicited Advice,Jeff Neurman,Negative
17108,Unsolicited Advice,Jeff Neurman,Negative
17109,FDA Ruxience,MDedge Hematology Oncology,Negative
17110,FDA,CancerTherapyAdvisor,Negative
17111,Pentostatin Rituximab Followed two RR,COPD News,Negative
17112,FDA UPDATE,Lymphoma Research Foundation,Negative
17113,de la decada los primeros regimenes de inmunoterapia fueron quimioterapia el tratamiento de la Leucemia Linfocitica Cronica,AMIIF Mexico,Negative
17115,FDA Pfizer,Horizon Oncology,Postive
17116,Tuesday,Patient Empowerment Network,Negative
17117,IgG CLL GileadSciences,RIOH,Negative
17118,CLL,SpecialtyPTimes,Negative
17120,CLL One,AbbVie US,Negative
17123,CLL CLLsm,CLL Society Inc,Postive
17124,Yucai Wang Brian Koffman CLL CLLsm,CLL Society Inc,Negative
17125,Peter Hillmen PhD CLL,Health,Negative
17127,CLL US Cello Health Scott CLL,Ruth Gemmell,Postive
17128,SelfRegional SunriseLasVegas CLL,ACCC,Postive
17129,two CLARITY,Vall Hebron Institute Oncology VHIO,Postive
17130,FDA Alert Oncology HemOnc,Oncology Times,Postive
17131,William Wierda Leukemia Leukemia Lymphocytic,MD Anderson Leukemia,Postive
17132,US Cello Health Scott,Andrew Scott,Postive
17133,CLL US Cello Health Scott CLL AndrewScottTV,Proactive,Postive
17136,yesterday first STELLARTrial OUHospitals STELLAR first RandomisedTrial RichtersTransformation CLL TrialsAccelerationProgramme,Cancer Research UK Clinical Trials Unit,Negative
17137,CML FCR CLL,The Lancet Haematology,Postive
17139,Approves Pfizer Rituximab Biosimilar,Gil Morgan,Negative
17140,CLL,MoJo,Negative
17141,CLL,Michele,Postive
17142,RT PhysRelations Study EndCancer Leukemia,Robert Orlowski,Negative
17143,Pentostatin Rituximab Followed two Trial Cancer Research Group Acta Haematologica Karger Publishers,Benlazar Amine,Negative
17145,FDA,The Medical Letter,Negative
17146,GastricCancer Linfomas BreastCancer,MDDigitasTV,Negative
17147,GastricCancer Linfomas BreastCancer LungCancer ProstateCancer OvarianCancer,Jose Arley,Negative
17148,"Register Accessing CLL Care Sat Great Wolf Lodge two thousand, five hundred thousand and Register Free",OHC,Postive
17149,July twentythree two thousand and nineteen FDA Rituxan rituximab NHL CLL Ruxience Prescribing Information,Bichoy Gabra,Negative
17151,CLL,CancerTherapyAdvisor,Negative
17152,FDA Pfizer CellTherapy SaveLives,Cellero,Negative
17154,The Food Drug Administration second,CURE Magazine,Postive
17156,CLL CLL CLL DanaFarber LombardiCancer,Expert Perspectives Oncology,Negative
17157,CLARITY Ibrutinib Plus Venetoclax Relapsed Refractory,The ASCO Post,Postive
17158,Peter Hillmen PhD CLL CancerNews,Sarah Williams,Negative
17159,August six eleven AM PM Eastern Connect CLL LIVE Ask Expert,Patient Power,Negative
17160,CLL,TrialBulletin,Postive
17161,Sudan,Lymphoma Papers,Negative
17162,Last week Summer Graduation Ceremony Jon Degree CLL PhD,CLL Warwick Uni,Negative
17164,OncoAlert CLL,Raul Cordoba MD PhD,Negative
17166,CLL Mammograms PatientPower,Michele,Postive
17167,Check CLL CLLsm,CLL Society Inc,Negative
17168,Chronic,TrialBulletin,Negative
17169,CLL Edinburgh September,Sigrid Skanland,Negative
17170,NitinJainMD,MD Anderson Cancer Center,Negative
17171,CLL CLL,Patient Empowerment Network,Negative
17174,Chronic Lymphocytic two thousand and nineteen Global Industry,Career Biotech,Negative
17175,BloodAdvances IgHV,Benlazar Amine,Negative
17176,two thousand and nineteen Global Industry Analysis two thousand,Sheetal,Negative
17178,New Treatment Options PubMed,Benlazar Amine,Postive
17179,New Treatment Options,Lymphoma Papers,Postive
17180,five NatImmunol Susan Pierce Colleagues NIAIDNews CLL,Prof John,Postive
17181,CLL,Kathleen Hoffman,Negative
17182,CLL,CLL Society Inc,Postive
17184,Drs Mohamed Mayo Javier Pinilla Kumar Mayo Clinic Hematology Session two NOSCM congress,Edgardo Santos FACP,Negative
17185,Pneumatic Reverse Pseudohyperkalemia Patient,EurekaMag,Negative
17186,British Columbia Canada,Lymphoma Papers,Negative
17188,Jeg SSTSundhed BlodcancerDk md cmml,LyLe Foreningen,Postive
17189,Duterte Philippine autoimmune,PLM CMSC,Negative
17191,Cancer Leukemia,Place Matters,Negative
17192,Venetoclax,Oncology Learning Network,Negative
17193,SaturdayMorning NEW HemOnc Times,Oncology Times,Negative
17194,two MRD CLL,Health,Negative
17195,CLL,Anthony Norris,Negative
17196,CLL US News today,Anthony Mato,Negative
17197,fifty Bearish List today XPD BWNG,SwingTradeBot UK,Negative
17198,Jacqueline Barrientos Feinstein Institute Medical Research LymphomaHub,The Patient Channel,Postive
17199,Oncology Nurse,Ashley Carter,Negative
17201,August CLL,Phoebe Needles,Negative
17202,CLL,Taylor Lab UM,Postive
17205,Langerhans,Lymphoma Papers,Negative
17206,KnowyourSubtype Learn Hodgkin NonHodgkin CLL,LymphomaAction,Negative
17207,AidenPincombe RMLL CLL,Magic Max,Negative
17208,CLL,Michael Wang MD,Negative
17209,ThrowbackThursday SunderlandFDN million two thousand and eighteen Cambridge Tower three BMT CLL,KU Cancer Center,Negative
17210,Preclinical Research Suggests Role ITK Inhibition CLL Monocytic,Renal Cell Carcinoma,Negative
17211,Tenemos de la que creemos coincidencias acercan CLL,Jany,Negative
17212,VIDEO ASH two thousand and nineteen David Maloney Lymphoma CLL,VJHemOnc,Negative
17213,Aptose Biosciences one,Cancer Stem Cell News,Negative
17214,Venetoclax Combo Effective,SciTech Research,Negative
17215,CTImaging PennMedicine Anthony Mato,Radiology Clinics,Negative
17217,CLL vos jours de repos,JU,Negative
17219,Today seven CLL MMX one KETL SRT,Jon,Negative
17220,two CLL,Aziz Khan,Negative
17221,CLL three one,WheelieDealer,Postive
17222,CLL Cello Health first half CLL,Ruth Gemmell,Negative
17223,CLL,Andrew Scott,Negative
17224,VIDEO David Maloney Lymphoma CLL,VJHemOnc,Negative
17225,CLL Cello Health first half CLL AndrewScottTV,Proactive,Negative
17226,CLARITY CLL MRD,chadi nabhan MD MBA FACP,Negative
17227,The Untold Story Tcell,Bruce Levine,Negative
17228,CLL CLL,AbbVie US,Postive
17229,Venetoclax Ibrutinib CLL FunctionalPrecisionMedicine,Sigrid Skanland,Negative
17230,SelfRegional SunriseLasVegas CLL,ACCC,Postive
17232,The Untold Story Longest Persisting Cells CLL,Penn Path Lab Medicine,Negative
17233,Chronic CLL one three year ago,Mike Dicks,Negative
17234,dans mon CLL,JU,Negative
17235,Chronic CLL one three,Mike Dicks,Negative
17239,first CLL,The Lancet Haematology,Postive
17240,CLL Brazilian Nice Bcells,Prof John,Negative
17241,Cirugia Oral Implantologia Urizar Gorosarri Feliz de parte de todo el equipo CLL LacasaLitner,Clinica Lacasa Litner,Negative
17243,CLL,JU,Negative
17245,TeamDavao Davao Davao Stop Visayas,IG,Negative
17246,CLL,Kathleen Hoffman,Negative
17247,Plesiomonas Leukemia Lymphoma Mansour Alfayez,Naveen Pemmaraju MD,Negative
17248,CLL,CancerDotNet,Negative
17249,five,Ezzy,Negative
17250,four,Ezzy,Negative
17251,three,Ezzy,Negative
17252,two,Ezzy,Negative
17253,one,Ezzy,Negative
17254,two Peter Hillmen MRD CLL CancerNews,Sarah Williams,Negative
17255,Tuesday August,Patient Empowerment Network,Negative
17256,Zielgerichtete Krebstherapie Leukamie CLL langfristig wirksam al die Chemotherapie five Jahren Patienten Leben Gefunden,Pharma Fakten,Negative
17257,BTK CLL,CellworksLife,Negative
17258,August six eleven AM PM Eastern Connect CLL LIVE Ask Expert,Patient Power,Negative
17259,Learn CLL AML CME today,Oncology CE,Postive
17260,APTO two two CLL twelve hour week,Joe,Negative
17261,APTO CLL APTO FDA AML,Joe,Postive
17262,nuestro equipo CLL Carmen Meno de Atencion al Paciente Ademas,Clinica Lacasa Litner,Negative
17263,CLL BTK twentyeight day seven DSMB,Joe,Negative
17265,David Maloney Lymphoma CLL,VJHemOnc,Negative
17267,twenty,Ezzy,Negative
17268,nineteen,Ezzy,Negative
17269,eighteen,Ezzy,Negative
17270,seventeen,Ezzy,Negative
17271,sixteen,Ezzy,Negative
17272,fifteen,Ezzy,Negative
17285,thirty,Ezzy,Negative
17287,CLL,Benlazar Amine,Negative
17289,TGTX Phase two Evaluate Efficacy Safety Patients With Chronic,ClinicalTrialsData,Negative
17291,This afternoon LymphomaManagement CLL Hodgkin George Follows Rifca LeDieu BloodCancer,LymphomaAction,Negative
17292,fifth Richard Rosenquist Brandell NGS Genomic Medicine,Biotexcel,Negative
17293,PET CLL BloodCancer,LymphomaAction,Negative
17294,Global Chronic Lymphocytic Leukemia Treatment Market two thousand and nineteen AB Science SA Amgen Celgene Corporation Dynavax Technologies Corporation Eisai,HAM,Negative
17296,District Championship Intermediate Provincial Championship Junior Provincial Championship Good CLL postseason journey,Coquitlam LL,Postive
17297,CLARITY first one TAP Trialsacclerationprogramme CLL JCO,Becky Bishop,Postive
17298,Oxidative CLL LeukemiaJnl,Deyan Yosifov,Negative
17299,Sunday Chronic CLL Today,Mission Bio,Postive
17300,Lianne Palmer CLL OxfordHaem CLL LymphomaMasterclass LivingwithandbeyondCancer CNS,LymphomaAction,Negative
17301,CLL three BloodJournal,Florian Slimano,Postive
17304,MRD PB CLL obinutuzumab venetoclax,Michael Hallek,Negative
17306,BTK,Oncology Nursing News,Negative
17307,CLL,Kathleen Hoffman,Negative
17308,CLL one,Amber Koehler,Negative
17309,CLL Arnon Kater,VJHemOnc,Negative
17310,Myeloma two thousand and eighteen,Oncology Tube,Negative
17311,CLL MRD MRD CR one PD FLAIR,Toby Eyre,Postive
17312,CLL,Michele,Negative
17314,Study Rituximab,Trip Database,Negative
17315,CLL CLL STATnews,Pharmacyclics AbbVie Company,Negative
17316,DYK eighty CLL Learn CLL,JanssenUS,Negative
17318,Commentary Quest CLL,Blood Journal,Negative
17319,CLL one,PeerView,Negative
17320,CLL,Blood Journal,Negative
17321,SriCity Platinum Green Building Council IGBConline CII,Rishikumar Vundi,Negative
17322,Blood Journal,Dr Comeau MD,Negative
17323,next week CLL Tuesday sixteen July Prepare FAQ,CLL Warwick Uni,Negative
17324,European EPAR MabThera Lymphoma Arthritis Rheumatoid,Pharma Regulatory,Negative
17326,fifth UK NonHodgkin CLL Image,LymphomaAction,Negative
17329,Study Assess Efficacy,CureHuntr,Negative
17330,Study Evaluate Impact Ibrutinib Quality Life,CureHuntr,Negative
17331,Cancer Language,Jeff Neurman,Negative
17332,BloodJournal led Roberts Seymour Efficacy CLL,Haematology Peter MacCallum CC Royal Melbourne,Negative
17333,Blood Journal Patients CLL,Izaskun Zeberio,Negative
17334,CLL BloodJournal,Raul Cordoba MD PhD,Negative
17335,CLL BloodJournal,Raul Cordoba MD PhD,Negative
17336,two hundred and four CLL CLL BTK thirteen BTK Raises,Toby Eyre,Negative
17337,SelfRegional SunriseLasVegas CLL,ACCC,Postive
17339,Study Assess Efficacy,TrialBulletin,Negative
17340,CLL,TrialBulletin,Negative
17342,thirty,The Governor EVOO,Negative
17343,arrivata la Ematoinfo Focus Conference Malignant Lymphoma CLL,EmatoInfo,Negative
17344,Durante la International Conference Malignant Lymphoma dati Alessandra Tedeschi Marco Montillo li hanno commentati CLL,EmatoInfo,Negative
17345,DanaFarber DrTonyLetai FunctionalPrecisionMedicine CLL Boston,Sigrid Skanland,Postive
17346,Prognostic Score Cytogenetic Risk Classification Chronic,Benlazar Amine,Negative
17347,Prognostic Score Cytogenetic Risk Classification Chronic,Cure Cancer Now,Negative
17349,Venclexta Venetoclax Drug Report two thousand and nineteen,MedFirst MedComms,Negative
17350,CLL,CLL Society Inc,Negative
17351,CLL,CLL Society Inc,Postive
17352,Register CLL Society CLL twentytwo AM PDT PM EDT CLL CLLsm,CLL Society Inc,Postive
17353,CLL,Blood Journal,Negative
17354,CLL,CancerTherapyAdvisor,Negative
17355,Tuesday,Patient Empowerment Network,Negative
17357,Zanubrutinib BeiGene Global Drug Report two thousand and nineteen,SPI News,Negative
17358,Venclexta Venetoclax Drug Report two thousand and nineteen,SPI News,Negative
17360,CLL,AbbVie US,Negative
17361,KPTI Phase one,ClinicalTrialsData,Negative
17362,two,ClinicalTrialsData,Negative
17363,First Dueling first,Jeff Neurman,Postive
17364,Francesc Bosch Sidnavigare Dr Riccardo Chronic NatRevClinOncol,Sabela Bobillo,Postive
17365,Retracement Bearish today BON ANP CLL MGR,SwingTradeBot UK,Negative
17366,Scan Bearish Engulfing today LTG IOM ORM,SwingTradeBot UK,Negative
17367,Farah MD,COPD News,Negative
17370,August six eleven AM PM Eastern Connect CLL LIVE Ask Expert,Patient Power,Negative
17371,CLL Cello Health Germany Berlin CLL,Ruth Gemmell,Negative
17372,CLL Cello Health Germany Berlin CLL AndrewScottTV,Proactive,Negative
17373,CLL,Gillian Slater,Negative
17374,CLL,Kathleen Hoffman,Negative
17376,DYK CLL Learn CLL,Pharmacyclics AbbVie Company,Negative
17378,Josh Brody MD Icahn School Medicine Mount Sinai The Mount Sinai Hospital,Oncology Tube,Negative
17379,three Moon Shots Program CLL Learn CancerMoonshot,MD Anderson Cancer Center,Negative
17380,CLL,iwCLL,Negative
17381,CLL one,Taylor Lab UM,Postive
17383,Susan Brien MD CLL CLL,Expert Perspectives Oncology,Negative
17384,The Kansas Society Clinical Oncology ACCCBuzz Koffman CLL,Oncology State Societies ACCC,Postive
17385,European EPAR Rituzena Tuxella rituximab Lymphoma Microscopic Polyangiitis Leukemia seven Status Withdrawn,Pharma Regulatory,Negative
17386,BloodJournal,ASH,Negative
17387,IDIVALdireccion FANCA CLL,IDIVAL,Negative
17388,VIDEO Venetoclax CLL Arnon Kater HemeOnc,VJHemOnc,Negative
17389,two Broadway tomorrow CLL,Matt Trinite,Postive
17390,Prognostic Score Cytogenetic Risk Classification Chronic,Chocolatiere Phys,Negative
17391,CARTcells CRS CLL Gauthier Concurrent,Targeted Oncology,Negative
17393,first Lymphocytic Leukemia Chronic Lymphocytic CLL,COPD News,Postive
17394,CLL,Raul Cordoba MD PhD,Negative
17395,day one Gordonsville Day two Broadway Community three CLL,Matt Trinite,Negative
17396,CLL,CellworksLife,Negative
17398,three two thousand and nineteen EHA Congress CLLsm,Targeted Oncology,Negative
17399,Venclexta Improves Outcomes Among Chronic,Cancer Health,Negative
17400,Saanich today tonight Intermediate AllStars GameChanger,Brad Robinson,Postive
17401,CLL Barbara Eichhorst HemeOnc,VJHemOnc,Negative
17402,Adrian Wiestner NIH Love Bethesda CLL,Sigrid Skanland,Postive
17403,Venetoclax,Medivizor,Negative
17404,Venetoclax,Medivizor,Negative
17405,one,Renal Cell Carcinoma,Postive
17406,HematologicalMalignancies NatureComms LaStatale CLL,Hematopoiesis News,Negative
17408,ICYMI Blood Journal Chronic Jaco van Bruggen,AA MDSIF,Negative
17409,CLL NatRevClinOncol,MoJo,Negative
17410,Retracement Bearish today SFE NAIT HCM IGAS CLL,SwingTradeBot UK,Negative
17412,Subcutaneous Rituximab Follicular,EurekaMag,Negative
17413,Prognostic Score Cytogenetic Risk Classification Chronic CLL,CellworksLife,Negative
17414,Brian Koffman CLL six CLL CLLsm,CLL Society Inc,Negative
17415,FANCA,HEMMOL,Negative
17417,two Suffering FridayThoughts CLL,Mike ForThePeople,Negative
17418,Leukemia CLL Bosch Sidnavigare VHIO Review,ImmunoSCOPE,Negative
17419,one Maximilian Koch PhD CLL TME,Michael Hallek,Postive
17421,CLL CARTcells CLLsm,Raul Cordoba MD PhD,Negative
17422,Retracement Bearish today PGIT WRKS ACC ALB SFE,SwingTradeBot UK,Negative
17423,de la decada los primeros regimenes de inmunoterapia fueron quimioterapia el tratamiento de la Leucemia Linfocitica Cronica,AMIIF Mexico,Negative
17424,ha evolucionado el tratamiento de la leucemia linfocitica Decadas de investigacion los cientificos medico nuevas alternativas terapeuticas Nos lo,AMIIF Mexico,Negative
17427,Venetoclax CLL,Lymphoma Hub,Negative
17428,Independence Day,Jeff Neurman,Negative
17430,New Medivizor Combining,Medivizor,Negative
17431,Leukamie kurz CLL Breitengraden Blutkrebsart Die Behandlungsmoglichkeiten Erkrankung Jahren,Pharma Fakten,Negative
17433,CLL recent year Learn,AplusA World,Negative
17434,CLL,Kathleen Hoffman,Negative
17435,CLL,chadi nabhan MD MBA FACP,Negative
17436,Prognostic Score Cytogenetic Risk Classification Chronic,Cure Cancer Now,Negative
17437,ClinicalUpdates Review AML CLL Drs Delgado Eichhorst SapienzaRoma,Medscape Education,Postive
17438,Ian Flinn CLL,Sarah Cannon Docs,Negative
17439,Earlier year Read CLL,Oncology State Societies ACCC,Postive
17440,KOs CLL Stanford,Blood Journal,Negative
17443,CLL Hirayama HemeOnc,VJHemOnc,Negative
17444,Lori Leslie MD Hackensack University Medical Center Lymphoma CLL,Oncology Tube,Negative
17445,CLL FANC FASEBJournal Elevated FANCA IDIVALdecilla,Prof John,Negative
17446,CLL,Blood Journal,Negative
17447,Instagram CLL Westwood squirrel cll,CLL Warwick Uni,Postive
17449,DYK CLL Learn,AbbVie US,Negative
17450,StemCells Chemotherapy Drug Molecule,Danish hussain,Negative
17451,Clinical Molecular Evidence Atovaquone,Bloodsucking Parasites,Negative
17452,Download eBook,AplusA World,Postive
17455,ImmunoTherapy Cancer Chronic,dr upendra sharma,Negative
17457,CLL CLLAdvocates,Natacha Bolanos,Negative
17458,two thousand and nineteen Now CLL today CLL CLLsm,CLL Society Inc,Postive
17460,Retracement Bearish today ACSO,SwingTradeBot UK,Negative
17461,Linfomas,MDDigitasTV,Negative
17462,OncLive LymphocyticLeukemia,Levine Cancer Institute,Negative
17463,VIDEO CLL HematologyTweet Kuwait Cancer Control Center HemeOnc,VJHemOnc,Negative
17465,today Summer Reading Challenge CLL,Ysgolllanbedr,Negative
17466,Coutre BloodJournal CLL,Amber Koehler,Negative
17467,Visits one hundred and one Forums CLL Points seven hundred Exchanges CLL,CryptoLiveLeak,Negative
17468,"two thousand, five hundred Register call Join OHC",OHC,Postive
17469,CLL,Ysgolllanbedr,Negative
17470,CLL CLL,Patient Power,Postive
17472,CLL,CLL Society Inc,Negative
17474,CLL Sept Edinburg Scotland Press,iwCLL,Negative
17476,seven year eighteen year ago one CLL PMA,Rustique Chic,Negative
17477,The Food Drug Administration Venclexta obinutuzumab Gazyva,National Cancer Institute,Negative
17478,MRD,AJMC,Negative
17479,HemOnc Fellow Welcoming,Duke Hematologic Malignancies Cellular Therapy,Postive
17480,six STATnews CLL,Pharmacyclics AbbVie Company,Negative
17481,first fifty year ago today,JanssenUS,Negative
17482,one Learn CLL,Catherine Velazquez,Negative
17483,Chronic,Lampe Company,Negative
17486,CLL Leukaemia Fatigue,Mike Scrabble,Negative
17487,Chemotherapy CML CLL,Tha Dze,Negative
17488,Graduation month CLL,CLL Warwick Uni,Negative
17489,LPL,EurekaMag,Negative
17492,CLL,CellworksLife,Negative
17494,CLL,Kathleen Hoffman,Negative
17495,one seven day Scouts summer Camp Long Lake,cetan,Postive
17497,CLL two,Raul Cordoba MD PhD,Negative
17498,three hundred and eightyfour CLL lymsm,Raul Cordoba MD PhD,Negative
17499,Hu et al mut ATM Rai Binet TTFT del mut CK TTFT MVA ATM CLL,Toby Eyre,Negative
17501,Center International Blood Marrow Transplant Research,Cure Cancer Now,Negative
17503,ASH two thousand and sixteen two Update New Chronic,Oncology Tube,Negative
17504,ASH two thousand and sixteen three,Oncology Tube,Negative
17505,ASH two thousand and sixteen Pagel two Update New Chronic,Oncology Tube,Negative
17506,one Mighty,Jeff Neurman,Negative
17507,Leukemia MAb Roche,Mary Ruberry,Negative
17508,CLL,CLL Society Inc,Negative
17509,CLL Lugano Stay,Lymphoma Hub,Negative
17510,first CLL American Journal Hematology,Raul Cordoba MD PhD,Negative
17511,three FCR CllSociety CLL,Tom Henry MBA RPh CPh,Postive
17512,first CLL TTNT QoL ALC,Mahmoud Aljurf,Negative
17513,VIDEO Venetoclax CLL Arnon Kater Leukemia,VJHemOnc,Negative
17514,Cathy Skinner myeloma livewell AndrewSchorr PatientPower,Patient Power,Postive
17515,Speech Language Difficulties Discover CLL,Early Years LSC FE VocEd EYFS,Postive
17516,XPS,SwingTradeBot UK,Negative
17517,Incompetence By Design,Jeff Neurman,Negative
17518,obinutuzumab CLL CLLsm,Raul Cordoba MD PhD,Negative
17519,JMIR Mobile Apps Increasing Treatment Adherence Systematic Review Journal Medical Internet Research CLL,Raul Cordoba MD PhD,Negative
17520,Venetoclax,Medivizor,Negative
17521,CLL Trial FCR Ibrutinib,Michele,Postive
17522,Michael Reff Kirollos Hanna CLL,SpecialtyPTimes,Negative
17524,livewell AndrewSchorr PatientPower,Patient Power,Negative
17525,CLL Bcells,Prof John,Postive
17526,Effects Estrogen Receptors,Research Watch,Negative
17527,CLL,CLL Ireland,Negative
17528,Check Venetoclax,Medivizor,Negative
17529,Venclexta Gazyva Reduces Disease Progression CLL,Robinson Ortiz MD,Negative
17530,CLL,Kathleen Hoffman,Negative
17531,HL,Oncology Tube,Negative
17534,FLAKY BTK CLL IBRUTINIB,Prof John,Negative
17535,CLL,Hematology Advisor,Negative
17537,The Nordic CLL Study Group NCLLSG Educational Meeting Oslo April two thousand and twenty CLL Care Cure,Sigrid Skanland,Postive
17539,StimulusReport LymphoidNeoplasia,Blood Advances,Negative
17540,Gait Speed Predict,Michele,Negative
17542,DRG United States Western Europe DRGinsights CLL AstraZeneca,DRG Epidemiology,Negative
17544,July CLL CML Read,The Lancet Haematology,Negative
17545,Aspergillus CLL CLLsm,Raul Cordoba MD PhD,Negative
17546,Bittersweet Little League Sean fourteen year Santa,Susan Oehlers,Negative
17547,year ago,Kiana Danial,Postive
17548,CLL Edinburgh Sept,iwCLL,Negative
17550,MC Squared,Jeff Neurman,Negative
17553,ChronicLymphocyticLeukemia CLL,Patient Worthy,Negative
17554,Wang et al two hundred four CLL CLL UK two Rx MVA SCT,Toby Eyre,Postive
17555,CME Webinar Participate Oncology VideoWebinars CMEcredits Click Melanoma CLL,Paradigm Med Comm,Negative
17556,APTO today ARQL APTO CLL,Joe,Negative
17557,CLL three,Raul Cordoba MD PhD,Negative
17558,HallekMichael University Cologne Germany CLL,VJHemOnc,Negative
17559,Rod Humerickhouse The Importance Minimal Residual Disease Negativity AbbVieUS Leukemia CLL,Oncology Tube,Negative
17560,Gm Talk RackoonMix CLL Chocolate,RackooN CiTy,Negative
17561,TrialTuesday Jennifer Woyach Alliance,Alliance Clinical Trials Oncology,Negative
17562,CLL Full CLL,CLL Society Inc,Postive
17563,CancerCare frailty CancerCareMBFdn Drs Dawe Banerji CLL,RIOH,Negative
17566,ChemoFree CLL Satellite Symposium,Lymphoma Hub,Negative
17567,CLL Thornton HallekMichael JanRynne CllSociety CLLAdvocates,Michael Rynne,Postive
17568,Motivates GCLLSG CLL LEUsm UKKoeln,Michael Hallek,Postive
17570,CLL,David Panian,Negative
17571,Prof Patrick Thornton attendee recent National Information Day CLL,CLL Ireland,Postive
17572,CLL Brian Koffman CLL,Toula Castillo,Negative
17573,CLL,Journal Clinical Pathways,Negative
17574,CLL John Pagel Swedish,ACCC,Postive
17576,CLL today CLL,Pharmacyclics AbbVie Company,Negative
17577,CLL,SpecialtyPTimes,Negative
17578,CLLSociety CLL Society Alert CLL CLL,Verastem Oncology,Postive
17579,FDA CLL SLL,Jacinto Convit World Organization,Negative
17580,Susan Brien MD CLL,Expert Perspectives Oncology,Negative
17581,Davids TRANSCEND CLL four CLLsm,Targeted Oncology,Negative
17582,von der Lugano Videoberichte ZNSL von der Alle Videos Informationen,Kompetenznetz Maligne Lymphome,Negative
17583,Das Kompetenznetz Videoberichten ZNSL von der Alle Videos,idw Nachrichten,Negative
17584,CLL HEDGEHOG Bcells,Prof John,Negative
17586,MEIP Reveals FL CLL,Hottest Stocks Now,Negative
17588,CLL,CLL Society Inc,Negative
17589,Andrew Esther Schorr CLL Jeff Folloder CLL AndrewSchorr PatientPower,Patient Power,Negative
17590,CLL,Marc Braunstein MD PhD FACP,Negative
17591,Michael Hallek Step Vimeo,oncoletter,Negative
17592,Roundup Weed Killer Multiple Victims,missmaybell,Negative
17593,Jan seventeen lost eleven lb last three week,Chris Douglas,Negative
17594,CLL Last day,chadi nabhan MD MBA FACP,Negative
17595,CLL one two AttentionMining summer CLL,CryptoLiveLeak,Negative
17596,Clinical Kidney Journal,Luis Enrique Alvarez,Negative
17597,Ohio State CLL,The James,Negative
17598,CLL,Flow Paradigm,Negative
17599,Italian,Benlazar Amine,Negative
17600,CLL,Blood Journal,Negative
17601,CLL Tune ASH two thousand and eighteen,Patient Power,Negative
17602,June Session fourteen Digital Health,Carevive,Negative
17603,OurHealth Eric Wallisa CLL,OurHealth,Postive
17604,CLL,Blood Journal,Negative
17605,Statin Manitoba Canada,Cancer Epidemiology Biomarkers Prevention,Negative
17606,Lugano Lymsm CLL,linfopedia,Negative
17607,statin fluvastatin CLL CancerCareMB,Gary Annable,Negative
17608,Condoluci Binet CLL one three,Michael Hallek,Negative
17609,CARTcells CLL,MoJo,Negative
17610,CARTcells CLL,MoJo,Negative
17611,CONGRESS CLL,Lymphoma Hub,Negative
17612,CLL,Toby Eyre,Postive
17613,day BBCBreakfast one CLL,Orla Stewart,Negative
17614,CLLuster statin CLL,RIOH,Negative
17615,CLL Ibrutinib today DrRaulCordoba,chadi nabhan MD MBA FACP,Negative
17616,Delgado EBMT CIBMTR recommendation CLL,Jordan Gauthier,Negative
17617,HallekMichael one CLL Lugano,linfopedia,Negative
17618,CLL,Kathleen Hoffman,Negative
17619,CLL Learn PatientPower CllSociety CllIreland,Michele,Negative
17620,CLL Wierda AndrewSchorr,Patient Power,Negative
17623,The Beginning End,Jeff Neurman,Negative
17624,livewell patientpower,Esther Schorr,Negative
17625,Scan Hammer Candlestick today CLL FTC ITX RED BXP HLCL,SwingTradeBot UK,Negative
17626,Bruton,Dermatology News,Negative
17627,Venclexta Venetoclax,Lampe Company,Negative
17628,Agree Genetic CLL,Michael Hallek,Postive
17629,CLL,CancerTherapyAdvisor,Negative
17631,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
17632,CLL year,SpecialtyPTimes,Negative
17633,NEWS BeiGene BTK Read,BeiGene,Negative
17634,BeiGene Announces Phase Clinical Results,SPI News,Negative
17635,CLL,CancerTherapyAdvisor,Negative
17636,two thousand and nineteen,OEAPS EU International Scientific Association,Negative
17640,Umbralisib KI CLL Definition KI,Raul Cordoba MD PhD,Negative
17641,First CLL first,Toby Eyre,Negative
17642,CLL,Michele,Negative
17643,CLL Kirsten Fischer Michael Hallek John Seymour CLL,Christian Reinhardt,Negative
17644,NEWS BeiGene two BTK Read,BeiGene,Negative
17645,BeiGene Presents Pivotal Phase two,Crwe World,Negative
17646,CLL UniCologne CLLsm,VJHemOnc,Negative
17647,Das KML Lugano Samstag Videobeitragen Ergebnisse zur CLL NHL Alle Grusswort von HallekMichael,Kompetenznetz Maligne Lymphome,Negative
17649,MYC,Richard Rosenquist Brandell,Negative
17650,Richard Furman MD Personalized Management WCMCLymphoma,Oncology Tube,Negative
17651,Rituximab,Medivizor,Negative
17652,one,CURE Magazine,Negative
17653,HallekMichael CLL Lymsm,Stephanie Hill,Postive
17654,Darwin CLL Jose Carreras two thousand and,Talbot Alexis,Postive
17657,CLL BTK,Oncology Clinical Pathways Congress,Negative
17658,cll,Dr Sylvia Benjamin,Negative
17659,Siempre un escuchar esa CLL,Jany,Negative
17660,Petra Langerbeins Lugano CLL GCLLSG UKKoeln,Michael Hallek,Postive
17661,CLL Session three CLL,Roche,Negative
17662,Jos Melenhorst Research,Penn IFI,Negative
17663,CLL Petra Langerbeins HallekMichael GCLLSG,Marek Trneny,Postive
17664,Brian Parkinson,AACR Foundation,Negative
17665,ibrutinib ritux MCL ORR Ritux,Toby Eyre,Negative
17666,CLL Steering Committee HallekMichael Lugano,Lymphoma Hub,Negative
17668,CLL,Raul Cordoba MD PhD,Negative
17669,Notable,Toby Eyre,Negative
17670,Petra Langerbeins UniCologne three CLL Lymphoma,Lymphoma Hub,Negative
17671,CLL,News,Negative
17672,Science Henrik Bendiksen Congratulations TaskenLab UiB Bergen CLL,Sigrid Skanland,Postive
17673,Carl June CLL DLBCL,Thilo Zander MD,Postive
17674,CLL,JADPRO,Negative
17675,Bayesian three MURANO Study,Lymphoma Papers,Negative
17676,CLL BTK CLL CLL,Targeted Oncology,Postive
17677,CONGRESS CLL Lymphoma DanaFarber,Lymphoma Hub,Postive
17678,NICR Inhibition Selectively Induces Gene Signature,Newcastle University Centre Cancer,Negative
17679,CLL two thousand and nineteen HallekMichael,Juan Marquet,Negative
17680,CONGRESS CLL first second CLL UniCologne,Lymphoma Hub,Negative
17682,CLL,Kathleen Hoffman,Negative
17683,Rod Humerickhouse The Importance Minimal Residual Disease Negativity AbbVie CLL,Oncology Tube,Negative
17684,three CLLsm,Targeted Oncology,Negative
17685,CLL Chemotherapy,Dallas Thompson,Negative
17686,CLL CLLsm,Mike Thompson MD PhD FASCO,Negative
17687,one,Jeff Neurman,Negative
17688,Ibrutinib GenericImbruvica Mantle Chronic Mfg InceptaPharma Ltd GenericIbrutinib OvarianCancer Leukemia CancerDrugs,Medicine For World,Negative
17689,Scan Bearish Centerline Cross today LVCG NLB GLO UPL PIN,SwingTradeBot UK,Negative
17690,CLLSA Virgin London July Sarah CLL,CLLSA,Postive
17691,CLL NHL OranoMed,Savepig Invest GotSilver,Postive
17692,CLL,iwCLL,Negative
17693,two hundred and four Haematologica CLL CLLsm,Raul Cordoba MD PhD,Negative
17694,CONGRESS HallekMichael CLL,Lymphoma Hub,Negative
17695,HallekMichael CLL,Judith Trotman,Postive
17696,Listen,Patient Power,Negative
17697,Vit CLL two thousand and eleven CLLsm SuppOnc,Mike Thompson MD PhD FASCO,Negative
17698,one thousand nine hundred CLLsm NorthwellHealth BrookhavenLab NYULMC,Mike Thompson MD PhD FASCO,Negative
17699,one thousand nine hundred Rai et al BloodJournal,Mike Thompson MD PhD FASCO,Negative
17700,CLL,Scott Merville,Negative
17701,CLL,AbbVie US,Negative
17702,RT Conclusions CLL HSCT,Amber Koehler,Postive
17703,Veneclexta Imbruvica CLL two MDAnderson Read,Cancer Education Research Institute,Negative
17704,This week NewstalkFM CllIreland CLL CllSociety Check,Futureproof,Negative
17705,SunesisPharma SunesisPharma Pharmaceutical CLL EHA,Mateen Dalal,Negative
17706,Michael Hallek Twitter CLL,Dr Timos Papagatsias,Postive
17708,Venclexta Imbruvica MDAndersonNews,National Cancer Institute,Negative
17709,The Food Drug Administration Venclexta obinutuzumab Gazyva,National Cancer Institute,Negative
17710,one Jo Pleaseeeeee CLL,Amanda Marie,Negative
17711,CLL Petra EFS two,Michael Hallek,Postive
17712,InvestigatorProfile,TrialSite News,Negative
17713,two CLL DanaFarber,Medscape Education,Postive
17714,JuLa Creole Cuisine Eating Well Peter Jaret Chemotherapy,Big Artists Agency,Negative
17715,fifty Bearish List TRG CLL CTP EHG,SwingTradeBot UK,Negative
17717,CLL,Lymphoma Hub,Postive
17719,Coutre CLL Diarrheoa Prevalence HTN inc AEs thirteen eleven,Toby Eyre,Negative
17723,Darin CLL Grusswort von HallekMichael,Kompetenznetz Maligne Lymphome,Negative
17724,Jennifer Brown Bruce Susan Brien CLL CLL DanaFarber LombardiCancer,Expert Perspectives Oncology,Negative
17725,Michael Hallek wurde Jose Carreras Award Arbeit Bereich CLL Gute News Patienten Durch Forschung konnen Behandlungsmethoden Herzlichen Gluckwunsch,AbbVie Deutschland,Negative
17727,ARQL ARQ five one CLL five hundred SNSS Imbruvica,BioPharm Insight,Negative
17728,nine,CDD press,Negative
17729,CLL BayArea Biotech,San Francisco Biotechnology Network Jobs,Negative
17730,CLL Watch CLLsm Leusm,VJHemOnc,Negative
17731,CLL Share Ulrich,Gary Nolan,Postive
17732,CLL three Interesting UniCologne,MoJo,Negative
17733,two thousand and,Markets Reports,Negative
17735,CLL Philip Thompson MedscapeEdu,Medscape Education,Negative
17736,CLL CLLsm,Raul Cordoba MD PhD,Negative
17737,two,Targeted Oncology,Postive
17738,Monday Matt Royal Marsden tomorrow,MerMer Goodburn,Negative
17739,CLL Improved PFS,Caner Saygin MD,Negative
17740,Six year ago next month today Day Dad,Reviews,Negative
17741,obinutuzumab VenG CLL,Marta Gunjaca,Negative
17742,MedscapeLIVE The Changing Face CLL Treatment John Seymour PeterMacCC Stephan Stilgenbauer,Medscape Education,Postive
17743,Venetoclax Obinutuzumab Untreated,Medscape Education,Negative
17744,six CLL John Seymour PeterMacCC,Medscape Education,Negative
17745,five Ibrutinib Ofatumumab Notable John Seymour PeterMacCC,Medscape Education,Negative
17746,four Ibrutinib John Seymour PeterMacCC,Medscape Education,Negative
17747,Times three,Medscape Education,Negative
17748,two Ibrutinib Rituximab FCR Study Design,Medscape Education,Negative
17749,MedscapeLIVE The Changing Face CLL Treatment Moving With Times seven one FCR MDAndersonNews,Medscape Education,Negative
17750,CLL Kater CLL CLL,Dr Effie Kostareli,Postive
17751,CLL,Raul Cordoba MD PhD,Postive
17752,Petra Langerbeins UKKoeln Ibrutinib CLL TTNT AES HallekMichael,Paula Cramer,Postive
17753,Immunosuppressive Treg,ImmunologyPapers,Negative
17754,three MURANO BloodCancer Hematology,Targeted Oncology,Negative
17755,Las mejores Tuyucua Felicitaciones la chicas de por LasGumarelas CLL,Revista El Repollero,Negative
17756,Ramlal Clinical Case Reports,Hartford Hospital Pathology,Negative
17757,CLL two thousand and nineteen,Club Libertad Limpeno,Negative
17758,CLL Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
17759,CLL CDC,Club Libertad Limpeno,Negative
17760,CLL ST,Club Libertad Limpeno,Negative
17761,CLL CDC,Club Libertad Limpeno,Negative
17762,CLL CDC Ingresa Angelica Liz Pena,Club Libertad Limpeno,Negative
17763,CLL CDC fourteen ST,Club Libertad Limpeno,Negative
17764,CLL CDC,Club Libertad Limpeno,Negative
17765,CLL CDC DE LA PRIMERA,Club Libertad Limpeno,Negative
17766,CLL CDC,Club Libertad Limpeno,Negative
17767,CLL CDC ten,Club Libertad Limpeno,Negative
17768,CLL CDC,Club Libertad Limpeno,Negative
17769,CLL Alicia Bobadilla Laurie Cristaldo Joana Galeano Cortaza Liz Pena,Club Libertad Limpeno,Negative
17770,FathersDay past year Darryl September eighteen CancerSucks Darryl,Denver Water,Negative
17771,Second CLL BTK,Raul Cordoba MD PhD,Negative
17772,Infections CLL,Raul Cordoba MD PhD,Negative
17773,Abbvie,Toby Eyre,Postive
17774,CLL CLL Registration two thousand and Edinburgh Scotland,BioAscend,Negative
17775,afternoon NKRdata,Avinash Dinmohamed,Postive
17776,Efficacy Ibrutinib CLL MURANO first eight PR mDOR,Raul Cordoba MD PhD,Negative
17778,CLL Financial AML LeukaemiaCareUK,Zack,Postive
17779,CLL,Raul Cordoba MD PhD,Negative
17780,di rilievo per chi si CLL Il Francesca Mauro micdicataldo MariaTeresaEs ciollistefania albertomussetti AGiustacchini DoctorDianaP,EmatoInfo,Negative
17781,Miguel Cll BTK,Dr Effie Kostareli,Negative
17782,Saskia Rudat CLL,Dr Effie Kostareli,Negative
17783,BloodCancers,Targeted Oncology,Negative
17784,two thousand and Topps Cactus League Topps ToppsBaseball Baseball Sports CardCollecting eBay,Chad Slagter,Negative
17785,CLL Clinical Trial iFCR DanaFarber PatientPower CllSociety,Michele,Postive
17786,CLL,Marek Trneny,Negative
17787,CLL,MoJo,Negative
17788,CLL Genetics one hundred and one Everything You Need Know About Genetic Testing CLL,Michele,Negative
17789,today CLL YoungEHA,chadi nabhan MD MBA FACP,Postive
17790,Amsterdam RT CLL AML,AbbVie,Postive
17792,next hour NewstalkFM briankoffman join one decade,Futureproof,Negative
17793,CLL Venetoclax,chadi nabhan MD MBA FACP,Negative
17794,FIRE RWD French CLL Ibrutinib,chadi nabhan MD MBA FACP,Negative
17795,AFib three,PersonalizeAF,Negative
17796,Polish Adult Leukemia Study Group,Lymphoma Papers,Negative
17798,Dutch CLL afternoon NKRdata,Avinash Dinmohamed,Postive
17799,UKKoeln GCLLSG Leukemia Leusm,Michael Hallek,Postive
17800,RAI Amsterdam first JanssenEMEA MM CLL,European Hematology Association,Negative
17801,CMLologist CLL Thinking one,Juan Luis Steegmann,Negative
17802,breakfast morning CLL Houlston Sutton Kater Robak LornaWarwick JanRynne CllSociety,Michael Rynne,Negative
17803,EPA Reps,Catherine Gegaris,Negative
17804,Davids TRANSCEND CLL four CLLsm Leukemia,Targeted Oncology,Negative
17805,Jacqueline Barrientos Sequencing Monotherapy v Combination,Oncology Tube,Negative
17807,Andrew Esther Schorr CLL Jeff Folloder CLL AndrewSchorr PatientPower,Patient Power,Negative
17810,Obinutuzumab Use CLL LeukaemiaCareUK,DocWire News,Postive
17811,NHL CLL,Matthews Associates,Negative
17812,BSI Connected Learning Live CLL Watch CLL,BSI America,Negative
17813,Cathy Skinner myeloma livewell AndrewSchorr PatientPower,Patient Power,Postive
17814,today Amsterdam CLL CllIreland CllSociety,Michael Rynne,Negative
17815,two thousand and nineteen,Crwe World,Negative
17816,Wendtner CLL,The Lancet Haematology,Negative
17817,two CLL,The Lancet Haematology,Negative
17818,Kirsten Fischer UniCologne obinutuzumab,EmatoInfo,Negative
17819,TCell CLL,MoJo,Negative
17820,NewsletterEpignetik Fur von Krebs Leukamie CLL Das Abo,Peter Spork,Negative
17821,CLL Maloney CRS Tcells,MoJo,Negative
17822,CLL Peter Hillmen UniversityLeeds CLL CLLsm Leusm MRD,VJHemOnc,Negative
17823,CLL al DoNOT,Pallawi Torka,Negative
17824,CLL UK,Pallawi Torka,Postive
17825,CLL Maloney CRS three,Alexandra MD,Negative
17826,FDA,ADIL Med Monitor,Negative
17827,CLL one Response MRD,Charlotte Martin,Negative
17828,lymsm GIMEMA Rituximab CLL,Raul Cordoba MD PhD,Negative
17829,New Study Identifies Patterns Technology Research News,Denise Fetters,Negative
17830,CLL daily,Taylor Lab UM,Negative
17831,LR ARQL five hundred four six CLL seven QD KOLs,dough,Postive
17832,Jose Carreras CLL Amsterdam,Amit,Negative
17833,Prof Hallek CLL,The Lancet Haematology,Postive
17834,Said CLL,Mike ForThePeople,Postive
17835,CLL MRD LeukaemiaCareUK,Charlotte Martin,Negative
17836,Vision Arnon Kater CLL Vision,Eduardo Flavio Oliveira Ribeiro,Negative
17837,five year CLL LeukaemiaCareUK,Charlotte Martin,Negative
17838,CONGRESS CLL,Lymphoma Hub,Negative
17839,Kings College london,Lectures London,Negative
17840,CONGRESS Othman UniCologne VenG karyotpye CLL,Lymphoma Hub,Negative
17841,Cristof Scneider German CLL CLL,Eduardo Flavio Oliveira Ribeiro,Negative
17842,CLL PrecisionMedicine,Sigrid Skanland,Negative
17843,obinutuzumab CLL AratMutlu,EmatoInfo,Negative
17844,Nuclear Power,Jeff Neurman,Negative
17846,CllIreland Ireland CLL Amsterdam coming day,CLL Ireland,Postive
17847,FCR,Diagnostics News,Negative
17848,CLL Registration,Esther Schorr,Postive
17849,GoHealio John Pagel CLL,ACCC,Postive
17850,CLL,Nasser Nourallah,Postive
17851,Eric Anderson Sr US Anderson,Am Clinical Lab Assn,Negative
17852,CLL Susan Brien,Sigrid Skanland,Negative
17853,CLL AML,AbbVie,Postive
17854,CLL Paolo Ghia Ericllorg,VJHemOnc,Negative
17855,Carol Moreno CLL,Dr Effie Kostareli,Negative
17856,CLL,Lymphoma Hub,Negative
17857,Paolo Ghia CLL,Dr Effie Kostareli,Negative
17858,paso de la consagracion tremendo triunfo de la gumarelas de en la primera Kari Liza Griselda dejar Falta todavia falta vamos CLL LasGumarelas,Revista El Repollero,Negative
17859,CLL Peter Hillmen UniversityLeeds Paolo Ghia,VJHemOnc,Postive
17860,Ulrich Jager David Maloney CLL,VJHemOnc,Negative
17861,Ibrutinib CLL,CLL Society Inc,Negative
17863,European EPAR Truxima rituximab Lymphoma Arthritis Rheumatoid eight,Pharma Regulatory,Negative
17864,CLL year StJude CLLsm,VJHemOnc,Postive
17866,second Amsterdam first MM CLL,Janssen EMEA,Negative
17867,Viruses Stupid,Scott Wessels,Negative
17868,Tolero Pharmaceuticals Announces,PressReleasePoint,Negative
17869,livewell AndrewSchorr PatientPower,Patient Power,Negative
17870,Amsterdam CLL,CLL Advocates Network,Negative
17871,CDC fifty ST Griselda Garay,Club Libertad Limpeno,Negative
17872,CDC CLL Liza Larrea el,Club Libertad Limpeno,Negative
17873,CDC CLL ST CLLPY UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
17874,CDC CLL,Club Libertad Limpeno,Negative
17875,CDC ST CLLPY UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
17876,CDC Karina Vega,Club Libertad Limpeno,Negative
17877,CDC,Club Libertad Limpeno,Negative
17878,CDC CLL,Club Libertad Limpeno,Negative
17879,TRANSCEND CLL four CLL SLL Therapies,Beacon Targeted Therapies,Postive
17880,CDC CLL twenty,Club Libertad Limpeno,Negative
17881,CDC thirteen,Club Libertad Limpeno,Negative
17882,CDC CLL six,Club Libertad Limpeno,Negative
17883,CDC CLL Partido,Club Libertad Limpeno,Negative
17884,Saturday June fifteen,Verastem Oncology,Negative
17885,CLL,Kathleen Hoffman,Negative
17886,Paul Barr CLL ChronicLymphocyticLeukemia CLL,LYMPHOMA MYELOMA CONNECT,Negative
17887,New Study Identifies Patterns,SciTech Research,Negative
17888,one DAY AWAY Join CLL,Medscape Education,Postive
17889,CLL Treatment NEWS Therapy Deemed Safe Active,Michele,Postive
17890,first Research Projects AML CLL,HARMONY Alliance,Postive
17891,CLL,The Lancet Haematology,Negative
17894,Verastem Congress tomorrow one thousand ten,Verastem Oncology,Negative
17895,CLL CLLsm Ibrutinib,CLL Society Inc,Postive
17896,Davids TRANSCEND CLL four CLLsm,Targeted Oncology,Negative
17897,CLL,CancerTherapyAdvisor,Negative
17899,Rod Humerickhouse obinutuzumab VenG AbbVieUS CLL ChronicLymphocyticLeukemia,Oncology Tube,Negative
17901,CLL Ian Flinn,VJHemOnc,Negative
17903,Broad DanaFarber CLL,Verastem Oncology,Postive
17904,Philip Baldwin Prof Paul Moss,Birmingham Alumni,Postive
17905,DRG United States Western Europe DRGinsights CLL AstraZeneca,DRG Epidemiology,Negative
17906,one cll,Amanda Marie,Negative
17907,NGS twenty CLL four BTK three Mutations month,Nagy Akos,Negative
17908,CLL Ian Flinn Tennessee ImmunoOnc,VJHemOnc,Negative
17909,CLL The Association Community Cancer Centers Multidisciplinary Chronic Lymphocytic CLL CLLsm,CLL Society Inc,Postive
17910,CLL Folks Patterns Broad Institute CLLSociety CLLFighters PatientPower,Michele,Negative
17911,CLL Sept Edinburg Scotland Press,iwCLL,Negative
17912,CLL CLL CLLsm,Patient Empowerment Network,Negative
17913,CllSociety Ireland Nick Brian Patty,Michael Rynne,Postive
17914,CLL NEJM,Lymphoma Hub,Postive
17916,AIM CLL Cello Health PLC,AIM Alerts,Negative
17918,Uygur Han Xinjiang Uygur Autonomous Region China,EurekaMag,Negative
17919,CLL,Kathleen Hoffman,Negative
17921,esta en la gran Enorme torneo de la gumarelas un ma de ratificar la supremacia el premio de campeon Ahora VamosGUMA CLL,Revista El Repollero,Negative
17925,ST,Club Libertad Limpeno,Negative
17926,ST,Club Libertad Limpeno,Negative
17927,eight,Club Libertad Limpeno,Negative
17929,CCP CLL DE LA PRIMERA,Club Libertad Limpeno,Negative
17933,eighteen,Club Libertad Limpeno,Negative
17934,ten,Club Libertad Limpeno,Negative
17936,Alicia Bobadilla Laurie Cristaldo Joana Galeano Cortaza Liz Pena,Club Libertad Limpeno,Negative
17938,EYE fifteen kellyackroyd CLL EYtwittertagteam EYMatters,Early Years LSC FE VocEd EYFS,Negative
17939,CLL CLL,Patient Power,Postive
17940,German CLL CLL,Miguel Canales,Negative
17941,Weirda three MURANO,Targeted Oncology,Negative
17942,Fischer et NEJM three hundred and eighty CLL one HOVON Nordic CLL GCLLSG,Michael Hallek,Negative
17944,Medivizor,Chocolatiere Phys,Negative
17945,Floyd Hasenruck Floydiiii Friday one Koln CLL,Michael Hallek,Postive
17946,CLL GCLLSG UKKoeln,Michael Hallek,Negative
17947,John Seymour PeterMacCC three CLL,Medscape Education,Postive
17948,ASCO CLL,MedPage Today,Negative
17951,CLL Wierda AndrewSchorr,Patient Power,Negative
17952,Venclexta Gazyva,CURE Magazine,Negative
17953,Barrientos,Targeted Oncology,Negative
17954,CLL one hundred and one,CLL Ireland,Negative
17956,CLL Tune ASH two thousand and eighteen,Patient Power,Negative
17957,CLL Philip Thompson MedscapeEdu,Medscape Education,Negative
17959,CLL David Maloney CLL,Patient Power,Negative
17960,EPS one,Kerry,Negative
17961,KAT Oncotarget two thousand and eighteen six hundred,Acetylome,Negative
17962,Rod Humerickhouse The Importance Minimal Residual Disease Negativity CLL,Oncology Tube,Negative
17963,Barrientos Feinstein Institute Medical Research Lymphoma Prognosis CancerTherapy,The Patient Channel,Postive
17964,CLL CLL Malkavian Damn,Mike ForThePeople,Postive
17965,Burke BloodCancer,Targeted Oncology,Negative
17966,obinutuzumab VenG MRD CLL,Oncology Tube,Negative
17967,Mayo Clinic Curtis Hanson,Mayo Clinic Labs,Negative
17970,CLL,Hematology Advisor,Negative
17973,Cancer Hobby laughterasmedicine,Jeff Neurman,Negative
17974,CLL Richard Dannay one Gonzalez,Cowan Liebowitz,Postive
17976,Two IreneGhobrial today CLL Jennifer Brown tomorrow,David Steensma MD,Postive
17977,Tune Michele,Patient Power,Negative
17978,Love NEJM CLL,Amber Koehler,Postive
17980,obinutuzumab Learn,NEJM Resident three hundred and sixty,Negative
17981,Catherine Wu MD one,Laurie Glimcher MD,Negative
17982,two thousand and nineteen,Pharmacutical Daily,Negative
17983,obinutuzumab,Oncology Nursing News,Negative
17984,Rituxuimab As Treatment For Patients With Chronic,CHItraders,Negative
17985,CLL EHA,Xenia Schmidt,Negative
17986,CLL Ireland Saturday,CLL Ireland,Postive
17987,three CVP four Illumina CLL,Michael Hallek,Postive
17988,one GCLLSG two Obinutuzumab CLL two thousand and,Michael Hallek,Postive
17989,MRD CLL Susan,VJHemOnc,Negative
17990,CLL Asco,donnashort,Negative
17991,WorldJuniors CLL,Magic Max,Postive
17992,one Gnoccchi,Mira Larkin,Postive
17993,CllSociety,Anthony Mato,Negative
17994,two thousand and nineteen Now CLL today CLL CLLsm,CLL Society Inc,Postive
17998,ST,Club Libertad Limpeno,Negative
18000,ST,Club Libertad Limpeno,Negative
18001,twenty,Club Libertad Limpeno,Negative
18002,eight,Club Libertad Limpeno,Negative
18006,Liz Pena,Club Libertad Limpeno,Negative
18008,CLL,Matthew Davids MD MMSc,Postive
18010,CLL,Blood Journal,Negative
18011,Alicia Bobadilla Laurie Cristaldo Joana Galeano Cortaza Liz Pena,Club Libertad Limpeno,Negative
18013,KebleConference July CLL,LymphomaAction,Postive
18014,CLL Quick Take,NEJM,Negative
18015,two thousand and nineteen Chicago one Click CLL,Lymphoma Hub,Negative
18016,CLL,Kathleen Hoffman,Negative
18017,CLL Research NitinJainMD NEJM,MedPage Oncology,Negative
18018,un chimiotherapie base de venetoclax Abbvie ligne de la LLC dans New England Journal Medicine,oncohebdo,Negative
18019,Lion CLL Epigenetics,Lab,Postive
18020,CLL Spanish,MoJo,Negative
18023,Study Chronic Leukemia Roche,PharmaShots Incisive news three shot,Negative
18024,three two thousand and nineteen Published New England Journal Medicine,PressReleasePoint,Negative
18025,Twitter You,Haitham Abdelhakim,Negative
18026,CLL Congratulations,Jose Sandoval MD FACP,Postive
18027,Time CLL,Emily Smith,Negative
18028,Parabens MosqueraOrgeira de Hematoloxia CHUS,Xose Rey,Negative
18029,GTXI Interim Oncternal Therapeutics,MAISA,Negative
18030,fifty year,Angus Macaulay,Negative
18031,CLL Genetech Gazyva Obinutuzumab CLL,Neil Sankar MPH,Postive
18032,Neue Kombinationstherapie CLL Neue Studie Uniklinik Krebs CGCLLSG,Uniklinik Koln,Negative
18033,CLL UKKoeln GCLLSG,Michael Hallek,Postive
18034,today NEJM CLL GCLLSG,Michael Hallek,Postive
18036,Congratulation GCLLSG CLL,Paul Brockelmann,Postive
18037,Dr Kanti Rai Rai Staging Chronic CLL,Neil Sankar MPH,Postive
18038,CLL,Michael Hallek,Negative
18039,CLL CLLsm,CLL Society Inc,Postive
18040,CLL,Michael Hallek,Negative
18043,CLL One CLL,AbbVie,Negative
18044,obinutuzumab ibrutinib CLL Messi Ronaldo CLL CLLsm,Toby Eyre,Postive
18045,Obinutuzumab four hundred eight CLL Rx PB Congrats,Toby Eyre,Postive
18047,CLL,Brotman Baty,Negative
18048,CONGRESS ASCO CLL ROUND one,Lymphoma Hub,Negative
18049,Richard Furman Novel Treatment Options CLL WeillCornell Weill Cornell Medicine CLL,Oncology Tube,Negative
18050,Updates Cognitive Function Impaired,Oncology Times,Negative
18051,hemonctoday,Chocolatiere Phys,Negative
18052,CLL Time PFS MRD Venetoclax Ibrutinib ASCO NEJM,Bachar Samra MD,Negative
18053,Venetoclax Obinutuzumab CLL,MoJo,Negative
18054,NEJM ROG RHHBY,Roche,Negative
18056,three two thousand and nineteen Published New England Journal Medicine,Pharmacutical Daily,Negative
18057,CLLsm CLL CLL,The Lancet Haematology,Negative
18059,three,Crwe World,Negative
18060,CLL CLL,Talbot Alexis,Negative
18063,CLL CLL,NEJM,Negative
18064,Genentech Abbvie Venetoclax,CHItraders,Negative
18065,Today CLL Learn,Genentech,Negative
18067,RHHBY Press Release four Pivotal Phase three two thousand and nineteen Published New England Journal Medicine,Flash Alert,Negative
18068,Nancy Bartlett MD,Siteman Cancer Center,Negative
18069,CLL Drs Danielle Brander Jacqueline Barrientos Younger,Michael Hallek,Postive
18070,CONGRESS Jacqueline Claudia Barrientos NorthwellHealth,Lymphoma Hub,Negative
18071,Join CLL Register CLL CLLsm,CLL Society Inc,Negative
18072,Help Join Register CLL,CLL Society Inc,Postive
18073,Tanya Siddiqi seven thousand five hundred and one today CLL,City Hope,Negative
18074,Danielle Brander MD Frontline CLL,Duke Hematologic Malignancies Cellular Therapy,Negative
18076,CLL Ibrutinib,Taro Shiga,Negative
18078,plasma membrane LeukemiaResearch CLL,Jackson ImmunoResearch,Negative
18079,CLL,CancerWallonia,Negative
18080,David Bond second CLL BTK,Jennifer Smith,Negative
18081,Paul Barr SLL,Jennifer Smith,Negative
18082,Venetoclax AML CLL BreastCancer,Bachar Samra MD,Postive
18083,CLL,AbbVie,Negative
18084,year CLL CANCER NatureComms,Dr Richard Birkinshaw,Negative
18085,MRD CLL FOCUS MRD,VJHemOnc,Negative
18086,Ian Flinn CARTtherapy CLL CLLsm Leusm,VJHemOnc,Postive
18087,CLL WilmotCancer,Carla Casulo,Negative
18088,CLL chicago,ipharmacenter,Negative
18089,CLL,Pharmacyclics AbbVie Company,Postive
18090,CLL CLL JanssenGlobal,info,Negative
18091,three one Nicholas Moore CLL,calliecoombs,Postive
18092,tomorrow June Esther Schorr Jim Harlan CLL,Patient Power,Negative
18093,Ali McBride NSCLC CLL Myeloma UofA ACCC NSCLC CLL Myeloma,Oncology Tube,Negative
18094,CLL three,JanssenUS,Negative
18096,John Allan first CLL,WCM Lymphoma,Negative
18097,Data Two Pivotal Phase three Studies ASCO EHA Demonstrate Sustained Efficacy Safety Patients Chronic CLL,RazzleTazzle,Negative
18098,two Cancer Natalia,School Cancer Pharmaceutical Sciences,Negative
18099,CLL,Pharmacyclics AbbVie Company,Negative
18100,CLL,JanssenUS,Negative
18101,Oncology News Australia,Oncology News Australia,Negative
18102,Scans,Chocolatiere Phys,Negative
18103,Imbruvica First Treatment New Standard CLL,Cancer Care,Negative
18105,CLL,linfopedia,Postive
18106,Monday two hundred Hematologic Chronic SarahCannonDocs,Verastem Oncology,Negative
18107,paso sigue comandando el futbol LasGumarelas CLL,Revista El Repollero,Negative
18108,fifteen CLL,Club Libertad Limpeno,Negative
18109,fifteen CLL,Club Libertad Limpeno,Negative
18110,fifteen CLL,Club Libertad Limpeno,Negative
18111,fifteen CLL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18112,fifteen CLL Damia Cortaza,Club Libertad Limpeno,Negative
18113,fifteen,Club Libertad Limpeno,Negative
18114,fifteen,Club Libertad Limpeno,Negative
18115,fifteen CLL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18116,fifteen CLL Karina Vega,Club Libertad Limpeno,Negative
18117,fifteen CLL PT Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18118,fifteen CLL twenty Karina Vega,Club Libertad Limpeno,Negative
18119,fifteen CLL twelve Karina Vega,Club Libertad Limpeno,Negative
18120,fifteen CLL,Club Libertad Limpeno,Negative
18121,one one Chronic two thousand and twelve two thousand and seventeen one grateful day Salute,Bennia Johnson,Postive
18123,DYK eighty CLL CLL,Pharmacyclics AbbVie Company,Negative
18124,Hepatitis Pancreatitis Rash,Mazen,Negative
18125,DYK ten CLL seventeen Learn,JanssenUS,Negative
18127,Gina,AbbVie Canada,Postive
18128,one six year,MOBO System,Postive
18129,ASCO CLL,MedPage Today,Negative
18131,Hematologic Flinn CLL tomorrow,Sarah Cannon Docs,Negative
18133,Rituximab,Medivizor,Negative
18135,CLL Krebszellen au dem,MEDtalks CH,Negative
18136,Love Love Flora CLL MZL,Amy Cavers,Negative
18138,CLL SEQUENTIAL CIT Upfront,follower,Postive
18139,CLL Leusm,Medscape,Postive
18140,Inclusion,Phillip Scheinberg,Postive
18141,Chronic Lymphocytic Lymphocytic CLL Bogota,Onica Pinzon MD,Negative
18142,John Pagel Cancer Institute Advisory Committee ACCC CLL CllSociety,ACCC,Negative
18143,CLL Information Day Email,CLL Ireland,Negative
18144,DYK CLL,Pharmacyclics AbbVie Company,Negative
18145,This year Caring Every Patient Learning Every CLL,JanssenUS,Postive
18146,DYK eighty CLL,Janssen Global,Negative
18148,OncoAlert CLL Tweet tomleblancMD OncoAlert,OncoAlert,Negative
18149,Tuesday MRD CLL,Thomas LeBlanc MD MA MHS FAAHPM,Negative
18150,CLL MRD Upfront,Thomas LeBlanc MD MA MHS FAAHPM,Negative
18151,CLL,NEJM,Negative
18152,CLL Register Edinburgh Scotland,iwCLL,Postive
18153,Ibrutinib two,NEJM Resident three hundred and sixty,Negative
18156,one CLL one TY BernKingComms,Michele,Postive
18157,CLL,Kathleen Hoffman,Negative
18158,CLL,JanssenUS,Postive
18159,ASCO CLL,MedPage Oncology,Negative
18160,CLL twelve CR CR MRD eighteen CR SSBMT,SSBMT lkhlyljdh`y@,Negative
18161,The Magic Normal CLL,Pharmacyclics AbbVie Company,Negative
18162,CLL,Pharmacyclics AbbVie Company,Postive
18163,DYK eighty CLL CLL,Pharmacyclics AbbVie Company,Negative
18164,DYK CLL,Pharmacyclics AbbVie Company,Negative
18165,The Magic Normal CLL,Pharmacyclics AbbVie Company,Negative
18166,United States,RTI Health Solutions,Negative
18167,CLL,JanssenUS,Negative
18168,DYK ten CLL seventeen Learn,JanssenUS,Negative
18169,This year Caring Every Patient Learning Every CLL,JanssenUS,Postive
18170,CLL,JanssenUS,Postive
18172,Acute Tubular Injury American Journal Hematology MayoClinic Denver Nephrology CLL,HofNorthwell Kidney,Negative
18174,Dr LymphomaManagement July Trainees CLL BritSocHaem OxfordHaem,LymphomaAction,Postive
18175,Denny,AbbVie Canada,Postive
18176,one CLL second Portland cll,Esther Schorr,Postive
18177,two CLL NEJM,Krizsan Szilvia MD,Negative
18178,CLL twelve MRDneg CLL,Toby Eyre,Negative
18179,complex paradigm,SpecialtyPTimes,Negative
18180,today Chicago Monday June four thousand sixtythree,Verastem Oncology,Negative
18181,CLL,The Match Advocacy,Negative
18182,ICYMI two NitinJainMD,MD Anderson Cancer Center,Negative
18187,CLL,Amanda Marie,Negative
18188,CLL,linfopedia,Postive
18189,Wu CLL Cathy Wu DanaFarber,Satyen Gohil,Postive
18190,two CLL CancerMoonshot,MD Anderson Cancer Center,Postive
18191,today DanaFarber,Hematopoiesis News,Negative
18192,DanaFarber BrighamWomens,Amit Sud,Negative
18193,CLL NitinJain TapKadia NEJM,Rashmi MD,Negative
18194,DTHSTR,DTHSTR,Negative
18196,Catherine Wu DanaFarber CLL,Leukemia Lymphoma Society Research,Postive
18197,Tong Ding Xie Bing,Wo tsutamamaJin Huo Jin Di Jin Mai Qu riSuo ,Negative
18199,DanaFarber Broad Institute UW CLL,Broad Institute,Negative
18200,Morgane CLL CLL,Charles Herbaux,Postive
18201,three Shuo Ma MD CLL,Lurie Cancer Center,Negative
18202,PennMedicine,Nucleus Biologics,Negative
18203,Ibrutinib two Learn,NEJM,Negative
18205,CLL BloodJournal,Raul Cordoba MD PhD,Negative
18206,Nature Exponential MichaelaGruber Ivana Bozic Cathy Wu,Martin Nowak,Postive
18207,first CLL,Amber Koehler,Postive
18208,CLL,Muzaffar Qazilbash,Negative
18213,Covaris transcription Mallm,Covaris,Negative
18215,HallekMichael CLL LymHubSS two thousand and nineteen ChemoFree CLL Lymsm,Lymphoma Hub,Negative
18216,NitinJainMD CancerMoonshot,MD Anderson Cancer Center,Negative
18218,New Medivizor Rituximab,Medivizor,Negative
18219,HOVON Nordic CLL GCLLSG Amsterdam CLL Clinicaltrial,Michael Hallek,Postive
18221,CLL,MoJo,Negative
18225,Ibrutinib Venetoclax,Hematologia Salamanca,Negative
18226,CLL NitinJainMD TapKadia,Sanam Loghavi MD,Postive
18231,transcription,Hematopoiesis News,Negative
18233,one CLL WVCancer UCSDHealth CompassOncology,Theresa Clementi Doan,Postive
18234,Liliane Paquette Canadian Baumhedlund GMOFreeUSA RachelsNews,Clean Food,Negative
18235,CLL MRD NitinJainMD,chadi nabhan MD MBA FACP,Negative
18237,NitinJainMD NEJM CLL,MedPage Oncology,Negative
18242,Study The University Texas Anderson Cancer Center,Art Fridrich,Negative
18245,Cancer Institute Broad Institute Massachusetts General Hospital University Washington,Art Fridrich,Negative
18246,CLL Learn,NEJM,Negative
18249,fourteen CLL,Club Libertad Limpeno,Negative
18250,fourteen CLL Karina Vega,Club Libertad Limpeno,Negative
18251,fourteen CLL Karina Vega,Club Libertad Limpeno,Negative
18252,fourteen CLL Laurie Cristaldo,Club Libertad Limpeno,Negative
18253,fourteen CLL fourteen Liz Pena,Club Libertad Limpeno,Negative
18254,fourteen CLL six Carmen Benitez,Club Libertad Limpeno,Negative
18255,fourteen CLL four ST Angeles Portillo UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
18256,Watch,SpecialtyPTimes,Negative
18260,fourteen CLL,Club Libertad Limpeno,Negative
18261,fourteen CLL Karina Vega,Club Libertad Limpeno,Negative
18264,fourteen CLL,Club Libertad Limpeno,Negative
18268,fourteen CLL Karina Vega,Club Libertad Limpeno,Negative
18269,fourteen CLL Griselda Garay,Club Libertad Limpeno,Negative
18274,Science daily News,Md Abul Khair,Negative
18277,fourteen CLL sixteen Karina Vega UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18278,fourteen CLL two Karina Vega,Club Libertad Limpeno,Negative
18279,fourteen CLL one Karina Vega UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18280,fourteen CLL Alicia Bobadilla Laurie Cristaldo Cortaza Karina Vega,Club Libertad Limpeno,Negative
18284,CLL,News,Negative
18285,Attending Discover Verastem Oncology Drop Booth four thousand sixtythree u cll lymsm HemeOnc,Verastem Oncology,Negative
18287,ChaligneRonan WeiilCornell CLL,Manel Esteller,Postive
18288,RT DKFZ Epigenetische Signale Entstehung von Leukamie Entstehung CLL Form von Blutkrebs Signale,Cancer Core Europe,Negative
18289,Epigenetische Signale Entstehung von Leukamie Entstehung CLL Form von Blutkrebs,DKFZ,Negative
18290,Latest Research two thousand StemCells Chemotherapy Drug Molecule Opportunities,Danish hussain,Negative
18291,CLL CLL,Patient Power,Postive
18292,Myeloma two thousand and eighteen,Oncology Tube,Negative
18293,Burke ImmunoOnc CLLsm,Targeted Oncology,Negative
18294,Lindsey Roeker CLL,Anthony Mato,Negative
18295,Chl Ofatumumab Chl CI CI CI CLLsm Blooducation CLL,Toby Eyre,Negative
18296,VenG CI PB VenG CLL,Toby Eyre,Negative
18297,AF CLL thirteen two twelve,Toby Eyre,Negative
18298,CLL SBP BP,Toby Eyre,Postive
18299,TN RR CLL RR TN PD fifteen thirtythree SPM two four three,Toby Eyre,Negative
18300,CLL CLLsm,CLL Society Inc,Negative
18301,today CLL Norwegian Great Hotel Olavsgaard,Sigrid Skanland,Postive
18302,CLL,Kathleen Hoffman,Negative
18304,Weltblutkrebstag Fur PatientInnen Diagnose CLL Erfahren Sie Belastung selbst aktiv konnen CLL,selpers fur chronisch Kranke,Negative
18305,CLL,SwingTradeBot UK,Negative
18306,Check Rituximab,Medivizor,Negative
18307,Brian Koffman William Wierda MRD CLL CLLsm,CLL Society Inc,Negative
18308,CLL cll,linfopedia,Postive
18309,CLL,Hematology Advisor,Negative
18310,Vietnam two thousand and nine,Real Heroes Wear Mask,Negative
18311,CLL around fourteen three three year Investors Chronicle,WheelieDealer,Negative
18312,NP Plasma Chronic Cleveland Clinic Journal Medicine,Liz Brem,Postive
18313,CLL,Sanam Loghavi MD,Negative
18315,transcription,Srl,Negative
18316,thirteen Santani,Club Libertad Limpeno,Negative
18317,thirteen Santani Karina Vega,Club Libertad Limpeno,Negative
18318,thirteen Santani Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18319,thirteen Santani Griselda Garay,Club Libertad Limpeno,Negative
18320,thirteen Santani,Club Libertad Limpeno,Negative
18321,thirteen Santani CLL,Club Libertad Limpeno,Negative
18322,thirteen Santani Belen Benitez,Club Libertad Limpeno,Negative
18323,thirteen Santani CLL eight,Club Libertad Limpeno,Negative
18324,thirteen Santani CLL EN,Club Libertad Limpeno,Negative
18325,thirteen Santani,Club Libertad Limpeno,Negative
18326,thirteen Santani Laurie Cristaldo,Club Libertad Limpeno,Negative
18327,thirteen Santani CLL Damia Cortaza,Club Libertad Limpeno,Negative
18328,thirteen Santani,Club Libertad Limpeno,Negative
18329,thirteen Santani CLL,Club Libertad Limpeno,Negative
18330,thirteen Santani CLL Liz Pena,Club Libertad Limpeno,Negative
18331,New Rituximab,Medivizor,Negative
18332,thirteen Santani CLL fourteen Karina Vega,Club Libertad Limpeno,Negative
18333,thirteen Santani,Club Libertad Limpeno,Negative
18334,thirteen Santani,Club Libertad Limpeno,Negative
18335,thirteen Santani Alicia Bobadilla Laurie Cristaldo Cortaza Karina Vega,Club Libertad Limpeno,Negative
18336,PD twelve anthonymatomd et al two thousand and eighteen CLL,Toby Eyre,Negative
18339,Rituximab,Medivizor,Negative
18340,The Untold Story Longest Persisting Cells CLL,Oncology Strategies,Negative
18341,CLL David Maloney CLL,Patient Power,Negative
18342,Ofatumumab Malignancies,Naveen Pemmaraju MD,Postive
18343,Canadian CLL Venetoclax CLLsm,CLL Society Inc,Negative
18344,Bedankt MichielHageman EllaVisserman CLL,Hematon,Negative
18345,Gisteren EllaVisserman Samenbeslissen Bekijk de cll keuzehulp lymfatische leukemie HematonNL hovon,Michiel Hageman,Negative
18347,Autoimmune Hemolytic Anemia Immune Mediated Thrombocytopenia Phase three RESONATETM Study Ibrutinib Vs Ofatumumab,Alexander,Negative
18348,John CLL CLL Cancer Hospital Solove Research Institute ChronicLymphocyticLeukemia,Oncology Tube,Negative
18349,FDA,Health,Postive
18350,CLL,Toby Eyre,Negative
18351,Computer aided Drug Designing Lymphocytic CLL,EurekaMag,Negative
18353,transcription,Transcriptomes,Negative
18354,Expansion Breakout today SEC CLL,SwingTradeBot UK,Negative
18355,Richters DVVavoulis Jenny lymsm,Toby Eyre,Postive
18357,CLL ATLL,Milos Miljkovic,Negative
18358,PatientPower CLL CllSociety CllIreland,Michele,Negative
18359,Tune Michele,Patient Power,Negative
18360,one Learn CLL,Genentech,Negative
18361,one WeillCornell Sangmin Lee Research Nurse June Greenberg CLL Bob Azopardi,Weill Cornell Leukemia,Negative
18363,AIM CLL Cello Health PLC Block Interim Review,AIM Alerts,Negative
18364,two thousand and nineteen two thousand,ABNewswire,Negative
18365,transcription,CTCF Papers,Negative
18366,CLL,The Lancet Haematology,Negative
18367,DRG United States Western Europe DRGinsights CLL Roche,DRG Epidemiology,Negative
18369,CLL US,OKCHEM,Postive
18370,Immunoglobulin Cryoglobulinemic Vasculitis,Cureus,Negative
18371,Richard Furman CLL CllSociety Patient Caregiver Education Forum WeillCornell,WCM Lymphoma,Negative
18372,CLL,Kathleen Hoffman,Negative
18373,two,Lung Cancer News,Negative
18374,Listen Vishva Dixit,Catherine Velazquez,Negative
18375,Tune Michele,Esther Schorr,Negative
18377,CLL Hematology ICOnoticies Spanish CLL,Hematologia ICO Hospitalet,Negative
18378,Bcell Friday May Hyatt Regency Chicago today PeerView CLL,Jen Silverman,Negative
18379,Pharmaceutical Alliance pCPA,Crwe World,Postive
18380,Info Leukaemia CLL Dublin,Kathrinabentley KB,Negative
18381,one four CLL,limbic,Negative
18382,AbbVie Food Drug Administration Venclexta obinutuzumab Gazyva,Drug Store News,Negative
18383,Myeloma two thousand and eighteen,Oncology Tube,Negative
18384,UPENN eight year ago CLL Interesting READ Biotechnology CellTherapy,Comprehensive Cell Solutions New York Blood Center,Negative
18385,twelve CLL,Club Libertad Limpeno,Negative
18386,twelve CLL Fiorela Martinez,Club Libertad Limpeno,Negative
18387,twelve CLL Karina Vega,Club Libertad Limpeno,Negative
18388,twelve CLL Karina Vega,Club Libertad Limpeno,Negative
18389,twelve CLL NACIONAL EN,Club Libertad Limpeno,Negative
18391,twelve CLL,Club Libertad Limpeno,Negative
18392,twelve CLL Liz Pena,Club Libertad Limpeno,Negative
18393,twelve CLL thirty Griselda Garay,Club Libertad Limpeno,Negative
18394,twelve CLL Nacional,Club Libertad Limpeno,Negative
18395,twelve CLL NACIONAL eleven PT Laurie Cristaldo,Club Libertad Limpeno,Negative
18396,twelve CLL Nacional,Club Libertad Limpeno,Negative
18397,twelve CLL VS Nacional Alicia Bobadilla Laurie Cristaldo Carmen Benitez Cortaza Karina Vega,Club Libertad Limpeno,Negative
18398,US,MedPipeline,Negative
18399,Schmidt Bill Borchard Mary Kevlin Bob English two thousand and International Trademark Association Annual Boston CLL Trademark Boston,Cowan Liebowitz,Postive
18400,CLL CLLsm,CLL Society Inc,Postive
18401,FDA CLL SLL,CellworksLife,Negative
18402,CLL Nueva el VHIO Bosch Gran CLL,ACINDES Internacional,Negative
18403,transcription,Mary Ruberry,Negative
18404,transcription KarstenRippe More CLL,Gene Regulation,Postive
18405,transcription,Mazen,Negative
18407,ER,Lymphoma Papers,Negative
18408,transcription,DNA Test Hub,Negative
18409,one two two thousand and ten one David Maloney,Fred Hutch,Postive
18412,los Campeones en Equipo de XNL CLL,WWE Noticias FM,Negative
18414,two thousand and eighteen ASH annual Susan Brien UC Irvine Javier Pinilla Cancer Center CLL,Andrew Schorr,Negative
18415,Better Worse Better Worse,Jeff Neurman,Negative
18416,obinutuzumab NitinJainMD medpagetoday,MD Anderson Cancer Center,Postive
18418,CLL Leukemia Center wwierda endcancer,MD Anderson Leukemia,Negative
18419,CLL CLL CLL,Andrew Schorr,Negative
18421,three Ibrutinib one two three India CLL BTK,Saadvik Raghuram,Negative
18422,FDA Lymphocytic CLL,Lampe Company,Negative
18423,RNA Chronic Jenny Klintman Jenny Taylor,Dimitris Vavoulis,Negative
18424,CLL,iwCLL,Postive
18426,Verastem Oncology three,Verastem Oncology,Negative
18427,FDA CLL SLL,Health,Negative
18428,EHA CLL,DEEPAK Thimiri Govinda Raj,Negative
18429,CLL CLL,CLL Society Inc,Negative
18430,CLL,iwCLL,Postive
18431,Related Articles,Wnt publication,Negative
18432,Chronic,Javier Santoyo,Negative
18433,DRG United States Western Europe DRGinsights CLL,DRG Epidemiology,Negative
18434,Chronic,bioRxiv Genomics,Negative
18435,Chronic,bioRxiv,Negative
18436,STELLAR CLL Opening UK,Toby Eyre,Negative
18437,Brian Koffman Venetoclax Obinutuzumab CLL SLL Venetoclax,CLL Society Inc,Postive
18438,The Untold Story Longest Persisting Cells CLL,CLL Society Inc,Negative
18439,US,FDA Daily,Negative
18440,CLL,Esther Schorr,Postive
18441,NitinJainMD Jennifer Brown MD DanaFarber CLL,MedPage Oncology,Negative
18442,CLL,Genentech,Negative
18443,AIM CLL Cello Health PLC Issue,AIM Alerts,Negative
18444,The Untold Story Longest Persisting Cells CLL,Nela,Negative
18445,Jan Joseph Melenhorst PhD CARTcells,Randi Hernandez,Negative
18446,FDA,Physician Weekly,Negative
18447,FDA Venclexta,The Cancer Letter,Negative
18448,CLL News FDA CLL PatientPower,Michele,Negative
18450,Diagnosis Mayo Clinic,EAC Year,Negative
18451,Arnon Kater CLL six EAFO Hematology Forum,Michael Hallek,Postive
18452,CLL,Kathleen Hoffman,Negative
18453,FDA,vshariharakrishnan,Negative
18454,Impressive CLL DrMatasar HallekMichael DrRaulCordoba,chadi nabhan MD MBA FACP,Postive
18455,LA Times CLL CLLSociety PatientPower,Michele,Negative
18456,FDA Obinutuzumab Combo Frontline CLL,CancerWallonia,Negative
18457,Bellechasse CLL,Journal Voix du Sud,Negative
18460,Clinical,filippo masini,Negative
18462,Jeff Sharman CLL,Esther Schorr,Postive
18463,Fecha eleven GralDiaz CLL,Club Libertad Limpeno,Negative
18464,BTK,Thilo Zander MD,Negative
18465,Fecha eleven CLL ST Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18466,Fecha eleven CLL ST,Club Libertad Limpeno,Negative
18467,Fecha eleven GralDiaz CLL nineteen ST Fabiola Sandoval,Club Libertad Limpeno,Negative
18468,Fecha eleven GralDiaz CLL nineteen ST UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18469,Portland CLL PatientPower JeffreyMenashe MichaelChoi CLL,Amy Cavers,Postive
18470,two,ClinicalTrialsData,Negative
18471,Fecha eleven GralDiaz CLL Stephenie Lacoste UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18472,Fecha eleven GralDiaz CLL ten Griselda Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18473,Fecha eleven GralDiaz CLL five,Club Libertad Limpeno,Negative
18474,Fecha eleven GralDiaz CLL four ST Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18475,Fecha eleven GralDiaz CLL,Club Libertad Limpeno,Negative
18476,Fecha eleven CLL Karina Vega,Club Libertad Limpeno,Negative
18477,Fecha eleven CLL Karina Vega,Club Libertad Limpeno,Negative
18478,Fecha eleven CLL,Club Libertad Limpeno,Negative
18479,Fecha eleven GralDiaz CLL Karina Vega,Club Libertad Limpeno,Negative
18480,Fecha eleven GralDiaz CLL eighteen,Club Libertad Limpeno,Negative
18481,Last minute three hundred and two CLL,Amber Koehler,Negative
18482,Fecha eleven CLL seven Liz Pena,Club Libertad Limpeno,Negative
18483,Fecha eleven GralDiaz CLL el nido,Club Libertad Limpeno,Negative
18484,CLL PowerfulPatients,Patient Power,Negative
18485,Fecha eleven GralDiaz CLL Alicia Bobadilla Joana Galeano Griselda Lopez Liz Pena,Club Libertad Limpeno,Negative
18486,Crowdsourced Stock Ratings,MissKonfidentielle Valerie Desforges,Negative
18487,Crowdsourced Stock Ratings BioTechnology BioTech,Ashish Bedekar,Negative
18488,WVCancer Jeanne Schaffer ClinicalTrial CLL,Patient Power,Negative
18489,Maloney CLL,Patient Power,Negative
18490,Crowdsourced Stock Ratings,Paleo Leo International Food Blogger,Negative
18492,Listen Vishva Dixit,Genentech,Negative
18493,FDA,Mazen,Negative
18494,one six month,MichaelSDeVries,Negative
18495,CLL SSundaramMD RoswellPark Hematology Malignancy,Pallawi Torka,Postive
18496,Prognostic CLL,Taylor Lab UM,Negative
18497,FDA,YoBuzz,Negative
18498,New CME Event FDA,CME Schedule,Negative
18499,Venetoclas,Drug Topics,Negative
18500,FDA Venetoclax,Rondaxe Pharma,Negative
18501,three hundred and two tomorrow CLL,Amber Koehler,Negative
18502,one,COPD News,Negative
18503,FDA,Medical Xpress,Negative
18504,Abbvie Roche CLL Venclexta CLL Rituxan combination Gazyva ROG,Bionest Partners,Negative
18505,CLL NEBiolabs CLL,Epigenetics Experts,Postive
18507,FDA,PharmacyChecker,Negative
18508,NCCN Chronic Lymphocytic Lymphocytic CLL SLL,National Comprehensive Cancer Network NCCN,Negative
18509,Drizzy Nips Jacamo CLL,Coventry University Cricket Club,Negative
18510,CLL,AbbVie US,Negative
18511,AbbVie Roche CLL Gazyva FiercePharma Roche,Plexus Ventures,Negative
18512,Small Lymphocytic Lymphoma Analysis Two German,Lymphoma Papers,Negative
18513,CLL,CLL Ireland,Negative
18514,MasarykUni CLL,Bryjalab,Postive
18515,one,Moises Uriarte,Negative
18517,Roche FDA Venclexta plus Gazyva,George Huba PhD,Negative
18518,RA pharma update approved combination abbvie Venclexta Roche Gazyva CLL SLL,Roots Analysis,Postive
18519,US FDA Lymphocytic first Oncology Priority Review Program fourth,ipharmacenter,Postive
18520,CLL CLLsm Venetoclax,CLL Society Inc,Postive
18522,Genentech Gazyva second Oncology Review Assessment Aid FDAApproval CLL SLL,SFBay,Negative
18523,FDA CLL,Genentech,Negative
18525,FDA,SpecialtyPTimes,Negative
18526,CLL SLL,CancerCare,Negative
18529,The Food Drug Administration CLL SLL,LLS Chapter,Negative
18530,Roche FDA Venclexta plus Gazyva CLL Reuters,Advera Health,Negative
18531,FDA,Roche,Postive
18532,CLL,Pharmacy Times,Postive
18534,CllSociety CLL Advocacy,CLL Advocates Network,Postive
18535,Roche FDA Roche,Physician Weekly,Negative
18536,Roche FDA Venclexta plus Gazyva,Maya Dolly,Negative
18538,The Food Drug Administration CLL SLL,LLS Georgia Chapter,Negative
18539,CLL FDAOncology,MoJo,Negative
18540,Gazyva Venclexta,ABABioBlurb,Negative
18541,Genentech FDA,The Pharmaceutical Marketing Group,Negative
18542,FDA Abbvie associe obinutuzumab Roche,oncohebdo,Negative
18543,Roche FDA Venclexta plus Gazyva,The Pharmaceutical Marketing Group,Negative
18546,FDA Bavencio RCC FDA Approves,VHSPL,Postive
18547,CLL,Michele Porro Lura,Postive
18548,CLL zero eight twelve,Reg Myers,Negative
18550,Subcutaneous Rituximab Follicular,Lymphoma Papers,Negative
18551,FDA RHHBY ROG,Roche,Postive
18552,Roche FDA Venclexta plus Gazyva,Shahid Raz,Negative
18553,Roche FDA Venclexta plus Gazyva,Angela Keen,Negative
18554,La approuve Venclexta combinaison avec le CLL qualifie de percee Sante AliceLHABOUZ,Club Trecento Sante,Negative
18555,Roche FDA Venclexta plus Gazyva,FaceMyDoc,Negative
18556,FDA Roche Venclexta Gazyva,EMG GOLD,Negative
18557,Roche FDA Venclexta plus Gazyva,world CROs,Negative
18558,Roche FDA Venclexta plus Gazyva,Sai Legal Services,Negative
18559,one,Dr Alexandros Kanellopoulos,Negative
18560,Roche AbbVie Venclexta Gazyva obinutuzumab Receive Leukemia Roche,PharmaShots Incisive news three shot,Negative
18562,one CLL CLLsm,Raul Cordoba MD PhD,Negative
18563,Roche FDA Venclexta plus Gazyva,CNA,Negative
18564,Roche FDA Venclexta plus Gazyva,TheArticleTrunk,Negative
18565,Roche FDA Venclexta plus Gazyva De,chorley chicken,Negative
18566,Roche FDA Venclexta plus Gazyva LatestComments,Latest Commentary LatestComments,Negative
18568,Roche FDA Venclexta plus Gazyva,FirstPressNG,Negative
18569,Roche FDA Venclexta plus Gazyva,Ibex News twentyfour,Negative
18571,Roche FDA Venclexta plus Gazyva,Ray Noble The Thin End Show,Negative
18574,Andrew Roberts CLL BloodJournal CLL,limbic,Negative
18575,FDA CLL SLL,Snowdome Foundation,Negative
18576,CLL,Anna Deveau,Negative
18577,Overcoming Barriers Oral Oncolytic Access CLL,SpecialtyPTimes,Negative
18578,ABBV MRD Ibr Gazyva HR PFS Ibr Gazyva DrRaulCordoba,Paul DeSantis PharmD,Negative
18579,CLL SLL,The Leukemia Lymphoma Society,Negative
18580,FDA CLL,Amber Koehler,Negative
18581,CLL,Liz Brem,Negative
18583,FDA Venclexta obinutuzumab,MAISA,Postive
18584,FDA VENCLEXTA Genentech CLL SLL,FDA Oncology,Negative
18585,Breaking News FDA FDA,Nasser Nourallah,Postive
18586,Jacqueline Barrientos Best Drug Sequence Treat CLL,Oncology Tube,Postive
18587,CLL,AbbVie US,Postive
18588,CLL,Pharmacy Times,Postive
18589,Venclexta plus Gazyva,CURE Magazine,Negative
18590,Venclexta CLL genentech,HemOnc Today,Negative
18591,Genentech FDA,Pharmacutical Daily,Negative
18592,Genentech FDA,Pharmacutical Daily,Negative
18593,first CLL First ChaligneRonan Gu WeillCornell,Leukemia Lymphoma Society Research,Postive
18594,FDA CLLsm BloodCancer,Targeted Oncology,Negative
18595,FDA CLL,Lisa Astor,Postive
18596,PubMed NCBI,Dr Richard Palmquist,Negative
18597,CLL,SpecialtyPTimes,Negative
18598,Venclexta obinutuzumab Gazyva,Oncology Nursing News,Negative
18600,May fifteen US,Flash Alert,Negative
18602,Genentech FDA,FDA Daily,Negative
18603,Roche Genentech FDA,Armando Guglielmetti,Negative
18604,Genentech FDA,Crwe World,Negative
18605,CLL Oncology Review Read,AbbVie,Postive
18607,Genentech FDA,Sharon Johnson,Negative
18608,Venclexta Gazyva FDA,Andrew Dunn,Postive
18610,RHHBY Press Release May fifteen Genentech FDA,Flash Alert,Negative
18612,FDA,JHC,Negative
18613,CLL,Blood Journal,Negative
18614,CLL,CellworksLife,Negative
18615,Barrett Barrett Ofc Jon Cleveland Barrett,Normal PD,Postive
18616,May CLL Society,CLL Society Inc,Negative
18617,CLL,BSI America,Postive
18619,London today CLL Say,Marcia Villalba,Negative
18620,Kabouter Funds CLL CLL,WheelieDealer,Postive
18621,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
18622,Mug Leukemia Mug,Simply,Negative
18624,JITC Research plasma membrane,Society Immunotherapy Cancer,Negative
18626,Rod Humerickhouse MD CLL ChronicLymphocyticLeukemia,Oncology Tube,Negative
18627,three MURANO CLLsm BloodCancer,Targeted Oncology,Negative
18628,CLL,Kathleen Hoffman,Negative
18629,annual Lyonel Israels Memorial Tait Shanafelt Stanford CLL,RIOH,Negative
18630,CLL CLLsm,CLL Society Inc,Postive
18631,one BI eight hundred and thirtysix thousand eight hundred,Clinical Connection,Negative
18632,May fourteen PM EDT Join CLL CME CLL,BioAscend,Negative
18633,CLL,Karim Bhaloo,Negative
18635,CLL UniBarcelona,Oncology Tube,Negative
18636,three CLL CLL ChronicLymphocyticLeukemia,Oncology Tube,Negative
18637,Big Words,Jeff Neurman,Negative
18640,BSI BSI CLL,BSI America,Negative
18641,May CLL ContinuousLifecycle,Conflux,Postive
18642,Leukemia Cll,Kristen Spitty Photography,Postive
18643,CLL CLLsm,Raul Cordoba MD PhD,Negative
18644,CRISPR Celegans PhD Leukemia CLL,Ceron Lab,Negative
18645,one Chronic one AI HEARD NO BELL Mickey,Lance Violator,Negative
18647,ten CLL,Club Libertad Limpeno,Negative
18648,ten CLL RiverPlate six Kari Vega Angelica Vazquez,Club Libertad Limpeno,Negative
18649,ten CLL RiverPlate Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18650,ten CLL RiverPlate two,Club Libertad Limpeno,Negative
18651,ten CLL RiverPlate,Club Libertad Limpeno,Negative
18652,ten CLL RiverPlate,Club Libertad Limpeno,Negative
18653,ten CLL RiverPlate Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18654,ten CLL RiverPlate Kari Vega,Club Libertad Limpeno,Negative
18655,ten CLL Griselda Lopez UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18656,ten CLL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18657,ten CLL Griselda Lopez,Club Libertad Limpeno,Negative
18658,ten CLL RiverPlate,Club Libertad Limpeno,Negative
18659,ten CLL RiverPlate,Club Libertad Limpeno,Negative
18660,ten CLL RiverPlate Kari Vega,Club Libertad Limpeno,Negative
18661,ten CLL Kari Vega,Club Libertad Limpeno,Negative
18662,ten CLL RiverPlate Belen Benitez,Club Libertad Limpeno,Negative
18663,ten CLL,Club Libertad Limpeno,Negative
18664,ten CLL RiverPlate Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18665,ten CLL twelve Karina Vega,Club Libertad Limpeno,Negative
18666,CLL RiverPlate Carmen Benitez,Club Libertad Limpeno,Negative
18667,ten CLL,Club Libertad Limpeno,Negative
18668,CLL two Kari Vega,Club Libertad Limpeno,Negative
18669,CLL RiverPlate EL,Club Libertad Limpeno,Negative
18670,ten CLL RiverPlate Alicia Bobadilla Laurie Cristaldo Belen Benitez Liza Larrea Monica Vega Natalia,Club Libertad Limpeno,Negative
18673,three MURANO BloodCancer,Targeted Oncology,Negative
18674,April two thousand and nineteen thirty,IPSCIO,Postive
18676,April two thousand and nineteen thirty,ValueDiscovery,Postive
18677,AstraZeneca Phase three Clinical Trial Halted,TrialSite News,Postive
18678,one,Lymphoma Papers,Negative
18679,BTK Barrientos CLLsm Leukemia,Targeted Oncology,Negative
18681,CLL DukeCancer,Thomas LeBlanc MD MA MHS FAAHPM,Postive
18682,Blood Jouornal Ibrutinib Elias Morande,AA MDSIF,Negative
18683,CLL two CLL CLL,Patient Power,Negative
18684,Health Stacey Worthy Aimed Alliance CLL,Patient Power,Postive
18685,CLL,Hematology Advisor,Negative
18686,CLL,Blood Journal,Negative
18687,CLL,Kathleen Hoffman,Negative
18688,ClinicalTrials Michele,Michele,Negative
18689,eight year CLL,Mike ForThePeople,Postive
18691,Christoph Bock CLL,Leonardo,Negative
18692,European EPAR Arzerra Leukemia Lymphocytic BCell Date nineteen million Status Withdrawn European EPAR Arzerra,Renal Cell Carcinoma,Negative
18693,last year CLL NHL Blood,Nagy Akos,Negative
18695,Imbruvica Market Million two thousand Analysis Trends Size Share Price Growth Drivers Business Opportunities Adroit Market Research,Adroit Market Research,Postive
18697,APSNoletha AssocSupBattle CLL TeacherAppreciation Gift,Beecher Hills ES,Postive
18698,CLLSociety CLL,Tom Henry MBA RPh CPh,Negative
18700,CLL CLL,Patient Empowerment Network,Negative
18701,CLL Talha Munir LeedsHospitals BritSocHaem CLLsm Leukemia,VJHemOnc,Negative
18702,CLL,iwCLL,Postive
18703,two,Cancer News,Negative
18704,OncoAlert Ibrutinib CLL,Raul Cordoba MD PhD,Negative
18705,OncoAlert Ibrutinib CLL,Raul Cordoba MD PhD,Negative
18706,two,ClinicalTrialsData,Negative
18709,Chronic Lymphocytic Leukemia Treatment Industry Research Report,Ricerca Alfa,Negative
18710,Signalling CLL,Nature Reviews Disease Primers,Negative
18711,one,ClinicalTrialsData,Negative
18712,one,NASDAQ,Negative
18713,Vit CLL three two thousand Shanafelt Drake et al MayoLeukemiaMDS BloodJournal CLLsm SuppOnc,Mike Thompson MD PhD FASCO,Negative
18716,CLL Tuesday three day DevOps,Continuous Lifecycle London online,Negative
18718,today webinar Key Takeaways two thousand and eighteen ASH CLL,Oncology State Societies ACCC,Negative
18719,GC CLL,Club Libertad Limpeno,Negative
18720,GC CLL thirty ST UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
18721,GC CLL,Club Libertad Limpeno,Negative
18722,GC CLL thirteen Liz Pena,Club Libertad Limpeno,Negative
18723,GC CLL eleven,Club Libertad Limpeno,Negative
18724,GC CLL seven ST Cortaza,Club Libertad Limpeno,Negative
18725,GC CLL,Club Libertad Limpeno,Negative
18726,GC CLL PT Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18727,GC CLL,Club Libertad Limpeno,Negative
18728,GC CLL Damia Cortaza,Club Libertad Limpeno,Negative
18729,GC CLL,Club Libertad Limpeno,Negative
18730,GC CLL,Club Libertad Limpeno,Negative
18731,GC CLL ten Liz Pena,Club Libertad Limpeno,Negative
18732,GC CLL,Club Libertad Limpeno,Negative
18733,GC CLL,Club Libertad Limpeno,Negative
18735,GC CLL Diana Salinas Laurie Cristaldo Cortaza Liza Larrea Natalia,Club Libertad Limpeno,Negative
18736,CLL two CLL CLL,Andrew Schorr,Negative
18737,CLL David Maloney CLL,Andrew Schorr,Postive
18739,Health Stacey Worthy Aimed Alliance CLL,Esther Schorr,Postive
18740,Tuesday May fourteen PM EDT Monthly CLL Register CME CLL,BioAscend,Negative
18742,May fifteen Mechanism Cell,Immunol,Negative
18743,AIM CLL Cello Health PLC Result,AIM Alerts,Negative
18744,CLL Health Consulting Cello Signal Decent Forward Divvy three one,WheelieDealer,Postive
18745,CLL Cello Health first half CLL AndrewScottTV,Jon Bircher,Postive
18746,CLL Cello Health first half CLL,Ruth Gemmell,Postive
18747,CLL Cello Health first half CLL AndrewScottTV,Proactive,Postive
18748,Today five CLL EHG JSG KEYS VTU,Jon,Negative
18749,AIM CLL Cello Health PLC AGM Statement,AIM Alerts,Negative
18750,BMT CLL,Amber Koehler,Negative
18751,Tomorrow noon Nadia Khan Elena Gitelson Memorial Lectureship annual Gitelson Jefferson two thousand and thirteen CLL,Sidney Kimmel Cancer Center Jefferson Health,Negative
18752,CLL,Mohamad Mohty,Negative
18753,CLL,Taylor Lab UM,Postive
18754,CLL University Awards two thousand and nineteen Elaine Moore Steve Gascoigne Natalie Purnell,CLL Warwick Uni,Postive
18755,Talha Munir CLARITY CLL,Alasdair Rankin,Postive
18756,Katrine Melvold CLL,Sigrid Skanland,Postive
18757,VIDEO Lessons CLL CLARITY Talha Munir LeedsHospitals BritSocHaem LEUsm CLLsm,VJHemOnc,Postive
18760,Peptide Vaccination With Patients With Chronic,CureHuntr,Negative
18761,today CLL SLL,Sidbury,Postive
18762,DanaFarber CllSociety CLL ChronicLymphocyticLeukemia,Michele,Postive
18763,Drug Sensitivity Screening CLL Amsterdam June,Sigrid Skanland,Negative
18764,CLL,Kathleen Hoffman,Negative
18765,JITC Research plasma membrane,Society Immunotherapy Cancer,Negative
18768,CLL CLLsm,Raul Cordoba MD PhD,Negative
18769,two thousand and National CLL Patient Carer Information Day Saturday Deborah Sims CLL Ireland,CLL Ireland,Negative
18770,one CLL,Talal Hilal,Negative
18771,weekly CLL,CLL Society Inc,Negative
18772,one April one one,Fleets Axanar,Negative
18773,almost fifty CLL ten FCR,AplusA World,Negative
18775,July Woohoo CancerSucks CLL,Sarah Sunshine,Postive
18777,obinutuzumab Haematologica,Mahmoud Aljurf,Negative
18780,Register MDS CLL AML,Leukemia Research Foundation,Postive
18781,CLL LeukemiaUpdate,Maria Roussakis MLT MSc,Negative
18782,today Jan Burger MDAndersonNews Register,The Leukemia Lymphoma Society,Negative
18783,One SOC ten year TalalHilal,David Steensma MD,Negative
18784,CLL Da chronische lymphatische Leukamie CLL Erkrankung Verwirrung CLL Hier zum,selpers fur chronisch Kranke,Negative
18786,two thousand and nineteen Roche,Total Pharma News,Negative
18787,CLL,Toby Eyre,Postive
18791,DOR,Chan Cheah,Negative
18792,Download eBook,AplusA World,Postive
18793,CLL Akershus University Hospital today Hoa Tran,Sigrid Skanland,Postive
18794,Blood Journal Less BCR,Izaskun Zeberio,Negative
18795,Bair two thousand and nineteen American Journal Hematology,Dr Comeau MD,Negative
18796,dia del IBT,juan moises arana,Negative
18797,CLL,Kathleen Hoffman,Negative
18798,IFTA CLL CLL CLL,Lynn Cornell,Negative
18800,Watch Follicular Lymphoma Update American Society Hematology Stanford University Neel Gupta CLL,Patient Power,Negative
18801,BCR,Francesco Bertoni,Negative
18802,one CLL one nineteen month one,Shouting people underpants,Negative
18805,Lymphoma Research Foundation Announces More Than twenty Lymphoma Chronic Lymphocytic Leukemia Research Grants Investment Supports Young Investigators Dedicated Developing Patient Therapies May one two thousand and nineteen,CRO Contract Res,Postive
18807,CLL,Patient Power,Negative
18808,Mechanisms Inhibitors Efficacy Toxicity ESH three thousand and ten UNMC,UNMC Pathology Microbiology,Negative
18809,AIM CLL Cello Health PLC,AIM Alerts,Negative
18811,Vit CLL two thousand and eleven,Mike Thompson MD PhD FASCO,Negative
18813,fifty CLL,SwingTradeBot UK,Negative
18814,tomorrow Leawood CLL CMO CllSociety two thousand and eighteen Annual Meeting,ACCC,Postive
18815,AAS Det,Majlen Saarinen,Postive
18816,Perth one LinearClinical Btk,Chan Cheah,Negative
18817,morning Baa Black Sheep CLL,Ashbridge Nursery Maxy Farm,Postive
18818,Today,EYFS Resources,Negative
18820,twenty million Peripheral Blood Mononuclear Cells fifty,Bay Biosciences LLC,Negative
18830,Leukemia two thousand and five CLL,Debbie La Torre,Postive
18831,JITC Research plasma membrane,Society Immunotherapy Cancer,Negative
18832,Lymphocytic Leukemia CLL CMEcredits Oncology,Paradigm Med Comm,Negative
18833,Geoff Grubbs Georgetown Lombardi Bruce Cheson MD,Georgetown Lombardi,Postive
18834,two thousand Imbruvica ChronicLymphocyticLeukemia CLL,Evaluate Pharma,Negative
18835,Adrian NIH,CLL Society Inc,Postive
18836,Alison Duffy CLL,SpecialtyPTimes,Negative
18837,CLL,The Match Advocacy,Negative
18838,CLL,Kingwood Emergency Hospital,Negative
18839,birdsong today CLL,Woodvale Primary Academy,Postive
18842,OLIMPIA VS CLL,Club Libertad Limpeno,Negative
18843,OLIMPIA VS CLL el ST UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
18844,three,mHmd Swn,Negative
18845,OLIMPIA VS CLL,Club Libertad Limpeno,Negative
18846,OLIMPIA VS CLL,Club Libertad Limpeno,Negative
18847,May one The JI The Next Target Chronic ReadtheJI,Immunol,Negative
18848,von Willebrand,Lymphoma Papers,Negative
18850,CLL Bendamustine CI,Toby Eyre,Negative
18859,CLL,Kathleen Hoffman,Negative
18860,Polish Lymphoma Research Group CLLSLL HL,CRO Contract Res,Negative
18861,OncologyNews Rituximab CLL,Elsevier Oncology,Negative
18862,Brian Koffman Neil Kay Society Minneapolis one hundred attendee Excellent CLL CLLsm,CLL Society Inc,Postive
18863,CLL CllSociety Minneapolis morning YucaiWangMD,Amber Koehler,Negative
18864,andrewschorr TY PatientPower CLL,Michele,Postive
18865,CLL CLL CllSociety YucaiWangMD,Saad kenderian,Negative
18866,CLL Minneapolis Diagnosis Treatment CLL CllSociety,Saad kenderian,Negative
18867,Polish Lymphoma Research Group,Lymphoma Papers,Negative
18869,rituximab idelalisib placebo CLL,Gil Morgan,Negative
18877,CLL,Oncology Tube,Negative
18878,Catriona Jamieson Leukemia Lymphoma Society UC San Diego today,Andrew Schorr,Negative
18879,This Dominic LeBlanc second April two thousand and seventeen last October,CTV Atlantic,Negative
18880,North west annual PLAYR CLL NWCRCentre,Yasin,Negative
18881,Mechanisms Inhibitors Efficacy Toxicity ESH three thousand and ten UNMC,UNMC Pathology Microbiology,Negative
18882,CancerResearch,Nature Communications,Negative
18883,Gary four CLL ten year first TNT ChiMarathon TNT Catch NJMarathon,Team In Training,Negative
18884,one day Universe PatientPower CLLSupport CllSociety CLLAdvocates CLL,Michele,Postive
18885,CLL Watch WVCancer,Patient Power,Negative
18886,ChemoFree LymHubSS Save eighteen June two thousand and CLL,Lymphoma Hub,Postive
18887,eleven fourteen,Lymphoma Papers,Negative
18888,JCO Final Results Rituximab,Cancer Library VCC,Negative
18889,eleven fourteen,histopathology,Negative
18890,OncoAlert CLLsm,Raul Cordoba MD PhD,Negative
18893,Bulk CLL DOR Efficacy,Toby Eyre,Negative
18895,BCR,Public Health,Negative
18896,CLL Neil Kay CLL,Oncology Tube,Negative
18897,Copenhagen today,CLL Advocates Network,Postive
18898,Jacqueline Barrientos,Oncology Tube,Negative
18899,Carsten Niemann,LyLe Foreningen,Negative
18900,One Christian Poulsen BlodcancerDk,LyLe Foreningen,Negative
18901,Susanne CLL,LyLe Foreningen,Postive
18902,Lymphoma Hub Satellite Symposium CLL,Lymphoma Hub,Negative
18903,CLL MDAndersonNews,Patient Power,Postive
18904,Tamar Tadmor Haifa Israel CLL today CLL,Jonathan Pearce,Negative
18905,CLL,Kathleen Hoffman,Negative
18906,PepperOAIC National Meeting today Washington DC CLL,David Bartlett PhD,Postive
18907,plasma membrane Immunother Cancer,TRP Channel Bot,Negative
18908,CLL JPearceCEO Tamar Tadmor,LyLe Foreningen,Negative
18909,CLL Copenhagen Exciting,Jonathan Pearce,Negative
18910,cll fokusdag villyochristens kbh LCE BlodcancerDk,LyLe Foreningen,Negative
18911,Aspin Ridge Tenderloin Cipolinni Onions Bone Marrow Crumb Horseradish Gel,Brian Barrett,Negative
18912,Mato CLLsm,Targeted Oncology,Negative
18913,Horizon CLL,Oncology Tube,Negative
18915,Cerro el futbol Tanto Liza Larrea CLL,Revista El Repollero,Negative
18916,eight PML lymphopenia,NEJM,Negative
18917,CLL,Club Libertad Limpeno,Negative
18918,CLL,Club Libertad Limpeno,Negative
18919,CLL,Club Libertad Limpeno,Negative
18920,CLL eighteen Cambio Liz,Club Libertad Limpeno,Negative
18921,CLL eighteen Cambio Kari,Club Libertad Limpeno,Negative
18922,CLL fifteen,Club Libertad Limpeno,Negative
18923,CLL nine,Club Libertad Limpeno,Negative
18924,CLL two Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
18926,CLL,Club Libertad Limpeno,Negative
18927,CLL,Club Libertad Limpeno,Negative
18928,CLL thirty,Club Libertad Limpeno,Negative
18929,CLL,Club Libertad Limpeno,Negative
18930,CLL twenty,Club Libertad Limpeno,Negative
18931,CLL sixteen,Club Libertad Limpeno,Negative
18932,CLL five,Club Libertad Limpeno,Negative
18933,CLL Alicia Bobadilla Laurie Cristaldo Cortaza Natalia Karina Vega,Club Libertad Limpeno,Negative
18935,Only three day CLL CllSociety Minneapolis Saturday,Amber Koehler,Negative
18936,Study Rituximab,Jose Queizan,Negative
18937,SingleCell CLL CLL,DDNews Online,Negative
18938,almost fifty CLL ten FCR Download,AplusA World,Postive
18940,Copenhagen tomorrow CLL,Jonathan Pearce,Negative
18941,HealthInsurance Eliot Finkelstein CLL LivingWell,Patient Power,Negative
18942,three CLL,ASCO Publications,Negative
18943,Stephen Ansell PhD Jennifer Brown Nitin Jain MD MBBS,Oncology CE,Negative
18944,two thousand,The Chief Observer,Postive
18945,Lymsm Lymphoma CLL,Lymphoma Hub,Negative
18949,TLS CLL TheBloodMD AndreGoyMD,chadi nabhan MD MBA FACP,Negative
18950,CLL,FEDERICO GAITI,Negative
18951,NatureComms Dan Landau WeillCornell Congrats,Ankur Singh,Postive
18957,James Jennifer Woyach CLL,The James,Postive
18959,MOMENTO LuchaLibre pisoton,Lenko Sins,Negative
18960,CLL MedicalCollege tonight Milwaukee Keep,OncLive SOSS,Negative
18961,Key Clinical Trials Know Chronic CLL,SpecialtyPTimes,Negative
18962,AbdelWahablab CLL,Lab,Postive
18963,OncoAlert CLL Eradicates Minimal Residual Disease three,Raul Cordoba MD PhD,Negative
18964,New JITC Research plasma membrane,Society Immunotherapy Cancer,Negative
18965,Waldenstrom CME,Healio CME,Postive
18966,one Leawood KS CLL CMO CllSociety two thousand and eighteen Annual Meeting,ACCC,Postive
18967,CLL RBC first RBC ISBTScience VoxSanguinis CLL,ISBT Central Office,Negative
18968,CLL,Cancer Care,Negative
18969,CLL three week three day DevOps,Continuous Lifecycle London online,Negative
18970,CLL Tanya Siddiqi TheEBMT ImmunoOnc CLL LYMsm,VJHemOnc,Negative
18971,eighteen minute Lymphocytic CLL Biosimilar rituximab,LLSCanada,Postive
18972,NDA CLL,Bill,Negative
18973,CLL CLL,CLL Society Inc,Negative
18974,BarbyIngle one Ken CLL PatientPower,Michele,Postive
18975,un nuevo modelo de abordaje Linfocitica CLL,Gorka Coloma,Negative
18976,Jacqueline Barrientos MD MS CLL,Oncology Learning Network,Negative
18977,MarissaZeppieri Keep CLL PatientPower,Michele,Postive
18978,CLL,Michele,Negative
18979,CLL Indolent Click,VuMedi,Negative
18981,CLL Sept Edinburg Scotland Press,iwCLL,Negative
18982,Roche,Research,Postive
18984,HOY CLL ChileLuchaLibre VivaLaBotch IWC,The Pepex Family,Negative
18985,HOY CLL ChileLuchaLibre VivaLaBotch IWC,Thu Pepex,Negative
18986,HOY CLL ChileLuchaLibre VivaLaBotch IWC,Thu Pepex,Negative
18987,HOY CLL ChileLuchaLibre VivaLaBotch IWC,Thu Pepex,Negative
18988,HOY CLL ChileLuchaLibre VivaLaBotch IWC,Thu Pepex,Negative
18989,FCR StanfordMed Tait Shanafelt,ASH Clinical News,Negative
18990,Duelo Cerro el futbol VamosGUMA CLL,Revista El Repollero,Negative
18991,IDELA rituximab alone CLL,CellworksLife,Negative
18992,one IKEAUK nearly two year EarlyYears CLL KUW,Rache,Postive
18993,Gnocchi Kitty Gnocchi,Mira Larkin,Postive
18995,CLL,CLL Society Inc,Negative
18996,LYMPHOCYTIC,Ezzy,Negative
18997,LYMPHOCYTIC,Ezzy,Negative
18998,LYMPHOCYTIC,Ezzy,Negative
19000,Study Rituximab,maria jose agustin,Negative
19001,Myeloma Lymphoma MRD hour,VJHemOnc,Postive
19002,Wierda MDAndersonNews,Targeted Oncology,Negative
19003,CLL Signup,Michele,Negative
19004,Jennifer Woyach rituximab standard care,ASH Clinical News,Negative
19006,CLL,Kathleen Hoffman,Negative
19007,one CLL,Toby Eyre,Negative
19009,CLL Learn World Podcast,The James,Negative
19010,CLL LombardiCancer MedStarGUH,Maryam Yazdy MD,Negative
19011,nine,Ezzy,Negative
19012,LYMPHOCYTIC,Ezzy,Negative
19013,LYMPHOCYTIC,Ezzy,Negative
19014,LYMPHOCYTIC,Ezzy,Negative
19015,LYMPHOCYTIC,Ezzy,Negative
19016,LYMPHOCYTIC,Ezzy,Negative
19017,LYMPHOCYTIC twenty,Ezzy,Negative
19018,afternoon CLL,Jon Juane,Postive
19019,RWE Venetoclax TLS CLL,MoJo,Negative
19020,Watch CLL,Toby Eyre,Negative
19021,TLS MVA two hundred VEN CLL Renal,Toby Eyre,Postive
19022,TLS two hundred CLL one one,Michael Hallek,Negative
19023,CLL Watch CLL Richard Furman WeillCornell,Patient Power,Negative
19024,CLL ThePatient,Michele,Postive
19026,MRD CLL Watch,AbbVie US,Negative
19028,sur la protection de donnees notre solution de gestion de la fidelisation de client CLinkLoyalty GDPR CLL Decryptage,Symag BNP Paribas PF,Negative
19029,two thousand and nineteen Roche Johnson Johnson Market,Total Pharma News,Negative
19030,Annie Fitzgerald one medicare Blue Shield three Chronic,Joshua,Negative
19031,Oncological Love,Jeff Neurman,Negative
19033,PharmaTimes CLL,Plexus Ventures,Negative
19034,CLL CLLsm,CLL Society Inc,Negative
19035,AML,Leukemia Research Foundation,Postive
19036,Through Health Canada,CanadianBiosimilars,Negative
19037,Wierda MDAndersonNews BloodCancers,Targeted Oncology,Negative
19038,Anil Awesti Senior Teaching Fellow Tutor two CLL Association Academic Outreach two thousand and,CLL Warwick Uni,Negative
19039,two AITP CLL HemaSphere,European Hematology Association,Negative
19040,CLL nine PD CLL,Toby Eyre,Negative
19041,CLL CLL,Paul DeSantis PharmD,Postive
19042,CLL CLLsm,CLL Society Inc,Negative
19043,year one idelalisib cll,Jeff Sharman,Negative
19044,ASHClinicalNews,ASH Clinical News,Negative
19045,The Kansas Society Clinical Oncology CLL Brian Koffman one two thousand and eighteen Annual Meeting Register,Oncology State Societies ACCC,Postive
19046,CLL CLL SOC UK CLL,Toby Eyre,Negative
19047,Alison Duffy NCCNnews CLL,SpecialtyPTimes,Negative
19048,LYMPHOCYTIC eighteen,Ezzy,Negative
19049,BloodCancers,Targeted Oncology,Postive
19050,CLL,Patient Power,Negative
19051,UAA CLL,Club Libertad Limpeno,Negative
19052,UAA VS CLL Damia Cortaza,Club Libertad Limpeno,Negative
19053,UAA CLL Liz Pena,Club Libertad Limpeno,Negative
19054,UAA CLL Carmen Benitez,Club Libertad Limpeno,Negative
19055,UAA VS CLL forty Karina Vega,Club Libertad Limpeno,Negative
19056,UAA CLL PT Fabiola Sandoval UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
19057,UAA VS CLL Karina Vega,Club Libertad Limpeno,Negative
19058,UAA Fiorella Martinez,Club Libertad Limpeno,Negative
19059,UAA VS CLL thirty Karina Vega,Club Libertad Limpeno,Negative
19060,UAA Griselda Garay Karina Vega,Club Libertad Limpeno,Negative
19061,UAA Karina Vega,Club Libertad Limpeno,Negative
19062,UAA twenty,Club Libertad Limpeno,Negative
19063,UAA VS CLL sixteen Griselda Garay,Club Libertad Limpeno,Negative
19064,UAA VS CLL seven eight nine Liz Griselda Garay Karina Vega,Club Libertad Limpeno,Negative
19065,UAA VS CLL two three Karina Vega,Club Libertad Limpeno,Negative
19066,UAA CLL,Club Libertad Limpeno,Negative
19067,UAA CLL EQUIPO Diana Salinas Stephanie Lacoste Fiorela Martinez Cortaza Karina Vega,Club Libertad Limpeno,Negative
19068,CLL,Targeted Oncology,Negative
19069,CLL Ibrutinib Imbruvica Idelalisib BloodCancer,LymphomaAction,Postive
19070,CLL PowerfulPatients,Patient Power,Negative
19071,CLL,CLL Society Inc,Negative
19072,CLL,Michele,Postive
19074,Han four CMS de jugar gaudir Riu cm riuamunt cll La Carral,Gech,Negative
19075,Scan Bearish Engulfing today,SwingTradeBot UK,Negative
19076,CLL,MD Anderson Cancer Center,Negative
19077,VIDEO Ublituximab CLL Loretta Nastoupil BritSocHaem CLLsm,VJHemOnc,Negative
19078,CLL CLL,CLLSA,Negative
19079,ChronicLymphocyticLeukemia,Mayo Clinic Cancer Center,Negative
19081,BloodCancer,Targeted Oncology,Negative
19083,Norway,Lymphoma Papers,Negative
19084,Skola Seminarium Lars Svedberg Tammerfors,Utbildning och IT pa Kimitoon,Negative
19085,CLL,Kathleen Hoffman,Negative
19086,Lisa CLL Lisa,Leukaemia Care,Postive
19088,LYMPHOCYTIC ten,Ezzy,Negative
19089,one Leawood KS CLL CMO CllSociety two thousand and eighteen Annual Meeting,ACCC,Postive
19090,CLL Cells CpG CLL Bcells,Prof John,Negative
19091,CLL YoungEHA,Fabienne McClanahan Lucas,Negative
19092,CLL Watch CLL Richard Furman WeillCornell today AskTheExpert,Patient Power,Negative
19093,AIM CLL Cello Health PLC Annual,AIM Alerts,Negative
19097,Lymphoid Sarka Pospisilova CLL,CEITEC Connect,Postive
19099,Leukemia Medical,gilbert faure,Negative
19106,LeukaemiaCareUK LEUsm CLL CLLsm,VJHemOnc,Negative
19107,CLL CLLsm,Raul Cordoba MD PhD,Negative
19108,OncoAlert Bendamustine NHL CLL,Raul Cordoba MD PhD,Negative
19109,Leukaemia CLL,CLL Ireland,Negative
19110,VIDEO Communication CLL Ben Kennedy,VJHemOnc,Negative
19111,Hammer Facebook Amy Promise WTF,Jhawn Paul,Negative
19112,Ultmann Chicago Lymphoma Symposium CLL CLL,Amy Cavers,Negative
19115,NHL CLL University Chicago Drs Sonali Smith Leo Gordon Barbara Pro,Amy Cavers,Negative
19116,CLL Choi UCSDHealth Menashe Get May Portland,Patient Power,Negative
19118,fifth Richard Rosenquist Brandell Genomic Medicine NGS,Biotexcel,Negative
19120,CLL,Michele,Postive
19121,Read CLL,HemOnc Today,Postive
19122,CLL Ben Kennedy Ibrutinib Rituximab,VJHemOnc,Negative
19123,CLL,Cancer Care,Negative
19124,night CLL four,Patient Power,Negative
19125,CSD Board School Directors Julie Haywood Times News first Saturday Cheltenham Little League,Cheltenham SD,Negative
19128,Study Evaluate Safety Leukemia Non,TrialBulletin,Negative
19129,Talk Power Patients Inspirational CLL PatientPower,Michele,Postive
19130,September two thousand and nineteen Edinburgh More two thousand and nineteen CLL,BioAscend,Negative
19132,CLL One,AbbVie US,Negative
19133,ClinicalTrials Clinical Trial Coordinator,Sophie Cramp,Negative
19134,DanaFarber OncLive OncLiveSOSS,Kristi Rosa,Postive
19135,PCROWD DanaFarber CLL,Promise Study,Negative
19136,CLL fifteen minute Dr Richardson,donnashort,Negative
19137,Chronic Clinical,Panoptika Partners,Postive
19138,ASCO BloodJournal,MedPage Oncology,Postive
19139,Conexao Lado Leste muito Rap CLL,Conexao Lado Leste,Negative
19141,VIDEO Update CLL Memorial Sloan Kettering BritSocHaem CLLsm,VJHemOnc,Negative
19144,One CLL,iwCLL,Negative
19145,WeillCornell rituximab patient CLL GreatDebatesHem,Oncology Learning Network,Negative
19146,CLL Cello Health Plc Elevator Pitch CLL,Ruth Gemmell,Negative
19147,CLL,Kathleen Hoffman,Negative
19148,CLL Cello Health Plc Elevator Pitch CLL AndrewScottTV,Proactive,Negative
19149,CLL Cello Health Plc Elevator Pitch CLL AndrewScottTV,Proactive,Negative
19150,CLL,LymphomaAction,Postive
19151,Teva Canada TRUXIMA first Canada,The PMI Pharmaceutical Managers Institute,Negative
19153,two,Lymphoma Papers,Negative
19154,Canada,DennisPartners,Negative
19157,CLL,Club Libertad Limpeno,Negative
19158,CLL ST Ingresa Liz Karina Vega,Club Libertad Limpeno,Negative
19159,CLL,Club Libertad Limpeno,Negative
19160,CLL ST Karina Vega,Club Libertad Limpeno,Negative
19161,CLL,Club Libertad Limpeno,Negative
19162,CLL Liza Larrea UNIDASPORELOBJETIVO CLLPY,Club Libertad Limpeno,Negative
19163,CLL,Club Libertad Limpeno,Negative
19164,CLL,Club Libertad Limpeno,Negative
19165,CLL,Club Libertad Limpeno,Negative
19166,CLL twenty,Club Libertad Limpeno,Negative
19167,CLL nine Karina Vega,Club Libertad Limpeno,Negative
19168,kaenada jincul,yahanjuju,Negative
19169,CLL five,Club Libertad Limpeno,Negative
19170,ClinicalUpdates Review AML CLL Drs Delgado Eichhorst SapienzaRoma,Medscape Education,Postive
19171,CLL ChronicLymphocyticLeukemia,Michele,Negative
19173,CLL Watch WVCancer,Patient Power,Negative
19174,CLL CLLsm,Raul Cordoba MD PhD,Negative
19175,Idelalisib CLL,Blood Advances,Negative
19176,CLL,MoJo,Postive
19177,CLL Capital Markets Event,Oilman Jim,Negative
19178,AIM CLL Cello Health PLC Capital Markets Event,AIM Alerts,Negative
19179,two CLL CLLsm,Raul Cordoba MD PhD,Negative
19180,CLL CLL CLLsm Leukemia,CLL Society Inc,Negative
19181,HealthInsurance Eliot Finkelstein CLL LivingWell,Patient Power,Negative
19182,CLL CLL,Patient Empowerment Network,Negative
19183,ChronicLymphocyticLeukemia StemCells Read Advancing Science,Mayo Clinic Cancer Center,Negative
19184,New Research Article Targeting CLL,Clinical Cancer Research,Negative
19185,James Listen Jennifer Woyach CLL,The James,Postive
19186,CLL MDAndersonNews,Patient Power,Postive
19188,seven OutspokenOncology one MarkWolfinger CLL,chadi nabhan MD MBA FACP,Negative
19189,Summer CLL Book,CLL Warwick Uni,Negative
19190,one Blood Journal,Dr Comeau MD,Negative
19191,CLL BTK CLLsm,VJHemOnc,Negative
19192,CLL,Kathleen Hoffman,Negative
19193,CLL,Health Stories Project,Negative
19194,Brian Koffman CLL CLLsm,CLL Society Inc,Negative
19195,one,Juan Marquet,Negative
19196,ten CLL LivingwithLymphoma,LymphomaAction,Negative
19197,CLL Watch CLL Richard Furman,Patient Power,Negative
19198,CLL,iwCLL,Negative
19199,CLL,Scradley,Postive
19200,CLL GCLLSG Billy Michael Chelliah Ulm Germany,Michael Hallek,Postive
19202,rituximab patient,Bachar Samra MD,Negative
19203,May three Berger MDAnderson,Michele,Negative
19205,CLL,Club Libertad Limpeno,Negative
19206,CLL VS SanLorenzo GOOL Laurie Cristaldo,Club Libertad Limpeno,Negative
19207,CLL ST,Club Libertad Limpeno,Negative
19208,CLL,Club Libertad Limpeno,Negative
19209,CLL,Club Libertad Limpeno,Negative
19210,CLL twenty,Club Libertad Limpeno,Negative
19211,CLL twelve Laurie Cristaldo,Club Libertad Limpeno,Negative
19212,CLL five,Club Libertad Limpeno,Negative
19213,CLL,Club Libertad Limpeno,Negative
19214,CLL,Club Libertad Limpeno,Negative
19215,CLL,Club Libertad Limpeno,Negative
19216,CLL,Club Libertad Limpeno,Negative
19217,CLL,Club Libertad Limpeno,Negative
19218,CLL,Club Libertad Limpeno,Negative
19219,CLL ten,Club Libertad Limpeno,Negative
19220,CLL seven,Club Libertad Limpeno,Negative
19221,CLL Diana Salinas Laurie Cristaldo Cortaza Joana Galeano Griselda Lopez Claudia Liza Larrea Monica Vega UNIDASPORELOBJETIVO,Club Libertad Limpeno,Negative
19222,CLL CllSociety CllIreland LymphomaAction JanRynne CLLSupport,CLL Advocates Network,Postive
19223,CLL,Dana,Negative
19224,CllSociety CLL CLLsm,Xenia Schmidt,Postive
19225,CLL Watch CLL Richard Furman WeillCornell,Patient Power,Negative
19227,CLL Follicular LivingwithLymphoma,LymphomaAction,Postive
19228,CLL CLLsm,CLL Society Inc,Negative
19229,De Novo MDS,Lymphoma Papers,Negative
19231,RNA,Cancer Papers,Negative
19232,LCE Lymphoma CLL Community Advisory Board Brussels,Lymphoma Coalition,Negative
19233,CLL Portland May eighteen Portland,Patient Power,Postive
19234,one CLL CAB CLL LornaWarwick,Michael Rynne,Postive
19235,first CLL Community Advisory Board LymphomaMatters,LymphomaAction,Postive
19237,WmukInfo Guytavori BolanosNat LornaWarwick CLLAdvocates,Jonathan Pearce,Negative
19238,CLL,CURE Magazine,Negative
19239,Lymphoma CLL Community Advisory Board long week Europe,Jonathan Pearce,Postive
19240,RNA Hematol,CancerEpiPapers,Negative
19241,Hunt Mrs Seddon CLL EAD,Oak Tree Primary School,Negative
19242,FDA IMBRUVICA,PressReleasePoint,Negative
19243,Leukemia Imbruvica,Cancer Health,Negative
19245,TBT two thousand and seventeen genentech CLL,The Galien Foundation,Postive
19246,Smudge Smudge CLL,KHALID HEMATOLOGIST,Negative
19247,CLL CLLsm,CLL Society Inc,Negative
19248,CLL,CellworksLife,Negative
19249,CLL,GEDEFO,Negative
19250,Watch PatientCafe CLL,Patient Power,Postive
19251,one,CURE Magazine,Negative
19252,CLL,Kathleen Hoffman,Negative
19253,AIM CLL Cello Health PLC,AIM Alerts,Negative
19254,Chromatin,Fabrice Leclerc,Postive
19256,CLL scRNAseq ATACseq,Andre Rendeiro,Negative
19257,Changing Treatment Options CLL Leukemia Executive Medical CLL William Wierda,MD Anderson Leukemia,Negative
19258,CLL PowerfulPatients,Patient Power,Negative
19261,two thousand and Oncology,ResearchByMarkets,Negative
19262,CLL,MD Anderson Cancer Center,Negative
19264,Tomorrow AML,Bioevents Sharing Biomed Knowledge,Negative
19266,Combinations New Agents,Tom,Negative
19267,Dustin Blast Chronic March Register today,Hyde Park Blast,Negative
19268,CLL,Cure Cancer Now,Negative
19269,Genentech,PressReleasePoint,Negative
19270,CLL,CLL Society Inc,Negative
19271,Watch CLL MoffittNews,Patient Power,Negative
19272,Lymphoid Malignancy Fantastic two day CLL View,NLTP,Postive
19273,kan CLL Europa Vi sa folg BlodcancerDk,LyLe Foreningen,Negative
19275,First LCE Community Advisory Board three European CLL,Lymphoma Coalition,Postive
19276,Lymphoma Coalition Europe Lymphoma CLL Community Advisory Board Brussels,Jonathan Pearce,Negative
19277,PubSaludMurcia High rituximab rituximab maintenance,BVirtual Murciasalud,Negative
19279,FDA,Krishna Talluri MD,Negative
19280,Tang et al,Oxford Nanopore,Negative
19281,April CLL,Phoebe Needles,Negative
19282,Esteban Koichi Takahashi AML CLL MissionBio ten minute SingleCell,Aaron Llanso,Postive
19283,CLL CLLsm LeuSM HemOnc,VJHemOnc,Postive
19284,tomorrow Register CLL,iwCLL,Negative
19285,tomorrow Sept two thousand and nineteen biennial CLL,iwCLL,Negative
19286,Review Series Dissecting CLL,Blood Journal,Negative
19287,CLL Watch Javier CLL,Patient Power,Postive
19288,Ben Kennedy,Helen Parry,Postive
19289,two thousand and nineteen AB Science SA Amgen Celgene Corporation Dynavax Technologies Corporation Eisai,HAM,Negative
19290,two thousand and nineteen CLL,CLL Society Inc,Negative
19292,Melanoma,Patrick Benusiglio,Negative
19293,LibertadLimpeno de la manera el thirteen zero Guarani su estreno del sabado de Nacional Estaremos la temporada LasGumarelas CLL,Revista El Repollero,Negative
19295,LeukaemiaCareUK Including BritSocHaem AML,VJHemOnc,Postive
19296,Brussels Community Advisory Board three European CLL,Jonathan Pearce,Postive
19299,Carl CLL,LymphomaAction,Postive
19300,one one SundayMorning CLL,Mike ForThePeople,Negative
19302,chlorambucil rituximab treatment elderly,Research UMCG,Negative
19303,rituximab rituximab maintenance,Juan Marquet,Negative
19304,CLL,Kathleen Hoffman,Negative
19305,CLL HBV,XpertDox,Negative
19306,CLL CLL CLLsm,CLL Society Inc,Negative
19307,two UK CLL two thousand and sixteen CLL,Toby Eyre,Negative
19308,FCR CLL MRD MRD four MRD six CLL,Toby Eyre,Negative
19309,CLL Society CLL CLLsm,CLL Society Inc,Negative
19310,Nature CLL,CLL Society Inc,Negative
19311,Chronic CLL night Awesome,XpertDox,Negative
19312,Comparison,JAAD Journals,Negative
19314,Florida Blood Cancer Conference CLL,Jose Sandoval MD FACP,Negative
19315,CLL Watch CLL Richard Furman WeillCornell today AskTheExpert,Patient Power,Negative
19316,CLL CNSmasterclass KebleConference Oxford,LymphomaAction,Negative
19317,CLL Woke weekend,Mike ForThePeople,Postive
19318,CLL,CLL Society Inc,Negative
19320,ASH CLL LLSusa EndCancer Venetoclax HealthTalk MedEd,Oncology Tube,Negative
19321,LeukaemiaCareUK,Zack,Postive
19322,Annual Meeting Frankfurt CLL coming day,Lymphoma Hub,Postive
19323,Types second,TerkkoLib,Negative
19324,nine,CDD press,Negative
19325,CLL,Prof John,Postive
19326,HemeOnc QoL CLL Please,VJHemOnc,Postive
19327,CLL BCR Tissue,Jose Sandoval MD FACP,Negative
19328,twelve LSC OpenAccess Research viaFAC Leukemia,Flinders Uni Library,Negative
19329,three MURANO Trial ASH CLL LLSusa EndCancer,Oncology Tube,Negative
19330,CLL Portland Oregon WVCancer CompassOncology,Patient Power,Postive
19332,Venetoclax Carfilzomib Dose Escalation Study ASH CLL LLSusa EndCancer Venetoclax Carfilzomib,Oncology Tube,Negative
19333,Tom Kipps CLL Bcells,Prof John,Negative
19334,CLL Tune CLL MRD,Patient Power,Postive
19335,Researchers United States Ibrutinib,Modern Trials,Postive
19336,CLL Society Patient Caregiver Forum next Friday April five NIH CLL CLLsm Leukemia,CLL Society Inc,Negative
19337,Marie Jose Kersten TheEBMT CAR SCT SCT CLL,Lymphoma Hub,Negative
19338,yesterday evening Text World Theory CLL,Jeremy Scott,Postive
19339,CALGB seventy thousand six hundred and three Alliance,Lymphoma Papers,Negative
19341,ASH CLL LLSusa EndCancer healthcare,Oncology Tube,Negative
19342,nine,UCL Discovery,Negative
19343,nine,UCL Discovery,Negative
19344,CLL finnCap Cello Health two thousand and eighteen CLL AndrewScottTV,Proactive,Postive
19345,CLL,Hematology Advisor,Negative
19346,Tanya Siddiqi City Duarte CA CLL CLLsm,CLL Society Inc,Postive
19347,Brian Koffman CLL CLL,CLL Society Inc,Postive
19348,Save one BSI CLL,BSI America,Postive
19349,Tanya Siddiqi TRANSCEND CLL ImmunoOnc,VJHemOnc,Negative
19351,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
19352,Love Building,Foundation Stage,Postive
19353,today,finnCap,Postive
19354,two thousand,Research,Postive
19356,CLL,Kathleen Hoffman,Negative
19357,CLL four,Andrew Schorr,Postive
19358,Clinicopathologic Hematologia,Biosimilar Today iMagazine,Negative
19359,CLL,Margaret Walker,Negative
19360,CLL,CLL Society Inc,Negative
19361,TrialTuesday Alliance Jennifer Woyach MD Alliance Learn CLLSM NCI NCTN,Alliance Clinical Trials Oncology,Negative
19362,CLL nine six month AML Rezvani,Dr Tony Truong,Postive
19363,CLL CLL,MoJo,Negative
19365,NCCN Guidelines Insights Chronic Lymphocytic Lymphocytic Lymphoma Version,Serv Farmacia CHUAC,Negative
19366,Supporting Emergent Literacy CLL,Early Years LSC FE VocEd EYFS,Negative
19367,Tanya Siddiqi CLL TRANSCEND four TheEBMT BMTsm CLLsm Leusm,VJHemOnc,Postive
19368,Dr Siddiqi TRANSCEND CLL CARTcell CLL,Razan Mohty,Negative
19372,CLL CLL,Ex Dividend Date,Negative
19373,CLL,Lymphoma Hub,Negative
19374,ChronicLymphocyticLeukemia,Wellzio,Negative
19378,CLL Watch CLL Richard Furman,Patient Power,Negative
19379,Khalid Asghar Controller Radio Pakistan Lahore Am Chronic PBC Radio Cancer Hospital one DG PBC,Khalid Asghar,Negative
19380,New Advances Therapies Chronic CLL Paraneswaran Venugopal RushMedical Sat Treatment Options Blood Cancer Patients Conference Register today,Leukemia Research Foundation,Negative
19381,CLL CLL,CLL Society Inc,Negative
19382,Venetoclax earlier week CLL,CLL Society Inc,Negative
19383,Richard Maziarz Interview CLL,Lymphoma Hub,Negative
19384,IISAragon GVADrPeset ICOnoticies IdipazScience IISLaFe,IDIVAL Direccion,Negative
19387,Annual Meeting Frankfurt tomorrow CLL,Lymphoma Hub,Postive
19389,Los investigadores esperan al comprender como deteriora la funcion de la medula osea la linfocitica mejorar la funcion de la medula osea encontrar Lea ma,SEBASTIAN UGARTE,Negative
19390,ChronicLymphocyticLeukemia,Mayo Clinic,Negative
19391,CLL CLLsm,Raul Cordoba MD PhD,Negative
19392,obintuzumab seventeen CLL PB Congrats MartinJSDyer,Toby Eyre,Postive
19393,VIDEO Key Magnus,VJHemOnc,Negative
19394,CLL Watch Javier CLL,Patient Power,Postive
19395,Watch CLL MoffittNews,Patient Power,Negative
19396,one CLL,Blood Journal,Negative
19397,CLL Watch Richard Furman WeillCornell CLL,Patient Power,Postive
19398,CLL CLL,Andrew Schorr,Negative
19399,RGL Sarka Pospisilova MasarykUni one IMI Czech CLL Study Group annual one,CEITEC,Postive
19400,CLL Susan Brien Javier Pinilla CLL,Patient Power,Postive
19401,CancerMoonshot,Cancer Frontline,Postive
19402,International Chronic Lymphocytic Leukemia Treatment Market two thousand and eighteen two thousand and twentythree,Kiran Bhole,Negative
19404,CLL,Kathleen Hoffman,Negative
19405,Chronic CLL,Clinical Trials Congress two thousand and nineteen,Negative
19406,one,Krizsan Szilvia MD,Negative
19407,one Blood Journal,Izaskun Zeberio,Negative
19408,one,Neil Dunavin,Negative
19410,Watch PatientCafe CLL,Patient Power,Postive
19411,one,Garbine Lizeaga,Negative
19412,Beginning Catalan ASBschool Catalan Call Wild CLL,ASBlearns,Negative
19413,Intense Uptake Liposomal Curcumin Multiple Myeloma Cell,SignPath Pharma,Negative
19414,Foundation twenty,Lymphoma Research Foundation,Postive
19415,one CLL CLLsm,Raul Cordoba MD PhD,Negative
19416,WBC today CLL,Leo Reap,Negative
19417,Jennifer Woyach,Abel Costa Neto MD,Negative
19419,UnitempsBear CLL Unitemps,CLL Warwick Uni,Postive
19420,Ian Flinn Copiktra September,CURE Magazine,Negative
19421,SEPTEMBER US CLL HORIZONS two thousand and ENDINBURGH SCOTLAND INTERNATIONAL April,CLL Advocates Network,Postive
19422,CLL Cello Health Plc two thousand and nineteen CLL AndrewScottTV,Proactive,Postive
19423,MedscapeEdu CLL Jacqueline Barrientos,Medscape Education,Negative
19424,Today ResearchHighlight,finnCap,Postive
19425,CLL one one,WheelieDealer,Postive
19426,five AML,Bioevents Sharing Biomed Knowledge,Postive
19427,CLL two thousand and nineteen CLL AndrewScottTV,Proactive,Postive
19428,CLL Cello first CLL AndrewScottTV,John Harrington,Negative
19429,AIM CLL Cello Health PLC,AIM Alerts,Negative
19430,Today five CLL,Jon,Negative
19431,mirtazapine pml cll,Anna Deveau,Postive
19432,ASH CLL LLSusa EndCancer healthcare,Oncology Tube,Negative
19433,AML ASCO Leukemia CLL,MedPage Oncology,Postive
19434,March CLLSA CLL,CLLSA,Postive
19435,Scan today CLL HRI,SwingTradeBot UK,Negative
19436,Neil Kay KRAS NRAS twelve,Amber Koehler,Negative
19437,Cambridge George Follows ACTcharity CLL,CLLSA,Postive
19438,CLL,Blood Advances,Postive
19439,CLL Three,Patient Power,Negative
19440,CLL Hematology ChronicLymphocyticLeukemia,hematologist,Negative
19441,CLL Read CLL David Lauder,Patient Power,Negative
19442,PatientReporter PatientPower PatientExperience CLL,Michele,Negative
19443,two thousand and nineteen CLL,iwCLL,Negative
19444,CLL BloodTests,DOCTOR,Negative
19446,AbbVie Venetoclax today CLL,CLL Society Inc,Negative
19447,Data Study,CureHuntr,Negative
19448,one ACA,joan settina,Negative
19449,Fly United American Airlines bryan airport plane brazos,Easterwood Airport,Postive
19450,obinutuzumab CLL,Milos Miljkovic,Negative
19451,CLL Drs Brien,Andrew Schorr,Postive
19452,Learn,NCICancerTrials,Negative
19453,Venetoclax More CLL,CLL Society Inc,Negative
19454,ninety CLL CancerMoonshot NitinJainMD,Cancer Frontline,Negative
19456,NationalBroadcast Grand Rounds LiveStream ChronicLymphocyticLeukemia Earn CMEcredits Register CLL,Paradigm Med Comm,Postive
19458,Frankfurt CLL,Lymphoma Hub,Negative
19459,two Ibrutinib CLL fortyfour month twelve,Toby Eyre,Postive
19460,Duvelisib New Treatment Relapse Refractory CLL DanaFarber CllSociety CLL LLSusa LeukemiaRF LMCongress ImedexCME Idelalisib Duvelisib Copanlisib EndCancer,Oncology Tube,Negative
19461,YoungEHA CLL,Fabienne McClanahan Lucas,Negative
19462,CLL OhioState,Blood Journal,Negative
19463,Drs Luedke Wang Two one hundred and ninetynine Tuesday Exhibition Hall,DukePathDept,Negative
19464,CLL Watch CLL,Patient Power,Negative
19466,Blood Journal,Ellery littlefield,Negative
19468,CLL Watch CLL Jennifer Brown DanaFarber wwierda LeukemiaMDA,Patient Power,Negative
19470,Only two week CLL AML AMLsm MMsm LYMsm LEUsm,VJHemOnc,Postive
19471,CLL CNSMasterclass KebleConference Oxford fourteen July AdvancedNursing ClinicalNurseSpecialists Haematology TeamHaem OxfordHaem ResNurse,LymphomaAction,Negative
19472,CLL ChileLuchaLibre Inicio De Temporada two thousand and nineteen IWC LuchaLibreChilena Pepex,The Pepex Family,Negative
19473,ChronicLymphocyticLeukemia StemCells Read Advancing Science,Mayo Clinic,Negative
19474,New Medivizor,Medivizor,Negative
19476,Barrientos Feinstein Institute Medical Research Lymphoma CancerTherapy,The Patient Channel,Postive
19477,CLL Society CLL,CLL Society Inc,Negative
19478,CLL,CLL Ireland,Postive
19480,CLL,Blood Journal,Negative
19481,pml cll,Anna Deveau,Negative
19483,Yesterday Moreno dr Mulligan,Carlos Chiattone,Postive
19485,Tonight Nicholas tonight CLL,Amy Ramos,Postive
19486,IBB XBI CLL,dough,Negative
19487,yesterday,Jimmy Side Eye,Negative
19489,CLL CLL,Patient Power,Negative
19490,ActiveMonitoring WatchandWait BloodCancer CLL,LymphomaAction,Negative
19492,UK Stocks News GMAA MAI MGR JDG KAPE,Jon,Negative
19493,CLL,CancerWallonia,Negative
19494,Blood Journal,Jitakshi,Negative
19497,Whistler two thousand and nineteen CLL,Anthony Mato,Negative
19500,Barrientos Feinstein Institute Medical Research Lymphoma Prognosis CancerTherapy,The Patient Channel,Postive
19502,Rituximab CLL,Michael Cautillo,Negative
19504,Clinicopathologic Hematologia,Biosimilar Today iMagazine,Negative
19505,CLL,NCI Center Cancer Research,Negative
19506,New Medivizor,Medivizor,Negative
19507,week one CLL,Mrs Dickens,Postive
19508,CLL NitinJainMD Javier MoffittNews CLL MDAndersonNews,Patient Power,Negative
19509,JLB transcription CLL VDJ,Journal Leukocyte Biology,Negative
19510,hemonctoday,Chocolatiere Phys,Postive
19512,Blood Journal,Dr Comeau MD,Negative
19513,Dysregulated Expression Receptors NK Cells Patients Chronic Sharifian,NK paper,Negative
19514,Dysregulated Expression Receptors NK Cells Patients Chronic,COPD News,Negative
19516,NHL Chronic,Hetero Healthcare,Negative
19518,CLL JanssenUS genentech,HemOnc Today,Postive
19520,New Outcomes,Medivizor,Negative
19521,Scan Stochastic Sell Signal today FOUR CLL VLS AEWU,SwingTradeBot UK,Negative
19522,CancerSurvivor CLL Interesting,CLL Society Inc,Negative
19523,Brian Koffman,CLL Society Inc,Postive
19524,CLL BloodJournal CLLsm,Raul Cordoba MD PhD,Negative
19526,Listen Kamala Maddali CLL,CLL Society Inc,Negative
19527,Boston OMIonc CLL,Amy Cavers,Negative
19528,Blood Journal High,Izaskun Zeberio,Negative
19529,John first one thousand nine hundred CLL Learn,The Ohio State University College Medicine,Postive
19530,Dr Christina,Biotexcel,Negative
19531,FDA Healio FDA,Oncology Board,Postive
19532,CLL Tune Nicole Lamanna ColumbiaMed,Patient Power,Negative
19533,Ibrutinib Imbruvica CLL FDA,CellworksLife,Negative
19535,CLL Sept Edinburgh Scotland Press,iwCLL,Negative
19536,CLL CLL VEN,Suvir Singh,Negative
19537,Anil Awesti CLL BREXIT Brexit,CLL Warwick Uni,Postive
19538,Itemas,Blog,Negative
19539,Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive,Daniel Auclair,Negative
19540,LeukaemiaCareUK CLLSupport two abbvieuk CLL,Nick,Postive
19541,LeukaemiaCareUK CLLSupport two abbvieuk CLL,Nick,Postive
19542,Check Guidelines,Medivizor,Negative
19543,Two CLLSA IsleofWight CLLSA two Clinical Nurse Specialist Isle Wight CLLSAIOW CLL,CLLSA,Postive
19544,CLL,Kathleen Hoffman,Negative
19545,Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive,Raul Cordoba MD PhD,Negative
19546,EricBerry NFL KC two thousand and fourteen recent season PatientPower CLL,Michele,Negative
19547,CLLSupport CLL JanRynne CllIreland CllSociety,CLL Advocates Network,Postive
19548,CLL,Jose Sandoval MD FACP,Negative
19549,March PeterMacCC UMCCR,Cancer Discovery,Negative
19550,CLL Kscancerimm,Orentas,Postive
19551,RNAseq,SeraCare,Negative
19552,CLL ClinicalTrial tomorrow today,Andrew Schorr,Postive
19553,The Importance Early Comprehensive Testing Retesting CLL,Dr kamala maddali DVM PhD,Postive
19554,Leukemia,HemOnc Today,Negative
19555,CLL WednesdayWisdom yourwarwick warwickuni IttWarwick,CLL Warwick Uni,Negative
19556,CLL three day CI tonight,Continuous Lifecycle London online,Negative
19557,two CLL,CLLSA,Postive
19558,CLL CNSMasterclass KebleConference Oxford July,LymphomaAction,Negative
19559,Assay Format NDMOxford Bcells CLL,Prof John,Postive
19560,CLL Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive,Triona Ni Chonghaile,Negative
19563,New Medivizor Effectiveness,Medivizor,Negative
19566,Joseph Rosenblatt CLL,Sylvester Comprehensive Cancer Center,Negative
19567,Consensus Dr Rosenblatt,donnashort,Negative
19568,Scan Stochastic Sell Signal JKX MTC CLL TSTL,SwingTradeBot UK,Negative
19569,Lymphoma,Tinu,Negative
19570,NationalBroadcast Grand Rounds LiveStream ChronicLymphocyticLeukemia Earn CMEcredits Tuesday March nineteen two thousand and nineteen PM PM PST three four PM EST CLL,Paradigm Med Comm,Postive
19571,Duvelisib New Treatment Relapse Refractory CLL DanaFarber CllSociety CLL LLSusa LeukemiaRF LMCongress ImedexCME Idelalisib Duvelisib Copanlisib EndCancer,Oncology Tube,Negative
19572,CLL Edinburgh,iwCLL,Negative
19573,one anna head,Anna shaikh,Negative
19574,CLL Kerry Rogers CLL,Patient Power,Negative
19575,Chris Chris Pepper UK CLL,Toby Eyre,Postive
19576,Imbruvica,CURE Magazine,Postive
19578,CLL William Wierda CLL andrewschorr way Leusm,Patient Power,Postive
19579,Patientenleitlinie Chronische der entsprechenden two thousand and eighteen erschienen CLL,Krebsgesellschaft,Negative
19580,Sudanese,Lymphoma Papers,Negative
19581,two thousand and,EPR Network,Negative
19582,DRG United States Western Europe Japan two thousand and eighteen DRGinsights Roche CLL,DRG Epidemiology,Negative
19583,Check Effectiveness,Medivizor,Negative
19584,CELG Celgene The Phase SLL August two thousand and twentyone December two thousand and twenty,dough,Negative
19585,Best Drug Sequence Treat CLL CllSociety CLL LLSusa LeukemiaRF LMCongress ImedexCME Imedex Ibrutinib Rituximab EndCancer MedEd,Oncology Tube,Negative
19586,Kinase Inhibitors Autoimmune Toxicity DanaFarber CllSociety CLL LLSusa LeukemiaRF LMCongress ImedexCME Idelalisib Duvelisib Copanlisib EndCancer,Oncology Tube,Negative
19587,New Effectiveness,Medivizor,Negative
19588,CLL Matthew Davids MD,CRO Contract Res,Postive
19589,CLL OhioState,Blood Journal,Negative
19590,CLL Lee Swanson CLL,Patient Empowerment Network,Negative
19591,Better Combine Ibrutinib Rituximab ZuckerSoM CllSociety CLL LMCongress Ibrutinib Rituximab EndCancer MedEd,Oncology Tube,Negative
19592,Genentech,AA MDSIF,Negative
19593,Idelalisib Duvelisib Copanlisib DanaFarber CllSociety CLL LMCongress Idelalisib Duvelisib Copanlisib EndCancer,Oncology Tube,Negative
19594,CLL Ibrutinib Watch Richard Furman WeillCornell,Patient Power,Negative
19595,Plenary Paper Randomized CLL,Blood Journal,Negative
19596,CLL CARE Canada Read,Education,Postive
19598,one CLL Deborah CLL Society Please CLLsm Leukemia,CLL Society Inc,Postive
19601,Monday Student Engagement Coordinator CLL,CLL Warwick Uni,Postive
19602,FDA Abbvie Roche,oncohebdo,Negative
19603,Check Outcomes,Medivizor,Negative
19605,Pharma Update fifth,Roots Analysis,Negative
19607,seven hundred eighty foot Durkan LLSusa,Tim Durkan,Negative
19608,Jennifer Woyach James CLL,The James,Negative
19609,Venetoclax CLL,annemarie,Postive
19611,Cambridge Friday ACTcharity Thankyou CLL,CLLSA,Postive
19612,Columbia Univ Medical Center Investigator CLL Trial Site News,TrialSite News,Negative
19614,Deborah Sims hundred CLL Australia Venetoclax Irish,CLL Ireland,Postive
19615,one Technology Test one CLL,AURELIAN UDRISTIOIU,Negative
19617,New Medivizor Outcomes Leukemia,Medivizor,Negative
19618,CLL,Kathleen Hoffman,Negative
19619,weekly CLL CLL,CLL Society Inc,Negative
19620,Australia CLL,CLL Society Inc,Negative
19621,CLL,CLL Society Inc,Negative
19622,Houston CLL Saturday March,CLL Society Inc,Negative
19623,Focus Acute,Cancer Papers,Negative
19624,CLL CLL,CellworksLife,Negative
19625,Jacqueline Barrientos MD MS CLL,PRC Clinical,Negative
19628,Today Fiona CLL One OFF,Fiona,Negative
19630,CLL Watch Richard Furman WeillCornell CLL,Patient Power,Postive
19631,CLL Susan Brien Javier Pinilla CLL,Patient Power,Postive
19632,FDA,CancerWallonia,Negative
19633,Funds ldnont communitylivinglondon CLL,RBC Place London,Postive
19635,Clinicopathologic Hematologia,Biosimilar Today iMagazine,Negative
19636,Newer Agents Extend Survival Reduce Toxicity CLL,CancerWallonia,Negative
19638,Emma afternoon Earlychildhood,CLL Warwick Uni,Negative
19639,CLL Three,Patient Power,Negative
19641,one,Lymphoma Papers,Negative
19643,CLL Cambridge today day,CLLSA,Postive
19644,Service ACTcharity George Follows Cambridge today CLL,CLLSA,Postive
19645,IBR VEN Data Randomized,Toby Eyre,Postive
19646,CLL CLL,MoJo,Negative
19647,Roche Veclexta US FDA,ipharmacenter,Negative
19648,Roche Veclexta US FDA Roche FDA Venclexta plus,ipharmacenter,Negative
19649,US FDA,Roche,Negative
19650,rituximab patient,Eduardo Flavio Oliveira Ribeiro,Negative
19652,Blood Journal,Dr Comeau MD,Negative
19653,FDA fifth FDA Venetoclax,TEAM Pharmacy Consulting,Negative
19654,CLL CLL AttentionMine Crypto UtilityToken EarnCrypto,CryptoLiveLeak,Negative
19655,CLL AttentionMining CLL AttentionMine Crypto UtilityToken EarnCrypto,Kenneth Garofalo,Negative
19656,two CLL Learn,Genentech,Negative
19657,CLL Journal CLLsm,Raul Cordoba MD PhD,Negative
19658,CLL Journal CLLsm,Raul Cordoba MD PhD,Negative
19659,FDA,Targeted Oncology,Negative
19660,BPTH FDA AML Venetoclax Roche Holding Ltd Genentech,MAISA,Postive
19661,Venclexta Gazyva CLL,HemOnc Today,Negative
19662,one hundred and one,Literacy Works,Negative
19663,Wouldn CLL second BTK two CLL,Andrew Schorr,Postive
19664,Today Prof Gibson,Ghia,Negative
19665,three Venetoclax Study Fixed Duration,Michael Oholendt,Negative
19666,CLL Tune Javier MoffittNews,Patient Power,Negative
19667,CLL CARTcell CLL,Michael Hallek,Postive
19668,Genentech,The Pharmaceutical Marketing Group,Negative
19669,CDATA Test Patients Treatment Response one Day,EIN Presswire Breast Cancer Newswire,Negative
19670,Gnocchi Alex Trebek four,Mira Larkin,Negative
19671,Genentech Leukemia Genentech Roche Group SIX New Drug Application,cafepharma,Negative
19672,three Venetoclax Study Fixed Duration,Algoslinger,Negative
19673,one Shanmugapriya Thangavadivel John,Cancer Discovery,Negative
19674,CLL,CellworksLife,Negative
19675,three Venetoclax Study Fixed Duration,RazzleTazzle,Negative
19676,three Venetoclax Study Fixed Duration,Pharma News,Negative
19677,CME CLL AML,Vindico Medical Education,Postive
19678,ABBV March seven three Venetoclax Study Fixed Duration,Flash Alert,Negative
19679,three CLL Breakthrough Therapy Designation Oncology Review,AbbVie,Negative
19680,three Venetoclax Study Fixed Duration,Bio,Negative
19681,three Venetoclax Study Fixed Duration,Crwe World,Negative
19682,Genentech,Crwe World,Negative
19684,FDA CLL two FDA,Genentech,Negative
19685,RHHBY March seven Genentech,Flash Alert,Negative
19686,Genentech,Latest News Business Wire,Negative
19687,Application Sequential Multiple Assignment,maria jose agustin,Postive
19688,NagajaCapitani CosimaBaldari,SIBBM,Negative
19689,deficiency mouse,SIBBM,Negative
19690,CLL LymphomaAction CNSmasterclass KebleConference Oxford July,LymphomaAction,Negative
19691,Dean Howes Dean Teaching Fellow CLL,CLL Warwick Uni,Postive
19692,CLL PatientPower,CLL Ireland,Postive
19693,CLL Watch CLL,Patient Power,Negative
19694,CLL Read CLL David Lauder,Patient Power,Negative
19695,CLL,Michele,Negative
19696,Expansion Breakout today ETO MTO,SwingTradeBot UK,Negative
19697,Scan Signal Line Cross RMP XPP IDEA,SwingTradeBot UK,Negative
19698,Blood Journal,Steve Williamson,Negative
19700,CLL,Anthony Mato,Negative
19701,CLL BloodCancers PatientPower,The Match Advocacy,Negative
19702,CLL BC,Shouting people underpants,Negative
19703,CLL,CancerTherapyAdvisor,Negative
19704,Leukemia two FREE CLL CLLsm Leukemia SmartPatients,CLL Society Inc,Postive
19705,CLL,CLL Society Inc,Postive
19706,second USA second CLL CLL,CLL Society Inc,Postive
19707,HallekMichael CLL,CLL Society Inc,Negative
19708,Cathy Wu CLL,DMM Journal,Negative
19709,CLL Watch Philip Thompson CLL,Patient Power,Negative
19710,today Barbara Merrill Scott CLL,CLL Warwick Uni,Negative
19711,CLL,NEJM,Negative
19712,CLL CLL Jennifer Brown DanaFarber,Patient Power,Negative
19713,NHL CLL,Lymphoma Hub,Negative
19714,Sharma CLL,paper link,Negative
19715,New OfficialNIHR Elevated IgM,Europe PMC article,Postive
19716,New Medivizor Combining,Medivizor,Negative
19718,Reduced Toxicity CLL Trial Site News,TrialSite News,Negative
19719,LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19721,CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer,Oncology Tube,Negative
19722,Lisa CLL Lisa,Leukaemia Care,Postive
19723,New Agents Pipeline Treat CLL ZuckerSoM CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19724,fifty Bearish List today ICGT CLL PARK AFX NCCL UAI TLY,SwingTradeBot UK,Negative
19725,CLL DanaFarber CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19726,future Join u The International Workshop Chronic Scotland CLL,iwCLL,Negative
19727,Rituximab,Medivizor,Negative
19729,Time Treatment Prediction Chronic New Transcriptional Patterns PubMed one Time Treatment Prediction Chronic,Fabrice Leclerc,Negative
19731,Hodgkin CLL,NEJM Resident three hundred and sixty,Negative
19732,CLL one African American,CancerCare,Negative
19733,LeukaemiaCareUK CLL EndCancer MedEd,Oncology Tube,Negative
19734,Moon Shot CancerMoonshot,Cancer Frontline,Negative
19735,Verastem Oncology three two Annual International Congress Hematologic Malignancies CLL HemeOnc,Verastem Oncology,Negative
19736,CLL September,Nick,Postive
19737,CME CLL AML,Oncology CE,Postive
19738,CancerFrontline CancerMoonshot,MD Anderson Cancer Center,Postive
19739,two thousand,Research,Postive
19740,Arzerra Gazyva CLL,Robinson Ortiz MD,Negative
19741,CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19742,Upfront Management WeillCornell CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer,Oncology Tube,Negative
19743,CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19744,CLL CllSociety CLL LLSusa LeukemiaRF LMCongress EndCancer MedEd,Oncology Tube,Negative
19745,CLL abbvieuk CLLsm CLL,CLL Society Inc,Negative
19746,BTK,Targeted Oncology,Negative
19747,The Changing Paradigm In The Treatment Of CLL ZuckerSoM LMCongress CLL EndCancer MedEd,Oncology Tube,Negative
19748,ChronicLymphocyticLeukemia Learn CLL,Mayo Clinic Cancer Center,Negative
19749,CLL March nine Portland March sixteen Houston CLL CLLsm,CLL Society Inc,Postive
19750,Token CLL BasicAttentionToken,CryptoLiveLeak,Postive
19751,Three CLL,CLL Society Inc,Postive
19752,CLL LymphomaAction KebleConference Oxford July,Sophie Baczynski,Negative
19753,CLL WVCancer FDA CLL,Patient Power,Postive
19754,CLL,ACS Journal Cancer,Negative
19755,Ibrutinib CLL Susan Brien American Society Hematology,Patient Power,Negative
19756,one hundred Corona CLL,Nestoret,Negative
19757,one hundred,Markets,Negative
19758,Brian Koffman CLL CLL,CLL Society Inc,Negative
19759,Hundreds Roundup Lymphoma Chronic,Matthews Associates,Negative
19760,CLL,Patient Power,Negative
19761,BCJ Blood Cancer Journal,Vincent Rajkumar,Negative
19763,CI pharma,Dr Timos Papagatsias,Postive
19765,Affiliate Program Check Link Earn five hundred CLL Points ten CLL Points Referral Visitor CLLToken CLL CLL,CryptoLiveLeak,Negative
19766,CLL Cancer Sharma,Researchphilia,Negative
19767,Ad Space CLL Tokens Token Ad AttentionMining,CryptoLiveLeak,Negative
19768,CLL Watch CLL Jennifer Brown DanaFarber wwierda LeukemiaMDA,Patient Power,Negative
19769,CLL Cancer Sharma,Researchphilia,Negative
19772,JeM CLL Islamabad Azhar last six month MasoodAzhar JEM,Sohail Khan,Negative
19773,yesterday CLL CLL CLL Nick York,CLL Ireland,Postive
19774,CLL,Kathleen Hoffman,Negative
19775,FDA Approves CLL,SpecialtyPTimes,Negative
19776,CLL CLL,Patient Power,Negative
19778,NCCN Updates Clinical Practice Guideline CLL,CLL Society Inc,Negative
19779,Interesting CLLsm CLL,CLL Society Inc,Negative
19780,first CLL Learn Medical Lab Scientist,Laboratory Career,Negative
19781,CLL Drs Davids Wierda Barrientos,donnashort,Negative
19782,CLL FCR Dr Wierda Dr Davids,donnashort,Negative
19783,CLL Dr Davids,donnashort,Negative
19785,today CLL Mary Cahill Emma Lane Fiona Moriarty day,CLL Ireland,Postive
19786,CLL Article,Anand Rotte,Negative
19787,rituximab,Society Immunotherapy Cancer,Negative
19788,CLL NitinJainMD Javier MoffittNews CLL MDAndersonNews,Patient Power,Negative
19791,Michael Kneba MRD many year CLL,Michael Hallek,Postive
19792,JohnPLeonardMD NYC CLL Richard Furman,WCM Lymphoma,Negative
19793,CLL CNSmasterclass KebleConference Oxford fourteen July AdvancedNursing,LymphomaAction,Negative
19794,CLL,Linical Americas,Negative
19796,March six,RIOH,Negative
19797,CLL Cancer Sharma,Researchphilia,Negative
19798,two thousand and,Latest News Business Wire,Negative
19799,one one Roller Coasters CLL,Mike ForThePeople,Postive
19800,Gestion Agricole,Gestion agricole,Negative
19801,CLL Patient CllIreland tomorrow,Cork ARC Cancer Support House,Postive
19802,one one CLL almost two year ago one,Mike ForThePeople,Postive
19803,three NEJM CLL,CCTG,Negative
19804,Postdoc RNA,Life Science Jobs,Negative
19806,Today CLL CLL,CryptoLiveLeak,Negative
19807,February two thousand and eight age twentyeight CLL,lacey vega,Negative
19809,one March It day three year ago Croydon Matt Matt Leukaemia CLL BloodCancer DiagnosisDay,MerMer Goodburn,Negative
19810,CLL Tune Nicole Lamanna ColumbiaMed,Patient Power,Negative
19811,FCR CLL CLLsm CLL,CLL Society Inc,Negative
19812,CLL,Shouting people underpants,Negative
19813,March fourteen Anyone,Literacy Works,Postive
19815,DYK Learn CLL,JanssenUS,Negative
19816,FDAPatientinfo April Patients Voice RareDisease CLL,Michele,Negative
19817,CLL Hold CLL PatientReporter PatientPower CllSociety CLLAdvocates CllIreland,Michele,Negative
19818,CLL,MDedge Hematology Oncology,Negative
19819,three CLL Canada one thousand nine hundred and twelve ALLIANCE,Education,Postive
19820,two CLL Society second BloodCancer CLL CLLsm,CLL Society Inc,Negative
19821,MURANO ASCO CLL,MedPage Oncology,Negative
19822,Neha Godiwala Goyal CLL Learn CLL,AbbVie US,Negative
19823,single nucleotide Egyptian,MedCrave Publishing,Negative
19824,last day February year CLL Rare Disease Please,CLL Ireland,Postive
19826,almost fifty CLL ten FCR Read,AplusA World,Negative
19827,Sharma CLL,paper link,Negative
19830,Sharma CLL,paper link,Negative
19831,New Guidelines,Medivizor,Negative
19832,FDA Approval Ibrutinib Plus Obinutuzumab,Oncology Times,Negative
19833,el hijo del querido Juan Carlos Landa Carpio,Minerva Vila,Negative
19835,The Roll Of Chemotherapy LeukaemiaCareUK CLL EndCancer,Oncology Tube,Negative
19836,CLL,ACS Journal Cancer,Postive
19837,CLL,Patient Power,Negative
19838,Leukemia,Medivizor,Negative
19840,Leukemia month Congratulations PhD,Cancer Research Wales,Postive
19843,Elias Campos Campos GeNoMe LeuKeMia International Cancer GeNoMe Consortium SPaiN,Alfredo Ballesteros Ainsa,Negative
19845,Blood,Kaplan Medical,Negative
19847,CLL,Medical Tribune,Negative
19848,Jennifer Crombie eight February two thousand and nineteen,Syed Abutalib,Postive
19849,Venetoclax CLL,Raul Cordoba MD PhD,Negative
19850,Canadian CPG,Joule Inc,Negative
19851,Andrew Schorr,HealthCentral,Postive
19852,motherboard sacjai PatientReporter CLL,Michele,Postive
19853,CLL CLLPatients PatientReporter ChronicLymphocyticLeukemia HealthUnlocked,Michele,Negative
19854,CLL Kerry Rogers CLL,Patient Power,Negative
19855,one five year,JackieJacksonHolland,Negative
19856,CLL CLL,CLL Society Inc,Postive
19857,one CLL Portland Oregon CLL Society Patient Caregiver Education Forum March nine Register,CLL Society Inc,Negative
19858,CLL Leukemia BloodCancer,CLL Society Inc,Negative
19859,CLL,Blood Cancer UK Research,Postive
19860,The University Clinic Lymphoma MayoClinic theNCI,Mayo Clinic Cancer Center,Negative
19861,one Reception three today one CLL,Lucy Middleton,Postive
19862,CLL Watch CLL jonathonbcohen WinshipAtEmory,Patient Power,Negative
19863,CLL,Kathleen Hoffman,Negative
19864,Euchempa Derivates CLL,PROvendis GmbH,Negative
19865,CLL LymphomaAction KebleConference Oxford July,Sophie Baczynski,Negative
19866,CLL Ibrutinib Watch Richard Furman WeillCornell,Patient Power,Negative
19867,SCI Steven Coutre CLL StanfordCancer NEJM,Steven Artandi MD PhD,Postive
19868,CLL William Wierda CLL andrewschorr way Leusm,Patient Power,Postive
19869,MedEd,Oncology Times,Negative
19872,APTO Aptose myeloid,Joe,Negative
19873,Leukaemia CLL BloodCancer,MerMer Goodburn,Negative
19874,CLL LymphomaAction KebleConference Oxford July,Sophie Baczynski,Negative
19875,five AML,Bioevents Sharing Biomed Knowledge,Postive
19876,CLL Australia Venetoclax rituximab CLL,CLL Ireland,Postive
19877,one one CLL CancerSucks,CLL Society Inc,Postive
19878,FirstTweet CLL Spring,Xenia Schmidt,Postive
19879,Congrats Lili Wang first,Jean Fan,Postive
19880,Davide Rossi CLL BloodJournal,Michael Hallek,Negative
19882,CLL,CancerWallonia,Negative
19883,CllSociety CLL today CLL,Alan Skarbnik,Postive
19884,CLL Society CLL,CLL Society Inc,Negative
19886,CllSociety CLL,Michele,Negative
19887,Nicole Lamanna MD Columbia CLL OncLive,CLL Society Inc,Postive
19888,CLL,CLL Society Inc,Postive
19889,CLL CLL,CLL Society Inc,Negative
19890,weekly CLL,CLL Society Inc,Postive
19891,CLL PatientPower,CLL Ireland,Negative
19892,Alemtuzumab ten percent United States,Nouf Al Marshdi,Postive
19893,CLL,Sarah Jayne Liptrott,Postive
19896,CLLsm,Targeted Oncology,Negative
19897,CLL Tune Javier MoffittNews,Patient Power,Negative
19898,CLL,CLL Society Inc,Postive
19899,Immersing Verastem SVP Strategic,Amy Cavers,Postive
19900,MRD CLL Susan Leclair,Patient Power,Negative
19901,Steering Committee NHL CLL,Lymphoma Hub,Negative
19902,CLL,Deyan Yosifov,Negative
19903,CLL BloodJournal,Deyan Yosifov,Negative
19904,Followers Twitter Everyone Retweets one hundred CLL FreeCrypto Blockchain Giveaway,CryptoLiveLeak,Negative
19905,CLL Playbook Smart CLL,CLL Society Inc,Negative
19906,CLL,AbbVie US,Negative
19907,CLL WVCancer FDA CLL,Patient Power,Postive
19908,CLL WVCancer,Andrew Schorr,Negative
19909,CLL LymphomaAction KebleConference Oxford July,Sophie Baczynski,Negative
19910,Jeff Sharman CLL,Journal Clinical Pathways,Negative
19911,CLL Nice HallekMichael CLL,Toby Eyre,Postive
19912,rituximab,Society Immunotherapy Cancer,Negative
19913,CLL,Toby Eyre,Negative
19914,one CLL one one SocialGenpacter,Himanshu Joshi,Negative
19917,Ibrutinib CARTcells CLL Complete CARTS CLL,Mussetti,Negative
19918,CARTcells CLL,Adriana Bello,Negative
19919,CARTcells Ibrutinib CLL,Patrick Hanley,Negative
19920,Jordan Gauthier CARTcell CST,Fred Hutch,Negative
19921,CLL Phil Thompson CLL Houston,Andrew Schorr,Negative
19923,FDA Approval Ibrutinib Plus Obinutuzumab,Oncology Times,Negative
19924,CLL,Kathleen Hoffman,Negative
19925,CLL Society Cancer CLL BloodCancer,CLL Society Inc,Negative
19926,BTK CLL,CellworksLife,Negative
19927,JanRynne CLL John Seymour Australia Dublin,CLL Ireland,Postive
19928,CLL,Dr Sylvia Benjamin,Negative
19929,CLL CNS KebleConference Oxford Book today AdvancedNursing ClinicalNurseSpecialists Haematology TeamHaem OxfordHaem ResNurse,LymphomaAction,Negative
19931,CLL Society CLL CancerSurvivor Smart EndCancer,CLL Society Inc,Postive
19932,Kambhampati MD two thousand and eighteen ASH Annual,COPD News,Postive
19933,CLL,CLL Society Inc,Postive
19934,CLL CLL BTK,Cellero,Negative
19935,CLL Philip Thomson Tx CLL,Cellero,Negative
19937,CLL Watch Philip Thompson CLL,Patient Power,Negative
19938,CLL Piers Blombery CLLsm,VJHemOnc,Negative
19939,Barbara Andersen ASC,OSU Psych Advising,Negative
19940,Ibrutinib CLL Susan Brien American Society Hematology,Patient Power,Negative
19941,Charlotte Seattle Portland Houston Bethesda Minneapolis Boston New York San Diego Sign one CLL CLL,CLL Society Inc,Negative
19942,CLL,Andrew Schorr,Postive
19943,OncLive Venetoclax CLL,CLL Society Inc,Postive
19944,TipTuesday Download Lymphocytic Leukemia Resource Center MedEd,Oncology Times,Negative
19945,TrialTuesday Alliance Jennifer Woyach MD Alliance Learn,Alliance Clinical Trials Oncology,Negative
19946,CLL Form Biology Therapy,MoJo,Postive
19947,HemaSphere,European Hematology Association,Postive
19948,GlaxoSmithKline Roche Novartis Johnson,Pramod,Postive
19950,CLL,Lymphoma Papers,Postive
19951,Angeles CIB,CIB Margarita Salas CSIC,Negative
19952,Thinking CLL,Damian Bullimore,Postive
19953,Heilungschancen bei CLL Behandlungsmoglichkeiten Krebs,Daniela Hennrich,Negative
19955,Moreno obinutuzumab Leukemia,Targeted Oncology,Postive
19956,CLL CLL,Cancer Frontline,Negative
19957,CLLsm,VJHemOnc,Negative
19958,CLL CLL Jennifer Brown DanaFarber,Patient Power,Negative
19959,CLL CLL Society Expert Program BloodCancer,CLL Society Inc,Negative
19960,Peter Hillman Ibrutinib Obinutuzumab CLL,CLL Society Inc,Negative
19961,CLL CLL Society,CLL Society Inc,Negative
19962,Doubt Taiwo CLL third,CLL Warwick Uni,Negative
19963,CLL LymphomaAction KebleConference Oxford July,Sophie Baczynski,Negative
19964,Ibrutinib CLL Oncology Pharmacology,Research Results Pharmacology,Negative
19965,CLL Alteren two Jahren CLL,Onko Community,Negative
19966,February CLL Society CLL,CLL Society Inc,Negative
19967,Athina Christoph Rader Scripps Research Institute Chronic Lymphocytic CLL,Jacqui Matthews,Negative
19968,Suman Kambhampati MD FDA Imbruvica obinutuzumab Gazyva CLL,CLL Society Inc,Negative
19969,The CLL Society Tribune quarterly CLL CLL,CLL Society Inc,Negative
19970,CllSociety,CLL Advocates Network,Postive
19971,CLL,CLL Society Inc,Negative
19972,CLL,Patient Power,Negative
19973,Juan Sebastian Acute Liselotte Ponce,Minerva Vila,Negative
19974,one Read Koffman CLL,CLL Society Inc,Negative
19975,MRD John Seymour PeterMacCC,VJHemOnc,Negative
19976,CLL,CLL Society Inc,Negative
19977,Peter Hillmen UniversityLeeds Leusm,VJHemOnc,Postive
19978,CLL,Kathleen Hoffman,Negative
19979,The CLL Society Patient Playbook CLL,CLL Society Inc,Negative
19980,one CLL DoAGrouchAFavorDay,CLL Warwick Uni,Negative
19981,seven year CLL,CLL Society Inc,Postive
19982,Brian Koffman CLL Society CMS CLL,CLL Society Inc,Negative
19984,MRD CLL,CLL Society Inc,Negative
19985,CMS Progress CLL,CLL Society Inc,Negative
19986,John Pagel CLL Video,CLL Society Inc,Negative
19987,CLL,CLL Society Inc,Negative
19988,CLL Jeff Sharman PatientPower,CLL Ireland,Negative
19989,CLL,Raul Cordoba MD PhD,Negative
19990,CLL Lymphoma CLLsm,Raul Cordoba MD PhD,Negative
19992,BTK CLL HallekMichael,Thilo Zander MD,Negative
19993,anthonymatomd share news CLL BCR Venetoclax CLL CllIreland,Michele,Negative
19994,Time Treatment Prediction Chronic Antelo Rodriguez Natalia Vence Angeles Arias Nicolas Varela Marta,Frontiers Oncology,Negative
19995,Future Implications,Oncology Times,Negative
19996,CLL,Patient Power,Postive
19997,week CLL,Michelle Toman,Postive
19999,Great day CLL AML SSBMT BipinSavani,Saad kenderian,Postive
20000,Susan Leclair Philip Thompson CLL,Patient Power,Negative
20001,CLL congress,Deyan Yosifov,Negative
20002,MRD twelve CLL CARTable Carl June,Mussetti,Negative
20003,mdpijcm Psoas Abscess Due Mycobacterium avium Patient Report Review,JCM MDPI,Negative
20004,Davids Leukemia BloodCancer,Targeted Oncology,Negative
20006,Ji Xing Gu Sui Xing Xie Bing myeloid AML Xing Gu Sui Xing Xie Bing myeloid CML Ji Xing Xie Bing ALL Man Xing Xie Bing CLL,Yi Shi Ma Nan ,Postive
20007,TBT William Wierda,Oncology Times,Negative
20009,Tune CLL MantleCell MedscapeEdu Mollie Moran MSN,Medscape Education,Negative
20010,RT PhysRelations William Wierda PhD,Robert Orlowski,Negative
20011,William Wierda PhD,Caprice,Negative
20012,William Wierda CLL Medical Oncology Hematology two thousand and nineteen Leukemia CLL,Robert Orlowski,Negative
20013,RT PhysRelations Coming CLL William Wierda Medical Oncology Hematology two thousand and nineteen Leukemia CLL EndCancer,Robert Orlowski,Negative
20014,VIDEO Ibrutinib CLL Lydia Scarfo,VJHemOnc,Negative
20015,JanssenUS Ada Drug Read CLL ChronicLymphocyticLeukemia AmericanCancer FDAPatientinfo CLLAdvocates CllSociety,Michele,Negative
20016,Whitaker CLLsm IDonc,Mike Thompson MD PhD FASCO,Negative
20018,today,CLL Warwick Uni,Postive
20019,HemaSphere CLLsm,Raul Cordoba MD PhD,Postive
20020,Read CLL PowerfulPatient,Patient Power,Negative
20021,HemaSphere Chimeric Antigen Receptor,European Hematology Association,Negative
20022,CLL,CellworksLife,Negative
20023,The day CLL,CLL Warwick Uni,Postive
20024,Central Nervous System Lymphoma,Lymphoma Papers,Negative
20026,Yesterday Kathleen Chronic Today two day earlier one one Peaker SamHeughan,Jasmine Rockwell,Postive
20027,Leukamie CLL Hamatologen Kongress Georg Hess Uniklinik Mainz Stephan Stilgenbauer Uniklinik Ulm,Leukamiehilfe Rhein Main,Negative
20028,un neceista la,Simon Veliz,Negative
20029,hermano seria de gran un neceista la,Simon Veliz,Negative
20030,CLL,Felix Keller,Negative
20031,hermano seria de gran un,Simon Veliz,Negative
20032,Saludos LuisChataing de gran un neceista la,Simon Veliz,Negative
20033,hermano seria de gran un neceista la,Simon Veliz,Negative
20034,CLL,Patient Power,Negative
20035,Scan Centerline Cross today CLIN OCT THRU BRFI BAB CRU CLL,SwingTradeBot UK,Negative
20036,CIENCIASMEDICASNEWS,Victor Norberto Cerasale Morteo,Negative
20037,rituximab,Society Immunotherapy Cancer,Negative
20038,CLL Burger British Journal Haematology CLLsm,Raul Cordoba MD PhD,Negative
20039,la journee et Toutes Tempete,Cegep de Levis,Negative
20040,HOS Folkhalsan UBS CLL,Elisabet,Negative
20041,hashtags lar vara Viktigt CLL,Bjorn Nyberg,Negative
20042,Watch CLL Jonathan Cohen Kerry Rogers WinshipAtEmory,Patient Power,Negative
20043,al livuniITM ProximityLigation RNA CLL,Nature Protocols,Negative
20044,several hour,adam,Negative
20045,Annual Exposition three hundred CLL,Targeted Oncology,Negative
20046,CLL Cancer Care Associates CLL,Patient Power,Negative
20047,Pakistan India Read CML CLL,BloodCancerCure,Negative
20048,five AML,Bioevents Sharing Biomed Knowledge,Postive
20049,two thousand and nineteen two thousand,EIN Presswire Press Releases,Negative
20050,Centre last week CLL Brian Teaching Fellow Brian WarwickEquality,CLL Warwick Uni,Postive
20051,Le Cegep Consultez Bonne,Cegep de Levis,Negative
20052,CLL Jennifer Woyach OhioState CLLsm Leusm,VJHemOnc,Negative
20055,CLL,Patient Power,Postive
20056,Imbruvica,CURE Magazine,Postive
20057,CLL CLL,Toby Eyre,Negative
20058,EMF Paper Hardell Group one thousand nine hundred,Graviola Finland,Negative
20059,CLL CLL WinshipAtEmory,Patient Power,Negative
20060,TransformationTuesday CLL Sue IttWarwick,CLL Warwick Uni,Postive
20061,Today European Mannheim Acute Acute Myeloid EFPIA,HARMONY Alliance,Negative
20062,five AML,Bioevents Sharing Biomed Knowledge,Postive
20063,Imbruvica CLL,Robinson Ortiz MD,Negative
20064,Disculpen pueden ayudar difundirlo ayudarian mucho,Ori,Negative
20065,nuestro amigo nuestro Gracias,Maria Angulo,Negative
20066,Dr Banerji CLL Israels Dr Murphy,RIOH,Negative
20067,Seymour PeterMacCC CLLsm,Targeted Oncology,Negative
20068,Scan Above fifty RDT ASAI LVCG CRU CTEC PCFT CLL,SwingTradeBot UK,Negative
20069,CLL Watch CLL Cohen WinshipAtEmory,Andrew Schorr,Negative
20070,CLL Lee Swanson CLL,Patient Empowerment Network,Negative
20072,CLL,Kathleen Hoffman,Negative
20073,CLL,Amber Koehler,Negative
20074,CLL Watch CLL jonathonbcohen WinshipAtEmory,Patient Power,Negative
20075,CLL,AplusA World,Negative
20076,Idelalisib,ImmunotherapyPapers,Negative
20078,VIDEO Current CLL Lindsey Roeker Leusm,VJHemOnc,Negative
20079,FDA Lymphocytic,ChemDiv,Postive
20080,BRAF,Ingentium Melanoma,Negative
20083,Con Todo el Pawaaaa,AGRESSOR,Negative
20084,VIDEO Ibrutinib CLL Carol Moreno HospitalSantPau Leusm,VJHemOnc,Negative
20086,MRD CLL DrMatasar DrRaulCordoba,chadi nabhan MD MBA FACP,Postive
20088,BRAF,Lymphoma Papers,Negative
20090,John Terry Chelsea,The Lion Shed,Negative
20093,five yr ago month CLL,Amber Koehler,Postive
20094,CLL,Himanshu Joshi,Negative
20095,Scan Signal Line Cross today MWG SAV BLVN BEZ,SwingTradeBot UK,Negative
20096,CLL FightClub GlovesOff,Dr Katrina Farrell,Postive
20097,Multiplexed RNA CLL,Yasin,Postive
20098,second third,CURE Magazine,Negative
20099,ChronicLymphocyticLeukemia CLL,UCI Health,Postive
20100,Europe Article Europe PMC,gilbert faure,Negative
20101,Europe Article Europe PMC,Krishan Maggon,Negative
20103,CLL Lee Swanson Anthony Mato CLL,Patient Empowerment Network,Negative
20104,CLL,leukemia,Negative
20105,CLL nearly one hundred OncLive,CLL Ireland,Postive
20106,Friday today Two CLL London IttWarwick,CLL Warwick Uni,Postive
20108,CLL Lauren Thurgood Flinders,Anubhav Srivastava,Negative
20109,today CLL Brian,Michelle Collett,Postive
20112,VIDEO CLL ASH two thousand and eighteen Ibrutinib John Gribben CLLsm Leusm,VJHemOnc,Negative
20113,CLL,The Oncologist,Negative
20114,TargetedOnc CLLsm,Danielle Ternyila,Negative
20115,CLL Mascot Brian,CLL Warwick Uni,Postive
20116,MRD CLL Susan Leclair,Patient Power,Negative
20117,one Knitting Gill Principal Teaching Fellow Careers Coaching CLL Warwick Week WarwickEquality,CLL Warwick Uni,Postive
20119,Educate Lymphocytic CLL EACCME CME,Medthority,Postive
20120,CLL mascot Brian today WarwickEquality IttWarwick mascot warwickstory wellbeingpets,CLL Warwick Uni,Negative
20121,AIM CLL Cello Health PLC Notice Full Year Results,AIM Alerts,Negative
20122,seventy year,The Oncologist,Postive
20123,Anderson Paolo MD,Oncology Times,Negative
20125,CLL one Bcells Immunotherapy,Prof John,Negative
20126,Two,Jen Tiernay,Negative
20127,Chronic,Patient Worthy,Postive
20128,FDA Chronic,Lampe Company,Negative
20130,one Hematologic Malignancies,TrialBulletin,Negative
20131,CLL Carol Preston CLL,Patient Power,Postive
20132,nine year ago one one quoteoftheday,Anastasia Turchetta,Postive
20133,Significant Highlights four morning CLL NICE CLL,Nick,Postive
20134,This Friday Anniversary Elias Campo Clinical next Friday February eight,CIC bioGUNE,Negative
20135,CLL,AplusA World,Negative
20136,Leukemia,Medivizor,Negative
20137,NCCN Guidelines Insights Chronic Lymphocytic Lymphocytic Lymphoma Version,Irene Mangues,Negative
20138,FDA gazaiba obinutuzumab,Shohta Kadomura Hospital Pharmacist,Negative
20140,CLL,Blood Journal,Negative
20141,Venetoclax Venclaxa CLL MMSM AML,MyelomaTeacher Cindy Chmielewski,Postive
20142,CLL Lee Swanson Kerry Rogers CLL ASH two thousand and eighteen,Patient Empowerment Network,Negative
20143,MRD CLL obinutuzumab rituximab,Blood Journal,Negative
20144,Lisa CLL Lisa,Leukaemia Care,Postive
20145,New Rituximab,Medivizor,Negative
20146,CLL,Kathleen Hoffman,Negative
20147,AI Teemu Roos Stort Hanasaari Cultural Centre,Utbildning och IT pa Kimitoon,Negative
20149,seven,Lymphoma Papers,Negative
20151,CAR CLL CLL,Michele,Negative
20152,Ada four year old Please,guillotineka,Negative
20153,Mayo Clinic YouTube,Andrew Taylor,Negative
20154,New Medivizor Combinations rituximab,Medivizor,Negative
20155,one EM CLL one,RIOH,Negative
20156,Peter Hillmen UniversityLeeds Leusm,VJHemOnc,Negative
20158,Janssen Imbruvica Gazyva Genentech Janssen Imbruvica CLL,Pharmacy Practice News,Negative
20159,US FDA,Orbis Biosciences,Negative
20160,one one CLL one,RIOH,Negative
20161,second CLL,Amber Koehler,Postive
20162,thirty April two thousand and nineteen CLL CancerResearch,BioAscend,Negative
20163,Today one one,Lorna Warwick,Negative
20164,UK NEQAS LI cml md mm,UKNEQASLI,Postive
20165,UK CLL,CLLSA,Negative
20167,two TheCrick ImperialMed BloodJournal two Bcells CLL,Prof John,Negative
20169,un el meu granet de sorra en la CLL,Heribert,Negative
20170,Melbourne AUS tonight tomorrow Wednesday Peter MacCallum,Andrew Schorr,Negative
20171,Today CLL,CLL Ireland,Negative
20172,CML CLL India CML CLL BMT,BloodCancerCure,Negative
20173,GoPats,CryptoLiveLeak,Negative
20175,Rituximab,Medivizor,Negative
20176,Check Lenalidomide,Medivizor,Negative
20177,FDA Approves CLL,SpecialtyPTimes,Negative
20179,Murine Model,Christopher DeBoever,Negative
20180,Hematologists Nurses Tune CLL WATCH MedscapeEdu,Medscape Education,Negative
20181,Chronic Morning lark night Sorting,Broad Institute,Postive
20182,Check Comparing chr,Medivizor,Negative
20183,three Ganolfan Dwr Cilfynydd Cofiwch Gwisgwch esgidiau ysgafn dim bin DiscoverDwr,Melin Gruffydd,Negative
20184,New Medivizor Comparing,Medivizor,Postive
20185,CLL Worry Fear Worry,CLL Ireland,Negative
20187,CLL Atm,Broad Institute,Negative
20188,three,Mahmoud Aljurf,Negative
20189,Marc Hoffmann CLL Practice,sganguly,Negative
20190,CLL,The Oncologist,Negative
20191,Cancer News Robert Preidt five hundred,Malachy Chidera,Negative
20192,FDA Approves Ibrutinib Plus Obinutuzumab Frontline SLL,CancerWallonia,Negative
20193,CLL CLL SarahCannonDocs HCAMidwest,OncLive SOSS,Postive
20194,Watch CLL Jonathan Cohen Kerry Rogers WinshipAtEmory,Patient Power,Negative
20195,Saturday March,annemarie,Postive
20196,Sat two March FREE CLL CLL Cork Clayton Hotel Silver Springs Haematology Mary Cahill Emma Lane Registration,CLL Ireland,Postive
20197,Buckeyes CLL,The James,Negative
20198,CLL First FDA CLL Combination Therapy ChronicLymphocyticLeukemia,Michele,Postive
20199,Check Rituximab,Medivizor,Negative
20200,Rituximab,Medivizor,Negative
20201,CLL CancerCare,Ron Grunsby,Negative
20202,Future Implications,Oncology Times,Negative
20203,seventy year,The Oncologist,Postive
20205,CancerChat,Atrium Health Navicent,Negative
20206,two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20207,Hematologists Nurses Learn CLL MedscapeEdu,Medscape Education,Negative
20208,Susan Leclair Philip Thompson CLL,Patient Power,Negative
20210,NSCLC CLL AML,ACCC,Postive
20211,CLL AVHAHOUpdates,Federal Practitioner,Negative
20212,Nasta CLL PennCancer two thousand and nineteen HemOnc,Penn Medicine MD,Negative
20213,The ILLINOISsocialwork Community Learning Lab one thousand nine hundred Learn CLL,ILLINOIS Social Work,Negative
20214,eBook mm aml Key Information,AplusA World,Postive
20216,CLL CLL,CLL Ireland,Negative
20219,Chronic CLL Know Subscribe,InfocusRx Today,Negative
20220,CLL,MDedge Hematology Oncology,Negative
20221,tonight CLL Haemophage,MDedge Hematology Oncology,Postive
20222,CLL,MDedge Hematology Oncology,Negative
20223,CLL,Rebecca Williams,Negative
20224,CLL,MDedge Hematology Oncology,Negative
20225,Andrew Brunner General Hospital two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20226,CLL Mary Ellen Schneider Hematology News tonight,MDedge Hematology Oncology,Negative
20227,CLL,Taylor Lab UM,Negative
20228,CLL ten minute,MDedge Hematology Oncology,Negative
20229,Catherine Wu DanaFarber Lili Wang ATM CLL Current LLSSFellow,Leukemia Lymphoma Society Research,Negative
20231,MRD CLL obinutuzumab rituximab,Raul Cordoba MD PhD,Negative
20232,CLL MRD CLLsm,Raul Cordoba MD PhD,Negative
20233,four hour Twitter Clear evening CLL,MDedge Hematology Oncology,Postive
20234,New Resource Center The Evolving Treatment Chronic,Oncology Times,Negative
20235,NebraskaMed CLL,Ravi Madan,Negative
20236,Read CLL PowerfulPatient,Patient Power,Negative
20237,Leukemia Read Leukemia MDAndersonNews,Rajan Chaudhari,Negative
20238,two,IUOPA,Negative
20239,CLL,Nature Reviews Disease Primers,Negative
20240,Another day Adrian Bloor Myeloid CML CLL Leukaemia,Anna Perkins,Postive
20241,CLL OGT,SysmexBNL,Postive
20242,Ohio State Pelotonia James SPON,Local,Negative
20243,Imbruvica Mantle Cell CancerDrugs CureCancer,Medicine For World,Negative
20244,Two Nursery TalesToolkit EYFS CLL TalesToolkit,Oak Tree Primary School,Negative
20245,AnthonyMatomd ERIC Consortium Conference CLL,Michele,Postive
20246,CLL CLL CLLPatients,Michele,Negative
20247,Dad Ensure CLL CLLPatients,Michele,Postive
20248,lymphocyte Lymphomas,Atrium Health Navicent,Negative
20249,Scan Hammer Candlestick today LMS,SwingTradeBot UK,Negative
20250,SET SET,Anthony Mato,Postive
20251,first Read,LLS Greater,Postive
20252,Online Exclusive From HemOnc Times Ibrutinib More Effective Compared Standard CLL Treatment,Oncology Times,Postive
20253,FDA,Zheng Zhao,Negative
20254,one day Twitter CLL seven EST MDedgeChats,MDEdge,Negative
20257,Cancer Care Associates CLL,Patient Power,Negative
20258,CLL,iwCLL,Negative
20259,This HUGE BREAKING NEWS Food Drug Administration first,ArkansasLLS,Postive
20260,Watch CLL Philip Thompson CLL,Patient Power,Negative
20261,Anna Schuh UniofOxford CLL Lots,Blood Cancer UK Research,Postive
20265,CLL,Sophia Kelly,Negative
20266,CLL,Kathleen Hoffman,Negative
20267,CLL,AplusA World,Negative
20268,CML CLL Read,BloodCancerCure,Negative
20271,Enhanced Nuclear Translocation CLL,CellworksLife,Negative
20272,Weir PhD,KU Cancer Center,Negative
20273,FDA Ibrutinib,CLL Advocates Network,Postive
20274,FDA Imbruvica obinutuzumab Gazyva,MAISA,Negative
20275,Rituximab CLL CLLsm,Raul Cordoba MD PhD,Negative
20276,New JITC Short Report rituximab,Society Immunotherapy Cancer,Negative
20278,Johnson Johnson Imbruvica CLL Gazyva Imbruvica CLL JNJ ABBV,Bionest Partners,Postive
20279,VIDEO Venetoclax CLL Lindsey Roeker Leusm,VJHemOnc,Negative
20280,BREAKING NEWS FDA first Read breakthrough,Coast To Coast Cures,Postive
20281,DYK CLL,Janssen Global,Negative
20282,first Read,The Leukemia Lymphoma Society,Postive
20283,two,CURE Magazine,Negative
20284,watch webinar CLL Cathy Hamilton,Patient Power,Negative
20285,Dennis,JanssenUS,Negative
20286,CLL Brian Hill Anthony Mato CLL seven pm ET,MDedge Hematology Oncology,Negative
20287,DrLaCasce Program DanaFarber CLL SLL,The Leukemia Lymphoma Society,Postive
20288,FDA Approves Leukemia Ibrutinib Obinutuzumab CLL SLL,Alvin,Negative
20289,monthly CLL,Lymphoma Hub,Negative
20290,Lots CLL,Oak Tree Primary School,Postive
20291,CLL US Ibrutinib obinutuzumab LornaWarwick,CLL Advocates Network,Negative
20292,Bcells,Prof John,Negative
20293,Two CLL Brian Koffman CllSociety CLL CLL,CLL Ireland,Postive
20295,JNJNews Imbruvica CLL,pharmaphorum,Negative
20296,FDA Approves Ibrutinib Combination Obinutuzumab SLL ASCO Post,CancerWallonia,Negative
20297,FDA Imbruvica,FDA Daily,Negative
20298,FDA Approves GENbio,Jeff Karp Pronouns,Negative
20300,Johnson Johnson Imbruvica CLL Gazyva FiercePharma,Advera Health,Postive
20302,four day first CLL Fatigue ChronicLymphoceticLeukemia LLSusa CLL,RJW,Negative
20303,ICYMI FDA first CLL,Pharmacyclics AbbVie Company,Negative
20304,ICYMI Imran Khan CLL,JanssenUS,Negative
20305,FDA first Imbruvica Gazyva ResearchMatters,Cellero,Negative
20306,SygnatureDiscov ApconiXLtd winterbournehg CLL,JSF Group,Postive
20307,fifty year later CLL today BTK,Felix Keller,Negative
20308,seven pm ET CLL Cancer Research Group,MDedge Hematology Oncology,Negative
20309,IMBRUVICA Read More,Lymphoma Research Foundation,Negative
20310,Imbruvica Genentech,MAISA,Negative
20312,CLL,JanssenUS,Negative
20313,FDA SLL Imbruvica Gazyva lymsm,MDedge Hematology Oncology,Negative
20315,CLL,The Oncologist,Negative
20316,CLL first Read,Jaime Rosenberg,Negative
20317,FDA Approves CLL,SpecialtyPTimes,Negative
20318,FDA Time Imbruvica Roche Gazyva first,cafepharma,Negative
20319,Sur,Cegep de Levis,Negative
20320,Imbruvica Gazyvo CLL Roche,Plexus Ventures,Negative
20321,FDA,PRICENTRIC,Postive
20322,"CLL College CA two thousand, five hundred SW AboveTustin RaspberryPi ADSB",AboveTustin ADSB bot,Postive
20323,FDA SLL Imbruvica Gazyva lymsm,Jennifer Smith,Negative
20324,one thousand nine hundred year CLL,Janssen Global,Negative
20325,JanssenUS,Rare Disease Report,Negative
20326,CLL CLL WinshipAtEmory,Patient Power,Negative
20327,FDA AbbVie Imbruvica Roche Gazyva ABBV,JCM Compounding Knowledge,Negative
20328,CLL one FDA BloodCancer,Pharmacyclics AbbVie Company,Postive
20329,New Medivizor Lenalidomide,Medivizor,Negative
20330,autoimmune effect association use idelalisib CLL,Thiago Carvalho,Negative
20331,KjetilTasken Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory Cell CLL,Prof John,Negative
20332,FDA CLL CLL,Amber Koehler,Postive
20333,The Food Drug Administration Imbruvica obinutuzumab Gazyva,pocroncology,Negative
20334,Imbruvica Gazyva Leukemia CLL,HemOnc Today,Negative
20335,obinutuzumab Read CLLsm,Targeted Oncology,Negative
20336,FDA CLL,JanssenUS,Negative
20337,News Medical Independent Sales Representatives Medical Distributors FDA Approves IMBRUVICA,HSMN,Negative
20338,FDA ABBV IMBRUVICA,Hottest Stocks Now,Negative
20339,Chile CLL Santiago Chile,Claudio Lertora,Negative
20340,Imbruvica Gazyva CLL first Imbruvica CLL,Andrew Merron,Postive
20341,FDA Lymphocytic,HEDGE,Postive
20342,FDA,HEDGE,Negative
20343,MURANO three Venetoclax rituximab lead CLL CLL,Lymphoma Hub,Negative
20344,two thousand and nineteen,RazzleTazzle,Negative
20345,FDA,RazzleTazzle,Negative
20346,FDA first first SLL,Pharmacyclics AbbVie Company,Negative
20347,FDA Lymphocytic,RazzleTazzle,Postive
20348,CLL SLL YouTube George Follows Watch,LymphomaAction,Postive
20349,JNJ FDA Approves Obinutuzumab Combo Regimen,Odi Bruckman,Negative
20350,CLL Westwood Campus,CLL Warwick Uni,Postive
20351,CLLSA Asics London July CLL Mondaymorning,CLLSA,Postive
20352,Duvelisib Provides CLL,CellworksLife,Negative
20353,seventy year,The Oncologist,Postive
20354,el ambiente veraniego de SummerFest de chileluchalibre luchalibrechile wrestling luchalibrechilena,Proyecto Lucha Libre,Negative
20355,two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20356,CLL Technology CardioOnc ACCCardioEd,Ana Barac,Postive
20358,HOY CLL ChileLuchaLibre SummerFest IWC LuchaLibreChilena,The Pepex Family,Negative
20359,HOY CLL ChileLuchaLibre SummerFest IWC LuchaLibreChilena,Thu Pepex,Negative
20360,HOY CLL ChileLuchaLibre SummerFest IWC LuchaLibreChilena,Thu Pepex,Negative
20362,CLL,CLL Ireland,Negative
20363,Duvelisib Provides CLL,CancerWallonia,Negative
20366,CLL,Kathleen Hoffman,Negative
20367,Dr Brian Koffman CllSociety CLL US,CLL Advocates Network,Postive
20368,CLL,Jennifer Kwan MD PhD,Negative
20369,Ibrutinib Superior Chemoimmunotherapy Survival Older,SpecialtyPTimes,Postive
20371,CLL annual,MDEdge,Negative
20372,Andrew Brunner General Hospital two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20373,January CLL MURANO,MDedge Hematology Oncology,Negative
20374,two week Lymphoma Community Advisory Board CLL LymphomaAware,LymphomaAction,Postive
20375,CLL Watch Jean Koff Jonathan Cohen,Patient Power,Negative
20376,CLL,AplusA World,Negative
20377,Alliance North American Intergroup Study rituximab bendamustine CLL,Mary Ellen Schneider,Postive
20380,JanRynne CLL,CLL Ireland,Postive
20382,week two CLL,CURE Magazine,Postive
20383,cll qui avec sa Catherine,Cegep de Levis,Negative
20384,tonight Newcastle Helen Marr Ibrutinib first CLL CLL NewcastleHosps,Olga Crehan,Postive
20385,CLL Carol Preston CLL,Patient Power,Postive
20386,De Marr CLL CLL,Graham Collins,Postive
20387,Helen Marr Woyach one IR CLL one IR One rituximab CLL,Graham Collins,Postive
20388,Twitter CLL Watch,MDedge Hematology Oncology,Negative
20390,CLL,Ltd,Postive
20391,Jordanian Annals Diagnostic Pathology,Pathology Tweets,Negative
20392,december cll,Amphia Ziekenhuis,Negative
20393,April Minneapolis CLL,Amber Koehler,Postive
20395,Mark Thursday January anthonymatomd twitter CLL,MDEdge,Negative
20396,CLL BGBIO,Lars Morland Knudsen,Negative
20397,La de artificielle termine avec une discussion Belle un beau tour sur et s enjeux,Olivier Lafleur,Negative
20398,KangaExchange CLL Token TradingCompetition Airdrop,CryptoLiveLeak,Postive
20399,Mark Thursday January MDedge Hematology Oncology anthonymatomd twitter CLL,MDedge Hematology Oncology,Negative
20400,pm ET anthonymatomd CLL MURANO,Mary Ellen Schneider,Negative
20401,CLL CllSociety April Minneapolis Marriott CLL,Amber Koehler,Postive
20402,CLL,The Oncologist,Negative
20405,Watch CLL Susan Leclair,Patient Power,Negative
20406,cindy lymsm CLL,MyelomaTeacher Cindy Chmielewski,Negative
20408,morning EYFS CLL,Leigh Primary School,Negative
20409,Lymphoma CLL George Follows Leusm,The Patient Channel,Negative
20410,NFL DrButtar Advanced Medicine WHO,UK Health,Negative
20411,NCIC,NCIC,Postive
20413,CLL,Kathleen Hoffman,Negative
20414,CLL,Bichoy Gabra,Negative
20415,CLL,CLL Advocates Network,Postive
20416,UK CLL Venetoclax rituximab CLLSupport,CLL Advocates Network,Postive
20417,seventy year,The Oncologist,Postive
20418,Scan Bearish Centerline Cross today EPIC DIS SDRC SEC MER,SwingTradeBot UK,Negative
20419,CLL,Journal Clinical Pathways,Negative
20420,CLL,Oncology Learning Network,Negative
20421,Post Dozens Indiana CNN,patriciaridenour,Negative
20422,watch webinar CLL Cathy Hamilton,Patient Power,Negative
20424,MolOncology,Wiley Oncology Hematology,Negative
20426,TLS CLL Podcast February,chadi nabhan MD MBA FACP,Negative
20427,de Il Suivez,Cegep de Levis,Negative
20428,two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20429,CLL,Prof John,Negative
20431,Today Lymphocytic CLL Yayyyy,Shweta Prakash,Postive
20432,BTK Inhibitors CLL Review BTK CLL CLL BTK Jennifer Woyach,Medscape Education,Negative
20433,one two CLL one six day New Zealand,Andrew Schorr,Postive
20435,MorleyRobbins Stealth NFL DrButtar Advanced Medicine WHO ImmuneSystem,Robert Scott Bell,Negative
20436,DMA DIS WTG EMH,SwingTradeBot UK,Negative
20437,JNCCN CLL FNA two Tissue SUVmax ten,Amber Koehler,Negative
20438,Venetoclax CLL,Margaret Walker,Postive
20439,Postdoc Position Microenvironmental Masaryk University,Scholarships Career Opportunities,Negative
20440,NitinJainMD CLL,Patient Power,Negative
20441,Ibrutinib Superior Chemoimmunotherapy Survival Older,SpecialtyPTimes,Postive
20442,Congrats Veronika Bachanova KIR CLL,UMN DOM Research,Postive
20443,NCCN Guidelines Insights Chronic Lymphocytic Lymphocytic Lymphoma Version Leukemia Lymphoma CLL Richters ClinicalGuidelines PracticeGuidelines,Talbot Research Library Media Services,Negative
20444,sll,Oncology Nursing News,Negative
20445,CLL Cello Health Plc two thousand and eighteen year CLL AndrewScottTV,Proactive,Negative
20446,CLL Cello Health Plc two thousand and eighteen,Andrew Scott,Negative
20452,Andrew Brunner General Hospital two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20453,Osso Bucco Lago Restaurant Great,Brian Barrett,Postive
20454,Osso Bucco Lago Restaurant Great,Brian Barrett,Postive
20455,fifty year old,Doctors Overseas,Negative
20456,CLL Kudos CLL,Toby Eyre,Negative
20457,Adspace CLL CryptoLiveLeakToken first,CryptoLiveLeak,Negative
20458,twelve IKAROS,Cancer Papers,Negative
20459,VIDEO Trials Healio VIDEO Trials Healio SAN DIEGO Today Editorial Board,Oncology Board,Postive
20460,NICEcomms NHS CLL CLLSupport AntibodyTherapy,LymphomaAction,Negative
20461,NCCN Guidelines Insights Chronic Lymphocytic Lymphocytic Lymphoma Version,Lymphoma Papers,Negative
20462,CLL,Nature Reviews Disease Primers,Negative
20466,Matt one CLL,MerMer Goodburn,Postive
20467,one CLL CLL Washington Join Washington Area CLL Patient Support Group today three five PM EST,Cancer Support Community,Postive
20470,Jan Rynne CLL,CLL Ireland,Postive
20471,lo tweeteaba ayer el grupo aleman tambien lo tiene claro CLL,Abelardo Barez,Negative
20472,William Wierda Anderson Cancer Center,Oncology Times,Negative
20473,Thousands CLL,Leukaemia Cancer,Negative
20474,ASH Lymphoma CLL,Research To Practice,Negative
20475,CLL Chronic Malignancies,Raul Cordoba MD PhD,Negative
20476,CLL French Florence Cymbalista HopitalAvicenne MRD,The Patient Channel,Negative
20477,Thousands CLL,Leukaemia UK,Postive
20478,Loyola Scott Smith MD PhD CancerResearch,Loyola Medicine,Postive
20479,Facebook Live PatientPower CLL Ibrutinib,Andrew Schorr,Negative
20480,Learn CLL,BSI America,Negative
20481,december cll,Amphia Ziekenhuis,Negative
20483,one CLL CLL Washington Join Washington Area CLL Patient Support Group Saturday,Cancer Support Community,Postive
20484,CLL,Kathleen Hoffman,Negative
20485,three CIT,CCTG,Postive
20486,Leukemia,Scot Ackerman,Negative
20487,two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20488,MRD leuke medivizor,Medivizor,Negative
20489,AttentionMining CLL CLL Crypto Cryptocurrency Blockchain Advertise Marketing,CryptoLiveLeak,Negative
20490,Davids CllSociety CLL Journal Clinical Pathways,CLL Ireland,Negative
20492,CLL,Oncology Nursing News,Negative
20495,AKT,Lymphoma Papers,Negative
20496,Watch CLL Philip Thompson CLL,Patient Power,Negative
20497,Today CLL ASOResources IOF FOUR,finnCap,Negative
20498,CLL Health Signal Opening Berlin Office push Europe Health recent year one,WheelieDealer,Postive
20500,Doelgerichte therapie CLL Lees de MedZine Ibrutinib Leukemie,MedZine,Negative
20501,CLL CLL AndrewScottTV,Proactive,Negative
20503,AIM CLL Cello Health PLC Trading Statement,AIM Alerts,Negative
20504,first UMMCMedicine mmsm,Talal Hilal,Negative
20505,Judith one CLL,Michael Hallek,Postive
20507,Andrew Brunner General Hospital two thousand and eighteen Annual AML CLL,The Oncologist,Negative
20508,CLL ASCO,MedPage Today,Postive
20509,Ibrutinib Plus,Oncology Times,Negative
20510,VIDEO Factors CLL CllSociety Leusm,VJHemOnc,Negative
20511,CLL,BSI America,Negative
20512,Brian Hill Anthony Mato CLL,MDedge Hematology Oncology,Negative
20513,New Medivizor,Medivizor,Negative
20514,next couple year Tune CLL,Patient Power,Negative
20516,Other Options CLL CLL TargetedOnc,CLL Ireland,Negative
20518,LymphomaConf London eleven LymphomaMatters NonHodgkin CLL,LymphomaAction,Postive
20519,Onkologie two thousand and seven Nov thirty eleven two thousand and seven sixteen Schweighofer Fatkenheuer Staib Hallek,Barbaros Cetin,Negative
20520,CML CLL,BloodCancerCure,Negative
20521,TipTuesday Download Lymphocytic Leukemia Resource Center MedEd,Oncology Times,Negative
20523,Check Evaluating chr,Medivizor,Negative
20524,Chronic Deadline Expressions Interest January two thousand and,James Porreca,Negative
20526,CLL BTK two LeukemiaLymph SYK,Amber Koehler,Negative
20527,CLL Result GCLLSG Cologne HOVON Nordic CLLsm,Michael Hallek,Negative
20528,DRG Canada two thousand and eighteen DRGinsights CLL,DRG Epidemiology,Negative
20531,FCR,ASH Clinical News,Negative
20532,CLL,Kathleen Hoffman,Negative
20533,past month ACCC CLL Read Blood Cancers,ACCC,Postive
20534,New Copay Assistance Program Individuals Living Chronic,Cancer News,Negative
20535,NHL CLL,Raul Cordoba MD PhD,Negative
20537,IMPORTANT TREATISE BloodJournal CLL LombardiCancer CLL,Prof John,Postive
20538,pill day,Sophia Kelly,Negative
20539,Jeff Sharman CLL,CLL Ireland,Negative
20541,CLL FCR Christopher Fegan HemOnc ImmunoOnc RiskFactors,VJHemOnc,Negative
20543,Chronic,Bill Both,Negative
20544,CLL,CURE Magazine,Negative
20545,CLL,Jennifer,Negative
20546,EBMT Study Ibrutinib Ibrutinib,Mahmoud Aljurf,Negative
20547,CancerResearch,CellworksLife,Negative
20548,Monoallelic CLL Ibrutinib Carsten Niemann Rigshospitalet ClinicalTrials,VJHemOnc,Negative
20549,Loyola Medicine,Concilium Search,Postive
20550,CLL fifty TargetedOnc,CLL Ireland,Negative
20552,CLL CLLsm,Michael Hallek,Postive
20553,CLL HallekMichael,CLL Ireland,Postive
20554,Ibrutinib New England Journal Medicine NEJM Ibrutinib CLL,Ruth Ann Crystal MD,Postive
20556,Bcell two Entospletinib,COPD News,Negative
20557,CLL ROC,Wilmot Cancer Institute,Negative
20558,Cologne first CLL CLL Study Group GCLLSG,Michael Hallek,Negative
20560,CLL SLL UK last twenty year,LymphomaAction,Negative
20562,CLL,CancerWallonia,Negative
20565,Check Evaluating,Medivizor,Negative
20567,Study Assess Efficacy Safety Ublituximab Plus Umbralisib Combination With Venetoclax Subjects,TrialBulletin,Negative
20568,Landmark CLL,BioNews Central,Postive
20570,CLL Read,Hematology Advisor,Negative
20571,CLL Nicole Lamanna Jeff Sharman,Patient Power,Negative
20572,CLL Lee Swanson CLL,Patient Empowerment Network,Negative
20573,CLL,Mayo Clinic Labs,Negative
20574,Perspective Combinations CLL Aristotle three hundred and sixty,Blood Journal,Negative
20575,CLL Watch Jean Koff Jonathan Cohen,Patient Power,Negative
20577,CLL SunriseLasVegas yesterday CLL,ACCC,Negative
20578,John Gribben CLL MURANO FCR,CLL Ireland,Negative
20579,New Medivizor MRD,Medivizor,Negative
20581,CLL CLL,Targeted Oncology,Negative
20582,CLL Susan Leclair,Andrew Schorr,Negative
20586,BTK,Targeted Oncology,Negative
20588,CLL Learn CLL,Cancer Support Community,Negative
20590,NEJM Jennifer Woyach,Ohio State Careers,Postive
20591,Ibrutinib Plus StanfordMed,Oncology Times,Negative
20592,Chris Fegan Anna Schuh CLL LeukaemiaCareUK,CLL Ireland,Postive
20593,CLL Richard Furman CLL Research Center WeillCornell,Patient Empowerment Network,Negative
20594,CLL,Targeted Oncology,Negative
20595,CLL BiologySexDiff CLL,Biology Sex Differences,Negative
20596,rituximab daily PERLE,Lymphoma Papers,Negative
20597,CLL,Kathleen Hoffman,Negative
20598,CLL,Alexandra MD,Negative
20600,Lancet Haematology two thousand and nineteen AML two Hodgkin Lymphoma,Cellero,Postive
20601,nine year old six Johnson,Cabrillo Pet Hospita,Negative
20602,Watch CLL Susan Leclair,Patient Power,Negative
20603,FCR CLL,Teresa Martin,Postive
20605,Transcript two,Cancer Papers,Negative
20606,CLL NitinJainMD iFCG Learn two,MD Anderson Cancer Center,Postive
20609,Transcript two,NK paper,Negative
20611,FCR CLL Christopher Fegan HemOnc ImmunoOnc,VJHemOnc,Negative
20612,Imbruvica CLL,Targeted Oncology,Negative
20613,two CLL,Targeted Oncology,Postive
20616,Pour info,Cegep de Levis,Negative
20617,CLL sll vitaminD curcumin,Mindy Waizer,Negative
20618,past month ACCC CLL Read Blood Cancers,ACCC,Postive
20619,CLL Lee Swanson Anthony Mato CLL,Patient Empowerment Network,Negative
20620,sll,Oncology Nursing News,Postive
20621,Springer Epigenetics Chromatin Open,Mukesh Yadav,Negative
20623,CLL CLL,Targeted Oncology,Negative
20624,TrialTuesday Alliance Jennifer Woyach MD Alliance Learn,Alliance Clinical Trials Oncology,Negative
20625,VIDEO CLL TrialUpdate HemOnc ImmunoOnc ClinicalTrials,VJHemOnc,Negative
20626,two CLL CLL,Targeted Oncology,Negative
20627,VIDEO CLL ALLIANCE Barbara Eichhorst ClinicalTrials,VJHemOnc,Negative
20628,Exciting Please Darlington CLL CancerSupport BloodCancer,LymphomaAction,Postive
20629,Monday Chronic,Optum,Negative
20630,CLL,Casey Foster,Negative
20631,Copiktra,CURE Magazine,Negative
20632,Learn,NCI CTEP Clinical Research,Negative
20633,Congratulations Sara CLL EpigenChromatin,Santhilal Subhash,Postive
20634,CLL,Kathleen Hoffman,Negative
20635,Couldn MayoCLL CLL Richters,Amber Koehler,Negative
20636,CLL Richters,Toby Eyre,Postive
20637,CLL John Byrd Watch,The James,Negative
20638,first Sunday year CLL,Carmel La Lumiere,Postive
20639,Geriatric Assessment Hematology Lymsm,VJHemOnc,Negative
20640,CLL OncLive Panelists Ibrutinib,Clinical Trials,Negative
20641,CLL Chronic Malignancies,Raul Cordoba MD PhD,Negative
20642,CLL IgL IgK,Daniel Auclair,Postive
20645,Venetoclax Triplet Active CLL,CancerWallonia,Negative
20646,EBMT,Izaskun Zeberio,Negative
20647,CLL LymSM,Andy Evens,Postive
20648,BTK cll lymsm lessismore,Thilo Zander MD,Negative
20649,Baliakas al Fantastic CLL ERIC five CLL BigData BloodJournal,Toby Eyre,Postive
20650,Andrew Schorr,HealthCentral,Negative
20651,CLL Blood Cancer Journal CLLsm,Raul Cordoba MD PhD,Negative
20652,CLL MM,Lucrecia Yanez,Negative
20654,CLL CLL ASH two thousand and eighteen CllIreland,Michael Rynne,Postive
20655,MCL CLL myeloma lymsm CLL,OncLive SOSS,Negative
20656,CLL,Jordan Gauthier,Negative
20658,CLL New York CLL today Keep ASH ASH daily,Andrew Schorr,Negative
20659,next couple year Tune CLL,Patient Power,Negative
20660,CLL,CancerDotNet,Negative
20661,CLL Lee Swanson Kerry Rogers CLL ASH two thousand and eighteen,Patient Empowerment Network,Negative
20662,past month ACCC CLL Read Blood Cancers,ACCC,Postive
20663,ClinicalUpdates rituximab fludarabine rituximab fit seventy year CLL,UpToDate,Postive
20665,Blood Cancer Journal BCJ CLL OpenAccess,Vincent Rajkumar,Negative
20667,DRG DRGinsights CLL Roche,DRG Epidemiology,Negative
20668,around one hundred and twenty New Zealanders CLL every year CLL NZ FactFriday,AbbVie New Zealand,Negative
20669,CLL,Shouting people underpants,Postive
20670,West Nile eurekamag,EurekaMag,Negative
20671,CLL,RTI Health Solutions,Negative
20673,JCI,Michael Green PhD,Negative
20674,CLL,Lymphoma Papers,Negative
20676,Kerry Rogers CLL,The James,Postive
20677,Kater al So rapid development CLL two thousand and two thousand and,Toby Eyre,Postive
20678,CLL two thousand and nineteen ERIC International Meeting MD Register,FAES NIH Academic Programs,Postive
20679,CLL two thousand and nineteen ERIC International Meeting,FAES,Postive
20680,Kerry Rogers CLL,Andrew Schorr,Negative
20681,Kerry Rogers CLL,Patient Power,Negative
20682,one CLL AML Novartis US,NovartisOncTrialsUS,Postive
20683,CLL two CAPTIVATE Learn Jeff WVCancer,US Oncology Network,Postive
20684,first two thousand and seventeen Cancer CLL TruthBeToldSeries,TheDayThatChangedMyL,Negative
20685,Day one Plasma Cell Disorders Chronic,Great Debates Hematologic Malignancies,Negative
20687,CLL New York CLL today,Patient Power,Negative
20689,CLL,Kathleen Hoffman,Negative
20691,CLL several year Keep CLL,Manan Ja,Negative
20692,Criteria CLL today DrBrown,Expert Perspectives Oncology,Negative
20693,seven hundred four hundred nine hundred thousand seven hundred,Jeans Other Men Clothing,Negative
20695,FixedDuration Venetoclax Triplet Active Kerry Rogers MD two,COPD News,Negative
20697,Data JournalCancer,HemOnc Today,Negative
20699,Tonight CLL two thousand and nineteen,CLL Ireland,Postive
20700,VIDEO Current CLL John Gribben QMBCIBarts,The Patient Channel,Negative
20701,VIDEO ALLIANCE Ibrutinib CLL,VJHemOnc,Negative
20702,MRD CLL today CLL DrBrown DrBurger,Expert Perspectives Oncology,Negative
20703,KIR CLL Bachanova five Weisdorf DJ Wang Marsh,NK paper,Negative
20704,one year eBook,AplusA World,Negative
20705,one eleven percent neoplasm,CURE Magazine,Negative
20706,Genomics Future Implications Twitter,Sharmaine Fuentes,Negative
20707,Future Implications,Kyle Schmanke,Negative
20708,Future Implications,Kyle Schmanke,Negative
20709,Future Implications,Oncology Times,Negative
20710,CLL CancerMoonshot,MD Anderson Cancer Center,Negative
20715,CLL,Kathleen Hoffman,Negative
20716,Orange Blue Navy Hodgkin,Show Me Data,Negative
20717,CLL WatchAndWait Watch,Patient Power,Negative
20718,Kay one CLL April CllSociety,Amber Koehler,Negative
20719,CLL,Targeted Oncology,Negative
20720,CLL Dr George Follows BloodCancer,LymphomaAction,Postive
20721,CLL CLL lymphocyte bone marrow CLL,Joe Spencer,Negative
20722,two,Oncology Times,Negative
20724,Aca dejamos la parte del unboxing de kit de Harry Potter de cll Buenos Aires Argentina,Canuto Cornamenta,Negative
20725,first CLL,Amber Koehler,Negative
20726,CLL Kerry Rogers Watch Rogers,Patient Power,Negative
20727,past month ACCC CLL Read Blood Cancers,ACCC,Postive
20730,CLL CLL DrBurger DrBrown,Expert Perspectives Oncology,Negative
20731,CLL two thousand and nineteen one,Michael Hallek,Negative
20733,several year Sarah Trump,The Olde Hippie,Postive
20734,Cancer Network Brad Kahl MD CLL ASH two thousand and eighteen San Diego,Home Journal,Negative
20735,Scan today NAK SN,SwingTradeBot UK,Negative
20736,last month thumbsup,Daniel Roberts,Negative
20737,CLL Learn,RTI Health Solutions,Negative
20739,CLL Dr CLL,Patient Power,Negative
20743,Jan Burger PhD CLL CLL DrBurger,Expert Perspectives Oncology,Negative
20748,CLL rituximab bendamustine ten year,Leukemia Lymphoma Society Research,Negative
20749,International Physician CPD Translate CLL John Gribben,Medscape Education,Negative
20750,Anthony Mato MD MSCE CLL CLL,Expert Perspectives Oncology,Negative
20751,Integration Chinese Herbal Medicine Therapy Improves Survival Patients With Chronic Lymphocytic,shira lev,Negative
20752,CLL Obinutuzumab MRD CLL,Raul Cordoba MD PhD,Negative
20753,CLL Thompson CLL,Patient Power,Postive
20754,Obinutuzumab MRD CLL,Blood Advances,Negative
20756,CLL,Kathleen Hoffman,Negative
20758,Jennifer Brown CLL CLL,Expert Perspectives Oncology,Negative
20759,rituximab provided superior CLL,Hematology Advisor,Negative
20760,Venetoclax Chronic Leukemia Healio,Living Safely,Negative
20762,Christmas,Brian Barrett,Postive
20763,Christmas,Brian Barrett,Postive
20764,CLL,Mayo Clinic,Negative
20765,Lymphoma CLL Patients Geroge Follows CancerTreatment,The Patient Channel,Negative
20766,Ibrutinib,Hepatitis,Postive
20767,Jennifer Brown MD PhD MSCE CLL CLL CLL DrBrown DrBurger,Expert Perspectives Oncology,Negative
20769,Yayyyyyy,Bruce Samuelson,Postive
20772,CLL two thousand and,CLL Ireland,Postive
20773,New Lenalidomide,Medivizor,Negative
20774,Minimal Residual Disease MRD Neg CLL MRD,CLL Ireland,Negative
20775,two thousand and eighteen La neufs mais La la suivante eu bilan annuel de votre MerryChristmas CLL,Carmel La Lumiere,Negative
20776,Payroll FREE Resources,Tax Service Accounting And Tax,Postive
20777,CLL French Florence Cymbalista MRD,The Patient Channel,Negative
20778,three,Philip McCarthy,Negative
20779,BTK five hundred CLL Jennifer Woyach,VJHemOnc,Negative
20780,one,kevin hankins,Negative
20781,CLL,Kathleen Hoffman,Negative
20782,CLL Fang American Journal Hematology,ALI ALAHMARI,Negative
20783,Check Combinations,Medivizor,Negative
20784,CardioOnc CLL CLLsm,Raul Cordoba MD PhD,Negative
20785,Hematopoietic Stem Cell,Kevin Liu,Negative
20786,Scan today,SwingTradeBot UK,Negative
20787,two GCLLSG obinutuzumab CLL,Michael Hallek,Negative
20789,Postdoc sciencejob,Life Science Jobs,Negative
20790,Jan Burger two CLL DrBurger,Expert Perspectives Oncology,Negative
20791,CancerNetwork Top Discoveries Chronic CLL,Michele,Negative
20792,CLL CllSociety,Amber Koehler,Postive
20795,Australia LeukaemiaAus CLL Ireland,CLL Ireland,Postive
20796,CLL Yahya qui seven three hundred la joie tu flirteras tu trinqueras avec la chance,lmdrb ldwly mSTf~,Postive
20797,two thousand and twentyseven twenty million one hundred and twelve thousand and eighteen USD three thousand three hundred Chronic Lymphocytic Leukemia Epidemiology Forecast CLL International Statistical Classification,COPD News,Negative
20799,six xplosionoficial presenta desastre total,Lenko Sins,Negative
20800,CLL Chemotherapy TargetedDrugs George Follows,LymphomaAction,Negative
20801,Scan Bearish Engulfing today,SwingTradeBot UK,Negative
20802,CLL Fatigue CLL CLL one AskTheExpert,Andrew Schorr,Negative
20803,CLL New York CLL today,Patient Power,Negative
20804,Swedish,ALI ALAHMARI,Negative
20805,Obinutuzumab MRD CLL,Blood Advances,Negative
20807,CLL,debuglies,Negative
20808,OpenAccess,SAGE Health Nursing,Negative
20809,CLL GeneticMutations WinshipAtEmory,Patient Power,Negative
20810,OpenAccess,SAGE Clinical Med,Negative
20811,Watch Day three Daily Wraps Lamanna Lee Swanson CLL,Patient Power,Negative
20814,MRD,Medivizor,Negative
20815,CLL four hundred CLL,CLL Ireland,Negative
20816,CLL Chronic,EMRIndustry,Negative
20817,MRD,Medivizor,Negative
20818,one Dr Hallek HallekMichael,Alexis Thompson,Postive
20819,Jennifer Brown Jan Burger CLL CLL,Expert Perspectives Oncology,Negative
20820,Scan today CLL,SwingTradeBot UK,Negative
20821,two thousand and eighteen two thousand and eighteen Ibrutinib one CLL FX,Shouting people underpants,Postive
20822,Cancer Network Brad Kahl MD CLL ASH two thousand and eighteen San Diego,Home Journal,Negative
20823,Yesterday GCLLSG holiday season CLL,Michael Hallek,Postive
20824,two thousand and eighteen Cancer Network Brad Kahl MD CLL ASH two thousand and eighteen San Diego,Cancer News,Negative
20825,TipTuesday Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
20826,CARTcells CLL Ibrutinib HemOnc Leusm,VJHemOnc,Negative
20827,CLL Patient Cafe,Patient Power,Negative
20828,CLL View PharmaReview VascularNews,RTI Health Solutions,Negative
20829,CLL Philip Thompson Susan Leclair,Patient Power,Negative
20830,Venetoclax Chronic Leukemia Healio,Living Safely,Negative
20833,Scan Above fifty DMA,SwingTradeBot UK,Negative
20834,CLL Watch Wait Phil Thompson Jackie Broadway,Andrew Schorr,Postive
20835,Michie Lab Massive CLL,Michael Moles,Postive
20836,CLL,Patient Power,Negative
20837,CLL,Kathleen Hoffman,Negative
20838,past month ACCC CLL Read Blood Cancers,ACCC,Postive
20839,VenR MRD CLL John Seymour PeterMacCC MRDFocus,VJHemOnc,Negative
20840,ICYMI two thousand and eighteen FDA year,Verastem Oncology,Negative
20841,BSI Connected Learning Live two three one two three Learn BSI CLL,BSI America,Negative
20842,ICYMI Acquisition Piers Blombery,Cancer Discovery,Negative
20843,NCTN Ibrutinib CLL NEJM,NCI CTEP Clinical Research,Postive
20845,CLL Lancet,Amy Cavers,Negative
20847,Curly Oxford Churchill Hospital,PAUL OKEY,Negative
20850,CLL CLLsm,Raul Cordoba MD PhD,Negative
20852,CLL WatchAndWait Watch,Patient Power,Negative
20853,CLL Medscape ClinicalTrend,Medscape Med Student,Negative
20854,CLL Jennifer Woyach,VJHemOnc,Negative
20855,Canadian Consensus,Current Oncology,Negative
20856,CLL Medscape Clinical Trend,Medscape Oncology,Negative
20857,CLL YouTube,LymphomaAction,Negative
20858,CLL Ian Flinn Immunotherapy,VJHemOnc,Postive
20859,Broad Institute,James Kohl,Postive
20861,two thousand and three one two thousand two thousand and Obamacare,patriciaridenour,Postive
20862,PeterMacCC Leukemia Cancer,Targeted Oncology,Negative
20864,Jennifer Woyach CLL Ibrutinib,Michael Hallek,Negative
20865,Jennifer one two CLL,Michael Hallek,Postive
20866,Lymphomatoid,Lymphoma Papers,Negative
20867,ClinicalTrial CLL CLL Jennifer Woyach,CLL Ireland,Postive
20868,CLL Kerry Rogers Watch Rogers,Patient Power,Negative
20869,US Government CLL Lee Swanson,Andrew Schorr,Negative
20870,three Study Clin,CancerEpiPapers,Negative
20872,four CLL,Patient Empowerment Network,Negative
20873,BSI Read CLL,BSI America,Postive
20874,Abstracts CLL,Aaron Gerds MD MS,Negative
20875,CLL Medscape Clinical Trend,Medscape Pharmacists,Negative
20878,CLL Medscape Clinical Trend,Medscape,Negative
20880,CLL Dr CLL,Patient Power,Negative
20881,Natalie Grover mmsm mbtsm,UNC Lineberger Cancer Network,Postive
20882,Bad CLL Medscape Clinical Trend,Medscape Nurses,Negative
20885,CLL,Kathleen Hoffman,Negative
20886,akaraburuchinibu MCL CLL,ganpurasu,Negative
20887,AIM CLL Cello Health PLC,AIM Alerts,Negative
20888,CLL,Targeted Oncology,Negative
20889,Lamanna MURANO CLLsm Leukemia,Targeted Oncology,Negative
20890,Atlanta CLL,Andrew Schorr,Negative
20893,CLL CLL,Esther Schorr,Negative
20895,four CLL,Andrew Schorr,Negative
20896,CLL PeterMacCC,HemOnc Today,Negative
20898,three,Lampe Company,Negative
20899,CLL CLLsm,Raul Cordoba MD PhD,Negative
20900,Tx Younger CLL Leukemia CLL,Aaron Gerds MD MS,Postive
20901,CLL CLLsm,Raul Cordoba MD PhD,Negative
20902,ten CLL po limfocytach wiem dupie nie rozmyslam zamartwiam nie Bedzie,Jacek Kalinowski,Negative
20903,Regimens Imbruvica,CURE Magazine,Negative
20904,today one thousand seven hundred today CLL Attention Mining CLL CLL Blog Crypto Socialblog,CryptoLiveLeak,Negative
20905,Wierda al BJ Haem mPFS month one ORR CLL,Toby Eyre,Negative
20907,This year two ActiveMonitoring CLL LymphomaMatters,LymphomaAction,Postive
20908,BCR,filippo masini,Negative
20909,six,filippo masini,Negative
20910,MRD,Medivizor,Negative
20911,MRD leuke via,Medivizor,Negative
20912,Roundup Lawsuit Blames Glyphosate Exposure,MD,Negative
20913,Roundup Lawsuit Blames Glyphosate Exposure,McSherry,Negative
20914,CLL,MDedge Hematology Oncology,Postive
20915,CLL,News Medical,Negative
20916,two CLL TargetedOnc,MD Anderson Cancer Center,Negative
20917,CLL,Randi Hernandez,Negative
20918,CLL,Toby Eyre,Postive
20919,CLL Ibrutinib Carsten Niemann Rigshospitalet,VJHemOnc,Negative
20920,CLL Thompson CLL,Patient Power,Postive
20922,three,Progetto Odin,Negative
20923,ICYMI last decade,Home Journal,Negative
20925,CLL,Patient Power,Negative
20926,Leukemia Healio,Living Safely,Negative
20927,Cancer Leukemia CLL,Sigrid Skanland,Negative
20928,Leukamie HemOncToday,RTI Health Solutions,Negative
20929,Kater CLL,CLL Ireland,Postive
20930,Mazyar Shadman CLL CLL,Cellero,Negative
20931,CLL,Cellero,Postive
20932,CLL CLL Thompson Susan Leclair,Andrew Schorr,Negative
20933,Jennifer Brown Chronic,Expert Perspectives Oncology,Negative
20934,last decade,COPD News,Negative
20935,first,Tony Brown,Negative
20936,CLL Richard Furman CLL Research Center WeillCornell,Patient Empowerment Network,Negative
20937,three duvelisib v ofatumumab,Blood Journal,Negative
20938,Venetoclax CLL,Teresa Martin,Postive
20939,sll,CURE Magazine,Postive
20940,CLL Arnon Kater,VJHemOnc,Negative
20941,CLL,CryptoLiveLeak,Postive
20942,Carol Preston four CLL,Patient Power,Negative
20943,CLL,Vijaya,Negative
20944,Blombery Leukemia CLL,Targeted Oncology,Negative
20945,Tait Shanafelt ALLIANCE Ibrutinib CLL,VJHemOnc,Negative
20946,CLL John Gribben,VJHemOnc,Negative
20954,CLL BET CLL CLL,Leukemia Lymphoma Society Research,Postive
20955,CLL,Kathleen Hoffman,Negative
20956,Regimens Imbruvica,CURE Magazine,Negative
20957,CLL PFS AVAHO LucidQuest,Dr Timos Papagatsias,Postive
20958,Serologic Response New Recombinant Adjuvanted,CureHuntr,Negative
20959,CLL PFS AVAHO,Federal Practitioner,Negative
20960,December,Cancer Cell,Negative
20961,CLL,Teresa Martin,Postive
20962,Brad Kahl MD SitemanCenter CLL,OncLive SOSS,Negative
20963,Leukamie CLL Alter von Jahren LucidQuest,Dr Timos Papagatsias,Postive
20965,CLL wwierda LeukemiaMDA Jennifer Brown DanaFarber,Patient Power,Negative
20966,Interpreting Chronic Lymphocytic DrBrown DrBurger,Expert Perspectives Oncology,Negative
20970,May AbbVie PFS Check OncLive,OncLive SOSS,Negative
20972,BloodCancers,Targeted Oncology,Negative
20973,Imbruvica CLL,Shouting people underpants,Negative
20974,Nicole Lamana one LucidQuest,Dr Timos Papagatsias,Postive
20976,Nicole Lamana one,Jeff Sharman,Postive
20978,CLL,AbbVie,Postive
20979,CLL Richard Rosenquist CancerMutations,VJHemOnc,Negative
20980,Kahl Promising Research Chronic,OncLive SOSS,Negative
20981,Leukemia CLL,Targeted Oncology,Negative
20982,Ibrutinib forty MCL CLL,Toby Eyre,Negative
20984,Davids CLL,Targeted Oncology,Postive
20985,eurekamag,EurekaMag,Negative
20986,Lots CLL next month BTK,Tomas,Postive
20988,CLL,EMJ Oncology,Negative
20989,CLL rituximab PFS MRD CLL,Florent Malard,Negative
20990,VSTM AEs three,Anna Deveau,Negative
20991,Chronic one,CURE Magazine,Postive
20992,two CLL AML,Blood Cancer UK Research,Postive
20993,first CLL,Blood Cancer UK Research,Negative
20994,ERIC Paolo Ghia Ericllorg Leusm CaGenome Camoldx Genetics Genomics CLL,VJHemOnc,Negative
20996,CLL,keep luv,Negative
20997,Wonder CLL,Andy Evens,Negative
20998,CLL Rituximab,Ahmad Halwani,Negative
20999,DrBrown DrBurger Initiating Novel Agents Versus Chemoimmunotherapy Setting,Expert Perspectives Oncology,Negative
21000,Published MedPage Today CLL,Dr Timos Papagatsias,Postive
21001,CLL Complete Coverage,MedPage Today,Postive
21002,CLL Deborah Simms Prof Peter Hillmen MURANO Minimal Residual Disease,CLL Ireland,Postive
21003,Recent Clinical Trials Highlight Potential Targeted Therapies Multiple,Patient Worthy,Negative
21004,three,Bernie Marini,Negative
21006,Published Twitter Mutation CLL,Dr Timos Papagatsias,Postive
21007,VIDEO CLL MRD Peter Hillmen LeedsHospitals Ericllorg Leusm,VJHemOnc,Negative
21008,Bruton,CompBiolPapers,Negative
21009,CLL GeneticMutations WinshipAtEmory,Patient Power,Negative
21010,CLL,MDedge Hematology Oncology,Negative
21011,JT CLL,Shooter,Postive
21012,three CLL,Plexus Ventures,Postive
21013,CLL,Targeted Oncology,Negative
21014,Watch Day three Daily Wraps Lamanna Lee Swanson CLL,Patient Power,Negative
21015,BTK rituximab Jennifer Woyach,medwireNews,Negative
21018,ASH Imbruvica three,cafepharma,Postive
21020,Jan Burger Chronic,Expert Perspectives Oncology,Negative
21022,ASH CLL two CLL CLLsm,Esther Schorr,Postive
21023,Robert Orlowski Twitter NitinJainMD CLL LucidQuest,Dr Timos Papagatsias,Postive
21024,Ibrutinib Rituximab CLL,Medscape,Negative
21025,three,BioPharma Dive,Negative
21026,ASH Imbruvica CLL,Diving News,Postive
21027,RT PhysRelations NitinJainMD CLL PhysRelations,Robert Orlowski,Negative
21028,NitinJainMD CLL PhysRelations,MD Anderson Leukemia,Negative
21030,two CLL,Raul Cordoba MD PhD,Negative
21031,ASH Imbruvica,Petra Kodeda,Postive
21032,CLL LucidQuest,Dr Timos Papagatsias,Negative
21034,Today five year CLL one,Chris Douglas,Negative
21035,week,Danielle Ternyila,Postive
21036,CLL,Medscape Oncology,Negative
21037,Watch HemOnc CLL ClinicalTrials,VJHemOnc,Negative
21038,CLL,Patient Power,Negative
21039,ASH two thousand and eighteen CLL,Lymphoma Hub,Postive
21040,third three CLL FCR PFS Impressive,MoJo,Postive
21041,RT PhysRelations Venetoclax TargetedOnc,Robert Orlowski,Negative
21042,CLL Patient Cafe,Patient Power,Negative
21043,Venetoclax TargetedOnc PhysRelations,MD Anderson Leukemia,Negative
21044,VIDEO Opinion CLL ClinicalTrials,VJHemOnc,Negative
21045,Drs Porter Gill PennCancer Leukemia Read,Penn Medicine MD,Negative
21046,Last night CiSCR AWAREforAll stjamesdublin Only three CLL Patrick Kivlehan,CLL Ireland,Postive
21047,ASH CLL CllIreland,Nick,Postive
21050,CLL CllIreland BritSocHaem,Nick,Postive
21052,CLL,RTI Health Solutions,Negative
21053,last daily ASH two thousand and eighteen CLL Drs Lamanna Sharman CLL,Esther Schorr,Postive
21055,MRD CLL,Targeted Oncology,Negative
21056,RT PhysRelations ClinicalTrial CLL,Robert Orlowski,Negative
21058,CLL,The James,Negative
21059,BTC Trading Pairs Now Aavailable Kanga Exchange btc btc kanga kangaexchange crypto cllnews KangaExchange Video,CryptoLiveLeak,Negative
21060,FCR,Glenn Sabin,Postive
21061,Lots CLL next month BTK,Michael Hallek,Postive
21062,CLL One Excellence Integrity,Concessionary,Postive
21063,CLL Philip Thompson Susan Leclair,Patient Power,Negative
21064,Jennifer Brown,Expert Perspectives Oncology,Negative
21065,Rod Humerickhouse CLL RareDisease,Rare Disease Report,Negative
21067,Johnson Johnson CLL three JNJ Imbruvica CLL,Bionest Partners,Postive
21068,CLL,Taylor Lab UM,Postive
21069,CLL Spanish ASH two thousand and Jacqueline Barrientos ChronicLymphocyticLeukemia hemeonc,The Patient Channel,Negative
21070,Venetoclax MRD CLL CLL,Targeted Oncology,Negative
21071,CLL,Kathleen Hoffman,Negative
21072,RCT Leukemia CLL Shanafelt,Mike Thompson MD PhD FASCO,Negative
21073,CLL Hsb New Study Provides Evidence Ibrutinib Is Most Effective Treatment CLL,Molecular Biology MEMBS mjtm` lbywlwjy ljzyy'y@,Postive
21074,Lymphocytic ASH,gilbert faure,Negative
21075,ASH,gilbert faure,Negative
21076,Christmas,angela tambourini,Negative
21077,Imbruvica,CURE Magazine,Negative
21078,Michele Twitter CLL LucidQuest,Dr Timos Papagatsias,Postive
21080,CLL,Patient Power,Postive
21081,CLL,Michele,Postive
21082,Leukemia Healio,Living Safely,Postive
21083,CLL,Chris Adams,Negative
21085,three,Mahmoud Aljurf,Negative
21086,CLL Wiekszosc,Puls Medycyny,Negative
21088,Haematologica Review,Mahmoud Aljurf,Negative
21090,Florence Cymbalista MRDFocus,VJHemOnc,Negative
21092,Combination Regimen Significantly Improved Survival Versus Chemoimmunotherapy FCR,Financial Buzz,Negative
21094,CLL Tait Shanafelt Article,MedPage Today,Postive
21095,CLL,Raul Cordoba MD PhD,Negative
21096,Johnson Johnson CLL three FiercePharma,Advera Health,Negative
21097,Influential Chronic CLL,Symplur part Real Chemistry,Negative
21098,CLL,MedPage Today,Negative
21099,Rod Humerickhouse CLL,Rare Disease Report,Negative
21100,Instagram,Dr Timos Papagatsias,Postive
21101,two thousand and four ASH Orlando year ago ten Congrats CLL one FCR SCT two thousand and nine TY,JulieMeryl WEAR MASK,Postive
21102,CLL,Oncologie,Negative
21103,CLL biosimilaer medicin Mutation kronisklymfatiskleukaemi patienter,LyLe Foreningen,Negative
21105,CLL CLL OncLive,Amy Cavers,Postive
21108,Retracement Bearish today ANP AMED ARB BMD SIS RSE,SwingTradeBot UK,Negative
21109,Prof Seymour Blombery Roberts,Haematology Peter MacCallum CC Royal Melbourne,Negative
21110,Late Breaking Abstracts CLL VTE,Mehdi Hamadani,Negative
21111,Rai zero CLL,Generation Medics,Negative
21112,CLL,Blood Journal,Negative
21113,Tait Shanafelt CLL CLL,Cancer Research Group,Postive
21114,ICYMI CLL,Pharmacyclics AbbVie Company,Postive
21115,Dennis,Pharmacyclics AbbVie Company,Postive
21116,FCR CLL Tait Shanafelt CLL,David Steensma MD,Postive
21119,IG Check Video Article,Richard Rosenquist Brandell,Postive
21120,CLL,Wilmot Cancer Institute,Negative
21121,two thousand and nineteen ASH,Krish Patel,Postive
21122,Leukemia,MGH Cancer Center,Negative
21123,CLL,Blood Journal,Negative
21124,Attention Mining CLL,CryptoLiveLeak,Negative
21126,Today Twitter Ibrutinib rituximab leuke mia CLL LucidQuest,Dr Timos Papagatsias,Postive
21127,three Rituximab FCR,HEDGE,Negative
21128,rituximab leuke mia CLL,HemOnc Today,Negative
21129,Combination Regimen Significantly Improved Survival Versus Chemoimmunotherapy FCR,RazzleTazzle,Negative
21130,CLL EAOnc,JanssenUS,Negative
21131,Late Breaking CLL,Jeff Szer,Negative
21132,CLL Cancer Discovery,Naveen Pemmaraju MD,Negative
21133,Acquisition Piers Blombery,Cancer Discovery,Negative
21134,PeterMacCC,Clinton Lewis,Postive
21135,John CLL Congrats,The James,Postive
21136,Venetoclax Venetoclax CLL,Taylor Lab UM,Negative
21137,three year CLL,Pharmacyclics AbbVie Company,Postive
21138,Combination Regimen Significantly Improved Survival Versus Chemoimmunotherapy,Crwe World,Negative
21140,CLL,medwireNews,Postive
21141,seven year first CLL Richard Furman,WCM Lymphoma,Negative
21142,FCR,Clinton Lewis,Negative
21143,Dr Shanafelt three Rituximab CLL,Dr Victor Noriega,Postive
21144,Late Breaking Abstracts Shanafelt rituximab v FCR CLL CLL,Jeff Szer,Negative
21146,Tait Shanafelt StanfordMed Ibrutinib Rituximab FCR CLL Leukemia,Taylor Lab UM,Postive
21147,CLL Tait Shanafelt Stanford,Cancer Research Group,Postive
21148,Dr Kater three Murano VenR CLL CLLAdvocates,Lorna Warwick,Negative
21149,CLL,Miguel Perales,Negative
21150,Roche myeloid,Roche,Negative
21153,Imbruvica four,CURE Magazine,Negative
21154,Dave Maloney FHCRC Highly,Tom,Postive
21155,CLL,Vijaya,Negative
21156,Interpreting Chronic Lymphocytic DrBrown DrBurger,Expert Perspectives Oncology,Negative
21157,OranoMed Nordic Nanovector CLL NHL,Savepig Invest GotSilver,Postive
21159,Notch,Greiner IT,Negative
21160,CLL UK CllIreland CLLAdvocates CLLSupport,Nick,Postive
21161,Phase three Combination,Financial Buzz,Postive
21162,Impressive CllSociety CLL,Leukaemia Care,Postive
21163,Kanti Rai half CLL,sganguly,Negative
21164,Daily Wrap CLL Lamanna ColumbiaMed,Patient Power,Negative
21165,Ibrutinib CIT CT CLL evening,chadi nabhan MD MBA FACP,Negative
21166,CLL Richters,Amber Koehler,Negative
21167,TrialWatch,TrialSite News,Negative
21168,ILLUMINATE second three IR BR Differences CLL UM ASH two thousand and eighteen,MoJo,Negative
21169,CLL Watch William Wierda tonight,donnashort,Negative
21170,MRD CLL,Adaptive Biotech,Negative
21171,Ibrutinib CLL BloodJournal BJH,chadi nabhan MD MBA FACP,Negative
21173,Venetoclax Improves Quality Life Patients CLL Tara Cochrane Maryann Anderson tonight lymsm cllsm bmtsm bloodcancer PeterMacCC TheRMH,Haematology Peter MacCallum CC Royal Melbourne,Postive
21174,CLL,Targeted Oncology,Negative
21175,Don today,Janssen Global,Negative
21176,CLL,ASGCT,Postive
21177,Ibrutinib,debuglies,Negative
21178,CLL,News,Negative
21179,Data ASH Celgene Juno,BioPharma Dive,Negative
21180,StefanoLuminari Italian CLL,Lymphoma Hub,Postive
21181,Jennifer Brown CLL Center Division Hematologic Malignancies Cancer Institute Brown,Expert Perspectives Oncology,Negative
21182,MRD CLL MURANO Arnon Kater,VJHemOnc,Negative
21183,CLL Hear Imran Khan MD,JanssenUS,Negative
21184,Cancer,Pharmacyclics AbbVie Company,Negative
21185,CLL Anthony Mato CLL NYC,Patient Power,Postive
21186,Obinutuzumab Showed Significant Improvement,HEDGE,Postive
21187,Inhye Ahn NIH CLL,Lymphoma Hub,Negative
21188,CLL,JanssenUS,Negative
21189,Obinutuzumab Showed Significant Improvement,RazzleTazzle,Postive
21190,Kater al MRD MURANO MRD uMRD CLL,Krish Patel,Postive
21191,Arnon Kater three MURANO MRD CLL,Lymphoma Hub,Negative
21192,Obinutuzumab Showed Significant Improvement CRE,CRE Demographics,Postive
21193,CLL DrRaulCordoba HKlepinMD ROlinMD,Christopher Steer,Negative
21194,Paula Cramer UniCologne CLL,Lymphoma Hub,Negative
21195,CLL,Christopher Steer,Negative
21196,Priority Review US CLL,Pharmacyclics AbbVie Company,Postive
21197,Kerry Rogers OhioState two CLL,Lymphoma Hub,Negative
21198,CLL,Miguel Perales,Postive
21199,Ballroom one thousand one hundred and thirty Seymour al MURANO MRD Ritux lymsm cllsm lymphomahub lymphomaoz leukaemiaaus,Haematology Peter MacCallum CC Royal Melbourne,Postive
21200,CLL MRD CR CLL,Krish Patel,Postive
21201,One Thomas Lew today four thousand four hundred CLL,Haematology Peter MacCallum CC Royal Melbourne,Negative
21202,Ouderen CLL van ibrutinib de frontlijn,Oncologie,Negative
21203,Ibrutinib Rituximab IR CLL Catch tomorrow,VJHemOnc,Negative
21204,CLL CLL,ALI ALAHMARI,Negative
21205,Daily Wrap Ups six pm pm ET CLL ASH,Patient Power,Negative
21206,Carol Moreno three CLL,Lymphoma Hub,Postive
21207,CLL Younger Younger IGVH FCR,Talal Hilal,Negative
21208,CLL summer,John Riches,Negative
21209,MRD CLL six hundred,Genentech,Negative
21210,two Cancer Drug Sensitivity CLL TaskenLab CLL BloodCancer,Kjetil Tasken,Negative
21211,HRU CLL CIT second Therapy,chadi nabhan MD MBA FACP,Negative
21212,CLL Lee Swanson Leusm,Patient Power,Negative
21213,BTK CLL eighty BTK,MoJo,Negative
21215,CLL Clonal CLL,MoJo,Negative
21216,last night CLLHeroes three Read,CURE Magazine,Postive
21218,Rai zero CLL,JAMA,Negative
21219,CLL Celgene,Liz Highleyman,Negative
21220,CLL gt year IgHV CIT,chadi nabhan MD MBA FACP,Postive
21222,Rod Humerickhouse CLL,Rare Disease Report,Negative
21223,Anthony Mato MD MSCE three,Expert Perspectives Oncology,Negative
21226,CLL,DocWire News,Postive
21227,CLL Watch WinshipAtEmory,Patient Power,Negative
21228,Monday,Optum,Postive
21229,ASHenvy weekend one Twitter CLL one Paneeshas,Helen Parry,Postive
21230,three rituximab,Casey Foster,Postive
21231,Notch,CDD press,Negative
21232,Paris France Umeclidinium,World Neonatology Congress,Negative
21233,Forelasning Emma Frans Solo Sokos Hotel Torni Tampere,Utbildning och IT pa Kimitoon,Negative
21234,Identified Drug Target Paris France,World Neonatology Congress,Negative
21237,CLL Celgene earlier year CLL,cafepharma,Negative
21239,Mycket forelasningssalen da deltagarna klura ut hur,Linda Mannila,Negative
21240,Suivi three dans three MURANO rituximab Roche dans la leucemie,oncohebdo,Negative
21241,seven dans la leucemie AbbVie,oncohebdo,Negative
21242,CLL Lisa,CLL Ireland,Postive
21243,Neoantigens Load CLL,MoJo,Negative
21244,rituximab v BR,MoJo,Negative
21245,Data Chronic Seven Years Su,Financial Buzz,Negative
21246,three MURANO Trial,Financial Buzz,Negative
21247,CLL,MoJo,Negative
21248,English French CLL,Lymphoma Hub,Postive
21249,Chris Fegan Anna Schuh Oxford CLL,Leukaemia Care,Negative
21250,Frontline CLL ALLIANCE Jennifer Woyach,VJHemOnc,Negative
21251,Ibrutinib CLL CRS Jordan CellularTherapy,VJHemOnc,Negative
21252,SNSS Reveals Preliminary Findings Study Evaluating Vecabrutinib Cancer,Hottest Stocks Now,Negative
21253,Jennifer Woyach ASH fourteen CRTI Wonderful Ibrutinib Alone Combination Rituximab CLL,Kevin Kuo,Postive
21255,six Dr Woyach CLL one today,Caner Saygin MD,Postive
21256,Lymphocytic CLL,Symplur part Real Chemistry,Negative
21257,CLL,Krista Rossi,Negative
21258,three thousand one hundred and thirtyfour today Prof Seymour Roberts CLL cllsm lymphomahub lymphomaoz VicompcancerCr PeterMacCC,Haematology Peter MacCallum CC Royal Melbourne,Negative
21259,Jennifer Woyach Alliance North American Intergroup CLL,Lymphoma Hub,Negative
21260,CLL rituximab superior ibrutinib NEJMGroup OhioState,wandering md,Negative
21261,RCT Leukemia CLL Shanafelt,Mike Thompson MD PhD FASCO,Negative
21262,CLL Ibrutinib rituximab superior PFS CR Alliance North American,Haematology Reg,Negative
21263,three MURANO CLL READ,Rare Disease Report,Negative
21264,Jennifer Woyach al RCT Alliance Ibrutinib Ritux Ibrutinib CLL five hundred CIT PFS PlenarySession,Firas El Chaer MD,Negative
21265,Ibrutinib rituximab,Miguel Perales,Negative
21267,Ibrutinib rituximab,Miguel Perales,Negative
21271,Jennifer Woyach Alliance Ibrutinib Rituximab CLL,Taylor Lab UM,Negative
21272,year,Pharmacyclics AbbVie Company,Negative
21274,rituximab,Miguel Perales,Negative
21275,CAR CLL Armando van Bruggen,Oncologie,Negative
21276,FCR CLL,Joana Koury,Negative
21277,today Drs Flinn Davids CLL SLL six hundred SarahCannonDocs DanaFarber,Verastem Oncology,Postive
21278,CLL San Diego Combinations MRD LeukaemiaCareUK,Zack,Negative
21279,David Lesoway today American Society Hematology today,Pharmacyclics AbbVie Company,Negative
21280,NEJM,Jeff Sharman,Postive
21281,CLL,Patient Power,Negative
21282,CLL,Janssen Global,Negative
21283,CLL,Teresa Martin,Postive
21284,VIDEO Watch Steering Committee StefanoLuminari UNIMORE MZL CLL,Lymphoma Hub,Negative
21286,one CLL,Pharmacyclics AbbVie Company,Negative
21288,Venetoxlax Bendamustine Rituximab Obinutuzumab CLL Stephan,VJHemOnc,Negative
21289,Data Chronic Seven Years Surviv,Crwe World,Negative
21290,one thousand nine hundred year CLL Rai Rai Staging System CLL HistoryofBloodCancer,Pharmacyclics AbbVie Company,Negative
21291,DYK CLL,JanssenUS,Negative
21292,Steering Committee StefanoLuminari UNIMORE MZL Stay CLL,Lymphoma Hub,Postive
21293,CLL,Oncologie,Negative
21294,RT PhysRelations Paolo Strati MD Combination Lenalidomide Rituximab Pts,Robert Orlowski,Negative
21295,CLL Read MRD FierceBiotech,AbbVie,Negative
21296,CLL,Anna Deveau,Negative
21299,New Concurrent CARTcell CLL Jordan Gauthier,Fred Hutch,Postive
21300,Data Chronic Seven Years eighty Percent,HEDGE,Negative
21301,seven year eighty,Odi Bruckman,Negative
21302,Data Chronic Seven Years eighty Percent,RazzleTazzle,Negative
21303,Tanya Siddiqi TRANSCEND CLL four,Lymphoma Hub,Negative
21304,Love Kanti Rai,Jeff Sharman,Postive
21306,CARTcells CLL,MoJo,Postive
21307,Jordan Gauthier two week three month CLL,Lymphoma Hub,Negative
21308,CLL,Anna Deveau,Negative
21309,CLL,Anna Deveau,Negative
21310,CARTcell CLL,HemOnc Today,Negative
21311,Saar Gill PennMedicine CAR CLL,Lymphoma Hub,Negative
21312,CARTcells Ibrutinib CLL,MoJo,Postive
21314,Anthony Mato CLL RT,Lymphoma Hub,Negative
21315,two hundred,Penn Medicine News,Negative
21316,Susan CLL YouTube,Verastem Oncology,Negative
21317,Paolo Strati MD Combination Lenalidomide Rituximab Pts,MD Anderson Leukemia,Negative
21318,RT PhysRelations two twenty CLL,Robert Orlowski,Negative
21319,Brian Koffman CllSociety CLL,AbbVie,Postive
21321,Paolo Strati rituximab effective CLL,Lymphoma Hub,Postive
21322,six four,Jeff Sharman,Postive
21323,Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive CLL Blombery,Mike Thompson MD PhD FASCO,Negative
21325,Jordan Gauthier CARTcell,Fred Hutch,Negative
21326,two twenty CLL PhysRelations,MD Anderson Leukemia,Negative
21327,RT PhysRelations Rituximab Pts,Robert Orlowski,Negative
21328,Rituximab Pts twenty PhysRelations,MD Anderson Leukemia,Negative
21329,CLL,MoJo,Negative
21331,CLL,Anna Deveau,Negative
21332,CLL,Anna Deveau,Negative
21334,CLL Michael Hallek,rfcb,Postive
21335,Published Twitter CLL Overall Treatment Savings With Ibrutinib Imbruvica Despite Higher Prescription Costs CLL,Dr Timos Papagatsias,Postive
21336,CLL,Anna Deveau,Negative
21338,Today Drs DavidSteensma AML,News,Postive
21339,CLL,Anna Deveau,Negative
21340,CLL Overall Treatment Savings With Ibrutinib Imbruvica Despite Higher Prescription Costs CLL Janssen,info,Negative
21341,Catch CARTcells CellularTherapy CLL Lymphoma LeuSM LymSM,VJHemOnc,Negative
21342,YouTube SLL CLL,LymphomaAction,Postive
21343,CLL,Rima Darwiche,Negative
21344,three MURANO Trial Combination Rituximab,Seattle Banker,Negative
21345,Frontline CLL,MoJo,Negative
21346,CLL,Yuksel Urun,Negative
21347,Ami Solutions News three MURANO Trial,Laurent Francis,Negative
21349,CLL CLL,MoJo,Negative
21350,TCR Clonality CLL,MoJo,Negative
21351,CLL,Xie Ye Nei Ke Yi  Zhong Cun  Xing Si ,Negative
21352,Haroun MD SamahNd NEJM LucidQuest,Dr Timos Papagatsias,Postive
21353,one CAR NHL CLL lymsm,Lymphoma Hub,Negative
21354,CLL,Jordan Gauthier,Negative
21355,Reversion CLL,Jordan Gauthier,Negative
21356,Maria Joao Baptista TCR San Diego,Keith Hoots,Negative
21357,CLL,Danielle Ternyila,Negative
21358,CLL,Patient Empowerment Network,Negative
21359,Jennifer Woyach today CLL tomorrow Learn,The James,Negative
21360,three MURANO Trial Combination Rituximab,HEDGE,Negative
21361,Nitin Jain CLL,Lymphoma Hub,Postive
21362,three MURANO Trial Combination Ritux,Crwe World,Negative
21363,CLL anthonymatomd Keep ASH Minne,Amber Koehler,Postive
21364,John Seymour PeterMacCC MURANO CLL,Lymphoma Hub,Negative
21365,CLL,Lymphoma Hub,Negative
21366,MURANO CLL,Odi Bruckman,Negative
21367,John Seymour MURANO CLL,Jeff Szer,Negative
21368,three MURANO CLL,AbbVie,Negative
21369,three MURANO Trial Combination Rituximab CRE,CRE Demographics,Negative
21370,three MURANO Trial Combination Rituximab,RazzleTazzle,Negative
21371,John Seymour MURANO VenR Combination Therapy Chronic CLL,Jeff Szer,Negative
21372,One MURANO Prof Seymour cll lymsm amlsm cllsm bmtsm lymphomahub lymphomaoz VicompcancerCr PeterMacCC,Haematology Peter MacCallum CC Royal Melbourne,Negative
21373,Peter Hillmen UniversityLeeds CLL MRD,Lymphoma Hub,Negative
21374,DYK CLL,Janssen Global,Negative
21375,CLL rituximab Jennifer Woyach OhioState Article,MedPage Today,Postive
21376,Andy Rawstron LeedsHospitals obinutuzumab ibrutinib CLL,Lymphoma Hub,Postive
21378,CLL,MoJo,Negative
21379,cll,ISTH President,Negative
21380,Michael Hallek CLL SSBMT,SSBMT lkhlyljdh`y@,Negative
21381,CLL MRD,Amit,Negative
21383,CLLsm Lecture On Architecture Translational Research Designed Control,Mike Thompson MD PhD FASCO,Negative
21384,CLLsm Lecture On Architecture Translational Research Designed Control CLL Ven,Mike Thompson MD PhD FASCO,Negative
21385,Dr Hallek CLL today CLL,Alan Skarbnik,Postive
21386,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21387,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21388,CLLsm Lecture On Architecture Translational Research Designed Control CLL CLL IPI,Mike Thompson MD PhD FASCO,Negative
21389,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21390,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21391,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21392,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21393,CLLsm Lecture On Architecture Translational Research Designed Control CLL,Mike Thompson MD PhD FASCO,Negative
21394,Lecture CLL Micheal Hallek,Razan Mohty,Negative
21395,CLL,Lymphoma Hub,Postive
21396,milesvanderrohe godisintbedetails hamwasserman,ISTH President,Postive
21397,Michael Hallek Hall AB,Keith Hoots,Negative
21398,Con Tam zunubrutinib today amlsm cllsm bmtsm VicompcancerCr PeterMacCC,Haematology Peter MacCallum CC Royal Melbourne,Negative
21399,CLL,Patient Empowerment Network,Negative
21400,ASH AML CLL AcuteLeuk LeukaemiaCareUK,Zack,Postive
21401,CLL,Molly McElroy,Negative
21402,today two Jennifer Woyach Maria Domenica Cappellini,VJHemOnc,Postive
21403,Frontline CLL,MoJo,Negative
21404,rituximab CLL,Prof Dr Mustafa Benekli,Negative
21407,San Diego JanssenOncology,JanssenUS,Postive
21408,CLL Hear Imran Khan MD,JanssenUS,Negative
21412,morning AML CLL,Zack,Postive
21418,CLL Jennifer Brown CARTcells,SSBMT lkhlyljdh`y@,Negative
21420,Today CLL one hundred and eightyfour,Genentech,Negative
21422,Neil Kay MayoClinic CllSociety CLL PRO,chadi nabhan MD MBA FACP,Postive
21429,one thousand nine hundred year CLL Rai Rai Staging System CLL HistoryofBloodCancer,Pharmacyclics AbbVie Company,Negative
21430,Today Jen Brown CLL Center DanaFarber CLL three six hundred,Verastem Oncology,Negative
21431,CLL,MoJo,Negative
21432,CLL CLL,John Riches,Postive
21433,rituximab regard,Chirurgie Esthetique,Negative
21434,rituximab regard,Michelle Flament,Negative
21436,rituximab regard,NEJM,Negative
21439,one CLL,Wilmot Cancer Institute,Negative
21440,DYK CLL,JanssenUS,Negative
21441,Dennis,Pharmacyclics AbbVie Company,Postive
21442,Cancer,Pharmacyclics AbbVie Company,Negative
21443,year CLL,Pharmacyclics AbbVie Company,Negative
21444,one CLL,Pharmacyclics AbbVie Company,Negative
21447,rituximab,Medivizor,Negative
21449,today San Diego CLL,CLL Ireland,Postive
21450,CLL,Kathleen Hoffman,Negative
21451,Brad Kahl MD SitemanCenter CLL,OncLive SOSS,Postive
21452,Don IR one CLL Woyach Plenary,Caner Saygin MD,Negative
21453,Impressive Superior PFS CLL Intergroup Study,Raul Cordoba MD PhD,Postive
21454,Chris Fegan Cardiff CLL Lots,Leukaemia Care,Postive
21455,One CLL Chris Fegan Quality Life CLL,Zack,Postive
21456,Jennifer Woyach Sunday CLL Plenary Scientific Session,The James,Negative
21457,CLL,MoJo,Negative
21458,CLL,Lymphoma Hub,Postive
21459,FDAOncology two thousand Idelalisib Treatment Follicular Survival Are Associated Modified Charlson Score two,FDA Oncology,Negative
21460,CLL,Patient Power,Negative
21461,CLL Lymsm,Lymphoma Hub,Negative
21462,CLL,Jordan Gauthier,Negative
21463,Murine CLL First Evidence Dysfunctional Cell Responses,Jordan Gauthier,Negative
21465,twenty PhysRelations,MD Anderson Leukemia,Negative
21467,two CLL,Teresa Martin,Negative
21469,Jan Burger BTK,Expert Perspectives Oncology,Negative
21470,RT PhysRelations Obinutuzumab iFCG twenty,Robert Orlowski,Negative
21471,twenty PhysRelations,MD Anderson Leukemia,Negative
21472,CLL,Anna Deveau,Negative
21473,CLL WinshipAtEmory OSUMedCenter CLL,Andrew Schorr,Negative
21474,Duvelisib Resistant,The ASCO Post,Negative
21475,CLL View,RTI Health Solutions,Negative
21476,Brad Kahl MD SitemanCenter CLL,OncLive SOSS,Negative
21477,Patient Power CLL,Patient Power,Postive
21478,CLL,ALI ALAHMARI,Negative
21479,VIDEO CLL ASH two thousand and eighteen Peter Hillmen LeedsHospitals Ericllorg Leusm,VJHemOnc,Negative
21480,CLL SLL CLL CLL FactFriday,LymphomaAction,Negative
21481,one Find Hematology Oncology Program,Cleveland Clinic Abu Dhabi,Negative
21482,one one two CLL three,Jeff Sharman,Postive
21483,This weekend Zack ZPWLC San Diego Follow AML CLL,Leukaemia Care,Postive
21484,CLL Randomized Phase three,MoJo,Negative
21485,Lymphocyte Leukemia Background CLL fifteen Obinutuzumab,Cancer News,Negative
21486,Interesting Epigenetic Chronic,Krishna,Postive
21487,Lymphocyte Leukemia,TrialBulletin,Negative
21489,today Lee Swanson,Andrew Schorr,Negative
21490,FDA Black Box Warning MS,Johnson Becker PLLC,Negative
21491,two thousand and eighteen LMCongress Richard Furman CLL,Oncology Learning Network,Negative
21492,trouverez la SNU FO CFDT CLL de Greve Pole Emploi,SNU Pole Emploi FSU Occitanie,Negative
21493,Week November two thousand and eighteen five month ago,AJNR,Negative
21494,LLS CLL December two thousand and eighteen Pikesville MD Event,LLS National Capital,Postive
21495,CAR one,Molly McElroy,Negative
21497,Jennifer Brown Anthony Mato MD MSCE MRD CLL DrBrown DrBurger,Expert Perspectives Oncology,Negative
21498,Jordan Gauthier CARTcell,Fred Hutch,Negative
21499,Jan Burger Medicine MD Houston USA View Burger,Expert Perspectives Oncology,Negative
21501,Leukeran CLL See Chlorambucil,LGC,Postive
21502,CLL ASH two thousand and eighteen Stephan Stilgenbauer Ericllorg Leusm ClinicalTrials,VJHemOnc,Negative
21504,Instagram,Dr Timos Papagatsias,Postive
21505,Global Clinical Trials Review two thousand and eighteen million eighteen USD one hundred,CRO Contract Res,Negative
21506,Richard Furman CLL study drug,WCM Lymphoma,Negative
21507,San Diego JanssenOncology,JanssenUS,Postive
21508,kick week,Janssen Global,Negative
21509,Truxima Truxima Europe,Alaric DeArment,Negative
21510,Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive,Mahmoud Aljurf,Negative
21511,CLL webinar,Patient Power,Negative
21512,Carol Preston four CLL,Patient Power,Negative
21513,CLL,Kathleen Hoffman,Negative
21514,CLL CLL Horizons two thousand and eighteen CllIreland,Nick,Negative
21515,WednesdayWisdom CLL LymphomaMatters,LymphomaAction,Negative
21516,CLL,VJHemOnc,Negative
21517,CLL SSC NguvuMoja,Juma Malyunga Jr,Negative
21518,CLL,Blood Journal,Postive
21519,Dinner Event December two San Diego,Anna Deveau,Negative
21520,Deborah Sims CLL Australia UK,CLL Ireland,Postive
21521,two thousand GlobalData,IPIMediaworld,Negative
21522,Chronic Waldenstrom Mantle,Derek Clarke,Negative
21523,Danish,Dr Jean Pierre Laroche,Negative
21524,Del Mar Breathe two BLESSED Janie Licosati,Amy Cavers,Postive
21526,FCR CLL,Teresa Martin,Negative
21527,Anthony Mato MD CLL Program View Mato,Expert Perspectives Oncology,Negative
21530,CLL wwierda LeukemiaMDA Jennifer Brown DanaFarber,Patient Power,Negative
21532,one Health Central CLL,Andrew Schorr,Negative
21535,Walter Styer CAR Cell David Porter,Penn IFI,Negative
21536,CLL,Andrew Schorr,Postive
21538,CLL two thousand and seventeen two thousand,GlobalData Pharma,Negative
21539,The National Institute Health Care Excellence rituximab chronic,ASH Clinical News,Postive
21540,cll,Anna Deveau,Negative
21541,Jan Burger Chronic Lymphocytic Leukemia,Expert Perspectives Oncology,Negative
21543,Blwyddyn three Nadolig Fictorianaidd Pwll Mawr CLl,Melin Gruffydd,Negative
21545,CLL Ericllorg Leusm CaGenome CancerGenetics CancerResearch Epigenetics,VJHemOnc,Negative
21546,John Chris Dwyer Lisa Minkove CLL CLL,CLL Ireland,Postive
21548,CLL CARTcells,Jordan Gauthier,Negative
21549,CLL,Champions Laser League,Negative
21551,Kan de een two tegelijk echt pistool letterlijk tegen hoofd helaas maken toch de CLL ten Dus ben de vergeten wel de waarde van de,Bla Fino,Negative
21552,CLL Jeff Sharman Willamette Valley Cancer Institute Research Center,Patient Empowerment Network,Negative
21553,CLL Ericllorg Leusm Remission Immunotherapy HemOnc ImmunoOnc,VJHemOnc,Negative
21554,CLL one Fwd twelve Healthcare Marketing,WheelieDealer,Negative
21555,CLL one one UnFuckwitable,Miss Joyce,Negative
21556,CLL ASH,Lorna Warwick,Negative
21560,DrBrown DrBurger Chronic,Expert Perspectives Oncology,Postive
21561,Targeted Alpha Therapy Treatment NHL RIT,Savepig Invest GotSilver,Postive
21562,OncologyTimes,RTI Health Solutions,Negative
21563,Leukemia Sangdun Choi,ImmunoSCOPE,Negative
21564,aprendan enanos asi LuchaLibre pisoton,Lenko Sins,Negative
21565,BloodJournal,ASH,Negative
21567,CLL SLL Learn Dr George Follows Consultant Haematologist,LymphomaAction,Negative
21568,United States,CURE Magazine,Negative
21570,Robin Foa Rome Italy CLL,CLL Ireland,Negative
21571,CLL,Thiago Carvalho,Negative
21572,CLL,Anna Deveau,Negative
21574,Blood Journal CLL CLLsm,Raul Cordoba MD PhD,Negative
21575,Blood Journal CLL CLLsm,Raul Cordoba MD PhD,Negative
21576,Blood Journal CLL CLLsm,Raul Cordoba MD PhD,Negative
21577,Inactivation Antagonizes Chronic Lymphocytic Leukemia,Immune Regulation News,Negative
21578,ClinicalTrials MRD CLL Barbara Eichhorst UniCologne MRDFocus GlobOnc,VJHemOnc,Negative
21579,CancerCare Topics Covered Overview Chronic,Bag It Cancer Support,Postive
21581,CLL LucidQuest,Dr Timos Papagatsias,Postive
21582,Susan University California Irvine Health CLL OncLive,CLL Ireland,Negative
21583,CLL ScientificEducationSupport,Lymphoma Hub,Negative
21585,CLL,VJHemOnc,Negative
21586,Rainham London today LymphomaAction Hodgkin NHL CLL,Helen Jane Mee,Negative
21587,New Combinations rituximab,Medivizor,Negative
21588,three Rituximab FCR Chemoimmunotherapy,Rafael Fonseca MD,Negative
21589,CLL,Teresa Martin,Postive
21591,Anthony Mato,Expert Perspectives Oncology,Negative
21592,Haematologica,Mahmoud Aljurf,Negative
21593,Inaki Ericllorg Leusm Epigenetics Genome Genetics,VJHemOnc,Negative
21595,NHS,Shankara Paneesha,Postive
21596,CLL,Blood Journal,Negative
21597,Dft l~ YouTube l~ CLL,Reem,Negative
21598,Online Social Blog Attention Mine CLL Marketing Hosting Speaking Message,CryptoLiveLeak,Negative
21599,CLL,CLL Ireland,Postive
21600,CLL,Kathleen Hoffman,Negative
21601,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
21602,CLL Beatrice,Patient Power,Postive
21603,Nu Joki Joki Turku,Utbildning och IT pa Kimitoon,Negative
21604,Canadian,Lymphoma Papers,Negative
21605,CLL Eva Kimby KarolinskaUnsju Ericllorg Leusm,VJHemOnc,Negative
21606,LymphomaAction CLL,CLL Ireland,Postive
21607,one,Rabbits Class,Negative
21609,New Medivizor Treatment,Medivizor,Negative
21610,Impressive CLL BTK Clinical BloodJournal,Matthew Cheung,Postive
21611,CLL Blood Journal,Jitakshi,Postive
21612,VIDEO CLL Daniel Catovsky,VJHemOnc,Negative
21613,Jennifer Brown Chronic,Expert Perspectives Oncology,Negative
21614,Trump Spat,Patient Worthy,Negative
21615,Blood Journal CLL,Jaksic,Negative
21616,Blood Journal CLL,CLL,Negative
21617,CLL Watch WinshipAtEmory,Patient Power,Negative
21618,Thanksgiving CLL,CryptoLiveLeak,Postive
21619,CLL,Blood Journal,Negative
21621,VIDEO CLL Emili Montserrat Ericllorg,VJHemOnc,Negative
21622,Framtidsdalen Unga Georg Henrik Wrede cll Biocity Turku,Utbildning och IT pa Kimitoon,Negative
21623,RT Refining Wallenberg Clinical Scholar Richard Rosenquist Brandell CLL,Cancer Core Europe,Negative
21624,Wallenberg Clinical Scholar Richard Rosenquist Brandell CLL,KAW,Negative
21625,CLL FCR RCT,BloodWork,Postive
21627,VIDEO Immune CLL,VJHemOnc,Negative
21628,Scan Week Closing Low today SIT SENS CSRT SUR ALM MTPH AEG,SwingTradeBot UK,Negative
21629,CLL PatientPower,Ron Grunsby,Negative
21630,CLL first,Hugo Cabrera,Postive
21631,Big Ideas Better Health Award Team CLL,LiveYourLife,Postive
21632,UK CLL HospitalLaFe HematoLaFe GVAsanitat,Guillermo Sanz,Negative
21633,CLL,Patient Power,Postive
21634,eurekamag,EurekaMag,Negative
21636,three,Dr Timos Papagatsias,Postive
21637,VIDEO CLL Andreas Agathangelidis CERTHellas OncoPath,VJHemOnc,Negative
21639,CLL Randomized Phase three Rituximab FCR Chemoimmunotherapy,Jaksic,Negative
21641,Immune Dysfunction Infection Risk Chronic DrBurger DrBrown,Expert Perspectives Oncology,Negative
21642,Ralph Medicinal Cannabis May two thousand and seventeen,RJW,Negative
21644,Aristotle,Dr Sylvia Benjamin,Negative
21645,Cancer Research Group CLL,Mussetti,Negative
21646,CLL Ibrutinib,Lab,Negative
21647,CLL CIT FCR Plenary,Lucrecia Yanez,Postive
21648,two FCR CLL IMO DrMatasar JohnPLeonardMD,chadi nabhan MD MBA FACP,Negative
21649,Jennifer Brown Managing Bleeding Risk Patients With Chronic Lymphocytic,Expert Perspectives Oncology,Negative
21650,Myeloma CLL,Dr Timos Papagatsias,Postive
21651,CLL IR three Ibr How,Jeff Sharman,Postive
21652,three Ibrutinib Rituxumab FCR CLL Cancer Research Group CLL,Sabela Bobillo,Negative
21653,Pratice Myeloma CLL,Milton Aranha,Negative
21655,CLL FCR,Anna Deveau,Negative
21656,ASH CLL,Jeff Sharman,Negative
21657,NCCN Pharmacy Updates November Leukemia MedEd CLL,National Comprehensive Cancer Network NCCN,Negative
21658,CLL,Anna Deveau,Negative
21659,third CLL One one Duvelisib Dr FDA,Andrew Schorr,Negative
21660,CLL Robin Foa,VJHemOnc,Negative
21661,CLL Learn,RTI Health Solutions,Negative
21662,three Rituximab FCR Chemoimmunotherapy CLL,Naveen Pemmaraju MD,Negative
21663,John Byrd Chronic Lymphocytic Leukemia,ASCI,Negative
21664,three Rituximab FCR Chemoimmunotherapy,ALI ALAHMARI,Negative
21665,Darlington nine January CLL,LymphomaAction,Postive
21666,TDTCML Cancer CancerAwareness,TheDayThatChangedMyL,Negative
21667,PeterMacCC VicCompCancerCr Acquisition Recurrent Mutation Confers Resistance Venetoclax Patients Progressive Chronic,Michael Dickinson,Postive
21668,Learn TuesdayMotivation,Oncology Times,Negative
21670,three Rituximab FCR Chemoimmunotherapy,CLL,Negative
21671,three Cancer Research Group,MoJo,Negative
21672,CLL,Blood Advances,Negative
21673,CLL Dr George Follows BloodCancer,LymphomaAction,Postive
21674,CLL FCR,Amber Koehler,Postive
21675,Late Breaking Abstract Session FRC CLL seventy,Guillermo Sanz,Postive
21676,CitynIslington CLL,Finsbury Park Stroud Green Neighbourhood Forum,Postive
21677,thirty,Anna Deveau,Negative
21678,rituximab FCR CLL,Anna Deveau,Postive
21679,Yi Liao CLL PFS,QLifeProYi Liao Qing Bao ,Negative
21680,CLL SLL two BloodCancer Around ten UK CLLSupport CllIreland,LymphomaAction,Negative
21681,Nursery Rhyme two cll,Rabbits Class,Negative
21682,CLL,Kathleen Hoffman,Negative
21683,Chronic eight three week CAP CT CardsRads,Jacobo Kirsch,Negative
21684,BeiGene Initiates Global Phase three,Hematopoiesis News,Negative
21685,WTG UT System Bill McRaven two thousand and eighteen,No FBR Lists Please,Negative
21686,War Hero University Texas GOP,Mom No Longer Needs To Resist WE WON,Negative
21687,one last six year JCI,Shuai Schway Dong,Negative
21689,Trump,Artislove,Negative
21690,CLL Session Furman WeillCornell,Patient Power,Negative
21691,CLL PhoebeNeedlesCenter Phoebe Needles Christmas,Phoebe Needles,Postive
21692,two thousand and ten Taliban Afghanistan,Peacock,Negative
21693,Project Improve Communication,TrialBulletin,Negative
21694,CLL KarolinskaUnsju Ericllorg Leusm,VJHemOnc,Negative
21695,fifty MRD Allo Tcellrx,Anna Deveau,Negative
21696,William McRaven University Texas bin Laden,William Meyer,Negative
21697,CLL BCR,Anna Deveau,Negative
21698,Proximas de su campeonAbsoluto de cll one al titulo de ngen de noviembre ngen de diciembre xnl de,Lenko Sins,Negative
21699,Jennifer Woyach,ASH Clinical News,Negative
21700,Chronic Lymphocytic DrBrown DrBurger,Expert Perspectives Oncology,Negative
21701,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
21702,ARQL CLL,Anna Deveau,Negative
21703,Lymphoma CLL Patients Geroge Follows CancerTreatment,The Patient Channel,Negative
21704,Hodgkin NHL CLL,LiveYourLife,Negative
21705,Campo al haematologica CLLSM,Chan Cheah,Negative
21706,Marc Auckland Trustee CLL four year Marc Charity CLLSA CLL Champions ThankYou,CLLSA,Postive
21707,Frank Mercer CLL two thousand and fifteen Frank October two thousand and seventeen ThankYou Frank,CLLSA,Negative
21708,two thousand and,Epidemiology Live two thousand and twenty,Negative
21709,Rupert Beazley CLLSA two thousand and fifteen CLL Nephrotic Syndrome Rupert ThankYou Rupert,CLLSA,Postive
21710,John Moore October two thousand and fifteen CLL two thousand and fourteen John CLLSA ThankYou John,CLLSA,Postive
21711,David Innes Chair CLLSA David CLL May two thousand and eleven two thousand seventeen ThankYou,CLLSA,Negative
21712,CLL CLLSA UK CLL,CLLSA,Postive
21713,EU Venclyxto MabThera Leukemia CLL,Pf Magazine,Negative
21714,CLLSA CLL YouMadeItHappen ThankYou MondayMotivation,CLLSA,Postive
21715,CombinationTherapy CLL UniCologne,VJHemOnc,Negative
21716,Hillary Clinton Obama Texas bin Laden,Peacock,Postive
21718,McRaven University Texas two thousand and,Anthony Rivera,Negative
21720,CLL CLL Combinations Sequences Targeted Agents CLL Aristotle three hundred and sixty,Toby Eyre,Postive
21721,This week World Nursery Rhyme Week first Nursery Rhyme Friday five,Rabbits Class,Negative
21722,CLL,Michele,Negative
21723,tomorrow CLL Richard Furman WeillCornell,Patient Power,Negative
21726,one,CURE Magazine,Postive
21728,FDA FollicularLymphoma CLL,Targeted Oncology,Negative
21729,Florence Cymbalista,VJHemOnc,Negative
21731,VIDEO CLL Nicholas Chiorazzi FeinsteinIMR,VJHemOnc,Negative
21732,CLL one year ago SEER FAIL,Eric Whitman MD,Negative
21733,CLL Treatment Advances YouTube,SSBMT lkhlyljdh`y@,Negative
21734,EU CLL,SSBMT lkhlyljdh`y@,Negative
21735,Paolo Ghia Ericllorg Leusm CaGenome Camoldx Genetics Genomics,VJHemOnc,Negative
21736,Thanksgiving thanksgiving thankYouLORD tYL The Palms Country Club,Leiy Bustamante,Postive
21739,Salamat IMsupported thankYouLORD tYL The Palms Country Club,Leiy Bustamante,Negative
21741,John Allan CLL,WCM Lymphoma,Postive
21742,CLL,Blood Advances,Negative
21743,three CLL,Targeted Oncology,Negative
21744,CURE Media Group Host First,SPI News,Postive
21745,CURE Media Group Host First,MJH Life Sciences,Postive
21746,MRD CLL FDA Peter Hillmen MRDFocus Prognosis,VJHemOnc,Negative
21747,CLL DrBrown DrBurger,Expert Perspectives Oncology,Negative
21748,Patient Power CLL,Patient Power,Postive
21750,Canadian CLL CurrentOncology Versha Banerji,RIOH,Negative
21751,The Gigantic Turnip PowerofReading CLL ParentHub,Mrs Prince,Negative
21752,Notch,Lymphoma Papers,Negative
21753,Current Emerging Treatment Options CLL TargetedOnc,CLL Ireland,Negative
21754,CLL Genomics KarolinskaUnsju Ericllorg Leusm,VJHemOnc,Negative
21756,Marwan Ghosn,Ordre Pharmaciens LB,Negative
21757,CLL,Kathleen Hoffman,Negative
21758,November,Targeted Oncology,Negative
21759,Founder Aygun Sahin Boston Chapter National Chronic CLL,Cancer Education Research Institute,Negative
21760,ICYMI WATCH Paolo Strati ASCO two,Oncology Times,Postive
21761,John Hayslip CLL,AbbVie,Negative
21763,Imbruvica four,CURE Magazine,Negative
21764,Duvelisib Ofatumumab Monotherapy CLL Stephan Stilgenbauer ClinicalTrials,VJHemOnc,Negative
21765,one Rick Furman CLL Monday,Andrew Schorr,Postive
21766,Anthony Mato Chronic,Expert Perspectives Oncology,Postive
21767,two week CLL,chadi nabhan MD MBA FACP,Negative
21768,MRD CLL Robin Foa MRDFocus,VJHemOnc,Negative
21769,two CLL,ipharmacenter,Negative
21771,one,Dr Comeau MD,Negative
21772,CLL,chadi nabhan MD MBA FACP,Negative
21773,Xenograft first one thousand nine hundred,Altogen Labs,Negative
21774,Scan Week Closing Low today LAHL IRV VENN,SwingTradeBot UK,Negative
21776,one CLL,Invitro Diagnostics News Research,Negative
21777,CLL ScienceWeek,CLL Ireland,Negative
21778,one CLL,Jill Annable,Negative
21779,Spinal Muscular Healthcare,Wolf Inspector,Negative
21781,Spinal Muscular Healthcare,Faith Free Furry,Negative
21782,four CLL,Patient Empowerment Network,Negative
21783,VIDEO European Research Initiative,VJHemOnc,Negative
21784,six,SunAWARE,Postive
21785,six,Children Melanoma,Postive
21786,DrBrown DrBurger Initiating Novel Agents Versus Chemoimmunotherapy Setting,Expert Perspectives Oncology,Negative
21787,CLL View ISPORBarcelona,RTI Health Solutions,Negative
21788,GlaxoSmithKline Teva,ChaitanyaG,Negative
21790,CLL BTK CARTcells,VJHemOnc,Negative
21792,CLL,Anna Deveau,Negative
21793,CLL Genetics DanaFarber Jennifer Brown Register,Patient Power,Negative
21794,CLL,Anna Deveau,Negative
21795,Ibrutinib Obinutuzumab three,Cancer News,Negative
21796,Terry CLL Terry Strawn,Glen Janred,Negative
21797,Learn Jennifer Woyach CLL ASHClinicalNews,ASH,Negative
21798,Paolo Strati ASCO Award two,Oncology Times,Postive
21799,EU Venclyxto MabThera Leukemia CLL,Pf Magazine,Negative
21800,Jan Burger Chronic,Expert Perspectives Oncology,Negative
21801,Ann Hewitson Trasanidis Ann CLL,Blood Cancer UK Research,Negative
21802,afternoon Prof Tatjana Stankovic,Blood Cancer UK Research,Negative
21804,November CLL,Targeted Oncology,Negative
21805,CLL,Patient Power,Negative
21806,CLL CancerMoonshot,Pamela Schlembach MD,Negative
21807,Haematologica,Dr Comeau MD,Negative
21809,VIDEO Integrating Molecular Cellular Therapies CLL Ericllorg,VJHemOnc,Negative
21810,PhD CLL,Blood Cancer UK Research,Negative
21811,CLL,Verastem Oncology,Postive
21812,CLL CancerMoonshot,MD Anderson Cancer Center,Negative
21813,MRD MIA CLL,AbbVie,Negative
21814,Richard Furman CLL,WCM Lymphoma,Postive
21815,CLL,Kathleen Hoffman,Negative
21817,Ritux Trial MUT IGVH CLL LucidQuest,Dr Timos Papagatsias,Postive
21818,WeizmannScience,Journal Clinical Investigation,Negative
21819,BloodCancer Drop one thousand one hundred cll,Verastem Oncology,Negative
21820,twelve,Daniel Babu MD,Negative
21821,Arnon Kater CLL,touchONCOLOGY,Negative
21822,CLL Daniel Catovsky Ericllorg LEUSM,VJHemOnc,Negative
21823,one one six month one Read andrewschorr CLL second,Patient Power,Negative
21824,Jennifer Brown,Expert Perspectives Oncology,Negative
21825,AIM CLL Cello Health PLC Directorate Change,AIM Alerts,Negative
21826,Last week CLL Brazilian Sidnavigare,Marta Crespo,Postive
21828,Check Furman,Targeted Oncology,Negative
21832,HOY CLL ChileLuchaLibre Segunda Semifinal two thousand and eighteen IWC LuchaLibreChilena Pepex,The Pepex Family,Negative
21833,HOY CLL ChileLuchaLibre Segunda Semifinal two thousand and eighteen IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
21834,HOY CLL ChileLuchaLibre Segunda Semifinal two thousand and eighteen IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
21835,one Melissa On Guard Forgive,Mira Larkin,Postive
21836,Interpreting Chronic Lymphocytic DrBrown DrBurger,Expert Perspectives Oncology,Negative
21837,Twitter,Sharmaine Fuentes,Negative
21838,Download,Kyle Schmanke,Negative
21839,VIDEO CLL Blanca Espinet imimat,VJHemOnc,Negative
21840,Croatian Lacrosse League Zagreb Patriots EuropeLacrosse,Emina Science Pit,Postive
21841,ten one one,Ayesha Hawkins,Negative
21842,Download,Kyle Schmanke,Negative
21843,CLL George Calin,Francesco Bertoni,Negative
21845,Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
21846,LymphomaAction nineteen Nov Hodgkin NHL CLL Book,LiveYourLife,Postive
21847,Idelalisib Rituximab,Carlo Franzini,Negative
21848,sll,Tinu,Negative
21850,VIDEO Tailoring CLL Alessandra Tedeschi MedOnc CaxTx,VJHemOnc,Negative
21851,CLL LeukaemiaCareUK,Nick,Negative
21852,Three Two,leukemia,Negative
21853,CLL CllSociety CLLSupport,CLL Ireland,Postive
21854,Lymphoma,Tinu,Negative
21855,CLL,MD Anderson Leukemia,Negative
21856,Louise Driscoll Senior Clinical Psychologist recent evening CLL,CLL Ireland,Postive
21858,CLL Elias Campo,VJHemOnc,Negative
21859,one November two thousand and eighteen European Commission EC CLL one,Solomon Kamal,Postive
21860,CLL Beatrice,Patient Power,Postive
21862,BGNE BTKinhibitor zanubrutinib Waldenstrom CLL,JamesTLeePhD,Negative
21863,DavyChiodin CDDFworkshop MRD AML CLL,CDDF,Postive
21864,MRD CLL Daniel Catovsky Ericllorg CLLsm,VJHemOnc,Negative
21866,second MRD CLL CDDFworkshop,CDDF,Negative
21867,CLL VS,AGRESSOR,Negative
21868,CllSociety CLL next Saturday November CLL,Cancer Support Community,Negative
21869,CLL,Kathleen Hoffman,Negative
21870,past decade,Targeted Oncology,Postive
21871,CLL,CLL Ireland,Negative
21872,Telejournal Quebec de cll,Cegep de Levis,Negative
21874,CLL one Register CLL Global Research Foundation November one PM CT one hour webinar,Patient Power,Negative
21875,Royal Marsden CLL today London,Nick,Postive
21876,Myeloma two thousand and eighteen,gilbert faure,Negative
21877,Transplant CARTcells Jennifer Brown DanaFarber Ericllorg BMTSM HemOnc,VJHemOnc,Negative
21878,CLL Richard Furman,Patient Power,Negative
21879,MRD AML CLL Two day,CDDF,Postive
21880,Last meeting MRD AML CLL London UK,Anissa Brennet,Postive
21881,Joe Park SocietyofMSKCC CLL Advances Symposiumin Madrid HospitalLaFe GVAsanitat PatLacruz,Guillermo Sanz,Negative
21882,CLL Silvia Deaglio Ericllorg OncoPath ImmunoOnc,VJHemOnc,Negative
21883,London LeukaemiaCareUK CLL CLLSupport,Nick,Negative
21884,SNU CFTC Perpignan San Vicens de reunion de la greve,SNU Pole Emploi FSU Occitanie,Negative
21885,Evaluation Safety Efficacy Association Ibrutinib,CureHuntr,Negative
21886,Study Zanubrutinib,CureHuntr,Negative
21887,CLL George Canellos JohnPLeonardMD,Joshua Brody MD,Postive
21888,Myeloma two thousand and eighteen,Oncology Tube,Negative
21889,BREAKING BeiGene three,BeiGene,Negative
21892,Lymphoma,Matthews Associates,Negative
21893,first ERIC International Meeting CLL Emili Montserrat Ericllorg Leusm,VJHemOnc,Negative
21894,next Tuesday CLL Genetics one hundred and one William Wierda Jennifer Brown,Patient Power,Negative
21895,BeiGene Initiates Global Phase three,Financial Buzz,Negative
21897,BGNE Initiates Phase three,Bio,Negative
21898,BGNE Initiates Global Phase three,Odi Bruckman,Negative
21899,CLL Adrian,VJHemOnc,Negative
21901,Melanoma,Suzette Serving You,Negative
21902,Melanoma,Melanoma MRV,Negative
21903,Melanoma,Melanoma On My Mind,Negative
21904,California This year Dr Versha CLL Ryan Zarychanski two,RIOH,Negative
21905,Just twentyfour hour Yorkshire NHL CLL,Helen Jane Mee,Postive
21906,CLL MRD Alessandra Tedeschi Ericllorg DrugTherapy Leusm MedOnc,VJHemOnc,Negative
21907,Oct eleven two thousand and eighteen Rogers et al BloodJournal CLLsm,Mike Thompson MD PhD FASCO,Negative
21908,last five ten year Leusm,Targeted Oncology,Negative
21909,Venclyxto MabThera CLL Roche Abbvie,Myeloid Lymphoid disorder practice,Postive
21910,Twitter VIDEO CLL Peter Hillmen,Dr Timos Papagatsias,Postive
21911,EU Venclyxto MabThera Leukemia CLL,Pf Magazine,Negative
21912,CLL,Tinu,Negative
21913,VIDEO CLL Peter Hillmen Globonc Supponc,VJHemOnc,Negative
21916,one,Mohammad Alhomoud,Negative
21917,WilmotCancer Clive Zent CLL,Wilmot Cancer Institute,Negative
21918,Melanoma WilmotCancer,HemOnc Today,Negative
21919,Retracement Bearish today BRY FJET TCN DOTD CLL,SwingTradeBot UK,Negative
21920,ICYMI three HELIOS rituximab CLL Cancer,Home Journal,Negative
21921,Catherine Wu DanaFarber TCR System CLL LLSScholar,Leukemia Lymphoma Society Research,Negative
21922,CLL Stephan Stilgenbauer Ericllorg ImmunoOnc,VJHemOnc,Negative
21923,CLL,Dimitris Mastellos,Negative
21924,CLL Chris Jones CLL AndrewScottTV,Proactive,Negative
21925,AIM CLL Cello Health PLC Directorate Change,AIM Alerts,Negative
21926,Flinn Danilov CLL three hundred November SarahCannonDocs OHSUKnight,Verastem Oncology,Postive
21927,Alkoxy Bad CLL Brunati CLL UniPadova,SzaboLab,Negative
21928,VIDEO Microenvironmental Silvia Deaglio Ericllorg Leusm,VJHemOnc,Negative
21929,rituximab Roche dans la leucemie MURANO,oncohebdo,Negative
21930,Mutations,Juan Garcia Valero,Negative
21931,BIOEurope Derivates CLL,PROvendis GmbH,Negative
21932,CLL,Kathleen Hoffman,Negative
21934,Musicadelatarde Cll,Arturo Victoriano,Postive
21935,CLL one Read CLL,Targeted Oncology,Postive
21936,VIDEO Therapeutically TranscriptionFactors CLL Inaki Ericllorg Leusm Lymsm Epigenetics Genome Genetics Camoldx,VJHemOnc,Negative
21937,First IDIVALdecilla ICOnoticies UAHes Biodonostia UPFBarcelona CIBERONC,IDIVAL Direccion,Negative
21938,VIDEO Sequential DrugResistance CLL Stephan Stilgenbauer Ericllorg Leusm,VJHemOnc,Negative
21939,CLL,VJHemOnc,Negative
21940,CLL Nitin Jain Bill Wierda,Naveen Pemmaraju MD,Negative
21941,CLL,Silvana Novelli,Negative
21944,past decade,AJMC,Negative
21946,Roche AbbVie CLL PharmaTimes Roche,Plexus Ventures,Negative
21947,MRD MRD CLL,Pharmacyclics AbbVie Company,Negative
21948,Brazil CLL Andrew Davis,Joana Koury,Negative
21949,Venclexta Gazyva CLL two,Bionest Partners,Negative
21950,Rituximab Combo Approved CLL,CancerWallonia,Negative
21953,Roche,Connie Hampton,Negative
21954,EuropeanCommission rituximab Venclyxto CLL,MDedge Hematology Oncology,Negative
21956,Abramson Cancer Center University Pennsylvania CLL,Marty Chilberg,Negative
21957,Nov CLL Genetics CLL,Patient Power,Postive
21958,MRD AML CLL four NOVEMBER CDDFworkshop EMA,CDDF,Postive
21959,CLL,Deepakdev,Postive
21960,ICYMI Roche CLL,AbbVie,Postive
21961,UK CLL twelve month MRD PB BM Combination FLAIR first CLL,Toby Eyre,Postive
21962,Breaking News EU Venetoclax Rituximab CLL CLL Ireland EU States,CLL Ireland,Postive
21963,IBR Ritux Trial MUT IGVH CLL,Toby Eyre,Postive
21964,three CLL Guess VEN CLL,Toby Eyre,Negative
21965,three,Medklik,Negative
21966,Venetoclax first CLL HematoLaFe HospitalLaFe IISLaFe PatLacruz DrRaulCordoba,Guillermo Sanz,Negative
21967,Roche,Connie Hampton,Negative
21968,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
21969,ICYMI Duvelisib BloodJournal CLL,HemOnc Today,Negative
21970,CLL PhIII,Endpoints News,Postive
21972,Venclexta Gazyva CLL FiercePharma,Advera Health,Negative
21973,CLL Watch,Andrew Schorr,Postive
21974,Scan today UBI FRES FORT CLL HALO,SwingTradeBot UK,Negative
21975,Kahl Highlights Frontline,CancerWallonia,Negative
21976,CLL,Anna Deveau,Negative
21977,CLL John Allan four year,Joana Koury,Negative
21979,CLL,Anna Deveau,Negative
21980,three,Roche,Negative
21981,Roche Medicine Pharma Biotech,JD PUENTES,Negative
21982,Roche Roche three today,BioSpace,Negative
21983,SEER CLL,ACS Journal Cancer,Negative
21984,EMA,Medklik,Negative
21985,EMA,Roche,Negative
21987,Today,SpecialtyPTimes,Negative
21988,Roche three ROG,Medklik,Negative
21989,Roche three ROG,Roche,Negative
21990,AbbVieUS genentech,HemOnc Today,Negative
21991,CLL obinutuzumab outperformed chlorambucil obinutuzumab Genentech WeberShandwick,DDNews Online,Negative
21994,Roche,BioCalifornia,Negative
21995,eight Read,Verastem Oncology,Negative
21997,Rm Improvement Immuniz Pts Monoclonal Lymphocytosis Whitaker CLLsm IDonc,Mike Thompson MD PhD FASCO,Negative
21998,HSMN European Commission Plus Rituximab Treatment Patients Chronic,HSMN,Negative
21999,second CLL Catherine second,Patient Power,Postive
22000,Roche EU Venclyxto MabThera,PRICENTRIC,Negative
22001,Ibrutinib Gazyva Combo CLL first,CLL Ireland,Postive
22002,CLL,AbbVie,Negative
22004,CMScript Chronic CLL CLL CMScript PMBs,CMS,Negative
22005,MRD AML CLL four NOVEMBER CDDFworkshop EMA,CDDF,Postive
22006,Haematological Western Chronic,Plant Based Health Professionals UK,Negative
22007,European Commission,Seattle Banker,Negative
22009,Eight FDA last decade Read,Targeted Oncology,Postive
22010,European Commission,Crwe World,Negative
22011,Ami Solutions News,Laurent Francis,Postive
22012,European Commission,HEDGE,Negative
22013,European Commission CRE,CRE Demographics,Negative
22014,European Commission One,Today News,Negative
22015,European Commission,RazzleTazzle,Negative
22016,three,Financial Buzz,Postive
22018,Phase three Data Showed,Allen,Negative
22019,CLL year ago one PatientPower,Andrew Schorr,Postive
22020,Scan Hammer Candlestick today CLL,SwingTradeBot UK,Negative
22021,CLL,AbbVie,Negative
22022,Congratulations French Invectys seventeen million Invectys two,Novateur Ventures,Postive
22023,Previ,Crwe World,Negative
22024,three,Armando Guglielmetti,Negative
22025,three CLL,Genentech,Postive
22027,CLL,Patient Power,Negative
22028,LPL Epigenomics,Victor Lobanenkov,Negative
22029,CLL,Kathleen Hoffman,Negative
22030,CLL,Elsevier Hematology,Negative
22031,karyotype disruption,histopathology,Negative
22032,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22033,CLL,Health,Negative
22034,last decade,AJMC,Postive
22035,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
22038,one one six month one Read andrewschorr CLL second,Patient Power,Negative
22040,Sabias ERIC Iniciativa su sede esta BCN Hematocat Hematored CLL,Hematologia SantPau,Negative
22041,Watch CLL Mark CarePartner Nelia,Patient Power,Negative
22042,Mayo Clinic CLL two thousand and eighteen CLL,Amber Koehler,Negative
22043,MRD AML CLL four NOVEMBER CDDFworkshop EMA,CDDF,Postive
22044,Moffitt Ronnie,Sherry Zimmermann,Postive
22045,Chronic last week Mother Leukemia Fundraiser,Melissa Nickolson,Postive
22046,Check Comparing,Medivizor,Negative
22047,CLL November Richard Furman WeillCornell,Patient Power,Postive
22048,VIDEO Current CLL John Gribben QMULBartsTheLon,The Patient Channel,Negative
22051,CLL Great,Vincent Rajkumar,Postive
22052,IgM,Cure Cancer Now,Negative
22053,CLL CLLSupport CllIreland LornaWarwick BritSocHaem SpotLeukaemia,Nick,Postive
22054,weekend one first Moffitt Moffitt,Sherry Zimmermann,Postive
22055,fifteen Millions two two Houston USA CLL,Gilles Petitot,Negative
22056,Paolo Strati University Texas Anderson Cancer Center,Oncology Times,Negative
22060,twelve,Cancer Papers,Negative
22061,MCL Lymphoma,Targeted Oncology,Negative
22062,CLL Cancer,Jose Sandoval MD FACP,Postive
22066,CLL,Kathleen Hoffman,Negative
22067,Melanoma Leukemia,South Shore Skin CTR,Negative
22071,cll sll,Tinu,Negative
22072,five year old one Battle Bloodstream,Jason Ferber,Negative
22073,Prof Patrick Thornton CLL,CLL Ireland,Postive
22077,Ericllorg PatientCare Stay Biomarkers Immunogenetics CLLsm CLL,VJHemOnc,Negative
22079,Blanca Espinet Florence Cymbalista HopitalAvicenne Alessandra Tedeschi Ericllorg Emili Montserrat CLL,VJHemOnc,Negative
22080,CLL HematologyNews Paul Barr ROC,Wilmot Cancer Institute,Negative
22081,Kahl Highlights Frontline,CancerWallonia,Negative
22082,CLL,CancerWallonia,Negative
22083,Venetoclax Venclexta,Random PubMed,Negative
22084,EU CLL,eightyfour,Postive
22085,tonight Tait Shanafelt MayoClinic two thousand Monoclonal Lymphocytes,Cancer Research Group,Postive
22086,InformedConsent CLL,Natacha Bolanos,Negative
22087,Associacao Portuguesa de Leucemias CLL Lisbon,Natacha Bolanos,Negative
22088,CLL,Anna Deveau,Negative
22089,Abbvie Venclyxto AbbVie pharma NICEcomms,Pharmafocus,Negative
22090,EU UK Brexit Physicians CLL neoplasia deserve HospitalLaFe HematoLaFe,Guillermo Sanz,Negative
22091,CLL November thirteen one hundred and one CLL,Patient Power,Postive
22092,Ericllorg Paola Ghia first ERIC CLL,VJHemOnc,Postive
22093,two CLL Adrian John Seymour Peter Hillmen LeedsHospitals Kostas Stamatopoulos CERTHellas Ericllorg,VJHemOnc,Negative
22094,CLL Barcelona Jikta Malcikova MasarykUni Jennifer Brown DanaFarber,VJHemOnc,Negative
22095,Yesterday CLLTreatment MonoclonalAntibodies CLLsm,VJHemOnc,Negative
22096,CLL,Anna Deveau,Negative
22097,CLL second,Patient Power,Negative
22098,Abbvie Venclyxto AbbVie pharma NICEcomms,Pharmafocus,Negative
22099,CLL Jacqueline Barrientos,The Patient Channel,Postive
22100,CLL Barcelona first ERIC Great,Marta Crespo,Postive
22101,ETHealthworld MedGenome,Girl,Negative
22102,ETHealthworld MedGenome,ETHealthWorld,Negative
22103,yesterday Ericllorg Nicholas Chiorazzi NorthwellHealth Elias Campo Inaki UniBarcelona CLL,VJHemOnc,Negative
22105,News MedGenome,MedGenome,Negative
22107,Study Evaluate Ibrutinib Retention,TrialBulletin,Negative
22109,Study Evaluate Ibrutinib Retention,CureHuntr,Negative
22110,CLL Brian Hill,COPD News,Negative
22111,CLL CLLsm,Raul Cordoba MD PhD,Negative
22112,SEER,ACS Journal Cancer,Negative
22113,Haematologica Mutations,IUOPA,Negative
22114,CLL,CancerTherapyAdvisor,Negative
22115,Barcelona Ericllorg CLL,Richard Kiss MD PhD,Postive
22116,CLL Jeff Sharman Willamette Valley Cancer Institute Research Center,Patient Empowerment Network,Negative
22117,last month CLL November WeillCornell,Patient Power,Postive
22118,Flu CLL,CLL Ireland,Negative
22120,CLL Daniel Catovsky Kanti Rai NorthwellHealth Ericllorg,VJHemOnc,Negative
22121,MCL,Targeted Oncology,Negative
22123,MRD AML CLL AML CLL,CDDF,Postive
22125,ERCSyG dotada amb milions Mes,Centre Genomic Regulation CRG,Negative
22126,eleven Myeloma FollicularNHL CLL QOL,BloodWork,Negative
22127,CLL,Kathleen Hoffman,Negative
22128,one,Anna Deveau,Negative
22130,Waldenstrom Macroglobulinemia Lymphocytic two Learn,Pharmacyclics AbbVie Company,Negative
22132,one one CLLRooted CLL,Higher Ground Lake Louise,Negative
22133,Chronic Lymphocytic Leukemia five Read,SunAWARE,Negative
22134,Chronic Lymphocytic Leukemia five Read,Children Melanoma,Negative
22136,first two thousand and ten,AJMC,Negative
22137,first CLL Patient Cafe five,Patient Power,Negative
22138,Pulmonary,Cardio Medicine,Negative
22139,BeiGene Announces Acceptance New Drug Application China Pivotal,Crwe World,Negative
22140,BGNE Announces NDA China Pivotal CLL Small Lymphocytic,Bio,Negative
22141,BGNE Acceptance NDA China Pivotal CLL,Odi Bruckman,Negative
22142,Lymphoma CLL George Follows Leusm NovelTherapy CTSM,The Patient Channel,Negative
22146,CRGenomica Synergy,Biocat,Postive
22149,Peter Mac Prof John Seymour Prof Andrew Roberts two thousand and Victoria Prize Life Sciences CLL,Peter Mac Cancer Centre,Postive
22152,four four Canada Regional Combines two thousand and nineteen Friday CLL,Canadian Lacrosse League,Negative
22153,ICYMI duvelisib adult Copiktra VerastemOncolog CLL,HemOnc Today,Postive
22155,Antineutrophil,Nephrology India,Negative
22156,IvoGut CRGenomica EliasCampo InakiMartinSubero Synergy Grant Congrats BCLLatlas,Parc Cientific de Barcelona,Postive
22158,ERC Proud EU Human SingleCell Atlas CLL Inaki Elias Campo,Holger Heyn,Postive
22159,Combination Trials Signal Next Wave Treatment CLL OncLive CLL US Irish,CLL Ireland,Negative
22161,CRG ERC Synergy BCLLatlas,Centre Genomic Regulation CRG,Postive
22162,five hundred CLL today CLL October two thousand and eighteen Crypto,Kanga Exchange,Postive
22163,Leukemia Roman,FriendsShow,Postive
22165,John Burke MD CLL,CCO Oncology,Negative
22166,SEER,ACS Journal Cancer,Negative
22167,Connie Robinson two thousand and nine Mayo Clinic Arizona CLL,Mayo Clinic Cancer Center,Negative
22169,CLL,VJHemOnc,Postive
22170,CLL Registration November CLL William Wierda Jennifer Brown,Patient Power,Negative
22171,New Medivizor Comparing,Medivizor,Negative
22172,BlodcancerDk,LyLe Foreningen,Postive
22173,CLL Watch CLL Sue second,Patient Power,Postive
22174,SEER,Cancer Papers,Negative
22175,Learn Nirali Shah,National Cancer Institute,Negative
22177,Download Resource Center MedEd,Oncology Times,Negative
22178,CLL HematoLaFe IISLaFe GVAsanitat,Guillermo Sanz,Negative
22180,BCell two thousand and eighteen fourteen million eighteen USD BCell Pharmaceutical Healthcare,COPD News,Negative
22181,CLL,Kathleen Hoffman,Negative
22182,one today David four four This Monday,Don Corbett,Negative
22184,Louise CLL last night,CLL Ireland,Postive
22185,Ericllorg CLL,VJHemOnc,Negative
22186,three HELIOS hematologia HUInfantaElena,Adriana Pascual,Negative
22187,two hundred MRD AML CLL Munich,CDDF,Postive
22188,WCMCLymphoma Andrew Lipsky,SeqComplete,Negative
22190,twenty DanaFarber UnMaskCancer CLL,Michele,Negative
22191,Mosaad Zaki Mohamed Zahran Metwaly Hafez Hussein Elaiw Mohammed,NK paper,Negative
22193,one LymphomaAction UK FREE NHL CLL,Helen Jane Mee,Postive
22194,Watch CLL Mark CarePartner Nelia,Patient Power,Negative
22195,Great Day three CLL one thousand one hundred Clinicaltrial WCMCLymphoma LMCongress,Jill Kleczko MPA CCRP,Postive
22196,CLL Richard Furman,WCM Lymphoma,Negative
22197,Andrew Lipsky CLL LMCongress WeillCornell,Jorge Monge MD,Postive
22198,weillcornell nyphospital hematology Andrew Lipsky,WCM Lymphoma,Negative
22199,Quality,Lymphoma Coalition,Negative
22200,CLL,Boston,Negative
22201,two week LiveBroadcast Flinn SarahCannonDocs OHSUKnight,Verastem Oncology,Negative
22202,MRD CLL Trials,chadi nabhan MD MBA FACP,Postive
22203,Tumor Microenvironment,Philip McCarthy,Negative
22204,Gordon two thousand and eighteen Cancer Wiley Online,Philip McCarthy,Negative
22206,two thousand and eighteen Blood Cancer Journal,Dr Comeau MD,Negative
22207,New Comparing,Medivizor,Negative
22209,FDA Imbruvica Gazyva Chronic CLL,Robinson Ortiz MD,Negative
22210,two thousand and seven Eagle Pharmaceuticals,Crain New York,Negative
22211,first,ASH Clinical News,Negative
22212,Drug Duo Granted Priority,CURE Magazine,Negative
22213,fifty Bearish List today STVG SBTX HSTN,SwingTradeBot UK,Negative
22214,ICYMI Yesterday FDA Chronic CLL,Pharmacyclics AbbVie Company,Postive
22215,Nicole Lamanna MD CLL,CCO Oncology,Postive
22216,VIDEO Medication CLL Barbara Eichhorst UniCologne HemeOnc CaxTx,VJHemOnc,Postive
22217,Imbruvica obinutuzumab Gazyva,MDedge Hematology Oncology,Negative
22218,CLL MedGenome India,CLL Ireland,Negative
22219,Gribben EHA CLL Tallinn,European Hematology Association,Negative
22220,La FDA prioritaire la obinutuzumab Roche,oncohebdo,Negative
22221,CLL Leukaemia LeukaemiaCareUK CLLSupport CllIreland SpotLeukaemia BritSocHaem,Nick,Postive
22222,CLL,Kathleen Hoffman,Negative
22223,Update FDA Priority,Targeted Oncology,Negative
22224,two thousand and eighteen Parikh SA two thousand and eighteen ten,Jose Queizan,Negative
22226,second CLL Catherine second,Patient Power,Postive
22227,FDA Imbruvica obinutuzumab Gazyva,MAISA,Negative
22228,CLL SLL NYSE ABBV FDA Priority Review sNDA Imbruvica Gazyva obinutuzumab,cafepharma,Postive
22232,CLL CLL,Patient Power,Postive
22233,Ericllorg CLL MRD CTSM Leusm CLLsm HemOnc,VJHemOnc,Postive
22234,HSMN Combination Obinutuzumab GAZYVA Previously CLL,HSMN,Negative
22235,Accepted Priority Review FDA Combination,Odi Bruckman,Negative
22236,FDA Chronic,Pharmacyclics AbbVie Company,Postive
22241,Ofatumumab,Lymphoma Papers,Negative
22243,four myeloid Acute myeloid AML Chronic,The Moore Foundation,Postive
22245,Love Tanner Love last month CLL,Sue Ettinger DVM,Postive
22246,Join VerastemOncolog Flinn Danilov Register CLL,Verastem Oncology,Postive
22247,today Jen Woyach CLL Center Ohio James Cancer,Matthew Davids MD MMSc,Negative
22248,Bcell,Elies Campo,Negative
22249,CLL BloodJournal first update decade,BloodWork,Negative
22252,Ja trafilem los nazwa CLL zdarzyc ze ja kiedys BialejSuce lewa czy prawa,Jacek Kalinowski,Negative
22255,CLL,chadi nabhan MD MBA FACP,Negative
22257,CLL,Andrew Schorr,Negative
22258,Richard Furman one CLL Join Furman CLL Register one,Andrew Schorr,Negative
22259,NewMonographMonday Copiktra two three,epocrates,Negative
22260,CLL,elizabeth,Negative
22261,Chronic CLL,Chantel Martiromo,Negative
22262,CLLsm,Anna Deveau,Negative
22263,CLL Seminar Seminar Renee Beekman seventeen Barcelona,BioCores,Negative
22264,Pilot Study,Carlos Chiattone,Negative
22265,The Light Chain Defines New Poor Prognostic Subgroup Chronic,Jerry Lee,Negative
22267,CLL,CLL Ireland,Postive
22268,New Chlorambucil,Medivizor,Negative
22269,CLL first,Raul Cordoba MD PhD,Negative
22270,CLL CLLsm,Raul Cordoba MD PhD,Negative
22271,Leukemia CLL CLLsm,Raul Cordoba MD PhD,Negative
22272,three HELIOS Leukemia CLL CLLsm,Raul Cordoba MD PhD,Negative
22274,CLL CLL CLLsm,Raul Cordoba MD PhD,Negative
22275,CLL,Kathleen Hoffman,Negative
22277,Interesantisimo CLL,Hematologia SantPau,Negative
22278,TX CLL AnneMarie BloodCancerIRL,CLL Ireland,Postive
22279,CLL CLLsm,Raul Cordoba MD PhD,Negative
22280,CLL EHASWGaging CLLsm,Raul Cordoba MD PhD,Negative
22281,Combination Trials Signal Next Wave Treatment CLL,CancerWallonia,Negative
22282,Novel Agents Approaches Continue Advance Through,CancerWallonia,Negative
22284,BM Hematopoietic Dysfunction MayoClinic,Hematopoiesis News,Negative
22285,three CLL,CLL Ireland,Postive
22286,two thousand and eighteen Sameer two thousand and eighteen October three eight,Jose Queizan,Negative
22287,Kanga Exchange Trading Competition CLL Exchange,Kanga Exchange,Postive
22288,three Duvelisib,Hematopoiesis News,Negative
22289,CLL CLL CLL,CryptoLiveLeak,Negative
22290,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22291,Canada CLL,Teresa Martin,Negative
22292,CLL CLL Harry Potter,RIOH,Negative
22294,October HealthLiteracyMonth CLL Learn CLL,Patient Empowerment Network,Negative
22295,CLL second,Patient Power,Negative
22297,CLL DanaFarber,Blood Journal,Negative
22300,Xun Wu AdminImmuUMB Manitoba CLL,RIOH,Negative
22301,last month CLL November WeillCornell,Patient Power,Postive
22302,twentytwo year ago CLL Please,Andrew Schorr,Negative
22304,CLL,Blood Journal,Negative
22305,CLL CLL,Kanga Exchange,Postive
22308,HemOnc Times,Oncology Times,Negative
22309,FDA Copiktra,AllMedx Oncology,Negative
22313,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22315,CLL Cello Health ten CLL AndrewScottTV,Proactive,Negative
22316,Ibrutinib Obinutuzumab three,Cancer News,Negative
22317,National Comprehensive Cancer Network Verastem Oncology Clinical Practice Guidelines Oncology Chronic NCCN NCCNnews,Verastem Oncology,Negative
22318,three September,CatrionaMDowling PhD,Postive
22319,Distinct Activities,Monterey Holistic,Negative
22321,first CLL Patient Cafe five,Patient Power,Negative
22322,Eight FDA last decade CLL,Targeted Oncology,Postive
22323,FDA Celltrion Rituxan FDA Roche Rituxan second CLL RA,Bionest Partners,Postive
22324,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
22326,DanaFarber,JCI insight,Negative
22327,first ninety minute CLL Atlanta Learn,Patient Power,Negative
22328,Cancer Institute Boston,Betsy Mullen,Negative
22330,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22331,CLL ITP,MDedge Hematology Oncology,Negative
22332,Duvelisib SLL,MDedge Hematology Oncology,Postive
22333,Congress European Hematology Association,Cancer Papers,Negative
22334,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22335,CLL,Kathleen Hoffman,Negative
22336,one yesterday,Lauren Nguyen,Postive
22337,two thousand and eighteen Blood Cancer Journal,Mahmoud Aljurf,Negative
22338,Rare Instance Simultaneous Infection Disseminated Nocardia Leukemia Dotson,Cureus,Negative
22339,Angela Brooks,Thomas Roy Webb,Negative
22340,TipTuesday Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
22341,Shadman Hear CLL,Targeted Oncology,Negative
22342,Jeff Sharman USOnetwork,Andrew Schorr,Negative
22343,National Comprehensive Cancer Capsules Clinical Practice Guidelines Oncology Chronic,The Pharmaceutical Marketing Group,Negative
22344,Memorial Sloan,Zusia Dr Jackie Volk,Negative
22345,CLL Michael Keating Alessandra Ferrajoli,Patient Power,Negative
22346,Token cll Exchange,Kanga Exchange,Postive
22347,two three US,Prophetess Deborah Allen,Postive
22348,National Comprehensive Cancer Capsules Clinical Practice Guidelines Oncology Chronic,Latest News Business Wire,Negative
22349,Pilot Study Paris France,World Neonatology Congress,Negative
22350,Emma Kennedy Catovsky annual UK CLL Forum Friday September,BSMS,Postive
22351,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22352,Penn Hall school Young wolverhampton,Wolverhampton LTT,Postive
22353,tomorrow CancerMoonshot,MD Anderson Cancer Center,Negative
22354,CLL UTC,The Lion Shed,Negative
22355,GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine Show,Robin Daly,Negative
22356,John Allan CLL NCCNnews,WCM Lymphoma,Postive
22357,fifty,SwingTradeBot UK,Negative
22358,CLL SLL,Jose Sandoval MD FACP,Postive
22362,Lymphoma HCL,Matthews Associates,Negative
22363,FDA Copiktra Refractory SLL two Cancer,Lampe Company,Negative
22364,CLL CLL KangaExchange,CryptoLiveLeak,Negative
22365,CLL,Future Science OA,Negative
22367,CLL Watch Nicole Lamanna ColumbiaMed Alessandra Ferrajoli,Patient Power,Negative
22369,Mark Silverstein CLL two thousand and ten,Patient Power,Negative
22370,Check CllIreland Oct Mullingar Park Hotel CLL,BCNI,Postive
22371,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22373,ICYMI Cyclacel Pharmaceuticals CLL AML,MD Anderson Cancer Center,Postive
22375,John Terry Villa CLL,The Lion Shed,Negative
22377,ATM,Ataxia Telangiectasia Info,Negative
22378,one Legend CLL UTC,The Lion Shed,Negative
22379,Guest GlennSabin one ExceptionalResponder twentyfive year CLL IntegrativeMedicine,UK Health,Negative
22380,CLL,Targeted Oncology,Negative
22382,This weekend Last year CLL Thanksgiving,Krystal,Postive
22383,Slawek Zawdzki Lukas Minkiewicz Boston Made KangaExchange CLL Kanga,Kanga Exchange,Negative
22384,Manso BA Zhang Mikkelson MG Gwin KA Secreto Ding Parikh SA Kay NE Medina,NK paper,Negative
22385,Leukemia DUO IRC PFS,Marek Trneny,Postive
22386,CLL,Kathleen Hoffman,Negative
22387,cll,Brian Chutskoff CD MD FRCSC ret,Negative
22388,Check Chlorambucil,Medivizor,Negative
22389,Dominic LeBlanc,Brad Perry,Postive
22390,Dominic LeBlanc,The Wave News,Postive
22391,Dominic LeBlanc,CHSJ News,Postive
22392,CLL,CancerWallonia,Negative
22394,New Medivizor Lenalidomide Leukemia,Medivizor,Negative
22395,FDA Duvelisib COPIKTRA CLL SLL ECM,Medical Evidence,Negative
22396,KangaExchange CLL,CryptoLiveLeak,Negative
22398,Nobel Prize Jim Allison CLL,CLL Ireland,Postive
22399,FDA Duvelisib COPIKTRA CLL SLL ECM,Professione Farmacia,Negative
22401,CML CLL LeukaemiaCareUK,Charlotte Martin,Postive
22402,five two,Toby Eyre,Postive
22403,CLL CLLsm,Raul Cordoba MD PhD,Negative
22404,Control Chronic Lymphocytic,Human Immunology News,Negative
22405,Venetoclx Genentech,Lambda Kappa Sigma,Negative
22406,VIDEO MRD CLL NitinJainMDfrom MRD Mutations Chemotherapy Immunotherapy,VJHemOnc,Negative
22407,ARTICLE The Impact Diet CLL Glenn Sabin Glenn CLL,Shouting people underpants,Postive
22408,CLL SLL,Patient Worthy,Negative
22409,Tettenhall Wood Special School Working CLL Wolverhampton,Wolverhampton LTT,Postive
22410,CLL Watch CLL Sue second,Patient Power,Postive
22413,Status CARTcell CLL,MDedge Hematology Oncology,Negative
22416,Algorithm CLL two thousand and eighteen Dubrovnik,MDedge Hematology Oncology,Negative
22418,CLL,SSBMT lkhlyljdh`y@,Negative
22420,Becomes Small Lymphocytic Leukemia TwitterHomework,Brandon Zelman DO,Negative
22421,CLL CLL,Hellen Greenblatt,Negative
22423,today Dr Dean hyper,donnashort,Negative
22425,CLL two IgVH Gogo Slow,donnashort,Negative
22426,CLL,OncLive SOSS,Negative
22427,PennCancer Hematological Malignancies Updates Philadelphia,Total Health Conferencing,Negative
22428,Mentalhealth,Marilyn Heine,Negative
22429,Duvelisib BloodJournal CLL,HemOnc Today,Negative
22430,ksticcoMD Pathology CLL,Stony Brook Pathology,Negative
22432,CLL,VJHemOnc,Negative
22433,al Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Chan Cheah,Postive
22434,Last week UK CLL Forum Clinical Sciences Day London CLL SLL every day Doreen LymphomaStory,LymphomaAction,Postive
22435,Cyclacel Pharmaceuticals CLL AML,MD Anderson Cancer Center,Postive
22436,Michael Keating CLL,Patient Power,Postive
22437,kdjhaveri CLL Kidney CKJsocial,HofNorthwell Kidney,Negative
22438,Check Comparing,Medivizor,Negative
22439,CLL,Home Journal,Negative
22440,CLL CLL,Patient Power,Postive
22441,CONQUER Magazine,Heather Swift Morrison,Negative
22443,CLL CA Main,NursingToRemember,Negative
22444,three LyLe Nyt kan Kommenter kan ho lyle kun thirtysix kr porto,LyLe Foreningen,Postive
22445,two CLL,TF binding paper,Negative
22446,Paul Keane CLL CllIreland,CLL Ireland,Postive
22447,CLL Treatment Outcomes Oncology World Hematology two thousand and eighteen,Vijaya,Negative
22448,CLL,Kathleen Hoffman,Negative
22449,ScienceDirect,Anthony Mato,Negative
22450,CLL,Home Journal,Negative
22451,GC Identification Distinct Unmutated,ImmuneGCPapers,Negative
22454,Boston two thousand and eighteen FreeCrypto Attention CLL CLL Token,CryptoLiveLeak,Negative
22455,Smart Importers CustomsClearingProcess CLL Partner Professionalism Transparency,Concessionary,Postive
22456,Ibarz CLL CLL,Targeted Oncology,Postive
22457,transcript,Naqvi,Negative
22458,CLL first CLLsm,Raul Cordoba MD PhD,Negative
22459,Targeted Alpha Therapy Treatment NHL,Savepig Invest GotSilver,Negative
22460,one two hit month,Elaine Schattner,Postive
22461,New Lenalidomide,Medivizor,Negative
22462,Nick York SpotLeukaemia,The Patient Channel,Negative
22463,Knackered Tcells CLL CLL,Prof John,Negative
22464,Skargardshavets Lokala ska nytta av att kanna biosfaromradet ArchipelagoBios,Abo Akademi University,Negative
22465,FDA Duvelisib COPIKTRA CLL SLL ECM,Professione Farmacia,Negative
22466,FDA Duvelisib COPIKTRA CLL SLL ECM,Medical Evidence,Negative
22467,AIM CLL Cello Health PLC Appointment,AIM Alerts,Negative
22468,New Medivizor Sequential,Medivizor,Negative
22469,Novartis Pharmaceuticals Gleevec,Drug Store News,Negative
22472,rituximab You Canada CANADA,Anna Deveau,Postive
22473,September FDA CLL SLL,Univadis,Negative
22474,CLL,Kenneth Garofalo,Postive
22475,INFI twentytwo million Verastem US Food Drug Administration,MAISA,Negative
22476,two thousand,Coherent one,Postive
22477,CLL Lavender House New York Great,Randall Weis,Postive
22478,Media Group Chuck Pagano Guest two thousand and eighteen Lymphocytic,Women Health News,Postive
22479,Media Group Chuck Pagano Guest two thousand and eighteen Lymphocytic,SPI News,Postive
22481,CLL LymphomaCanada BloodCancerMonth RocheCanada,Sandy Spiro,Negative
22482,CLL Michael Keating,Patient Power,Negative
22483,Hampshire Thursday LymphomaAction Cosham Hodgkin NHL CLL portsmouthCCG,Helen Jane Mee,Postive
22484,TasukuHonzo NSCLC CLL RCC,Ardalan Ahmad,Negative
22485,FDA Duvelisib COPIKTRA CLL SLL ECM,dario pasqualini,Negative
22486,October September CLL,CLLSA,Negative
22487,John Terry Chelsea UTC CLL,The Lion Shed,Negative
22488,New Venetoclax,Medivizor,Negative
22489,vi taler BloodCancerAwarenessMonth Folg CML CLL,LyLe Foreningen,Negative
22490,Sunday one Click,Toretha Wright,Postive
22491,CLL LymphomaCanada BloodCancerMonth RocheCanada,marc osborne,Negative
22494,CLL BloodJournal CLL,CLL Ireland,Negative
22495,CLL,Anna Deveau,Negative
22496,CLL BCR,Xuan Shirley Li,Negative
22497,Temadag BLOX CLL Folg BloodCancerAwarenessMonth,LyLe Foreningen,Negative
22499,cll Dr Martin SanFrancisco Tx,donnashort,Postive
22500,FDA Duvelisib CLL Follicular Lymphoma,CancerWallonia,Negative
22501,University Barbara Andersen first,Arts Sciences,Negative
22502,CLL Leukemia HemeOnc,VJHemOnc,Negative
22503,CLL,Kathleen Hoffman,Negative
22504,Lisa Chen al doi one,Nimish shah,Negative
22505,New Sequential,Medivizor,Negative
22506,fifty today,SwingTradeBot UK,Postive
22507,CLL CLL,Andrew Schorr,Postive
22508,CLL LymphomaCanada BloodCancerMonth,Roche Canada,Negative
22509,CLL Watch Nicole Lamanna ColumbiaMed Alessandra Ferrajoli,Patient Power,Negative
22510,ten year CLL,ron white,Negative
22511,seven Imbruvica,Stephen Brown,Negative
22513,HamHealthSci CLL,Chris Hillis,Negative
22515,Rezvani CLL,Blood Cancer UK Research,Postive
22516,Rezvani MD Anderson CLL,Blood Cancer UK Research,Negative
22517,CLL,Blood Cancer UK Research,Negative
22518,CLL CLARITY,Blood Cancer UK Research,Postive
22519,CLL Next CancerResearch,Wilmot Cancer Institute,Negative
22520,CLL UK CLL Forum Numbers SCT LeukaemiaCareUK SpotLeukaemia,Nick,Negative
22521,CLL PcpaActifs SolidLaique TUNISIE BIZERTE,Ahlem Bousserwel,Negative
22522,CLL Prof Francis Bosch Barcelona UK CLL Forum LeukaemiaCareUK SpotLeukaemia,Nick,Negative
22523,Francesc Bosch Richters Syndrome Adequate,Blood Cancer UK Research,Negative
22524,Francesc Bosch seventy Richters CLL Myc CLL RichtersSyndrome,Blood Cancer UK Research,Negative
22525,Richters,Blood Cancer UK Research,Negative
22526,Prof Fox CLARITY,Blood Cancer UK Research,Postive
22527,UK cll,Blood Cancer UK Research,Postive
22528,UK Venetoclax,Blood Cancer UK Research,Negative
22529,Chris Fox idelasib CLL,Blood Cancer UK Research,Negative
22530,UK CLL Forum Donna Munro CLL Prof Anna Schuh CLL SpotLeukaemia,Nick,Postive
22531,CLL TheBloodMD,chadi nabhan MD MBA FACP,Negative
22532,CLL,Blood Cancer UK Research,Postive
22533,CLL,Dr Anya Hotinski,Negative
22534,CAR CLL World Hematology two thousand and eighteen,Vijaya,Negative
22535,New Medivizor Chlorambucil Leukemia,Medivizor,Negative
22536,Rezvani CLL,Targeted Oncology,Negative
22538,Physicians Earn CPD CLL John Seymour PeterMacCC Peter Hillmen,Medscape Education,Negative
22539,DYK FightBloodCancer,Pharmacyclics AbbVie Company,Negative
22540,WVCancer Session CLL,Patient Power,Negative
22541,Kindergarten CLL,Early Years LSC FE VocEd EYFS,Postive
22542,CLL SLL FL,US Bioservices,Negative
22543,Matthew Davids Jennifer Woyach,ASH Clinical News,Negative
22544,ChronicLymphoblasticLeukemia CLL Hudson CLL UTAustin Patient,The Patient Channel,Negative
22545,today CLL three pm ET TheUSONetwork WVCancer,Patient Empowerment Network,Postive
22546,VIDEO Identifying CLL Anna Schuh UniofOxford,VJHemOnc,Negative
22547,FDA,GoFIR,Postive
22548,today AbbVie Receives Approval Health Canada,HRI Portal,Negative
22549,today Receives Approval Health Canada The Combination Rituximab Treatment Patients Chronic,HRI Portal,Negative
22550,ICYMI CLL SLL,Rare Disease Report,Postive
22551,William Wierda CLL,CLL Ireland,Postive
22552,Mark Silverstein CLL two thousand and today,Patient Power,Negative
22553,Chronic CLL CLL Support Association Lots,Shouting people underpants,Postive
22556,Prof Robin Foa CLL KFSHRC Riyadh,Saudi Leukemia Net,Negative
22557,Prof Robin Foa CLL KFSHRC Riyadh,Saudi Leukemia Net,Negative
22558,Saturday CLL Atlanta,Patient Power,Negative
22559,spring CLL PatientPower LLSusa,Michele,Negative
22560,September two thousand and three Edward Said sixtyseven year age New York City,Sean Breathnach,Negative
22561,duvelisib COPIKTRA Verastem CLL SLL,MedChem ONCo,Negative
22562,tomorrow CLL earlier week,Patient Empowerment Network,Postive
22563,Verastem KI Piyush Gupta Eric Lander Robert first FDA VerastemOncolog,Koch Institute MIT,Negative
22564,CLL Michael Keating Alessandra Ferrajoli,Patient Power,Negative
22565,Don CLL Join tomorrow,Patient Empowerment Network,Postive
22567,CLL past Saturday Jeff Sharman Please,Andrew Schorr,Postive
22569,US Verastem PharmaTimes CLL SLL FollicularLymphoma,Plexus Ventures,Negative
22570,CLL PatientPower tomorrow,Lab Tests Online,Negative
22571,CLL,Kathleen Hoffman,Negative
22572,TOMORROW Sept twelve pm Live CLL Session TheUSONetwork WVCancer twelve pm Register Qs,Patient Power,Negative
22573,Marc CLL Marc SpotLeukaemia,Leukaemia Care,Postive
22574,autoimmune hemolytic WAIHA CLL,Anna Deveau,Negative
22576,Health Canada Notice Compliance,Ro Patel,Negative
22577,FDA duvelisib Copiktra CancerDrugs CLL,CellworksLife,Negative
22578,ICYMI Comorbidities Max Gordon OHSUKnight CLL Imbruvica,HemOnc Today,Negative
22580,MedicalAffairs FDA CLL SLL,Melody Davis,Negative
22581,FDA Verastem Copiktra two,PharmacyChecker,Postive
22582,FDA Copiktra duvelisib CLL SLL FL,Bichoy Gabra,Negative
22583,Copiktra,MPR,Negative
22584,Affiliate Program Open CLL CLL Getpaidtopost Blockchain,CryptoLiveLeak,Negative
22586,FDA Copiktra duvelisib Capsules Chronic Lymphocytic Lymphocytic Lymphoma Follicular,Advera Health,Negative
22587,Copiktra CLL SLL two,CancerCare,Negative
22588,FL CLL SLL duvelisib dualinhibitor CLL SLL,Neil Sankar MPH,Postive
22589,duvelisib COPIKTRA CLL SLL FL,Lymphoma Research Foundation,Negative
22590,The European Medicines Agency Committee Medicinal Products Human Use CLL,Targeted Oncology,Postive
22591,Food Drug Administration FDA Duvelisib COPIKTRA Verastem CLL SLL two,Joyjeet Paul,Postive
22592,VerastemOncolog CLL SLL two,Rare Disease Report,Negative
22594,CLL Carol Preston five CLL,Patient Empowerment Network,Negative
22595,FDA,INDLUB UK LTD,Negative
22596,CLL Leukemia ImmunoOnc,VJHemOnc,Postive
22597,duvelisib adult Copiktra VerastemOncolog CLL,HemOnc Today,Postive
22598,TG Therapeutics FDA three,cafepharma,Negative
22599,duvelisib COPIKTRA Verastem CLL SLL,Renovatio Biomedica,Negative
22600,duvelisib COPIKTRA Verastem CLL SLL,Mussetti,Negative
22601,duvelisib adult CLL SLL,Talbot Research Library Media Services,Negative
22602,FDA Verastem CLL SLL,Michael Mijares,Negative
22603,FDAapproves,FDA Drug Information,Negative
22605,CLL,PROvendis GmbH,Negative
22606,FDAapproves Copikra CLL two,Randy Hatton,Negative
22608,Verastem FDA first CLL SLL,Liseth Parra PhD,Negative
22609,Cello Health CLL US Germany,James Flavin,Negative
22610,four last year,CURE Magazine,Negative
22611,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22612,CLL Keating,Patient Power,Negative
22613,VerastemOncolog Copiktra Leukemia Click,Roots Analysis,Postive
22614,FDA CLL SLL CLL FDA Genentech SLL Venclexta,mediPr Yi Xue Zuo Jia Xiang Gang ,Negative
22615,Duvelisib FDA CLL SLL CLL Copiktra duvelisib FDA SLL Verastem,Zhong Liu Xue Xin Zhi  Cancer Informer,Negative
22616,Duvelisib FDA CLL SLL CLL Copiktra duvelisib FDA SLL Verastem,mediPr Yi Xue Zuo Jia Xiang Gang ,Negative
22617,CARTcells,VJHemOnc,Negative
22618,duvelisib COPIKTRA Verastem CLL SLL,Stefan Busch,Negative
22619,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22622,FDA Copiktra Chronic Lymphocytic Lymphocytic Lymphoma Follicular,New Drug Approvals,Negative
22624,Breaking News FDA Duvelisib CLL,Robinson Ortiz MD,Negative
22625,FDA Copiktra duvelisib Capsules Chronic Lymphocytic Lymphocytic Lymphoma Follicular,EIN Presswire Lung Cancer Newswire,Negative
22626,FDA Copiktra duvelisib Capsules Chronic Lymphocytic Lymphocytic Lymphoma Follicular,FDA Daily,Negative
22627,Read,The Leukemia Lymphoma Society,Postive
22628,Duvelisib two,Lisa Astor,Postive
22629,FDA,PharmacyTimesCE,Postive
22630,three two OncLive,PER,Negative
22631,FDA,VuMedi Oncology,Negative
22632,two thousand and eighteen,Cancer Papers,Negative
22633,Cronica,Manuel Muro,Negative
22634,duvelisib COPIKTRA Verastem CLL SLL,Anna Deveau,Negative
22635,One CLL Drs Lamanna Ferrajoli,Andrew Schorr,Negative
22636,FDA,FDA Oncology,Postive
22637,Thursday Sept twentyseven twelve pm PT Live CLL Session TheUSONetwork WVCancer twelve pm Register Qs,Patient Power,Negative
22638,Possibilities Fund Golf Tournament next year CLL,Southland,Negative
22639,Chronic CLL,Pharmacyclics AbbVie Company,Negative
22640,today LymphomaAction November Hodgkin NHL CLL,NLTP,Postive
22641,Today CancerWeek CLL,CLL Ireland,Negative
22642,CLL,MDedge Hematology Oncology,Negative
22643,Global Clinical Trials Review two thousand and eighteen Ken Research,Ken Research,Negative
22644,Global Clinical Trials Review two thousand and eighteen Ken Research,Ken Research,Negative
22645,Mark Silverstein CLL two thousand and ten,Patient Power,Negative
22646,LeukaemiaCareUK SpotLeukaemia London Leukaemia BloodCancer Leukaemia CLL EarlyDiagnosis,Zack,Postive
22647,Zytux Iranian rituximab biosimilar MabThera,CenterForBiosimilars,Negative
22648,CLL Spanish ASH two thousand and Jacqueline Barrientos ChronicLymphocyticLeukemia,The Patient Channel,Negative
22649,AIM CLL Cello Health PLC FTSE Healthcare,AIM Alerts,Negative
22650,Edinburgh Sharing CLL John John MondayMotivation Scotland,CLLSA,Postive
22651,Check Sequential,Medivizor,Negative
22652,Vayan Instagram Nninitaa CLL los ganadores el one Evento el fourteen de octubre CONCURSO LuchaLibre CLL Chile,Giannina,Negative
22653,CLL CLL,Ex Dividend Date,Negative
22656,CLL,Kathleen Hoffman,Negative
22657,EU CLL,CancerWallonia,Negative
22658,CLL,CancerWallonia,Negative
22659,CLL DCLLSG Prof Hallek CLL Koln,Marta Crespo,Postive
22660,CLL AmericanCancer,CLL Ireland,Negative
22664,day nola cheerfam audobonzoo,Gina Angel,Negative
22665,CLL,Patient Power,Negative
22666,CLL EmoryMedicine WinshipAtEmory,Patient Power,Negative
22667,CLL,Patient Power,Negative
22668,BloodCancerAwarenessMonth CLL,ecancerpatient,Negative
22669,four Leukemia one Acute Myeloid AML two Myeloid CML three Acute Lymphocytic four Lymphocytic CLL cmlday,wambui,Postive
22670,BloodCancerAwarenessMonth,AJMC,Negative
22672,Paris France Feb WorldCancerMeet,World Neonatology Congress,Negative
22673,Harnessing Power Rituximab Bispecific Antibody CLL Paris France Feb WorldCancerMeet,World Neonatology Congress,Negative
22674,Individualized Lenalidomide Plus Chlorambucil Paris France Feb WorldCancerMeet CureLeukaemia,World Neonatology Congress,Negative
22675,Oxidative,Cancer Papers,Negative
22676,two thousand and eighteen American Society Clinical Oncology annual,Diagnostics News,Negative
22677,Love TaylorSwift,Gina Angel,Postive
22678,four five CR CRS CLL one,Anna Deveau,Negative
22679,Tomorrow CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
22681,Roche CLL,AbbVie,Postive
22683,Rituximab Treatment Fixed Duration One,RazzleTazzle,Postive
22684,Rituximab Treatment Fixed Duration,PRICENTRIC,Postive
22685,EU Committee Opinion Combination Rituximab Treat Chronic,Bio,Postive
22686,Oxidative,Lymphoma Papers,Negative
22687,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22688,cll MRD ninety,Anna Deveau,Negative
22689,CLL,AbbVie Canada,Negative
22690,CLL MCI,GateToMedicine PG,Negative
22691,CLL,CellworksLife,Negative
22692,September BloodCancerAwarenessMonth Find one CLL,Patient Empowerment Network,Negative
22693,Waldenstrom Mexico,Robert Orlowski,Negative
22694,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
22695,CLL,AllSaintsCEFarnworth,Negative
22696,Elias Campo,Ville Pimenoff,Negative
22697,Elias Campo,Oncobell Symposium,Negative
22699,Success CLL NHL Non Hodgking Manel Juan,Butler Scientifics,Postive
22700,AIM CLL Cello Health PLC Shareholding,AIM Alerts,Negative
22701,CLL BloodCancerAwarenessMonth,AJMC,Negative
22702,CLL Dr Shadmar Dr Radich,donnashort,Negative
22703,CLL,Lynn Cornell,Negative
22704,Tokenfest Interview Video TotleCrypto DEX airswap kybernetwork CLL,CryptoLiveLeak,Negative
22705,Etsy CLL,BOSS Bodyworks,Negative
22706,Check Lenalidomide,Medivizor,Negative
22707,CLL,Kathleen Hoffman,Negative
22708,Michael Keating CLL,Patient Power,Postive
22709,CLL Sign LIVE Ask Expert WVCancer Sept,Patient Empowerment Network,Negative
22710,CLL,CancerTherapyAdvisor,Negative
22711,One CLL Venetoclax Ibrutinib Hear Keating,Andrew Schorr,Postive
22712,CLL CLL CLL,Andrew Schorr,Postive
22713,BloodCancerAwareness Read,Wiley Oncology Hematology,Negative
22714,CLL CLL AndrewScottTV,Proactive,Postive
22715,MoffittNews Watch BloodCancerAwarenessMonth Leukemia,Targeted Oncology,Negative
22716,CLL Read Larry Saltzman LLSusa,Patient Power,Postive
22717,four They Acute Myeloid AML Myeloid CML Acute Lymphocytic,KKL Trust,Postive
22718,OncologyNews Remission Maintenance Treatment Options,Elsevier Oncology,Negative
22719,CLL Mark Scott three year one one,WheelieDealer,Postive
22720,CLL Cello Health ten CLL AndrewScottTV,Proactive,Negative
22721,Today nine IDP APH CLL,Jon,Negative
22722,AIM CLL Cello Health PLC,AIM Alerts,Negative
22723,today seven IDP APH CLL ECK Plus,Jon,Negative
22725,CLL SLL,NIH NHLBI,Negative
22726,Associate Manitoba LLSusa CancerCareMB,UM Human Resources,Negative
22727,first,Cancer Papers,Negative
22728,Session TheUSONetwork WVCancer twelve pm Register Qs,Patient Power,Negative
22729,first CLL Frontline,COPD News,Negative
22730,Lymphocytic Leukemia Research University Manitoba Winnipeg MB maintenance mouse,MB Top Employers,Negative
22732,Kerry Rogers CLL,The James,Postive
22733,Pharmacy Times Continuing Presents Live Broadcast Chronic,ANTELLIS,Negative
22735,CLL Dr Jennifer Brown Dr Jan Burger Anthony Mato CLL,CLL Ireland,Postive
22736,Role Prognostic,Internal Medicine Open Access,Negative
22738,five two,Solomon Kamal,Negative
22741,two Polyphenon Rai zero two,Integra Medical,Negative
22742,Mark Silverstein Toronto Canada CLL convo journey lesson u,Andrew Schorr,Postive
22743,Immunoglobulin BCR,Cancer Papers,Negative
22744,two Condition Summary Acute,TrialBulletin,Negative
22745,CLL Michael Keating,Patient Power,Negative
22746,cll,Anna Deveau,Negative
22747,CLL CLL Register,Andrew Schorr,Negative
22748,ChronicLymphocyticLeukemia Learn LeukemiaAwarenessMonth MayoClinic,Mayo Clinic Cancer Center,Negative
22749,CARTcells Ibrutinib CLL,Arjun Law,Negative
22751,second CME Pan Pacific Lymphoma Conference four Drs DrMDavids DrJFriedberg Thomas Kipps John Gribben CLL twenty,Research To Practice,Negative
22753,Saturday CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
22754,CLL,Kathleen Hoffman,Negative
22755,The Usual Suspects Rituximab CLL Bcells,Prof John,Negative
22756,CLL Kinase Find BloodCancerAwareness Leukaemia,ecancer,Negative
22758,Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Matthew Wakefield,Postive
22759,Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Garbine Lizeaga,Postive
22760,WES twenty CLL eightyfour twenty ATM,Anna Deveau,Negative
22761,CLL,CLL Ireland,Postive
22762,RT MedlyPharmacy Medical News,Chirag Kulkarni,Negative
22763,Medical News,Medly Pharmacy,Negative
22764,CLL French ASH two thousand and seventeen Florence Cymbalista,Anna Deveau,Negative
22765,CLL,Anna Deveau,Negative
22766,CAR CLL,Anna Deveau,Postive
22767,VIDEO Identifying Diagnostic CLL Anna Schuh,VJHemOnc,Negative
22768,Today September CLL SLL,CLL Ireland,Negative
22769,CLL CARTcells Leukemia ImmunoOnc Leusm,VJHemOnc,Negative
22771,Florence Cymbalista CLL one Richters,Jose Sandoval MD FACP,Postive
22772,RT PhysRelations Phillip Thompson PhysRelations CLL,Robert Orlowski,Negative
22773,RT PhysRelations CLL PhysRelations,Robert Orlowski,Negative
22774,Phillip Thompson PhysRelations CLL,MD Anderson Leukemia,Negative
22775,Files New Russell Brooks,InciNotes,Negative
22776,Anna Schuh MD University Oxford CLL,MD Anderson Leukemia,Negative
22777,Florencia Cymbalista PhD Hopital Avicenne CLL,MD Anderson Leukemia,Negative
22778,two thousand and eighteen CLL EndCancer PatientPower,Michele,Negative
22779,The month September Month September fifteen World Lymphoma Awareness Day,MerMer Goodburn,Negative
22780,Michael Jan CLL,CLL Ireland,Negative
22781,CLL today,Jordan Gauthier,Postive
22783,RT PhysRelations Saturday nine CLL Phillip Thompson CancerMedMDA PhysRelations,Robert Orlowski,Postive
22784,RT PhysRelations Saturday nine CLL AM Study Case,Robert Orlowski,Negative
22785,Saturday nine CLL Phillip Thompson CancerMedMDA PhysRelations,MD Anderson Leukemia,Postive
22786,Saturday nine CLL AM Study Case,MD Anderson Leukemia,Negative
22787,Hodgkin,HEORO,Negative
22789,CLL Learn,Pharmacyclics AbbVie Company,Postive
22790,one Matt DECEMBER CLL,MerMer Goodburn,Negative
22791,CLL Barbara Eichhorst hemeonc cllsm,VJHemOnc,Negative
22792,IgG CLL Alessandra Ferrajoli,Patient Power,Postive
22793,CLL three OhioState,AAU,Negative
22794,MyHusband SickDay BloodCancerAwarenessMonth CLL,MerMer Goodburn,Negative
22795,Token Fest TWO CLL,CryptoLiveLeak,Negative
22796,CLL Lamanna ColumbiaMed,Patient Power,Postive
22797,transcript,Eduardo Eyras,Negative
22798,Hodgkin,HEORO,Negative
22799,UK third September CLL,CLLSA,Negative
22800,Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Jerry Lee,Postive
22801,Widespread GenomeWeb,Lab,Negative
22802,Jeff Folloder one CLL CLL Read ATL,Andrew Schorr,Postive
22803,Western Live Video Broadcast Register Comment,PharmacyTimesCE,Negative
22804,new drug CLL,The James,Postive
22806,Day ONE Day TWO CLL,CryptoLiveLeak,Postive
22808,one fourteen minute September CLL myeloma haemtology JanssenUK,CLLSA,Postive
22809,Lucas Easy MINE Video EMT CLL,CryptoLiveLeak,Postive
22810,Obinutuzumab CLL FightBloodCancer,HemOnc Today,Negative
22811,CARTcell CLL NitinJainMD,VJHemOnc,Negative
22812,Zach CLL,CryptoLiveLeak,Negative
22813,Warwickshire tonight NHL Hodgkin CLL nhsuhcw GEHNHSnews HealthwatchWarw LymphomaMatters,Helen Jane Mee,Negative
22814,Cryptonews Decentralize boston CLL,CryptoLiveLeak,Negative
22815,TotleCrypto CLL,CryptoLiveLeak,Negative
22816,Mark Silverstein CLL two thousand and today,Patient Power,Negative
22817,three MURANO FDA,Targeted Oncology,Negative
22818,CLL Pat Conlin first Robert Pike CLL,CryptoLiveLeak,Postive
22819,IDonc,Mike Thompson MD PhD FASCO,Negative
22821,CLL,CryptoLiveLeak,Negative
22822,next week CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
22823,MRD MRD one CLL AML,Genevieve Crane MD PhD,Postive
22825,CLL Zent,Dr Tristan Mehta,Postive
22827,CLL Find Leukaemia,ecancer,Negative
22829,Bruton CLL,Blood Journal,Negative
22830,CARTcell CLL,VJHemOnc,Negative
22831,Venetoclax FDA Minimal Residual Disease AbbVie CLL MabThera rituximab Roche Venclexta,Zhong Liu Xue Xin Zhi  Cancer Informer,Negative
22832,Venetoclax FDA Minimal Residual Disease AbbVie CLL MabThera rituximab Roche Venclexta,mediPr Yi Xue Zuo Jia Xiang Gang ,Negative
22833,CLL Sign LIVE Ask Expert WVCancer Sept twelve PM,Patient Empowerment Network,Negative
22834,cll two thousand and eighteen,Willy van der Most,Negative
22835,RT PhysRelations Wednesday seven CLL Katy Rezvani,Robert Orlowski,Negative
22836,CvNieuwenhuizen HettyKlavers InaAdema hundred,Joost van de Beek,Negative
22838,RT PhysRelations Wednesday seven CLL CARTcell Leukemia CART CancerMedMDA PhysRelations,Robert Orlowski,Negative
22839,Wednesday MTP seven CLL Katy Rezvani,MD Anderson Leukemia,Negative
22840,Wednesday MTP seven CLL CARTcell Leukemia CART CancerMedMDA PhysRelations,MD Anderson Leukemia,Negative
22841,CLL,Kathleen Hoffman,Negative
22842,CLL CLL,Mithu Storoni MD PhD,Negative
22843,CLL,OncologyNurseAdvisor,Negative
22844,FDA Venclexta CLL MRD three,MAISA,Negative
22845,Therapy JAX,The Jackson Laboratory,Negative
22846,Venclexta CLL,MPR,Negative
22847,September BloodCancerAwareness Month CLl ASH,Bag It Cancer Support,Postive
22848,Individualized Treatment Chronic CLL,Cancer Papers,Negative
22850,CLL Keating,Patient Power,Negative
22851,CLL,MDedge Hematology Oncology,Negative
22852,OhioState Barbara Andersen,Ohio State News,Negative
22853,today CLL Michael Keating,Patient Power,Postive
22855,New Medivizor Comparing,Medivizor,Negative
22856,Chronic CLL,knowmedge,Negative
22858,VIDEO Current CLL John Gribben QMULBartsTheLon,The Patient Channel,Negative
22859,BELSPO Belgium European Research Initiative CloudComputing,EGI,Postive
22861,today CLL,Dr Anya Hotinski,Negative
22862,four last year,CURE Magazine,Negative
22864,Javier MD PhD CLL,Health Adviser,Postive
22866,CLL,touchONCOLOGY,Negative
22867,OncologyNews Remission Maintenance Treatment Options,Elsevier Oncology,Negative
22869,Individualized Lenalidomide Plus Chlorambucil CLL,CLL Ireland,Negative
22870,Freda Stevenson first UK CLL,Allison Stratford,Postive
22871,one hundred and thirtyfour Stop Target one hundred and sixty four hundred CLL,Market Trading Tips,Negative
22872,CLL Treatments Review CLL Jennifer Brown,Medscape Education,Negative
22873,CLL,Anna Deveau,Negative
22874,CLL,Kathleen Hoffman,Negative
22875,CLL Quebec HealthCanada Canada,Anna Deveau,Negative
22878,Today last day CLL first CLLHeroes,CURE Magazine,Postive
22879,NGS,ArcherDX Inc,Negative
22880,six LEVER MED BlodcancerDk md HeretoHelpMDS,LyLe Foreningen,Postive
22881,CLL,CLL Ireland,Negative
22882,Alison Michie CLL,LymphomaAction,Negative
22883,CLL Wilmot Cancer Institute,AAIDA,Negative
22885,lymsm cll China one,Anna Deveau,Negative
22886,September Yesterday Royal Marsden Today Spot Leukaemia LeukaemiaCareUK SpotLeukaemia CLL,MerMer Goodburn,Negative
22887,Comparison Turkey,Cancer Papers,Negative
22889,Nominate Recognize BloodCancerAwarenessMonth,Verastem Oncology,Postive
22890,today CLL,CURE Magazine,Negative
22891,nanopores transcript,SeqComplete,Negative
22892,De la belle Les LAnglicane CultureLevis CLL,Anglicane,Negative
22893,one National Blood Cancer Awareness Chronic Lymphocytic Leukemia Healthcare RIGHT one FightBloodCancer,Rachel Crooks,Negative
22894,CLL two CME SSH Join,healthbook,Postive
22895,CLL ColumbiaMed,Patient Power,Postive
22896,Chronic CLL Register Cancer Support Community CLL,Northwest Radiology,Negative
22897,Comparison Turkey,Lymphoma Papers,Negative
22901,LPL,DNA Methylation,Negative
22902,week May five,Jeff Lafferty,Negative
22905,The United States,Mahmoud Aljurf,Negative
22907,CLL Read Larry Saltzman LLSusa,Patient Power,Postive
22909,transcript,bioRxiv Genomics,Negative
22910,transcript,bioRxiv,Negative
22911,CLL Sign LIVE Ask Expert WVCancer Sept twelve PM,Patient Power,Negative
22912,Chronic,Nature Partner Jnls,Negative
22913,CLL MSK Anthony Mato,Memorial Sloan Kettering Cancer Center,Negative
22914,Lymphoma CLL George Follows Leusm,The Patient Channel,Negative
22916,Paris LLSusa,World Neonatology Congress,Negative
22917,Individualized Lenalidomide Chlorambucil Rituximab CLL Paris MayoClinic,World Neonatology Congress,Negative
22918,Pulmonary,Cardio Medicine,Negative
22919,NGS,ArcherDX Inc,Negative
22921,Susan MD CLL,CCO Oncology,Negative
22922,CLL,Kathleen Hoffman,Negative
22924,Chronic,Barabas PhD,Negative
22925,CLL,Talal Hilal,Negative
22926,CLL ColumbiaMed LivingWell,Patient Power,Postive
22927,ICYMI CLL,Home Journal,Negative
22928,September,ASH Clinical News,Negative
22929,Ibrutinib CLL,Home Journal,Postive
22930,fourteen MINUTES UK WednesdayWisdom CLL,CLLSA,Negative
22931,IgG,ImmunologyPapers,Negative
22932,CLL Learn Leukaemia BloodCancerAwareness Bloodcancer,ecancer,Negative
22933,PhD one CLL,Dr Anya Hotinski,Negative
22934,Perth one TGTherapeutics Btk LinearClinical LymSM,Chan Cheah,Negative
22936,CLL,CancerTherapyAdvisor,Negative
22937,CLL,Patient Power,Negative
22939,fifty DWHA MRL EMR,SwingTradeBot UK,Negative
22940,Harrogate LymphomaAction NHL Hodgkin CLL,LiveYourLife,Negative
22943,CLL,Anthony Mato,Negative
22944,LabMedicine Critically Elevated Potassium Female Leukemia Learn,Blair Holladay,Negative
22945,MRD Negativity Chronic,Anthony Mato,Negative
22947,Dept Immunotechnology BioInvent Int AB,Mats Ohlin,Postive
22948,CLL CR,Jordan Gauthier,Negative
22949,CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
22951,BloodCancer Ireland Today day MyelomaIreland CLL,CLL Ireland,Negative
22952,twentyfour month Ibrutinib first CLL,Raul Cordoba MD PhD,Negative
22953,BloodJournal CLL,ASH,Negative
22955,btk,Anna Deveau,Negative
22956,University Berlin Acute Myeloid AML,HARMONY Alliance,Postive
22957,NGS CLL Bryone five Leichhardt Oval,Judith Trotman,Negative
22958,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
22959,CLL BloodCancerAwareness,ecancerpatient,Negative
22960,three CLL Horizons two thousand and eighteen Prague Lymphoma Australia CLL one CLL,Donna Gairns,Postive
22961,one Sunday Mail yesterday,Dr Anya Hotinski,Negative
22963,Carsten Niemann Rigshospitalet CLL CLLsm,VJHemOnc,Negative
22964,CLL,Kathleen Hoffman,Negative
22965,CLL,MDS You MDS og Dig,Negative
22966,CLL EU SpotLeukaemia LeukaemiaCareUK CllIreland,Nick,Negative
22967,CLL Barbara Eichhorst,VJHemOnc,Negative
22968,three Prof Tal Minor Leeds UK CLL LeukaemiaCareUK SpotLeukaemia CllIreland,Nick,Negative
22969,BloodCancers,Targeted Oncology,Postive
22970,CLL Venetoclax,chadi nabhan MD MBA FACP,Negative
22972,CLL,ecancer,Negative
22974,CLL United States,Raul Cordoba MD PhD,Negative
22975,year CLL,Raul Cordoba MD PhD,Negative
22976,CLL three,Raul Cordoba MD PhD,Negative
22977,HOUSE CLL MPN SpotLeukaemia,Nick,Negative
22978,spotleukaemia kick BloodCancerAwarenessMonth Cll CllIreland,Nick,Postive
22979,three,Mahmoud Aljurf,Negative
22980,Comparison Tumor Staging Systems Cutaneous Squamous Cell,Mazen,Negative
22982,Memorial Sloan Kettering,Zusia Dr Jackie Volk,Negative
22983,one two thousand and sixteen Love,Christine Phillips,Postive
22984,Comparison Tumor Staging Systems Cutaneous Squamous Cell CLL,COPD News,Negative
22985,IgG CLL Alessandra Ferrajoli,Patient Power,Postive
22986,Davids CLL CLLSupport,Patient Worthy,Negative
22987,two thousand and eighteen Global Market Key Players two thousand IndustryToday,Industry Today,Negative
22988,Ways CLL Davids Cancer Institute Harvard Medical School,CLL Ireland,Negative
22989,CLL,Coping Cancer,Negative
22990,CLL Lamanna ColumbiaMed,Patient Power,Postive
22991,CLL,News,Postive
22992,three Chronic,gilbert faure,Negative
22993,Michael Prague CLL Horizons two thousand and eighteen Conference Dr Brian Koffman CllSociety Dr Talha Munir LeedsHospitals,CLL Ireland,Postive
22994,CLL Emma SolihullCollege two year Degree Pathway Firstly,CLL Warwick Uni,Postive
22995,Comparison Tumor Staging Systems Cutaneous Squamous Cell,dermatologyf,Negative
22997,CLL today cll,Dr Anya Hotinski,Negative
22998,September Tcell CLL Hodgkin,The Lancet Oncology,Negative
22999,Global Clinical Trials Review two thousand and eighteen,Markets Reports,Negative
23000,Global Clinical Trials Review two thousand and eighteen,Markets Reports,Negative
23001,CLLsm,Raul Cordoba MD PhD,Negative
23002,CLLsm,Anna Deveau,Negative
23003,CLL,Blood Journal,Negative
23004,Paul Leukaemia Research Centre ten CLL LymphomaAction,Helen Jane Mee,Negative
23005,CLL Saturday Sunday one UK Covhour,CLL Warwick Uni,Postive
23008,CLL Sign LIVE Ask Expert WVCancer Sept twelve PM,Patient Power,Negative
23009,VIDEO Novel CLL Jennifer Woyach,VJHemOnc,Negative
23010,CLL,CLL Ireland,Postive
23012,Chronic CLL,Angela White,Negative
23013,Acanthamoeba CLL Voshtina,Francisco Marty MD,Negative
23015,Amebic Encephalitis Patient,AmoebaPapers,Negative
23018,Virtual Tumor Board,Targeted Oncology,Negative
23019,Warwick Campus CLL CLLcommunity,CLL Warwick Uni,Negative
23020,two thousand and eighteen,Markets Reports,Negative
23021,seven Acute Acute Myeloid AML,HARMONY Alliance,Negative
23022,cllsm cll,Anna Deveau,Negative
23023,today CLL Michael Keating,Patient Power,Postive
23024,CLL PatientPower,Ziopharm Oncology,Negative
23026,CLL,Kathleen Hoffman,Negative
23027,OncologyNews Remission Maintenance Treatment Options,Elsevier Oncology,Negative
23028,Hairy CLL,Matthews Associates,Negative
23029,CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
23030,Chronic Lymphocytic Leukemia,Curatio Technologies,Negative
23031,Chronic Lymphocytic Leukemia,Curatio Technologies,Negative
23032,LymphocyticLeukemia Trial Site News,TrialSite News,Negative
23033,CLL,Raul Cordoba MD PhD,Postive
23034,Max Gordon OHSUKnight CLL Imbruvica,HemOnc Today,Negative
23035,Wilmslow Sainsbury Charity fifteen LymphomaAction UK NewsWilmslow BloodCancer CLL,Helen Jane Mee,Postive
23036,CNS Chronic CLL,Lung Cancer News,Negative
23038,Liverpool LinerHotel NHL Hodgkin CLL,LiveYourLife,Postive
23039,Chronic mRNA,Curatio Technologies,Negative
23040,Chronic mRNA,Mahesh Jain,Negative
23041,ALC HSM MBL CLL MCL NHL HCL,Uriel Suarez,Negative
23042,New Medivizor Obinutuzumab,Medivizor,Negative
23043,Damon Runyon AbdelWahablab CLL,Damon Runyon Cancer Research Foundation,Negative
23044,Twist CLL,Elaine Schattner,Negative
23046,four Acute Myeloid AML Myeloid CML CLL Acute Lymphoblastic LLSusa KnowledgeIsPower,Medicine ten,Postive
23047,CLL,Duke Geriatrics,Negative
23048,CLL Peter Hillmen LeedsHospitals CLL ClinicalTrials CLL Information Day,CLL Ireland,Postive
23051,CLL,Targeted Oncology,Negative
23052,four CLL one Graduates WarwickshireCol SolihullCollege,CLL Warwick Uni,Negative
23053,Albumin Fibrinogen Paris France CureLeukaemia,World Neonatology Congress,Negative
23054,two three US,Prophetess Deborah Allen,Postive
23059,CLL,Verastem Oncology,Postive
23060,CLL Kerry Rogers Atlanta James,Andrew Schorr,Postive
23061,Watch Purva Lad CLL Wesley Bishop first LivingWell,Patient Power,Negative
23063,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
23064,CLL CLL,CLL Ireland,Postive
23065,CELG SLL,dough,Negative
23066,Christopher Fox CLL CaGenome,VJHemOnc,Negative
23067,nine Supporting Emergent Literacy CLL Literacyskills CLL harlowcollegeEY CACHEint,Early Years LSC FE VocEd EYFS,Negative
23068,one YouTube CLL,Med Perfectionalis,Negative
23069,Leukemia Approach,Doctr,Negative
23070,nine six LANGUAGE CLL,Early Years LSC FE VocEd EYFS,Negative
23071,CLL Chris Fegan BritSocHaem CLLsm Leusm,VJHemOnc,Negative
23072,CLL,Kathleen Hoffman,Negative
23074,Information Day CLL Patrick Thornton CLL Ireland Watch amp Wait,CLL Ireland,Negative
23075,CLL YouTube,Med Perfectionalis,Negative
23076,one YouTube Diagnosis CLL,Med Perfectionalis,Negative
23077,Sumamos el titulo Vamos Limpeno CLL,Meli Parada,Negative
23078,CLL,Jah Kuu,Negative
23079,Global Chronic Lymphocytic Leukemia Treatment Market two thousand and eighteen Overview Cost Structure Analysis Growth Opportunities Forecast two thousand and twentythree,Tech Journal Hub,Postive
23080,FLAIR Trial CLL,CLLSA,Negative
23083,Pericardial Involvement Chronic Lymphocytic Lymphocytic,Lymphoma Papers,Negative
23085,Obinutuzumab,Medivizor,Negative
23086,Brian Parkinson,AACR Foundation,Negative
23087,Pharmacy Times Continuing Presents Live Broadcast Chronic,Brenda Feldman,Negative
23088,one,Matt,Negative
23089,CLL obinutuzumab venetoclax,MDedge Hematology Oncology,Negative
23090,New Obinutuzumab,Medivizor,Negative
23091,CLL YouTube,Med Perfectionalis,Negative
23092,CLL today NovelAgents anthonymatomd wwierda HemOnc,VJHemOnc,Negative
23093,CLL,Nature Reviews Disease Primers,Negative
23094,Clive Zent CLL,Wilmot Cancer Institute,Negative
23097,KarolinskaUnsju Ibrutinib transcription CLL,Prof John,Negative
23098,four Leukemia one Acute AML two Acute three Chronic CML four Chronic CLL,Monitor Healthcare Ltd MHL,Negative
23099,two thousand and eighteen Drug Description Target Finding Key Players,Tech Journal Hub,Negative
23100,two thousand and eighteen,Financial Buzz,Negative
23101,CLL Drs Keating Lamanna,Andrew Schorr,Negative
23102,Sept big weekend Emory Hem TWO Patient Power CLL WinshipAtEmory,Andrew Schorr,Negative
23103,CLL ColumbiaMed LivingWell,Patient Power,Postive
23104,Pharmacy Times Continuing Presents RareDiseases,Rare Diseases,Negative
23105,CLL Arnon Kater,VJHemOnc,Negative
23106,CLL Patients Ireland,CLL Ireland,Postive
23107,two thousand and eighteen,ANTELLIS,Negative
23108,twelve,Anna Deveau,Negative
23109,CLL today NovelAgents Listen Peter Hillmen,VJHemOnc,Negative
23110,John Fox PriorityHealth CLL,AJMC,Postive
23111,William Wierda Anderson Cancer Center,Oncology Times,Negative
23112,Leusm,Targeted Oncology,Negative
23113,Sandi Schussel Lynn Matthew Center,WEEI,Negative
23115,month one Lymphocytic Leukemia WBC one Basically,Pamela Combs,Negative
23116,CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
23117,Glasgow eight Alison Michie UofGlasgow CLL LymphomaMatters,Helen Jane Mee,Postive
23118,CLL Wesley Bishop CLL Watch,Patient Power,Negative
23119,ICYMI Silvia Mele et al Blood Advances,AA MDSIF,Negative
23120,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
23122,NHL Hodgkin CLL NHSForthValley CRUKGlasgow MacmillanScot,Helen Jane Mee,Negative
23124,John Fox PriorityHealth CLL,AJMC,Postive
23125,CLL,Smitt Wesson,Negative
23126,CLL,Kathleen Hoffman,Negative
23127,Texas,Blake Fisher,Postive
23128,The Fans Real Soon CLL,Smitt Wesson,Negative
23129,Moffitt Cancer Center MoffittNews Leukemia,Targeted Oncology,Negative
23130,two thousand,The Pharmaceutical Marketing Group,Negative
23132,CLL today,CURE Magazine,Postive
23134,ASHCLinicalNews,ASH,Negative
23137,CLL,CancerTherapyAdvisor,Negative
23138,England National Health Service Imbruvica CLL,pharmaphorum,Negative
23139,ICER,CancerTherapyAdvisor,Negative
23140,Freda CLL,Prof John,Postive
23142,CLL Dutch ASH two thousand and Arnon Kater DutchLanguage,The Patient Channel,Negative
23143,Toxicol Appl Pharmacol two thousand and eighteen seventeen,Wnt publication,Negative
23144,six hundred CLL,Andrew Lloyd ALA,Negative
23145,Jamie She Coventry City Centre today CLL,CLL Warwick Uni,Negative
23146,New Medivizor Outcomes,Medivizor,Negative
23149,Pericardial Involvement Chronic Lymphocytic Lymphocytic Lymphoma,Zedu wearamask,Negative
23150,Check Venetoclax leuke via,Medivizor,Negative
23151,two year,Michael Pharmacy,Postive
23153,Ibrutinib CLL Oncology Biosimulation CLL,CellworksLife,Negative
23156,CLL SLL Office Patient Recruitment NIH,NIH Clinical Center,Negative
23157,CLL NHSengland CLL CLLSupport ChronicLymphocyticLeukaemia,LymphomaAction,Negative
23158,CLL ColumbiaMed,Patient Power,Postive
23160,CLL BM BM,CLL Ireland,Negative
23162,five,Michele,Negative
23163,CLL,Kathleen Hoffman,Negative
23164,BloodAdvances,ASH,Negative
23165,duvelisib VSTM CLL RR CR PR TN RR TN,Anna Deveau,Negative
23166,Response one hundred ninety CLL Bendamustine Followed Obinutuzumab Plus Venetoclax CLL ASCO,CLL Ireland,Postive
23168,Chronic Lymphocytic Leukemia Proliferation Centers Bone Marrow,Kathleen Montone,Negative
23170,CLL Sue Jon Emma today,CLL Warwick Uni,Postive
23171,today CLL PrideCov earlier summer,CLL Warwick Uni,Postive
23178,Quoi de mieux la nouvelle annee scolaire sou de la sante un Faire,Cegep de Levis,Negative
23179,Chronic CLL,The Curable Recipes,Negative
23180,CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
23181,CLL Treatments Review CLL Jennifer Brown,Medscape Education,Negative
23183,Lymphoma CLL George Follows DrugAccess Leusm EndCancer,The Patient Channel,Negative
23185,AIM CLL Cello Health PLC Notification,AIM Alerts,Negative
23186,one first CLL Wesley Bishop,Andrew Schorr,Negative
23187,Cirmtuzumab UCSDnews,Bradley Fikes,Negative
23188,McRaven,EricaGrieder,Postive
23189,Coventry City Centre Library tomorrow CLL August tomorrow week Covhour,CLL Warwick Uni,Negative
23190,CLL six hundred,Gerry Ward,Negative
23191,CLL six hundred percent,Peter Schellinck,Negative
23192,CLL,MDedge Hematology Oncology,Negative
23193,Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Marlowe Tessmer,Postive
23194,six hundred CLL,Betty Jung,Negative
23196,Stan Kurtz Catalina Channel last week Stan Please,Gerry Rodrigues,Postive
23197,CLL CLL,Lymphoma Coalition,Negative
23198,CR BloodJournal,Chan Cheah,Negative
23199,Kerry Rogers et al Blood Journal,AA MDSIF,Negative
23200,AIM CLL Cello Health PLC,AIM Alerts,Negative
23201,WilmotCancer six hundred percent,University Rochester,Negative
23202,AIM CLL Cello Health PLC Board Changes,AIM Alerts,Negative
23203,Carol Preston five CLL CLL,Patient Power,Postive
23206,CLL,Kathleen Hoffman,Negative
23208,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
23210,CLL SLL Learn,NIH NHLBI,Negative
23211,CLL,Kathryn Evans Nunez,Negative
23212,CLL Renowned Nicole Lamanna ColumbiaMed today CLL,Patient Power,Negative
23213,Hodgkin NHL CLL Sat Glasgow NHSGGC CRUKGlasgow NHSForthValley,Helen Jane Mee,Negative
23214,Read Leusm Leukemia CancerResearch,Targeted Oncology,Postive
23215,Cancer Awareness Month UK CLL Thanks Prof Pete Hillmen NCRI CLL CllIreland CLLSupport LeukaemiaCareUK SpotLeukaemia,Nick,Postive
23216,Tumor Microenvironment,paper,Negative
23217,one GTC Australia New Zealand WorldCourier Melbourne Journeyofabox ClinicalSupplySolutions CLL,World Courier Operational Alerts,Negative
23218,CLL six hundred WilmotCancer four hundred and seventy CLL Read ELShematology,Wilmot Cancer Institute,Negative
23220,today ZTF CLL EGL KIT,SwingTradeBot UK,Negative
23221,Scan Centerline Cross today MTFB CPX CLL BEZ UEN,SwingTradeBot UK,Negative
23223,James Barnes,AA MDSIF,Negative
23224,CLL CLL HealthGuru,Healthguru,Negative
23227,LuchaLibre LUCHAlibreChilena puntadiamante cll,Lenko Sins,Negative
23228,first,The Lancet Oncology,Negative
23229,Melanoma Wilmot,All WNY News,Negative
23230,eSahai Number two Remember fortyseven million,eSahai,Negative
23232,CLL,CLL Ireland,Postive
23234,Learn Larry CLL,Patient Power,Postive
23237,Medical News,Free Medical Consultation,Negative
23238,Medical News,ViziMedical,Negative
23240,Medical News,Brandy News,Negative
23242,Crypto Posts Check Introductory Video Here Newsocialmedia CLL,CryptoLiveLeak,Negative
23244,Medical News,Mazen,Negative
23245,six hundred UofR CLL ROC WilmotCancer,Univ Rochester School Medicine Dentistry,Negative
23246,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
23251,Medical News,Awareness,Negative
23252,Medical News,Scott Filler,Negative
23253,Medical News,Endsars protest,Negative
23254,Medical News,Triple Medical Solutions LLC,Negative
23256,six hundred UofR CLL ROC WilmotCancer,UR Medicine,Negative
23257,Scan Signal Line Cross today SNR,SwingTradeBot UK,Negative
23258,CLL,AbbVie US,Postive
23262,Leukemia CLL,Targeted Oncology,Negative
23263,CLL,MDedge Hematology Oncology,Negative
23264,CLL Atlanta WinshipAtEmory EmoryMedicine,Patient Power,Negative
23266,CLL,Blood Advances,Negative
23267,Watch Purva Lad CLL Wesley Bishop first LivingWell,Patient Power,Negative
23268,MRD CLL Drs John Gribben BartsHospital Barbara Eichhorst Andrew Rawstron,Medscape Education,Negative
23269,Melanoma CLL,CancerWallonia,Negative
23270,two thousand and,RazzleTazzle,Negative
23271,Chronic,dough,Negative
23272,CLL Emotional Support nineteen October two thousand and eighteen,CLL Ireland,Postive
23274,Obinutuzumab,Medivizor,Negative
23275,CLL ImmuneSystem Prevention HemOnc HemeOnc,VJHemOnc,Negative
23276,Six,Norm Stahl,Negative
23277,Brander DukeCancer,Targeted Oncology,Postive
23278,SciReports,The Nanopore Site,Negative
23280,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Indy Wrestling Chile,Negative
23281,CLL six hundred CLL,CLL Ireland,Negative
23282,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Don Pepex,Negative
23283,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,The Pepex Family,Negative
23284,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
23285,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
23286,Melanoma CLL,melanomacan,Negative
23287,VIDEO Does CLL MURANO Arnon Kater Leukemia CLLsm HemeOnc,VJHemOnc,Negative
23288,Melanoma Study,CLL Society Inc,Negative
23290,zero three hundred and two zero three hundred and two CLL,Bikudo,Negative
23291,CAR,Targeted Oncology,Postive
23292,CLL,Kathleen Hoffman,Negative
23293,CLL Jacqueline Barrientos PatientEducation MedEd,The Patient Channel,Postive
23294,Duvelisib one,Cancer Papers,Negative
23295,Duvelisib one,Lymphoma Papers,Negative
23298,Wesley Bishop East Texas CLL Wesley,Andrew Schorr,Postive
23299,fifty Bearish List IGAS RIV SLA RCN CLL,SwingTradeBot UK,Negative
23300,one CLL,AbbVie US,Postive
23301,Download Bethesda Handbook Clinical Hematology MedEd,Oncology Times,Negative
23302,Bristol CLLSA CLL,CLLSA,Postive
23303,CLL,MDedge Hematology Oncology,Negative
23306,CLL,MDedge Hematology Oncology,Negative
23307,Frontline CLL Option seven hundred CLL rituximab obinutuzumab head head,CLL Ireland,Negative
23308,CLL one Lamanna ColumbiaMed,Patient Power,Postive
23314,Melanoma Study,Jenkers News ENG,Negative
23316,Hindustan Times,Doctr,Negative
23317,Ibrutinib,Welty,Postive
23318,Melanoma,Mein Doppelganger,Negative
23319,CLL three month IMBRUVICA US Please,Patient Power,Postive
23321,CLL One,AbbVie US,Postive
23322,UK CLL NHSEngland Ibrutinib month,CLLSA,Postive
23323,Arnon Kater CLL CLLsm HCSM,VJHemOnc,Negative
23325,CLL six hundred,John Williams,Negative
23329,CLL proudDad KyleBradleyMD JMGardnerMD,Juan Carlos Garces,Negative
23330,Sandra CLL CancerMoonshot,MD Anderson Cancer Center,Negative
23331,obinutuzumab CLL,Targeted Oncology,Postive
23332,CLL,Patient Power,Postive
23333,Dominik Wodarz University California Irvine Happening,SIAM,Negative
23334,CLL CLL,Sofia Garces MD,Negative
23335,und von Menschen Krebs RuderngegenKrebs Informationen zur chronischen Leukamie CLL,AbbVie Deutschland,Negative
23337,Ray He Nuneaton today CLL week,CLL Warwick Uni,Negative
23338,CLL Family,AbbVie US,Postive
23339,one CLL AML Novartis US,NovartisOncTrialsUS,Postive
23340,CLL Wesley Bishop CLL Watch,Patient Power,Negative
23341,five year ago Mother Chronic,Amie,Postive
23343,RolfatWarwick CLL worldcatday,CLL Warwick Uni,Negative
23345,CLL,Kathleen Hoffman,Negative
23346,CLL ColumbiaMed Nicole Lamanna BoneMarrowBiopsy,Andrew Schorr,Negative
23347,Central,Angela Reeves Tate,Negative
23348,Identify GenoptixInc MRD Help CancerProgression CLL,GenoptixInc,Negative
23350,Lymphoma Vol,filippo masini,Negative
23352,anthonymatomd,Targeted Oncology,Postive
23353,Venclexta CLL CLL Susan Brien,Patient Power,Postive
23355,Nuneaton today Thursday CLL Library Tour week,CLL Warwick Uni,Negative
23356,CLL,Targeted Oncology,Postive
23357,three obinutuzumab CLL,Targeted Oncology,Negative
23358,CLL Renowned CLL Nicole Lamanna ColumbiaMed today CLL,Andrew Schorr,Postive
23359,General Aviation Terminal,Chef Tai Lee,Negative
23360,CLL SLL Determination,AbbVie US,Postive
23361,ICYMI BritSocHaem LymphomaMatters CLL Haematology,LymphomaAction,Negative
23363,CLL CLL ColumbiaMed,Patient Power,Negative
23365,Check Obinutuzumab,Medivizor,Negative
23366,karyotype disruption,histopathology,Negative
23367,Classic Chronic Clumped Leukaemia,Swathi Prabhu MD,Negative
23368,Kogyo Rituxan rituximab Japan,MEDWAVE,Negative
23369,CLL HPA CLL,Proactive Australia,Negative
23370,Barrientos CLL,Targeted Oncology,Negative
23372,WATCH William Wierda,Oncology Times,Negative
23373,Today two thousand and George Duke,Uncle Duke,Negative
23374,two thousand thirteen GeorgeDuke TWIMH onthisday,Teddy Ruxspizzle,Negative
23377,Rai MD forty year Hematologic Malignancies two thousand and Giants,Cancer News,Postive
23378,CLL,Kathleen Hoffman,Negative
23379,CLL BloodJournal,CLL Ireland,Negative
23382,New Transplant,Medivizor,Negative
23383,NorthwellHealth CancerResearch,Targeted Oncology,Negative
23384,CLL,Amy Cavers,Postive
23385,CLL Grace Cherry Barbara Rogers Laura Zitella Michael Ball Chicago School Of Nursing Oncology four,donnashort,Negative
23389,Obinutuzumab,Medivizor,Negative
23390,CLL Lamanna ColumbiaMed,Patient Power,Postive
23391,CLL,AbbVie US,Negative
23392,CLL first CLLHeroes,CURE Magazine,Postive
23393,LighttheNight Jerry five LLSCanada,Tim James,Negative
23395,BSI BSI CLL,BSI America,Postive
23396,CLL,Blood Journal,Negative
23397,CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
23399,VIDEO Current CLL John Gribben,The Patient Channel,Negative
23400,Emma Leamington today CLL WarwickHistory,CLL Warwick Uni,Negative
23401,Bantay Bata one hundred three,Kapamilya Defenders,Negative
23402,Bantay Bata one hundred three,Entertainment,Negative
23403,MD The Ohio State University Comprehensive,Abdullah Al Mosabbir,Postive
23404,Xue Sheng Shi Lu Huang Xue Da Xue Lu Yong Cu Jin pj Lu pasupoto Xue Sheng Shi Lu Lu,Huang Xue Guan Da Xue mieShi Lu pasupotoLi Yong Cu Jin PJ,Negative
23405,WATCH William Wierda,Oncology Times,Negative
23406,CLL,AbbVie US,Postive
23408,NEW Chemoimmunotherapy CLL CLL,Home Journal,Negative
23409,Carol Preston five CLL CLL,Patient Power,Postive
23410,CLL Michele five LivingWell,Patient Power,Postive
23411,WarwickHolidayScheme CLL,CLL Warwick Uni,Negative
23413,Smudge Gumprecht CLL Vimentin,Mario MD,Negative
23414,Comprehensive Safety Analysis Venetoclax Monotherapy Patients Chronic,Cure Cancer Now,Postive
23415,one two thousand and seventeen one one Cancer,TheDayThatChangedMyL,Negative
23416,CLL Renowned Nicole Lamanna ColumbiaMed today CLL,Patient Power,Negative
23417,CLL,AbbVie US,Postive
23418,Benzene Lymphoma NHL Acute Myeloid AML Acute Lymphocytic Myeloma Aplastic Anemia,Matthews Associates,Postive
23419,CLL,Patient Empowerment Network,Negative
23420,Learn Larry CLL,Patient Power,Postive
23421,Lymphoma,Lymphoma Papers,Negative
23422,First,Andrea MS BS,Negative
23423,Haematologica Adherence Western Prudent Mediterranean,IUOPA,Negative
23424,CLL rituximab French Innovative Leukemia Organization FILO,Raul Cordoba MD PhD,Postive
23425,rituximab French Innovative Leukemia Organization FILO,GEDEFO,Postive
23426,CLL,AbbVie,Postive
23427,CLL CLL,AbbVie,Negative
23428,CLL CLL,AbbVie,Negative
23429,CLL,AbbVie,Postive
23430,one CLL,AbbVie,Postive
23431,CLL,AbbVie,Postive
23432,six hundred CLL ThorstenZenz Arnon Kater CLL,Lab,Postive
23433,one four Ahh four week CLL,Amanda Wysokowski,Negative
23434,CLL,AbbVie US,Negative
23435,CLL Lamanna ColumbiaMed LivingWell,Patient Power,Negative
23436,NHL Hodgkin CLL Join Basingstoke,Helen Jane Mee,Postive
23437,VIDEO NovelTherapies CLL Guy Pratt Leukemia CaxTx Leusm,VJHemOnc,Negative
23438,Leamington Library today Friday CLL Library Tour week,CLL Warwick Uni,Negative
23439,Lymphoma Patient Research Registry CLL,Mekki MacAulay PEng PhD,Postive
23440,CLL CLL,AbbVie US,Negative
23441,ndy Hl@ DD Septicemia Dft Hj@ khr sh llh,`zyz knry,Negative
23443,CLL CLL,DawnKA,Negative
23444,CLL Lamanna ColumbiaMed,Patient Power,Negative
23445,one CLL year FriendshipDay,CLL Warwick Uni,Postive
23446,CLL ClinicalTrials NovelTherapy,VJHemOnc,Negative
23448,CLL,Kathleen Hoffman,Negative
23449,Duvelisib FCR CLL DanaFarber Leusm CLLsm HemeOnc,VJHemOnc,Postive
23452,New Medivizor Ibrutinib,Medivizor,Negative
23453,May two thousand and ten Medifocus,Shop Like Freak,Negative
23454,SmirnoffNg LeoNigeria NascoGroup CLL,Concessionary,Postive
23455,mosaic UK Biobank Harvard CLL,Home Journal,Negative
23456,CLL one Lamanna ColumbiaMed,Patient Power,Postive
23457,CLL Keating Ferrajoli Lamanna ColumbiaMed CLL,Andrew Schorr,Negative
23459,Watch CLL ColumbiaMed CLL,Patient Power,Negative
23460,Marek Mraz Starting Grant Signaling Propensity Microenvironment,CEITEC,Postive
23461,"one thousand, nine hundred GlennSabin Today Glenn Learn",Radical Remission,Negative
23462,Paolo Ghia CLL Leukemia Leukaemia HemeOnc GeneticTesting ChronicLymphocyticLeukemia NovelTherapy,VJHemOnc,Negative
23463,CLL BritSocHaem CLL,MedShr,Negative
23464,Two CLL,AbbVie,Negative
23465,JenWinSaunders CLL,Michael Wilburn,Negative
23466,CLL Drs John Seymour William Wierda,Medscape Education,Negative
23467,today CLL,CURE Magazine,Negative
23469,CLL,Patient Power,Postive
23470,Venetoclax,Medivizor,Negative
23471,CLL,Anna Deveau,Negative
23472,Minutes Ed Bradley,Cancer Today,Negative
23473,CLL CLL,Patient Power,Negative
23474,CLL,Kathleen Hoffman,Negative
23475,Kudos CLL,Adriana Scarcella Froncillo,Negative
23476,CLL David LivingWell PowerfulPatient,Patient Power,Negative
23477,CLL,Delphine Klein,Negative
23478,Wu Chen Chen Zhang,NK paper,Negative
23479,Joe CLL Lymphocytic Leukemia many year,PBC,Postive
23480,CLL Carol Preston five CLL,Patient Empowerment Network,Negative
23482,Smudge Smudge CLL,Internist,Negative
23483,CLL Leamington Library next week thirty July five August,CLL Warwick Uni,Negative
23484,Barrientos NorthwellHealth CLL,Targeted Oncology,Negative
23485,CLL two,AbbVie,Negative
23486,tonight Callout Crew,Lodge two hundred and eighty,Postive
23487,FDA Combination Rituximab Fixed CLL,Rob Wilson,Negative
23489,MD Anderson Cancer William Wierda TuesdayThoughts,Oncology Times,Negative
23490,MD,COPD News,Negative
23492,FAN CLL,SwingTradeBot UK,Negative
23493,CLL Michele tomorrow,Patient Power,Postive
23494,Scan Stochastic Sell Signal LEK GLTR CLL MYI TSL PIER,SwingTradeBot UK,Negative
23495,CLL CLL Carol Preston five CLL,Andrew Schorr,Negative
23496,Time CLL Michele five,Andrew Schorr,Postive
23497,CLL,Rob Wilson,Postive
23498,MRDFocus Discover HemOnc,VJHemOnc,Postive
23499,New Medivizor Venetoclax,Medivizor,Negative
23500,Venetoclax,Medivizor,Negative
23501,Venclexta CLL CLL Susan Brien,Patient Power,Postive
23502,Mato,Targeted Oncology,Negative
23503,MRD CLL Florence Cymbalista APHP,VJHemOnc,Negative
23504,Brander Leusm,Targeted Oncology,Negative
23505,OverallSurvival Health Care Costs Medicare Patients Previously Treated Chronic,Scirp Papers,Negative
23506,Kameron Anderson Kitchkinet,Lodge two hundred and eighty,Postive
23508,The Food Drug Administration Venclexta,National Cancer Institute,Negative
23509,Anthony Mato MD MSCE,COPD News,Negative
23510,Results PROFILES OpenAccess,ACS Journal Cancer,Negative
23511,The Prognostic Significance Clone Size CLL Patients MURANOStudy ChronicLymphocyticLeukaemia,touchONCOLOGY,Negative
23512,CLL MRDFocus ChronicLymphocyticLeukemia HemOnc Leukemia CLLsm,VJHemOnc,Negative
23513,CLL CLL ColumbiaMed,Patient Power,Negative
23514,First,Boston,Negative
23515,CllSociety Brian Koffman CLL,AbbVie,Negative
23517,Gail Gary Canadian Gary CLL LymphomaCanada,CLL Ireland,Negative
23518,Today last day CLL first CLLHeroes,CURE Magazine,Postive
23519,Lymphoma CLL George Follows Lymsm Leusm PatientCare PatientEducation CancerTreatment,The Patient Channel,Negative
23520,one first year Maura year CLL,CLL Warwick Uni,Postive
23521,Bristol Friday Chris Fegan Stephen Man CLL,CLLSA,Postive
23522,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
23524,CLL Token Exchange EasyTrade Cryptoexchange Exchangelisting,CryptoLiveLeak,Negative
23525,Andy Moore Andy Buclaw John CLLSA Goodluck CLL,CLLSA,Postive
23526,InflectionBiosciences CLL,EPM Magazine,Negative
23527,CLL Jacqueline Barrientos BMTSM Leusm,The Patient Channel,Postive
23528,Andy Moore Andy Buclaw today CLL,CLLSA,Postive
23529,ICYMI three CLL SLL,HemOnc Today,Negative
23530,Ramon Amieva El Fantasma presidente de la CLL Lucha Patrimonio Cultural de la Ciudad de Mexico CLL,TVBUS Noticias de Oaxaca,Negative
23531,CLL,Kathleen Hoffman,Negative
23532,Venetoclax,Medivizor,Negative
23533,Check Transplant,Medivizor,Negative
23534,CLL CLL Lamanna ColumbiaMed,Andrew Schorr,Negative
23535,three Asembia Live Webinar July five eight pm ET Chronic,PharmacyTimesCE,Postive
23536,Download Bethesda Handbook Clinical Hematology MedEd,Oncology Times,Negative
23537,CLL Symposium August CLLsm Registration,Alan Skarbnik,Negative
23538,CLL Monday CLL,CURE Magazine,Postive
23539,first,CancerTherapyAdvisor,Negative
23540,last night kickcancerinthedick leukemiaandlymphomasociety CLL,Amanda Marie,Negative
23541,Lu pasupoto Shen Du ri Huang Xue Guan Xue Shi,Huang Xue Guan Da Xue mieShi Lu pasupotoLi Yong Cu Jin PJ,Negative
23543,GeneticTests CLL,Patient Power,Negative
23544,Florence Cymbalista Minimal Residual Disease CLL FCR Chemotherapy,CLL Ireland,Negative
23545,NHL Hodgkin CLL eight St Glasgow Scotland CRUKScotland CRUKGlasgow,LiveYourLife,Postive
23546,CLARITY CLL Peter Hillmen MRD,VJHemOnc,Postive
23547,Bristol CLL FridayFeeling,CLLSA,Postive
23548,New Medivizor Transplant,Medivizor,Negative
23549,today CLL,SwingTradeBot UK,Negative
23550,MURANO CLL RELEVANCE Live OncologyGo,OncologyGo,Negative
23551,CLL,Kathleen Hoffman,Negative
23552,Acute,Essay Yard,Negative
23553,ELIAS,Oncobell Symposium,Negative
23554,five,Michele,Negative
23555,CLL Michele five LivingWell,Patient Power,Postive
23556,CLL Cancer Immunology Research,Retrogenix,Negative
23557,CLL,CancerDotNet,Negative
23558,Pneumonia Bored Tired Trials CLL,Damian Bullimore,Postive
23559,CLL Margins Health one,WheelieDealer,Negative
23560,Elias Campos,Oncobell Symposium,Negative
23561,CLL Summer FREE Seminars,CLL Warwick Uni,Postive
23562,CLL Derriford Plymouth Wednesday July,CLLSA,Postive
23563,AIM CLL Cello Health PLC Trading Update,AIM Alerts,Negative
23566,CLL,Matthews Associates,Negative
23568,CLL Roundup,Matthews Associates,Negative
23569,CLL Lawsuit,Matthews Associates,Negative
23571,today CLL,SwingTradeBot UK,Negative
23572,CLL,CLLSA,Postive
23573,InflectionBiosciences CLL,EPM Magazine,Negative
23574,American two thousand and eighteen Memorial Sloan,Zusia Dr Jackie Volk,Negative
23575,CLL Support Group July CLL,Derriford Hospital,Postive
23576,CLL Support Group July CLL,University Hospitals Plymouth NHS Trust,Postive
23577,Biolytica CERTHellas CLL,AEGLE,Negative
23578,one CLL four half year one Ferrajoli,Andrew Schorr,Negative
23579,CLL Lamanna ColumbiaMed LivingWell,Patient Power,Negative
23580,InflectionBiosciences CLL,EPM Magazine,Negative
23581,CLL Australian Melanoma,CLL Ireland,Negative
23582,CLL ColumbiaMed,Patient Power,Negative
23583,Congratulations,Sara Hattersley,Postive
23584,Lymphoma CLL George Follows,The Patient Channel,Negative
23585,Gail Wiegman CLLSA Gail Thomas Benedict Linda Cathy Sunday CLL,CLLSA,Postive
23586,CLL,Vijaya,Negative
23587,CLL,Vijaya,Negative
23589,Primeros se van lo digital los Onii ChanchoFelipe ZG CLL,Yuriko Suzuki,Negative
23590,tgtx sn CLL,Anna Deveau,Negative
23591,MSKCC CLL CllSociety,Anthony Mato,Postive
23593,CLL,Targeted Oncology,Negative
23594,CLL Lamanna ColumbiaMed,Patient Power,Negative
23596,CLL John Gribben CLL,CLL Ireland,Postive
23597,last decade CLL,Leukaemia Care,Negative
23598,CLL Learn Drs John Seymour William Wierda,Medscape Education,Negative
23600,Resolution Eosinophilia Elevated,Cancer Papers,Negative
23601,Stephen Robinson UHBristolNHS CAR HematologicalMalignancies BritSocHaem Leusm HemOnc MMSM AML CellularTherapy,VJHemOnc,Postive
23602,AIM CLL Cello Health PLC Change,AIM Alerts,Negative
23603,Hematology Oncology two thousand and,Vijaya,Negative
23605,Exciting Advances Treatment Patients Chronic CLL,CONQUER patient voice,Negative
23606,three month CLLSA Thankyou MondayMotivation CLL,CLLSA,Postive
23607,CLL,Blood Journal,Negative
23609,two thousand and eighteen,Vijaya,Negative
23610,Watch William Wierda University Texas Anderson Cancer Center,Oncology Times,Negative
23611,six,Internal Medicine Open Access,Negative
23612,CLL,SpecialtyPTimes,Negative
23613,Nick Rawlings yesterday CLLSA Show CLL,CLLSA,Postive
23614,Davids,Targeted Oncology,Negative
23615,Imbruvica Mantle Cell CancerDrugs OncologyDrugs,Medicine For World,Negative
23616,CLL BloodJournal,ASH,Negative
23617,CLL Chris Fegan BritSocHaem CARTcells ImmunoOnc NovelTherapy Leusm Genetics TelomereShortening,VJHemOnc,Negative
23619,Kay CLL,Targeted Oncology,Negative
23620,CLL Platt Admissions,CLL Warwick Uni,Negative
23622,CLL,Smitt Wesson,Negative
23623,CLL,Kathleen Hoffman,Negative
23624,CLL,Targeted Oncology,Negative
23625,BloodAdvances,ASH,Negative
23627,AML NCCN Leukemia Congress August Columbus Ohio amlsm cllsm,National Comprehensive Cancer Network NCCN,Postive
23628,Read CLL Leusm,Targeted Oncology,Negative
23630,Mauro TKI CML Deeper CML,Graham Collins,Negative
23634,one CLL,Robert Orlowski,Negative
23635,Obinutuzumab,Targeted Oncology,Postive
23636,Moxetumomab NCIMedia CLL,Oncology Tube,Negative
23637,The Food Drug Administration Venclexta,National Cancer Institute,Negative
23638,New Lymphoma Leukemia Resource Center Watch William Wierda,Oncology Times,Negative
23640,CLL Denny Marchel one Read Denny Juli Bonneville Speedway,The Leukemia Lymphoma Society,Negative
23641,New Ibrutinib,Medivizor,Negative
23642,Watch CLL ColumbiaMed,Patient Power,Negative
23643,Check Ibrutinib,Medivizor,Negative
23647,America CLL morning Gothia GothiaCup Denmark,Lucy Mills,Negative
23648,VIDEO Promises CLL Jennifer Woyach BritSocHaem Leusm HemOnc NovelTherapy HemeOnc BTK Leukemia Relapse Refractory,VJHemOnc,Negative
23650,BTK CLL Letter BloodJournal DanaFarber IFD,Francisco Marty MD,Negative
23651,CLL,Liz Brem,Negative
23652,CLL,Targeted Oncology,Negative
23653,Canadian David CLL CLL Niagara Falls,Andrew Schorr,Negative
23654,FollicularLymphoma CLL Please autumn,Patient Power,Postive
23655,CLL,Kathleen Hoffman,Negative
23656,CLL David LivingWell PowerfulPatient,Patient Power,Negative
23657,JimJUK PGDE,CLL Warwick Uni,Negative
23658,CLL Summer Social summer,CLL Warwick Uni,Negative
23660,Ibrutinib Imbruvica Venclexta CLL MRD ASCO,CLL Ireland,Negative
23661,VIDEO Current CLL John Gribben Leusm idelalisib rituximab,The Patient Channel,Negative
23662,CLL,CLLSA,Postive
23663,CLL,Oncology Tube,Negative
23664,Tolerance CLL Penn VJHemonc,Oncology Tube,Negative
23665,CLL,Oncology Tube,Negative
23666,CLL chance nominate first CLLHeroes,CURE Magazine,Postive
23667,Robert Talley MD SarahCannonDocs CAPTIVATE,OncLive SOSS,Negative
23669,Lymphomas Bethesda MedEd,Oncology Times,Negative
23671,CLL Anthony Mato BTK,CLL Ireland,Negative
23672,DrGinaEagle LiverpoolUni SCIEXnews,British Society Proteome Research,Postive
23673,Lymphoma CLL George Follows DrugAccess,The Patient Channel,Negative
23675,The Food Drug Administration FDA CLL SLL,CheckRare,Postive
23676,one CLL four half year,Andrew Schorr,Negative
23677,CLL Drs John Seymour William Wierda,Medscape Education,Postive
23678,Immunoglobulin first CLL Mutational one thousand three,Garbine Lizeaga,Negative
23679,one Chronic today one one three four one,Dan Radford,Postive
23680,one CLL,Blood Journal,Negative
23682,CLL ColumbiaMed,Patient Power,Negative
23683,Tolerance Alternative Kinase Inhibitors CLL CLLWarwick,HappiDoc,Negative
23684,Phas PubMed,BibliotecaHUVH ICS,Negative
23685,BestTherapy YoungPatient CLL Jacqueline Barrientos,The Patient Channel,Negative
23687,CLL,Talal Hilal,Negative
23688,CLL SLL Office Patient Recruitment NIH,NIH Clinical Center,Negative
23689,MondayMotivation Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
23690,CLL,Kathleen Hoffman,Negative
23691,MGEN,Dan Cohen,Negative
23692,PhII CLL,Luisa Izzi,Negative
23693,MRD first six Wierda MDAndersonNews,Targeted Oncology,Postive
23696,three Read PFS CLL,Targeted Oncology,Negative
23697,Osteomyelitis Chronic Fatigue Chronic NHS,Tony Rothwell,Negative
23698,Earlier last month FDA CLL Read CLL,Targeted Oncology,Postive
23699,VIDEO MRD CLL Peter Hillmen,VJHemOnc,Negative
23701,MarlenMurillo CLL,Corporacion Lady Lee,Postive
23704,CLL,Home Journal,Negative
23705,CRISPR ProstateCancer CLL,Nancy Gough PhD,Negative
23706,Kay CLL,Targeted Oncology,Negative
23707,CLL FCR twentyfour month,Home Journal,Negative
23708,DOWNLOAD SLIDES Defining What Care Patients Chronic CLL,Carevive,Negative
23709,VIDEO Tolerance KinaseInhibitors CLL ASCO Leusm Leukemia BTKInhibitors PFS TreatmentToxicity,VJHemOnc,Negative
23710,GeneticTests CLL,Patient Power,Negative
23711,UniofOxford,EGA archive,Negative
23712,three CLL RMLL,Mahmoud Turki,Negative
23713,CLL FCR Nicole Lamanna ColumbiaMed CLL,Patient Power,Negative
23714,three CLL CLL,Targeted Oncology,Negative
23715,CIPFciencia CLL Cytometry,CIPF,Negative
23716,Bendamustine Rituximab UK,Dr Comeau MD,Negative
23718,Ibrutinib Rituximab one CLL CLLsm,Raul Cordoba MD PhD,Negative
23719,Haematologica,CLL Society Inc,Negative
23720,EYFS,Wolverhampton LTT,Negative
23721,PIM CLL Wiley Online,Michael,Negative
23723,CLL,Rhoda,Negative
23725,The Food Drug Administration FDA Venetoclax CLL FDA NationalCancerInstitute NCI,NFCR,Postive
23726,Midmark Teammates two Mark Thomas three hundred and thirty Midmark two,Midmark News,Postive
23727,CLL CLLsm,Raul Cordoba MD PhD,Negative
23728,CLL Allstars,Vincent McKee,Negative
23729,CLL Deborah Sims John Seymour,CLL Ireland,Negative
23730,Expression Chronic Lymphocytic,Medical Surgical Pathology,Negative
23731,Olaparib ProstateCancer CLL Andrew Jackson,Arnaud Legrand,Negative
23734,CLL Summer Social Our Centre summer summer,CLL Warwick Uni,Postive
23735,CLL Peter Hillmen MeasurableResidualDisese Leusm,VJHemOnc,Negative
23736,Leukemia,PatientMD,Negative
23737,CLL,Kathleen Hoffman,Negative
23738,Blackburn September LymphomaAction NHL CLL,LiveYourLife,Postive
23740,Birmingham today CLL WednesdayWisdom,CLLSA,Negative
23741,CLL,Blood Journal,Negative
23742,CLL ColumbiaMed,Patient Power,Negative
23743,PrimeView CLL,Nature Reviews Disease Primers,Negative
23744,CLL,Blood Advances,Negative
23745,CLL,Cancer Papers,Negative
23746,RT TargetedOnc June FDA FDA melsm lymsm,Catalyst Trading,Negative
23747,June FDA FDA melsm lymsm,Targeted Oncology,Negative
23748,Alison Job CLL two thousand and five,CLL Warwick Uni,Negative
23749,CLL obinutuzumab zanubrutinib Peter Hillmen HemOnc Leukemia Antibodies,VJHemOnc,Negative
23750,Elias Campos first Cancer,Oncobell Symposium,Negative
23751,twenty tomorrow okc cll,The Fried Taco OKC,Negative
23752,Scan today CLL,SwingTradeBot UK,Negative
23753,rituximab first UK CLL FORUM,Garbine Lizeaga,Negative
23754,CLL,MedSource,Negative
23755,MURANO CLL theNCI,Emre Eskazan MD,Negative
23756,The Food Drug Administration Venclexta,National Cancer Institute,Negative
23758,two thousand and seventeen Ibrutinib NICEcomms LeukaemiaCareUK,Adrian Warnock,Negative
23759,CLL Thomas Kipps,Patient Power,Negative
23760,VIDEO Moxetumomab Robert Kreitman theNCI ASCO CLL ImmunoOnc,VJHemOnc,Negative
23762,Naeste Temadag Sep Kbh handler AML Saet AUHdk Rigshospitalet,LyLe Foreningen,Postive
23763,CLL Learn Laura Zitella Drs Bethfaiman KurtinSandra,Medscape Education,Negative
23764,CLL Samantha Ecuador,Andrew Schorr,Negative
23765,CLL,MDedge Hematology Oncology,Negative
23766,FDA CLL SLL,LLS National Capital,Negative
23767,UniCologne,MDLinx,Negative
23768,Grand Rounds BCell Malignancies Click one BTK CLL,CEC Oncology,Postive
23769,CLL,CLL Ireland,Negative
23771,CLL,Kathleen Hoffman,Negative
23772,CLL,Targeted Oncology,Postive
23773,last month CLL,CURE Magazine,Postive
23774,MRD PredictiveMarker CLL Peter Hillmen,VJHemOnc,Negative
23775,Asco Dr Talley,donnashort,Postive
23776,CLL CLL Cancer,Targeted Oncology,Negative
23777,Plasma Cell Malignancies Regional Summit Minneapolis Myeloma NHL,DAVA Oncology,Postive
23778,CLL Christopher Fox BritSocHaem Leusm Leukemia HemOnc TargetedTherapy,VJHemOnc,Negative
23779,CLL UCH Hospital London ShineCancer Bloodwise,Paul DuBois,Negative
23780,last decade CLL,Leukaemia Care,Negative
23781,CLL,PharmaFactz,Negative
23783,Tecfidera,Must Stop MS,Postive
23784,Global Industry two thousand and eighteen,Tech Journal Hub,Postive
23785,MDAndersonNews today CancerSucks MDAnderson CLL,Aly,Postive
23787,CLL Nicole Lamanna CLL,Patient Power,Negative
23789,today WestMidlands next eleven July Wolverhampton NHL HL CLL HWwolverhampton,LiveYourLife,Postive
23790,obinutuzumab,Medivizor,Negative
23791,CLL,Patient Power,Negative
23794,CLL,Univadis UK,Negative
23795,CLL ASCO Leusm HemOnc,VJHemOnc,Negative
23796,obinutuzumab obinutuzumab CLL Goede CLL,Targeted Oncology,Negative
23797,CLL,Anna Deveau,Postive
23800,CLL Mercatox Crypto Cryptoexchange CLL Cryptovote Binance Kucoin,CryptoLiveLeak,Negative
23801,CLL,Kathleen Hoffman,Negative
23802,CLL US FCR CLL Nicole Lamanna,Andrew Schorr,Negative
23803,Samuel Ng DanaFarber Hodgkin,WorldCare Medical Second Opinions,Negative
23804,two thousand and eighteen CLL CLLsm,Raul Cordoba MD PhD,Negative
23805,Venetoclax CLL,UpToDate,Negative
23806,obinutuzumab,Medivizor,Negative
23809,hemophilia,Hematology Conference,Negative
23810,Update CLL Sidnavigare Next CLL,Marta Crespo,Negative
23811,Venetoclax,EurekaMag,Negative
23812,one YouTube,Brian Mbuvi Mutiso,Negative
23813,Venetoclax,EurekaMag,Negative
23816,Venetoclax Patients Previously Treated Chronic,EurekaMag,Negative
23817,Venetoclax Management Care Patients With Relapsed Refractory,EurekaMag,Negative
23818,FCR,Targeted Oncology,Negative
23819,CLL LLSNatCap NYC,Anthony Mato,Postive
23820,CLL Pub BloodJournal Need CLL four Rai DrMatasar JohnPLeonardMD VinayPrasadMD,chadi nabhan MD MBA FACP,Negative
23821,CLL ColumbiaMed,Patient Power,Negative
23823,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
23824,Cancer Research UK one Pretty Muddy Saturday June two thousand and eighteen Chronic,Sophia Joseph,Negative
23825,New Post Combo Extends Undetectable Disease CLL,Lymphoma News Today,Negative
23827,obinutuzumab Leukemia,Medivizor,Negative
23828,Clinical Hematology AutoImmune Hemolytic,Archi Miedes,Negative
23830,TipTuesday Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
23831,CLL CLL Kipps UCSDHealth,Patient Power,Negative
23832,two thousand and eighteen East Tennessee Saturday June thirty ten,BillyLushBoards Brew,Negative
23833,CLL Michael Kea,CLL Ireland,Negative
23834,CLL Jacqueline Barrientos KnowledgeIsPower PatientEngagment,The Patient Channel,Postive
23835,CLL Florence Cymbalista Leukemia HemOnc,VJHemOnc,Negative
23836,today one Diagnosed ago cll four BRUTAL daily Survivor TeamToman CancerSucks,Ed Toman,Negative
23837,Susan UC Irvine CLL Venclexta Venclexta Rituxan,Andrew Schorr,Negative
23838,Al Dia Health News,CubaHeal,Postive
23839,ETH Cryptoliveleak,CryptoLiveLeak,Negative
23840,Chronic,OBR,Negative
23841,CLL,Anna Deveau,Negative
23842,FreeCryptocurrency AttentionMining today CLL CryptoNews,CryptoLiveLeak,Negative
23843,CLL CLcares,Saltanat Shafqat,Negative
23844,CLL Nicole Lamanna ColumbiaMed CLL,Patient Power,Postive
23846,CLL obinutuzumab chlorambucil,MDedge Hematology Oncology,Negative
23848,The Food Drug Administration Venclexta,National Cancer Institute,Negative
23849,CLL,Kathleen Hoffman,Negative
23850,Attention CLL Tokens CLL today CLL CLL Utilitytoken ETH BTC Crypto,CryptoLiveLeak,Negative
23851,three CLL,Targeted Oncology,Negative
23852,CLL Richard Furman CLL YouTube,CLL Ireland,Postive
23853,obinutuzumab,Medivizor,Negative
23855,obinutuzumab,Medivizor,Negative
23856,two thousand and eighteen,Markets Reports,Negative
23857,cll,Anna Deveau,Negative
23858,CLL,Anna Deveau,Negative
23859,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Indy Wrestling Chile,Negative
23860,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,The Pepex Family,Negative
23861,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
23862,HOY CLL ChileLuchaLibre IWC LuchaLibreChilena Pepex,Thu Pepex,Negative
23863,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23864,RT Rt HarmonynetEU VIDEO BigData HemOnc Europe Jesus Maria Hernandez Rivas CLL Leusm,Chared Good Comms,Postive
23865,VIDEO BigData HemOnc Europe Jesus Maria Hernandez Rivas CLL Leusm,European Hematology Association,Postive
23866,VIDEO BigData HemOnc Europe Jesus Maria Hernandez Rivas CLL HemeOnc,VJHemOnc,Postive
23867,Oxford LymphomaManagement today CLL lymsym,LymphomaAction,Negative
23869,Colorectal Cancer Charity,Colorectal Cancer Charity,Negative
23870,CLL Dr Lamanna Dr Borczuk,donnashort,Negative
23871,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23872,CLL Valentin Goede PressBriefing Leusm HemOnc,VJHemOnc,Negative
23873,last night eighteen nineteen year old two Towncroft CLL,Steve Hunsley,Postive
23874,CLL,chadi nabhan MD MBA FACP,Negative
23875,CLL,GLEZY,Negative
23876,CLL first CLLHeroes,CURE Magazine,Postive
23877,melsm,Danielle Ternyila,Negative
23879,fifty GAN CLL,SwingTradeBot UK,Negative
23882,news week Targeted Oncology Melanoma BreastCancer OvarianCancer,Targeted Oncology,Negative
23883,Kostas Stamatopoulos Semmelweis University,Csaba Bodor,Postive
23884,Tambien de Consulten con la primera LuchaLibrechilena Wrestler Cll,Giannina,Negative
23885,Estan,Giannina,Negative
23886,Nat Med,IUOPA,Negative
23887,CLL FCR Nicole Lamanna ColumbiaMed CLL,Patient Power,Negative
23888,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
23889,CLL Token Store CLL TokenStore Decentralizedexchange CLL,CryptoLiveLeak,Negative
23890,CLL,Kathleen Hoffman,Negative
23891,Brian Koffman Betsy Dennison CLL Society,Pillar Patient Advo,Postive
23892,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23893,MRD CLL,MDedge Hematology Oncology,Negative
23894,CLL,MDedge Hematology Oncology,Negative
23895,CLL Nicole Lamanna ColumbiaMed GeneticTesting CLL,Patient Power,Negative
23896,CLL CLLsm,Raul Cordoba MD PhD,Negative
23897,Autoimmune CLL CLLsm,Raul Cordoba MD PhD,Negative
23898,Spanish CLL Edition Educational Meeting CLL Sidnavigare next year,Raul Cordoba MD PhD,Postive
23899,Darwin NGS CLL,Raul Cordoba MD PhD,Negative
23900,Immunosuppressive Treg,ImmunologyPapers,Negative
23901,CLLsm,Raul Cordoba MD PhD,Negative
23902,CLL CLLsm,Raul Cordoba MD PhD,Negative
23903,nine IkBz,Autophagy Papers,Negative
23904,seventytwo BTK,CLL Ireland,Negative
23905,CLL CLLsm,Raul Cordoba MD PhD,Negative
23906,Moscow Russia Share,World Neonatology Congress,Negative
23907,rituximab CLL CLL,AU Oncology Reviews,Negative
23908,CLL,Targeted Oncology,Negative
23909,FDA two CLL Learn Hematology Hub,Gary Ross,Negative
23910,CLL,Blood Journal,Postive
23911,four CLL,Gitte Pedersen,Negative
23912,FDA two CLL Learn Hematology Hub,JennyB,Negative
23913,CllSociety Deborah Sims CLL Venetoclax,CLL Ireland,Postive
23914,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23915,one CLL one monthly CLL Tom Kipps UCSDHealth,Andrew Schorr,Negative
23916,CLL CLL,Hematology News,Negative
23917,CLL SLL,Talbot Research Library Media Services,Negative
23918,Davids FCR CLL CLL,Targeted Oncology,Negative
23919,FDA SLL del Venclexta,MDedge Hematology Oncology,Negative
23920,CLL Jacqueline Barrientos ChronicLymphocyticLeukemia,The Patient Channel,Negative
23922,CLL,Anna Deveau,Negative
23923,Kinase Inhibitor CLL AML,Anna Deveau,Postive
23925,Autoimmune,Cancer Papers,Negative
23927,CLL Tx,chadi nabhan MD MBA FACP,Postive
23928,Check Bendamustine,Medivizor,Negative
23929,Safety Chronic Lymphocytic Leukemia Combination Therapy Fair Number Hematologic,Oncology Tube,Negative
23930,today monthly,Anthony,Negative
23931,FDA Approves New Treatment Option Previously Treated Chronic genentech,Cord Blood News,Negative
23932,CLL seventy year old Weirda CLL,Targeted Oncology,Negative
23933,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23934,CLL Thomas Kipps,Patient Power,Negative
23935,CLL FCR CLL,Targeted Oncology,Postive
23938,AIM CLL Cello Health PLC Holding Company,AIM Alerts,Negative
23939,rschilsky highlighting CLL,chadi nabhan MD MBA FACP,Negative
23940,United States PubMed,Richard Schilsky,Negative
23941,thirteen,Government PEI,Negative
23942,Daniel EYFS Melvin CLL,Barton Clough Primary School,Postive
23943,CLL July Book,CLL Warwick Uni,Postive
23945,three,AmericanPharmacyNews,Negative
23946,FDA Combination Rituximab,AmericanPharmacyNews,Negative
23947,CLL one monthly Tom Kipps UC San Diego Health cll,Andrew Schorr,Negative
23949,FDA CLL Venetoclax Rituxumab one,Andrew Schorr,Postive
23951,BTK,Home Journal,Postive
23953,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23954,de nouvelles donnees de de phase three MURANO Venclyxto Abbvie rituximab dans la,oncohebdo,Negative
23955,Tomorrow one CLL Susan UCIrvine Venclexta,Andrew Schorr,Negative
23956,Deciphering Functional Chronic Manuel Fuentes CHPP,ProteoRed ISCIII,Negative
23957,Azacitidine AML AZA CLL,Joanna Zawacka Pankau,Postive
23958,Peter Hillmen MRD CLL CLL next five year,CLL Ireland,Negative
23959,CLL All Personal Health,ALL UNIVERSITY NEWS,Negative
23960,Neue Medikamente Chancen Lymphatischer Leukamie CLL Jetzt von einem,Pharma Fakten,Negative
23962,Genentech FDA genentech,Hematopoiesis News,Negative
23964,FDA,Home Journal,Negative
23965,FDA CLL,Pharmacy Practice News,Postive
23966,Ella Azusa California million,EKLLRF,Postive
23967,Venetoclax,Medivizor,Negative
23968,MRD CLL,Squared Communications,Negative
23969,CLL,Kathleen Hoffman,Negative
23970,Value Innovation News CLL CLL,CryptoLiveLeak,Postive
23972,EHA livskvalitet laes CLL,LyLe Foreningen,Postive
23973,New Medivizor Venetoclax Leukemia,Medivizor,Negative
23974,CLL kan,LyLe Foreningen,Negative
23975,CLL,Blood Advances,Negative
23976,La Lydia Scarfo al il Congresso,Uni San Raffaele,Negative
23978,EHA Sore two Yasuragi CLL MF FoodBetterThanExpected FemSmaHus LeRouge NoshAndChow GriffinsSteak Meatballs,Amy Cavers,Postive
23979,EHA Sore two Yasuragi CLL MF FoodBetterThanExpected FemSmaHus LeRouge NoshAndChow GriffinsSteak Meatballs,Amy Cavers,Postive
23980,Bcells CLL,Prof John,Negative
23981,Chronic Leukemia CLL,Leukemia Helpline,Negative
23982,Kay Big four,Targeted Oncology,Negative
23983,Barrientos Ibrutinib ChronicLymphocyticLeukemia,Targeted Oncology,Postive
23986,CLL AML year congress,AbbVie,Postive
23987,BloodJournal,ASH,Negative
23988,Ode Demazong Sikkim,TEDxGangtok,Postive
23989,Patrick Thornton Venetoclax Lymphocytic CLL Ireland CllIreland two thousand and eighteen Information Day Dublin Ireland,CLL Ireland,Negative
23990,Fraietta CLL,Targeted Oncology,Postive
23991,Lina CLL NKRdata,Avinash Dinmohamed,Negative
23992,Strefford Bloodwise CLL,Blood Cancer UK,Negative
23994,today Andrew Wei ALL Lina Straten CLL,VJHemOnc,Postive
23995,Arnon Kater CLL obinutuzumab CTSM,VJHemOnc,Postive
23997,Last day first CLL,Beth Torr,Negative
23998,cll,Anna Deveau,Negative
23999,Breakthrough CLL AML CTSM,VJHemOnc,Postive
24000,Swiss CLL,Marek Trneny,Postive
24001,Venetoclax,Medivizor,Negative
24002,RT Rt HarmonynetEU CLL HARMONY LA four thousand Ericllorg,Chared Good Comms,Postive
24003,CLL HARMONY LA four thousand Ericllorg,European Hematology Association,Postive
24004,CLL HARMONY LA four thousand Ericllorg,HARMONY Alliance,Postive
24005,AML CLL,Leukaemia Care,Postive
24006,JanssenGlobal First coming week CLL AML,Chared Good Comms,Postive
24007,JanssenGlobal First coming week CLL AML,European Hematology Association,Postive
24008,HARMONY JanssenGlobal First coming week CLL AML,HARMONY Alliance,Postive
24009,fourteen eighteen trisomy twelve,Cancer Papers,Negative
24010,Australian CLL ZPWLC,Leukaemia Care,Negative
24011,today William Wierda Maria Cappellini CLL,VJHemOnc,Postive
24012,Twitter ClinicalExperts CLL Leukemia Leusm,VJHemOnc,Negative
24013,Grace Anthony Mato half KI Intolerance CLL Classy Calm,Amy Cavers,Postive
24014,Umbralisib CLL KI,chadi nabhan MD MBA FACP,Negative
24015,CLL today,chadi nabhan MD MBA FACP,Negative
24016,FCR CLL,chadi nabhan MD MBA FACP,Negative
24017,CLL today,chadi nabhan MD MBA FACP,Negative
24018,Younger CLL FCR,Beth Torr,Negative
24019,MRD CLL,George Ioannidis,Negative
24020,MRD CLL Learn,AbbVie,Negative
24021,CLL Anthony Mato MSK CLL,Memorial Sloan Kettering Cancer Center,Negative
24022,Pete Hillmen Leeds MRD three MURANO CLL rituximab,Beth Torr,Negative
24023,today CLL,CURE Magazine,Negative
24024,three Victoria Hall,Medklik,Negative
24025,three Victoria Hall,Roche,Negative
24026,today,Medklik,Negative
24027,Time WT five,Toby Eyre,Negative
24028,Rituximab CLL ClinicalTrial CLL,Targeted Oncology,Negative
24029,This week FDA CLL SLL CLL SLL,Targeted Oncology,Negative
24030,John Byrd Watch CLL,The James,Postive
24031,CLL Lamanna ColumbiaMed,Andrew Schorr,Negative
24032,three Chronic Lymphocytic Lymphocytic Lymphoma Haematologica,JanssenUS,Negative
24033,CLL,Anna Deveau,Postive
24034,CLL Nadine Tolman,Duke Cancer,Negative
24035,CLL Nicole Lamanna CLL,Patient Power,Negative
24036,today,Roche,Negative
24037,Roundup Lawsuit,McSherry,Negative
24039,Science Stop Not Sunday MF CLL NHL,Amy Cavers,Negative
24040,CLL Barbara Eichhorst ClinicalTrials,VJHemOnc,Negative
24043,TomoTherapy LHSCCanada Read RadOnc,Accuray,Negative
24044,Subbarao Bondada June fifteen The Journal Immunology Congratulations Access,UK Research,Postive
24045,three Chronic Rituximab European Hematology Association Annual Congress AbbVie Newsroom,Mike Gauthier,Negative
24048,CLL,Blood Cancer UK Research,Negative
24049,Wonderful five year CLL US,chadi nabhan MD MBA FACP,Postive
24050,CLL today,chadi nabhan MD MBA FACP,Postive
24051,Watch Gustaf CLL,Janssen EMEA,Negative
24052,Yucai Wang CLL ninety minute three hundred Visit Hall seven,Adaptive Biotech,Negative
24053,CLL,Anna Deveau,Negative
24055,Carsten Niemann CLL,Beth Torr,Negative
24056,CLL,Kathleen Hoffman,Negative
24057,CLL,Anna Deveau,Negative
24058,three Chronic Rituximab European Hematology Association Congress,HSMN,Negative
24059,CLL,Patient Power,Negative
24060,Today Presidential Symposium Room,Medklik,Negative
24061,Today Presidential Symposium Room,Roche,Negative
24062,Anna Schuh one CLL OXPLORED,OCTO Oxford,Negative
24063,five CLL MYELOMA,Prof John,Negative
24064,TWEET DISRUPTS AXIS CLL,Prof John,Negative
24065,CLL Craig Sinclair Australian,CLL Ireland,Negative
24066,Related Articles Circular,Wnt publication,Negative
24068,MOR Presents Clinical Data Blood Cancer Candidate,Odi Bruckman,Negative
24069,CLL two thousand and eighteen Hallek,Jose Queizan,Negative
24070,one CLL two thousand and eighteen Second Hallek,Jose Queizan,Negative
24071,one CLL two thousand and eighteen First Hallek,Jose Queizan,Negative
24072,one hundred Differentiation CLL Reference EpiGenome CRG NatureMedicine,Centre Genomic Regulation CRG,Negative
24073,MorphoSys Presents Clinical Data Blood Cancer Candidate EHA two thousand and,SPI News,Negative
24074,around half CLL one two BTK,Beth Torr,Negative
24075,Rosenquist,Jose Queizan,Negative
24076,CLL Rosenquist,Jose Queizan,Negative
24077,CLL This month CLL,Beth Torr,Negative
24078,CLL FCR,Beth Torr,Negative
24079,MOR Presents Clinical Data Blood Cancer Candidate,flosz,Negative
24080,CLL Ibrutinib CLL,Beth Torr,Postive
24081,three,Financial Buzz,Negative
24082,Friday today CLL CLL one,Beth Torr,Postive
24083,MorphoSys Presents Clinical Data Blood Cancer Candidate EHA two thousand and,James Dean,Negative
24084,MorphoSys Presents Clinical Data Blood Cancer Candidate EHA two thousand and,Dean James,Negative
24085,EHA two thousand and,James Dean,Negative
24086,EHA two thousand and,Dean James,Negative
24087,three ROG,Medklik,Negative
24088,three ROG,Roche,Negative
24089,MorphoSys Presents Clinical Data BloodCancer,MC Services AG,Negative
24090,three Chronic Rituximab European Hematology Association Congress,Seattle Banker,Negative
24091,European Hematology Association Overall Survival,Seattle Banker,Negative
24092,European Hematology Association Overall Survival,Seattle Banker,Negative
24093,MorphoSys Presents Clinical Data Blood Cancer Candidate EHA two thousand and eighteen,BIO Deutschland,Negative
24094,European Hematology Association Overall Survival,Sicilia Informazioni,Negative
24095,three Chronic Rituximab European Hematology Association Congress,RazzleTazzle,Negative
24096,MOR MorphoSys Presents Clinical Data Blood Cancer Candidate EHA two thousand and,BioGer,Negative
24097,European Hematology Association Overall Survival,RazzleTazzle,Negative
24099,Australia CLL CluniesRoss,Frank Sotzik,Negative
24100,The Food Drug Administration FDA CLL SLL,CheckRare,Postive
24102,Leukemia Medical CLL PhysRelations CancerMedMDA,MD Anderson Leukemia,Negative
24103,Leukemia Medical CLL PhysRelations,MD Anderson Leukemia,Negative
24104,CLL,Nature Reviews Disease Primers,Negative
24105,CLL SLL Retweet,AbbVie US,Negative
24107,one CML AML Europe US tomorrow AML CLL LiveTracker,CAPART,Postive
24109,Carol Preston CLL,Patient Power,Negative
24110,Genentech CLL DYK Learn Genentech,Hashimoto,Negative
24111,TLS CLL today tomorrow Venetockax,chadi nabhan MD MBA FACP,Negative
24112,CLL today,chadi nabhan MD MBA FACP,Negative
24113,CLL,chadi nabhan MD MBA FACP,Negative
24114,CLL,chadi nabhan MD MBA FACP,Negative
24115,CLL year,chadi nabhan MD MBA FACP,Negative
24117,MRD CLL,chadi nabhan MD MBA FACP,Negative
24118,CLL,chadi nabhan MD MBA FACP,Postive
24119,CLL,chadi nabhan MD MBA FACP,Negative
24120,six PM CEST CLL FL,Gilead Sciences,Negative
24121,CLL seventy year old Weirda Hematology CLL,Targeted Oncology,Negative
24123,Neue Updates Behandlung von CLL Heute Zukunft,AbbVie Schweiz,Negative
24124,Check Venetoclax,Medivizor,Negative
24126,Venetoclax Venclexta CLL,Trip Database,Negative
24127,Chronic,castawaywilson,Negative
24128,CLL Anthony Mato MSK CLL,Memorial Sloan Kettering Cancer Center,Negative
24129,today,SwingTradeBot UK,Negative
24131,CLL,Blood Journal,Negative
24132,First today FUN CLL CLL,CryptoLiveLeak,Postive
24133,lymsm mmsm mdssm mpnsm hematology CLL AML,VJHemOnc,Postive
24134,DYK Learn,Catherine Velazquez,Negative
24136,tomorrow PM six Stockholmsmassan CLL FL,Gilead Sciences,Negative
24137,LYMSM CLL,Anna Deveau,Negative
24139,Glen Sabin,CCAR,Negative
24140,Jackie MDAndersonNews CLL,Patient Power,Negative
24142,Genentech FDA,Connie Hampton,Negative
24143,This week FDA two CLL CLL,Jayson Johnson,Negative
24145,CLL CLL Kipps UCSDHealth,Patient Power,Negative
24146,AbbVie Roche CLL ABBV RHHBY lymsm,Bionest Partners,Postive
24147,Genentech FDA,Connie Hampton,Negative
24148,Pennsylvania first CLL,ASGCT,Negative
24149,TipTuesday Download Lymphomas Bethesda Resource Center MedEd,Oncology Times,Negative
24150,today,SwingTradeBot UK,Negative
24151,three SLL,Pharmacyclics AbbVie Company,Negative
24152,CLL Nicole Lamanna ColumbiaMed CLL,Andrew Schorr,Negative
24153,Expression Chronic Lymphocytic Lymphocytic,histopathology,Negative
24155,CLL Nicole Lamanna ColumbiaMed CLL,Patient Power,Postive
24156,obinutuzumab bendamustine CLL,healthbook,Negative
24158,ASCO last week CARTtherapy CLL AML,Blood Cancer UK Research,Postive
24159,FDA Venetoclax CLL SLL seventeen deletion ECM,dario pasqualini,Negative
24160,CLL,Kathleen Hoffman,Negative
24162,Genentech FDA,FDA Daily,Negative
24163,FDA,PLN,Postive
24164,ASH two thousand and Atlanta John CLL YouTube,CLL Society Inc,Negative
24169,AbbVie Roche CLL FiercePharma,Advera Health,Negative
24170,DYK Learn,Genentech,Negative
24171,Years Learn Vishva,Genentech,Negative
24173,FDA,Medklik,Negative
24174,FDA,Roche,Negative
24175,Drs Seymour Stilgenbauer Hillmen LeedsHospitals CLL CLL Register,Medscape Education,Negative
24176,Venclexta Will CLL SLL ROG ABBV,Bionest Partners,Postive
24177,Chronic Genentech Roche,Pharm Processing,Negative
24179,AbbVie Roche FDA AbbVie FDA Venclexta Rituxan,cafepharma,Postive
24180,US Venclexta Rituxan PharmaTimes Roche CLL SLL rituximab pharma,Plexus Ventures,Negative
24181,FDA CLL seventeen deletion CLL,Susan Ehret,Negative
24182,Roche Announces,Rare Diseases,Negative
24183,Venclexta plus Rituxan FDA CLL lymsm,Lymphoma Hub,Negative
24184,Michael Hallek University Hospital Cologne CLL,CLL Ireland,Negative
24185,Venclexta Rituxan FDA CLL,PRICENTRIC,Negative
24186,LRF,gilbert faure,Negative
24187,Pharmaceutical Business Review FDA Roche CLL,GESDAT GmbH,Negative
24188,Roche FDA three RHHBY ROG,Medklik,Negative
24189,Roche FDA three RHHBY ROG,Roche,Negative
24190,The Role Expression Differential Diagnosis,JournalAgent,Negative
24191,Genetherapy,Vijaya,Negative
24192,one Trial Cirmtuzumab Inhibits,Cancer Stem Cell News,Negative
24193,one Trial Cirmtuzumab Inhibits,Hematopoiesis News,Negative
24195,Genentech FDA,PressReleasePoint,Negative
24197,Michael Hallek CLL,Lymphoma Hub,Negative
24198,CLL FDA CLL SLL one Venclexta,Elaine Schattner,Negative
24199,Distinct Activities,Monterey Holistic,Negative
24200,Der Entwurf Patientenleitlinie Chronische lymphatische Leukamie au dem Konsultation Das AZQ Dokumente CLL,Krebsgesellschaft,Negative
24201,Distinct Activities,Hypoxia Adaptation,Negative
24202,ChronicLymphocyticLeukemia,EMJ Hematology,Negative
24203,Brian Koffman CllSociety almost one thousand one hundred and fifty CLL US One CLL,CLL Ireland,Postive
24204,Lisa CLL Lisa,Leukaemia Care,Postive
24207,ICYMI Leukemia CLL SLL,Rare Disease Report,Negative
24209,Venclexta FDA CLL,Robinson Ortiz MD,Negative
24210,ICYMI This week FDA Learn,Genentech,Negative
24211,FDA CLL SLL one MURANO Venetoclax Rituximab Bendamustine Rituximab three hundred CLL,CLL Ireland,Postive
24212,FDA Approves Venetoclax Chronic,Stayin Alive Body Mind Spirit,Postive
24214,FDA Venetoclax Chronic,CLLSA,Negative
24215,Genentech FDA,The Pharmaceutical Marketing Group,Negative
24217,FDA,UKiwiS,Negative
24218,three MURANO Venclexta FDA CLL SLL,Solomon Kamal,Postive
24219,Genentech FDA,Financial Buzz,Negative
24220,FDA Combination Rituximab Fixed,Financial Buzz,Negative
24222,one Trial Finds Experimental Drug Safe Treating Chronic,BIOCIENCIA,Negative
24223,FDA VENCLEXTA Genentech CLL SLL,PharmAnt,Postive
24224,CLL Tom Kipps Venetoclax Rituxamab,Andrew Schorr,Postive
24225,FDA CLL CLLsm,Alan Skarbnik,Postive
24226,CLL Over one thousand CllSociety OncologyTimes,chadi nabhan MD MBA FACP,Negative
24227,FDA Roche Genentech CLL SLL,MAISA,Postive
24228,VENCLEXTA CLL SLL,Lymphoma Research Foundation,Negative
24229,Genentech FDA,Pharma Commons,Negative
24230,Venetoclax CLL,chadi nabhan MD MBA FACP,Postive
24231,Genentech FDA,DennisPartners,Negative
24232,FDA Combination Rituximab Fixed Duration One,FDA Daily,Negative
24233,Genentech FDA,FDA Daily,Negative
24234,Genentech FDA,ANTELLIS,Negative
24235,FDA Combination Rituximab Fixed Duration One,RazzleTazzle,Negative
24236,SLL CLL FDA Approves,Leukemia Research Foundation,Negative
24237,FDA FDA CLL,Hematology News,Postive
24238,Roche Genentech FDA,Armando Guglielmetti,Negative
24239,Genentech FDA YahooFinance,Anand Rotte,Negative
24243,FDA Approves Venetoclax,UKiwiS,Negative
24244,FDA Small Lymphocytic Lymphoma,UKiwiS,Negative
24246,FDA Read CLL,Targeted Oncology,Postive
24247,Venclexta,CURE Magazine,Negative
24248,CLL Nicole Lamanna ColumbiaMed GeneticTesting CLL,Patient Power,Negative
24250,BreakingNews Leukemia CLL SLL,Rare Disease Report,Negative
24252,FDA CLL seventeen deletion,Liseth Parra PhD,Negative
24253,FDA CLL seventeen deletion,Kerri Wachter,Negative
24254,FDA seventeen deletion,FDA Oncology,Postive
24255,PennMedicine year,STEMCELL Tech,Postive
24256,CLL Nicole Lamanna ColumbiaMed Alessandra Ferrajoli,Patient Power,Negative
24257,UCSanDiego cirmtuzumab monoclonal drug measurably,KualiResearch,Negative
24258,one CLL,Amanda Marie,Negative
24259,New Venetoclax,Medivizor,Negative
24262,CLL second CLL August two September two thousand and eighteen Prague Czech Republic,CLL Advocates Network,Postive
24263,CLL England CLL UK,CLL Ireland,Negative
24264,Venetoclax,Medivizor,Negative
24265,yesterday NHSE Ibrutinib NICE CLL LeukaemiaCareUK,Nick,Negative
24266,Twitter Chipinge Harare seven hundred and eightytwo million four hundred and eight thousand,Denney,Negative
24267,CLL,CancerWallonia,Negative
24268,Response Venetoclax CLL CLLsm,Raul Cordoba MD PhD,Negative
24269,The United States,Raul Cordoba MD PhD,Negative
24270,one hundred and forty CLL Outcomes,chadi nabhan MD MBA FACP,Negative
24271,New Medivizor Update International Workshop Chronic,Medivizor,Negative
24272,CLL,Kathleen Hoffman,Negative
24273,CLL CLLsm,Raul Cordoba MD PhD,Negative
24274,House CLL,CLLSA,Negative
24276,one,Cancer Stem Cell News,Negative
24277,Non Hopkins Lymphoma Living CLL four,TSmrecansky,Negative
24278,CRG CLL,Centre Genomic Regulation CRG,Negative
24280,CLL CLLsm United States,Alan Skarbnik,Negative
24281,Drs Seymour Stilgenbauer Hillmen LeedsHospitals CLL CLL Register,Medscape Education,Negative
24282,ffg hhh Man Monster Destroyer Paperback,James Banks,Negative
24284,Love hug Lymphocytic Thursday morning GoodVibes,Rachel Haywood,Postive
24285,Cancer Survivorship Celebration Steve CLL,Sidney Kimmel Cancer Center Jefferson Health,Postive
24286,IBO Rewards Participation CLL CLL IBO Altcoins CryptoNews Bitcoin,CryptoLiveLeak,Postive
24287,fifty ELLA BKG,SwingTradeBot UK,Negative
24288,year,Hematology News,Negative
24289,year,MDEdge,Negative
24290,CLL CLL,Immunol,Negative
24291,CLL CLL Students,CLL Warwick Uni,Negative
24292,CLL today,CURE Magazine,Postive
24293,CLL Tom Kipps FBLive Canada,Patient Power,Negative
24294,makerspaceiskolan fortbildning,Linda Mannila,Negative
24295,WF six eleven ASCO FL CLL,dough,Negative
24296,CLL today WednesdayWisdom CLL,CLL Warwick Uni,Postive
24297,Blood Cancers Advances Treatment Friday June Beaumont Hospital Dublin CLL,CLL Ireland,Postive
24298,two thousand and eighteen,The Pharmaceutical Marketing Group,Negative
24299,Rituxan Hycela cindy cll,MyelomaTeacher Cindy Chmielewski,Negative
24302,LISTEN Wednesday June Camp Lake Louise Click CLL CLLRooted,Higher Ground Lake Louise,Negative
24303,CLL,Alan Skarbnik,Postive
24304,ASCO CLL two thousand and eighteen,Anthony Mato,Postive
24305,CllSociety ASCO CLL,Anthony Mato,Postive
24306,seventy CancerNetwrk,MD Anderson Cancer Center,Negative
24309,Anthony Mato CLL,Memorial Sloan Kettering Cancer Center,Negative
24310,two thousand and eighteen Sends TG Therapeutics Stock Soaring ten Today CLL BTK Imbruvica Zydelig,cafepharma,Negative
24313,CLL one one,Adrian Warnock,Negative
24314,PennMedicine CLL,Oncology Times,Negative
24315,CLL,Kathleen Hoffman,Negative
24317,Jacob Soumerai Lymphoma,MGH Cancer Center,Negative
24319,two CLL ASCO,chadi nabhan MD MBA FACP,Negative
24320,Adam Sklar Appellate Division New Jersey Construction,Cole Schotz,Negative
24322,Stefan Barta Hodgkin,Fox Chase Cancer Center,Negative
24323,Jos Melenhorst Joseph Fraietta CLL two thousand thirteen five year,Penn Microbiology,Negative
24324,two hundred CLL,chadi nabhan MD MBA FACP,Negative
24325,CLL,Pere Barba,Negative
24326,two,Tom Silver,Negative
24327,Anthony Mato two CLL BTK one hundred ASCO,Memorial Sloan Kettering Cancer Center,Negative
24328,two thousand and eighteen Cancer CLLSupport BrandcastHealth CLL LeukaemiaCareUK,Nick,Negative
24329,Hodgkin Children Oncology Group Justine Kahn Hematologic Session AM Hall,Children Oncology Group,Negative
24330,CancerResearch Genomics,MapTheGap,Negative
24331,one Trial Cirmtuzumab,NeuroStemCells,Negative
24332,Krebskongress ASCO Behandlung von Krebs Leukamie CLL Neue Medikamente Chancen,Pharma Fakten,Negative
24334,two Early Data Show High Rates Responses,christopher franskin,Negative
24335,two Early Data Show High Rates Responses Patient,Financial Buzz,Negative
24336,View Wierda CLL PhysRelations CancerMedMDA,MD Anderson Leukemia,Negative
24337,CLL,Anna Deveau,Negative
24338,one Trial Cirmtuzumab Stem Cell cancerSC,Jim Till,Negative
24339,IMBRUVICA Ibrutinib Plus GAZYVA Obinutuzumab Phase three,Hematopoiesis News,Negative
24340,CLL John Allan,WCM Lymphoma,Negative
24341,Tonight Beyond Guidelines Investigator,BMS Myeloma,Negative
24344,AbbVie day,Stock Bot,Negative
24346,CLL Stephan Stilgenbauer Leukemia Leusm Chemoimmunotherapy,VJHemOnc,Negative
24347,"one thousand, nine hundred Kanti Rai CLL",JanssenUS,Postive
24349,two Early Data Show High Rates Responses Patients,Crwe World,Negative
24350,"today three CLL seven thousand, five hundred and eight",Genentech,Postive
24351,View Wierda CLL,MD Anderson Leukemia,Negative
24352,View Wierda CLL,MD Anderson Leukemia,Negative
24353,View Wierda CLL,MD Anderson Leukemia,Negative
24354,View Wierda CLL,MD Anderson Leukemia,Negative
24355,View Wierda CLL,MD Anderson Leukemia,Negative
24356,vincente nella linfatica cronica ten MRD,PharmaStar,Negative
24358,MRD CLL Learn,AbbVie,Negative
24359,CLL,Raul Cordoba MD PhD,Negative
24360,MRD MURANO Peter Hillmen,VJHemOnc,Negative
24362,CR CLL Ibrutinib Venetoclax first,Raul Cordoba MD PhD,Negative
24363,two Early Data Show High Rates Responses Patients Chronic CLL,ShareHRnews,Negative
24364,two Early Data Show High Rates Responses Patients Chronic CLL,Newswire,Negative
24365,IMBRUVICA,Pharmacyclics AbbVie Company,Postive
24366,two Early Data Show High Rates Responses Patients CLL CRE,CRE Demographics,Negative
24367,June three two thousand and eighteen,RazzleTazzle,Negative
24368,two Early Data Show High Rates Responses Patients Chronic CLL,RazzleTazzle,Negative
24369,two Early Data Show High Rates Responses Patients CLL June three two thousand and eighteen,Biedex Markets,Negative
24370,two CLL,Odi Bruckman,Negative
24371,British Journal Haematology WGS CLL,Genomics England,Postive
24372,View Wierda CLL,Robert Orlowski,Negative
24373,Christopher Flowers Hematologic Malignancies,Winship Cancer Institute Emory University,Negative
24374,View Wierda CLL,MD Anderson Leukemia,Negative
24375,two Sunday al Location,Robert Orlowski,Negative
24376,two Sunday al Location,Cancer Medicine,Negative
24377,CLL Zaprasza,Jacek Kalinowski,Negative
24378,today CDT,Roche,Negative
24379,Westminster,Andrea Levy,Negative
24380,CLL,Tarik Suljic,Postive
24382,one CLL,CLL Ireland,Negative
24383,CLL Watch CLL,Janssen EMEA,Postive
24386,Jin Ri CLL,komatsubara Dong Jing bizaShen Qing sapoto,Negative
24387,John Allan Rick Furman CLL,WCM Lymphoma,Negative
24388,CLL Thompson today ASCO,chadi nabhan MD MBA FACP,Negative
24389,CLL ClinicalTrial,BioNews Central,Negative
24390,CLL,Lymphoma Hub,Postive
24391,Oftentimes CLL,Oncology Board,Postive
24395,one Trial Finds Experimental Drug Safe Treating Chronic,newswise,Negative
24396,Leukemia,debuglies,Negative
24398,one Trial Finds Experimental Drug Safe Treating Chronic,Omprakash Nautiyal,Negative
24399,GLP Chronic,Cancer Papers,Negative
24400,Science Magazine,Deirdre Walsh,Negative
24401,German CLL,palliativewise,Negative
24402,Only one week CLL NuneatonNews,CLL Warwick Uni,Negative
24403,two thousand and eighteen,EPR Network,Negative
24404,IFLScience,Anna Ercilla,Negative
24405,CLL,Life Extension,Negative
24407,Western CLL,Stephen Cohen MD,Negative
24412,one Trial Finds Experimental Drug Safe Treating Chronic,Stephen Harris,Negative
24413,one Trial Finds Experimental Drug Safe Treating Chronic,BIOCIENCIA,Negative
24414,LLSCanada CLL CancerResearch,Margaret Lynch Writer,Postive
24415,CME,MayoProceedings,Negative
24416,USA Attention Hematologists annual Chicago Earn two hundred MCL CLL ASCO,Community,Negative
24418,one Trial Finds Experimental Drug Safe Treating Chronic,Patrick Arieno,Negative
24419,one today CLL Study NIH,UC San Diego School Medicine,Negative
24422,CLL,Kathleen Hoffman,Negative
24423,CLL Jacqueline Barrientos one,CLL Ireland,Postive
24425,Results UCSDMedSchool one cirmtuzumab Read CancerResearch CLL,UC San Diego Health,Negative
24427,Hodgkin Children Oncology Group Session Hematologic Malignancies Monday June,Children Oncology Group,Negative
24428,one Trial Finds Experimental Drug Safe Treating Chronic,Centro Medico Qx,Negative
24429,one Trial Finds Experimental Drug Safe Treating Chronic,MD,Negative
24431,Trial Finds Experimental Drug Safe Treating Chronic Blog News Reporting one University California San,SDBN,Negative
24432,one ChronicLymphocyticLeukemia CLL,Targeted Oncology,Postive
24436,ASCO CLL StayTuned,Lymphoma Hub,Negative
24437,CLL Alessandra Ferrajoli Michael Keating,Patient Power,Negative
24438,Cancer five year,Sid Shah,Negative
24439,AbbVie three,Pf Magazine,Negative
24442,two thousand and eighteen Exciting CLL,Anthony Mato,Negative
24443,CLL George Follows Leukemia NHL Hodgkin Cancer BloodCancer PatientCare,The Patient Channel,Negative
24444,Rose CLL CEIGHE,CLL Warwick Uni,Negative
24445,Venclexta Rituxan CLL Tom Kipps,Andrew Schorr,Postive
24446,CLL,Life Extension,Negative
24447,three,SpecialtyPTimes,Postive
24448,Carol Preston CLL,Patient Power,Negative
24449,Only one Leusm Lymsm HemeOnc AML CLL,VJHemOnc,Postive
24450,Two week Leusm Lymsm CLL AML,VJHemOnc,Postive
24451,June Melenhorst,Berger Lab,Negative
24452,CLL ASCO NitinJainMD CLL,chadi nabhan MD MBA FACP,Negative
24453,John Gribben ChronicLymphocyticLeukemia PatientCare DiseaseAwareness Hematology idelalisib rituximab venetoclax,The Patient Channel,Negative
24454,Researchers University,Silas Aurelius,Negative
24457,one Penn CLL PennMedicine,Immunotherapy Foundation,Postive
24458,One CLL,Eslam Katab,Negative
24460,Science And Tech Top Chronic,PORTLAND OREGON,Negative
24461,CLL CLL two thousand thirteen,Medical Web Times,Negative
24462,Jackie MDAndersonNews CLL,Patient Power,Negative
24463,CLL first CLLHeroes,CURE Magazine,Postive
24465,Drs Max Gordon OHSUscholarship Comorbidities,OHSU IM Residency,Negative
24468,Five year CLL,Blood Journal,Negative
24469,Dean one thousand nine hundred,UNC Hussman School Journalism Media,Negative
24471,CLL two,Blood Journal,Negative
24472,CLL Ibrutinib NICEcomms,CLLSA,Postive
24473,CLL,Continuous Lifecycle London online,Negative
24474,today CLL,CLLSA,Negative
24476,CLL five year BloodJournal Higher Thoughts DrRaulCordoba,chadi nabhan MD MBA FACP,Negative
24477,ABBVIE Plus Phase three,AmericanPharmacyNews,Negative
24479,CLL Watch John Byrd CLL one,The James,Postive
24481,Matthew Davids MD one ChronicLymphocyticLeukemia CLL Oncology,Targeted Oncology,Postive
24482,CLL Genomics Genetics Cancer CLL,The North West Genomic Laboratory Hub,Negative
24483,Turkey,India Oncology,Negative
24484,CLL Ireland,CLL Ireland,Negative
24485,CLL CLLsm,Raul Cordoba MD PhD,Negative
24486,CLL CLL,Genomics England,Negative
24488,CLL MajumderCan,RIOH,Negative
24489,two BritSocHaem APPGBloodCancer CLLSupport Bloodcancer CLL BrandcastHealth HealthUnlocked,Nick,Negative
24490,John Gribben MD Read,Danielle Ternyila,Postive
24491,CLL,Kathleen Hoffman,Negative
24492,CLL Hear Keating,Patient Power,Negative
24493,CLL,Leukaemia Care,Postive
24494,CLL,Francesco Bertoni,Negative
24495,CLL,Targeted Oncology,Negative
24496,NatureMedicine,Joao Monteiro,Negative
24498,CLL CancerResearch NatRevClinOncol,Crown Bioscience,Negative
24500,Today CLL Cancer Day,CLL Ireland,Negative
24501,three Ibrutinib Imbruvica Obinutuzumab Gazivaro Roche ligne de traitement de la PFS,oncohebdo,Negative
24502,Check Update,Medivizor,Negative
24503,UK NHL,LiveYourLife,Negative
24504,CLL Jacqueline Barrientos,The Patient Channel,Postive
24506,IMBRUVICA Plus GAZYVA Phase three,Cord Blood News,Negative
24508,one CLL AML Novartis US,NovartisOncTrialsUS,Postive
24512,CLL,CLL Ireland,Negative
24513,Leeds Enjoy CLL,CLLSA,Postive
24514,CancerResearch CARTcells MRD ASCO Annual Meeting MMSM HemOnc Leukemia Lymphoma CLL AML,VJHemOnc,Postive
24517,three CLL JanssenGlobal READ,Rare Disease Report,Negative
24518,Frontline Ibrutinib Plus three CLL,CancerWallonia,Negative
24519,CME,MayoProceedings,Negative
24520,CLL,Kathleen Hoffman,Negative
24521,three Imbruvica Gazyva obinutuzumab CLL SLL PharmaTimes,CLL Ireland,Negative
24522,Bowen Li Dominick Amato Chen Wang,leukemia,Negative
24523,three CLL JanssenGlobal READ,Rare Disease Report,Negative
24524,CLL Tom Kipps,Andrew Schorr,Negative
24525,Lymphoma Hub Annual,Lymphoma Hub,Negative
24526,IMBRUVICA,Rare Diseases,Negative
24527,CLL Nicole Lamanna ColumbiaMed Alessandra Ferrajoli,Patient Power,Negative
24528,ONSCongress Adrianna Janicik BSN RN OCN CLL,Health,Negative
24529,obinutuzumab obinutuzumab CLL Lymphoma,Targeted Oncology,Negative
24530,CLL SLL Learn,NIH NHLBI,Negative
24531,three CLL SLL,HemOnc Today,Negative
24533,AbbVie three PFS,Parallel Learning,Negative
24534,Imbruvica Gazyva CLL AbbVie AVVX,Bionest Partners,Negative
24535,three CLL JanssenGlobal READ,Rare Disease Report,Negative
24536,CLL Lamanna ColumbiaMed Keating,Patient Power,Negative
24538,three,MoJo,Negative
24539,Infection Ibrutinib,ImmunologyPapers,Postive
24540,CLL two TN five year BloodJournal,CLL Ireland,Postive
24541,Curcumin myeloma mmsm,Turmeric,Negative
24542,one MGUS CLL one,Talal Hilal,Negative
24543,MIRROR two FDA,Brandon Beaber,Postive
24544,CME,MayoProceedings,Negative
24545,TDTCML Cancer CancerAwareness CLL,TheDayThatChangedMyL,Negative
24546,today CLL,CURE Magazine,Negative
24547,AbbVie Imbruvica CLL Gazyva AbbVie Imbruvica,cafepharma,Negative
24548,Genomic Research,Psomagen Inc,Negative
24550,daunorubicin Acute myeloid Acute Kaposi,PharmaFactz,Negative
24554,three CLL JanssenGlobal READ,Rare Disease Report,Negative
24555,one one CLL,Smitt Wesson,Negative
24556,CLL,Pharmacyclics AbbVie Company,Negative
24557,CLL Michael Keating CLL,Andrew Schorr,Negative
24558,CLL two CLLsm,Raul Cordoba MD PhD,Negative
24561,Keesha Paleo French two thousand and four last week,Keesha Ewers,Negative
24562,CLL CLLsm,Raul Cordoba MD PhD,Negative
24564,AbbVie Imbruvica,EMG GOLD,Negative
24565,Tom Kipps Canada CLL,Patient Power,Negative
24567,ABBV,Liseth Parra PhD,Negative
24568,three,OBR,Negative
24569,Chronic ya English,sharona,Postive
24570,JNJ Imbruvica Gazyva PFS CLL Exciting CLL,Matthew Maryniak,Negative
24571,little month ago,Amanda Marie,Negative
24573,three,Crwe World,Negative
24574,three,Odi Bruckman,Negative
24575,CLL one Shine Chris,Shine Cancer Support,Postive
24576,Infection Ibrutinib,Cancer Papers,Postive
24577,four,Targeted Oncology,Negative
24580,NatureMedicine,Blueprint,Negative
24581,CLL John Gribben CLLsm,Raul Cordoba MD PhD,Negative
24582,first CLL,Smitt Wesson,Negative
24583,CLL,Smitt Wesson,Negative
24584,CLL,Andrew Schorr,Postive
24586,The American Journal Surgical Pathology,Giuseppe Ingravallo,Negative
24587,two Lethal Shortcut Del Chronic,TumorImmunoPapers,Negative
24588,Patrick CLL,CLL Ireland,Postive
24589,Highlights good day beachday longbranch newjersey nj,Amanda Marie,Negative
24590,CLL UCSDHealth Tom Kipps,Andrew Schorr,Negative
24594,CLL,Nature Medicine,Negative
24595,ASH CLL ASH,Alan Skarbnik,Negative
24596,UniBarcelona CLL,News Life Sciences,Negative
24597,Dr Crowther CLL,McMaster Textbook Internal Medicine,Negative
24598,IWCLL,ASH Clinical News,Negative
24599,TFS CLL Annals Hematology,CLL Ireland,Negative
24600,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
24603,two Lethal Shortcut Del Chronic,Cancer Papers,Negative
24604,NICEcomms Ibrutinib Please two hundred CLL,CLLSA,Postive
24605,ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24606,Lymphomas Download Resource Center MedEd TuesdayThoughts,Oncology Times,Postive
24608,CME,MayoProceedings,Negative
24611,NICEcomms Ibrutinib Please two hundred CLL,CLLSA,Postive
24612,CLL CLL,Green Tea HP,Negative
24613,NICEcomms Ibrutinib Please two hundred CLL,CLLSA,Postive
24616,Infraestructura Cientifica CLL,Beatriz Albella Rdgz,Negative
24618,CLL UK Leukaemia,Paul DuBois,Negative
24619,Spanish Chronic CLL,EmbajadaEspanaLetonia,Negative
24620,CLL,Kathleen Hoffman,Negative
24621,Ryan Jacobs MD,OncLive SOSS,Negative
24622,CLL Novel ELShematology Bcells,Prof John,Postive
24623,CLL John Gribben TheEBMT Leukemia ChronicLymphoblasticLeukemia idelalisib rituximab NewDrugs KnowledgeIsPower MedEd,The Patient Channel,Negative
24624,MBL MBL CLL,Haematologica,Negative
24625,CLL CLL WarwickStory,CLL Warwick Uni,Negative
24626,CLL Spanish CLL,Chared Good Comms,Negative
24627,CLL Spanish CLL,European Hematology Association,Negative
24628,CLL Spanish CLL NatureMedicine,HARMONY Alliance,Negative
24629,ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24630,Role Allogeneic Stem Cell,leukemia,Negative
24632,rituximab younger fit,Targeted Oncology,Negative
24638,Mike CLL CLL DukeCancer,David Bartlett PhD,Negative
24640,CME CLL Awan MD MS,Health,Negative
24641,obinutuzumab ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24642,CedarsUnion September This Creative Lunch Learn CLL DallasArt,Maddrey PLLC,Postive
24643,CLL OncLive,CLL Ireland,Postive
24644,UniBarcelona,Elies Campo,Postive
24645,CIBERONC NatureMedicine,Houlston Lab ICR,Negative
24647,NatureMedicine,Continuum AEP,Negative
24648,CLL Oncology,Targeted Oncology,Negative
24649,CME,MayoProceedings,Negative
24651,CLL,Jah Kuu,Negative
24652,CLL Oncology,Targeted Oncology,Negative
24654,six,Internal Medicine Open Access,Negative
24655,ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24657,Ryan Jacobs MD,OncLive SOSS,Negative
24658,Venetoclax,Targeted Oncology,Negative
24659,CLL,CancerWallonia,Negative
24660,CLL,CancerWallonia,Negative
24661,Leukemia,Targeted Oncology,Negative
24662,around people year CLL UK DM,LymphomaAction,Negative
24663,New Update,Medivizor,Negative
24664,Zur Kommentierung Patientenleitlinie Chronische Leukamie CLL,MirjamBauer,Negative
24665,CLL Haimatus Latam Sao Paulo Susan Brien CLL,Francesc Bosch,Negative
24667,CME,MayoProceedings,Negative
24669,two CLL BTK CLLsm,Raul Cordoba MD PhD,Negative
24670,CLL,Targeted Oncology,Negative
24671,ChronicLymphocyticLeukemia,Targeted Oncology,Negative
24672,CLL Data ASCO,chadi nabhan MD MBA FACP,Negative
24673,CLL Data ASCO,chadi nabhan MD MBA FACP,Negative
24674,one thousand one hundred CLL Importance ASCO CllSociety,chadi nabhan MD MBA FACP,Negative
24675,Wednesday May thirty PM Joseph Hofmeister Columbus Oncology Hematology Associates CLL Leukemia Lymphoma Society,Cancer Support Ohio,Negative
24677,CLL,Kathleen Hoffman,Negative
24680,CLL LeukemiaLymph,chadi nabhan MD MBA FACP,Negative
24681,ASCO CLL,VuMedi Oncology,Negative
24682,CLL,Louise Arnold,Negative
24683,Scheuermann June seven ACTRI Seminar Computational Methods Analysis Flow Mass Cytometry Data,UC San Diego ACTRI,Negative
24684,ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24685,Patientenleitlinie lymphatischen Leukamie zur Kommentierung Netz Berlin Das Arztliche Zentrum Qualitat Medizin AZQ Patientenleitlinie Leukamie CLL,Deutsches Arzteblatt,Negative
24686,Letter CLL Forum today NHSEngland CLL three year NHS,CLLSA,Negative
24687,CLL Alessandra Ferrajoli Michael Keating,Patient Power,Negative
24690,Sweden Limitations Subsidized CLL,NovelHealthStrategie,Negative
24691,Sunday today KingsCollegeNHS CLL,LymphomaAction,Negative
24692,Thumb Lake Come summer CLL,Higher Ground Lake Louise,Postive
24693,Emma Teaching Fellow CLL tonight,CLL Warwick Uni,Postive
24694,Kay MayoClinic four CLL CLL,Targeted Oncology,Negative
24696,CNS HNS Irish CNS HNS hour HSE CLL CNS HNS MyelomaIreland,CLL Ireland,Postive
24698,CLL BTK Umbralisib,dough,Postive
24699,CLL Project Update Upcoming Speaking Event CLL Cryptoliveleak Highsocietynetworking,CryptoLiveLeak,Negative
24700,Without Ibrutinib,Welty,Postive
24701,rituximab chronic NEJM,ASH Clinical News,Negative
24702,CME,MayoProceedings,Negative
24703,BajoCero Campeon Nacional de two thousand thirteen Campeon Absoluto de CLL Contraataque,XNL,Negative
24704,year Switch Thorsten DevOperation CLL,Claranet,Postive
24705,CLL one ninety nine hundred,Anna Deveau,Negative
24706,eight hundred and six CLL,Anna Deveau,Negative
24707,CLL OFA,Anna Deveau,Negative
24708,CLL,Anna Deveau,Postive
24709,CLL BTK BGNE,Anna Deveau,Negative
24710,CLL,Anna Deveau,Negative
24711,Last week two CLL,CLL Ireland,Negative
24712,Andreas Agathangelidis Alexandra Kosvyra CERTHellas CLL,AEGLE,Negative
24714,EGRX,MAISA,Postive
24715,CME,MayoProceedings,Negative
24716,Expression Chronic Lymphocytic Lymphocytic,Sameer Parikh,Negative
24717,CLL,MDedge Hematology Oncology,Negative
24718,Expression Chronic Lymphocytic Lymphocytic,Dendritic cell,Negative
24719,twentyfour hour ago four Cuneo Italy four SnowcappedMtns Cuneo Lymphoma CLL IsThisReallyFranceOrSwitz,Amy Cavers,Negative
24720,CLL,WCM Lymphoma,Negative
24722,Expression Chronic Lymphocytic Lymphocytic,ImmunotherapyPapers,Negative
24723,CLL Hear Keating,Patient Power,Negative
24724,CLL,MDLinx,Negative
24725,Jeremy Hunt NICEcomms CLL,CLLSA,Postive
24727,ICYMI,HemOnc Today,Negative
24728,two Watch CLL,Andrew Schorr,Postive
24729,CME,MayoProceedings,Negative
24731,TDTCML Cancer CancerAwareness CLL,SOLUTIONS Cancer,Negative
24732,CLL,QuadShot News,Negative
24733,Paul CLL two thousand and three Watch Wait two thousand and twelve Paul,Leukaemia Care,Postive
24734,EAD CLL STM,Miss,Negative
24735,recent day CLL LymphomaMatters,LymphomaAction,Postive
24737,CME,MayoProceedings,Negative
24738,New Drug Combination,Patient Worthy,Negative
24739,CLL Canada year old two Imbruvica Zydelig Cindy Leusm,MyelomaTeacher Cindy Chmielewski,Negative
24741,CombinationTherapy CLL CLL Nicole Lamanna ColumbiaMed,Andrew Schorr,Negative
24742,University week Goodluck CLL MondayMotivaton,CLL Warwick Uni,Negative
24743,Nat Med,Penn Path Lab Medicine,Negative
24745,Will Respond Kymriah,CLL Ireland,Postive
24746,CLL PennMedicine PennCancer NatureMedicine,Crown Bioscience,Postive
24748,Derek Clarke Chronic Follicular,Derek Clarke,Negative
24749,red cll,Josh Towsley,Negative
24750,cll coquitlamlittleleague littleleague littleleaguebaseball,Josh Towsley,Negative
24751,Blake Makin Yard,Josh Towsley,Negative
24752,CME,MayoProceedings,Negative
24753,CLL Matthew Davids MD DanaFarber,CLL Ireland,Negative
24754,CLL yesterday LymphomaConf,Helen Jane Mee,Postive
24755,New Medivizor,Medivizor,Negative
24756,two,Philip McCarthy,Negative
24757,CLL,Kathleen Hoffman,Negative
24758,CLL Coquitlam,Josh Towsley,Negative
24760,NewWork CLL,Jah Kuu,Negative
24762,American CLL Australia,Judith Trotman,Negative
24763,Healthier CellTherapy,ASGCT,Postive
24764,one CLL,John Walker,Negative
24766,CME,MayoProceedings,Negative
24767,CLL,Raul Cordoba MD PhD,Negative
24768,CLL,Raul Cordoba MD PhD,Negative
24769,NatureComms,STEMCELL Organoids,Negative
24770,Leukemia CancerResearch,Targeted Oncology,Negative
24771,four Leukemia Leusm,Targeted Oncology,Negative
24772,CLL Venclexta Rituximab Please autumn,Patient Power,Postive
24773,En Danza,akemi enriquez,Negative
24774,CLL Lamanna ColumbiaMed Keating,Patient Power,Negative
24775,Whippoorwill summer today CLL,Higher Ground Lake Louise,Negative
24776,CLL Michael Keating,Patient Power,Negative
24781,CLL,NaturesZestNutrition,Negative
24783,CLL,Joe Fournet,Negative
24784,two thousand and seventeen American,Cancer Papers,Negative
24785,two thousand and seventeen American,Cancer Papers,Negative
24787,CME,MayoProceedings,Negative
24788,CLL Information Session one PrideCov,CLL Warwick Uni,Postive
24789,CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
24790,CLL,BioAgilytix,Negative
24791,CLL,SpecialtyPTimes,Negative
24792,Lymphoma Chronic Lymphocytic Lymphocytic Lymphoma Neuralstemcells,NeuroStemCells,Negative
24793,VIDEO Current CLL John Gribben ChronicLymphoblasticLeukemia PatientCare DiseaseAwareness Hematology,The Patient Channel,Negative
24794,iPads Merridale Primary School EYFS Wolverhampton,Wolverhampton LTT,Postive
24796,Ozturk two thousand and eighteen American Journal Hematology Wiley Online,keremozturk,Postive
24797,one Leukemia one one PSA Loganberry Trust,LoganBerry,Postive
24803,SouthCentral sixty CLL,LymphomaAction,Negative
24804,Basingstoke LymphomaForum sixty CLL RCHOP,LymphomaAction,Negative
24805,CLL,CLL Warwick Uni,Negative
24806,Stephan Stilgenbauer two Chronic CR,Chan Cheah,Postive
24807,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
24808,CLL,Jeffrey Miller,Postive
24809,EBV Positive Diffuse Large Cell,The Organic Institute CLG,Postive
24810,CLL Cello Health two thousand and eighteen CLL AndrewScottTV,Proactive,Postive
24811,AGM CLL one Health,WheelieDealer,Postive
24812,Biomarker,ReR,Postive
24813,Cello Health CLL year,Share Prophets,Postive
24814,CLL,Kathleen Hoffman,Negative
24816,EBV Positive Diffuse Large Cell,Cancers MDPI,Postive
24817,myeloma cll clinicaltrials,Sarah Brown,Postive
24818,Waldenstrom CLL twelve May Manchester CLL,Helen Jane Mee,Postive
24820,one Cathy Burton TuesdayThoughts LymphomaMatters CLL,LymphomaAction,Negative
24821,DanaFarber CLL,The Leukemia Lymphoma Society,Postive
24822,NeoGenomics CLL,NeoGenomics,Negative
24823,CLL,Nursing Homeworks,Negative
24824,CLL George Follows Leukemia NHL Hodgkin Cancer BloodCancer KnowledgeIsPower,The Patient Channel,Negative
24831,two thousand and seventeen two thousand Healthcare,Doctr,Negative
24833,Cancer CLL Haematology Dietitian,CLL Ireland,Postive
24838,twelve eighteen Peripheral Lymphoma,Kobe Univ Kernel,Negative
24839,one CLL,Smitt Wesson,Negative
24840,TrenchFoot CLL,Smitt Wesson,Negative
24841,CLL,Smitt Wesson,Negative
24842,Leukemia,Targeted Oncology,Negative
24843,three CLL,Marilyn Heine,Negative
24844,two,Mahmoud Aljurf,Negative
24845,CLL,chadi nabhan MD MBA FACP,Negative
24846,"one thousand, nine hundred LaPrade two thousand and five CLL",benzenelawyers,Negative
24847,First John Byrd MD Ohio State University myeloid,Cancer Papers,Negative
24849,CLL CML,Juan Luis Steegmann,Negative
24852,John FirstPerson Read,ACS Journal Cancer,Negative
24853,Penn Learn,Akron Biotech,Negative
24854,KGlugni wNunn Inytbk one,Roger Naegeli,Negative
24855,afternoon CLL,CLL Warwick Uni,Negative
24856,Ibrutinib HCT TheEBMT Chronic Malignancies,EBMT,Negative
24857,CLL,NWSLC,Negative
24858,Alvarado Ibarra Martha Mena Veronica Ortiz Alvarez Vera Jose Espitia Rios Maria Jimenez Alvarado,leukemia,Negative
24859,APTO Aptose AML CLL,Grant Beasley,Postive
24860,CLL,Natalie McGreevy,Postive
24861,CLL,CLL Warwick Uni,Postive
24862,CLL,CLL Warwick Uni,Negative
24863,Today today CLL,CLL Warwick Uni,Postive
24865,two CLL,Targeted Oncology,Negative
24867,Lymphocytic CLL,Turmeric,Negative
24868,VIDEO Evolving CLL UK CLL first George Follows,VJHemOnc,Negative
24869,EBMT,Krishan Maggon,Negative
24870,Nanay two year Nanay one,REGISTER TO VOTE,Negative
24871,one CLL,Shouting people underpants,Negative
24872,Erica CLL fourteen year ago Watch Wait Erica,Leukaemia Care,Postive
24873,today,Adaptive Biotech,Negative
24876,MCL CLL,Hematology News,Negative
24878,cll,Anna Deveau,Negative
24879,CLL,Kathleen Hoffman,Negative
24880,CLL CllIreland UK next Saturday CLL,Helen Jane Mee,Postive
24881,UK fifth NHL Hodgkin CLL Cecily KingsCollegeNHS,LiveYourLife,Negative
24882,Today CllIreland Information Day CLL Ireland Prof Hillmen Prof Thornton IrishCancerSoc Rachel Fox Eleanor Sweeney,CLL Ireland,Postive
24883,CLL,Raul Cordoba MD PhD,Negative
24884,Bendamustine Rituximab UK,Raul Cordoba MD PhD,Negative
24885,CI CI CLL,Raul Cordoba MD PhD,Negative
24886,three four CLL,Raul Cordoba MD PhD,Negative
24887,Kudos CLL one,Raul Cordoba MD PhD,Postive
24888,three four CLL,Raul Cordoba MD PhD,Negative
24889,BloodJournal CLL,chadi nabhan MD MBA FACP,Negative
24893,one CLL HL CLL,Andy Evens,Negative
24894,John Gribben Chicago CLL BCR,Andy Evens,Negative
24898,You Isaiah one CLL,Anita Ayres,Postive
24899,Venetoclax rituximab CLL NEJM,ASH Clinical News,Negative
24900,CLL,Feedkast Medical,Negative
24901,US CLL Venclexta Email,Andrew Schorr,Negative
24902,CLL US Venclexta Please autumn,Patient Power,Postive
24904,CLL LymphomaConf,LymphomaAction,Negative
24905,Update Signal Inhibitors Chronic,Allied Conferences,Negative
24906,Ibrutinib CLL,Teresa Martin,Negative
24907,One two three,Higher Ground Lake Louise,Postive
24908,CLL,CLL Warwick Uni,Negative
24910,Venetoclax Found Effective,Meagan Bryan RN,Negative
24911,Venetoclax Found Effective,OncologyNurseAdvisor,Negative
24912,year CLL ten Covhour,CLL Warwick Uni,Postive
24918,Lomas last night EYFS today CLL,Barton Clough Primary School,Negative
24919,VSTM Verastem Oncology Lymphocytic Lymphocytic Lymphoma Follicular,SNN Network,Negative
24920,PR Newswire Global Oncology Partnering PR Newswire Chronic,Oncology Board,Negative
24921,BTK CLL,Anna Deveau,Negative
24922,six CLL,Anna Deveau,Negative
24923,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
24924,Yesterday Verastem Oncology New York Chronic Lymphocytic Lymphocytic Lymphoma Follicular,Verastem Oncology,Negative
24925,Verastem Oncology Lymphocytic Lymphocytic Lymphoma Follicular Inv,ANTELLIS,Negative
24926,VSTM,nightmyworld,Negative
24927,Verastem Oncology Lymphocytic Lymphocytic Lymphoma Follicular Business Wire Verastem Oncology Reports Lymphocytic Lymphocytic Lymphoma Follicular,Oncology Board,Negative
24928,Verastem Oncology Lymphocytic Lymphocytic Lymphoma Follicular,The Pharmaceutical Marketing Group,Negative
24929,VSTM Verastem Oncology Lymphocytic Lymphocytic,Stocknewsalerts,Negative
24930,Verastem Oncology LeukemiaSmall Lymphocytic,Cancer News,Postive
24931,Kathleen Hoffman,Digital Health Space,Negative
24932,CLL CLL Find,Leukaemia Care,Postive
24933,CLL,Kathleen Hoffman,Negative
24934,two,FarmaOnco,Negative
24935,andrewschorr tomorrow four pm pm PT Andrew CLL Denver,Patient Power,Postive
24936,CLL one Keating,Andrew Schorr,Negative
24937,ICYMI Achieving MRD CLL,Home Journal,Negative
24938,five CNS,NEJM CPC,Negative
24939,two,Home Journal,Negative
24942,Polish Adult Leukemia Group,Cancer Papers,Negative
24943,two,Cancer Papers,Negative
24944,CLL Chornobyl Juhi Ojha Iryna Dyagil Robert Reiss Adam de Smith Semira Zhou Helen Hansen Amy Sherborne,ecotoxicology,Negative
24945,ASCO Educational Book CLL,chadi nabhan MD MBA FACP,Negative
24946,CLL,CLL Ireland,Negative
24947,LYMSM CLL,Anna Deveau,Negative
24949,Half CLL Venetoclax two year,Daniel Ernst,Negative
24951,Venetoclax Ibrutinib Treating Participants,President Elect John Jason Fallows,Negative
24952,Update Signal Inhibitors Chronic,Hematology Conference,Negative
24954,Venetoclax Plus,The ASCO Post,Negative
24955,CLL CllSociety,chadi nabhan MD MBA FACP,Negative
24956,Nicole Lamanna CLL ColumbiaMed,Andrew Schorr,Negative
24957,Saturday two day Jerry LLSCanada,Tim James,Negative
24958,QueenOfMemeStyle Dia two Twitter Wrestling CONFIRMENLAPROXIMAFECHADECLLPORFAVAAR,Crashilda Corvis,Negative
24959,CLL ImmunoOnc,Raul Cordoba MD PhD,Negative
24960,CLL,Raul Cordoba MD PhD,Negative
24962,Determinants Response,Cell Therapy News,Negative
24963,CARTcell CLL,MDedge Hematology Oncology,Negative
24966,Venetoclax Ibrutinib Treating Participants,CureHuntr,Negative
24967,Venetoclax Ibrutinib Treating Participants,TrialBulletin,Negative
24968,Venetoclax Ibrutinib Treating Participants,Kami Redd Chef Kami Redd,Negative
24969,CLL Congrats,Anna Deveau,Postive
24970,New Blog Post Check CLL,Higher Ground Lake Louise,Negative
24971,CLL BloodJournal,CLL Ireland,Postive
24973,Waldenstrom CLL twelve,LymphomaAction,Negative
24976,Nursery Saint Stephens Primary School Wolverhampton EYFS CLL,Wolverhampton LTT,Postive
24977,CLL,Samah Nassereddine MD,Negative
24978,NatureMedicine,Bruce Levine,Negative
24979,The Cytogenetic Quality Chronic Cocktail Pokeweed,AJ,Negative
24980,Farrukh Awan MD MS CLL AwanDoc,Health,Negative
24983,Philip Thompson CLL,MD Anderson Cancer Center,Negative
24984,Results PROFILES,ACS Journal Cancer,Negative
24985,Greg Simon BidenCancer CLL MIGlobal,Jen Horonjeff askpatients,Postive
24986,CLL,Tissue Solutions,Negative
24987,Seek Knowledge ASK CLL,The Leukemia Lymphoma Society,Negative
24988,NatureMedicine Determinants,Continuum AEP,Negative
24990,ICYMI Achieving MRD CLL,Home Journal,Negative
24991,Mondays one Bob Chronic,TRex,Negative
24992,Watch TargetedOnc Targeted Oncology first,Lisa Astor,Negative
24993,twelve UK Waldenstroms Lymphocyctic Leukemia CLL MF,Helen Jane Mee,Negative
24994,Alison Duffy Amy Seung Current Emerging Treatment Standards Patients CLL today,CSI Specialty Group,Negative
24995,RAC CLL BloodJournal Kipps Group Immunotherapy,Prof John,Negative
24996,Check recent Oncology ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
24997,Study Duvelisib Ofatumumab CLL Watch ChronicLymphocyticLeukemia CLL Leusm,Targeted Oncology,Negative
24998,CLL,Kathleen Hoffman,Negative
25000,PIM Kinases,Hematopoiesis News,Negative
25001,CLL CancerResearch,Targeted Oncology,Negative
25002,CLL NHS Health UK year,CLL Ireland,Postive
25003,tonight,Amy Ramos,Negative
25005,six Directions Oncology Pharmacy myeloid Learn More,PharmacyTimesCE,Negative
25007,OhioCancer CLL ChronicLymphocyticLeukemia CLL,Targeted Oncology,Negative
25008,Coffee Toxicities six hundred United States,Toby Eyre,Postive
25009,ChronicLymphocyticLeukemia Oncologist Watch CLL,Targeted Oncology,Postive
25010,ChronicLymphocyticLeukemia Read CLL,Targeted Oncology,Negative
25013,lymsm,Christopher Steer,Negative
25014,Hawkes Idelalisib GI Nice,Christopher Steer,Negative
25015,MRD CLL,Home Journal,Negative
25016,one two thousand and seventeen one one one Cancer CancerAwareness CancerTreatment CancerDiagnosis,TheDayThatChangedMyL,Negative
25017,Results PROFILES,Cancer Papers,Negative
25019,First CLL,Blood Journal,Negative
25020,Veterinarians OSUVetCollege OhioState,Rustin Moore DVM PhD,Negative
25021,CLL,Lymphoma Hub,Negative
25022,CLL Michael Keating,Patient Power,Negative
25023,Veterinarians OSUVetCollege,Reda Mohamed Guessoum DVM,Negative
25024,Veterinarians OSUVetCollege,AVMA American Veterinary Medical Association,Negative
25025,PX Leukemia PatientPower,MD Anderson Leukemia,Negative
25026,Christopher Oaks CLL,The James,Negative
25030,CLL,MDLinx,Negative
25031,two thousand and,EurekaMag,Negative
25032,John FlashbackFridays CLL,Higher Ground Lake Louise,Postive
25033,CLL,Kathleen Hoffman,Negative
25034,six month CLL,Graham Collins,Negative
25035,CLL CLLsm,Raul Cordoba MD PhD,Negative
25036,The Malignant Hematology Program Rituxan Hycela Follicular Lymphoma FL Diffuse Lymphoid CLL,Bichoy Gabra,Negative
25038,CLL,Raul Cordoba MD PhD,Negative
25039,CLL,Raul Cordoba MD PhD,Negative
25040,CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
25043,Results PROFILES,Dylan Fisher,Negative
25044,CLL SLL Learn,NIH NHLBI,Negative
25045,CLL,MDedge Hematology Oncology,Negative
25047,CLL,Molecular Cellular Proteomics,Negative
25048,one CLL,Blood Advances,Negative
25049,two year CLL,OncologyNurseAdvisor,Postive
25051,CLL FollicularLymphoma Lymphomas Lymsm,Targeted Oncology,Negative
25052,CllIreland five May Information Day Clarity Clinicaltrial CLL six month,CLL Ireland,Postive
25053,Drs Voorhees Bhutani OncLiveSOSS Carolinas,donnashort,Negative
25054,Lymphocytic Leukemia Review Treatment Options,Dr Comeau MD,Negative
25055,five Brien Dr Jacobs OncLiveSOSS Carolinas,donnashort,Postive
25057,CLL,Blood Journal,Negative
25058,two year CLL,OncologyNurseAdvisor,Negative
25061,AssistRx Amy Seung Current Emerging Treatment Standards Patients CLL AssistRx,AssistRx,Negative
25062,two year,OncologyNurseAdvisor,Negative
25063,CLL,Brian Uherek,Negative
25064,InsideEdition,CLL Ireland,Negative
25065,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
25066,rituximab first UK CLL FORUM,Dr Comeau MD,Negative
25067,CLL George Follows Leukemia NHL Hodgkin Cancer BloodCancer KnowledgeIsPower,The Patient Channel,Negative
25068,April Martin Peifer,Biotech Research Innovation Centre BRIC,Negative
25069,UK twelve WM CLL MF LymphomaAction Manchester WmukInfo PatientPower,Helen Jane Mee,Negative
25070,AML CLL Venetoclax Venclexta Leukemia Leusm,MyelomaTeacher Cindy Chmielewski,Postive
25071,Lymphoma Chronic Mark Bustoros David Zagzag Cynthia Liu Timothy Shepherd Deborah Gruber Bruce Raphael,Frontiers Neurology,Negative
25072,one CLL,Smitt Wesson,Negative
25073,Brian Parkinson,AACR Foundation,Negative
25074,Venetoclax CLL MD,The ASCO Post,Negative
25075,next month LymphomaConf inc BarbaraEAWilson Eileen Parry CLL today LymphomaMatters,LymphomaAction,Negative
25076,VIDEO Current CLL John Girbben ChronicLymphocyticLeukemia Leukemia Cancer BloodCancer Hematology,The Patient Channel,Negative
25077,CLL,AEGLE,Negative
25078,CLL CLL,Medit,Negative
25080,CLL today CLLWarwick,CLL Warwick Uni,Negative
25081,HemOncToday two year John Seymour PeterMacCC CLL NEJM,CellworksLife,Negative
25082,InterLymph Consortium Mayo Geffen Kleinstern CLL Association,Claire Vajdic,Negative
25083,CLL one MRD CLL Lamanna ColumbiaMed,Andrew Schorr,Postive
25085,CLL,CancerTherapyAdvisor,Negative
25087,ZydeligTablet Derek Clarke Chronic CLL,Derek Clarke,Negative
25090,NHL CI CI CLL,Raul Cordoba MD PhD,Negative
25091,CLL,Raul Cordoba MD PhD,Negative
25092,CLL,Raul Cordoba MD PhD,Postive
25093,CLL,Talal Hilal,Negative
25094,CLL NHL NHL JGO Cc,chadi nabhan MD MBA FACP,Postive
25095,CLL,Kathleen Hoffman,Negative
25096,CLL CLL Hematology,Targeted Oncology,Postive
25097,ICYMI NEJM John Seymour PeterMacCC CLL,HemOnc Today,Negative
25098,Venetoclax CLL Click ClinicalTrial Leusm,Targeted Oncology,Negative
25099,CLL CKJsocial,Kenar Jhaveri,Negative
25101,CLL PatientPower,CLL Ireland,Negative
25102,week Easter CLL,CLL Warwick Uni,Postive
25104,MayoClinic,CellworksLife,Negative
25105,one National Volunteer Week Leukemia Lymphoma Society Ann two thousand and eleven Click,Stayin Alive Body Mind Spirit,Postive
25106,one CLL,Blood Advances,Negative
25107,CLL,Jack Goertzen,Postive
25108,Notes Leeds CLLSA CLL,CLLSA,Postive
25109,rituximab first UK CLL FORUM,Toby Eyre,Negative
25110,Today AML World Awareness Day CLL Acute Myleoid Ireland IrishCancerSoc,CLL Ireland,Postive
25111,Notes Leeds CLLSA CLL,CLLSA,Postive
25112,four CLL,Talal Hilal,Postive
25113,Notes Leeds CLL,CLLSA,Postive
25114,Infections Cause Concern Among Patients With CLL,Cyberknife,Negative
25115,Patrizia Aureli Erica,Frontiers Oncology,Negative
25116,Niagara Falls Will FB Live Lamanna Kipps CLL,Patient Power,Negative
25117,CLL Kline today last year,chadi nabhan MD MBA FACP,Negative
25118,True Blue CFC CLL,Carefree Blues Pod,Postive
25119,AML CLL,MDedge Hematology Oncology,Postive
25122,ICYMI PFS CLL three MURANO,Home Journal,Negative
25124,CLL Nicole Lamanna ColumbiaMed Niagara Falls CLL one hundred and one,Andrew Schorr,Negative
25125,CLL,Lesoya,Negative
25126,LTHTrust Work Waldenstroms CLL Join Manchester,Helen Jane Mee,Negative
25127,first LymphomaConf LymphomaAction twelve May CLL,LymphomaAction,Postive
25128,five Leukemic,Fabrice Leclerc,Negative
25130,LymphomaAction LymphomaMatters Hodgkin CLL MZL,LiveYourLife,Postive
25132,RNAseq,Daniel Nicorici,Negative
25133,two thousand and eighteen,Financial Buzz,Negative
25135,two thousand and eighteen,The Pharmaceutical Marketing Group,Negative
25136,two thousand and eighteen,Latest News Business Wire,Negative
25138,RSSGeng Xin   five,Jun Shan Nu Zi Da Xue Tu Shu Guan ,Negative
25139,CLL,Kathleen Hoffman,Negative
25140,CLL Dragonchain eos latium,CryptoLiveLeak,Negative
25141,CLL,Raul Cordoba MD PhD,Negative
25142,CLL,Raul Cordoba MD PhD,Negative
25145,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
25147,Dominik Heim two thousand and eighteen CLL,healthbook,Postive
25148,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,tradingbrezz,Negative
25149,CLL,CancerTherapyAdvisor,Negative
25150,CLL CLL,Bon NC,Negative
25151,u month one CLL,CLL Warwick Uni,Negative
25152,CLL,Targeted Oncology,Negative
25153,Venetoclax CLL ORR BloodJournal,chadi nabhan MD MBA FACP,Negative
25154,CLL Medical Laboratory Scientist WBC,Laboratory Career,Negative
25155,Venetoclax,Philip McCarthy,Negative
25156,Venetoclax Read ClinicalTrial CLL,Targeted Oncology,Negative
25157,Daniel Landau,Dale Yuzuki,Negative
25159,one CLL,Blood Advances,Negative
25160,fifteen Rm CLL,Weill Cornell Medicine,Negative
25162,PatientPower,CLL Ireland,Negative
25164,CLL two thousand and eight,Marilyn Heine,Negative
25165,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,CLL Society Inc,Negative
25166,tomorrow,WCM Lymphoma,Negative
25167,Chronic CLL CLL,Medical Web Times,Postive
25168,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,BioNJ,Negative
25169,second Read download Living Well CLL,Leukaemia Care,Negative
25171,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,Financial Buzz,Negative
25172,CYCC Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,SNN Network,Negative
25173,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,StockGuru,Negative
25174,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,StockGuru,Negative
25175,CLL George Follows BritSocHaem cllsm hemeonc CTSM,VJHemOnc,Postive
25176,Cyclacel CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,SPI News,Negative
25177,Marc Auckland CLL LeukaemiaCareUK,CLLSA,Negative
25180,LeukaemiaCareUK CLL,CLL Ireland,Postive
25181,CLL Chris Fegan CLLSupport CllIreland CllSociety CLLAdvocates cll,Nick,Negative
25182,two today CLL SickleCell ImmunoOnc BritSocHaem oncoRN BleedingDisorders,VJHemOnc,Negative
25183,CLL CLL,Targeted Oncology,Postive
25186,Retracement Bearish today NWF TAM NTEA ITX QXT CLL,SwingTradeBot UK,Negative
25187,Scan Signal Line Cross today VENN CGH CLL,SwingTradeBot UK,Negative
25188,CLL Marc,Leukaemia Care,Postive
25189,CLL,Leukaemia Care,Postive
25190,CLL Spanish ASH two thousand and Jacqueline Barrientos ChronicLymphocyticLeukemia SpanishLanguage,The Patient Channel,Negative
25191,CLL,Kathleen Hoffman,Negative
25192,five LeukaemiaCareUK CLLSupport CLL,CLLSA,Postive
25193,four Clinical Nurse Specialist CLL,CLLSA,Negative
25194,five CLL two,CLLSA,Postive
25195,five CLL Watch Wait,CLLSA,Postive
25197,CLL,Anna Deveau,Negative
25198,CLL CLL Well Watch LeukaemiaCareUK CllIreland Cancer,Nick,Negative
25200,CLL,MoJo,Postive
25201,Listen CLL BBC CllIreland CllSociety,Nick,Negative
25202,Today WaitWaitWorry BritSocHaem today CLL MondayMotivation,CLLSA,Postive
25203,LeukaemiaCareUK WaitWaitWorry today CLL Ireland,CLL Ireland,Postive
25204,Matthew Davids MD DanaFarber two FCR CLL Watch,Targeted Oncology,Negative
25205,Con zenchi CLL Lucha Chilena,Joshua Mattassi,Negative
25206,Humalutin CLL Murine FL NANO,Lars Morland Knudsen,Negative
25208,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,The Pepex Family,Negative
25209,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,Thu Pepex,Negative
25210,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,Thu Pepex,Negative
25211,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,The Pepex Family,Negative
25212,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,The Pepex Family,Negative
25213,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,WWE Noticias FM,Negative
25214,HOY CLL ChileLuchaLibre ZenshiEnChile IWC LuchaLibreChilena,WWE Noticias FM,Negative
25215,Join Birmingham May Places CLL CLLSA Login,CLLSA,Postive
25216,CLL George Follows ChronicLymphocyticLeukemia,The Patient Channel,Negative
25217,WaitWaitWorry BritSocHaem tomorrow CLL,CLLSA,Postive
25218,ChronicLymphocyticLeukemia Click CancerResearch CLL,Targeted Oncology,Negative
25219,Birmingham May Places CLL CLLSA Login,CLLSA,Postive
25220,PeterMacCC comparing durvalumab ofatumumab CLL,Targeted Oncology,Negative
25221,new drug CLL Click,Targeted Oncology,Negative
25223,FDA,CancerWallonia,Negative
25224,Pharma CLL Yukon Pharma,Anna Deveau,Negative
25225,CLL,Anna Deveau,Negative
25226,Just three week National CLL Information Day CLLAdvocates,CLL Ireland,Postive
25227,CLL Click CLL,Targeted Oncology,Negative
25229,Leukemia CancerAwareness,Ryan HamNer,Negative
25230,Venetoclax,The ASCO Post,Negative
25231,Global Chronic Lymphocytic Latest Trend Share Analysis Growth Application two thousand,ABNewswire,Postive
25232,Triplet Combination Ibrutinib Venetoclax Obinutuzumab Effective Initial CLL Treatment CLL,Targeted Oncology,Negative
25233,Rituximab first,Avinash Dinmohamed,Negative
25234,Ibrutinib CLL,Targeted Oncology,Negative
25235,New Medivizor Pembrolizumab,Medivizor,Negative
25236,CLL,Kathleen Hoffman,Negative
25238,two CLL Tune ColumbiaMed CLL,Patient Power,Postive
25239,Smudge JIPMER,GateToMedicine PG,Negative
25240,CLL CLL AcuteLeuk theRCN LeukaemiaCareUK,CLL Advocates Network,Negative
25241,Jon CLL FridayFeeling Sheffield,CLL Warwick Uni,Postive
25242,Elias Campo Spanish TCGA CLL,AlfonsoValencia,Negative
25243,UK CLL CLLSupport CllSociety CllIreland CLLAdvocates BritSocHaem Leukaemia CLL,Nick,Negative
25244,Grade FlashbackFridays CLL,Higher Ground Lake Louise,Negative
25246,Review Targeting Adenosinergic Axis Chronic,IJMS MDPI,Negative
25247,Hematogenix Laboratory Services,RazzleTazzle,Negative
25248,ten International Meeting Hematology CLL,Chared Good Comms,Negative
25249,Rt HarmonynetEU day ten International Meeting Hematology CLL,European Hematology Association,Negative
25250,ten International Meeting Hematology CLL,HARMONY Alliance,Negative
25251,Hematogenix Laboratory Services,Sicilia Informazioni,Negative
25252,Leitlinie zur Diagnostik Therapie Leukamie CLL Kostenloser Download,Krebsgesellschaft,Negative
25254,RT Venetoclax,Robert Orlowski,Negative
25255,Venetoclax,Muzaffar Qazilbash,Negative
25256,Venetoclax,Carlos Plaza MD,Negative
25257,Venetoclax CLL,Raul Cordoba MD PhD,Negative
25259,CLL,Tom Iarocci MD,Negative
25261,year Learn NIH,Scripps Research,Negative
25262,CLL CLL Nicole Lamanna ColumbiaMed,Patient Power,Negative
25263,AKI,CKJ,Negative
25264,Session one CLL ColumbiaMed,Patient Power,Negative
25265,Kirman,VEuPathDB,Negative
25266,Degree Pathway Sheffield today tomorrow CLL,CLL Warwick Uni,Postive
25267,CLLAN CLL Lisa Minkove Lisa nine hundred CllIreland,CLL Advocates Network,Negative
25268,Gold Sponsor Possibilities Fund CLL Lymphatic Leukemia SouthCarolina,Southland,Postive
25269,Verastem FDA SLL,Plexus Ventures,Negative
25271,Duvelisib NDA,Joey Sales,Negative
25272,los resultados ma SpotLeukaemia LeukaemiaCareUK CLL AML LMC,LMC AELEMIC Espana,Postive
25273,Hematogenix Laboratory Services,Rare Diseases,Negative
25274,Clinical Kidney Journal CKJsocial,HofNorthwell Kidney,Negative
25275,Clinical Kidney Journal HofstraKidney CKJsocial,Kenar Jhaveri,Negative
25276,Leukemia,Targeted Oncology,Negative
25277,last year CLL year conf,Continuous Lifecycle London online,Negative
25279,CLL two thousand and eighteen last month Read SBCousins,CLL Warwick Uni,Postive
25280,Venetoclax,LabRoots,Negative
25281,Hematogenix Laboratory Services,Hikmat Daghestani,Negative
25282,Lisa Minokove CllIreland CLL Lisa CLL,CLL Ireland,Postive
25283,Interesting CLL,Luis Villela,Negative
25284,CR,Marta Crespo,Negative
25285,one CLL,Blood Advances,Negative
25286,Duvelisib NDA CLL SLL,MDedge Hematology Oncology,Negative
25288,Nos Instanebel CLL,Nebel,Negative
25289,Today Minimal Residual Disease CLL ERIC Method,Hematogenix,Negative
25290,today MRD European Research Initiative CLL,Kathryn Evans Nunez,Negative
25291,Hematogenix Laboratory Services,RazzleTazzle,Negative
25292,Venetoclax Plus,The ASCO Post,Negative
25294,LymphomaAssoc LymphomaConf twelve May CLL MF WmukInfo,Helen Jane Mee,Postive
25296,FDA Duvelisib PriorityReview CLL FollicularLymphoma biopharma pharma,Kara Jill Stancell,Negative
25297,Specifically Company CLL,CLL Ireland,Negative
25298,SpotLeukaemia LeukaemiaCareUK CLL AML,Zack,Postive
25299,LYLE Temadag lordag Aarhus Folg,LyLe Foreningen,Negative
25302,WONDERFUL Woken Matt Hardy Bray Wyatt Titus Worldwide al torneo de la semana RAW WWE CLL,Cultura Lucha Libre,Postive
25303,Duvelisib NDA,CLL Society Inc,Negative
25304,CLL,Michael Fraser,Negative
25305,VSTM CLL LYMSM,Anna Deveau,Negative
25306,VSTM LYMSM CLL,Anna Deveau,Negative
25307,PFS CLL,Anna Deveau,Postive
25308,FDA,HemOnc Today,Negative
25309,CLL,Kathleen Hoffman,Negative
25311,first Saturday April CLL,Higher Ground Lake Louise,Negative
25312,cll lymsm FDA,Anna Deveau,Negative
25313,CLL Irish CLL four,CLL Ireland,Postive
25315,Therapy Related Myeloid Neoplasm Patient,Hematology Thromboembolic Diseases,Negative
25316,Gracias Wrestlemania New Orleans la cosas Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25317,Brock Lesnar Universal Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25318,BOOOOOOOOOOOOOOOOO Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25319,un Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25320,STYLES HOLY SHIT HOLY SHIT Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25321,STYLES Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25322,obinutuzumab Gazyva Imbruvica Venclexta CLL two,Solomon Kamal,Negative
25323,CLL,Cultura Lucha Libre,Negative
25324,Daniel Bryan Zayn Owens CLL,Cultura Lucha Libre,Postive
25325,John Cena ten Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25326,Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25327,John Cena John Cena CLL,Cultura Lucha Libre,Negative
25328,Bludgeon Brothers Usos New Day Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25329,RondaRousey gana con armbar Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25330,NUEVO CLL,Cultura Lucha Libre,Negative
25331,Battle Royal NAOMI Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25332,Segundo CLL,Cultura Lucha Libre,Negative
25333,WOOOOW el Charlotte Flair el titulo Wrestlemania WWE NEWORLEANS CLL,Cultura Lucha Libre,Negative
25334,CLL,Silvana Novelli,Postive
25335,LeukaemiaCareUK CLL,CLLSA,Negative
25336,ICYMI CAR David Porter,HemOnc Today,Negative
25337,PatientsIncluded PatientsFirst CLL,Michele,Negative
25338,Anas Younes MD DrAnasYounes CLL,Targeted Oncology,Postive
25339,CLL six hour Rituximab seven eight minute,CLL Ireland,Negative
25340,Venetoclax rituximab CLL,Vroom Ten Wolde,Negative
25341,Obinutuzumab Venetoclax CLL,Vroom Ten Wolde,Negative
25344,CLL Venetoclax Verbluffend maar erg,Vroom Ten Wolde,Negative
25345,One month today CLL,CLL Warwick Uni,Postive
25346,one Priceline Houston BCS CLL IAH eighteen year ago NWSHouston,Ed Moran,Negative
25347,CLL NEJM,Gwen Nichols,Postive
25348,ASH,CancerWallonia,Negative
25349,This week NEJM rituximab Click,medwireNews,Negative
25350,CLL FlashbackFridays,Higher Ground Lake Louise,Postive
25351,CLL CLL,Targeted Oncology,Postive
25353,Help Tess,Sophie HelpPH,Negative
25354,CLL,Kathleen Hoffman,Negative
25356,CLL,Targeted Oncology,Postive
25357,Today one CLL Lisa Minkove Seattle Today,Andrew Schorr,Postive
25358,Medivizor,Brad,Negative
25360,CLL CLL,Alexandra MD,Negative
25361,CLL Unequivocally Venetoclax Prof Seymour,CLL Ireland,Negative
25363,Two Venetoclax Rituximab Ibrutinib CLL,CLL Ireland,Negative
25364,PeterMacCC Cancer Centre Venetoclax Beats Chemotherapy CLL Biotech Daily,David Langsam,Negative
25365,CLL two CLL Tune ColumbiaMed,Andrew Schorr,Negative
25366,one two thousand and fifteen Pittsburgh eighteen year,Dee,Negative
25371,Leukemic,Etan Marks DO,Negative
25374,Help Tess,FNest,Negative
25375,one CLL ChronicLymphocyticLeukemia,Talbot Research Library Media Services,Negative
25377,SoundCloud Aceahspadez VArsity CLL ElevatedMinds,five,Negative
25378,Combo Reduced Disease Progression three,Lymphoma News Today,Negative
25379,CLL two thousand and twentyseven fourteen million twentytwo thousand and eighteen USD three thousand two hundred and fifty,Tech News Qiosk,Negative
25380,Yine Yapti trt realmadrid Juventus,Cuneyt UNAL,Negative
25383,OncLive,CLL Ireland,Negative
25384,ChronicLymphocyticLeukemia CLL Jennifer Brown DanaFarber,Patient Power,Negative
25385,CLL CLL fifteen thirty,TradingView Aus,Negative
25387,Leukemia MURANO CLL,medwireNews,Negative
25389,El Emili la elaboracion de la nueva guia clinica el tratamiento de la leucemia linfatica cronica que publica BloodJournal CLL,Hospital CLINIC,Negative
25390,El Emili guia clinica al BloodJournal CLL,Hospital CLINIC,Negative
25391,Reviews Follicular Lymphoma Marginal Zone Lymphoma CLL,Raul Cordoba MD PhD,Negative
25392,NOS Days one hundred LBS Lifted LBS Total Lifted LBS Left Lift,rebecca gerber,Negative
25393,Medivizor,Brad,Negative
25395,CLL VitalikButerin,CryptoLiveLeak,Negative
25396,CLL CLL Listed Default Token MEW VitalikButerin,CryptoLiveLeak,Negative
25397,AMHH Madrid Association Hematology Hemotherapy Congress Check AMHH CLL,Oncocheck,Negative
25400,today CLL DanaFarber,Patient Power,Negative
25401,CLL,Kathleen Hoffman,Negative
25402,Bruton CLL,Blood Research Hematologic Diseases,Negative
25403,one CLL CLL,Targeted Oncology,Negative
25404,ICYMI CAR David Porter PennMedicine,HemOnc Today,Postive
25408,Help Tess,Billy Goco,Negative
25410,Leukemia,Medivizor,Negative
25411,Hire Meet Patrick,CryptoLiveLeak,Negative
25412,Venetoclax,two Minute,Negative
25413,Venetoclax,two Minute,Negative
25414,Venetoclax,Marc Succi MD,Negative
25415,two four FL,Home Journal,Negative
25416,two CLL ColumbiaMed CLL,Patient Power,Postive
25417,Drs Wierda Jain Davids Stay,Lisa Astor,Negative
25419,News Venetoclax rituximab chronic CLL,The Lancet Oncology,Negative
25420,CLL,Raul Cordoba MD PhD,Negative
25421,ChronicLymphocyticLeukemia CLL RichtersTransformation CLL Stephen Spurgeon OHSUKnight CLL,Patient Power,Negative
25422,July Winning Home Family Camp two CLL FlashbackFridays,Higher Ground Lake Louise,Postive
25423,xenograft,paper,Negative
25426,CLL CLLPatients,Michele,Negative
25428,Kathleen Hoffman,Paul Wright,Negative
25429,CLL,Kathleen Hoffman,Negative
25430,one Saturday CLL ColumbiaMed LLSusa,Patient Power,Negative
25432,one Roundup,Matthews Associates,Negative
25433,VIDEO Current CLL John Gribben idelalisib rituximab venetoclax bmtsm,The Patient Channel,Negative
25434,RT CLL CllIreland CllSociety SpotLeukaemia LeukaemiaCareUK,Nick,Negative
25435,monthly USD,Eliel Goco,Negative
25437,CLL Token Initial Bounty Offering BountyProgram,CryptoLiveLeak,Negative
25438,CLL NEJM,limbic,Negative
25442,SNSS CLL BTK,Anna Deveau,Negative
25443,twenty four year,Anna Deveau,Negative
25445,CLL AE,Raul Cordoba MD PhD,Negative
25446,CLL,Raul Cordoba MD PhD,Negative
25447,ECE English UK EAL CLL ECE CPD,Gill Budgell,Negative
25448,Venetoclax,The ASCO Post,Negative
25449,CLL Interesting,chadi nabhan MD MBA FACP,Negative
25450,CLL Ibrutinib,Anthony Mato,Negative
25454,Lars Bullinger ChariteBerlin seven Multiple Myeloma Acute,Chared Good Comms,Negative
25455,Lars Bullinger ChariteBerlin seven Multiple Myeloma Acute,European Hematology Association,Negative
25456,Lars Bullinger ChariteBerlin seven Multiple Myeloma Acute,HARMONY Alliance,Negative
25458,Acute Lymphocytic Leukemia ALL,ALL UNIVERSITY NEWS,Negative
25459,New Post Combo Reduced Disease Progression three,Lymphoma News Today,Negative
25460,Scan Stochastic Buy Signal CLL,SwingTradeBot UK,Postive
25461,CLL,WCMNYPJCTO,Negative
25462,ASH EBMT CLL,VJHemOnc,Postive
25463,Voxtalisib CLL,CancerTherapyAdvisor,Negative
25464,three CLL,healthbook,Negative
25466,ClaremontMinorsPirates,Amy Ramos,Postive
25467,Combo Delays Disease Progression Lymphocytic,CLL Society Inc,Negative
25468,CLL rituximab FCR DanaFarber LeukemiaMDA FCR,Andrew Schorr,Postive
25469,StateofScience MultipleMyeloma CLL AML OncLive,Andre Goy,Postive
25470,Neon Therapeutics CLL,Anna Deveau,Negative
25471,International CLL Group,Home Journal,Negative
25472,CLL,Kathleen Hoffman,Negative
25473,Gilead one three Zydelig GILD,FierceBiotech,Negative
25475,New Post Combo Delays Disease Progression Lymphocytic,News,Negative
25476,CLL,Education,Postive
25477,New post Drug Combination Improves Outlook Colorectal Cancer Charity,Colorectal Cancer Charity,Negative
25478,China two thousand and eighteen,Reports,Negative
25481,CLL one thousand,My name David,Negative
25482,three two thousand and eighteen fourteen million twentytwo thousand and eighteen USD,Tech News Qiosk,Negative
25484,CLL,Leukaemia Care,Negative
25486,Fellows Program Dr Wierda EBM CLL,Fumiko Ladd Chino MD,Negative
25488,rituximab chronic,Izaskun Zeberio,Negative
25489,The New England Journal Medicine Search Results,AGD Biomedicals,Negative
25490,Acute Lymphocytic Leukemia ALL,ALL UNIVERSITY NEWS,Negative
25492,CLL,Patient Power,Negative
25493,CLL,Patient Power,Negative
25494,Houston CLL PowerfulPatients Tune,Patient Power,Postive
25495,CLL Tune CanCare,Patient Power,Negative
25496,CLL ColumbiaMed,Patient Power,Negative
25497,two thousand and eighteen Engl Med two thousand and eighteen,RAUL FERRANDO,Negative
25498,Keating CLL,Patient Power,Negative
25499,CLL,Patient Power,Negative
25500,two OncLiveSOSS Skarbnik NYC,donnashort,Postive
25502,CLL CLL,CryptoLiveLeak,Postive
25503,three CLL New England Journal Medicine PharmaTimes,CLL Ireland,Negative
25505,CR fourteen,Anna Deveau,Negative
25506,Updates,Basel Haffar,Postive
25508,CLL,Targeted Oncology,Negative
25509,encuentras viejos video de tus Psychotaku CLL cllReborn,Monte,Negative
25510,two,Covington Beasley,Negative
25511,month Factors CLL,Raul Cordoba MD PhD,Negative
25513,CLL,Health,Postive
